UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
For the Fiscal Year Ended December 31, 2011 December 31, 2011
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 1-14106
DAVITA INC.
1551Wewatta Street
Denver, Colorado 80202
Telephone number (303) 405-2100
Delaware | 51-0354549 | |
(State of incorporation) | (I.R.S. Employer Identification No.) |
Securities registered pursuant to Section 12(b) of the Act:
Class of Security: |
Registered on: | |
Common Stock, $0.001 par value | New York Stock Exchange |
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
As of June 30, 2011, the number of shares of the Registrants common stock outstanding was approximately 93.5 million shares and the aggregate market value of the common stock outstanding held by non-affiliates based upon the closing price of these shares on the New York Stock Exchange was approximately $8.1 billion.
As of January 31, 2012, the number of shares of the Registrants common stock outstanding was approximately 93.7 million shares and the aggregate market value of the common stock outstanding held by non-affiliates based upon the closing price of these shares on the New York Stock Exchange was approximately $7.7 billion.
Documents incorporated by reference
Portions of the Registrants proxy statement for its 2012 annual meeting of stockholders are incorporated by reference in Part III of this Form 10-K.
PART I
Item 1. | Business |
We were incorporated as a Delaware corporation in 1994. Our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to section 13(a) or 15(d) of the Exchange Act are made available free of charge through our website, located at http://www.davita.com, as soon as reasonably practicable after the reports are filed with or furnished to the Securities and Exchange Commission, or SEC. The SEC also maintains a website at http://www.sec.gov where these reports and other information about us can be obtained. The contents of our website are not incorporated by reference into this report.
Overview
DaVita is a leading provider of kidney dialysis services primarily in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease, or ESRD. As of December 31, 2011, we provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. We also provide acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. Our U.S. dialysis and related lab services business accounts for approximately 93% of our consolidated net operating revenues. Our other ancillary services and strategic initiatives accounted for approximately 7% of our consolidated net operating revenues for the year ended December 31, 2011, and relate primarily to our core business of providing kidney dialysis services.
In addition, as of December 31, 2011, we provided dialysis and administrative services to a total of 11 outpatient dialysis centers located in three countries outside of the United States. Our international dialysis operations are currently in a start-up phase in which we primarily commenced operations during the fourth quarter of 2011. The total net operating revenues generated from our international operations were not material during 2011 and are included as a component of our ancillary services and strategic initiatives. Therefore, all references in this document to dialysis and related lab services continue to refer only to our U.S. dialysis and related lab services business for the year ended December 31, 2011.
The dialysis industry
The loss of kidney function is normally irreversible. Kidney failure is typically caused by Type I and Type II diabetes, high blood pressure, polycystic kidney disease, long-term autoimmune attack on the kidney and prolonged urinary tract obstruction. ESRD is the stage of advanced kidney impairment that requires continued dialysis treatments or a kidney transplant to sustain life. Dialysis is the removal of toxins, fluids and salt from the blood of ESRD patients by artificial means. Patients suffering from ESRD generally require dialysis at least three times a week for the rest of their lives.
According to United States Renal Data System, there were approximately 399,000 ESRD dialysis patients in the United States in 2009 and the underlying ESRD dialysis patient population has grown at an approximate compound rate of 4.0% from 2000 to 2009, the latest period for which such data is available. The growth rate is attributable to the aging of the population, increased incidence rates for diseases that cause kidney failure such as diabetes and hypertension, lower mortality rates for dialysis patients and growth rates of minority populations with higher than average incidence rates of ESRD.
Since 1972, the federal government has provided health care coverage for ESRD patients under the Medicare ESRD program regardless of age or financial circumstances. ESRD is the first and only disease state eligible for Medicare coverage both for dialysis and dialysis-related services and for all benefits available under the Medicare program. Beginning in January 2011, Congress established a new single bundled Medicare
2
payment rate system in which all ESRD payments are now made under a single bundled payment rate that provides for an annual inflation adjustment beginning in 2012, based upon a market basket index, less a productivity improvement factor. The bundled payment rate provides a fixed payment rate to encompass all goods and services provided during the dialysis treatment, including pharmaceuticals that were historically separately reimbursed to the dialysis providers, such as Epogen®, or EPO, vitamin D analogs and iron supplements, irrespective of the level of pharmaceuticals administered or additional services performed. Most lab services that used to be paid directly to laboratories are also included in the new bundled payment. The new bundled payment rate is also adjusted for certain patient characteristics, a geographic usage index and certain other factors.
Also, beginning January 1, 2014, certain oral-only ESRD drugs (currently paid separately to pharmacies under Medicare Part D) will be included in the ESRD bundled payment to dialysis facilities. It is currently unclear how CMS will price the oral-only drugs for inclusion in the ESRD bundle in 2014.
Although Medicare reimbursement limits the allowable charge per treatment, it provides industry participants with a relatively predictable and recurring revenue stream for dialysis services provided to patients without commercial insurance. For the year ended December 31, 2011, approximately 89% of our total patients were under government-based programs, with approximately 80% of our patients under Medicare and Medicare-assigned plans.
Treatment options for ESRD
Treatment options for ESRD are dialysis and kidney transplantation.
Dialysis Options
| Hemodialysis |
Hemodialysis, the most common form of ESRD treatment, is usually performed at a freestanding outpatient dialysis center, at a hospital-based outpatient center, or at the patients home. The hemodialysis machine uses an artificial kidney, called a dialyzer, to remove toxins, fluids and salt from the patients blood. The dialysis process occurs across a semi-permeable membrane that divides the dialyzer into two distinct chambers. While blood is circulated through one chamber, a pre-mixed fluid is circulated through the other chamber. The toxins, salt and excess fluids from the blood cross the membrane into the fluid, allowing cleansed blood to return into the patients body. Each hemodialysis treatment that occurs in the outpatient dialysis centers typically lasts approximately three and one-half hours and is usually performed three times per week.
Hospital inpatient hemodialysis services are required for patients with acute kidney failure resulting from trauma, patients in early stages of ESRD, and ESRD patients who require hospitalization for other reasons. Hospital inpatient hemodialysis is generally performed at the patients bedside or in a dedicated treatment room in the hospital, as needed.
Some ESRD patients who are healthier and more independent may perform home-based hemodialysis in their home or residence through the use of a hemodialysis machine designed specifically for home therapy that is portable, smaller and easier to use. Patients receive training, support and monitoring from registered nurses, usually in our outpatient dialysis centers, in connection with their dialysis treatment. Home-based hemodialysis is typically performed with greater frequency than dialysis treatments performed in outpatient dialysis centers and on varying schedules.
| Peritoneal dialysis |
Peritoneal dialysis uses the patients peritoneal or abdominal cavity to eliminate fluid and toxins and is typically performed at home. The most common methods of peritoneal dialysis are continuous ambulatory peritoneal dialysis, or CAPD, and continuous cycling peritoneal dialysis, or CCPD. Because it does not involve
3
going to an outpatient dialysis center three times a week for treatment, peritoneal dialysis is an alternative to hemodialysis for patients who are healthier, more independent and desire more flexibility in their lifestyle. However, peritoneal dialysis is not a suitable method of treatment for many patients, including patients who are unable to perform the necessary procedures and those at greater risk of peritoneal infection.
CAPD introduces dialysis solution into the patients peritoneal cavity through a surgically placed catheter. Toxins in the blood continuously cross the peritoneal membrane into the dialysis solution. After several hours, the patient drains the used dialysis solution and replaces it with fresh solution. This procedure is usually repeated four times per day.
CCPD is performed in a manner similar to CAPD, but uses a mechanical device to cycle dialysis solution through the patients peritoneal cavity while the patient is sleeping or at rest.
Kidney transplantation
Although kidney transplantation, when successful, is generally the most desirable form of therapeutic intervention, the shortage of suitable donors, side effects of immunosuppressive pharmaceuticals given to transplant recipients and dangers associated with transplant surgery for some patient populations limit the use of this treatment option.
Services we provide
Dialysis and Related Lab Services
Outpatient dialysis services
As of December 31, 2011, we operated or provided administrative services through a network of 1,809 outpatient dialysis centers located in the United States and 11 outpatient dialysis centers located outside the United States that are designed specifically for outpatient hemodialysis. In 2011, our overall network of outpatient dialysis centers increased by 208 primarily as a result of acquisitions and the opening of new centers, net of center closures and divestitures, representing a total increase of approximately 13%. A large portion of this increase was driven from the acquisition of DSI, a medium sized dialysis provider that we acquired in September 2011, that contributed a net 83 outpatient dialysis centers.
As a condition of our enrollment in Medicare, we contract with a nephrologist or a group of affiliated nephrologists to provide medical director services at each of our centers. In addition, other nephrologists may apply for practice privileges to treat their patients at our centers. Each center has an administrator, typically a registered nurse, who supervises the day-to-day operations of the center and its staff. The staff of each center typically consists of registered nurses, licensed practical or vocational nurses, patient care technicians, a social worker, a registered dietician, biomedical technician support and other administrative and support personnel.
Many of our outpatient dialysis centers offer certain support services for dialysis patients who prefer and are able to perform either home-based hemodialysis or peritoneal dialysis in their homes. Home-based hemodialysis support services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either home-based hemodialysis or peritoneal dialysis.
Under Medicare regulations, we cannot promote, develop or maintain any kind of contractual relationship with our patients which would directly or indirectly obligate a patient to use or continue to use our dialysis services, or which would give us any preferential rights other than those related to collecting payments for our services. Our total patient turnover which is based upon all causes averaged approximately 30% per year for the last two years. However, in 2011 the overall number of patients to whom we furnished services in the U.S. increased by approximately 13%, primarily from new centers and acquisitions, as well as continued growth within the industry and lower mortality rates.
4
Hospital inpatient hemodialysis services
As of December 31, 2011, we provided hospital inpatient hemodialysis services, excluding physician services, to patients in approximately 900 hospitals throughout the United States. We render these services for a contracted per-treatment fee that is individually negotiated with each hospital. When a hospital requests our services, we typically administer the dialysis treatment at the patients bedside or in a dedicated treatment room in the hospital, as needed. Hospital inpatient hemodialysis services are required for patients as discussed above. In 2011, hospital inpatient hemodialysis services accounted for approximately 4.5% of our total U.S. dialysis treatments.
ESRD laboratory services
We own two separately incorporated, licensed, clinical laboratories which specialize in ESRD patient testing. These specialized laboratories provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients. Our laboratories provide these tests predominantly for our network of ESRD patients throughout the United States. These tests are performed to monitor a patients ESRD condition, including the adequacy of dialysis, as well as other medical conditions. Our laboratories utilize information systems which provide information to certain members of the dialysis centers staff and medical directors regarding critical outcome indicators.
Management services
We currently operate or provide management and administrative services to 33 outpatient dialysis centers located in the United States and 3 outpatient dialysis centers located outside of the United States in which we either own a minority equity investment or are wholly-owned by third parties. These services are provided pursuant to management and administrative services agreements. Management fees are established by contract and are recognized as earned typically based on a percentage of revenues or cash collections generated by the centers.
Ancillary services and strategic initiatives
Ancillary services and strategic initiatives, which include our international dialysis operations, as described above, accounted for approximately 7% of our total consolidated net operating revenues for the year ended December 31, 2011, consist primarily of the following:
| Pharmacy services. DaVita Rx is a pharmacy that provides oral medications to DaVitas patients with ESRD. The main objectives of the pharmacy are to improve clinical outcomes by facilitating increased patient compliance and to provide our patients a convenient way to fill their prescription needs by delivering the prescriptions to the center where they are treated. Revenues are recognized as prescriptions are filled and shipped to patients. |
| Infusion therapy services. HomeChoice Partners provides comprehensive personalized infusion therapy services to patients typically in their own homes as a cost-effective alternative to inpatient hospitalization. Intravenous and nutritional support therapies are typically managed by registered and/or board-certified professionals including pharmacists, nurses and dieticians in collaboration with the patients physician in support of the patients ongoing health care needs. Revenues are recognized in the period when infusion therapy services are provided. |
| Disease management services. VillageHealth provides advanced care management services to health plans and government agencies for employees/members diagnosed with Chronic Kidney Disease (CKD) or ESRD. Through a combination of clinical coordination, medical claims analysis and information technology, we endeavor to assist our customers and patients in obtaining superior renal health care and improved clinical outcomes, as well as helping to reduce overall medical costs. Revenues are typically based upon an established contract fee and are recognized as earned over the contract period and can include additional fees for cost savings recognized by certain customers. |
5
| Vascular access services. Lifeline provides management and administrative services to physician-owned vascular access clinics that provide surgical and interventional radiology services for dialysis patients. Lifeline also is the majority-owner of one vascular access clinic. Management fees generated from providing management and administrative services are recognized as earned typically based on a percentage of revenues or cash collections generated by the clinics. Revenues associated with the vascular access clinic that is majority-owned are recognized in the period when physician services are provided. |
| ESRD clinical research programs. DaVita Clinical Research conducts research trials principally with dialysis patients and provides administrative support for research conducted by DaVita-affiliated nephrology practices. Revenues are based upon an established fee per study, as determined by contract with drug companies and other sponsors and are recognized as earned according to the contract terms. |
| Physician services. DaVita Nephrology Partners offers practice management and administrative services to physicians who specialize in nephrology under management and administrative services agreements. Practice management and administrative services typically include operations management, IT support, billing and collections, credentialing and coding, and other support functions. Management fees generated from providing practice management and administrative services to physician practices are recognized as earned typically based upon cash collections generated by the practices. |
Quality care
We employ 200 clinical service teammates. The primary focus of this group is assuring and facilitating processes that aim to achieve superior clinical outcomes at our centers.
Our physician leadership in the Office of the Chief Medical Officer (OCMO) includes nine senior nephrologists, led by our Chief Medical Officer, with a variety of academic, clinical practice, and clinical research backgrounds. Our Physician Council is an advisory body to senior management, currently composed of ten physicians with extensive experience in clinical practice in addition to the members of OCMO and currently six Group Medical Directors.
Sources of revenueconcentrations and risks
Our dialysis and related lab services business net operating revenues represent approximately 93% of our consolidated net operating revenues for the year ended December 31, 2011, with the balance of our revenues from ancillary services and strategic initiatives which also includes our international dialysis operations. Our dialysis and related lab services revenues are derived primarily from our core business of providing kidney dialysis services, the administration of pharmaceuticals, related laboratory services and to a lesser extent management fees generated from providing management and administrative services to certain outpatient dialysis centers.
The sources of our dialysis and related lab services revenues are principally from government-based programs, including Medicare and Medicare-assigned plans, Medicaid and Medicaid-assigned plans and commercial insurance plans.
6
The following table summarizes our dialysis and related lab services revenues by source for the year ended December 31, 2011:
Revenue percentages |
||||
Medicare and Medicare-assigned plans |
58 | % | ||
Medicaid and Medicaid-assigned plans |
5 | % | ||
Other government-based programs |
3 | % | ||
|
|
|||
Total government-based programs |
66 | % | ||
Commercial (including hospital inpatient dialysis services) |
34 | % | ||
|
|
|||
Total dialysis and related lab services revenues |
100 | % | ||
|
|
The following table summarizes our dialysis and related lab services revenues by modality for the year ended December 31, 2011:
Revenue percentages |
||||
Outpatient hemodialysis centers |
81 | % | ||
Peritoneal dialysis and home-based hemodialysis |
14 | % | ||
Hospital inpatient hemodialysis |
5 | % | ||
|
|
|||
Total dialysis and related lab services revenues |
100 | % | ||
|
|
Medicare revenue
Under the Medicare ESRD program, payment rates for dialysis are established by the U.S. Congress. On January 1, 2011 we implemented Medicares new payment system in which all ESRD payments are made under a single bundled payment rate that, beginning in 2012, will provide for an annual inflation adjustment based upon a market basket index, less a productivity adjustment that was determined to be 2.1% by the Centers for Medicare and Medicaid Services, or CMS, for 2012. Also beginning in 2012, the rule provides for up to a 2% annual payment withhold that can be earned back by the facilities that meet certain defined clinical performance standards. The new payment system reimburses providers based upon a single bundled or average payment for each Medicare treatment provided. This new bundled payment amount is designed to cover all dialysis services which were historically included in the composite rate and all separately billable ESRD services such as pharmaceuticals and laboratory costs. In the past the amount of services that were separately billable accounted for approximately 30% of our total dialysis and related lab services revenues. The new bundled payment rate is adjusted for certain patient characteristics, a geographic wage index and certain other factors. The initial 2011 bundled payment rate included reductions of 2.0% from the prior reimbursement and further reduced overall rates by 5.94% tied to an expanded list of case mix adjustors which can be earned back based upon the presence of certain patient characteristics and co-modalities at the time of treatment. There are also other provisions which may impact payment including an outlier pool and a low volume facility adjustment. With regard to the expanded list of case-mix adjusters, these are difficult and in some cases, have not been possible for our dialysis centers to document and track, which has resulted in lower reimbursement amounts than we would otherwise have received.
ESRD patients receiving dialysis services become eligible for primary Medicare coverage at various times, depending on their age or disability status, as well as whether they are covered by an employer group health plan. Generally, for a patient not covered by an employer group health plan, Medicare becomes the primary payor either immediately or after a three-month waiting period. For a patient covered by an employer group health plan, Medicare generally becomes the primary payor after 33 months, which includes a three month waiting period, or earlier if the patients employer group health plan coverage terminates. When Medicare becomes the primary payor, the payment rate we receive for that patient shifts from the commercial insurance plan rate to the Medicare payment rate.
7
Medicare pays 80% of the amount set by the Medicare system for each covered treatment. The patient is responsible for the remaining 20%. In most cases, a secondary payor, such as Medicare supplemental insurance, a state Medicaid program or a commercial health plan, covers all or part of these balances. Some patients, who do not qualify for Medicaid but otherwise cannot afford secondary insurance, can apply for premium payment assistance from charitable organizations through a program offered by the American Kidney Fund. We and other dialysis providers support the American Kidney Fund and similar programs through voluntary contributions. If a patient does not have secondary insurance coverage, we are generally unsuccessful in our efforts to collect from the patient the 20% portion of the ESRD composite rate that Medicare does not pay. However, we are able to recover some portion of this unpaid patient balance from Medicare through an established cost reporting process by identifying these Medicare bad debts on each centers Medicare cost report.
In 2011 we experienced a decrease in our operating costs primarily from a decline in the utilization of physician-prescribed pharmaceuticals due to continued evolution of clinical practices which helped minimize the overall negative financial impact that we incurred from reductions in our reimbursement amounts for services we provide to Medicare patients. However, certain operating expenditures, such as labor and supply costs, are subject to inflation, and without a compensating inflation-based increase in the new bundled payment rate system, could significantly impact our operating results. Our operating results can also be impacted by the cost of physician-prescribed pharmaceuticals.
In 2011, we operated a Medicare Advantage ESRD Special Needs Plan in partnership with a payor that works with CMS to provide ESRD patients full service health care. We are at risk for all medical costs of the program in excess of the capitation payments. We also participated in a CKD/ESRD demonstration program until April 2011, when we terminated the program. We were paid a management fee for program enrollees relating to CKD and ESRD disease states, which are subject to retraction if certain medical cost savings targets were not met. The demonstration program is still in the process of evaluating costs to determine whether these targets were actually met.
Medicaid revenue
Medicaid programs are state-administered programs partially funded by the federal government. These programs are intended to provide health coverage for patients whose income and assets fall below state-defined levels and who are otherwise uninsured. These programs also serve as supplemental insurance programs for co-insurance payments due from Medicaid-eligible patients with primary coverage under Medicare. Some Medicaid programs also pay for additional services, including some oral medications that are not covered by Medicare. We are enrolled in the Medicaid programs in the states in which we conduct our business.
Commercial revenues
Before a patient becomes eligible to have Medicare as their primary payor for dialysis services, a patients commercial insurance plan, if any, is responsible for payment of such dialysis services. Although commercial payment rates vary, average commercial payment rates are generally significantly higher than Medicare rates. The payments we receive from commercial payors generate nearly all of our profits. Payment methods from commercial payors include a single lump-sum per treatment, referred to as bundled rates, and in some cases separate payments for treatments and pharmaceuticals, if used as part of the treatment, referred to as fee for service rates. Commercial payment rates are the result of negotiations between us and insurers or third-party administrators. Our out-of-network payment rates are on average higher than in-network payment rates. In 2011, we continued to enter into some commercial contracts, covering certain patients that will primarily pay us a single bundled payment rate for all dialysis services provided to these patients. However, some of the contracts will pay us for certain other services and pharmaceuticals in addition to the bundled payment. These contracts typically contain annual price escalator provisions. We are continuously in the process of negotiating agreements with our commercial payors and if our negotiations result in overall commercial rate reductions in excess of our commercial rate increases, our revenues and operating results could be negatively impacted. In addition, if there
8
are sustained or increased job losses in the United States as a result of current economic conditions, or depending upon changes to the healthcare regulatory system, we could experience a decrease in the number of patients covered under commercial plans.
Approximately 34% of our dialysis and related lab services revenues and approximately 11% of our patients were associated with commercial payors for the years ended December 31, 2011. Our commercial patients as a percentage of our total patients declined in 2011 and 2010, but the actual number of commercial patients has increased during these same periods. In the fourth quarter of 2011, our actual percentage of commercial patients was approximately 10%. Less than 1% of our dialysis and related lab services revenues are due directly from patients. No single commercial payor accounted for more than 6% of total dialysis and related lab services revenues for the year ended December 31, 2011.
Revenue from EPO and other pharmaceuticals
Approximately 4% of our total dialysis and related lab services revenues for the year ended December 31, 2011 are associated with the administration of physician-prescribed pharmaceuticals that are separately billable, which help improve clinical outcomes when included with the dialysis treatment. These pharmaceuticals include EPO, vitamin D analogs and iron supplements.
EPO is an erythropoiesis stimulating agent, or ESA, genetically-engineered form of a naturally occurring protein that stimulates the production of red blood cells. EPO is used in connection with all forms of dialysis to treat anemia, a medical complication most ESRD patients experience. The administration of EPO, when separately billable, accounted for approximately 3% of our dialysis and related lab services revenues for the year ended December 31, 2011.
These percentages represent a significant decrease from prior years in the amount of revenue that we generated from separately billable pharmaceuticals as a result of implementing Medicares new single bundled payment rate system, whereby pharmaceuticals, including EPO, are now included in a single bundled payment. In addition, we also entered into some commercial contracts covering certain patients that also pay us under a single bundled rate for all dialysis services provided to these patients.
EPO is produced by a single manufacturer, Amgen. Any interruption of supply or product cost increases could adversely affect our operations. As an example, in 2011 we experienced an increase in the cost of EPO of approximately 5%. In November 2011, we entered into a seven year Sourcing and Supply Agreement with Amgen USA Inc. that expires on December 31, 2018. Under the terms of the agreement we will purchase EPO in amounts necessary to meet no less than 90% of our requirements for erythropoiesis stimulations agents. The agreement replaces in its entirety the prior one-year supply agreement between us and Amgen that expired on December 31, 2011. As long as certain conditions are met by us, the agreement limits Amgens ability to unilaterally decide to increase the price it charges us for EPO. The agreement, among other things, provides for discounted pricing and rebates for EPO. Some of the rebates are subject to various conditions including future pricing levels of EPO by Amgen and data submission by us. In the initial years of the agreement the total rebate opportunity is less than what was provided for in the agreement that expired as the end of 2011, however, the opportunity for us to earn discounts and rebates increases over the term of the agreement.
Since late 2006, there has been significant media discussion and government scrutiny regarding anemia management practices in the United States, which has created confusion and concern in the nephrology community. In late 2006, the U.S. House of Representatives Ways and Means Committee held a hearing on the issue of the utilization of ESAs, which include EPO, and in 2007, the FDA required changes to the labeling of EPO and Aranesp® to include a black box warning, the FDAs strongest form of warning label. An FDA advisory panel on ESA use met in October 2010, which meeting was similar to the prior meeting held in 2007 in that there was significant discussion and concern about the safety of ESAs. The panel concluded it would not recommend a change in ESA labeling. However, the FDA is not bound by the panels recommendation. In June
9
2011, the FDA required that the black box warning be slightly revised and also include more conservative dosing recommendations for patients with chronic kidney disease. In addition, in June 2011, CMS opened a National Coverage Analysis, or NCA, for ESAs. Further, in January 2011, CMS convened a meeting of the Medicare Evidence Development and Coverage Advisory Committee, or MEDCAC, to evaluate evidence for the pending NCA. In June 2011, CMS determined not to issue a national coverage determination for ESAs due to a lack of available evidence to establish coverage criteria or limitations.
The forgoing congressional and agency activities and related actions could result in further restrictions on the utilization and reimbursement for ESAs. Commercial payors have also increasingly examined their administration policies for EPO and, in some cases, have modified those policies. Further changes in labeling of EPO and other pharmaceuticals in a manner that alters physician practice patterns or accepted clinical practices, changes in private and governmental payment criteria, including the introduction of EPO administration policies or the conversion to alternate types of administration of EPO or other pharmaceuticals that result in further decreases in utilization or reimbursement for EPO and other pharmaceuticals, could have a material adverse effect on our revenues, earnings and cash flows.
Physician relationships
An ESRD patient generally seeks treatment at an outpatient dialysis center near his or her home where his or her treating nephrologist has practice privileges. Our relationships with local nephrologists and our ability to meet their needs and the needs of their patients are key factors in the success of our dialysis operations. Approximately 4,300 nephrologists currently refer patients to our outpatient dialysis centers. As is typical in the dialysis industry, one or a few physicians, including the outpatient dialysis centers medical director, usually account for all or a significant portion of an outpatient dialysis centers patient base. If a significant number of physicians, including an outpatient dialysis centers medical directors, were to cease referring patients to our outpatient dialysis centers, our business could be adversely affected.
Participation in the Medicare ESRD program requires that dialysis services at an outpatient dialysis center be under the general supervision of a medical director who is a licensed physician. We have engaged physicians or groups of physicians to serve as medical directors for each of our outpatient dialysis centers. At some outpatient dialysis centers, we also separately contract with one or more other physicians to serve as assistant or associate medical directors or to direct specific programs, such as home dialysis training programs. We have contracts with approximately 1,700 individual physicians and physician groups to provide medical director services.
Medical directors enter into written contracts with us that specify their duties and fix their compensation generally for periods of ten years. The compensation of our medical directors is the result of arms length negotiations and generally depends upon an analysis of various factors such as the physicians duties, responsibilities, professional qualifications and experience, among others.
Our medical director contracts generally include covenants not to compete. Also, when we acquire an outpatient dialysis center from one or more physicians or where one or more physicians own minority interests in our outpatient dialysis centers, these physicians have agreed to refrain from owning interests in other competing outpatient dialysis centers within a defined geographic area for various time periods. These non-compete agreements restrict the physicians from owning or providing medical director services to other outpatient dialysis centers, but do not prohibit the physicians from referring patients to any outpatient dialysis center, including competing centers. Many of these non-compete agreements continue for a period of time beyond expiration of the corresponding medical director agreements, although some expire at the same time as the medical director agreement. Occasionally, we experience competition from a new outpatient dialysis center established by a former medical director following the termination of his or her relationship with us.
10
Government regulation
Our dialysis operations are subject to extensive federal, state and local governmental regulations. These regulations require us to meet various standards relating to, among other things, government payment programs, dialysis facilities and equipment, management of centers, personnel qualifications, maintenance of proper records and quality assurance programs and patient care.
Because we are subject to a number of governmental regulations, our business could be adversely impacted by:
| Loss or suspension of federal certifications; |
| Loss or suspension of licenses under the laws of any state or governmental authority from which we generate substantial revenues; |
| Exclusion from government healthcare programs including Medicare and Medicaid; |
| Significant reductions or lack of inflation-adjusted increases in payment rates or reduction of coverage for dialysis and ancillary services and related pharmaceuticals; |
| Fines, damages and monetary penalties for anti-kickback law violations, Stark Law violations, submission of false claims, civil or criminal liability based on violations of law or other failures to meet regulatory requirements; |
| Claims for monetary damages from patients who believe their protected health information has been used or disclosed in violation of federal and state patient privacy laws; |
| Mandated changes to our practices or procedures that significantly increase operating expenses; or |
| Refunds of payments received from government payors and government health care program beneficiaries because of any failures to meet applicable requirements. |
We expect that our industry will continue to be subject to substantial regulation, the scope and effect of which are difficult to predict. Our activities could be reviewed or challenged by regulatory authorities at any time in the future. This regulation and scrutiny could have a material adverse impact on us.
Licensure and Certification
Our dialysis centers are certified by CMS, as is required for the receipt of Medicare payments. In some states, our dialysis centers also are required to secure additional state licenses and permits. Governmental authorities, primarily state departments of health, periodically inspect our centers to determine if we satisfy applicable federal and state standards and requirements, including the conditions of participation in the Medicare ESRD program.
To date, we have not experienced significant difficulty in maintaining our licenses or our Medicare and Medicaid authorizations. However, we have experienced delays in obtaining certifications from CMS.
CMS continues to study the regulations applicable to Medicare certification to provide dialysis services. On April 15, 2008, CMS issued new regulations for Medicare-certified ESRD facilities to provide dialysis services, referred to as Conditions for Coverage. The Conditions for Coverage were effective October 14, 2008, with some provisions having a phased in implementation date of February 1, 2009. The regulations are patient, quality and outcome focused. Among other things, they establish performance expectations for facilities and staff, eliminate certain procedural requirements, and promote continuous quality improvement and patient safety measures. We have established an interdisciplinary work group that includes a comprehensive auditing process to monitor our continued compliance with the Conditions of Coverage.
11
Federal anti-kickback statute
The anti-kickback statute contained in the Social Security Act imposes criminal and civil sanctions on persons who receive, make, offer or solicit payments in return for:
| The referral of a Medicare or Medicaid patient for treatment; |
| The ordering or purchasing of items or services that are paid for in whole or in part by Medicare, Medicaid or similar federal and state programs; or |
| Arranging for or recommending the ordering or purchasing of such items. |
Federal criminal penalties for the violation of the anti-kickback statute include imprisonment, fines and exclusion of the provider from future participation in the Medicare and Medicaid programs. Violations of the anti-kickback statute are punishable by imprisonment for up to five years and fines of up to $250,000 or both. Larger fines can be imposed upon corporations under the provisions of the U.S. Sentencing Guidelines and the Alternate Fines Statute. Individuals and entities convicted of violating the anti-kickback statute are subject to mandatory exclusion from participation in Medicare, Medicaid and other federal healthcare programs for a minimum of five years. Civil penalties for violation of this law include up to $50,000 in monetary penalties per violation, repayments of up to three times the total payments between the parties and suspension from future participation in Medicare and Medicaid. Court decisions have also held that the statute is violated whenever one of the purposes of remuneration is to induce referrals.
The Department of Health and Human Services regulations create exceptions or safe harbors for some business transactions and arrangements. Transactions and arrangements structured within these safe harbors are deemed to not violate the anti-kickback statute. A business transaction or arrangement must satisfy every element of a safe harbor to be protected by that safe harbor. Transactions and arrangements that do not satisfy all elements of a relevant safe harbor do not necessarily violate the statute, but can be subject to greater scrutiny by enforcement agencies.
Our medical directors refer patients to our centers, and these arrangements, by which we pay them for their medical director services, must be in compliance with the federal anti-kickback statute. Among the available safe harbors is one for personal services furnished for fair market value. However, most of our agreements with our medical directors do not satisfy all seven of the requirements of the personal services safe harbor. We believe that because of the nature of our medical directors duties, it is impossible to satisfy the anti-kickback safe-harbor requirement that services provided under an agreement on a part-time basis must specify the schedule of intervals of service, and their precise length and the exact charge for such intervals. Accordingly, while we believe that our agreements with our medical directors satisfy as many of the elements of this safe harbor as we believe is reasonably possible, our arrangements do not qualify for safe harbor protection, as precise scheduling is not possible. We also note that there is little guidance available as to what constitutes fair market value for medical director services. We believe that our agreements do not violate the federal anti-kickback statute; however, since the arrangements do not satisfy all of the requirements for safe harbor protection, these arrangements could be challenged.
We own a controlling interest in numerous dialysis related joint ventures. These joint ventures represented approximately 18% of our dialysis and related lab services revenues. In addition, we also own minority equity investments in several other dialysis related joint ventures. Our relationships with physicians and other referral sources relating to these joint ventures are required to comply with the anti-kickback statute. Although there is a safe harbor for certain investment interests in small entities, it is not clear if any of our joint ventures satisfies all of the requirements for protection by this safe harbor. Under current law, physician joint ventures are not prohibited but instead require a case-by-case evaluation under the anti-kickback statute. We have structured our joint ventures to satisfy as many safe harbor requirements as we believe are reasonably possible. We believe that these investments are offered on a fair market value basis and provide returns to the physician investors only in proportion to their actual investment in the venture. We believe that our agreements do not violate the federal anti-kickback statute; however, since the arrangements do not satisfy all of the requirements for safe harbor protection, these arrangements could be challenged.
12
We lease space for approximately 560 of our centers from entities in which physicians hold ownership interests and we sublease space to referring physicians at approximately 220 of our dialysis centers. These arrangements must be in compliance with the anti-kickback statute. We believe that we meet the elements of the safe harbor for space rentals in all material respects.
Some medical directors and other referring physicians may own our common stock. We believe that these interests materially satisfy the requirements of the safe harbor for investments in large publicly traded companies for the anti-kickback statute.
Because we are purchasing and selling items and services in the operation of our centers that may be paid for, in whole or in part, by Medicare or a state healthcare program and because we acquire certain items and services at a discount, we must structure these arrangements in compliance with the federal anti-kickback statute. Subject to certain requirements and limitations, discounts representing reductions in the amounts we are charged for items or services based on arms-length transactions can qualify for safe harbor protection if we fully and accurately report the discounts in the applicable Medicare cost reports. While some of the safe harbor criteria are subject to interpretation, we believe that our vendor contracts with discount provisions are in compliance with the anti-kickback statute.
Stark Law
Another federal law, known as the Stark Law, prohibits a physician who has a financial relationship, or who has an immediate family member who has a financial relationship, with entities providing designated health services, or DHS, from referring Medicare patients to such entities for the furnishing of such services, unless an exception applies. Stark Law DHS include home health services, outpatient prescription drugs, inpatient and outpatient hospital services and clinical laboratory services. The Stark Law also prohibits the DHS entity receiving a prohibited referral from filing a claim or billing for the services arising out of the prohibited referral. The prohibition applies regardless of the reasons for the financial relationship and the referral; unlike the federal anti-kickback statute, intent to induce referrals is not required. Sanctions for violation of the Stark Law include denial of payment for claims for services provided in violation of the prohibition, refunds of amounts collected in violation, a civil penalty of up to $15,000 for each service arising out of the prohibited referral, exclusion from the federal healthcare programs, including Medicare and Medicaid and a civil penalty of up to $100,000 against parties that enter into a scheme to circumvent the Stark Law prohibition. Stark Law violations also can form the basis for False Claims Act liability. The types of financial arrangements between a physician and a DHS entity that trigger the self-referral prohibitions of the Stark Law are broad and include direct and indirect ownership and investment interests and compensation arrangements.
CMS has adopted implementing regulations under the Stark Law, collectively, Stark Regulations. CMS has not yet adopted implementing regulations regarding application of the Stark Law to Medicaid, but has indicated that it anticipates issuing additional regulations regarding the application of the Stark Law to Medicaid referrals.
The definition of DHS under the Stark Law excludes services paid under a composite rate, even if some of the components bundled in the composite rate are DHS. Although the new ESRD bundled payment system is no longer titled a composite rate, we believe that the former composite rate payment system and the current bundled system are both composite systems excluded from the Stark Law. Since most services furnished to Medicare beneficiaries provided in our dialysis centers are reimbursed through a composite or bundled rate, the services performed in our facilities generally are not DHS, and the Stark Law referral prohibition does not apply to those services. The definition of DHS also excludes inpatient dialysis performed in hospitals that are not certified to provide ESRD services. Consequently, our arrangements with such hospitals for the provision of dialysis services to hospital inpatients do not trigger the Stark Law referral prohibition.
In addition, although prescription drugs are DHS, there is an exception in the Stark Regulations for EPO and other specifically enumerated dialysis drugs when furnished in or by an ESRD facility, in compliance with the
13
anti-kickback statute and applicable billing requirements. The exception is available only for drugs included on a list of CPT/HCPCS codes published by CMS, and in the case of home dialysis, the exception applies only to EPO, Aranesp® and equivalent drugs dispensed by the facility for use at home. While we believe that most drugs furnished by our dialysis centers are covered by the exception, dialysis centers may administer drugs that are not on the list of CPT/HCPCS codes and therefore do not meet this exception. In order for a physician who has a financial relationship with a dialysis center to order one of these drugs from the center and for the center to obtain Medicare reimbursement, another exception must apply.
We have entered into several types of financial relationships with referring physicians, including compensation arrangements. We believe that the compensation arrangements under our medical director agreements satisfy the personal services compensation arrangement exception to the Stark Law. While we believe that compensation under our medical director agreements, which is the result of arms length negotiations, results in fair market value payments for medical director services, an enforcement agency could nevertheless challenge the level of compensation that we pay our medical directors. If the arrangement does not meet a Stark Law exception, we could in the future be required to change our practices, face civil penalties, pay substantial fines, return certain payments received from Medicare and beneficiaries or otherwise experience a material adverse effect as a result of a challenge to payments made pursuant to referrals from these physicians under the Stark Law.
Some of our dialysis centers are leased from entities in which referring physicians hold interests and we sublease space to referring physicians at some of our dialysis centers. The Stark Law provides an exception for lease arrangements if specific requirements are met. We believe that our leases and subleases with referring physicians satisfy the requirements for this exception.
Some medical directors and other referring physicians may own our common stock. We believe that these interests satisfy the Stark Law exception for investments in large publicly traded companies.
Some of our referring physicians also own equity interests in entities that operate our dialysis centers. None of the Stark Law exceptions applicable to physician ownership interests in entities to which they make DHS referrals applies to the kinds of ownership arrangements that referring physicians hold in several of our subsidiaries that operate dialysis centers. Accordingly, these dialysis centers cannot bill Medicare for DHS referrals from physician owners. If the dialysis centers bill for DHS referred by physician owners, the dialysis center would be subject to the Stark Law penalties described above.
While we believe that most of our operations do not implicate the Stark Law, particularly under the new ESRD bundled payment system, and that to the extent that our dialysis centers furnish DHS, they either meet an exception or do not bill for services that do not meet a Stark Law exception, if CMS determined that we have submitted claims in violation to the Stark Law, we would be subject to the penalties described above. In addition, it might be necessary to restructure existing compensation agreements with our medical directors and to repurchase or to request the sale of ownership interests in subsidiaries and partnerships held by referring physicians or, alternatively, to refuse to accept referrals for DHS from these physicians. Any such penalties and restructuring could have a material adverse effect on our operations.
If any of our business transactions or arrangements, including those described above, were found to violate the federal anti-kickback statute of Stark Law, we could face criminal, civil or administrative sanctions, including possible exclusion from participation in Medicare, Medicaid and other state and federal healthcare programs. Any findings that we have violated these laws could have a material adverse impact on our operations.
Fraud and abuse under state law
Many states in which we operate dialysis centers have statutes prohibiting physicians from holding financial interests in various types of medical facilities to which they refer patients. Some of these statutes could be interpreted as prohibiting physicians who hold shares of our publicly traded stock from referring patients to our
14
dialysis centers if the centers use our laboratory subsidiary to perform laboratory services for their patients. Some states also have laws similar to the federal anti-kickback statute that may affect our ability to receive referrals from physicians with whom we have financial relationships, such as our medical directors. Some state anti-kickback statutes also include civil and criminal penalties. Some of these statutes include exemptions applicable to our medical directors and other physician relationships or for financial interests limited to shares of publicly traded stock. Some, however, include no explicit exemption for medical director services or other services for which we contract with and compensate referring physicians or for joint ownership interests of the type held by some of our referring physicians or for financial interests limited to shares of publicly traded stock. If these statutes are interpreted to apply to referring physicians with whom we contract for medical director and similar services, to referring physicians with whom we hold joint ownership interests or to physicians who hold interests in DaVita limited solely to publicly traded stock, we may be required to terminate or restructure some or all of our relationships with or refuse referrals from these referring physicians and could be subject to civil and administrative sanctions, refund requirements and exclusions from government healthcare programs, including Medicare and Medicaid. Such events could negatively affect the decision of referring physicians to refer patients to our centers.
The False Claims Act
The federal False Claims Act, or FCA, is a means of policing false bills or false requests for payment in the healthcare delivery system. In part, the FCA authorizes the imposition of up to three times the governments damages and civil penalties on any person who:
| Knowingly presents or causes to be presented to the federal government, a false or fraudulent claim for payment or approval; |
| Knowingly makes, uses or causes to be made or used, a false record or statement to get a false or fraudulent claim paid or approved by the federal government; |
| Conspires to defraud the federal government by getting a false or fraudulent claim allowed or paid; or |
| Knowingly makes, uses or causes to be made or used, a false record or statement to conceal, avoid or decrease an obligation to pay or transmit money or property to the federal government. |
In addition, recent amendments to the FCA impose severe penalties for the knowing and improper retention of overpayments collected from government payors. These amendments could subject our procedures for identifying and processing overpayments to greater scrutiny. We have made significant investments in additional resources to accelerate the time it takes to identify and process overpayments and we may be required to make additional investments in the future. An acceleration in our ability to identify and process overpayments could result in us refunding overpayments to government or other payors sooner than we have in the past. A significant acceleration of these refunds could have a material adverse affect on our operating cash flows.
The penalties for a violation of the FCA range from $5,500 to $11,000 for each false claim plus three times the amount of damages caused by each such claim. The federal government has used the FCA to prosecute a wide variety of alleged false claims and fraud allegedly perpetrated against Medicare and state healthcare programs, including coding errors, billing for services not rendered, the submission of false cost reports, billing for services at a higher payment rate than appropriate, billing under a comprehensive code as well as under one or more component codes included in the comprehensive code and billing for care that is not considered medically necessary. Although still subject to dispute, several courts have also determined that a violation of the federal anti-kickback statute can form the basis for liability under the FCA, and filing claims or failing to refund amounts collected in violation of the Stark Law can form the basis for liability under the FCA. In addition to the provisions of the FCA, which provide for civil enforcement, the federal government can use several criminal statutes to prosecute persons who are alleged to have submitted false or fraudulent claims for payment to the federal government.
15
The Health Insurance Portability and Accountability Act of 1996
The Health Insurance Portability and Accountability Act of 1996 and its implementing privacy and security regulations, as amended by the federal Health Information Technology for Economic and Clinical Health Act (HITECH Act) (collectively referred to as HIPAA), requires us to provide certain protections to patients and their health information (Protected Health Information, or PHI). HIPAA requires us to afford patients certain rights regarding their PHI, and to limit uses and disclosure of their PHI existing in any media form (electronic and hardcopy). HIPAA also requires us to implement administrative, physical, and technical safeguards with respect to electronic PHI. We believe our HIPAA Privacy and Security Program sufficiently address HIPAA requirements.
Other regulations
Our operations are subject to various state hazardous waste and non-hazardous medical waste disposal laws. These laws do not classify as hazardous most of the waste produced from dialysis services. Occupational Safety and Health Administration regulations require employers to provide workers who are occupationally subject to blood or other potentially infectious materials with prescribed protections. These regulatory requirements apply to all healthcare facilities, including dialysis centers, and require employers to make a determination as to which employees may be exposed to blood or other potentially infectious materials and to have in effect a written exposure control plan. In addition, employers are required to provide or employ hepatitis B vaccinations, personal protective equipment and other safety devices, infection control training, post-exposure evaluation and follow-up, waste disposal techniques and procedures and work practice controls. Employers are also required to comply with various record-keeping requirements. We believe that we are in material compliance with these laws and regulations.
A few states have certificate of need programs regulating the establishment or expansion of healthcare facilities, including dialysis centers. We believe that we are in material compliance with all applicable state certificate of need laws.
Corporate compliance program
Our dialysis operations are subject to extensive federal, state and local government regulations. Management has designed and implemented a company-wide corporate compliance program as part of our commitment to comply fully with all applicable laws and regulations and to maintain the high standards of conduct we expect from all of our teammates. We continuously review this program and enhance it as necessary. The primary purposes of the program include:
| Increasing, through training and education, the awareness of our teammates and affiliated professionals of the necessity of complying with all applicable laws and regulations; |
| Auditing and monitoring the activities of our dialysis centers, laboratories and billing offices on a regular basis to identify potential instances of noncompliance in a timely manner; |
| Establishing guidelines around physicians roles and responsibilities that require our physicians attest to their adherence to these guidelines on a periodic basis; and |
| Ensuring that we take steps to resolve instances of noncompliance or to address areas of potential noncompliance as promptly as we become aware of them. |
When evaluating the effectiveness of our corporate compliance program, we take into consideration a number of factors, including favorable results under various government inquiries and adherence to industry standards.
We have a code of conduct that each of our teammates and affiliated professionals must follow and we have a confidential toll-free hotline (888-458-5848) for teammates and patients to report potential instances of noncompliance. Our Chief Compliance Officer administers the compliance program. The Chief Compliance Officer reports directly to our Chief Executive Officer, our Chief Operating Officer and to the Compliance Committee of our Board of Directors.
16
Insurance
We maintain insurance for property and general liability, professional liability, directors and officers liability, workers compensation and other coverage in amounts and on terms deemed adequate by management based on our actual claims experience and expectations for future claims. Future claims could, however, exceed our applicable insurance coverage. Physicians practicing at our dialysis centers are required to maintain their own malpractice insurance and our medical directors are required to maintain coverage for their individual private medical practices. Our liability policies cover our medical directors for the performance of their duties as medical directors at our outpatient dialysis centers.
Capacity and location of our centers
We are able to increase our capacity by extending hours at our existing centers, expanding our existing centers, relocating our centers, developing new centers and by acquiring centers. The development of a typical outpatient dialysis center by us generally requires approximately $2.5 million for leasehold improvements, equipment and first-year working capital. Based on our experience, a new center typically opens within a year after the property lease is signed, normally achieves operating profitability in the second year after certification and normally reaches maturity within three to five years. Acquiring an existing outpatient dialysis center requires a substantially greater initial investment, but profitability and cash flow are generally initially more predictable. To a limited extent, we enter into agreements to provide management and administrative services to outpatient dialysis centers in which we either own a minority equity investment, or are wholly-owned by third parties in return for management fees, which are typically based on a percentage of revenues or cash collections of the managed operations.
The table below shows the growth of our company by number of dialysis centers.
2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
Number of centers at beginning of year |
1,612 | 1,530 | 1,449 | 1,359 | 1,300 | |||||||||||||||
Acquired centers |
178 | (1) | 41 | 19 | 20 | 16 | ||||||||||||||
Developed centers |
65 | 65 | 78 | 86 | 64 | |||||||||||||||
Net change in centers with management and administrative services agreements* |
4 | | 8 | (2) | 1 | (15 | )(3) | |||||||||||||
Sold and closed centers** |
(32 | )(1) | (10 | ) | (8 | ) | (9 | ) | (4 | ) | ||||||||||
Closed centers*** |
(7 | ) | (14 | ) | (16 | ) | (8 | ) | (2 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Number of centers at end of year |
1,820 | 1,612 | 1,530 | 1,449 | 1,359 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | In 2011, we acquired 113 dialysis centers and divested a total of 30 centers in connection with the acquisition of DSI. |
(2) | During 2009, we made minority equity investments in 6 centers and we entered into 2 additional management and administrative service agreements. |
(3) | In November 2007, one of our management and administration service agreements was terminated, in which we provided management and administrative services to 20 dialysis centers. |
* | Represents dialysis centers in which we either own a minority equity investment, or are wholly-owned by third parties. |
** | Represents dialysis centers that were sold and/or closed in which patients were not retained. |
*** | Represents dialysis centers that were closed and the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers. |
17
As of December 31, 2011, we operated or provided administrative services to a total of 1,820 outpatient dialysis centers, of which 1,809 are located in the United States and 11 are located in three countries outside of the United States. A total of 1,784 are consolidated in our financial statements. Of the remaining 36 unconsolidated outpatient dialysis centers, we own a minority equity investment in 19 centers and provide management and administrative services to 17 centers, of which three centers are located outside of the United States, that are wholly-owned by third parties. The locations of the 1,784 outpatient dialysis centers consolidated in our financial statements at December 31, 2011 were as follows:
State |
Centers | State |
Centers | State |
Centers | |||||||||||
California |
216 | New York |
40 | Kansas |
19 | |||||||||||
Texas |
151 | Minnesota |
39 | Nevada |
18 | |||||||||||
Florida |
139 | Kentucky |
32 | Nebraska |
14 | |||||||||||
Georgia |
105 | Oklahoma |
31 | Massachusetts |
13 | |||||||||||
Ohio |
84 | Colorado |
30 | Mississippi |
11 | |||||||||||
Pennsylvania |
75 | New Jersey |
30 | District of Columbia |
9 | |||||||||||
Illinois |
70 | Wisconsin |
28 | Idaho |
9 | |||||||||||
North Carolina |
62 | Louisiana |
27 | Utah |
4 | |||||||||||
Michigan |
56 | South Carolina |
26 | New Mexico |
4 | |||||||||||
Virginia |
55 | Arizona |
25 | West Virginia |
4 | |||||||||||
Maryland |
51 | Washington |
25 | South Dakota |
3 | |||||||||||
Indiana |
48 | Connecticut |
21 | New Hampshire |
2 | |||||||||||
Tennessee |
47 | Iowa |
20 | North Dakota |
2 | |||||||||||
Missouri |
46 | Oregon |
20 | Rhode Island |
1 | |||||||||||
Alabama |
44 | Arkansas |
20 | |||||||||||||
International |
Centers | |||||||||||||||
India |
6 | |||||||||||||||
Germany |
2 |
Competition
The U.S. dialysis industry has consolidated significantly over time but still remains highly competitive, particularly in terms of acquiring existing outpatient dialysis centers. We continue to face increased competition in the U.S. dialysis industry from large and medium-sized providers who compete directly with us for the acquisition of dialysis businesses, relationships with physicians to act as medical directors and for individual patients. In addition, as we continue our international dialysis expansion into various international markets, we will face competition from large and medium-sized providers for these acquisition targets as well. Acquisitions, developing new outpatient dialysis centers, patient retention and physician relationships are an important part of our growth strategy and our business could be adversely affected if we are not able to continue to make acquisitions on reasonable terms, experience significant patient attrition to our competitors and are not able to maintain or establish new relationships with physicians. Competition for qualified physicians to act as medical directors and for inpatient dialysis services agreements with hospitals is also intense. Occasionally, we have also experienced competition from former medical directors or referring physicians who have opened their own dialysis centers. In addition, we experience competitive pressures in connection with negotiating contracts with commercial healthcare payors.
The two largest dialysis companies, Fresenius Medical Care, or Fresenius, and our company, account for approximately two-thirds of outpatient dialysis patients in the United States with our company serving approximately 32% of the total outpatient dialysis patients. Approximately 47% of the centers not owned by us or Fresenius are owned or controlled by hospitals or non-profit organizations. Hospital-based and non-profit dialysis units typically are more difficult to acquire than physician-owned centers. Because of the ease of entry into the dialysis business and the ability of physicians to be medical directors for their own centers, competition for growth in existing and expanding markets is not limited to large competitors with substantial financial resources.
18
Fresenius also manufactures a full line of dialysis supplies and equipment in addition to owning and operating outpatient dialysis centers. This may give them cost advantages over us because of their ability to manufacture their own products. However, Fresenius has been one of our largest suppliers of dialysis products. In January 2010, we entered into an agreement with Fresenius which committed us to purchase a certain amount of dialysis equipment, parts and supplies from them through 2013. In addition, in August 2006 in connection with the DVA Renal Healthcare acquisition, we also entered into a product supply agreement with Gambro Renal Products that requires us to purchase a certain amount of our hemodialysis non-equipment product supplies, such as dialyzers, at fixed prices through 2015. Our purchases of products in these categories generally offered by both Fresenius and Gambro Renal Products represent approximately 4% of our total operating expenses. During 2011, we purchased hemodialysis products and supplies from Gambro Renal Products representing approximately 2% of our total operating expenses.
Teammates
As of December 31, 2011, we had approximately 41,000 teammates:
Licensed professional staff (nurses, dieticians and social workers) |
18,000 | |||
Other patient care and center support staff and laboratory personnel |
17,500 | |||
Corporate, billing and regional administrative staff |
5,500 |
Our dialysis business requires nurses with specialized training for treating patients with complex care needs. Recruitment and retention of nurses are continuing concerns for healthcare providers due to short supply. We have an active program of investing in our professional healthcare teammates to help ensure we meet our recruitment and retention targets, including expanded training opportunities, tuition reimbursements and other incentives.
19
Item 1A. | Risk Factors. |
This Annual Report on Form 10-K contains statements that are forward-looking statements within the meaning of the federal securities laws. These statements involve known and unknown risks and uncertainties including the risks discussed below. The risks discussed below are not the only ones facing our business. Please read the cautionary notice regarding forward-looking statements in Item 7 of this Part 1 under the heading Managements Discussion and Analysis of Financial Condition and Results of Operations.
If the average rates that commercial payors pay us decline significantly, it would have a material adverse effect on our revenues, earnings and cash flows.
Approximately 34% of our dialysis and related lab services revenues for the year ended December 31, 2011 were generated from patients who have commercial payors as the primary payor. The majority of these patients have insurance policies that pay us on terms and at rates that are generally significantly higher than Medicare rates. The payments we receive from commercial payors generate nearly all of our profit and all of our nonacute dialysis profits come from commercial payors. We continue to experience downward pressure on some of our commercial payment rates and it is possible that commercial payment rates could be materially lower in the future. The downward pressure on commercial payment rates is a result of general conditions in the market, recent and future consolidations among commercial payors, increased focus on dialysis services and other factors.
We are continuously in the process of negotiating our existing or potentially new agreements with commercial payors who tend to be aggressive in their negotiations with us. Sometimes many significant agreements are up for renewal or being renegotiated at the same time. In the event that our continual negotiations result in overall commercial rate reductions in excess of overall commercial rate increases, the cumulative effect could have a material adverse effect on our financial results. Consolidations have significantly increased the negotiating leverage of commercial payors. Our negotiations with payors are also influenced by competitive pressures. We expect that some of our contracted rates with commercial payors may decrease or that we may experience decreases in patient volume as our negotiations with commercial payors continue. In addition to increasing downward pressure on contracted commercial payor rates, payors have been attempting to impose restrictions and limitations on non-contracted or out-of-network providers. In some circumstances for some commercial payors, our centers are designated as out-of-network providers. Rates for out-of-network providers are on average higher than rates for in-network providers. We believe commercial payors have or will begin to restructure their benefits to create disincentives for patients to select or remain with out-of-network providers and to decrease payment rates for out-of-network providers. Decreases in out-of-network rates and restrictions on out-of-network access combined with decreases in contracted rates could result in a significant decrease in our overall revenue derived from commercial payors. If the average rates that commercial payors pay us decline significantly, it would have a material adverse effect on our revenues, earnings and cash flows.
If the number of patients with higher-paying commercial insurance declines, then our revenues, earnings and cash flows would be substantially reduced.
Our revenue levels are sensitive to the percentage of our patients with higher-paying commercial insurance coverage. A patients insurance coverage may change for a number of reasons, including changes in the patients or a family members employment status. Currently, for a patient covered by an employer group health plan, Medicare generally becomes the primary payor after 33 months, or earlier, if the patients employer group health plan coverage terminates. When Medicare becomes the primary payor, the payment rate we receive for that patient shifts from the employer group health plan rate to the lower Medicare payment rate. We have seen an increase in the number of patients who have government-based programs as their primary payors which we believe is largely a result of improved mortality and recent economic conditions which have a negative impact on the percentage of patients covered under commercial insurance plans. To the extent there are sustained or increased job losses in the United States, independent of whether general economic conditions might be improving, we could experience a continued decrease in the number of patients covered under commercial plans.
20
We could also experience a further decrease if changes to the healthcare regulatory system result in fewer patients covered under commercial plans or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates. In addition, our continuous process of negotiations with commercial payors under existing or potentially new agreements could result in a decrease in the number of patients under commercial plans to the extent that we cannot reach agreement with commercial payors on rates and other terms, resulting in termination or non-renewals of existing agreements or our inability to enter into new ones. If there is a significant reduction in the number of patients under higher-paying commercial plans relative to government-based programs that pay at lower rates, it would have a material adverse effect on our revenues, earnings and cash flows.
Changes in the structure of, and payment rates under the Medicare ESRD program, including the Budget Control Act of 2011 and other healthcare reform initiatives, could substantially reduce our revenues, earnings and cash flows.
Approximately 49% of our dialysis and related lab services revenues for the year ended December 31, 2011 was generated from patients who have Medicare as their primary payor. Prior to January 1, 2011, the Medicare ESRD program paid us for dialysis treatment services at a fixed composite rate. The Medicare composite rate was the payment rate for a dialysis treatment including the supplies used in those treatments, specified laboratory tests and certain pharmaceuticals. Certain other pharmaceuticals, including EPO, vitamin D analogs and iron supplements, as well as certain specialized laboratory tests, were separately billed.
In July 2008, MIPPA was passed by Congress. This legislation introduced a new payment system for dialysis services beginning in January 2011 whereby payment for dialysis treatment and related services is now made under a bundled payment rate which provides a fixed rate to encompass all goods and services provided during the dialysis treatment, including pharmaceuticals that were historically separately reimbursed to the dialysis providers, such as EPO, vitamin D analogs and iron supplements, as well as laboratory testing. On August 12, 2010, the Centers for Medicare & Medicaid Services, or CMS, published the final rule implementing the bundled payment in the Federal Register. The initial 2011 bundled rate included reductions of 2% from the prior reimbursement and further reduced overall rates by 5.94% tied to an expanded list of case-mix adjustors which can be earned back based upon the presence of these certain patient characteristics and co-morbidities at the time of treatment. There are also other provisions which may impact payment including an outlier pool and a low volume facility adjustment.
Another important provision in the new law is an annual adjustment, or market basket update, each year to the base ESRD Prospective Payment Rate (PPS). Absent action by Congress the PPS annual rate will be automatically updated by a formulaic inflation adjustment. On October 14, 2011, the Medicare Payment Advisory Commission, or MedPAC, sent a letter to chairmen and ranking members of the Senate Finance Committee and the House Committees on Ways and Means and Energy and Commerce that included a number of recommendations, including a reduction in the 2012 dialysis PPS update to 1.0% (rather than the 2.1% update that eventually was adopted). Although this 1.0% update was not adopted, the MedPAC focus on such a reduction indicates further scrutiny of the annual update is possible.
On November 1, 2011, CMS issued the final ESRD Prospective Payment System (PPS) rule for 2012. The base will increase by 2.1%, representing a market base of increase of 3.0% less a productivity adjustment of 0.9%. The increase in the final base rate for 2012 (2.1%) is slightly greater than the increase of 1.8% stated in the proposed 2012 ESRD PPS rule published in July 2011, and was made irrespective of the MedPAC recommendation for a reduction of the dialysis update. In 2012 and beyond the ESRD PPS system also includes a quality incentive program (QIP) that reduces payments by up to 2% and provides facilities the opportunity to earn all or some of the amount withheld based on meeting certain defined clinical goals. In December 2011, CMS published the list of facilities subject to a QIP reduction for 2012. The vast majority of our facilities will not be subject to a QIP reduction in 2012 and the overall reduction to our rates is 0.2%.
21
We believe the new payment system presents operating clinical and financial risks. For example, with regard to the expanded list of case-mix adjustors, there is a risk that our dialysis centers or billing and other systems may not accurately document and track the appropriate patient-specific characteristics, resulting in a reduction or overpayment in the amounts of the payments that we would otherwise be entitled to receive.
Beginning January 1, 2014, certain oral-only ESRD drugs (currently paid separately to pharmacies under Medicare Part D) will be included in the ESRD bundled payment to dialysis facilities. CMS delayed the inclusion of these oral only ESRD drugs until 2014 in order to assess whether the pricing mechanism used for oral drugs with injectable equivalents (included in the bundle beginning January 1, 2011) could be applied to oral only drugs. It is currently unclear how CMS will price the oral-only drugs for inclusion in the ESRD bundle in 2014. Inadequate pricing could have a significant negative financial impact on our dialysis facilities given the volume and value of these drugs.
We expect to continue experiencing increases in operating costs that are subject to inflation, such as labor and supply costs, regardless of whether there is a compensating inflation-based increase in Medicare payment rates or in payments under the new bundled payment rate system.
On August 2, 2011, the President signed into law the Budget Control Act of 2011 (Public Law 112-25), which raised the debt ceiling and put into effect a series of actions to reduce the federal budget deficit over ten years. The first phase required reductions of $917 billion in domestic and defense discretionary spending only. Under the second phase, the law created a 12-member Joint Select Committee on Deficit Reduction, or the Committee, which was given a goal of $1.5 trillion in deficit reduction, but a mandatory $1.2 trillion in deficit reduction over ten years. The deficit reduction could have been through spending cuts, increased revenues, or a combination of both. The Committee was required to report its recommendations to the Congress no later than November 23, 2011. The Congress was required to act on the recommendations, without amendment, by December 23, 2011. The Committee failed to report a deficit reduction bill by November 23, and the Congress subsequently failed to enact deficit reduction legislation. As a result, in January 2012, a $1.2 trillion sequestration order requiring across-the-board spending cuts will be developed. The order would take effect in January 2013 for the entire fiscal year 2013 budget. The cuts in the sequestration order will be distributed equally between defense and nondefense spending. Among the health-related programs exempted from sequestration are Social Security, Medicaid, Veterans Health Administration, or VA, benefits and pensions, federal retirement funds, civilian and military pay, child nutrition, SSI, and WIC. Medicare providers would be cut by 2% of total program costs.
We also cannot predict whether we will be able to comply with the CMS rules related to the bundled payment system as processes and systems are modified substantially to capture all required data. To the extent we are not able to adequately bill and collect for certain payment adjustors and are not able to offset the mandated reductions in reimbursement or if we face regulatory enforcement actions and penalties as a result of alleged improper billing of governmental programs, it could have a material adverse effect on our revenues, earnings and cash flows. (For additional details regarding the risks we face for failing to adhere to our Medicare and Medicaid regulatory compliance obligations, see the risk factor below under the heading If we fail to adhere to all of the complex government regulations that apply to our business, we could suffer severe consequences that would substantially reduce our revenues, earnings and cash flows).
Health care reform could substantially reduce our revenues, earnings and cash flows.
In March 2010, broad health care reform legislation was enacted in the United States. Although many of the provisions of the new legislation do not take effect immediately, and may be modified before they are implemented, the reforms could have an impact on our business in a number of ways. We cannot predict how employers, private payors or persons buying insurance might react to these changes or what form many of these regulations will take before implementation. In July 2011, the Department of Health and Human Services, or HHS, issued two proposed rules related to the establishment of health care insurance exchanges due to be operating by 2014 that will provide a
22
marketplace for eligible individuals to purchase health care insurance. The proposed rules provide clarifications on the requirements related to implementation of such exchanges, outline areas of state flexibility in their implementation of such exchanges and provide standards for certain risk adjustment mechanisms. We believe the establishment of health care insurance exchanges could result in a reduction in patients covered by commercial insurance or an increase of patients covered under more restrictive commercial plans with lower reimbursement rates. To the extent that the implementation of such exchanges results in a reduction in patients covered by commercial insurance or a reduction in reimbursement rates for our services from commercial and/or government payors, our revenues, earnings and cash flows could be adversely affected.
In October 2011, CMS issued a final rule concerning the Medicare Shared Savings Program established by the health care reform legislation, which under the statute was required to be implemented no later than January 1, 2012. The Medicare Shared Savings Program will provide financial incentives to health care providers and suppliers that work together to furnish coordinated, high-quality care to Medicare beneficiaries through accountable care organizations, or ACOs.
To qualify for financial incentives, ACOs must successfully satisfy quality performance standards and also reduce health care costs. ACOs will receive higher percentages of shared savings if they demonstrate they are providing high quality care and achieving a minimum savings based upon the average per capita Medicare expenditures for beneficiaries who have been assigned to the ACOs. Separate expenditure calculations will be made for certain Medicare beneficiary populations, including beneficiaries with ESRD. During an ACOs initial three-year agreement period, the ACO may elect to operate under a one-sided model, where the ACO shares in savings but is not responsible for losses (i.e., costs that exceed a target established by CMS) or a two-sided model, whereby the ACO is eligible for higher sharing rates but in addition to sharing in savings, is at risk for sharing in any losses. During subsequent agreement periods, the ACO must operate under the two-sided model.
CMS will start accepting applications from prospective ACOs in early 2012: ACOs may apply to participate in the program with a start date of April 1, 2012 or July 1, 2012. We are currently uncertain of the extent to which ACOs will impact the health care market. As a provider of dialysis services, we may choose to participate in one or several ACOs. Even if we do not participate in this program, we will need to be aware of how we are performing under the programs criteria. An ACOs quality measures and expenditures include the care furnished by non-participating providers. Therefore, if our patients are assigned to ACOs, the quality and cost of care that we furnish will be included in the ACOs calculations regardless of our participation in the program. We may also be competing against ACOs. If we are unable to perform at the levels established under the program we may be at risk for losing our Medicare patient base, which would have a materially adverse effect on our revenues, earnings and cash flow. Furthermore, even if providers and suppliers elect not to participate in ACOs, there are many similar initiatives with government and private payors that are being implemented and which may arise in the future, including the development of models similar to ACOs, Independent Practice Associations and Integrated Delivery Systems or evolutions of those concepts.
For example, the CMS Center for Medicare & Medicaid Innovation, or Innovation Center, has developed several other demonstration projects aimed at reforming care delivery that include shared savings, such as the Pioneer Accountable Care Organizations Model, the Bundled Payments for Care Improvement Initiative and the Comprehensive Primary Care Initiative. In addition, the Innovation Center may establish other demonstration projects that involve shared savings in the future and it is possible that partial capitation arrangements and specific diseases or care settings may be targeted. The further development of these types of models could create situations where ACOs or similar entities are accountable for coordinating more care for patients. This shift in accountability may require us to negotiate contracts for services with intermediaries instead of directly with the payors. It is possible that payment rates negotiated with intermediaries could be materially lower in the future, which would have a material adverse effect on our revenues, earnings and cash flows.
In addition, the health care reform legislation introduced severe penalties for the knowing and improper retention of overpayments collected from government payors. As a result, we have made significant investments
23
in additional resources to accelerate the time it takes to identify and process overpayments and we may be required to make additional investments in the future. Acceleration in our ability to identify and process overpayments could result in us refunding overpayments to government or other payors sooner than we have in the past, which could have a material adverse effect on our operating cash flows. The failure to return identified overpayments within the specified time frame is now a violation of the federal False Claims Act, or FCA.
The health care reform legislation also reduced the timeline to file Medicare claims, which now must be filed with the government within one calendar year after the date of service. To comply with this reduced timeline, we must deploy significant resources and may change our claims processing methods to ensure that our Medicare claims are filed in a timely fashion. Failure to file a claim within the one year window could result in payment denials, adversely affecting our revenues, earnings and cash flows.
Effective March 2011, CMS instituted new screening procedures and a new $500 enrollment fee for providers enrolling and re-enrolling in government health care programs. A provider is subject to screening upon initial enrollment and each time the provider re-validates its enrollment application. Screening includes verification of enrollment information and review of various federal databases to ensure the provider has valid tax identification, NPI numbers and is not excluded. We expect this screening process to delay the Medicare contractor approval process, potentially causing a delay in reimbursement. The enrollment fee is also applicable upon initial enrollment, re-validation, and each time an existing provider adds a new facility location. This fee is an additional expense that must be paid for each center every three years and could be more significant if other government and commercial payors follow this trend. Ultimately, we anticipate the new screening and enrollment requirements will require additional personnel and financial resources and will potentially delay the enrollment and revalidation of our centers which in turn will delay payment.
Other reform measures allow CMS to place a moratorium on new enrollment of providers and to suspend payment to providers upon a credible allegation of fraud from any source. These types of reform measures, or others, depending upon the scope and breadth of the implementing regulations, could adversely impact our revenues, earnings and cash flows.
Changes in state Medicaid or other non-Medicare government-based programs or payment rates could reduce our revenues, earnings and cash flows.
Approximately 16% of our dialysis and related lab services revenues for the year ended December 31, 2011 was generated from patients who have state Medicaid or other non-Medicare government-based programs, such as Medicare-assigned plans or the VA, as their primary coverage. As state governments and governmental organizations face increasing budgetary pressure, we may in turn face reductions in payment rates, delays in the timing of payments, limitations on eligibility or other changes to the applicable programs. For example, some programs, such as certain state Medicaid programs and the VA, have recently considered, proposed or implemented rate reductions.
On December 17, 2010, the Department of Veterans Affairs published a final rule in which it materially changed the payment methodology and ultimately the amount paid for dialysis services furnished to veterans in non-VA centers such as ours. In the final rule, the VA adopted the bundled payment system implemented by Medicare and estimated a reduction of 39% in payments for dialysis services to veterans at non-VA centers. Approximately 2% of our dialysis and related lab services revenues for the year ended December 31, 2011 was generated by the VA. The new VA payment methodology will have a significant negative impact on our revenues, earnings and cash flows as a result of the reduction in rates or as a result of the decrease in the number of VA patients we serve. We recently executed contractual agreements with the VA and there is some uncertainty as to when this rule will take effect for the patients covered by these contracts. While at this time the contracts remain in force, these agreements provide for the right for either party to terminate the agreement without cause on short notice. Further, patients who are not covered by the contractual arrangements will likely be reimbursed at Medicare rates beginning with the date of implementation of the rule. If the VA proceeds with payment rate reductions or fails to renew our existing contracts, we might have to cease accepting patients under this program and could even be forced to close centers.
24
State Medicaid programs are increasingly adopting Medicare-like bundled payment systems, but sometimes these new payment systems are poorly defined and could include all drugs (even those oral-only drugs that Medicare will not include in the bundled payment until 2014) and are implemented without any claims processing infrastructure, or patient or facility adjusters. If these new payment systems are implemented without any adjusters and claims processing changes, Medicaid payments will be substantially reduced and the costs to submit such claims may increase. In addition, some state Medicaid program eligibility requirements mandate that citizen enrollees in such programs provide documented proof of citizenship. If our patients cannot meet these proof of citizenship documentation requirements, they may be denied coverage under these programs. These Medicaid payment and enrollment changes, along with similar changes to other non-Medicare government programs could reduce the rates paid by these programs for dialysis and related services, delay the timing of payment for services provided, and further limit eligibility for coverage which could adversely affect our revenues, earnings and cash flows.
Changes in clinical practices, payment rates or regulations impacting EPO and other pharmaceuticals could reduce our revenues, earnings and cash flows.
Historically, Medicare and most Medicaid programs paid for EPO outside of the composite rate. This separate payment has long been the subject of discussions regarding appropriate dosing and payment in an effort to reduce escalating expenditures for EPO. Since January 1, 2011, Medicare has bundled EPO into the prospective payment system such that dosing variations will not change the amount paid to a dialysis facility. Although some Medicaid programs and other payors suggest movement towards a bundled payment system inclusive of EPO, some non-Medicare payors continue to pay for EPO separately from the treatment rate. The administration of EPO and other pharmaceuticals that are separately billable accounted for approximately 4% of our dialysis and related lab services revenues for the year ended December 31, 2011, with EPO alone accounting for approximately 3% of our dialysis and related lab services revenues for the same period. Changes in clinical practices that result in further decreased utilization of prescribed pharmaceuticals or changes in payment rates for those pharmaceuticals could reduce our revenues, earnings and cash flows.
Since late 2006, there has been significant media discussion and government scrutiny regarding anemia management practices in the United States which has created confusion and concern in the nephrology community. In late 2006, the U.S. House of Representatives Ways and Means Committee held a hearing on the issue of the utilization of ESAs, which include EPO, and in 2007, the FDA required changes to the labeling of EPO and Aranesp® to include a black box warning, the FDAs strongest form of warning label. An FDA advisory panel on ESA use met in October 2010, which meeting was similar to the prior meeting held in 2007 in that there was significant discussion and concern about the safety of ESAs. The panel concluded it would not recommend a change in ESA labeling. However, the FDA is not bound by the panels recommendation. In June 2011, the FDA required that the black box warning be slightly revised and also include more conservative dosing recommendations for patients with chronic kidney disease. In addition, in June 2011, CMS opened a National Coverage Analysis, or NCA, for ESAs. Further in January 2011, CMS convened a meeting of the Medicare Evidence Development and Coverage Advisory Committee, or MEDCAC, to evaluate evidence for the pending NCA. In June 2011, CMS determined not to issue a national coverage determination for ESAs due to a lack of available evidence to establish coverage criteria or limitations.
The forgoing congressional and agency activities and related actions could result in further restrictions on the utilization and reimbursement for ESAs. Commercial payors have also increasingly examined their administration policies for EPO and, in some cases, have modified those policies. Further changes in labeling of EPO and other pharmaceuticals in a manner that alters physician practice patterns or accepted clinical practices, changes in private and governmental payment criteria, including the introduction of EPO administration policies or the conversion to alternate types of administration of EPO or other pharmaceuticals that result in further decreases in utilization or reimbursement for EPO and other pharmaceuticals, could have a material adverse effect on our revenues, earnings and cash flows.
25
Changes in EPO pricing could materially reduce our earnings and cash flows and affect our ability to care for our patients.
In November 2011, we entered into a seven year Sourcing and Supply Agreement with Amgen USA Inc. Under the agreement we committed to purchase EPO in amounts necessary to meet no less than 90% of our requirements for erythropoiesis stimulating agents. The agreement replaces in its entirety the prior one-year supply agreement between us and Amgen that expired on December 31, 2011. As long as certain conditions are met by us, the agreement limits Amgens ability to unilaterally decide to increase the price for EPO. Future increases in the cost of EPO without corresponding increases in payment rates for EPO from commercial payors and without corresponding increases in the Medicare bundled rate could have a material adverse effect on our earnings and cash flows and ultimately reduce our income. Our agreement with Amgen for EPO provides for discounted pricing and rebates for EPO. Some of the rebates are subject to various conditions including but not limited to future pricing levels of EPO by Amgen and data submission by us. In addition, the rebates are subject to certain limitations. We cannot predict whether, over the seven year term of the agreement, we will continue to receive the rebates for EPO that we have received in the past, or whether we will continue to achieve the same levels of rebates within that structure as we have historically achieved. In the initial years of the agreement, however, the total rebate opportunity is less than what was provided in the agreement that expired at the end of 2011, however, the opportunity for us to earn discounts and rebates increases over the term of the agreement. Factors that could impact our ability to qualify for rebates provided for in our agreement with Amgen in the future include, but are not limited to, our ability to track certain data elements. We cannot predict whether we will be able to meet the applicable qualification requirements for receiving rebates. Failure to meet certain targets and earn the specified rebates could have a material adverse effect on our earnings and cash flows.
We are the subject of a number of inquiries by the federal government and two private civil suits, any of which could result in substantial penalties or awards against us, imposition of certain obligations on our practices and procedures, exclusion from future participation in the Medicare and Medicaid programs and, in certain cases, criminal penalties.
We are the subject of a number of inquiries by the federal government. We have received subpoenas or other requests for documents from the federal government in connection with the 2005 U.S. Attorney investigation, the Woodard private civil suit, the Vainer private civil suit, the 2010 U.S. Attorney physician relationship investigation, the 2011 U.S. Attorney physician relationship investigation and the 2011 U.S. Attorney Medicaid investigation. Certain current and former members of the Board and executives have been subpoenaed to testify before the grand jury in Colorado, and other Company representatives may also receive subpoenas for testimony related to the 2011 U.S. Attorney physician relationship investigation (see Part I, Item 3, of this report under the caption Legal Proceedings for additional details regarding these matters). After investigation, the government did not intervene and is not actively pursuing either the Woodard or the Vainer private civil suits mentioned above. In each of these private civil suits, a relator has filed a complaint against us in federal court under the qui tam provisions of the FCA and is pursuing the claims independently. The parties are engaged in active litigation. We are cooperating with the OIG and those offices of the U.S. Attorney still actively pursuing the matters mentioned above and are producing the requested records. Although we cannot predict whether or when proceedings might be initiated by the federal government, the scope of such proceedings or when these matters may be resolved, it is not unusual for investigations such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators. Responding to the subpoenas or investigations and defending ourselves in the private civil suits will continue to require managements attention and significant legal expense. Any negative findings could result in substantial financial penalties or awards against us, imposition of certain obligations on our practices and procedures, exclusion from future participation in the Medicare and Medicaid programs and, in certain cases, criminal penalties. To our knowledge, no proceedings have been initiated by the federal government against us at this time.
26
Continued inquiries from various governmental bodies with respect to our utilization of EPO and other pharmaceuticals will require managements attention, cause us to incur significant legal expense and could result in substantial financial penalties against us, repayment obligations or exclusion from future participation in the Medicare and Medicaid programs, and could have a material adverse effect on our revenues, earnings and cash flows.
In response to clinical studies which identified risks in certain patient populations related to the utilization of EPO and other ESAs, i.e., Aranesp®, and in response to changes in the labeling of EPO and Aranesp®, there has been substantial media attention and government scrutiny resulting in hearings and legislation regarding pharmaceutical utilization and reimbursement. Although we believe our anemia management practices and other pharmaceutical administration practices have been compliant with existing laws and regulations, as a result of the current high level of scrutiny and controversy, we may be subject to increased inquiries from a variety of governmental bodies and claims by third parties. Additional inquiries from or audits by various agencies and claims by third parties with respect to these issues would continue to require managements attention and significant legal expense and any negative findings could result in substantial financial penalties or repayments, imposition of certain obligations on our practices and procedures and the attendant financial burden on us to comply, or exclusion from future participation in the Medicare and Medicaid programs, and could have a material adverse effect on our revenues, earnings and cash flows.
If we fail to adhere to all of the complex government regulations that apply to our business, we could suffer severe consequences that would substantially reduce our revenues, earnings and cash flows.
Our dialysis operations are subject to extensive federal, state and local government regulations, including Medicare and Medicaid payment rules and regulations, federal and state anti-kickback laws, the Stark Law physician self-referral prohibition and analogous state referral statutes, the FCA and federal and state laws regarding the collection, use and disclosure of patient health information and the storage, handling and administration of pharmaceuticals. The Medicare and Medicaid reimbursement rules related to claims submission, enrollment and licensing requirements, cost reporting, and payment processes impose complex and extensive requirements upon dialysis providers. A violation or departure from any of these requirements may result in government audits, lower reimbursements, significant fines and penalties, the potential loss of certification and recoupments or voluntary repayments. CMS has indicated that after implementation of the Medicare bundled payment system, it will monitor use of EPO and whether blood transfusions replace EPO for anemia management.
The regulatory scrutiny of healthcare providers, including dialysis providers continues to increase. Medicare has increased the frequency and intensity of its certification inspections of dialysis centers. For example, we are required to provide substantial documentation related to the administration of pharmaceuticals, including EPO, and, to the extent that any such documentation is found insufficient, we may be required to refund to government or commercial payors any amounts received for such administration, and be subject to substantial penalties under applicable laws or regulations. In addition, Medicare contractors have increased their prepayment and post-payment reviews.
We endeavor to comply with all of the requirements for receiving Medicare and Medicaid payments, to structure all of our relationships with referring physicians to comply with state and federal anti-kickback laws and physician self-referral law (Stark Law), and for storing, handling and administering pharmaceuticals. However, the laws and regulations in these areas are complex, require considerable resources to monitor and implement and are subject to varying interpretations. For example, if an enforcement agency were to challenge the level of compensation that we pay our medical directors or the number of medical directors whom we engage, we could be required to change our practices, face criminal or civil penalties, pay substantial fines or otherwise experience a material adverse effect as a result of a challenge to these arrangements. In addition, amendments to the FCA impose severe penalties for the knowing and improper retention of overpayments collected from government payors. These amendments could subject our procedures for identifying and processing overpayments to greater scrutiny. We have made significant investments in additional resources to decrease the time it takes to identify and process overpayments and we may be required to make additional investments in the
27
future. An acceleration in our ability to identify and process overpayments could result in us refunding overpayments to government or other payors sooner than we have in the past. A significant acceleration of these refunds could have a material adverse affect on our operating cash flows. Additionally, amendments to the federal anti-kickback statute in the health reform law make anti-kickback violations subject to FCA prosecution, including qui tam or whistleblower suits.
If any of our operations are found to violate these or other government regulations, we could suffer severe consequences that would have a material adverse effect on our revenues, earnings and cash flows including:
| Suspension or termination of our participation in government payment programs; |
| Refunds of amounts received in violation of law or applicable payment program requirements; |
| Loss of required government certifications or exclusion from government payment programs; |
| Loss of licenses required to operate health care facilities or administer pharmaceuticals in some of the states in which we operate; |
| Reductions in payment rates or coverage for dialysis and ancillary services and related pharmaceuticals; |
| Fines, damages or monetary penalties for anti-kickback law violations, Stark Law violations, FCA violations, civil or criminal liability based on violations of law, or other failures to meet regulatory requirements; |
| Claims for monetary damages from patients who believe their protected health information has been used or disclosed in violation of federal or state patient privacy laws; |
| Mandated changes to our practices or procedures that significantly increase operating expenses; |
| Termination of relationships with medical directors; and |
| Harm to our reputation, which could impact our business relationships, ability to obtain financing and access to new opportunities. |
Delays in state Medicare and Medicaid certification of our dialysis centers could adversely affect our revenues, earnings and cash flows.
Before we can begin billing for patients treated in our outpatient dialysis centers who are enrolled in government-based programs, we are required to obtain state and federal certification for participation in the Medicare and Medicaid programs. As state agencies responsible for surveying dialysis centers on behalf of the state and Medicare program face increasing budgetary pressure, certain states are having difficulty keeping up with certifying dialysis centers in the normal course resulting in significant delays in certification. If state governments continue to have difficulty keeping up with certifying new centers in the normal course and we continue to experience significant delays in our ability to treat and bill for services provided to patients covered under government programs, it could cause us to incur write-offs of investments or accelerate the recognition of lease obligations in the event we have to close centers or our centers operating performance deteriorates, and it could have an adverse effect on our revenues, earnings and cash flows.
If our joint ventures were found to violate the law, we could suffer severe consequences that would have a material adverse effect on our revenues, earnings and cash flows.
As of December 31, 2011, we owned a controlling interest in numerous dialysis-related joint ventures, which represented approximately 18% of our dialysis and related lab services revenues for the year ended December 31, 2011. In addition, we also owned minority equity investments in several other dialysis related joint ventures. We anticipate that we will continue to increase the number of our joint ventures. Many of our joint ventures with physicians or physician groups also have the physician owners providing medical director services
28
to those centers or other centers we own and operate. Because our relationships with physicians are governed by the federal anti-kickback statute, we have sought to structure our joint venture arrangements to satisfy as many safe harbor requirements as we believe are reasonably possible. However, our joint venture arrangements do not satisfy all elements of any safe harbor under the federal anti-kickback statute (and possibly the Stark Law). The subpoena and related requests for documents we received from the U.S. Attorneys Office for the Eastern District of Missouri in the 2005 U.S. Attorney investigation, the OIGs Office in Dallas in the 2010 U.S. Attorney physician relationship investigation and the U.S. Attorneys Office for the District of Colorado in the 2011 U.S. Attorney physician relationship investigation, included requests for documents related to our joint ventures. We were advised by the U.S. Department of Justice that it is conducting civil and grand jury investigations into our financial relationships with physicians.
If our joint ventures are found to be in violation of the anti-kickback statute or the Stark Law provisions, we could be required to restructure the joint ventures or refuse to accept referrals for designated health services from the physicians with whom the joint venture centers have a financial relationship.
We also could be required to repay amounts received by the joint ventures from Medicare and certain other payors to the extent that these arrangements are found to give rise to prohibited referrals, and we could be subject to monetary penalties and exclusion from government healthcare programs. If our joint venture centers are subject to any of these penalties, we could suffer severe consequences that would have a material adverse effect on our revenues, earnings and cash flows.
There are significant estimating risks associated with the amount of dialysis revenue and related refund liabilities that we recognize and if we are unable to accurately estimate our revenue and related refund liabilities, it could impact the timing and the amount of our revenue recognition or have a significant impact on our operating results.
There are significant estimating risks associated with the amount of dialysis and related lab services revenues and related refund liabilities that we recognize in a reporting period. The billing and collection process is complex due to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage, and other payor issues. Determining applicable primary and secondary coverage for approximately 142,000 U.S. patients at any point in time, together with the changes in patient coverage that occur each month, requires complex, resource-intensive processes. Errors in determining the correct coordination of benefits may result in refunds to payors. Revenues associated with Medicare and Medicaid programs are also subject to estimating risk related to the amounts not paid by the primary government payor that will ultimately be collectible from other government programs paying secondary coverage, the patients commercial health plan secondary coverage or the patient. Collections, refunds and payor retractions typically continue to occur for up to three years and longer after services are provided. We generally expect our range of dialysis and related lab services revenues estimating risk to be within 1% of revenues for the segment, which can represent as much as 6% of consolidated operating income. If our estimates of dialysis and related lab services revenues and related refund liabilities are materially inaccurate, it could impact the timing and the amount of our revenue recognition and have a significant impact on our operating results.
The ancillary services we provide or the strategic initiatives, including our international dialysis operations, that we invest in now or in the future may generate losses and may ultimately be unsuccessful. In the event that one or more of these activities is unsuccessful, we may have to write off our investment and incur other exit costs.
Our ancillary services and strategic initiatives currently include pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs, physician services and our international dialysis operations. We expect to add additional service offerings and pursue additional strategic initiatives in the future as circumstances warrant, which could include healthcare services not related to dialysis. Many of these initiatives require or would require investments of both management and
29
financial resources and can generate significant losses for a substantial period of time and may not become profitable. There can be no assurance that any such strategic initiative will ultimately be successful. Any significant change in market conditions, or business performance, or in the political, legislative or regulatory environment, may impact the economic viability of any of these strategic initiatives. For example, during 2011 and 2010, several of our strategic initiatives generated net operating losses and some are expected to generate net operating losses in 2012. If any of our ancillary services or strategic initiatives, including our international dialysis operations, do not perform as planned, we may incur a material write-off or an impairment of our investment, including goodwill, in one or more of these activities or we could incur significant termination costs if we were to exit a certain line of business. As an example, during the second quarter of 2011 we recorded a goodwill impairment charge of $24 million related to a decrease in the implied fair value of goodwill below its carrying amount associated with our infusion therapy business.
If a significant number of physicians were to cease referring patients to our dialysis centers, whether due to regulatory or other reasons, it would have a material adverse effect on our revenues, earnings and cash flows.
We believe that physicians prefer to have their patients treated at dialysis centers where they or other members of their practice supervise the overall care provided as medical director of the center. As a result, the primary referral source for most of our centers is often the physician or physician group providing medical director services to the center. Neither our current nor former medical directors have an obligation to refer their patients to our centers. If a medical director agreement terminates, whether before or at the end of its term, and a new medical director is appointed, it may negatively impact the former medical directors decision to treat his or her patients at our center. If we are unable to enforce noncompetition provisions contained in the terminated medical director agreements, former medical directors may choose to provide medical director services for competing providers or establish their own dialysis centers in competition with ours. Also, if the quality of service levels at our centers deteriorates, it may negatively impact patient referrals and treatment volumes.
Our medical director contracts are for fixed periods, generally three to ten years, and at any given time a large number of them could be up for renewal at the same time. Medical directors have no obligation to extend their agreements with us, and there are a number of factors, including opportunities presented by our competitors or different affiliation models in the changing healthcare environment, that could negatively impact their decisions to extend their agreements with us. In addition, we may take actions to restructure existing relationships or take positions in negotiating extensions of relationships to assure compliance with the anti-kickback statute, Stark Law and other similar laws. These actions also could negatively impact the decision of physicians to extend their medical director agreements with us or to refer their patients to us. If the terms of any existing agreement are found to violate applicable laws, we may not be successful in restructuring the relationship which could lead to the early termination of the agreement, or cause the physician to stop referring patients to our dialysis centers. If a significant number of physicians were to cease referring patients to our dialysis centers, whether due to regulatory or other reasons, then our revenues, earnings and cash flows would be substantially reduced.
Current economic conditions as well as further disruptions in the financial markets could have a material adverse effect on our revenues, earnings and cash flows and otherwise adversely affect our financial condition.
Current economic conditions could adversely affect our business and our profitability. Among other things, the potential decline in federal and state revenues that may result from such conditions may create additional pressures to contain or reduce reimbursements for our services from Medicare, Medicaid and other government sponsored programs. Increasing job losses or slow improvement in the unemployment rate in the United States as a result of current or recent economic conditions has and may continue to result in a smaller percentage of our patients being covered by an employer group health plan and a larger percentage being covered by lower paying Medicare and Medicaid programs. Employers may also begin to select more restrictive commercial plans with
30
lower reimbursement rates. To the extent that payors are negatively impacted by a decline in the economy, we may experience further pressure on commercial rates, a further slowdown in collections and a reduction in the amounts we expect to collect. In addition, uncertainty in the financial markets could adversely affect the variable interest rates payable under our credit facilities or could make it more difficult to obtain or renew such facilities or to obtain other forms of financing in the future. Any or all of these factors, as well as other consequences of the current economic conditions which cannot currently be anticipated, could have a material adverse effect on our revenues, earnings and cash flows and otherwise adversely affect our financial condition.
We may engage in acquisitions, mergers or dispositions, which may affect our results of operations, debt-to-capital ratio, capital expenditures or other aspects of our business.
We may engage in acquisitions, mergers or dispositions, which may affect our results of operations, debt-to-capital ratio, capital expenditures, or other aspects of our business. There can be no assurance that we will be able to identify suitable acquisition targets or merger partners or that, if identified, we will be able to acquire these targets on acceptable terms or agree to terms with merger partners. There can also be no assurance that we will be successful in completing any acquisitions, mergers or dispositions that we might be considering or announce, or integrating any acquired business into our overall operations or operate them successfully as stand-alone businesses, or that any such acquired business will operate profitably or will not otherwise adversely impact our results of operations. Further, we cannot be certain that key talented individuals at the business being acquired will continue to work for us after the acquisition or that they will be able to continue to successfully manage or have adequate resources to successfully operate any acquired business.
If we are not able to continue to make acquisitions, or maintain an acceptable level of non-acquired growth, or if we face significant patient attrition to our competitors or a reduction in the number of our medical directors, it could adversely affect our business.
The dialysis industry is highly competitive, particularly in terms of acquiring existing dialysis centers. We continue to face increased competition in the U.S. dialysis industry from large and medium-sized providers which compete directly with us for acquisition targets as well as for individual patients and medical directors. In addition, as we continue our international dialysis expansion into various international markets, we will face competition from large and medium-sized providers for these acquisition targets as well. Acquisitions, patient retention and medical director retention are an important part of our growth strategy. Because of the ease of entry into the dialysis business and the ability of physicians to be medical directors for their own centers, competition for growth in existing and expanding markets is not limited to large competitors with substantial financial resources. Occasionally, we have experienced competition from former medical directors or referring physicians who have opened their own dialysis centers. In addition, Fresenius, our largest competitor, manufactures a full line of dialysis supplies and equipment in addition to owning and operating dialysis centers. This may give it cost advantages over us because of its ability to manufacture its own products. If we are not able to continue to make acquisitions, continue to maintain acceptable levels of non-acquired growth, or if we face significant patient attrition to our competitors or a reduction in the number of our medical directors, it could adversely affect our business.
If businesses we acquire have liabilities that we are not aware of, we could suffer severe consequences that would substantially reduce our earnings and cash flows.
Our business strategy includes the acquisition of dialysis centers and businesses that own and operate dialysis centers, as well as other ancillary and non-dialysis services and strategic initiatives. Businesses we acquire may have unknown or contingent liabilities or liabilities that are in excess of the amounts that we originally estimated. Although we generally seek indemnification from the sellers of businesses we acquire for matters that are not properly disclosed to us, we are not always successful. In addition, even in cases where we are able to obtain indemnification, we may discover liabilities greater than the contractual limits or the financial resources of the indemnifying party. In the event that we are responsible for liabilities substantially in excess of any amounts recovered through rights to indemnification, we could suffer severe consequences that would substantially reduce our earnings and cash flows.
31
Expansion of our operations to and offering our services in markets outside of the United States subjects us to political, legal, operational and other risks that could adversely affect our business, results of operations and cash flows.
We are undertaking an expansion of our operations and are in the early stages of offering our services outside of the United States, which increases our exposure to the inherent risks of doing business in international markets. Depending on the market, these risks include, without limitation, those relating to:
| changes in the local economic environment; |
| political instability, armed conflicts or terrorism; |
| social changes; |
| intellectual property legal protections and remedies; |
| trade regulations; |
| procedures and actions affecting approval, production, pricing, reimbursement and marketing of products and services; |
| foreign currency; |
| repatriating or moving to other countries cash generated or held abroad, including considerations relating to tax-efficiencies and changes in tax laws; |
| export controls; |
| lack of reliable legal systems which may affect our ability to enforce contractual rights; |
| changes in local laws or regulations; |
| potentially longer payment and collection cycles; and |
| financial and operational, and information technology systems integration. |
Conducting international operations requires us to devote significant management resources to implement our controls and systems in new markets, to comply with local laws and regulations and to overcome the numerous new challenges inherent in managing international operations, including those based on differing languages, cultures and regulatory environments, and those related to the timely hiring, integration and retention of a sufficient number of skilled personnel to carry out operations.
We anticipate expanding our international operations through acquisitions of varying sizes or through organic growth, which could increase these risks. Additionally, though we might invest material amounts of capital and incur significant costs in connection with the growth and development of our international operations, there is no assurance that we will be able to operate them profitably anytime soon, if at all. As a result, we would expect these costs to be dilutive to our earnings over the next several years as we start-up or acquire new operations.
These risks could have a material adverse effect on our financial condition, results of operations and cash flows.
The level of our current and future debt could have an adverse impact on our business and our ability to generate cash to service our indebtedness depends on many factors beyond our control.
We have substantial debt outstanding and we may incur additional indebtedness in the future. The high level of our indebtedness, among other things, could:
| make it difficult for us to make payments on our debt securities; |
| increase our vulnerability to general adverse economic and industry conditions; |
32
| require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and investments and other general corporate purposes; |
| limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate; |
| place us at a competitive disadvantage compared to our competitors that have less debt; and |
| limit our ability to borrow additional funds. |
Our ability to make payments on our indebtedness and to fund planned capital expenditures and expansion efforts, including any strategic acquisitions we may make in the future, will depend on our ability to generate cash. This, to a certain extent, is subject to general economic, financial, competitive, regulatory and other factors that are beyond our control.
We cannot provide assurance that our business will generate sufficient cash flow from operations in the future or that future borrowings will be available to us in an amount sufficient to enable us to service our indebtedness or to fund other liquidity needs. The borrowings under our Senior Credit Agreement are guaranteed by substantially all of our direct and indirect wholly-owned domestic subsidiaries and are secured by substantially all of DaVitas and its guarantors assets.
Increases in interest rates may increase our interest expense and adversely affect our earnings and cash flow and our ability to service our indebtedness.
A portion of our outstanding debt bears interest at variable rates. We are subject to LIBOR-based interest rate volatility from a floor of 1.50% to a cap of 4.00% on $1.25 billion notional amounts of our Term Loan B outstanding debt as a result of several interest rate cap agreements that were entered into in January 2011. The remaining $483 million of outstanding debt on the Term Loan B is subject to LIBOR-based interest rate volatility above a floor of 1.50%. At December 31, 2011, we were also subject to LIBOR-based interest rate volatility above a floor of 1.00% on $199.5 million of outstanding debt associated with our Term Loan A-2.
We also have approximately $350 million of additional borrowings available under our new Senior Secured Credit Facilities that are subject to LIBOR-based interest rate volatility. We may also incur additional variable rate debt in the future. Increases in interest rates would increase our interest expense of the variable portion of our indebtedness, which could negatively impact our earnings and cash flow and our ability to service our indebtedness which would be particularly significant in the event of rapid and substantial increases in interest rates.
At December 31, 2011, if interest rates were to hypothetically increase by 100 basis points it would have increased our interest expense by approximately $0.6 million, which increase solely relates to our Term Loan A-2 that is subject to LIBOR-based interest rate volatility above a floor of 1.00%.
However, interest expense would not be impacted by any LIBOR-based interest rate volatility associated with our other Term Loans since all of our Term Loan A is economically fixed and our Term Loan B is subject to LIBOR-based interest rate volatility above a floor of 1.50%, as described above. The current LIBOR rate in effect, plus a hypothetical increase of 100 basis points, is currently less than our Term Loan B floor of 1.50%. Therefore, LIBOR-based interest rates would have to increase above a floor of 1.50% for the Term Loan B to have a negative impact on our financial results. See Item 3Quantitative and Qualitative Disclosures about Market Risk for more information.
If there are shortages of skilled clinical personnel or if we experience a higher than normal turnover rate, we may experience disruptions in our business operations and increases in operating expenses.
We are experiencing increased labor costs and difficulties in hiring nurses due to a nationwide shortage of skilled clinical personnel. We compete for nurses with hospitals and other health care providers. This nursing
33
shortage may limit our ability to expand our operations. In addition, changes in certification requirements or increases in the required staffing levels for skilled clinical personnel can impact our ability to maintain sufficient staff levels to the extent our teammates are not able to meet new requirements or competition for qualified individuals increases. If we are unable to hire skilled clinical personnel when needed, or if we experience a higher than normal turnover rate for our skilled clinical personnel, our operations and treatment growth will be negatively impacted, which would result in reduced revenues, earnings and cash flows.
Our business is labor intensive and could be adversely affected if we were unable to maintain satisfactory relations with our employees or if union organizing activities were to result in significant increases in our operating costs or decreases in productivity.
Our business is labor intensive, and our results are subject to variations in labor-related costs, productivity and the number of pending or potential claims against us related to labor and employment practices. If political efforts at the national and local level result in actions or proposals that increase the likelihood of union organizing activities at our facilities or if union organizing activities increase for other reasons, or if labor and employment claims, including the filing of class action suits, trend upwards, our operating costs could increase and our employee relations, productivity, earnings and cash flows could be adversely affected.
Upgrades to our billing and collections systems and complications associated with upgrades and other improvements to our billing and collections systems could have a material adverse effect on our revenues, cash flows and operating results.
We are continuously performing upgrades to our billing systems and expect to continue to do so in the near term. In addition, we continuously work to improve our billing and collections performance through process upgrades, organizational changes and other improvements. We may experience difficulties in our ability to successfully bill and collect for services rendered as a result of these changes, including a slow-down of collections, a reduction in the amounts we expect to collect, increased risk of retractions from and refunds to commercial and government payors, an increase in our provision for uncollectible accounts receivable and noncompliance with reimbursement regulations. The failure to successfully implement the upgrades to the billing and collection systems and other improvements could have a material adverse effect on our revenues, cash flows and operating results.
Our ability to effectively provide the services we offer could be negatively impacted if certain of our suppliers are unable to meet our needs or if we are unable to effectively access new technology, which could substantially reduce our revenues, earnings and cash flows.
We have significant suppliers that are either the sole or primary source of products critical to the services we provide, including Amgen, Baxter Healthcare Corporation, NxStage Medical, Inc. and others or to which we have committed obligations to make purchases including Gambro Renal Products and Fresenius. If any of these suppliers are unable to meet our needs for the products they supply, including in the event of a product recall, or shortage, and we are not able to find adequate alternative sources, or if some of the drugs that we purchase are not reimbursed through the bundled payment rate by Medicare, our revenues, earnings and cash flows could be substantially reduced. In addition, the technology related to the products critical to the services we provide is subject to new developments and may result in superior products. If we are not able to access superior products on a cost-effective basis or if suppliers are not able to fulfill our requirements for such products, we could face patient attrition which could substantially reduce our revenues, earnings and cash flows.
We may be subject to liability claims for damages and other expenses not covered by insurance that could reduce our earnings and cash flows.
The administration of dialysis and related services to patients may subject us to litigation and liability for damages. Our business, profitability and growth prospects could suffer if we face negative publicity or we pay
34
damages or defense costs in connection with a claim that is outside the scope of any applicable insurance coverage, including claims related to adverse patient events, contractual disputes and professional and general liability claims. In addition, we have received several notices of claims from commercial payors and other third parties related to our historical billing practices and the historical billing practices of the centers acquired from Gambro Healthcare and other matters related to their settlement agreement with the Department of Justice. Although the ultimate outcome of these claims cannot be predicted, an adverse result with respect to one or more of these claims could have a material adverse effect on our financial condition, results of operations, and cash flows. We currently maintain programs of general and professional liability insurance. However, a successful claim, including a professional liability, malpractice or negligence claim which is in excess of our insurance coverage could have a material adverse effect on our earnings and cash flows.
In addition, if our costs of insurance and claims increase, then our earnings could decline. Market rates for insurance premiums and deductibles have been steadily increasing. Our earnings and cash flows could be materially and adversely affected by any of the following:
| the collapse or insolvency of our insurance carriers; |
| further increases in premiums and deductibles; |
| increases in the number of liability claims against us or the cost of settling or trying cases related to those claims; and |
| an inability to obtain one or more types of insurance on acceptable terms, if at all. |
Provisions in our charter documents, compensation programs and Delaware law may deter a change of control that our stockholders would otherwise determine to be in their best interests.
Our charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in our management, or limit the ability of our stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting our stockholders from acting by written consent; requiring 90 days advance notice of stockholder proposals or nominations to our Board of Directors; and granting our Board of Directors the authority to issue preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.
Most of our outstanding employee stock options include a provision accelerating the vesting of the options in the event of a change of control. We also maintain a change of control protection program for our employees who do not have a significant number of stock awards, which has been in place since 2001, and which provides for cash bonuses to the employees in the event of a change of control. Based on the market price of our common stock and shares outstanding on December 31, 2011, these cash bonuses would total approximately $277 million if a change of control transaction occurred at that price and our Board of Directors did not modify this program. These change of control provisions may affect the price an acquirer would be willing to pay for our Company.
We are also subject to Section 203 of the Delaware General Corporation Law that, subject to exceptions, would prohibit us from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder.
These provisions may discourage, delay or prevent an acquisition of our Company at a price that our stockholders may find attractive. These provisions could also make it more difficult for our stockholders to elect directors and take other corporate actions and could limit the price that investors might be willing to pay for shares of our common stock.
Item 1B. | Unresolved Staff Comments. |
None.
35
Item 2. | Properties. |
We own the land and buildings for 25 of our outpatient dialysis centers. We also own the buildings for seven other outpatient dialysis centers and the building at one of our Florida labs and we own two separate land parcels and sublease a total of five properties to third-party tenants. In addition, we also own the land associated with the development of our new corporate headquarters. Our remaining outpatient dialysis centers are located on premises that we lease.
Our leases generally cover periods from five to ten years but in some cases can extend for 15 years and typically contain renewal options of five to ten years at the fair rental value at the time of renewal. Our leases are generally subject to periodic consumer price index increases, or contain fixed escalation clauses. Our outpatient dialysis centers range in size from approximately 500 to 30,000 square feet, with an average size of approximately 6,800 square feet.
The following is a summary of our business, administrative offices, laboratories and pharmacies:
Office |
Location |
Square Feet | Expiration |
|||||||
Corporate Headquarters |
Denver, CO | 89,000 | 2012 | |||||||
Administrative Office |
Vernon Hills, IL | 29,000 | 2013 | |||||||
Administrative Office |
Burlingame, CA | 3,725 | 2012 | |||||||
Administrative Office |
Norfolk, VA | 20,000 | 2015 | |||||||
Administrative Office |
Tempe, AZ | 11,000 | 2016 | |||||||
Administrative Office |
Washington, DC | 5,000 | 2013 | |||||||
Business Office |
El Segundo, CA | 61,000 | 2013 | |||||||
Business Office |
Tacoma, WA | 201,000 | 2013 through 2021 | |||||||
Business Office |
Berwyn, PA | 182,000 | 2012 through 2022 | |||||||
Business Office |
Lakewood, CO | 82,000 | 2012 | |||||||
Business Office |
Brentwood, TN | 95,000 | 2021 | |||||||
Business Office |
Irvine, CA | 65,000 | 2015 | |||||||
Business Office |
Nashville, TN | 35,000 | 2017 | |||||||
Business Office |
Franklin, TN | 9,500 | 2013 | |||||||
DaVita Rx |
Orlando, FL | 17,000 | 2013 | |||||||
DaVita Rx |
Coppell, TX | 95,600 | 2013 | |||||||
DaVita Rx |
San Bruno, CA | 7,000 | 2015 | |||||||
Lab Warehouse |
DeLand, FL | 11,000 | 2015 | |||||||
Laboratory |
DeLand, FL | 40,000 | Owned | |||||||
Laboratory |
DeLand, FL | 20,000 | 2015 | |||||||
Laboratory |
Ft. Lauderdale, FL | 43,000 | 2015 | |||||||
Laboratory Administrative Office |
DeLand, FL | 23,000 | 2012 |
Some of our outpatient dialysis centers are operating at or near capacity. However, we believe that we have adequate capacity within most of our existing dialysis centers to accommodate additional patient volume through increased hours and/or days of operation, or, if additional space is available within an existing facility, by adding dialysis stations. We can usually relocate existing centers to larger facilities or open new centers if existing centers reach capacity. With respect to relocating centers or building new centers, we believe that we can generally lease space at economically reasonable rates in the areas planned for each of these centers, although there can be no assurances in this regard. Expansion of existing centers or relocation of our dialysis centers is subject to review for compliance with conditions relating to participation in the Medicare ESRD program. In states that require a certificate of need or center license, additional approvals would generally be necessary for expansion or relocation.
36
Item 3. | Legal Proceedings. |
Inquiries by the Federal Government and Certain Related Civil Proceedings
2005 U.S. Attorney Investigation: In March 2005, we received a subpoena from the U.S. Attorneys Office for the Eastern District of Missouri in St. Louis. The subpoena required production of a wide range of documents relating to our operations, including documents related to, among other things, pharmaceutical and other services provided to patients, relationships with pharmaceutical companies, and financial relationships with physicians and joint ventures. The subpoena covers the period from December 1, 1996 through March 2005. In October 2005, we received a follow-up request for additional documents related to specific medical director and joint venture arrangements. In February 2006, we received an additional subpoena for documents, including certain patient records relating to the administration and billing of EPO. In May 2007, we received a request for documents related to durable medical equipment and supply companies owned and operated by us. We cooperated with the inquiry and have produced the requested records. The subpoenas were issued in connection with a joint civil and criminal investigation. It is possible that criminal proceedings may be initiated against us in connection with this investigation. We have not received a communication from the St. Louis U.S. Attorneys Office on this matter in over two years.
Woodard Private Civil Suit: In February 2007, we received a request for information from the Office of Inspector General, U.S. Department of Health and Human Services, or OIG, for records relating to EPO claims submitted to Medicare. In August 2007, we received a subpoena from the OIG seeking similar documents. The requested documents relate to services provided from 2001 to 2004 by a number of our centers. The request and subpoena were sent from the OIGs offices in Houston and Dallas, Texas. We cooperated with the inquiry and have produced all previously requested records to date. We were contacted by the U.S. Attorneys Office for the Eastern District of Texas, which stated that this was a civil investigation related to EPO claims. On July 6, 2009, the United States District Court for the Eastern District of Texas lifted the seal on the civil qui tam complaint related to these previous requests for information. We were subsequently served with a complaint by the relator, Ivey Woodard, purportedly on behalf of the federal government, under the qui tam provisions of the federal False Claims Act. The government did not intervene and is not actively pursuing this matter. The relator is pursuing the claims independently and the parties are engaged in active litigation. The complaint contains allegations relating to our EPO practices for the period from 1992 through 2010 and seeks monetary damages and civil penalties as well as costs and expenses. The court has ruled that claims earlier than 1996 are beyond the statute of limitations. We believe that there is some overlap between the subject of this complaint and the review of EPO utilization in the 2005 U.S. Attorney investigation described above. We are vigorously defending this matter and intend to continue to do so. We can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
Vainer Private Civil Suit: In December 2008, we received a subpoena for documents from the OIG relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlecit and EPO, as well as other related matters. The subpoena covers the period from January 2003 to December 2008. We were in contact with the U.S. Attorneys Office for the Northern District of Georgia and the U.S. Department of Justice in Washington, DC, since November 2008 relating to this matter, and were advised that this was a civil inquiry. On June 17, 2009, we learned that the allegations underlying this inquiry were made as part of a civil complaint filed by individuals and brought pursuant to the qui tam provisions of the federal False Claims Act. On April 1, 2011, the United States District Court for the Northern District of Georgia ordered the case to be unsealed. At that time, the Department of Justice and U.S. Attorneys Office filed a notice of declination stating that the United States would not be intervening and not pursuing the relators allegation in litigation. On July 25, 2011, the relators, Daniel Barbir and Dr. Alon Vainer, filed their amended complaint in the United States District Court for the Northern District of Georgia, purportedly on behalf of the federal government. The allegations in the complaint relate to our drug administration practices for Vitamin D and iron agents for a period from 2003 through 2010. The complaint seeks monetary damages and civil penalties as well as costs and expenses. We are vigorously defending this matter and intend to continue to do so. We can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
37
2010 U.S. Attorney Physician Relationship Investigation: In May 2010, we received a subpoena from the OIGs office in Dallas, Texas. The subpoena covers the period from January 1, 2005 to May 2010, and seeks production of a wide range of documents relating to our operations, including documents related to, among other things, financial relationships with physicians and joint ventures. The general subject matter of the inquiry appears to overlap with the 2005 U.S. Attorney Investigation described above. We met with representatives of the government to discuss the scope of the subpoena and the production of responsive documents. We have been advised that this is a civil investigation. We are cooperating with the inquiry and are producing the requested records. We can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
2011 U.S. Attorney Physician Relationship Investigation: In August 2011, we announced we had learned that the U.S. Attorneys Office for the District of Colorado would be looking into certain activities of ours in connection with information being provided to a grand jury. We announced further that we understood that this investigation was at a very preliminary stage, and while its precise scope was unclear, it appeared to overlap, at least in part, with the 2005 U.S. Attorney Investigation and 2010 U.S. Attorney Physician Relationship Investigation described above. Subsequent to our announcement of this 2011 U.S. Attorney Physician Relationship Investigation, we received a subpoena for documents which substantially overlaps with the subpoena in the 2010 U.S. Attorney Physician Relationship Investigation described above and covers the period from January 2006 to September 2011. We are cooperating with the government and are producing the requested records. Certain current and former members of the Board and executives received subpoenas in November 2011 and thereafter to testify before the grand jury, and other Company representatives may also receive subpoenas for testimony related to this matter. We can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
2011 U.S. Attorney Medicaid Investigation: In October 2011, we announced that we would be receiving a request for documents, which could include an administrative subpoena from the Office of Inspector General for the U.S. Department of Health and Human Services. Subsequent to our announcement of this 2011 U.S. Attorney Medicaid Investigation, we received a request for documents in connection with the inquiry by the United States Attorneys Office for the Eastern District of New York. The request relates to payments for infusion drugs covered by Medicaid composite payments for dialysis. We believe this inquiry is civil in nature. We do not know the time period or scope. We understand that certain other providers that operate dialysis clinics in New York may be receiving or have received a similar request for documents. We intend to cooperate with the government to provide responsive documents.
Except for the private civil complaints filed by the relators as described above, to our knowledge, no proceedings have been initiated against us at this time in connection with any of the inquiries by the federal government. Although we cannot predict whether or when proceedings might be initiated or when these matters may be resolved, it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators. Responding to the subpoenas or inquiries and defending us in the relator proceedings will continue to require managements attention and significant legal expense. Any negative findings in the inquiries or relator proceedings could result in substantial financial penalties or awards against us, exclusion from future participation in the Medicare and Medicaid programs and, to the extent criminal proceedings may be initiated against us, possible criminal penalties. At this time, we cannot predict the ultimate outcome of these inquiries, or the potential outcome of the relators claims, or the potential range of damages, if any.
Other
We have received several notices of claims from commercial payors and other third parties related to historical billing practices and claims against DVA Renal Healthcare (formerly known as Gambro Healthcare), a subsidiary of ours, related to historical Gambro Healthcare billing practices and other matters covered by its 2004 settlement agreement with the Department of Justice and certain agencies of the U.S. government. We have
38
received no further indication that any of these claims are active, and some of them may be barred by applicable statutes of limitations. To the extent any of these claims might proceed, we intend to defend against them vigorously; however, we may not be successful and these claims may lead to litigation and any such litigation may be resolved unfavorably. At this time, we cannot predict the ultimate outcome of this matter or the potential range of damages, if any.
A wage and hour claim, which has been styled as a class action, is pending against us in the Superior Court of California. We were served with the complaint in this lawsuit in April 2008, and it has been amended since that time. The lawsuit, as amended, alleges that we failed to provide meal periods, failed to pay compensation in lieu of providing rest or meal periods, failed to pay overtime, and failed to comply with certain other California Labor Code requirements. In September 2011, the court denied the plaintiffs motion for class certification. Plaintiffs have appealed that decision. We intend to continue to vigorously defend against these claims. Any potential settlement of these claims is not anticipated to be material to our consolidated financial statements.
In October 2007, we were contacted by the Attorney Generals Office for the State of Nevada. The Attorney Generals Office informed us that it was conducting a civil and criminal investigation of our operations in Nevada and that the investigation related to the billing of pharmaceuticals, including EPO. In February 2008, the Attorney Generals Office informed us that the civil and criminal investigation had been discontinued. The Attorney Generals Office further advised us that Nevada Medicaid intended to conduct audits of end stage renal disease (ESRD) dialysis providers in Nevada and such audits would relate to the issues that were the subjects of the investigation. To our knowledge, no court proceedings have been initiated against us at this time. Any negative audit findings could result in a substantial repayment by us. At this time, we cannot predict the ultimate outcome of this matter or the potential range of damages, if any.
In June 2004, DVA Renal Healthcare was served with a complaint filed in the Superior Court of California by one of its former employees who worked for its California acute services program. The complaint, which is styled as a class action, alleges, among other things, that DVA Renal Healthcare failed to provide overtime wages, defined rest periods and meal periods, or compensation in lieu of such provisions and failed to comply with certain other California Labor Code requirements. The parties have reached an agreement, subject to approval by the court, which fully resolves this matter for an amount that did not materially impact our financial results.
In addition to the foregoing, we are subject to claims and suits, including from time to time, contractual disputes and professional and general liability claims, as well as audits and investigations by various government entities, in the ordinary course of business. We believe that the ultimate resolution of any such pending proceedings, whether the underlying claims are covered by insurance or not, will not have a material adverse effect on our financial condition, results of operations or cash flows.
Item 4. | Mine Safety Disclosures. |
Not applicable.
39
PART II
Item 5. | Market for the Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. |
Our common stock is traded on the New York Stock Exchange under the symbol DVA. The following table sets forth, for the periods indicated, the high and low closing prices for our common stock as reported by the New York Stock Exchange.
High | Low | |||||||
Year ended December 31, 2011: |
||||||||
1st quarter |
$ | 85.51 | $ | 69.07 | ||||
2nd quarter |
89.17 | 82.70 | ||||||
3rd quarter |
89.36 | 62.67 | ||||||
4th quarter |
76.81 | 60.64 | ||||||
Year ended December 31, 2010: |
||||||||
1st quarter |
$ | 64.19 | $ | 58.98 | ||||
2nd quarter |
66.63 | 60.43 | ||||||
3rd quarter |
69.03 | 56.83 | ||||||
4th quarter |
74.11 | 68.24 |
The closing price of our common stock on January 31, 2012 was $81.81 per share. According to The Bank of New York, our registrar and transfer agent, as of January 31, 2012, there were 9,240 holders of record of our common stock. We have not declared or paid cash dividends to holders of our common stock since 1994. We have no current plans to pay cash dividends and we are restricted from paying dividends under the terms of our Senior Secured Credit Facilities and the indentures governing our senior and senior subordinated notes. Also, see the heading Liquidity and capital resources under Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations and the notes to our consolidated financial statements.
Stock Repurchases
The following table summarizes our repurchases of our common stock during 2011:
Period |
Total Number of Shares Purchased |
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) |
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions) |
||||||||||||
March 131, 2011 |
162,300 | $ | 84.02 | 162,300 | $ | 667.9 | ||||||||||
April 130, 2011 |
969,100 | 87.08 | 969,100 | 583.5 | ||||||||||||
May 131, 2011 |
354,515 | 85.26 | 354,515 | 553.3 | ||||||||||||
June 130, 2011 |
2,224,171 | 84.45 | 2,224,171 | 365.4 | ||||||||||||
July 131, 2011 |
84,600 | 85.83 | 84,600 | 358.2 | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
3,794,686 | $ | 85.21 | 3,794,686 | ||||||||||||
|
|
|
|
|
|
(1) | On November 3, 2010, we announced that the Board of Directors authorized an additional $800 million for repurchases of our common stock. |
This stock repurchase program has no expiration date. We are authorized to make purchases from time to time in the open market or in privately negotiated transactions, depending upon market conditions and other
considerations. However, we are subject to share repurchase limitations under the terms of the Senior Secured Credit Facilities and the indentures governing our senior notes.
40
Item 6. | Selected Financial Data. |
The following financial and operating data should be read in conjunction with Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations and our consolidated financial statements filed as part of this report. The following table presents selected consolidated financial and operating data for the periods indicated. Effective January 1, 2009, we were required to present consolidated net income attributable to us and to noncontrolling interests on the face of the consolidated statement of income, which changed the presentation of minority interests (noncontrolling interests) in our consolidated statements of income. These consolidated financial results have been recast for all prior periods presented to reflect the retrospective application of adopting these new presentation and disclosure requirements for noncontrolling interests.
Year ended December 31, | ||||||||||||||||||||
2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
(in thousands, except share data) | ||||||||||||||||||||
Income statement data: |
||||||||||||||||||||
Net operating revenues |
$ | 6,982,214 | $ | 6,438,050 | $ | 6,100,648 | $ | 5,653,003 | $ | 5,257,425 | ||||||||||
Operating expenses and charges(1) |
5,851,432 | 5,441,490 | 5,161,020 | 4,783,977 | 4,348,770 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating income |
1,130,782 | 996,560 | 939,628 | 869,026 | 908,655 | |||||||||||||||
Debt expense(2) |
(241,090 | ) | (181,607 | ) | (185,755 | ) | (224,716 | ) | (257,147 | ) | ||||||||||
Debt refinancing and redemption charges |
| (74,382 | ) | | | | ||||||||||||||
Other income, net(3) |
2,982 | 3,419 | 3,706 | 12,410 | 22,459 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
892,674 | 743,990 | 757,579 | 656,720 | 673,967 | |||||||||||||||
Income tax expense |
315,744 | 260,052 | 278,213 | 235,443 | 245,478 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
576,930 | 483,938 | 479,366 | 421,277 | 428,489 | |||||||||||||||
Income from operations of discontinued operations, net of tax(4) |
1,221 | 281 | 393 | 43 | 154 | |||||||||||||||
Loss on disposal of discontinued operations, net of tax(4) |
(4,756 | ) | | | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
$ | 573,395 | $ | 484,219 | $ | 479,759 | $ | 421,320 | $ | 428,643 | ||||||||||
Less: Net income attributable to noncontrolling interests |
$ | (95,394 | ) | $ | (78,536 | ) | $ | (57,075 | ) | $ | (47,160 | ) | $ | (46,865 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income attributable to DaVita Inc. |
$ | 478,001 | $ | 405,683 | $ | 422,684 | $ | 374,160 | $ | 381,778 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Basic income from continuing operations per share attributable to DaVita Inc.(4) |
$ | 5.09 | $ | 3.99 | $ | 4.07 | $ | 3.56 | $ | 3.60 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted income from continuing operations per share attributable to DaVita Inc.(4) |
$ | 4.99 | $ | 3.93 | $ | 4.05 | $ | 3.53 | $ | 3.55 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted average shares outstanding:(6) |
||||||||||||||||||||
Basic |
94,658,000 | 101,504,000 | 103,604,000 | 105,149,000 | 105,893,000 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted |
96,532,000 | 103,059,000 | 104,168,000 | 105,940,000 | 107,418,000 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratio of earnings to fixed charges(5) |
3.31:1 | 3.44:1 | 3.58:1 | 3.01:1 | 2.92:1 | |||||||||||||||
Balance sheet data: |
||||||||||||||||||||
Working capital |
$ | 1,128,492 | $ | 1,698,509 | $ | 1,255,580 | $ | 965,233 | $ | 889,917 | ||||||||||
Total assets |
8,892,172 | 8,114,424 | 7,558,236 | 7,286,083 | 6,943,960 | |||||||||||||||
Long-term debt |
4,417,624 | 4,233,850 | 3,532,217 | 3,622,421 | 3,683,887 | |||||||||||||||
Total DaVita Inc. shareholders equity(6) |
2,141,075 | 1,978,422 | 2,135,066 | 1,767,747 | 1,504,285 |
(1) | Operating expenses and charges in 2011 include $24,000 of a non-cash goodwill impairment charge related to our infusion therapy business and $55,275 in 2007 of valuation gains on the alliance and product supply agreement with Gambro Renal Products, Inc. Operating expenses and charges in 2007 also includes $6,779 of gains from insurance settlements related to Hurricane Katrina and a fire that destroyed one center. |
41
(2) | Debt expense in 2007 includes the write-off of approximately $4.4 million of deferred financing costs associated with our principal prepayments on our term loans. |
(3) | Other income, net, includes $5,868 in 2007 of gains from the sale of investment securities. |
(4) | During 2011, we divested a total of 28 outpatient dialysis centers in conjunction with a consent order issued by the Federal Trade Commission on September 30, 2011 in order for us to complete the acquisition of DSI. In addition, we also completed the sale of two additional centers that were previously pending state regulatory approval in conjunction with the acquisition of DSI on October 31, 2011. The operating results of the historical DaVita divested centers are reflected as discontinued operations in our consolidated financial statements for all periods presented. In addition, the operating results for the DSI divested centers are reflected as discontinued operation in our consolidated financial statements beginning September 1, 2011. |
(5) | The ratio of earnings to fixed charges was computed by dividing earnings by fixed charges. Earnings for this purpose is defined as pretax income from continuing operations adjusted by adding back fixed charges expensed during the period. Fixed charges include debt expense (interest expense and the write-off and amortization of deferred financing costs), the estimated interest component of rental expense on operating leases, and capitalized interest. |
(6) | Share repurchases consisted of 3,794,686 shares of common stock for $323,348 in 2011, 8,918,760 shares of common stock for $618,496 in 2010, 2,902,619 shares of common stock for $153,495 in 2009, and 4,788,881 shares of common stock for $232,715 in 2008. Shares issued in connection with stock awards amounted to 1,260,259 in 2011, 1,771,384 in 2010, 2,104,304 in 2009, 1,314,074 in 2008, and 2,480,899 in 2007. |
42
Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations. |
Forward-looking statements
This Managements Discussion and Analysis of Financial Condition and Results of Operations contain statements that are forward-looking statements within the meaning of the federal securities laws. All statements that do not concern historical facts are forward-looking statements and include, among other things, statements about our expectations, beliefs, intentions and/or strategies for the future. These forward-looking statements include statements regarding our future operations, financial condition and prospects, expectations for treatment growth rates, revenue per treatment, expense growth, levels of the provision for uncollectible accounts receivable, operating income, cash flow, operating cash flow, estimated tax rates, capital expenditures, the development of new centers and center acquisitions, government and commercial payment rates, revenue estimating risk and the impact of our related level of indebtedness on our financial performance, including earnings per share. These statements involve substantial known and unknown risks and uncertainties that could cause our actual results to differ materially from those described in the forward-looking statements, including, but not limited to, risks resulting from uncertainties associated with government regulations, general economic and other market conditions, competition, accounting estimates, the variability of our cash flows, the concentration of profits generated from commercial payor plans, continued downward pressure on average realized payment rates from commercial payors, which may result in the loss of revenue or patients, a reduction in the number of patients under higher-paying commercial plans, a reduction in government payment rates under the Medicare ESRD program or other government-based programs, the impact of health care legislation that was enacted in the United States in March 2010, changes in pharmaceutical or anemia management practice patterns, payment policies or pharmaceutical pricing, our ability to maintain contracts with physician medical directors, legal compliance risks, including our continued compliance with complex government regulations, current or potential investigations by various government entities and related government or private-party proceedings, continued increased competition from large and medium-sized dialysis providers that compete directly with us, our ability to complete any acquisitions, mergers or dispositions that we might be considering or announce, or integrate and successfully operate any business we may acquire, expansion of our operations and services to markets outside the United States, or to businesses outside of dialysis and the risk factors set forth in this Annual Report on Form 10-K. We base our forward-looking statements on information currently available to us, and we undertake no obligation to update or revise these statements, whether as a result of changes in underlying factors, new information, future events or otherwise.
The following should be read in conjunction with our consolidated financial statements and Item 1. Business.
Overview
We are a leading provider of kidney dialysis services, primarily in the United States, through a network of approximately 1,809 outpatient dialysis centers and approximately 900 hospitals, located in the United States throughout 43 states and District of Columbia, serving a total of approximately 142,000 patients. We estimate that we have approximately a 32% market share in the United States based upon the number of patients that we serve. In 2011, our overall network of dialysis centers increased by 208 centers primarily as a result of acquisitions and from opening new centers. In September 2011 we acquired DSI, a medium sized dialysis provider, for approximately $723 million in net cash plus the assumption of certain liabilities. DSI contributed a net 83 dialysis centers, after which we agreed to divest a total of 30 dialysis centers in order to complete the acquisition of DSI. In addition, the overall number of patients that we serve in the U.S. increased by approximately 13.0% as compared to 2010.
In addition, as of December 31, 2011, we provided dialysis and administrative services to a total of 11 outpatient dialysis centers located in three countries outside of the United States. Our international dialysis operations are currently in a start-up phase in which we primarily commenced operations during the fourth quarter of 2011. The total net operating revenues generated from our international operations were not material
43
during 2011 and are included as a component of our ancillary services and strategic initiatives. Therefore, all references in this document to dialysis and related lab services continue to refer only to our U.S. dialysis and related lab services business for the year ended December 31, 2011.
Our national scale and size, among other things, allows us to provide industry-leading quality care with superior clinical outcomes that attracts patients and referring physicians, as well as qualified medical directors, provides our patient base with convenient locations and access to a full range of services and provides us the ability to effectively control certain costs while maintaining strong compliance programs.
Our stated mission is to be the provider, partner and employer of choice. We believe our attention to these three stakeholdersour patients, our business partners, and our teammatesrepresents the major driver of our long-term performance, although we are subject to the impact of external factors such as government policy and physician practice patterns. Accordingly, two principal non-financial metrics we track are quality clinical outcomes and teammate turnover. We have developed our own composite index for measuring improvements in our clinical outcomes, which we refer to as the DaVita Quality Index, or DQI. Our clinical outcomes as measured by DQI have improved over each of the past three years which we believe directly decreases patient mortalities. Although it is difficult to reliably measure clinical performance across our industry, we believe our clinical outcomes compare favorably with other dialysis providers in the United States and generally exceed the dialysis outcome quality indicators of the National Kidney Foundation. In addition, over the past several years our teammate turnover has remained relatively constant, which we believe was a major contributor to our continued clinical performance improvements and also a major driver of our ability to maintain or improve clinical hours per treatment. We will continue to focus on these stakeholders and our clinical outcomes as we believe these are fundamental long-term value drivers.
Our overall financial performance was strong for 2011 and was characterized by strong treatment volume growth, primarily from acquisitions and non-acquired growth rates and by decreased operating costs from a decline in the utilization of physician-prescribed pharmaceuticals due to continued evolution of clinical practices and physicians responding to the new FDA label for EPO.
Our major financial operating performance indicators in 2011 as compared to 2010 were as follows:
| consolidated revenue growth of approximately 8.5%; |
| an increase of approximately 9.1% in the overall number of treatments that we provided; |
| normalized non-acquired treatment growth of 4.6%; |
| consolidated operating income growth of approximately 13.4%, which includes the impact of a noncash goodwill impairment charge of 2.4%; |
| effective operating cost control initiatives; and |
| strong operating cash flows of $1,180 million. |
However, we believe that 2012 will continue to be challenging as we implement some additional Medicare billing requirements and as we implement system and process upgrades to enhance our ability to capture certain patient characteristics that can impact our overall reimbursements from Medicare. In addition, there remains significant scrutiny and uncertainty around the utilization of physician-prescribed pharmaceuticals, which along with pharmaceutical cost increases and changes in certain government policies, can have a significant impact on our operating results. We are also committed to our international expansion plans that will continue to require a significant investment in 2012. In addition, if the percentage of our patients with commercial payors continues to deteriorate this would also impact our operating results.
Approximately 93% of our 2011 consolidated net operating revenues were derived directly from our dialysis and related lab services business. Approximately 81% of our 2011 dialysis and related lab services revenues were derived from outpatient hemodialysis services in the 1,776 U.S. centers that we consolidate. Other dialysis
44
services, which are operationally integrated with our dialysis operations, are peritoneal dialysis, home-based hemodialysis, hospital inpatient hemodialysis services and management and administrative services. These services collectively accounted for the balance of our 2011 dialysis and related lab services revenues.
Our other business operations include ancillary services and strategic initiatives which are primarily aligned with our core business of providing dialysis services to our network of patients. These consist primarily of pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs, physician services and our international dialysis operations. These services generated approximately $514 million of net operating revenues in 2011, representing approximately 7% of our consolidated net operating revenues. We currently expect to continue to invest in our ancillary services and strategic initiatives including our continued expansion into certain international markets as we work to develop successful new business operations in the United States as well as outside the United States. However, any significant change in market conditions, business performance or in the regulatory environment may impact the economic viability of any of these strategic initiatives. Any unfavorable changes in these strategic initiatives could result in a write-off or an impairment of some or all of our investments, including goodwill, which occurred in 2011 when we recorded a non-cash goodwill impairment charge relating to our infusion therapy business, and could also result in significant termination costs if we were to exit a certain line of business.
The principal drivers of our dialysis and related lab services revenues are:
| the number of treatments, which is primarily a function of the number of chronic patients requiring approximately three treatments per week, as well as, to a lesser extent, the number of treatments for peritoneal dialysis services and home-based dialysis and hospital inpatient dialysis services; and |
| average dialysis revenue per treatment. |
The total patient base is a relatively stable factor, which we believe is influenced by a demographically growing need for dialysis services, our relationships with referring physicians, together with the quality of our clinical care which can lead to reduced patient mortalities, and our ability to open and acquire new dialysis centers. In 2011, we were able to increase our overall network of patients that we serviced in the U.S. by approximately 13% as compared to 2010.
Our average dialysis and related lab services revenue per treatment in 2011 was primarily driven by our mix of commercial and government (principally Medicare and Medicaid) patients, commercial and government payment rates, our billing and collecting operations performance, and the mix and intensity of physician-prescribed pharmaceuticals that are separately billable. Beginning in 2011, with the implementation of Medicares new single bundled payment rate system, the intensities of physician-prescribed pharmaceuticals had a lesser impact on our average dialysis and related lab services revenue per treatment since payment for these pharmaceuticals is included in a single bundled payment. In addition, some of our commercial contracts covering certain patients also pay us under a single bundled payment rate for all dialysis services provided.
On average, payment rates from commercial payors are significantly higher than Medicare, Medicaid and other government program payment rates, and therefore the percentage of commercial patients to total patients represents a major driver of our total average dialysis revenue per treatment. The percentage of commercial patients covered under contracted plans as compared to commercial patients with out-of-network providers can also significantly affect our average dialysis revenue per treatment. In 2011, the growth of our government-based patients continued to outpace the growth of our commercial patients, which has been a trend that we have experienced for the past several years. We believe the growth in our government-based patients is driven primarily by improved mortality and the current economic environment, which impacts the number of individuals that are covered under commercial insurance plans. This trend has negatively impacted our average dialysis revenue per treatment as a result of receiving a larger proportion of our revenue from government-based payors, such as Medicare, that reimburse us at lower payment rates.
45
The following table summarizes our dialysis and related lab services revenues for the year ended December 31, 2011:
Revenues | ||||
Medicare and Medicare-assigned plans |
58 | % | ||
Medicaid and Medicaid-assigned plans |
5 | % | ||
Other government-based programs |
3 | % | ||
|
|
|||
Total government-based programs |
66 | % | ||
Commercial (including hospital dialysis services) |
34 | % | ||
|
|
|||
Total dialysis and related lab services revenues |
100 | % | ||
|
|
Government payment rates in the United States are principally determined by federal Medicare and state Medicaid policy. These payment rates have historically had limited potential for rate increases and are sometimes at risk of reduction as federal and state governments face increasing budget pressures. On January 1, 2011 we implemented Medicares new payment system in which all ESRD payments are made under a single bundled payment rate that, beginning in 2012, will provide for an annual inflation adjustment based upon a market basket index, less a productivity adjustment. Also beginning in 2012, the rule provides for up to a 2% annual payment withhold that can be earned back by the facilities that meet certain defined clinical performance standards. The new payment system reimburses providers based upon a single bundled or average payment for each Medicare treatment provided. This new bundled payment amount is designed to cover all dialysis services which were historically included in the composite rate and all separately billable ESRD services such as pharmaceuticals and laboratory costs. In the past the amount of services that were separately billable accounted for approximately 30% of our total dialysis and related lab services revenues. The new bundled payment rate is adjusted for certain patient characteristics, a geographic wage index and certain other factors. The initial 2011 bundled payment rate included reductions of 2.0% from the prior reimbursement and further reduced overall rates by 5.94% tied to an expanded list of case mix adjustors which can be earned back based upon the presence of certain patient characteristics and co-modalities at the time of treatment. There are also other provisions which may impact payment including an outlier pool and a low volume facility adjustment with regard to the expanded list of case-mix adjusters. These are difficult and, in some cases, have not been possible for our dialysis centers to document and track, which has resulted in lower reimbursement amounts than we would otherwise have received.
On April 1, 2011, CMS released an interim final rule correcting the 3.1% transition adjustment factor to properly update the number of ESRD facilities that elected to opt fully into the new Prospective Payment System (PPS). This new rule is prospective and as a result, effective April 1, 2011 we began recognizing revenues in accordance with the new rule, which resulted in an increase in Medicare revenue per treatment of approximately 3.1% in comparison to our levels recorded in the first quarter of 2011. This reduced our transition adjustment to zero for the balance of 2011 and to an aggregate of approximately 0.75% for 2011.
On November 1, 2011, CMS issued the final ESRD Prospective Payment System (PPS) rule for 2012. The base rate will increase by 2.1%, representing a market basket increase of 3.0% less a productivity adjustment of 0.9%. The increase in the final base rate for 2012 (2.1%) is slightly greater than the increase of 1.8% stated in the proposed 2012 ESRD PPS rule published in July 2011, and higher than the 1.0% increase recommended by MedPAC. In 2012 and beyond, the ESRD PPS system includes additional quality measures that could result in decreased payments if a dialysis facility fails to meet the standards.
Also, beginning January 1, 2014, certain oral-only ESRD drugs (currently paid separately to pharmacies under Medicare Part D) will be included in the ESRD bundled payment to dialysis facilities. It is currently unclear how CMS will price the oral-only drugs for inclusion in the ESRD bundle in 2014.
We believe the new payment system presents additional operating clinical and financial risks that our dialysis centers or billing and other systems may not accurately document and track the appropriate patient-specific characteristics, resulting in a reduction or overpayment in the amounts of the payments that we would otherwise be entitled to receive.
46
Dialysis payment rates from commercial payors can vary and a major portion of our commercial rates are set at contracted amounts with payors and are subject to intense negotiation pressure. Our commercial payment rates also include payments for out-of-network patients that on average are higher than our in-network contract rates. In 2011, we were successful in increasing some of our commercial payment rates which contributed to an increase in our average dialysis revenue per treatment, which helped offset some of the overall decline in our average dialysis revenue per treatment. In 2011, we also entered into some commercial contracts covering certain patients that will primarily pay us a single bundled payment rate for all dialysis services provided to these patients. We are continuously in the process of negotiating agreements with our commercial payors, and payors are aggressive in their negotiations. If our negotiations result in overall commercial rate reductions in excess of overall commercial rate increases, this would have a material adverse effect on our operating results. In addition, if there are sustained or increased job losses in the United States as a result of current economic conditions, or depending upon changes to the healthcare regulatory system, we could experience a decrease in the number of patients under commercial plans.
Approximately 4% of our dialysis and related lab services revenues for the year ended December 31, 2011, were from physician-prescribed pharmaceuticals that are separately billable, with EPO accounting for approximately 3% of our dialysis and related lab services revenues. The impact of physician-prescribed pharmaceuticals on our overall revenues that are separately billable in 2011 has significantly decreased from prior years primarily as a result of implementing Medicares new single bundled payment system as well as some additional commercial contracts that pay us a single bundled payment rate. Therefore, in 2010 and prior, changes in physician practice patterns, pharmaceutical protocols, pharmaceutical intensities and changes in commercial and governmental payment rates for EPO had a greater significant influence on our revenues.
Our operating performance with respect to dialysis services billing and collection can also be a significant factor in the average dialysis and related lab services revenue per treatment we actually realize. Over the past several years we have invested heavily in upgrades to our systems and processes that we believe have helped improve our operating performance and reduced our regulatory compliance risks and we expect to continue to improve these systems and processes. In 2011, we continued to upgrade our information technology systems and implemented process changes and will continue to do so in 2012 to improve our ability to capture the necessary patient characteristics and certain other factors under Medicares new bundled payment system. We believe this will help us capture additional reimbursement amounts from Medicare and enhance our overall billing and collection performance. However, as we continue to make upgrades to our systems and processes, or as payors change their systems and requirements, our collection performance as well as our dialysis and related lab services revenue per treatment could be negatively impacted.
Our revenue recognition involves significant estimation risks. Our estimates are developed based on the best information available to us and our best judgment as to the reasonably assured collectability of our billings as of the reporting date based upon our actual historical collection experience. Changes in estimates are reflected in the then-current period financial statements based upon on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies.
Our annual average dialysis and related lab services revenue per treatment was approximately $330, $337 and $340 for 2011, 2010 and 2009, respectively. In 2011, the average dialysis and related lab services revenue per treatment decreased by approximately $7 per treatment primarily due to a decline in our Medicare reimbursements as a result of operating in the new single bundled payment system, a decline in the commercial payor mix, and a decline in the intensities of physician-prescribed pharmaceuticals, partially offset by an increase in some of our commercial payment rates. In 2010, the average dialysis and related lab services revenue per treatment decreased by approximately $3 per treatment primarily due to a decline in the intensities of physician-prescribed pharmaceuticals, and a decline in the commercial payor mix, partially offset by an increase of 1.0% in the Medicare composite rate and an increase in some of our commercial payment rates. Commercial payment rates, changes in the mix and intensities of physician-prescribed pharmaceuticals that are billed separately, government payment policies regarding reimbursement amounts for dialysis treatments and pharmaceuticals
47
under the new Medicare bundled payment rate system including our ability to capture all patient characteristics, and changes in the mix of government and commercial patients may materially impact our average dialysis and related lab services revenue per treatment in the future.
The principal drivers of our dialysis and related lab services patient care costs are clinical hours per treatment, labor rates, vendor pricing of pharmaceuticals, utilization levels of pharmaceuticals, business infrastructure, including the operating costs of our dialysis centers, and compliance costs. However, other cost categories can also represent significant cost variability, such as employee benefit costs and insurance costs. Our average clinical hours per treatment in 2011 were relatively flat or increased slightly compared to 2010, which continues to be impacted by our ability to maintain or reduce clinical teammate turnover and improve training and processes. We are always striving for improved productivity levels, however, changes in federal and state policies or regulatory billing requirements can adversely impact our ability to achieve optimal productivity levels. In addition, improvements in the U.S. economy could stimulate additional competition for skilled clinical personnel and result in higher teammate turnover which would adversely affect productivity levels. In 2011 and 2010, we experienced an increase in our clinical labor rates of approximately 2.0% in both years, as clinical labor rates have increased consistent with general industry trends, mainly due to the demand for skilled clinical personnel, along with general inflation increases. However, in 2011, we continued to implement certain cost control initiatives to minimize increases in our clinical labor rates. In addition, in 2011, we experienced an approximately 5.0% increase in our EPO costs. Our new agreement with Amgen requires us to purchase EPO in amounts necessary to meet no less than 90% of our requirements for erythropoiesis stimulation agents and provides for discounted pricing and rebates, which are subject to various conditions including future pricing levels of EPO and data submission, which could negatively impact our earnings if we are unable to continue to qualify for discount pricing and rebates. In the initial years of the agreement the total rebate opportunity is less than what was provided for in the agreement that expired at the end of 2011, however, the opportunity for us to earn discounts and rebates increases over the term of the agreement. In 2011, we also experienced increases in our infrastructure and operating costs of our dialysis centers, primarily due to the number of new centers opened, and general increases in rent, utilities and repairs and maintenance.
General and administrative expenses represented 9.9% of our net operating revenues in 2011 as compared to 9.0% in 2010. This represents a fairly significant increase in the dollar amount of our general and administrative expenses primarily related to strengthening our dialysis business, improving our regulatory compliance and other operational processes, responding to certain legal and compliance matters, professional fees associated with information technology matters and international growth initiatives, transaction and integration costs associated with the acquisition of DSI and supporting the growth in some of our ancillary services and strategic initiatives. We expect that these levels of expenditures on general and administrative expenses in 2012 will continue and could possibly increase as we seek out new business opportunities within the dialysis industry or to other healthcare services outside of dialysis, making additional investments in our existing long-term initiatives, such as our ancillary services and strategic initiatives, and the expansion of our international operations, as well as investments in improving our information technology infrastructure and the level of support required for our regulatory compliance and legal matters.
Outlook for 2012. Our operating income for 2012 is expected to be in the range of $1,200 million to $1,300 million. We also expect our operating cash flows for 2012 to be in the range of $950 million to $1,050 million. These projections and the underlying assumptions involve significant risks and uncertainties, and actual results may vary significantly from these current projections. These risks and uncertainties, among others, include those relating to the concentration of profits generated from commercial payor plans, continued downward pressure on average realized payment rates from commercial payors, which may result in the loss of revenue or patients, a reduction in the number of patients under higher-paying commercial plans, a reduction in government payment rates under the Medicare ESRD program or other government-based programs, the impact of healthcare legislation that was enacted in the United States in March 2010, changes in pharmaceutical or anemia management practice patterns, payment policies or pharmaceutical pricing, our ability to maintain contracts with physician medical directors, legal compliance risks, including our continued compliance with complex
48
government regulations, current or potential investigations by various government entities and related government or private-party proceedings, continued increased competition from large and medium-sized dialysis providers that compete directly with us, our ability to complete any acquisitions, mergers or dispositions that we might be considering or announce, or integrate and successfully operate any business we may acquire, and expansion of our operations and services to markets outside of the United States, or to businesses outside of dialysis. You should read Risk Factors in Item 1A of this Annual Report on Form 10-K and the cautionary language contained in the forward-looking statements and associated risks as discussed on page 43 for more information about these and other potential risks. We undertake no obligation to update or revise these statements, whether as a result of changes in underlying factors, new information, future events or otherwise.
Results of operations
We operate principally as a dialysis and related lab services business in the United States but also operate other ancillary services and strategic initiatives. These ancillary services and strategic initiatives consist primarily of pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs, physician services and our international dialysis operations. The U.S. dialysis and related lab services business qualifies as a separately reportable segment and all of the other ancillary services and strategic initiatives have been combined and disclosed in the other segments category.
Following is a summary of consolidated operating results for reference in the discussion that follows. The operating results of DSI are included in our operating results effective September 1, 2011.
Year ended December 31, | ||||||||||||||||||||||||
2011 | 2010 | 2009 | ||||||||||||||||||||||
(dollar amounts rounded to nearest million) | ||||||||||||||||||||||||
Net operating revenues: |
||||||||||||||||||||||||
Current period services |
$ | 6,982 | 100 | % | $ | 6,438 | 100 | % | $ | 6,101 | 100 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses and charges: |
||||||||||||||||||||||||
Patient care costs |
4,681 | 67 | % | 4,467 | 69 | % | 4,242 | 70 | % | |||||||||||||||
General and administrative |
691 | 10 | % | 579 | 9 | % | 532 | 9 | % | |||||||||||||||
Depreciation and amortization |
267 | 4 | % | 234 | 4 | % | 228 | 4 | % | |||||||||||||||
Provision for uncollectible accounts |
198 | 3 | % | 171 | 3 | % | 161 | 3 | % | |||||||||||||||
Goodwill impairment charge |
24 | | | | | | ||||||||||||||||||
Equity investment income |
(9 | ) | | (9 | ) | | (2 | ) | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses and charges |
5,851 | 84 | % | 5,441 | 84 | % | 5,161 | 85 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating income |
$ | 1,131 | 16 | % | $ | 997 | 16 | % | $ | 940 | 15 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes consolidated net operating revenues:
Year ended | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
(dollar amounts rounded to nearest million) | ||||||||||||
Dialysis and related lab services |
$ | 6,485 | $ | 6,063 | $ | 5,784 | ||||||
Otherancillary services and strategic initiatives |
514 | 384 | 334 | |||||||||
|
|
|
|
|
|
|||||||
Total segment revenues |
6,999 | 6,447 | 6,118 | |||||||||
Elimination of intersegment revenues |
(17 | ) | (9 | ) | (17 | ) | ||||||
|
|
|
|
|
|
|||||||
Consolidated net operating revenues |
$ | 6,982 | $ | 6,438 | $ | 6,101 | ||||||
|
|
|
|
|
|
49
The following table summarizes consolidated operating income:
Year ended | ||||||||||||
2011(1) | 2010 | 2009 | ||||||||||
(dollar amounts rounded to nearest million) | ||||||||||||
Dialysis and related lab services |
$ | 1,225 | $ | 1,039 | $ | 994 | ||||||
Otherancillary services and strategic initiatives loss |
(54 | ) | (6 | ) | (12 | ) | ||||||
|
|
|
|
|
|
|||||||
Total segment operating income |
1,171 | 1,034 | 982 | |||||||||
Reconciling items: |
||||||||||||
Stock-based compensation |
(49 | ) | (46 | ) | (44 | ) | ||||||
Equity investment income |
9 | 9 | 2 | |||||||||
|
|
|
|
|
|
|||||||
Consolidated operating income |
1,131 | 997 | 940 | |||||||||
Reconciliation of non-GAAP measure: |
||||||||||||
Add: Goodwill impairment charge |
24 | | | |||||||||
|
|
|
|
|
|
|||||||
Non-GAAP consolidated operating income |
$ | 1,155 | $ | 997 | $ | 940 | ||||||
|
|
|
|
|
|
(1) | For the year ended December 31, 2011 we have excluded a non-cash goodwill impairment charge from operating expenses and operating income because management believes that this presentation enhances a users understanding of our normal consolidated operating income by excluding a non-cash goodwill impairment charge that resulted from a decrease in the implied fair value of goodwill below its carrying amount associated with HomeChoice Partners (HCP), which provides infusion therapy services, during the second quarter of 2011 and is therefore more meaningful and comparable to our prior period results and more indicative of our normal consolidated operating income. |
Consolidated net operating revenues
Consolidated net operating revenues for 2011 increased by approximately $544 million or approximately 8.5% from 2010. This increase was primarily due to an increase in dialysis and related lab services net revenues of approximately $422 million, principally due to strong volume growth from additional treatments from non-acquired growth and acquisitions including the acquisition of DSI, partially offset by a decline of $7 in the average dialysis revenue per treatment, primarily from a decrease in our Medicare revenues as a result of operating in the new single bundled payment system, as described above. Consolidated net operating revenues also increased as a result of an increase of approximately $130 million in the ancillary services and strategic initiatives net revenues driven primarily from growth in our pharmacy services and from our disease management services.
Consolidated net operating revenues for 2010 increased by approximately $337 million or approximately 5.5% from 2009. This increase was primarily due to an increase in our dialysis and related lab services net revenues of approximately $279 million, principally due to an increase in the number of treatments from non-acquired growth and acquisitions, partially offset by a decline of $3 in the average dialysis revenue per treatment, as described above, and an increase of approximately $50 million in the ancillary services and strategic initiatives net revenues driven primarily from growth in our pharmacy services and from our infusion therapy services.
Consolidated operating income
Consolidated operating income of $1,131 million for 2011 increased by approximately $134 million, or 13.4%, from 2010 which includes the $24 million HCP goodwill impairment charge. Excluding this item, consolidated operating income would have increased by $158 million, or 15.8%, primarily due to an increase in the dialysis and related lab services net operating revenues as a result of strong volume growth in revenue from additional treatments as a result of non-acquired growth and acquisitions, partially offset by a decline in our
50
average dialysis revenue per treatment of approximately $7, as described below. Consolidated operating income also increased as a result of overall lower pharmaceutical costs mainly from a decline in the intensities of physician-prescribed pharmaceuticals, additional operating income from the acquisition of DSI and from cost control initiatives. However, consolidated operating income was negatively impacted by higher labor and benefit costs, an increase in our professional fees for compliance and legal initiatives, and for information technology matters, transaction and integration costs associated with the acquisition of DSI, an increase in EPO pharmaceutical costs and an increase in expenses associated with our international expansion.
Consolidated operating income of $997 million for 2010 increased by approximately $57 million, or 6.1%, from 2009. This increase was primarily attributable to an increase in revenue as a result of additional treatments from non-acquired growth and acquisitions in dialysis and related lab services, partially offset by a decline in our average dialysis revenue per treatment of approximately $3, as described below. Operating income also increased as a result of continued cost control initiatives, improved productivity, overall lower pharmaceutical costs and lower operating losses in our ancillary services and strategic initiatives, partially offset by the negative impact on our operating margin from a decline in the intensities of physician-prescribed pharmaceuticals, higher labor costs and increases in other operating costs of our dialysis centers.
Operating segments
Dialysis and Related Lab Services
Year ended | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
(dollar amounts rounded to nearest million, except per treatment data) |
||||||||||||
Revenues |
$ | 6,485 | $ | 6,063 | $ | 5,784 | ||||||
|
|
|
|
|
|
|||||||
Segment operating income |
$ | 1,225 | $ | 1,039 | $ | 994 | ||||||
|
|
|
|
|
|
|||||||
Dialysis treatments |
19,599,472 | 17,963,862 | 16,984,959 | |||||||||
Average dialysis treatments per treatment day |
62,618 | 57,392 | 54,352 | |||||||||
Average dialysis and related lab services revenue per treatment |
$ | 330 | $ | 337 | $ | 340 |
Net operating revenues
Dialysis and related lab services net operating revenues for 2011 increased by approximately $422 million or approximately 7.0% from 2010. The increase in net operating revenues was primarily due to strong volume growth from additional treatments of approximately 9.1% due to an increase in non-acquired treatment growth at existing and new centers and growth through acquisitions, which includes additional treatments associated with the acquisition of DSI. However, this increase was partially offset by a decrease in the average dialysis revenue per treatment of approximately $7, or 2.1%. The decrease in the average dialysis revenue per treatment in 2011, as compared to 2010, was primarily due to a decline in our Medicare reimbursements as a result of operating in the new single bundled payment system, continued decline in the commercial payor mix and a decline in the intensities of physician-prescribed pharmaceuticals, partially offset by an increase in some of our commercial payment rates.
Dialysis and related lab services net operating revenues for 2010 increased by approximately $279 million or approximately 4.8% from 2009. The increase in net operating revenues was primarily due to an increase in the number of treatments of approximately 5.8% due to an increase in non-acquired treatment growth at existing and new centers and growth through acquisitions. However, this increase was partially offset by a decrease in the average dialysis revenue per treatment of approximately $3, or 0.9%. The decrease in the average dialysis revenue per treatment in 2010, as compared to 2009, was primarily due to a decline in the intensities of physician-prescribed pharmaceuticals and a decline in the commercial payor mix, partially offset by a 1% increase in the Medicare composite rate and an increase in some of our commercial payment rates.
51
The following table summarizes our dialysis and related lab services revenues by modality for the year ended December 31, 2011:
Revenue percentages |
||||
Outpatient hemodialysis centers |
81 | % | ||
Peritoneal dialysis and home-based hemodialysis |
14 | % | ||
Hospital inpatient hemodialysis |
5 | % | ||
|
|
|||
Total dialysis and related lab services revenues |
100 | % | ||
|
|
Approximately 66% of our total dialysis and related lab services revenues for the year ended December 31, 2011 were from government-based programs, principally Medicare, Medicaid, and Medicare-assigned plans, representing approximately 89% of our total patients. Over the last several years, we have been experiencing growth in our government-based patients that has been outpacing the growth in our commercial patients which has negatively impacted our average dialysis and related lab services revenue per treatment. Our overall percentage of patients and revenues associated with commercial payors continued to decline in 2011. Less than 1% of our dialysis and related lab services revenues are due directly from patients. No single commercial payor accounted for more than 6% of total dialysis and related lab services revenues for the year ended December 31, 2011.
On average we are paid significantly more for services provided to patients covered by commercial healthcare plans in the United States than we are for patients covered by Medicare, Medicaid or other government plans such as Medicare-assigned plans. Patients covered by commercial health plans transition to Medicare coverage after a maximum of 33 months. As a patient transitions from commercial coverage to Medicare or Medicaid coverage, the payment rates normally decline substantially. Medicare payment rates are insufficient to cover our costs associated with providing dialysis treatments, and therefore we lose money on each Medicare treatment.
Nearly all of our net earnings from our dialysis and related lab services are derived from commercial payors, some of which pay at established contract rates and others which pay negotiated payment rates based on our usual and customary fee schedule for our out-of-network patients. If we experience a net overall reduction in our contracted and non-contracted commercial rates as a result of these negotiations or restrictions, it could have a material adverse effect on our operating results.
Our average dialysis and related lab services revenue per treatment can be significantly impacted by several major factors, including our commercial payment rates, government payment policies regarding reimbursement amounts for dialysis treatments and pharmaceuticals under the new Medicare bundled payment rate system, including our ability to capture all patient characteristics, changes in the mix of government and commercial patients, and changes in the mix and intensities of physician-prescribed pharmaceuticals that are billed separately.
Operating expenses and charges
Patient care costs. Dialysis and related lab services patient care costs are those costs directly associated with operating and supporting our dialysis centers and consist principally of labor, pharmaceuticals, medical supplies and operating costs of the dialysis centers. The dialysis and related lab services patient care costs on a per treatment basis were $217 and $232 for 2011 and 2010, respectively. The $15 decrease in the per treatment costs in 2011 as compared to 2010 was primarily attributable to a decline in the intensities of physician-prescribed pharmaceuticals, continued cost control initiatives, partially offset by higher labor and benefit costs, and higher EPO costs.
Dialysis and related lab services patient care costs on a per treatment basis were $232 and $235 for 2010 and 2009, respectively. The $3 decrease in the per treatment costs in 2010 as compared to 2009 was primarily attributable to a decline in the intensities of physician-prescribed pharmaceuticals, a decrease in our overall pharmaceutical costs and continued improvements in productivity, partially offset by higher labor rates.
52
General and administrative expenses. Dialysis and related lab services general and administrative expenses for the years ended 2011, 2010 and 2009 were approximately $551 million, $471 million and $428 million, respectively. The increase of approximately $80 million in 2011 as compared to 2010 was primarily due to increases in labor and benefit costs, an increase in our professional expenses for legal and compliance initiatives and for information technology matters as well as transaction and integration costs associated with the acquisition of DSI. The increase in general and administrative expenses of approximately $43 million in 2010 as compared to 2009 was primarily due to increases in labor and benefit costs, partially offset by the timing of certain other expenditures.
Depreciation and amortization. Dialysis and related lab services depreciation and amortization expenses for 2011, 2010 and 2009 were approximately $260 million, $227 million and $221 million, respectively. The increase of approximately $33 million in depreciation and amortization for dialysis and related lab services in 2011 and $6 million in 2010 were primarily due to growth through new center developments and acquisitions.
Provision for uncollectible accounts receivable. The provision for uncollectible accounts receivable for dialysis and related lab services was 2.9% for 2011, 2.7% for 2010, and 2.7% for 2009. The increase in the provision for uncollectible accounts during 2011 was primarily the result of a slowdown in our historical collection experience from some of our non-government payors. The current provision level of 3.0% at the end of 2011 may increase if we encounter problems with our billing and collection process as a result of sustained weakness in the U.S. economy.
Segment operating income
Dialysis and related lab services operating income for 2011 increased by approximately $186 million as compared to 2010. The increase in the operating income for 2011 as compared to 2010 was primarily due to strong treatment growth as a result of additional dialysis treatments from non-acquired growth and acquisitions, partially offset by a decrease in the average dialysis revenue per treatment of approximately $7 as described above. The dialysis and related lab services operating income also increased as a result of a decline in the intensities of physician-prescribed pharmaceuticals, and additional operating income from the acquisition of DSI. However, the dialysis and related lab services operating income was negatively impacted by higher labor and benefit costs, an increase in the cost of EPO, an increase in our professional fees in conjunction with compliance and legal initiatives and for information technology matters as well as transaction and integration costs associated with the acquisition of DSI.
Dialysis and related lab services operating income for 2010 increased by approximately $45 million as compared to 2009. The increase in the operating income for 2010 as compared to 2009 was primarily due to growth in the number of dialysis treatments from non-acquired growth and acquisitions, partially offset by a decrease in the average dialysis revenue per treatment of approximately $3 as described above. The dialysis and related lab services operating income also increased as a result of certain cost control initiatives, improved productivity, and overall lower pharmaceutical costs. However, the dialysis and related lab services operating income was negatively impacted by an operating margin decrease due to a decline in the intensities of physician-prescribed pharmaceuticals, higher labor costs and an increase in other operating costs of our dialysis centers.
OtherAncillary services and strategic initiatives
Year ended | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
(dollar amounts rounded to nearest million) | ||||||||||||
Revenues |
$ | 514 | $ | 384 | $ | 334 | ||||||
|
|
|
|
|
|
|||||||
Segment operating loss |
$ | (54 | ) | $ | (6 | ) | $ | (12 | ) | |||
|
|
|
|
|
|
53
Net operating revenues
The ancillary services and strategic initiatives net operating revenues for 2011 increased by approximately $130 million or 33.9% as compared to 2010, primarily from growth in pharmacy services, and from our disease management services.
The ancillary services and strategic initiatives net operating revenues for 2010 increased by approximately $50 million or 15.0% as compared to 2009, primarily from growth in pharmacy services, and from our infusion therapy services, partially offset by a decline in our net operating revenues in our disease management services as a result of discontinuing the full service health care plans at the end of 2009.
Operating expenses
Ancillary services and strategic initiatives operating expenses for 2011 increased by approximately $179 million from 2010, which includes the $24 million HCP goodwill impairment charged as described below. Excluding this item, ancillary services and strategic initiatives adjusted operating expenses would have increased by $155 million. This increase in operating expenses was primarily due to an increase in volume in our pharmacy business, an increase in expenses associated with our international dialysis expansion and an increase in labor and benefit costs.
Ancillary services and strategic initiatives operating expenses for 2010 increased by approximately $43 million from 2009, primarily due to an increase in volume in our pharmacy business and an increase in labor costs, partially offset by lower operating costs of our disease management services as a result of discontinuing the full service health care plans at the end of 2009.
Goodwill
In the second quarter of 2011, we determined that circumstances indicated it was more likely than not that the fair value of one of our ancillary businesses, HCP, which provides infusion therapy services, was less than its carrying amount. The primary factor informing our conclusion was the recent decline in the operating performance of HCP caused mainly by rapid expansion. This led management to revise its view of HCPs organizational growth capability and scale back significantly its current plans for HCPs future growth initiatives and to update HCPs forecasts and current operating budgets accordingly. These revisions reflected the current and expected future cash flows that we believed market participants would use in determining the fair value or the HCP business. As a result, in the second quarter of 2011, we estimated that the carrying amount of goodwill related to HCP exceeded its implied fair value by $24 million, resulting in a pre-tax goodwill impairment charge of that amount. As of December 31, 2011, after giving effect to this impairment charge, we have approximately $32 million of HCP goodwill remaining. During the fourth quarter of 2011, we finalized our calculation of this impairment charge, which did not change the goodwill impairment charge previously recorded.
Segment operating loss
Ancillary services and strategic initiatives operating losses for 2011 increased by approximately $48 million from 2010, which includes the $24 million HCP goodwill impairment charge, as described above. Excluding this item, ancillary services and strategic initiatives adjusted operating losses would have increased by $24 million. This increase in operating losses was primarily due to an increase in expenses associated with our international dialysis expansion and a deterioration in the operating performance of our infusion therapy services, partially offset by an increase in the operating performance of our pharmacy business, and in our vascular access services.
Ancillary services and strategic initiatives operating losses for 2010 decreased by approximately $6 million from 2009. The decrease in operating losses was primarily due to volume growth in revenues associated with our pharmacy business, and a decrease in operating losses in our disease management business as a result of discontinuing the full service health care plans at the end of 2009.
54
Corporate level charges
Stock-based compensation. Stock-based compensation of approximately $49 million for 2011 increased by approximately $3 million from 2010. Stock-based compensation of approximately $46 million for 2010 increased by approximately $2 million from 2009. The increase in 2011 resulted from an increase in the overall grant date fair value for the grant years that contributed expense to 2011, driven by both an increase in the grant date fair value of 2011 grants over that for recent years and an increase in the number of awards granted in 2011 over 2010. The increase in 2010 resulted principally from an increase in the overall grant date fair value for the grant years that contributed expense to 2010, driven in part by a substantial increase in the grant date fair value of 2010 grants over that for recent years offset by a significant reduction in the number of awards granted in 2010.
Debt expense. Debt expense for 2011, 2010, and 2009 consisted of interest expense of approximately $231 million, $172 million, and $176 million, respectively, including the amortization and accretion of debt discounts and premiums and the amortization of deferred financing costs of approximately $10 million in 2011, $9 million in 2010 and $10 million in 2009. The increase in interest expense in 2011 as compared to 2010 was primarily related to additional borrowings under our Senior Secured Credit Facilities that were issued in the fourth quarter of 2010 and additional borrowings associated with the new Term Loan A-2 that contain significantly higher interest rates than our previous facility. In addition, debt expense in 2011 was also impacted by the amount of interest rate swaps that resulted in a higher overall weighted average effective interest rate on the Term Loan A and from the amortization of an interest rate cap premium associated with our Term Loan B. However, debt expense in 2011 benefited from lower rates and lower outstanding balances associated with our new senior notes that were issued in the fourth quarter of 2010. Our overall weighted average effective interest rate in 2011 was 5.28% as compared to 4.68% in 2010.
The decrease in interest expense in 2010 as compared to 2009 was primarily related to lower average outstanding principal balances on our previously outstanding Term Loan A, lower average outstanding principal balances on our previously outstanding senior notes, lower interest rates associated with the issuance of our New Senior Notes and a decrease in our weighted average effective interest rate on the Term Loan B as a result of lower notional amounts of fixed rate swap agreements that contained higher rates. Our overall weighted average effective interest rate in 2010 was 4.68% as compared to 4.86% in 2009. However, interest expense in the fourth quarter of 2010 was negatively affected by the refinancing of our Senior Secured Credit Facilities that occurred on October 20, 2010, as the interest rates under our new Senior Secured Credit Facilities are substantially higher than the interest rates under the previous facility. Our overall weighted average effective interest rate in the fourth quarter of 2010 was 4.86%.
Equity investment income. Equity investment income was approximately $9.0 million in 2011 as compared to $9.0 million in 2010 and $2.4 million in 2009. Equity investment income in 2011 as compared to 2010 was flat but was impacted by an increase in the profitability of certain of our nonconsolidated joint ventures, offset by a decrease in the operating performance of certain other joint ventures. The increase in equity investment income in 2010 as compared to 2009 was primarily due to an increase in the profitability of our nonconsolidated joint ventures.
Other income. Other income was approximately $3 million, $3 million, and $4 million in 2011, 2010, and 2009, respectively, and consisted principally of interest income. Other income in 2011 was slightly down from 2010, primarily as a result of lower average interest rates and lower average cash balances. The decrease in 2010 as compared to 2009 was primarily the result of lower average interest rates, partially offset by higher average cash balances.
Provision for income taxes. The provision for income taxes for 2011 represented an effective annualized tax rate of 35.4%, compared with 35.0% and 36.7% in 2010 and 2009, respectively. The effective tax rate in 2011 was higher primarily due to non-deductible transaction costs associated with the DSI acquisition.
55
Impairments and valuation adjustments. We perform impairment or valuation reviews for our property and equipment, amortizable intangible assets with finite useful lives, equity investments in non-consolidated businesses, and our investments in ancillary services and strategic initiatives at least annually and whenever a change in condition indicates that an impairment review is warranted. Such changes include shifts in our business strategy or plans, the quality or structure of our relationships with our partners, or when a center experiences deteriorating operating performance. Goodwill is also assessed at least annually for possible valuation impairment using fair value methodologies. These types of adjustments are charged directly to the corresponding operating segment that incurred the charge. Except for the HCP goodwill charge in 2011, there were no other significant impairments or valuation adjustments recognized during the periods presented.
Noncontrolling interests
Net income attributable to noncontrolling interests for 2011, 2010 and 2009 was approximately $95 million, $79 million and $57 million, respectively. The increases in noncontrolling interests in 2011 and 2010 were primarily due to increases in the number of new joint ventures and increases in the profitability of our dialysis-related joint ventures. The percentage of dialysis and related lab services net operating revenues generated from dialysis-related joint ventures was approximately 18% in both 2011 and 2010.
Accounts receivable
Our accounts receivable balances at December 31, 2011 and 2010 represented approximately 61 days of revenue for both periods, net of bad debt allowance. Our days outstanding in 2011, represent solid improved cash collections that enabled us to keep pace with our growth in revenue. However, our cash collections in early 2012 could be negatively impacted as Medicare upgrades its systems to meet their new billing requirements.
As of December 31, 2011 and 2010, approximately $188 million and $153 million in unreserved accounts receivable, respectively, representing approximately 16% and 15% of our total accounts receivable balance, respectively, were more than six months old. During 2011, we experienced improved cash collections from certain government payors and certain commercial payors. There were no significant unreserved balances over one year old. Less than 1% of our revenues are classified as patient pay. Substantially all revenue realized is from government and commercial payors, as discussed above.
Amounts pending approval from third-party payors as of December 31, 2011 and 2010, other than the standard monthly billing, consisted of approximately $57 million in 2011 and $46 million in 2010, associated with Medicare bad debt claims, classified as other receivables. Currently, a significant portion of our Medicare bad debt claims are typically paid to us before the Medicare fiscal intermediary audits the claims. However, the payment received from Medicare is subject to adjustment based upon the actual results of the audits. Such audits typically occur one to four years after the claims are filed. As a kidney dialysis provider, our revenue is not subject to cost report settlements, except for potentially limiting the collectability of these Medicare bad debt claims.
Liquidity and capital resources
Available liquidity. As of December 31, 2011, our cash balance was $394 million and we had undrawn credit under our Senior Secured Credit Facilities totaling $350 million, of which approximately $52 million was committed for outstanding letters of credit. We believe that we will have sufficient liquidity, operating cash flows and access to borrowings to fund our scheduled debt service and other obligations for the foreseeable future. Our primary sources of liquidity are cash from operations and cash from borrowings.
Cash flow from operations during 2011 amounted to $1,180 million, compared with $840 million for 2010. The increase in our operating cash flows in 2011 as compared to 2010 was primarily due to improved cash earnings, a reduction in income tax payments and the timing of other working capital items, partially offset by an
56
increase in our accounts receivable balances from growth in revenue. Cash flow from operations in 2011 included cash interest payments of approximately $236 million and cash tax payments of $146 million. Cash flow from operations in 2010 included cash interest payments of approximately $191 million and cash tax payments of $207 million.
Non-operating cash outflows in 2011 included $436 million for capital asset expenditures, including $176 million for new center developments and relocations, and $260 million for maintenance and information technology. We also spent an additional $1,077 million for acquisitions. During 2011, we also received $49 million from the maturity and sale of investments. However, the majority of these proceeds was either used to repurchase other investments or was used to fund distributions from our deferred compensation plans. In addition, during 2011, we received $32 million associated with stock option exercises and other share issuances and the related excess tax benefits. We also made distributions to noncontrolling interests of $101 million, and received contributions from noncontrolling interests of $21 million associated with new joint ventures and from additional equity contributions. We also repurchased 3.8 million shares of our common stock for approximately $323 million.
Non-operating cash outflows in 2010 included $279 million for capital asset expenditures, including $120 million for new center developments and relocations, and $159 million for maintenance and information technology. We also spent an additional $189 million for acquisitions. During 2010, we also received $61 million from the maturity and sale of investments. However, these proceeds were either used to repurchase other investments or were used to fund distributions from our deferred compensation plans. In addition, during 2010, we received $60 million associated with stock option exercises and other share issuances and the related excess tax benefits. We also made distributions to noncontrolling interests of $84 million, and received contributions from noncontrolling interests of $10 million associated with new joint ventures and from additional equity contributions. We also repurchased 8.9 million shares of our common stock for approximately $619 million.
During 2011, we acquired a total of 178 dialysis centers, eight of which were located outside of the United States, opened 65 new dialysis centers, sold two centers, merged seven centers, and divested a total of 30 dialysis centers in connection with the acquisition of DSI. We also added three dialysis centers under management and administrative service agreements that are located outside of the United States and added one center in which we own a minority equity interest. During 2010, we acquired a total of 41 dialysis centers, opened 65 new dialysis centers, sold six centers, closed 18 centers, and made minority equity investments in three centers that were previously under management and administrative service agreements.
Acquisition
On September 2, 2011, we completed our acquisition of all of the outstanding common stock of CDSI I Holding Company, Inc., the parent company of dialysis provider DSI Renal Inc. (DSI), pursuant to an agreement and plan of merger for approximately $723 million in net cash, plus the assumption of certain liabilities totaling approximately $6.5 million, subject to certain post-closing adjustments. DSI had 113 outpatient dialysis centers that provided services to approximately 8,000 patients in 23 states. We also incurred approximately $22 million in transaction and integration costs during the year ended December 31, 2011 associated with this acquisition that are included in general and administrative expenses.
Pursuant to a consent order issued by the Federal Trade Commission on September 2, 2011, we agreed to divest a total of 30 outpatient dialysis centers and several home-based dialysis programs in order to complete the acquisition of DSI. In conjunction with the consent order, on September 30, 2011, we completed the sale of 28 outpatient dialysis centers to Dialysis Newco, Inc., or Dialysis Newco, a portfolio company of Frazier Healthcare VI, L.P. and New Enterprise Associates 13, Limited Partnership pursuant to an asset purchase agreement dated August 26, 2011. Effective October 31, 2011, we also completed the sale of two additional outpatient dialysis centers to Dialysis Newco that were previously pending state regulatory approval. We anticipate receiving total net cash consideration of approximately $82.0 million for all of the outpatient dialysis centers that were divested.
57
2011 capital structure changes and other items
On August 26, 2011, we entered into an Increase Joinder Agreement under our existing Senior Secured Credit Agreement. Pursuant to the Increase Joinder Agreement, we increased the revolving credit facility by $100 million, to a total of $350 million, and entered into an additional $200 million Term Loan A-2. The new Term Loan A-2 required a principal payment of $0.5 million on December 31, 2011 and thereafter requires annual principal payments of $2.0 million with the balance of $191.5 million due in 2016, and bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a rating based step-down to 3.25%.
During the year ended December 31, 2011 we made mandatory principal payments under our Senior Secured Credit Facilities totaling $50 million on the Term Loan A, $0.5 million on Term Loan A-2 and $17.5 million on the Term Loan B.
Interest rate swaps and caps
In January 2011, we entered into nine interest rate swap agreements with amortizing notional amounts totaling $1.0 billion that went effective on January 31, 2011, as a means of hedging our exposure to and volatility from variable-based interest rate changes as part of our overall risk management strategy. As of December 31, 2011, we maintained a total of nine interest rate swap agreements with amortizing notional amounts totaling $950 million. These agreements had the economic effect of modifying the LIBOR variable component of our interest rate on an equivalent amount of our Term Loan A to fixed rates ranging from 1.59% to 1.64%, resulting in an overall weighted average effective interest rate of 4.11%, including the Term Loan A margin of 2.50%. The swap agreements expire by September 30, 2014 and require monthly interest payments. During the year ended December 31, 2011, we accrued net charges of $12.6 million from these swaps which are included in debt expense. As of December 31, 2011, the total fair value of these swap agreements was a liability of $23.1 million. We estimate that approximately $10.9 million of existing unrealized pre-tax losses in other comprehensive income at December 31, 2011 will be reclassified into income over the next year.
In addition, in January 2011, we also entered into five interest rate cap agreements with notional amounts totaling $1.25 billion that went effective on January 31, 2011. These agreements have the economic effect of capping the LIBOR variable component of our interest rate at a maximum of 4.00% on an equivalent amount of our Term Loan B debt. The cap agreements expire on September 30, 2014. As of December 31, 2011, the total fair value of these cap agreements was an asset of $1.4 million. During the year ended December 31, 2011, we recorded $5.2 million, net of tax, as a decrease to other comprehensive income due to unrealized valuation changes in the cap agreements, net of the amortization of the interest rate cap premiums that were reclassified into net income.
As a result of the swap and cap agreements, our overall weighted average effective interest rate on the Senior Secured Credit Facilities was 4.61%, based upon the current margins in effect of 2.50% for the Term Loan A, 3.50% for the Term Loan A-2 and 3.00% for the Term Loan B, as of December 31, 2011.
As of December 31, 2011, interest rates on our Term Loan A-2 and Term Loan B are set at their LIBOR floors plus their interest rate margins. Interest rates on our senior notes and Term Loan A are fixed and economically fixed, respectively, with rates on the $1.25 billion of our Term Loan B subject to interest rate caps.
Our overall weighted average effective interest rate in 2011 was 5.28% and as of December 31, 2011 was 5.27%.
Stock repurchases
During 2011, we repurchased a total of 3,794,686 shares of our common stock for $323.3 million, or an average price of $85.21 per share, pursuant to a previously announced authorization by the Board of Directors on
58
November 3, 2010, that authorized an additional $800 million of share repurchases of our common stock. As a result of these transactions, the total outstanding authorization for share repurchases as of December 31, 2011 was $358.2 million. We have not repurchased any additional shares of our common stock from January 1, 2012 through February 24, 2012. This stock repurchase program has no expiration date.
Stock-based compensation
Stock-based compensation recognized in a period represents the straight-line amortization during that period of the estimated grant-date fair value of stock-based awards over their vesting terms, adjusted for expected forfeitures. Shares issued upon exercise of stock awards are generally issued from shares in treasury. We have utilized the Black-Scholes-Merton valuation model for estimating the grant date fair value of stock options and stock-settled stock appreciation rights granted in all prior periods. During 2011, we granted 2,707,500 stock-settled stock appreciation rights with a grant-date fair value of $59.4 million and a weighted-average expected life of approximately 4.2 years, and also granted 150,246 stock units with a grant-date fair value of $12.8 million and a weighted-average expected life of approximately 3.1 years.
For the years ended December 31, 2011 and 2010, we recognized $48.7 million and $45.6 million, respectively, in stock-based compensation expense for stock-settled stock appreciation rights, stock options, stock units and discounted employee stock plan purchases, which is primarily included in general and administrative expenses. The estimated tax benefits recorded for this stock-based compensation in 2011 and 2010 were $18.4 million and $17.3 million, respectively. As of December 31, 2011, there was $91.3 million of total estimated unrecognized compensation cost related to nonvested stock-settled compensation arrangements under our equity compensation and stock purchase plans. We expect to recognize this cost over a weighted average remaining period of 1.4 years.
During the years ended December 31, 2011 and 2010, we received $5.4 million and $48.7 million, respectively, in cash proceeds from stock option exercises and $38.2 million and $26.7 million, respectively, in total actual tax benefits upon the exercise of stock awards.
Other items
On July 22, 2010, we entered into a First National Service Provider Agreement, or the Agreement, with NxStage Medical Inc., or NxStage. Under the terms of the Agreement we have the ability to continue to purchase NxStage System One hemodialysis machines and related supplies at discount prices. In addition, we may, in lieu of cash rebate, vest in warrants to purchase NxStage common stock based upon achieving certain System One home patient growth targets by June 30, 2011, 2012 and 2013. The warrants are exercisable for up to a cumulative total of 5.5 million shares of common stock over the three years at an initial exercise price of $14.22 per share. From the period July 1, 2010 through June 30, 2011, we earned warrants to purchase 250,000 shares of NxStage common stock. In October 2011 we exercised our right to purchase 250,000 shares of NxStage common stock at $14.22 per share, for a total of approximately $3.6 million and in February 2012, we sold all 250,000 shares for approximately $5.2 million.
In July 2010, we announced that we will construct a new corporate headquarters in Denver, Colorado. In July 2010, we acquired the land and existing improvements for approximately $12 million. Effective December 18, 2010, we entered into a construction agreement for the construction of the new building. We currently estimate the total construction costs and other project costs of the building will be approximately $95 million. Construction began in early 2011, and is still estimated to be complete in the second half of 2012. Through December 31, 2011, we have paid construction costs and architecture and other design fees totaling approximately $49 million.
2010 capital structure changes
On October 20, 2010, we entered into a $3,000 million Senior Secured Credit Agreement (the Credit Agreement), consisting of a five year $250 million revolving line of credit, a five year $1,000 million Term Loan
59
A and a six year $1,750 million Term Loan B. We also have the right to request an increase to the borrowing capacity to a total aggregate principal amount of not more than $4,000 million subject to bank participation. The revolving line of credit and the Term Loan A initially bore interest at LIBOR plus an interest rate margin of 2.75% until June 30, 2011, when the interest rate margin was reduced to 2.50%. The interest rate margin is still subject to adjustment depending upon our leverage ratio and can range from 2.25% to 2.75%. The Term Loan A requires annual principal payments of $50 million in 2011, $50 million in 2012, $100 million in 2013, and $150 million in 2014, with the balance of $650 million due in 2015. The Term Loan B bears interest at LIBOR (floor of 1.50%) plus 3.00% subject to a ratings based step-down to 2.75%. The Term Loan B requires annual principal payments of $17.5 million in each year from 2011 through 2015 with the balance of $1,663 million due in 2016. The borrowings under the Credit Agreement are guaranteed by substantially all of our direct and indirect wholly-owned domestic subsidiaries and are secured by substantially all of DaVitas and its guarantors assets. The Credit Agreement contains customary affirmative and negative covenants such as various restrictions on investments, acquisitions, the payment of dividends, redemptions and acquisitions of capital stock, capital expenditures and other indebtedness, as well as limitations on the amount of tangible net assets in non-guarantor subsidiaries. However, many of these restrictions will not apply as long as our leverage ratio is below 3.50:1.00. In addition, the Credit Agreement requires compliance with financial covenants including an interest coverage ratio and a leverage ratio that determines the interest rate margins as described above.
On October 20, 2010, we also issued $775 million aggregate principal amount of 6 3/8% senior notes due 2018 and $775 million aggregate principal amount of 6 5/8% senior notes due 2020 (the New Senior Notes). The New Senior Notes will pay interest on May 1 and November 1, of each year beginning May 1, 2011. The New Senior Notes are unsecured senior obligations and rank equally to other unsecured senior indebtedness. The New Senior Notes are guaranteed by substantially all of our direct and indirect wholly-owned domestic subsidiaries. We may redeem some or all of the 6 3/8% senior notes at any time on or after November 1, 2013 at certain redemption prices and may redeem some or all of the 6 5/8% senior notes at any time on or after November 1, 2014 at certain redemption prices.
We received total proceeds of $4,300 million from these transactions, $2,750 million from the borrowings on Term Loan A and Term Loan B and an additional $1,550 million from the issuance of the New Senior Notes. We used a portion of the proceeds to pay-off the outstanding principal balances of our existing senior secured credit facilities plus accrued interest totaling $1,795 million and to purchase pursuant to a cash tender offer $558 million of the outstanding principal balances of our $700 million 6 5/8% senior notes due 2013 and $731 million of the outstanding balances of our $850 million 7 1/4% senior subordinated notes due 2015 (the Existing Notes), plus accrued interest totaling $1,297 million. The total amount paid for the Existing Notes was $1,019.06 per $1,000 principal amount of the 6 5/8% senior notes and $1,038.75 per $1,000 principal amount of the 7 1/4% senior subordinated notes. This resulted in us paying a cash tender premium of $39 million in order to extinguish this portion of the Existing Notes. On November 19, 2010, we redeemed the remaining outstanding balance of the existing 6 5/8% senior notes of $142 million at 101.656% per $1,000 and the remaining outstanding balance of the existing 7 1/4% senior subordinated notes of $119 million at 103.625% per $1,000 plus accrued interest totaling $265 million. In addition, we paid a call premium totaling $7 million. We also paid an additional $74 million in fees, discounts and other expenses. As a result of the above transactions, we received approximately $823 million in excess cash which we have been using for general purposes and other opportunities, including share repurchases, acquisitions and other growth investments.
In connection with these transactions, we expensed debt refinancing and redemption charges totaling $70.3 million in the fourth quarter of 2010, which includes the write off of certain existing deferred financing costs and other new financing costs, the cash tender and call premiums, as described above and other expenses.
On June 7, 2010, we redeemed $200 million aggregate principal amount of our outstanding 6 5/8% senior notes due 2013, at a price of 101.656% plus accrued interest. As a result of this transaction, we expensed debt redemption charges of $4.1 million, which includes the call premium and the net write-off of other finance costs.
60
Senior Secured Credit Facilities and senior and senior subordinated notes
During 2010, we made mandatory principal payments totaling $65.6 million on our prior outstanding Term Loan A. We did not make any principal payments on Term Loan B during 2010, nor were we required to.
All of the outstanding balances under the prior Term Loan A, Term Loan B and the senior and senior subordinated notes were extinguished as part of our debt refinancing transactions that occurred on October 20, 2010, as described above.
Stock repurchases
During 2010, we repurchased a total of 8,918,760 shares of our common stock for $618.5 million, or an average price of $69.35 per share, pursuant to previously announced authorizations by the Board of Directors.
Interest rate swaps
Our previous interest rate swap agreements expired on September 30, 2010. The agreements that were effective during 2010 had the economic effect of modifying the LIBOR variable component of our interest rate on an equivalent amount of our debt to fixed rates ranging from 4.05% to 4.70%, resulting in an overall weighted average effective interest rate of 5.84% on the hedged portion of our Senior Secured Credit Facilities, including the Term Loan B margin of 1.50%. During 2010 and 2009, we accrued net cash obligations of approximately $9.1 million and $17.3 million, respectively, from these swaps, which are included in debt expense.
Our overall weighted average effective interest rate on our Senior Secured Credit Facilities was 4.05%, based upon the current margins in effect of 2.75% for the Term Loan A and 3.00% for the Term Loan B, as of December 31, 2010.
As of December 31, 2010, interest rates on our Term Loan B are set at its LIBOR floors plus its interest rate margin and interest rates on our senior notes are fixed.
Our overall weighted average effective interest rate in 2010 was 4.68% and as of December 31, 2010 was 4.94%.
Off-balance sheet arrangements and aggregate contractual obligations
In addition to the debt obligations reflected on our balance sheet, we have commitments associated with operating leases and letters of credit as well as potential obligations associated with our equity investments in nonconsolidated businesses and to dialysis centers that are wholly-owned by third parties. Substantially all of our facilities are leased. We have potential acquisition obligations for several joint ventures and for some of our non-wholly-owned subsidiaries in the form of put provisions. If these put provisions were exercised, we would be required to purchase the third-party owners noncontrolling interests at either the appraised fair market value or a predetermined multiple of earnings or cash flow attributable to the noncontrolling interests put to us, which is intended to approximate fair value. For additional information see Note 22 to the consolidated financial statements.
We also have potential cash commitments to provide operating capital advances as needed to several other dialysis centers that are wholly-owned by third parties or centers in which we own an equity investment, as well as to physicianowned vascular access clinics that we operate under management and administrative services agreements.
61
The following is a summary of these contractual obligations and commitments as of December 31, 2011 (in millions):
Less Than 1 year |
2-3 years |
4-5 years |
After 5 years |
Total | ||||||||||||||||
Scheduled payments under contractual obligations: |
||||||||||||||||||||
Long-term debt |
$ | 85 | $ | 297 | $ | 2,531 | $ | 1,557 | $ | 4,470 | ||||||||||
Interest payments on the senior notes |
100 | 202 | 202 | 279 | 783 | |||||||||||||||
Interest payments on the Term Loan B(1) |
79 | 155 | 137 | | 371 | |||||||||||||||
Interest payments on the Term Loan A-2(2) |
9 | 18 | 16 | | 43 | |||||||||||||||
Capital lease obligations |
2 | 5 | 4 | 32 | 43 | |||||||||||||||
Operating leases |
258 | 444 | 370 | 636 | 1,708 | |||||||||||||||
Construction of the new corporate headquarters |
46 | | | | 46 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 579 | $ | 1,121 | $ | 3,260 | $ | 2,504 | $ | 7,464 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Potential cash requirements under existing commitments: |
||||||||||||||||||||
Letters of credit |
$ | 52 | $ | | $ | | $ | | $ | 52 | ||||||||||
Noncontrolling interests subject to put provisions |
260 | 98 | 76 | 44 | 478 | |||||||||||||||
Pay-fixed swaps potential obligations |
11 | 12 | | | 23 | |||||||||||||||
Operating capital advances |
4 | | | | 4 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 327 | $ | 110 | $ | 76 | $ | 44 | $ | 557 | |||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | Assuming no changes to LIBOR-based interest rates as the Term Loan B currently bears interest at LIBOR (floor of 1.50%) plus an interest rate margin of 3.00%. |
(2) | Assuming no changes to LIBOR-based interest rates as the Term Loan A-2 currently bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% |
The pay-fixed swap obligations represent the estimated fair market values of our interest rate swap agreements as reported by various broker dealers that are based upon relevant observable market inputs as well as other current market conditions that existed as of December 31, 2011, and represent the estimated potential obligation that we would be required to pay based upon the estimated future settlement of each specific tranche over the term of the swap agreements, assuming no future changes in the forward yield curve. The actual amount of our obligation associated with these swaps in the future will depend upon changes in the LIBOR-based interest rates that can fluctuate significantly depending upon market conditions, and other relevant factors that can affect the fair market value of these swap agreements.
In addition to the above commitments, we are obligated to purchase a certain amount of our hemodialysis products and supplies at fixed prices through 2015 from Gambro Renal Products, Inc. in connection with the Product Supply Agreement. Our total expenditures for the years ended December 31, 2011 and 2010 on such products were approximately 2% of our total operating costs in each year. In January 2010, we entered into an agreement with Fresenius which committed us to purchase a certain amount of dialysis equipment, parts and supplies from them through 2013. Our total expenditures for the year ended December 31, 2011 on such products were approximately 2% of our total operating costs.
The actual amount of purchases in future years from Gambro Renal Products and Fresenius will depend upon a number of factors, including the operating requirements of our centers, the number of centers we acquire, growth of our existing centers, and in the case of the Product Supply Agreement, Gambro Renal Products ability to meet our needs.
In November 2011, we entered into a seven year Sourcing and Supply Agreement with Amgen USA Inc. that expires on December 31, 2018. Under the terms of the agreement we will purchase EPO in amounts
62
necessary to meet no less than 90% of our requirements for erythropoiesis stimulating agents. The actual amount of EPO that we will purchase from Amgen will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that we serve.
Settlements of approximately $12 million of existing income tax liabilities for unrecognized tax benefits are excluded from the above table as reasonably reliable estimates of their timing cannot be made.
Contingencies
The information in Note 16 to the consolidated financial statements of this report is incorporated by reference in response to this item.
Critical accounting estimates and judgments
Our consolidated financial statements and accompanying notes are prepared in accordance with United States generally accepted accounting principles. These accounting principles require us to make estimates, judgments and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and temporary equity. All significant estimates, judgments and assumptions are developed based on the best information available to us at the time made and are regularly reviewed and updated when necessary. Actual results will generally differ from these estimates. Changes in estimates are reflected in our financial statements in the period of change based upon on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Interim changes in estimates are applied prospectively within annual periods. Certain accounting estimates, including those concerning revenue recognition and accounts receivable, impairments of long-lived assets, accounting for income taxes, quarterly and annual variable compensation accruals, purchase accounting valuation estimates, fair value estimates and stock-based compensation are considered to be critical to evaluating and understanding our financial results because they involve inherently uncertain matters and their application requires the most difficult and complex judgments and estimates.
Revenue recognition and accounts receivable. There are significant estimating risks associated with the amount of revenue that we recognize in a given reporting period. Payment rates are often subject to significant uncertainties related to wide variations in the coverage terms of the commercial healthcare plans under which we receive payments. In addition, ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage, and other payor issues complicate the billing and collection process. Net revenue recognition and allowances for uncollectible billings require the use of estimates of the amounts that will ultimately be realized considering, among other items, retroactive adjustments that may be associated with regulatory reviews, audits, billing reviews and other matters.
Revenues associated with Medicare and Medicaid programs are recognized based on (a) the payment rates that are established by statute or regulation for the portion of the payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, the estimated amounts that will ultimately be collectible from other government programs paying secondary coverage (e.g., Medicaid secondary coverage), the patients commercial health plan secondary coverage, or the patient. Effective January 1, 2011, our reimbursements from Medicare became subject to certain variations under Medicares new single bundled payment rate system whereby our reimbursements can be adjusted for certain patient characteristics and certain other factors. Our revenue recognition depends upon our ability to effectively capture, document and bill for Medicares base payment rate and these other factors. In addition, as a result of the potential range of variations that can occur in our reimbursements from Medicare under the new single bundled payment rate system, our revenue recognition is now subject to a greater degree of estimating risk.
Commercial healthcare plans, including contracted managed-care payors, are billed at our usual and customary rates; however, revenue is recognized based on estimated net realizable revenue for the services provided. Net realizable revenue is estimated based on contractual terms for the patients under healthcare plans
63
with which we have formal agreements, non-contracted healthcare plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in our billing and collection processes that can result in denied claims for payments, slow down in collections, a reduction in the amounts that we expect to collect and regulatory compliance issues. Determining applicable primary and secondary coverage for our more than 142,000 patients at any point in time, together with the changes in patient coverages that occur each month, requires complex, resource-intensive processes. Collections, refunds and payor retractions typically continue to occur for up to three years or longer after services are provided.
We generally expect our range of dialysis and related lab services revenues estimating risk to be within 1% of its revenue, which can represent as much as 6% of consolidated operating income. Changes in estimates are reflected in the then-current financial statements based on on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Changes in revenue estimates for prior periods are separately disclosed and reported if material to the current reporting period and longer term trend analyses, and have not been significant.
Lab service revenues for current period dates of services are recognized at the estimated net realizable amounts to be received.
Impairments of long-lived assets. We account for impairments of long-lived assets, which include property and equipment, equity investments in non-consolidated businesses, amortizable intangible assets with finite useful lives and goodwill, in accordance with the provisions of applicable accounting guidance. Impairment reviews are performed at least annually and whenever a change in condition occurs which indicates that the carrying amounts of assets may not be recoverable.
Such changes include changes in our business strategies and plans, changes in the quality or structure of our relationships with our partners and deteriorating operating performance of individual dialysis centers or other operations. We use a variety of factors to assess the realizable value of assets depending on their nature and use. Such assessments are primarily based upon the sum of expected future undiscounted net cash flows over the expected period the asset will be utilized, as well as market values and conditions. The computation of expected future undiscounted net cash flows can be complex and involves a number of subjective assumptions. Any changes in these factors or assumptions could impact the assessed value of an asset and result in an impairment charge equal to the amount by which its carrying value exceeds its actual or estimated fair value.
Accounting for income taxes. We estimate our income tax provision to recognize our tax expense for the current year, and our deferred tax liabilities and assets for future tax consequences of events that have been recognized in our financial statements, measured using enacted tax rates and laws expected to apply in the periods when the deferred tax liabilities or assets are expected to be realized. We are required to assess our tax positions on a more-likely-than-not criteria and to also determine the actual amount of benefit to recognize in the financial statements. Deferred tax assets are assessed based upon the likelihood of recoverability from future taxable income and, to the extent that recovery is not likely, a valuation allowance is established. The allowance is regularly reviewed and updated for changes in circumstances that would cause a change in judgment about the realizability of the related deferred tax assets. These calculations and assessments involve complex estimates and judgments because the ultimate tax outcome can be uncertain and future events unpredictable.
Variable compensation accruals. We estimate variable compensation accruals quarterly based upon the annual amounts expected to be earned and paid out resulting from the achievement of certain teammate-specific and/or corporate financial and operating goals. Our estimates, which include compensation incentives for bonuses, and other awards, are updated periodically based on changes in our economic condition or cash flows that could ultimately impact the actual final award. Actual results reflected in each fiscal quarter may vary due to the subjectivity involved in anticipating fulfillment of specific and/or corporate goals, as well as the final determination and approval of amounts by our Board of Directors.
64
Purchase accounting valuation estimates. We make various assumptions and estimates regarding the valuation of tangible and intangible assets, liabilities, noncontrolling interests and contractual as well as non-contractual contingencies associated with our acquisitions. These assumptions can have a material effect on our balance sheet valuations and the related amount of depreciation and amortization expense that will be recognized in the future.
Fair value estimates. We have recorded certain assets, liabilities and noncontrolling interests (temporary equity) subject to put provisions at fair value. The FASB defines fair value which is measured based upon certain valuation techniques that include inputs and assumptions that market participants would use in pricing assets, liabilities and noncontrolling interests subject to put provisions. We have measured the fair values of our applicable assets, liabilities and noncontrolling interests subject to put provisions based upon certain market inputs and assumptions that are either observable or unobservable in determining fair values and have also classified these assets, liabilities and noncontrolling interests subject to put provisions into the appropriate fair value hierarchy levels. The fair value of our investments available for sale are based upon quoted market prices from active markets and the fair value of our swap and cap agreements were based upon valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. For our noncontrolling interests subject to put provisions we have estimated the fair values of these based upon either the higher of a liquidation value of net assets or an average multiple of earnings based on historical earnings, patient mix and other performance indicators, as well as other factors. During the second quarter of 2010, we refined the methodology used to estimate the fair value of noncontrolling interests subject to put provisions by eliminating an annual inflation factor that was previously applied to the put provisions until they became exercisable. We believe that eliminating an annual inflation factor will result in a better representation of the estimated actual fair value of the noncontrolling interests subject to put provisions. The estimate of the fair values of the noncontrolling interests subject to put provisions involves significant judgments and assumptions and may not be indicative of the actual values at which the noncontrolling interests may ultimately be settled, which could vary significantly from our current estimates. The estimated fair values of the noncontrolling interests subject to put provisions can also fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary depending upon market conditions including potential purchasers access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners noncontrolling interests.
Stock-based compensation. Stock-based compensation recognized in a period represents the straight-line amortization during that period of the estimated grant-date fair value of stock-based awards over their vesting terms, adjusted for expected forfeitures. We estimate the grant-date fair value of stock awards using complex option pricing models that rely heavily on estimates from us about uncertain future events, including the expected term of the awards, the expected future volatility of our stock price, and expected future risk-free interest rates.
Significant new accounting standards
On January 1, 2012, we adopted FASBs Accounting Standard Update (ASU) No. 2011-08, Intangibles Goodwill and Other. This standard amends the current two-step goodwill impairment test required under the existing accounting guidance. This amendment allows entities the option to first assess certain qualitative factors to ascertain whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount to determine if the two-step impairment test is necessary. If an entity concludes that certain events or circumstances prove that it is more likely than not that the fair value of a reporting unit is less than its carrying amount then an entity is required to proceed to step one of the two-step goodwill impairment test. This standard is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard did not have a material impact on our consolidated financial statements.
65
On January 1, 2012, we adopted FASBs ASU No. 2011-07, Health Care Entities-Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts. This standard amends the current presentation and disclosure requirements for Health Care Entities that recognize significant amounts of patient service revenue at the time the services are rendered without assessing the patients ability to pay. This standard requires health care entities to reclassify the provision for bad debts from an operating expense to a deduction from patient service revenues. In addition, this standard requires more disclosure on the policies for recognizing revenue, assessing bad debts, as well as quantitative and qualitative information regarding changes in the allowance for doubtful accounts. This standard is applied retrospectively to all prior periods presented and is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard will require us to change the presentation in our financial statements.
On January 1, 2012, we adopted FASBs ASU No. 2011-05, Comprehensive IncomePresentation of Comprehensive Income. This standard amends the current presentation requirements for comprehensive income by eliminating the presentation of the components of other comprehensive income within the statement of equity. This standard allows two options on how to present the various components of comprehensive income. These options are either to report the components of comprehensive income separately on the income statement or to present total other comprehensive income and the components of other comprehensive income in a separate statement. This standard does not change the items that must be reported in other comprehensive income or when an item must be reclassified into net income. This standard is applied retrospectively and is effective for fiscal years and interim periods within those years beginning after December 15, 2011. Early adoption is permitted. The adoption of this standard will require us to change the presentation in our financial statements.
On January 1, 2012, we adopted FASBs ASU No. 2011-04, Fair Value Measurement. This standard amends the current fair value measurement and disclosure requirements to improve comparability between U.S. GAAP and International Financial Reporting Standards (IFRS). The intent of this standard is to update the disclosures that describe several of the requirements in U.S. GAAP for measuring fair value and to enhance disclosures about fair value measurements which will improve consistency between U.S. GAAP and IFRS. This standard does not change the application of the requirements on fair value measurements and disclosures. This standard is applied prospectively and is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard did not have a material impact on our consolidated financial statements.
Item 7A. | Quantitative and Qualitative Disclosures about Market Risk. |
Interest rate sensitivity
The tables below provide information about our financial instruments that are sensitive to changes in interest rates. For our debt obligations the table presents principal repayments and current weighted average interest rates on our debt obligations as of December 31, 2011. The variable rates presented reflect the weighted average LIBOR rates in effect for all debt tranches plus interest rate margins in effect at December 31, 2011. The Term Loan A margin currently in effect is 2.50% and along with the revolving line of credit is subject to adjustment depending upon changes in certain of our financial ratios including a leverage ratio. The Term Loan A-2 currently bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a ratings based step-down to 3.25%. The Term Loan B currently bears interest at LIBOR (floor of 1.50%) plus an interest rate margin of 3.00% subject to a ratings based step-down to 2.75%.
Expected maturity date | Total | Fair Value |
Average interest rate |
|||||||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | Thereafter | |||||||||||||||||||||||||||||||
(dollars in millions) | ||||||||||||||||||||||||||||||||||||
Long-term debt: |
||||||||||||||||||||||||||||||||||||
Fixed rate |
$ | 35 | $ | 24 | $ | 24 | $ | 24 | $ | 1,858 | $ | 1,585 | $ | 3,550 | $ | 3,543 | 5.59 | % | ||||||||||||||||||
Variable rate |
$ | 52 | $ | 101 | $ | 153 | $ | 652 | $ | 1 | $ | 4 | $ | 963 | $ | 951 | 2.81 | % |
66
Notional amount |
Contract maturity date | Pay fixed | Receive variable | Fair value |
||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||||||||||||||||||
(dollars in millions) | ||||||||||||||||||||||||||||||||
Swaps: |
||||||||||||||||||||||||||||||||
Pay-fixed rate |
$ | 950 | $ | 50 | $ | 100 | $ | 800 | $ | | $ | | 1.59% to 1.64% | LIBOR | $ | (23.1 | ) | |||||||||||||||
Cap agreements |
$ | 1,250 | $ | | $ | | $ | 1,250 | $ | | $ | | LIBOR above 4.00% | $ | 1.4 |
Our Senior Secured Credit Facilities, which include the Term Loan A, the Term Loan A-2 and the Term Loan B, consist of various individual tranches of debt that can range in maturity from one month to twelve months (currently, all tranches are one month in duration). For the Term Loan A, each tranche bears interest at a LIBOR rate that is determined by the duration of such tranche plus an interest rate margin. The LIBOR variable component of the interest rate for each tranche is reset as such tranche matures and a new tranche is established. LIBOR can fluctuate significantly depending upon conditions in the credit and capital markets.
The Term Loan A-2 and Term Loan B are subject to LIBOR floors of 1.00% and 1.50%, respectively. Because LIBOR, as of December 31, 2011, was lower than either of these floors, the interest rates on the Term Loan A-2 and the Term Loan B are treated as fixed for purposes of the table above. We have included both of these Term Loans in the fixed rate totals in the table above until such time as the LIBOR-based component of our interest rate exceeds 1.00% on the Term Loan A-2 and 1.50% on the Term Loan B. At such time, we will then be subject to LIBOR-based interest rate volatility on the LIBOR variable component of our interest rate on all of the Term Loan A-2, as well as for the Term Loan B, but limited to a maximum rate of 4.00% on $1.25 billion of outstanding principal debt on the Term Loan B. The remaining $483 million outstanding principal balance of the Term Loan B is subject to LIBOR-based interest rate volatility above a floor of 1.50%.
In January 2011, we entered into nine interest rate swap agreements with amortizing notional amounts totaling $1.0 billion that went effective on January 31, 2011, as a means of hedging our exposure to and volatility from variable-based interest rate changes as part of our overall risk management strategy. As of December 31, 2011, we maintained a total of nine interest rate swap agreements with amortizing notional amounts totaling $950 million. These agreements had the economic effect of modifying the LIBOR variable component of our interest rate on an equivalent amount of our Term Loan A to fixed rates ranging from 1.59% to 1.64%, resulting in an overall weighted average effective interest rate of 4.11%, including the Term Loan A margin of 2.50%. The swap agreements expire by September 30, 2014 and require monthly interest payments. During the year ended December 31, 2011, we accrued net charges of $12.6 million from these swaps which are included in debt expense. As of December 31, 2011, the total fair value of these swap agreements was a liability of $23.1 million. We estimate that approximately $10.9 million of existing unrealized pre-tax losses in other comprehensive income at December 31, 2011 will be reclassified into income over the next year.
In addition, in January 2011, we also entered into five interest rate cap agreements with notional amounts totaling $1.25 billion that went effective on January 31, 2011. These agreements have the economic effect of capping the LIBOR variable component of our interest rate at a maximum of 4.00% on an equivalent amount of our Term Loan B debt. The cap agreements expire on September 30, 2014. As of December 31, 2011, the total fair value of these cap agreements was an asset of $1.4 million. During the year ended December 31, 2011, we recorded $5.2 million, net of tax, as a decrease to other comprehensive income due to unrealized valuation changes in the cap agreements, net of the amortization of the interest rate cap premiums that were reclassified into net income.
As a result of the swap and cap agreements, our overall weighted average effective interest rate on the Senior Secured Credit Facilities was 4.61%, based upon the current margins in effect of 2.50% for the Term Loan A, 3.50% for the Term Loan A-2 and 3.00% for the Term Loan B, as of December 31, 2011.
67
As of December 31, 2011, interest rates on our Term Loan A-2 and Term Loan B are set at their LIBOR floors plus their interest rate margins. Interest rates on our senior notes and Term Loan A are fixed and economically fixed, respectively, with rates on the $1.25 billion of our Term Loan B subject to interest rate caps.
Our overall weighted average effective interest rate in 2011 was 5.28% and as of December 31, 2011 was 5.27%.
One means of assessing exposure to debt-related interest rate changes is a duration-based analysis that measures the potential loss in net income resulting from a hypothetical increase in interest rates of 100 basis points across all variable rate maturities (referred to as a parallel shift in the yield curve). Under this model, with all else constant, it is estimated that such an increase would have reduced net income by approximately $0.6 million, $11.1 million, and $8.5 million, net of tax, for the years ended December 31, 2011, 2010, and 2009, respectively.
Exchange rate sensitivity
We are currently not exposed to any significant foreign currency exchange rate risk.
Item 8. | Financial Statements and Supplementary Data. |
See the Index to Financial Statements and Index to Financial Statement Schedules included at Item 15. Exhibits, Financial Statement Schedules.
Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. |
None.
Item 9A. | Controls and Procedures. |
Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934, as amended, or Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and forms, and that such information is accumulated and communicated to our management including our Chief Executive Officer and Chief Financial Officer as appropriate to allow for timely decisions regarding required disclosures.
At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures in accordance with the Exchange Act requirements. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective for timely identification and review of material information required to be included in our Exchange Act reports, including this report on Form 10-K. Management recognizes that these controls and procedures can provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.
There has not been any change in our internal control over financial reporting that was identified during the evaluation that occurred during the fourth fiscal quarter and that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. | Other Information. |
None.
68
PART III
Item 10. | Directors, Executive Officers and Corporate Governance. |
In 2002, we adopted a Corporate Governance Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, and to all of our financial accounting and legal professionals who are directly or indirectly involved in the preparation, reporting and fair presentation of our financial statements and Exchange Act Reports. The Code of Ethics is posted on our website, located at http://www.davita.com. We also maintain a Corporate Code of Conduct that applies to all of our employees, which is posted on our website.
Under our Corporate Governance Guidelines all Board Committees including the Audit Committee, Nominating and Governance Committee and the Compensation Committee, which are comprised solely of independent directors as defined within the listing standards of the New York Stock Exchange, have written charters that outline the committees purpose, goals, membership requirements and responsibilities. These charters are regularly reviewed and updated as necessary by our Board of Directors. All Board Committee charters as well as the Corporate Governance Guidelines are posted on our website located at http://www.davita.com.
The other information required to be disclosed by this item will appear in, and is incorporated by reference from, the sections entitled Proposal No. 1. Election of Directors, Corporate Governance, and Security Ownership of Certain Beneficial Owners and Management included in our definitive proxy statement relating to our 2012 annual stockholder meeting.
Item 11. | Executive Compensation. |
The information required by this item will appear in, and is incorporated by reference from, the sections entitled Executive Compensation and Compensation Committee Interlocks and Insider Participations included in our definitive proxy statement relating to our 2012 annual stockholder meeting. The information required by Item 407(e)(5) of Regulation S-K will appear in and is incorporated by reference from the section entitled Compensation Committee Report included in our definitive proxy statement relating to our 2012 annual stockholder meeting; however, this information shall not be deemed to be filed.
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. |
The following table provides information about our common stock that may be issued upon the exercise of stock options, stock-settled stock appreciation rights, restricted stock units and other rights under all of our existing equity compensation plans as of December 31, 2011, including our omnibus 2011 Incentive Award Plan (formerly known as our 2002 Equity Compensation Plan) and our Employee Stock Purchase Plan. The material terms of these plans are described in Note 17 to the Consolidated Financial Statements.
Plan category |
Number of shares to be issued upon exercise of outstanding options, warrants and rights |
Weighted average exercise price of outstanding options, warrants and rights |
Number of shares remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
Total of shares reflected in columns (a) and (c) |
||||||||||||
(a) | (b) | (c) | (d) | |||||||||||||
Equity compensation plans approved by shareholders |
10,728,672 | $ | 56.90 | 9,192,928 | 19,921,600 | |||||||||||
Equity compensation plans not requiring shareholder approval |
| | | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
10,728,672 | $ | 56.90 | 9,192,928 | 19,921,900 | |||||||||||
|
|
|
|
|
|
|
|
69
Other information required to be disclosed by Item 12 will appear in, and is incorporated by reference from, the section entitled Security Ownership of Certain Beneficial Owners and Management included in our definitive proxy statement relating to our 2012 annual stockholder meeting.
Item 13. | Certain Relationships and Related Transactions and Director Independence. |
The information required by this item will appear in, and is incorporated by reference from, the section entitled Certain Relationships and Related Transactions and the section entitled Corporate Governance included in our definitive proxy statement relating to our 2012 annual stockholder meeting.
Item 14. | Principal Accounting Fees and Services. |
The information required by this item will appear in, and is incorporated by reference from, the section entitled Ratification of Appointment of Independent Registered Public Accounting Firm included in our definitive proxy statement relating to our 2012 annual stockholder meeting.
70
PART IV
Item 15. | Exhibits, Financial Statement Schedules. |
(a) Documents filed as part of this Report:
(1) Index to Financial Statements:
(2) Index to Financial Statement Schedules:
S-1 | ||||
S-2 |
(1) Exhibits:
2.1 | Stock Purchase Agreement dated as of December 6, 2004, among Gambro AB, Gambro, Inc. and DaVita Inc.(9) | |
2.2 | Amended and Restated Asset Purchase Agreement effective as of July 28, 2005, by and among DaVita Inc., Gambro Healthcare, Inc. and Renal Advantage Inc., a Delaware corporation, formerly known as RenalAmerica, Inc.(12) | |
2.3 | Agreement and Plan of Merger by and among DaVita Inc., DVA Acquisition Company, CDSI I Holding Company, Inc. and CDSI Representative LLC, dated as of February 4, 2011.(47) | |
3.1 | Amended and Restated Certificate of Incorporation of Total Renal Care Holdings, Inc., or TRCH, dated December 4, 1995.(1) | |
3.2 | Certificate of Amendment of Certificate of Incorporation of TRCH, dated February 26, 1998.(2) | |
3.3 | Certificate of Amendment of Certificate of Incorporation of DaVita Inc. (formerly Total Renal Care Holdings, Inc.), dated October 5, 2000.(4) | |
3.4 | Certificate of Amendment of Amended and Restated Certificate of Incorporation of DaVita Inc., as amended dated May 30, 2007.(23) | |
3.5 | Amended and Restated Bylaws for DaVita Inc. dated as of March 10, 2011.(25) | |
4.1 | Indenture for the 6 5/8% Senior Notes due 2013 dated as of March 22, 2005.(3) | |
4.2 | Indenture for the 7 1/4% Senior Subordinated Notes due 2015 dated as of March 22, 2005.(3) |
71
4.3 | First Supplemental Indenture, dated October 5, 2005, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(11) | |
4.4 | First Supplemental Indenture, dated October 5, 2005, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(13) | |
4.5 | Rights Agreement, dated as of November 14, 2002, between DaVita Inc. and the Bank of New York, as Rights Agent.(21) | |
4.6 | Second Supplemental Indenture (Senior), dated February 9, 2007, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(22) | |
4.7 | Second Supplemental Indenture (Senior Subordinated), dated February 9, 2007, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(22) | |
4.8 | Registration Rights Agreement for the 6 5/8% Senior Notes due 2013 dated as of February 23, 2007.(26) | |
4.9 | Third Supplemental Indenture, dated October 14, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(38) | |
4.10 | Third Supplemental Indenture, dated October 14, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(38) | |
4.11 | Indenture, dated October 20, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(39) | |
4.12 | Indenture, dated October 20, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(39) | |
4.13 | First Amendment to Rights Agreement, dated as of March 10, 2011, between DaVita Inc. and The Bank of New York Mellon Trust Company, N.A., as Rights Agent.(42) | |
10.1 | Employment Agreement, dated as of October 19, 2009, by and between DaVita Inc. and Kim M. Rivera.(40)* | |
10.2 | Employment Agreement, dated as of June 15, 2000, by and between DaVita Inc. and Joseph C. Mello.(6)* | |
10.3 | Second Amendment to Mr. Mellos Employment Agreement, effective December 12, 2008.(33)* | |
10.4 | Employment Agreement, effective as of August 16, 2004, by and between DaVita Inc. and Tom Usilton.(7)* | |
10.5 | Amendment to Mr. Usiltons Employment Agreement, dated February 12, 2007.(24)* | |
10.6 | Second Amendment to Mr. Usiltons Employment Agreement, effective December 12, 2008.(32)* | |
10.7 | Employment Agreement, effective as of November 18, 2004, by and between DaVita Inc. and Joseph Schohl.(14)* | |
10.8 | Amendment to Mr. Schohls Employment Agreement, effective December 30, 2008.(32)* | |
10.9 | Employment Agreement, dated as of October 31, 2005, effective October 24, 2005, by and between DaVita Inc. and Dennis Kogod.(13)* | |
10.10 | Amendment to Mr. Kogods Employment Agreement, effective December 12, 2008.(32)* |
72
10.11 | Employment Agreement, effective September 22, 2005, by and between DaVita Inc. and James Hilger.(15)* | |
10.12 | Amendment to Mr. Hilgers Employment Agreement, effective December 12, 2008.(32)* | |
10.13 | Employment Agreement effective February 13, 2008, by and between DaVita Inc. and Richard K. Whitney.(28)* | |
10.14 | Amendment to Equity Award Agreement, entered into on December 11, 2009, between DaVita Inc. and Richard K. Whitney.(40)* | |
10.15 | Amendment to Stock Appreciation Rights Agreements, effective November 2008, by and between DaVita Inc. and Richard K. Whitney.(36)* | |
10.16 | Employment Agreement, effective July 25, 2008, between DaVita Inc. and Kent J. Thiry.(29)* | |
10.17 | Employment Agreement, effective August 1, 2008, between DaVita Inc. and Allen Nissenson.(30)* | |
10.18 | Employment Agreement, effective March 3, 2008, between DaVita Inc. and David Shapiro.(32)* | |
10.19 | Amendment to Mr. Shapiros Employment Agreement, effective December 4, 2008.(32)* | |
10.20 | Employment Agreement, effective March 17, 2010, by and between DaVita Inc. and Javier Rodriguez.(35)* | |
10.21 | Employment Agreement, effective February 26, 2010, by and between DaVita Inc. and Luis Borgen.(36)* | |
10.22 | Amendment to Mr. Borgens Employment Agreement, effective March 18, 2010.(36)* | |
10.23 | Memorandum Relating to Bonus Structure for Kent J. Thiry.(36)* | |
10.24 | Memorandum Relating to Bonus Structure for Dennis L. Kogod.(36)* | |
10.25 | Memorandum Relating to Bonus Structure for Thomas O. Usilton, Jr.(36)* | |
10.26 | Form of Indemnity Agreement.(20)* | |
10.27 | Form of Indemnity Agreement.(14)* | |
10.28 | Executive Incentive Plan (as Amended and Restated effective January 1, 2009).(34)* | |
10.29 | Executive Retirement Plan.(32)* | |
10.30 | Post-Retirement Deferred Compensation Arrangement.(14)* | |
10.31 | Amendment No. 1 to Post Retirement Deferred Compensation Arrangement.(32)* | |
10.32 | DaVita Voluntary Deferral Plan.(11)* | |
10.33 | Deferred Bonus Plan (Prosperity Plan).(31)* | |
10.34 | Amendment No. 1 to Deferred Bonus Plan (Prosperity Plan).(32)* | |
10.35 | Amended and Restated Employee Stock Purchase Plan.(27)* | |
10.36 | Severance Plan.(36)* | |
10.37 | Change in Control Bonus Program.(32)* | |
10.38 | First Amended and Restated Total Renal Care Holdings, Inc. 1999 Non-Executive Officer and Non-Director Equity Compensation Plan.(5) | |
10.39 | Non-Management Director Compensation Philosophy and Plan.(28)* | |
10.40 | Amended and Restated 2002 Equity Compensation Plan.(10)* |
73
10.41 | Amended and Restated 2002 Equity Compensation Plan.(19)* | |
10.42 | Amended and Restated 2002 Equity Compensation Plan.(27)* | |
10.43 | Amended and Restated 2002 Equity Compensation Plan.(32)* | |
10.44 | DaVita Inc. 2002 Equity Compensation Plan.(37)* | |
10.45 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 1999 Non-Executive Officer and Non-Director Equity Compensation Plan.(18)* | |
10.46 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(7)* | |
10.47 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* | |
10.48 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.49 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(7)* | |
10.50 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* | |
10.51 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.52 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(32)* | |
10.53 | Form of Stock Appreciation Rights AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* | |
10.54 | Form of Stock Appreciation Rights AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.55 | Form of Stock Appreciation Rights AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.56 | Form of Stock Appreciation Rights AgreementBoard members (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.57 | Form of Restricted Stock Units AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.58 | Form of Restricted Stock Units AgreementBoard members (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.59 | Form of Non-Qualified Stock Option AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.60 | Form of Stock Appreciation Rights AgreementExecutives (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.61 | Form of Restricted Stock Units AgreementExecutives (DaVita Inc. 2011 Incentive Award Plan).(44)* |
74
10.62 | Credit Agreement, dated as of October 5, 2005, among DaVita Inc., the Guarantors party thereto, the Lenders party thereto, Bank of America, N.A., Wachovia Bank, National Association, Bear Stearns Corporate Lending Inc., The Bank of New York, The Bank of Nova Scotia, The Royal Bank of Scotland plc, WestLB AG, New York Branch as Co-Documentation Agents, Credit Suisse, Cayman Islands Branch, as Syndication Agent, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, JPMorgan Securities Inc., as Sole Lead Arranger and Bookrunner and Credit Suisse, Cayman Islands Branch, as Co-Arranger.(11) | |
10.63 | Credit Agreement, dated as of October 5, 2005, as Amended and Restated as of February 23, 2007, by and among DaVita Inc., the Guarantors party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A.(26) | |
10.64 | Amendment Agreement, dated February 23, 2007, by and among DaVita Inc., the Guarantors party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A.(26) | |
10.65 | Security Agreement, dated as of October 5, 2005, by DaVita Inc., the Guarantors party thereto and JPMorgan Chase Bank, N.A., as Collateral Agent.(11) | |
10.66 | Credit Agreement, dated as of October 20, 2010, by and among DaVita Inc., the guarantors party thereto, the lenders party thereto, Credit Suisse AG, Barclays Bank PLC, Goldman Sachs Bank USA, Wells Fargo Bank, National Association, Credit Agricole Corporate and Investment Bank, RBC Capital Markets, Scotia Capital (USA) Inc., SunTrust Robinson Humphrey, Inc. and Union Bank, N.A., as Co-Documentation Agents, Bank of America, N.A., as Syndication Agent, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC, Banc of America Securities LLC, Credit Suisse Securities (USA) LLC, Barclays Capital, Goldman Sachs Bank USA and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Joint Bookrunners.(46)** | |
10.67 | Perfection Certificate executed as of October 20, 2010 and delivered in connection with the closing of the Credit Agreement filed as Exhibit 10.66.(46)** | |
10.68 | Corporate Integrity Agreement between the Office of Inspector General of the Department of Health and Human Services and Gambro Healthcare, Inc. effective as of December 1, 2004.(11) | |
10.69 | Amended and Restated Alliance and Product Supply Agreement, dated as of August 25, 2006, among Gambro Renal Products, Inc., DaVita Inc. and Gambro AB.(17)** | |
10.70 | Letter dated March 19, 2007 from Willard W. Brittain, Jr. to Peter T. Grauer, Lead Independent Director of the Company.(22) | |
10.71 | Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. dated December 20, 2007.(31)** | |
10.72 | Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. dated December 17, 2010.(41)** | |
10.73 | DaVita Inc. 2011 Incentive Award Plan.(43)* | |
10.74 | Amendment No. 2 to Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. effective as of July 1, 2011.(45)** | |
10.75 | Sourcing and Supply Agreement between DaVita Inc. and Amgen USA Inc. effective as of January 1, 2012.ü** | |
12.1 | Computation of Ratio of Earnings to Fixed Charges.ü | |
14.1 | DaVita Inc. Corporate Governance Code of Ethics.(8) | |
21.1 | List of our subsidiaries.ü |
75
23.1 | Consent of KPMG LLP, independent registered public accounting firm.ü | |
24.1 | Powers of Attorney with respect to DaVita. (Included on Page II-1). | |
31.1 | Certification of the Chief Executive Officer, dated February 24, 2012, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.ü | |
31.2 | Certification of the Chief Financial Officer, dated February 24, 2012, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.ü | |
32.1 | Certification of the Chief Executive Officer, dated February 24, 2012, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.ü | |
32.2 | Certification of the Chief Financial Officer, dated February 24, 2012, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.ü | |
101.INS | XBRL Instance Document. | |
101.SCH | XBRL Taxonomy Extension Schema Document. | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. |
ü | Included in this filing. |
* | Management contract or executive compensation plan or arrangement. |
** | Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the SEC. |
(1) | Filed on March 18, 1996 as an exhibit to the Companys Transitional Report on Form 10-K for the transition period from June 1, 1995 to December 31, 1995. |
(2) | Filed on March 31, 1998 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 1997. |
(3) | Filed on March 25, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(4) | Filed on March 20, 2001 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2000. |
(5) | Filed on February 28, 2003 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2002. |
(6) | Filed on August 15, 2001 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2001. |
(7) | Filed on November 8, 2004 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. |
(8) | Filed on February 27, 2004 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2003. |
(9) | Filed on December 8, 2004 as an exhibit to the Companys Current Report on Form 8-K. |
(10) | Filed on May 4, 2005 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2005. |
(11) | Filed on November 8, 2005 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2005. |
(12) | Filed on October 11, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(13) | Filed on November 4, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(14) | Filed on March 3, 2005 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2004. |
76
(15) | Filed on August 7, 2006 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ending June 30, 2006. |
(16) | Filed on July 6, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(17) | Filed on November 3, 2006 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2006. |
(18) | Filed on October 18, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(19) | Filed on July 31, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(20) | Filed on December 20, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(21) | Filed on November 19, 2002 as an exhibit to the Companys Current Report on Form 8-K. |
(22) | Filed on May 3, 2007 as an exhibit to the Companys Quarterly Report as Form 10-Q for the quarter ended March 31, 2007. |
(23) | Filed on August 6, 2007 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. |
(24) | Filed on February 16, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(25) | Filed on March 17, 2011 as an exhibit to the Companys Current Report on Form 8-K/A. |
(26) | Filed on February 28, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(27) | Filed on June 4, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(28) | Filed on May 8, 2008 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. |
(29) | Filed on July 31, 2008 as an exhibit to the Companys Current Report on Form 8-K. |
(30) | Filed on November 6, 2008 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. |
(31) | Filed on February 29, 2008 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2007. |
(32) | Filed on February 27, 2009 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2008 |
(33) | Filed on May 7, 2009 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2009. |
(34) | Filed on June 18, 2009 as an exhibit to the Companys Current Report on Form 8-K. |
(35) | Filed on April 14, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
(36) | Filed on May 3, 2010 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2010. |
(37) | Filed on April 28, 2010 as Appendix A to the Companys Definitive Proxy Statement on Schedule 14A. |
(38) | Filed on October 19, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
(39) | Filed on October 21, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
(40) | Filed on February 25, 2010 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2009. |
(41) | Filed on December 29, 2011 as an exhibit to the Companys Annual Report on Form 10-K/A for the year ended December 31, 2010. |
(42) | Filed on May 6, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2011. |
(43) | Filed on April 27, 2011 as Appendix A to the Companys Definitive Proxy Statement on Schedule 14A. |
(44) | Filed on August 4, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2011. |
(45) | Filed on December 29, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q/A for the quarter ended June 30, 2011. |
(46) | Filed on January 17, 2012 as an exhibit to the Companys Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2011. |
(47) | Filed on February 10, 2011 as an exhibit to the Companys Current Report on Form 8-K. |
77
DAVITA INC.
MANAGEMENTS REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and which includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Companys assets that could have a material effect on the financial statements.
During the last fiscal year, the Company conducted an evaluation, under the oversight of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Companys internal control over financial reporting. This evaluation was completed based on the criteria established in the report titled Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
Based upon our evaluation under the COSO framework, we have concluded that the Companys internal control over financial reporting was effective as of December 31, 2011.
The Companys independent registered public accounting firm, KPMG LLP, has issued an attestation report on the Companys internal control over financial reporting, which report is included in this Annual Report.
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
DaVita Inc.:
We have audited the accompanying consolidated balance sheets of DaVita Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011. These consolidated financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of DaVita Inc. and subsidiaries as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2011, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), DaVita Inc.s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 24, 2012 expressed an unqualified opinion on the effectiveness of the Companys internal control over financial reporting.
/s/ KPMG LLP
Seattle, Washington
February 24, 2012
F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
DaVita Inc.:
We have audited DaVita Inc.s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). DaVita Inc.s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Managements Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Companys internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the companys assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, DaVita Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2011, based on criteria established in Internal ControlIntegrated Framework issued by COSO.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of DaVita Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, and our report dated February 24, 2012 expressed an unqualified opinion on those consolidated financial statements.
/s/ KPMG LLP
Seattle, Washington
February 24, 2012
F-3
DAVITA INC.
CONSOLIDATED STATEMENTS OF INCOME
(dollars in thousands, except per share data)
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Net operating revenues |
$ | 6,982,214 | $ | 6,438,050 | $ | 6,100,648 | ||||||
Operating expenses and charges: |
||||||||||||
Patient care costs |
4,680,772 | 4,467,107 | 4,242,147 | |||||||||
General and administrative |
691,243 | 579,000 | 531,531 | |||||||||
Depreciation and amortization |
266,628 | 233,730 | 228,396 | |||||||||
Provision for uncollectible accounts |
197,565 | 170,652 | 161,388 | |||||||||
Equity investment income |
(8,776 | ) | (8,999 | ) | (2,442 | ) | ||||||
Goodwill impairment charge |
24,000 | | | |||||||||
|
|
|
|
|
|
|||||||
Total operating expenses and charges |
5,851,432 | 5,441,490 | 5,161,020 | |||||||||
|
|
|
|
|
|
|||||||
Operating income |
1,130,782 | 996,560 | 939,628 | |||||||||
Debt expense |
(241,090 | ) | (181,607 | ) | (185,755 | ) | ||||||
Debt refinancing and redemption charges |
| (74,382 | ) | | ||||||||
Other income |
2,982 | 3,419 | 3,706 | |||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations before income taxes |
892,674 | 743,990 | 757,579 | |||||||||
Income tax expense |
315,744 | 260,052 | 278,213 | |||||||||
|
|
|
|
|
|
|||||||
Income from continuing operations |
576,930 | 483,938 | 479,366 | |||||||||
Discontinued operations: |
||||||||||||
Income from operations of discontinued operations, net of tax |
1,221 | 281 | 393 | |||||||||
Loss on disposal of discontinued operations, net of tax |
(4,756 | ) | | | ||||||||
|
|
|
|
|
|
|||||||
Net income |
573,395 | 484,219 | 479,759 | |||||||||
Less: Net income attributable to noncontrolling interests |
(95,394 | ) | (78,536 | ) | (57,075 | ) | ||||||
|
|
|
|
|
|
|||||||
Net income attributable to DaVita Inc. |
$ | 478,001 | $ | 405,683 | $ | 422,684 | ||||||
|
|
|
|
|
|
|||||||
Earnings per share: |
||||||||||||
Basic income from continuing operations per share attributable to DaVita Inc. |
$ | 5.09 | $ | 3.99 | $ | 4.07 | ||||||
|
|
|
|
|
|
|||||||
Basic net income per share attributable to DaVita Inc. |
$ | 5.05 | $ | 4.00 | $ | 4.08 | ||||||
|
|
|
|
|
|
|||||||
Diluted income from continuing operations per share attributable to DaVita Inc. |
$ | 4.99 | $ | 3.93 | $ | 4.05 | ||||||
|
|
|
|
|
|
|||||||
Diluted net income per share attributable to DaVita Inc. |
$ | 4.96 | $ | 3.94 | $ | 4.06 | ||||||
|
|
|
|
|
|
|||||||
Weighted average shares for earnings per share: |
||||||||||||
Basic |
94,658,027 | 101,504,373 | 103,603,885 | |||||||||
|
|
|
|
|
|
|||||||
Diluted |
96,532,110 | 103,059,171 | 104,167,685 | |||||||||
|
|
|
|
|
|
|||||||
Amounts attributable to DaVita Inc.: |
||||||||||||
Income from continuing operations |
$ | 481,755 | $ | 405,402 | $ | 422,291 | ||||||
Discontinued operations |
(3,754 | ) | 281 | 393 | ||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | 478,001 | $ | 405,683 | $ | 422,684 | ||||||
|
|
|
|
|
|
See notes to consolidated financial statements.
F-4
DAVITA INC.
(dollars in thousands, except per share data)
December 31, | ||||||||
2011 | 2010 | |||||||
ASSETS | ||||||||
Cash and cash equivalents |
$ | 393,752 | $ | 860,117 | ||||
Short-term investments |
17,399 | 23,003 | ||||||
Accounts receivable, less allowance of $250,343 and $235,629 |
1,195,163 | 1,048,976 | ||||||
Inventories |
75,731 | 76,008 | ||||||
Other receivables |
269,832 | 304,366 | ||||||
Other current assets |
49,349 | 43,994 | ||||||
Income tax receivable |
| 40,330 | ||||||
Deferred income taxes |
280,382 | 226,060 | ||||||
|
|
|
|
|||||
Total current assets |
2,281,608 | 2,622,854 | ||||||
Property and equipment, net |
1,432,651 | 1,170,808 | ||||||
Amortizable intangibles, net |
159,491 | 162,635 | ||||||
Equity investments |
27,325 | 25,918 | ||||||
Long-term investments |
9,890 | 8,848 | ||||||
Other long-term assets |
34,231 | 32,054 | ||||||
Goodwill |
4,946,976 | 4,091,307 | ||||||
|
|
|
|
|||||
$ | 8,892,172 | $ | 8,114,424 | |||||
|
|
|
|
|||||
LIABILITIES AND EQUITY | ||||||||
Accounts payable |
$ | 289,653 | $ | 181,033 | ||||
Other liabilities |
325,734 | 342,943 | ||||||
Accrued compensation and benefits |
412,972 | 325,477 | ||||||
Current portion of long-term debt |
87,345 | 74,892 | ||||||
Income taxes payable |
37,412 | | ||||||
|
|
|
|
|||||
Total current liabilities |
1,153,116 | 924,345 | ||||||
Long-term debt |
4,417,624 | 4,233,850 | ||||||
Other long-term liabilities |
132,006 | 89,290 | ||||||
Alliance and product supply agreement, net |
19,987 | 25,317 | ||||||
Deferred income taxes |
423,098 | 421,436 | ||||||
|
|
|
|
|||||
Total liabilities |
6,145,831 | 5,694,238 | ||||||
Commitments and contingencies |
||||||||
Noncontrolling interests subject to put provisions |
478,216 | 383,052 | ||||||
Equity: |
||||||||
Preferred stock ($0.001 par value, 5,000,000 shares authorized; none issued) |
||||||||
Common stock ($0.001 par value, 450,000,000 shares authorized; 134,862,283 shares issued; 93,641,363 and 96,001,535 shares outstanding) |
135 | 135 | ||||||
Additional paid-in capital |
596,300 | 620,546 | ||||||
Retained earnings |
3,195,818 | 2,717,817 | ||||||
Treasury stock, at cost (41,220,920 and 38,860,748 shares) |
(1,631,694 | ) | (1,360,579 | ) | ||||
Accumulated other comprehensive (loss) income |
(19,484 | ) | 503 | |||||
|
|
|
|
|||||
Total DaVita Inc. shareholders equity |
2,141,075 | 1,978,422 | ||||||
Noncontrolling interests not subject to put provisions |
127,050 | 58,712 | ||||||
|
|
|
|
|||||
Total equity |
2,268,125 | 2,037,134 | ||||||
|
|
|
|
|||||
$ | 8,892,172 | $ | 8,114,424 | |||||
|
|
|
|
See notes to consolidated financial statements.
F-5
DAVITA INC.
CONSOLIDATED STATEMENTS OF CASH FLOW
(dollars in thousands)
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ | 573,395 | $ | 484,219 | $ | 479,759 | ||||||
Adjustments to reconcile net income to cash provided by operating activities: |
||||||||||||
Depreciation and amortization |
267,315 | 234,378 | 228,986 | |||||||||
Stock-based compensation expense |
48,718 | 45,551 | 44,422 | |||||||||
Tax benefits from stock award exercises |
38,199 | 26,706 | 18,241 | |||||||||
Excess tax benefits from stock award exercises |
(20,834 | ) | (6,283 | ) | (6,950 | ) | ||||||
Deferred income taxes |
53,438 | 75,399 | 50,869 | |||||||||
Equity investment income, net |
354 | (3,298 | ) | (204 | ) | |||||||
Loss on disposal of assets and other non-cash charges |
20,329 | 9,585 | 20,945 | |||||||||
Goodwill impairment charge |
24,000 | | | |||||||||
Debt refinancing and redemption charges |
| 74,382 | | |||||||||
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: |
||||||||||||
Accounts receivable |
(88,848 | ) | 55,379 | (32,313 | ) | |||||||
Inventories |
10,270 | (3,892 | ) | 15,115 | ||||||||
Other receivables and other current assets |
53,697 | (44,719 | ) | (35,104 | ) | |||||||
Other long-term assets |
2,039 | 901 | 7,288 | |||||||||
Accounts payable |
84,400 | 4,228 | (104,879 | ) | ||||||||
Accrued compensation and benefits |
77,074 | 39,588 | (9,138 | ) | ||||||||
Other current liabilities |
(51,979 | ) | (111,444 | ) | (43,543 | ) | ||||||
Income taxes |
77,418 | (45,737 | ) | 44,578 | ||||||||
Other long-term liabilities |
11,061 | 4,740 | (11,362 | ) | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
1,180,046 | 839,683 | 666,710 | |||||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities: |
||||||||||||
Additions of property and equipment, net |
(400,156 | ) | (273,602 | ) | (274,605 | ) | ||||||
Acquisitions |
(1,077,442 | ) | (188,502 | ) | (87,617 | ) | ||||||
Proceeds from asset sales |
75,183 | 22,727 | 7,697 | |||||||||
Purchase of investments available-for-sale |
(5,971 | ) | (1,125 | ) | (2,062 | ) | ||||||
Purchase of investments held-to-maturity |
(37,628 | ) | (56,615 | ) | (22,664 | ) | ||||||
Proceeds from the sale of investments available-for-sale |
1,149 | 900 | 16,693 | |||||||||
Proceeds from maturities of investments held-to-maturity |
47,695 | 59,932 | 16,380 | |||||||||
Purchase of equity investments and other assets |
(2,398 | ) | (709 | ) | (2,429 | ) | ||||||
Distributions received on equity investments |
340 | 361 | 2,547 | |||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
(1,399,228 | ) | (436,633 | ) | (346,060 | ) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities: |
||||||||||||
Borrowings |
36,395,105 | 24,809,258 | 18,767,592 | |||||||||
Payments on long-term debt |
(36,249,584 | ) | (24,134,502 | ) | (18,828,824 | ) | ||||||
Interest rate cap premiums and other deferred financing costs |
(17,861 | ) | | | ||||||||
Debt refinancing costs including tender and call premiums |
| (113,810 | ) | (42 | ) | |||||||
Purchase of treasury stock |
(323,348 | ) | (618,496 | ) | (153,495 | ) | ||||||
Distributions to noncontrolling interests |
(100,653 | ) | (83,591 | ) | (67,748 | ) | ||||||
Stock award exercises and other share issuances, net |
11,316 | 53,760 | 67,908 | |||||||||
Excess tax benefits from stock award exercises |
20,834 | 6,283 | 6,950 | |||||||||
Contributions from noncontrolling interests |
21,010 | 9,510 | 13,071 | |||||||||
Proceeds from sales of additional noncontrolling interests |
9,687 | 3,410 | 9,375 | |||||||||
Purchases from noncontrolling interests |
(13,689 | ) | (14,214 | ) | (6,859 | ) | ||||||
|
|
|
|
|
|
|||||||
Net cash used in financing activities |
(247,183 | ) | (82,392 | ) | (192,072 | ) | ||||||
|
|
|
|
|
|
|||||||
Net (decrease) increase in cash and cash equivalents |
(466,365 | ) | 320,658 | 128,578 | ||||||||
Cash and cash equivalents at beginning of year |
860,117 | 539,459 | 410,881 | |||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of year |
$ | 393,752 | $ | 860,117 | $ | 539,459 | ||||||
|
|
|
|
|
|
See notes to consolidated financial statements.
F-6
DAVITA INC.
CONSOLIDATED STATEMENTS OF EQUITY
AND
COMPREHENSIVE INCOME
(dollars and shares in thousands)
Non-controlling interests subject to put provisions |
DaVita Inc. Shareholders Equity | Non-controlling interests not subject to put provisions |
Comprehensive income |
|||||||||||||||||||||||||||||||||||||||||||
Common stock | Additional paid-in capital |
Retained earnings |
Treasury stock | Accumulated other comprehensive income (loss) |
Total | |||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2008 |
$ | 291,397 | 134,862 | $ | 135 | $ | 584,358 | $ | 1,889,450 | (31,109 | ) | $ | (691,857 | ) | $ | (14,339 | ) | $ | 1,767,747 | $ | 59,152 | |||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||||
Net income |
38,381 | 422,684 | 422,684 | 18,694 | $ | 479,759 | ||||||||||||||||||||||||||||||||||||||||
Unrealized losses on interest rate swaps, net of tax |
(2,578 | ) | (2,578 | ) | (2,578 | ) | ||||||||||||||||||||||||||||||||||||||||
Less reclassification of net swap realized losses into net income, net of tax |
10,542 | 10,542 | 10,542 | |||||||||||||||||||||||||||||||||||||||||||
Unrealized gains on investments, net of tax |
986 | 986 | 986 | |||||||||||||||||||||||||||||||||||||||||||
Less reclassification of net investment realized gains into net income, net of tax |
(159 | ) | (159 | ) | (159 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income |
$ | 488,550 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Stock purchase shares issued |
2,135 | 107 | 2,387 | 4,522 | ||||||||||||||||||||||||||||||||||||||||||
Stock unit shares issued |
(1,570 | ) | 69 | 1,570 | | |||||||||||||||||||||||||||||||||||||||||
Stock options and SSARs exercised |
15,598 | 2,036 | 48,055 | 63,653 | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
44,422 | 44,422 | ||||||||||||||||||||||||||||||||||||||||||||
Excess tax benefits from stock awards exercised |
6,150 | 6,150 | ||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests |
(44,277 | ) | (23,471 | ) | ||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests |
10,502 | 2,569 | ||||||||||||||||||||||||||||||||||||||||||||
Sales and assumptions of additional noncontrolling interests |
13,483 | (529 | ) | (529 | ) | 4,039 | ||||||||||||||||||||||||||||||||||||||||
Purchases from noncontrolling interests |
(2,594 | ) | (3,721 | ) | (3,721 | ) | (544 | ) | ||||||||||||||||||||||||||||||||||||||
Changes in fair value of noncontrolling interests |
24,819 | (24,819 | ) | (24,819 | ) | | ||||||||||||||||||||||||||||||||||||||||
Other adjustments |
14 | (339 | ) | (339 | ) | (1,346 | ) | |||||||||||||||||||||||||||||||||||||||
Purchase of treasury stock |
(2,903 | ) | (153,495 | ) | (153,495 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balance at December 31, 2009 |
$ | 331,725 | 134,862 | $ | 135 | $ | 621,685 | $ | 2,312,134 | (31,800 | ) | $ | (793,340 | ) | $ | (5,548 | ) | $ | 2,135,066 | $ | 59,093 | |||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||||
Net income |
52,589 | 405,683 | 405,683 | 25,947 | $ | 484,219 | ||||||||||||||||||||||||||||||||||||||||
Unrealized losses on interest rate swaps, net of tax |
(134 | ) | (134 | ) | (134 | ) | ||||||||||||||||||||||||||||||||||||||||
Less reclassification of net swap realized losses into net income, net of tax |
5,557 | 5,557 | 5,557 | |||||||||||||||||||||||||||||||||||||||||||
Unrealized gains on investments, net of tax |
615 | 615 | 615 | |||||||||||||||||||||||||||||||||||||||||||
Less reclassification of net investment realized losses into net income, net of tax |
13 | 13 | 13 | |||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income |
$ | 490,270 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Stock purchase shares issued |
2,129 | 86 | 2,151 | 4,280 | ||||||||||||||||||||||||||||||||||||||||||
Stock unit shares issued |
(875 | ) | 32 | 875 | | |||||||||||||||||||||||||||||||||||||||||
Stock options and SSARs exercised |
455 | 1,740 | 48,231 | 48,686 | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
45,551 | 45,551 |
F-7
DAVITA INC.
CONSOLIDATED STATEMENTS OF EQUITY
AND
COMPREHENSIVE INCOME(Continued)
(dollars and shares in thousands)
Non-controlling interests subject to put provisions |
DaVita Inc. Shareholders Equity | Non-controlling interests not subject to put provisions |
Comprehensive income |
|||||||||||||||||||||||||||||||||||||||||||
Common stock | Additional paid-in capital |
Retained earnings |
Treasury stock | Accumulated other comprehensive income (loss) |
Total | |||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||
Excess tax benefits from stock awards exercised |
6,283 | 6,283 | ||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests |
(54,612 | ) | (28,979 | ) | ||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests |
5,439 | 4,071 | ||||||||||||||||||||||||||||||||||||||||||||
Sales and assumptions of additional noncontrolling interests |
4,059 | (298 | ) | (298 | ) | 2,308 | ||||||||||||||||||||||||||||||||||||||||
Purchases from noncontrolling interests |
(4,949 | ) | (5,537 | ) | (5,537 | ) | (3,728 | ) | ||||||||||||||||||||||||||||||||||||||
Impact on fair value due to change in methodology |
(24,571 | ) | 24,571 | 24,571 | ||||||||||||||||||||||||||||||||||||||||||
Changes in fair value of noncontrolling interests |
73,372 | (73,372 | ) | (73,372 | ) | |||||||||||||||||||||||||||||||||||||||||
Other adjustments |
(46 | ) | (46 | ) | ||||||||||||||||||||||||||||||||||||||||||
Purchase of treasury stock |
(8,919 | ) | (618,496 | ) | (618,496 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balance at December 31, 2010 |
$ | 383,052 | 134,862 | $ | 135 | $ | 620,546 | $ | 2,717,817 | (38,861 | ) | $ | (1,360,579 | ) | $ | 503 | $ | 1,978,422 | $ | 58,712 | ||||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||||||||||||||
Net income |
59,135 | 478,001 | 478,001 | 36,259 | $ | 573,395 | ||||||||||||||||||||||||||||||||||||||||
Unrealized losses on interest rate swap and cap agreements, net of tax |
(29,049 | ) | (29,049 | ) | (29,049 | ) | ||||||||||||||||||||||||||||||||||||||||
Less reclassification of net swap and cap agreements realized losses into net income, net of tax |
9,721 | 9,721 | 9,721 | |||||||||||||||||||||||||||||||||||||||||||
Unrealized losses on investments, net of tax |
(602 | ) | (602 | ) | (602 | ) | ||||||||||||||||||||||||||||||||||||||||
Less reclassification of net investment realized gains into net income, net of tax |
(57 | ) | (57 | ) | (57 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income |
$ | 553,408 | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Stock purchase shares issued |
4,268 | 175 | 6,554 | 10,822 | ||||||||||||||||||||||||||||||||||||||||||
Stock unit shares issued |
(2,866 | ) | 78 | 2,866 | | |||||||||||||||||||||||||||||||||||||||||
Stock options and SSARs exercised |
(37,370 | ) | 1,182 | 42,813 | 5,443 | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
48,718 | 48,718 | ||||||||||||||||||||||||||||||||||||||||||||
Excess tax benefits from stock awards exercised |
20,834 | 20,834 | ||||||||||||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interests |
(61,343 | ) | (39,310 | ) | ||||||||||||||||||||||||||||||||||||||||||
Contributions from noncontrolling interests |
12,547 | 8,463 | ||||||||||||||||||||||||||||||||||||||||||||
Sales and assumptions of additional noncontrolling interests |
49,343 | (1,299 | ) | (1,299 | ) | 55,566 | ||||||||||||||||||||||||||||||||||||||||
Purchases from noncontrolling interests |
(2,103 | ) | (9,486 | ) | (9,486 | ) | (2,100 | ) | ||||||||||||||||||||||||||||||||||||||
Changes in fair value of noncontrolling interests |
63,762 | (63,762 | ) | (63,762 | ) | |||||||||||||||||||||||||||||||||||||||||
Expired put provision |
(26,177 | ) | 16,717 | 16,717 | 9,460 | |||||||||||||||||||||||||||||||||||||||||
Purchase of treasury stock |
(3,795 | ) | (323,348 | ) | (323,348 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balance at December 31, 2011 |
$ | 478,216 | 134,862 | $ | 135 | $ | 596,300 | $ | 3,195,818 | (41,221 | ) | $ | (1,631,694 | ) | $ | (19,484 | ) | $ | 2,141,075 | $ | 127,050 | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-8
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(dollars in thousands, except per share data)
1. | Organization and summary of significant accounting policies |
Organization
DaVita Inc. principally operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals mainly across the United States. The Company also operates other ancillary services and strategic initiatives, which include the Companys international operations that relate primarily to its core business of providing kidney dialysis services. As of December 31, 2011, the Company operated or provided administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving approximately 142,000 patients. In addition, as of December 31, 2011, the Company operated or provided administrative services to 11 outpatient dialysis centers located in three countries outside of the United States. The Companys U.S. dialysis and related lab services business qualifies as a separately reportable segment and all other ancillary services and strategic initiatives, including the Companys international operations, have been combined and disclosed in the other segments category.
Basis of presentation
These consolidated financial statements are prepared in accordance with United States generally accepted accounting principles. The financial statements include DaVita and its subsidiaries, partnerships and other entities in which it maintains a 100% or majority voting interest, another controlling financial interest, or of which it is the primary beneficiary (collectively, the Company). All significant intercompany transactions and balances have been eliminated. Non-marketable equity investments are recorded under the equity or cost method of accounting based upon whether the Company has significant influence over the investee. The Company has evaluated subsequent events through the date these consolidated financial statements were issued, and have included all necessary disclosures. For the Companys international subsidiaries, local currencies are their functional currencies. A translation adjustment results from the process of translating the Companys international subsidiaries financial statements which are reflected at their functional currencies into the Companys reporting currency (USD). The translation adjustment as of and for the year ended December 31, 2011 was immaterial.
Use of estimates
The preparation of financial statements in conformity with United States generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and temporary equity. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and managements best judgments at the time made. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Interim changes in estimates related to annual operating costs are applied prospectively within annual periods.
The most significant assumptions and estimates underlying these financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of long-lived assets and valuation adjustments, accounting for income taxes, quarterly and annual variable compensation accruals, purchase accounting valuation estimates, fair value estimates and stock-based compensation. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.
F-9
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Net operating revenues and accounts receivable
Revenues associated with Medicare and Medicaid programs are recognized based on: (a) the payment rates that are established by statute or regulation for the portion of the payment rates paid by the government payor (e.g., 80% for Medicare patients) and (b) for the portion not paid by the primary government payor, estimates of the amounts ultimately collectible from other government programs paying secondary coverage (e.g., Medicaid secondary coverage), the patients commercial health plan secondary coverage, or the patient. Effective January 1, 2011, the Companys reimbursements from Medicare are now subject to certain variations under Medicares new single bundled payment rate system, whereby reimbursements can be adjusted for certain patient characteristics and other factors. The Companys revenue recognition will depend upon its ability to effectively capture, document and bill for Medicares base payment rate as well as these other variable factors. In addition, as a result of the potential range of variations that can occur in the Companys reimbursements from Medicare under the new single bundled payment rate system, the Companys revenue recognition is now subject to a greater degree of estimating risk.
Revenues associated with commercial health plans are estimated based on contractual terms for the patients under healthcare plans with which the Company has formal agreements, non-contracted health plan coverage terms if known, estimated secondary collections, historical collection experience, historical trends of refunds and payor payment adjustments (retractions), inefficiencies in the Companys billing and collection processes that can result in denied claims for payments, and regulatory compliance issues.
Operating revenues are recognized in the period services are provided. Revenues consist primarily of payments from Medicare, Medicaid and commercial health plans for dialysis and ancillary services provided to patients. A usual and customary fee schedule is maintained for the Companys dialysis treatments and other patient services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.
Commercial revenue recognition also involves significant estimating risks. With many larger, commercial insurers the Company has several different contracts and payment arrangements, and these contracts often include only a subset of the Companys centers. It is often not possible to determine which contract, if any, should be applied prior to billing. In addition, for services provided by non-contracted centers, final collection may require specific negotiation of a payment amount, typically at a significant discount from the Companys usual and customary rates.
Effective January 1, 2011, services covered by Medicare are now subject to a greater degree of estimating risk under Medicares new single bundled payment rate system, whereby reimbursements from Medicare can vary significantly depending upon certain patient characteristics and other variable factors. Prior to January 1, 2011, services covered by Medicare as well as Medicaid were less subject to estimating risks since both Medicare and Medicaid rates used a prospective payment method established in advance with definitive terms. Even with the new bundled payment rate system, Medicare payments for bad debt claims are still subject to individual center profitability, as established by cost reports, and require evidence of collection efforts. As a result, billing and collection of Medicare bad debt claims can be delayed significantly, and final payment is subject to audit.
Medicaid payments, when Medicaid coverage is secondary, can also be difficult to estimate. For many states, Medicaid payment terms and methods differ from Medicare, and may prevent accurate estimation of individual payment amounts prior to billing.
F-10
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Net revenue recognition and allowances for uncollectible billings require the use of estimates of the amounts that will ultimately be realized considering, among other items, retroactive adjustments that may be associated with regulatory reviews, audits, billing reviews and other matters. The Companys policy is to write-off any uncollectible accounts receivable balance only after all collection efforts have been exhausted or when write-off is mandated by federal or state policies or required by certain payor contracts. It is also the Companys policy to write-off any accounts receivable balance associated with any payors or patients upon the Company receiving notification of a bankruptcy filing.
The Companys range of revenue estimating risk for the dialysis and related lab services segment is generally expected to be within 1% of its revenue. Changes in revenue estimates for prior periods are separately disclosed, if material.
Management and administrative support services are provided to outpatient dialysis centers and physician practices and certain other clinics that the Company does not own or in which the Company owns a minority equity investment interest. The management fees are principally determined as a percentage of the managed operations revenues or cash collections and in some cases an additional component based upon a percentage of operating income. Management fees are included in net operating revenues when earned, and represent less than 1% of total consolidated operating revenues.
Other income
Other income includes interest income on cash investments and other non-operating gains from investment transactions.
Cash and cash equivalents
Cash equivalents are short-term highly liquid investments with maturities of three months or less at date of purchase.
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or market and consist principally of pharmaceuticals and dialysis-related supplies. Rebates related to inventory purchases are recorded when earned and are based on certain qualification requirements based upon a variety of factors including future pricing levels by the manufacturer and data submission.
Property and equipment
Property and equipment is stated at cost less accumulated depreciation and amortization and is further reduced by any impairments. Maintenance and repairs are charged to expense as incurred. Depreciation and amortization expenses are computed using the straight-line method over the useful lives of the assets estimated as follows: buildings, 20 to 40 years; leasehold improvements, the shorter of their economic useful life or the expected lease term; and equipment and information systems, principally 3 to 8 years. Disposition gains and losses are included in current operating expenses.
Investments
Based upon the Companys intentions and strategy involving investments in debt and equity securities, the Company classifies certain debt securities as held-to-maturity and measures them at amortized cost. Based upon
F-11
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
the Companys other strategies involving investments, the Company classifies equity securities that have readily determinable fair values and certain other debt securities as available for sale and measures them at fair value. Unrealized gains or losses from available for sale investments are recorded in other comprehensive income until realized.
Amortizable intangibles
Amortizable intangible assets and liabilities include non-competition and similar agreements, lease agreements, hospital acute services contracts, deferred debt financing costs and the Alliance and Product Supply Agreement, each of which have finite useful lives. Non-competition and similar agreements are amortized over the terms of the agreements, typically ten years, using the straight-line method. Lease agreements and hospital acute service contracts are amortized on a straight-line basis over the term of the lease and the contract period, respectively. Deferred debt financing costs are amortized to debt expense over the term of the related debt using the effective interest method. The Alliance and Product Supply Agreement intangible liability is being amortized using the straight-line method over the term of the agreement, which is ten years.
Goodwill
Goodwill represents the difference between the fair value of acquired businesses and the fair value of the identifiable tangible and intangible net assets acquired. Goodwill is not amortized, but is assessed for valuation impairment as circumstances warrant and at least annually. An impairment charge would be recorded to the extent the carrying amount of goodwill exceeds its implied fair value. The Company operates several reporting units for goodwill impairment assessments. See Note 10 to the consolidated financial statements for further details.
Impairment of long-lived assets
Long-lived assets, including property and equipment, equity investments in non-consolidated businesses, and amortizable intangible assets with finite useful lives, are reviewed for possible impairment at least annually and whenever significant events or changes in circumstances indicate that an impairment may have occurred, including changes in the Companys business strategy and plans, changes in the quality or structure of its relationships with its partners and deteriorating operating performance of individual outpatient dialysis centers or other operations. An impairment is indicated when the sum of the expected future undiscounted net cash flows identifiable to an asset or asset group is less than its carrying amount. Impairment losses are measured based upon the difference between the actual or estimated fair values, which are based on market values, net realizable values or projections of discounted net cash flows, as appropriate, compared to the carrying amount of the asset. Impairment charges are included in operating expenses.
Income taxes
Federal and state income taxes are computed at current enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in the recognition of tax positions and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.
F-12
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The Company uses a recognition threshold of more-likely-than not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements.
Self insurance
The Company maintains insurance reserves for professional and general liability and workers compensation in excess of certain individual and or aggregate amounts not covered by third-party carriers. The Company estimates the self-insured retention portion of professional and general liability and workers compensation risks using third-party actuarial calculations that are based upon historical claims experience and expectations for future claims.
Noncontrolling interests
Noncontrolling interests represent the third-partys minority equity ownership interests in consolidated entities which are majority-owned by the Company. As of December 31, 2011, third parties held noncontrolling ownership interests in 196 consolidated entities.
Stock-based compensation
The Companys stock-based compensation awards are measured at their estimated fair value on the date of grant. Stock-based compensation expense recognized in a period represents the straight-line amortization during that period of the estimated grant date fair value of current and prior stock-based awards over their vesting terms, adjusted for expected forfeitures.
Interest rate swap and cap agreements
The Company has entered into several interest rate swap agreements as a means of hedging its exposure to and volatility from variable-based interest rate changes as part of its overall risk management strategy. These agreements are designated as cash flow hedges and are not held for trading or speculative purposes. The swap agreements have the economic effect of converting the LIBOR variable component of the Companys interest rate to fixed rates. In addition, in January 2011, the Company entered into several interest rate cap agreements that have the economic effect of capping the Companys maximum exposure to LIBOR variable interest rate changes on specific portions of the Companys other variable-based rate debt. See Note 13 to the consolidated financial statements for further details.
Fair value estimates
The Company currently measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (temporary equity) based upon certain valuation techniques that include observable or unobservable market inputs and assumptions that market participants would use in pricing these assets, liabilities and temporary equity. The Company also has classified its assets, liabilities and temporary equity into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB). See Note 23 to the consolidated financial statements for further details.
New accounting standards
On January 1, 2012, the Company adopted FASBs Accounting Standard Update (ASU) No. 2011-08, Intangibles Goodwill and Other. This standard amends the current two-step goodwill impairment test required
F-13
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
under the existing accounting guidance. This amendment allows entities the option to first assess certain qualitative factors to ascertain whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount to determine if the two-step impairment test is necessary. If an entity concludes that certain events or circumstances prove that it is more likely than not that the fair value of a reporting unit is less than its carrying amount then an entity is required to proceed to step one of the two-step goodwill impairment test. This standard is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard did not have a material impact on the Companys consolidated financial statements.
On January 1, 2012, the Company adopted FASBs ASU No. 2011-07, Health Care Entities-Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts. This standard amends the current presentation and disclosure requirements for Health Care Entities that recognize significant amounts of patient service revenue at the time the services are rendered without assessing the patients ability to pay. This standard requires health care entities to reclassify the provision for bad debts from an operating expense to a deduction from patient service revenues. In addition, this standard requires more disclosure on the policies for recognizing revenue, assessing bad debts, as well as quantitative and qualitative information regarding changes in the allowance for doubtful accounts. This standard is applied retrospectively to all prior periods presented and is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard will require the Company to change the presentation in its financial statements.
On January 1, 2012, the Company adopted FASBs ASU No. 2011-05, Comprehensive Income Presentation of Comprehensive Income. This standard amends the current presentation requirements for comprehensive income by eliminating the presentation of the components of other comprehensive income within the statement of equity. This standard allows two options on how to present the various components of comprehensive income. These options are either to report the components of comprehensive income separately on the income statement or to present total other comprehensive income and the components of other comprehensive income in a separate statement. This standard does not change the items that must be reported in other comprehensive income or when an item must be reclassified into net income. This standard is applied retrospectively and is effective for fiscal years and interim periods within those years beginning after December 15, 2011. Early adoption is permitted. The adoption of this standard will require the Company to change the presentation in its financial statements.
On January 1, 2012, the Company adopted FASBs ASU No. 2011-04, Fair Value Measurement. This standard amends the current fair value measurement and disclosure requirements to improve comparability between U.S. GAAP and International Financial Reporting Standards (IFRS). The intent of this standard is to update the disclosures that describe several of the requirements in U.S. GAAP for measuring fair value and to enhance disclosures about fair value measurements which will improve consistency between U.S. GAAP and IFRS. This standard does not change the application of the requirements on fair value measurements and disclosures. This standard is applied prospectively and is effective during interim and annual periods beginning after December 15, 2011. The adoption of this standard did not have a material impact on the Companys consolidated financial statements.
2. | Earnings per share |
Basic net income per share is calculated by dividing net income attributable to DaVita Inc., net of the decrease (increase) in noncontrolling interest redemption rights in excess of fair value, by the weighted average number of common shares and vested stock units outstanding. Diluted net income per share includes the dilutive effect of outstanding stock-settled stock appreciation rights, stock options and unvested stock units (under the treasury stock method).
F-14
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The reconciliations of the numerators and denominators used to calculate basic and diluted net income per share are as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
(shares in thousands) | ||||||||||||
Basic: |
||||||||||||
Income from continuing operations attributable to DaVita Inc. |
$ | 481,755 | $ | 405,402 | $ | 422,291 | ||||||
Decrease (increase) in noncontrolling interest redemption rights in excess of fair value |
335 | (68 | ) | (267 | ) | |||||||
|
|
|
|
|
|
|||||||
Income from continuing operations for basic earnings per share calculation |
$ | 482,090 | $ | 405,334 | $ | 422,024 | ||||||
Discontinued operations attributable to DaVita Inc. |
(3,754 | ) | 281 | 393 | ||||||||
|
|
|
|
|
|
|||||||
Net income attributable to DaVita Inc. for basic earnings per share calculation |
$ | 478,336 | $ | 405,615 | $ | 422,417 | ||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding during the period |
94,655 | 101,497 | 103,595 | |||||||||
Vested stock units |
3 | 7 | 9 | |||||||||
|
|
|
|
|
|
|||||||
Weighted average shares for basic earnings per share calculation |
94,658 | 101,504 | 103,604 | |||||||||
|
|
|
|
|
|
|||||||
Basic income from continuing operations per share attributable to DaVita Inc. |
$ | 5.09 | $ | 3.99 | $ | 4.07 | ||||||
|
|
|
|
|
|
|||||||
Basic net income per share attributable to DaVita Inc. |
$ | 5.05 | $ | 4.00 | $ | 4.08 | ||||||
|
|
|
|
|
|
|||||||
Diluted: |
||||||||||||
Income from continuing operations attributable to DaVita Inc. |
$ | 481,755 | $ | 405,402 | $ | 422,291 | ||||||
Decrease (increase) in noncontrolling interest redemption rights in excess of fair value |
335 | (68 | ) | (267 | ) | |||||||
|
|
|
|
|
|
|||||||
Income from continuing operations for diluted earnings per share calculation |
$ | 482,090 | $ | 405,334 | $ | 422,024 | ||||||
Discontinued operations attributable to DaVita Inc. |
(3,754 | ) | 281 | 393 | ||||||||
|
|
|
|
|
|
|||||||
Net income attributable to DaVita Inc. for diluted earnings per share calculation |
$ | 478,336 | $ | 405,615 | $ | 422,417 | ||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding during the period |
94,655 | 101,497 | 103,595 | |||||||||
Vested stock units |
3 | 7 | 9 | |||||||||
Assumed incremental shares from stock plans |
1,874 | 1,555 | 564 | |||||||||
|
|
|
|
|
|
|||||||
Weighted average shares for diluted earnings per share calculation |
96,532 | 103,059 | 104,168 | |||||||||
|
|
|
|
|
|
|||||||
Diluted income from continuing operations per share attributable to DaVita Inc. |
$ | 4.99 | $ | 3.93 | $ | 4.05 | ||||||
|
|
|
|
|
|
|||||||
Diluted net income per share attributable to DaVita Inc. |
$ | 4.96 | $ | 3.94 | $ | 4.06 | ||||||
|
|
|
|
|
|
|||||||
Anti-dilutive stock-settled awards excluded from calculation (1) |
2,388 | 1,452 | 9,912 | |||||||||
|
|
|
|
|
|
(1) | Shares associated with stock-settled stock appreciation rights and stock options that are excluded from the diluted denominator calculation because they are anti-dilutive under the treasury stock method. |
F-15
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
3. | Accounts receivable |
Approximately 16% and 15% of the accounts receivable balances as of December 31, 2011 and 2010, respectively, were more than six months old, and there were no significant balances over one year old. Approximately 2% of the Companys accounts receivable as of December 31, 2011 and 2010, related to amounts due from patients. Accounts receivable are principally from Medicare and Medicaid programs and commercial insurance plans.
4. | Other receivables |
Other receivables were comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Supplier rebates and other non-trade receivables |
$ | 195,426 | $ | 238,156 | ||||
Medicare bad debt claims |
57,232 | 46,250 | ||||||
Operating advances under management and administrative services agreements |
17,174 | 19,960 | ||||||
|
|
|
|
|||||
$ | 269,832 | $ | 304,366 | |||||
|
|
|
|
Operating advances under management and administrative services agreements are generally unsecured.
5. | Other current assets |
Other current assets consist principally of prepaid expenses and operating deposits.
6. | Property and equipment |
Property and equipment were comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Land |
$ | 23,004 | $ | 23,182 | ||||
Buildings |
34,173 | 33,937 | ||||||
Leasehold improvements |
1,266,499 | 1,106,935 | ||||||
Equipment and information systems |
1,269,343 | 1,107,778 | ||||||
New center and capital asset projects in progress |
144,124 | 38,721 | ||||||
|
|
|
|
|||||
2,737,143 | 2,310,553 | |||||||
Less accumulated depreciation and amortization |
(1,304,492 | ) | (1,139,745 | ) | ||||
|
|
|
|
|||||
$ | 1,432,651 | $ | 1,170,808 | |||||
|
|
|
|
Depreciation and amortization expense on property and equipment was $249,060, $218,666 and $213,657 for 2011, 2010 and 2009, respectively.
Interest on debt incurred during the development of new centers and other capital asset projects is capitalized as a component of the asset cost based on the respective in-process capital asset balances. Interest capitalized was $4,887, $2,621 and $3,627 for 2011, 2010 and 2009, respectively.
F-16
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
7. | Amortizable intangibles |
Amortizable intangible assets were comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Noncompetition and other agreements |
$ | 335,012 | $ | 309,405 | ||||
Lease agreements |
8,081 | 8,466 | ||||||
Deferred debt financing costs |
66,011 | 61,405 | ||||||
|
|
|
|
|||||
409,104 | 379,276 | |||||||
Less accumulated amortization |
(249,613 | ) | (216,641 | ) | ||||
|
|
|
|
|||||
Total amortizable intangible assets |
$ | 159,491 | $ | 162,635 | ||||
|
|
|
|
Amortizable intangible liabilities were comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Alliance and product supply agreement commitment (See Note 22) |
$ | 68,200 | $ | 68,200 | ||||
Less accumulated amortization |
(48,213 | ) | (42,883 | ) | ||||
|
|
|
|
|||||
$ | 19,987 | $ | 25,317 | |||||
|
|
|
|
Net amortization expense from noncompetition and other agreements and the amortizable intangible liabilities was $17,568, $15,064 and $14,739 for 2011, 2010 and 2009, respectively. Lease agreements which are amortized to rent expense were $361 in 2011, $480 in 2010 and $565 in 2009, respectively. Deferred debt issuance costs are amortized to debt expense as described in Note 13 to the consolidated financial statements.
Scheduled amortization charges from intangible assets and liabilities as of December 31, 2011 were as follows:
Noncompetition and other agreements |
Deferred debt financing costs |
Alliance and Product Supply Agreement liability |
||||||||||
2012 |
24,453 | 10,552 | (5,330 | ) | ||||||||
2013 |
21,928 | 10,260 | (5,330 | ) | ||||||||
2014 |
19,724 | 9,747 | (5,330 | ) | ||||||||
2015 |
15,761 | 8,514 | (3,997 | ) | ||||||||
2016 |
6,669 | 5,017 | | |||||||||
Thereafter |
17,520 | 9,346 | |
8. | Equity investments |
Equity investments in non-consolidated businesses were $27,325 and $25,918 at December 31, 2011 and 2010, respectively. During 2011, 2010 and 2009, the Company recognized income of $8,776, $8,999 and $2,442, respectively, relating to equity investments in non-consolidated businesses under the equity method of accounting.
F-17
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
9. | Investments in debt and equity securities |
Based on the Companys intentions and strategy involving investments in debt and equity securities, the Company classifies certain debt securities as held-to-maturity and records them at amortized cost. Equity securities that have readily determinable fair values and other debt securities classified as available for sale are recorded at fair value.
The Companys investments consist of the following:
December 31, 2011 | December 31, 2010 | |||||||||||||||||||||||
Held to maturity |
Available for sale |
Total | Held to maturity |
Available for sale |
Total | |||||||||||||||||||
Certificates of deposit, money market funds and U.S. treasury notes due within one year |
$ | 11,754 | $ | | $ | 11,754 | $ | 21,803 | $ | | $ | 21,803 | ||||||||||||
Investments in mutual funds and NxStage common stock |
| 15,535 | 15,535 | | 10,048 | 10,048 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 11,754 | $ | 15,535 | $ | 27,289 | $ | 21,803 | $ | 10,048 | $ | 31,851 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Short-term investments |
$ | 11,754 | $ | 5,645 | $ | 17,399 | $ | 21,803 | $ | 1,200 | $ | 23,003 | ||||||||||||
Long-term investments |
| 9,890 | 9,890 | | 8,848 | 8,848 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 11,754 | $ | 15,535 | $ | 27,289 | $ | 21,803 | $ | 10,048 | $ | 31,851 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
The cost of the certificates of deposit and money market funds at December 31, 2011 and in addition, U.S. treasury notes at December 31, 2010, approximate fair value. As of December 31, 2011 and 2010, the available for sale investments included $(255) and $824, respectively, of gross pre-tax unrealized (loss) gains. During 2011 and 2010 the Company recorded gross pre-tax unrealized (loss) gains of $(986) and $1,007, respectively, in other comprehensive income associated with changes in the fair value of these investments. During 2011, the Company sold investments in mutual funds for net proceeds of $1,149, and recognized a pre-tax gain of $93, or $57 after tax, that was previously recorded in other comprehensive income. During 2010, the Company sold investments in mutual funds for net proceeds of $900, and recognized a pre-tax loss of $22, or $13 after tax, that was previously recorded in other comprehensive income.
In addition, the available for sale securities, as of December 31, 2011, include the fair value of NxStage Medical Inc. (NxStage) common stock totaling $4,445, which is based upon quoted prices as reported by NASDAQ. Under the terms of the NxStage First National Service Provider Agreement effective July 22, 2010, the Company may, in lieu of a cash rebate, vest in warrants to purchase NxStage common stock based on achieving certain System One home patient growth targets by June 30, 2011, 2012 and 2013. The warrants are exercisable for up to a cumulative total of 5,500,000 shares of common stock over three years at an initial exercise price of $14.22 per share. As of June 30, 2011, the Company earned warrants to purchase 250,000 shares of NxStage common stock and in October 2011, the Company exercised its right and purchased these shares for a total of $3,555. In February 2012, the Company sold all 250,000 shares for approximately $5,200.
The investments in mutual funds classified as available for sale are held within a trust to fund existing obligations associated with several of the Companys non-qualified deferred compensation plans.
As of December 31, 2011 and 2010, there were investments totaling $7,224 and $18,537, respectively, classified as held to maturity that were used to maintain certain capital requirements of the special needs plans of
F-18
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
VillageHealth, which is a wholly-owned subsidiary of the Company. As of December 31, 2009, the Company discontinued the VillageHealth special needs plans and is in process of paying out all incurred claims. During the fourth quarter of 2011, the Company received a total of $11,313 from various state regulatory agencies for the release of certain investments that were previously held to maintain certain capital requirements.
10. | Goodwill |
Changes in the book value of goodwill were as follows:
Year ended December 31, | ||||||||
2011 | 2010 | |||||||
Balance at January 1 |
$ | 4,091,307 | $ | 3,951,196 | ||||
Acquisitions |
889,506 | 152,252 | ||||||
Divestitures |
(9,837 | ) | (12,128 | ) | ||||
Impairment charge |
(24,000 | ) | | |||||
Other adjustments |
| (13 | ) | |||||
|
|
|
|
|||||
Balance at December 31 |
$ | 4,946,976 | $ | 4,091,307 | ||||
|
|
|
|
As of December 31, 2011, there was $4,865,864 and $81,112 of goodwill associated with the dialysis and related lab services business and the ancillary services and strategic initiatives, respectively.
As of December 31, 2010, there was $4,022,365 and $68,942 of goodwill associated with the dialysis and related lab services business and the ancillary services and strategic initiatives, respectively.
In the second quarter of 2011, the Company determined that circumstances indicated it was more likely than not that the fair value of one of its ancillary businesses, HCP, which provides infusion therapy services, was less than its carrying amount. The primary factor informing the Companys conclusion was the recent decline in the operating performance of HCP caused mainly by rapid expansion. This led management to revise its view of HCPs organizational growth capability and scale back significantly its plans for HCPs future growth initiatives and to update HCPs forecasts and current operating budgets accordingly. These revisions reflected the current and expected future cash flows that the Company believed market participants would use in determining the fair value or the HCP business. As a result, in the second quarter of 2011, the Company estimated that the carrying amount of goodwill related to HCP exceeded its implied fair value by $24,000, resulting in a pre-tax goodwill impairment charge of that amount. As of December 31, 2011, after giving effect to this impairment charge, the Company has approximately $32,000 of HCP goodwill remaining. During the fourth quarter of 2011, the Company finalized its calculation of this impairment charge, which did not change the goodwill impairment charge previously recorded.
11. | Other liabilities |
Other accrued liabilities were comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Payor refunds and retractions |
$ | 193,966 | $ | 216,655 | ||||
Insurance and self-insurance accruals |
69,962 | 65,950 | ||||||
Accrued interest |
17,469 | 22,905 | ||||||
Accrued non-income tax liabilities |
15,174 | 9,995 | ||||||
Other |
29,163 | 27,438 | ||||||
|
|
|
|
|||||
$ | 325,734 | $ | 342,943 | |||||
|
|
|
|
F-19
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
12. | Income taxes |
A reconciliation of the beginning and ending liability for unrecognized tax benefits that do not meet the more-likely-than-not threshold were as follows:
Year ended December 31, | ||||||||
2011 | 2010 | |||||||
Balance beginning |
$ | 8,138 | $ | 30,693 | ||||
Additions for tax positions related to current year |
2,052 | 1,515 | ||||||
Additions for tax positions related to prior years |
786 | 69 | ||||||
Reductions for tax positions related to prior years |
(2,033 | ) | (24,139 | ) | ||||
|
|
|
|
|||||
Balance ending |
$ | 8,943 | $ | 8,138 | ||||
|
|
|
|
As of December 31, 2011, unrecognized tax benefits totaling $8,943 would affect the Companys effective tax rate, if recognized.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in its income tax expense. At December 31, 2011 and 2010, the Company had approximately $3,420 and $3,177, respectively, accrued for interest and penalties related to unrecognized tax benefits, net of federal tax benefits.
The Company and its subsidiaries file U.S. federal income tax returns and various state returns. The Company is no longer subject to U.S. federal, state and local examinations by tax authorities for years before 2006.
Income tax expense consisted of the following:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Current: |
||||||||||||
Federal |
$ | 217,885 | $ | 153,502 | $ | 193,181 | ||||||
State |
44,403 | 31,338 | 34,415 | |||||||||
Deferred: |
||||||||||||
Federal |
46,779 | 67,901 | 44,376 | |||||||||
State |
6,659 | 7,498 | 6,493 | |||||||||
|
|
|
|
|
|
|||||||
$ | 315,726 | $ | 260,239 | $ | 278,465 | |||||||
|
|
|
|
|
|
The allocation of income tax expense was as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Continuing operations |
$ | 315,744 | $ | 260,052 | $ | 278,213 | ||||||
Discontinued operations |
675 | 187 | 252 | |||||||||
Loss on discontinued operations |
(693 | ) | | | ||||||||
|
|
|
|
|
|
|||||||
$ | 315,726 | $ | 260,239 | $ | 278,465 | |||||||
|
|
|
|
|
|
F-20
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Deferred tax assets and liabilities arising from temporary differences were as follows:
December 31, | ||||||||
2011 | 2010 | |||||||
Receivables |
$ | 125,159 | $ | 110,332 | ||||
Alliance and product supply agreement |
7,775 | 9,849 | ||||||
Accrued liabilities |
163,770 | 127,073 | ||||||
Net operating loss carryforwards |
118,745 | 11,272 | ||||||
Other |
64,120 | 49,096 | ||||||
|
|
|
|
|||||
Deferred tax assets |
479,569 | 307,622 | ||||||
Valuation allowance |
(15,642 | ) | (10,998 | ) | ||||
|
|
|
|
|||||
Net deferred tax assets |
463,927 | 296,624 | ||||||
|
|
|
|
|||||
Intangible assets |
(439,203 | ) | (377,456 | ) | ||||
Property and equipment |
(164,404 | ) | (110,472 | ) | ||||
Other |
(3,036 | ) | (4,072 | ) | ||||
|
|
|
|
|||||
Deferred tax liabilities |
(606,643 | ) | (492,000 | ) | ||||
|
|
|
|
|||||
Net deferred tax liabilities |
$ | (142,716 | ) | $ | (195,376 | ) | ||
|
|
|
|
At December 31, 2011, the Company had federal net operating loss carryforwards of approximately $288,604 that expire through 2031, and state net operating loss carryforwards of $390,774 that expire through 2031. The increase in federal and state net operating loss carryforwards is a result of the acquisition of DSI Renal, Inc. The utilization of a portion of these losses may be limited in future years based on the profitability of certain entities. The valuation allowance increase of $4,644 is primarily due to changes in the estimated tax benefit and utilization of federal and state operating losses.
The reconciliation between the Companys effective tax rate from continuing operations and the U.S. federal income tax rate is as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Federal income tax rate |
35.0 | % | 35.0 | % | 35.0 | % | ||||||
State taxes, net of federal benefit |
4.1 | 3.9 | 3.7 | |||||||||
Changes in deferred tax valuation allowances |
(0.3 | ) | (0.1 | ) | 0.2 | |||||||
Other |
0.8 | 0.2 | 0.8 | |||||||||
Impact of noncontrolling interests primarily attributable to non-tax paying entities |
(4.2 | ) | (4.0 | ) | (3.0 | ) | ||||||
|
|
|
|
|
|
|||||||
Effective tax rate |
35.4 | % | 35.0 | % | 36.7 | % | ||||||
|
|
|
|
|
|
F-21
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
13. | Long-term debt |
Long-term debt was comprised of the following:
December 31, | ||||||||
2011 | 2010 | |||||||
Senior Secured Credit Facilities: |
||||||||
Term Loan A |
$ | 950,000 | $ | 1,000,000 | ||||
Term Loan A-2 |
199,500 | | ||||||
Term Loan B |
1,732,500 | 1,750,000 | ||||||
Senior notes |
1,550,000 | 1,550,000 | ||||||
Acquisition obligations and other notes payable |
37,447 | 9,049 | ||||||
Capital lease obligations |
43,364 | 8,074 | ||||||
|
|
|
|
|||||
Total principal debt outstanding |
4,512,811 | 4,317,123 | ||||||
Discount on long-term debt |
(7,842 | ) | (8,381 | ) | ||||
|
|
|
|
|||||
4,504,969 | 4,308,742 | |||||||
Less current portion |
(87,345 | ) | (74,892 | ) | ||||
|
|
|
|
|||||
$ | 4,417,624 | $ | 4,233,850 | |||||
|
|
|
|
Scheduled maturities of long-term debt at December 31, 2011 were as follows:
2012 |
87,345 | |||
2013 |
125,106 | |||
2014 |
176,910 | |||
2015 |
676,293 | |||
2016 |
1,858,567 | |||
Thereafter |
1,588,590 |
Senior Secured Credit Facility
On August 26, 2011, the Company entered into an Increase Joinder Agreement under its existing Senior Secured Credit Agreement, as described below. Pursuant to the Increase Joinder Agreement, the Company increased the revolving credit facility by $100,000, to a total of $350,000, and entered into an additional $200,000 Term Loan A-2. The new Term Loan A-2 required a principal payment of $500 on December 31, 2011, and thereafter requires annual principal payments of $2,000 with a balance of $191,500 due in 2016, and bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a rating based step-down to 3.25%.
On October 20, 2010, the Company entered into a $3,000,000 Senior Secured Credit Agreement (the Credit Agreement), consisting of a five year $250,000 revolving line of credit, a five year $1,000,000 Term Loan A and a six year $1,750,000 Term Loan B. The Company also has the right to request an increase to the borrowing capacity to a total aggregate principal amount of not more than $4,000,000 subject to bank participation. The revolving line of credit and the Term Loan A bore interest at LIBOR plus an interest rate margin of 2.75% until June 30, 2011, when the interest rate margin was reduced to 2.50%. The interest rate margin is still subject to adjustment depending upon the Companys leverage ratio and can range from 2.25% to 2.75%. The Term Loan A requires annual principal payments of $50,000 in 2011, $50,000 in 2012, $100,000 in 2013, and $150,000 in
F-22
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
2014, with the balance of $650,000 due in 2015. The Term Loan B bears interest at LIBOR (floor of 1.50%) plus 3.00% subject to a ratings based step-down to 2.75%. The Term Loan B requires annual principal payments of $17,500 in each year from 2011 through 2015 with the balance of $1,662,500 due in 2016. The borrowings under the Credit Agreement are guaranteed by substantially all of the Companys direct and indirect wholly-owned domestic subsidiaries and are secured by substantially all of the Companys and its guarantors assets. The Credit Agreement contains customary affirmative and negative covenants such as various restrictions on investments, acquisitions, the payment of dividends, redemptions and acquisitions of capital stock, capital expenditures and other indebtedness, as well as limitations on the amount of tangible net assets in non-guarantor subsidiaries. However, many of these restrictions will not apply as long as the Companys leverage ratio is below 3.50:1.00. In addition, the Credit Agreement requires compliance with financial covenants including an interest coverage ratio and a leverage ratio that determines the interest rate margins as described above.
On October 20, 2010, the Company also issued $775,000 aggregate principal amount of 6 3/8% senior notes due 2018 and $775,000 aggregate principal amount of 6 5/8% senior notes due 2020 (collectively the New Senior Notes). The New Senior Notes will pay interest on May 1 and November 1 of each year, beginning May 1, 2011. The New Senior Notes are unsecured senior obligations and rank equally to other unsecured senior indebtedness. The New Senior Notes are guaranteed by substantially all of the Companys direct and indirect wholly owned domestic subsidiaries. The Company may redeem some or all of the 6 3/8% senior notes at any time on or after November 1, 2013 at certain redemption prices and may redeem some or all of the 6 5/8% senior notes at any time on or after November 1, 2014 at certain redemption prices.
The Company received total proceeds of $4,300,000 from these transactions, $2,750,000 from the borrowings on Term Loan A and Term Loan B and an additional $1,550,000 from the issuance of the New Senior Notes. The Company used a portion of the proceeds to pay-off the outstanding principal balances of its existing Senior Secured Credit Facilities plus accrued interest totaling $1,795,363 and to purchase pursuant to a cash tender offer $557,644 of the outstanding principal balances of the Companys $700,000 6 5/8% senior notes due 2013 and $730,827 of the outstanding balances of the Companys $850,000 7 1/4% senior subordinated notes due 2015, (the Existing Notes), plus accrued interest totaling $1,297,215. The total amount paid for the Existing Notes was $1,019.06 per $1,000 principal amount of the 6 5/8% senior notes and $1,038.75 per $1,000 principal amount of the 7 1/4% senior subordinated notes. This resulted in the Company paying a cash tender premium of $38,933 in order to extinguish this portion of the Existing Notes. On November 19, 2010, the Company redeemed the remaining outstanding balance of the existing 6 5/8% senior notes of $142,356 at 101.656% per $1,000 and the remaining outstanding balance of the existing 7 1/4% senior subordinated notes of $119,173 at 103.625% per $1,000 plus accrued interest totaling $264,742. In addition, the Company paid a call premium totaling $6,677. The Company also paid an additional $74,431 in fees, discounts and other expenses. As a result of the above transactions, the Company received approximately $823,000 in excess cash which it has been using for general purposes and other opportunities, including share repurchases, acquisitions and other growth investments.
In connection with these transactions, the Company expensed debt refinancing and redemption charges totaling $70,255, which includes the write off of certain existing deferred financing costs and other new financing costs, the cash tender and call premiums, as described above and other expenses.
On June 7, 2010, the Company redeemed $200,000 aggregate principal amount of its outstanding 6 5/8% senior notes due 2013, at a price of 101.656% plus accrued interest. As a result of this transaction, the Company expensed debt redemption charges of $4,127, which includes the call premium and the net write-off of other finance costs.
F-23
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Term Loans
Term Loan A, Term Loan A-2 and Term Loan B total outstanding borrowings can consist of various individual tranches that can range in maturity from one month to twelve months (currently all tranches are one month in duration). Each tranche for the Term Loan A bears interest at a LIBOR rate determined by the duration of such tranche plus an interest rate margin, currently 2.50%. The LIBOR variable component of the interest rate for each tranche is reset as such tranche matures and a new tranche is established. At December 31, 2011, the overall weighted average interest rate for the Term Loan A was determined based upon the LIBOR interest rates in effect for all of the individual tranches plus the interest rate margin. In January 2011, the Company entered into several interest rate swap agreements that had the economic effect of fixing all of the Term Loan A LIBOR variable component of the Companys interest rate, as described below. At December 31, 2011, the Term Loan A-2 bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a ratings based step-down to 3.25%. At December 31, 2011, the Term Loan B bears interest at LIBOR (floor of 1.50%) plus a margin of 3.00% subject to a ratings based step-down to 2.75%. The Company is subject to these LIBOR-based floors until such time as the LIBOR-based component of the interest rate exceeds 1.00% on the Term Loan A-2 and 1.50% on the Term Loan B. At such time, the Company will then be subject to LIBOR-based interest rate volatility on the LIBOR variable component of its interest rate and the overall weighted average interest rate for the Term Loan A-2 and Term Loan B will then be determined based upon the LIBOR interest rates in effect for all individual tranches plus the interest rate margin. In January 2011, the Company entered into several interest rate cap agreements that have the economic effect of capping the LIBOR variable component of the Companys interest rate at a maximum of 4.00% on $1,250,000 of outstanding principal debt on the Term Loan B, as described below. The remaining $483,000 outstanding principal balance of the Term Loan B is subject to LIBOR-based interest rate volatility above a floor of 1.50%.
During 2011 and 2010, the Company made mandatory principal payments totaling $50,000 and $65,625, respectively, on the current and previous outstanding Term Loan A. During 2011, the Company made principal payments totaling $500 on the Term Loan A-2 and made principal payments totaling $17,500 on the Term Loan B. During 2010, the Company did not make, nor was the Company required to make, any principal payments on the previous outstanding Term Loan B.
Revolving Lines of Credit
The Company has an undrawn revolving line under the Senior Secured Credit Facilities totaling $350,000, of which approximately $52,297 was committed for outstanding letters of credit.
Senior and Senior Subordinated Notes
The Companys senior notes, as of December 31, 2011 and 2010, consisted of $775,000 of 6 3/8 senior notes due 2018 and $775,000 of 6 5/8 senior notes due 2020, as discussed above.
Interest rate swaps and caps
In January 2011, the Company entered into several interest rate swap agreements as a means of hedging its exposure to and volatility from variable-based interest rate changes as part of its overall risk management strategy. These agreements are not held for trading or speculative purposes and have the economic effect of converting the LIBOR variable component of the Companys interest rate to a fixed rate. These swap agreements are designated as cash flow hedges, and as a result, hedge-effective gains or losses resulting from changes in the fair values of these swaps are reported in other comprehensive income until such time as each specific swap tranche is realized, at which time the amounts are reclassified into net income. Net amounts paid or received for each specific swap tranche that have settled have been reflected as adjustments to debt expense. In addition, in January 2011, the Company entered into several interest rate cap agreements that have the economic effect of capping the Companys maximum exposure to LIBOR variable interest rate changes on specific portions of the
F-24
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Companys Term Loan B debt, as described below. These cap agreements are also designated as cash flow hedges and as a result changes in the fair values of these cap agreements are reported in other comprehensive income. The amortization of the original cap premium is recognized as a component of debt expense on a straight line basis over the term on the cap agreements. The swap and cap agreements do not contain credit-risk contingent features.
As of December 31, 2011, the Company maintained a total of nine interest rate swap agreements with amortizing notional amounts totaling $950,000. These agreements had the economic effect of modifying the LIBOR variable component of the Companys interest rate on an equivalent amount of the Companys Term Loan A to fixed rates ranging from 1.59% to 1.64%, resulting in an overall weighted average effective interest rate of 4.11%, including the Term Loan A margin of 2.50%. The swap agreements expire by September 30, 2014 and require monthly interest payments. The Company estimates that approximately $10,900 of existing unrealized pre-tax losses in other comprehensive income at December 31, 2011 will be reclassified into income over the next twelve months.
As of December 31, 2011, the Company maintained five interest rate cap agreements with notional amounts totaling $1,250,000. These agreements have the economic effect of capping the LIBOR variable component of the Companys interest rate at a maximum of 4.00% on an equivalent amount of the Companys Term Loan B debt. The cap agreements expire on September 30, 2014.
During 2010, the Company had several interest rate swap agreements outstanding that had the economic effect of modifying the LIBOR variable component of the Companys interest rate on an equivalent amount of the Companys debt to fixed rates ranging from 4.05% to 4.70%, resulting in an overall weighted average effective interest rate of 5.84% on the hedged portion of the Companys Senior Secured Credit Facilities, including the margin of 1.50%. These agreements did not contain credit-risk contingent features and had expired as of September 30, 2010.
The following table summarizes the Companys derivative instruments as of December 31, 2011 and 2010:
Interest rate swap and cap agreements (liabilities and assets) | ||||||||||||
December 31, 2011 | December 31, 2010 | |||||||||||
Derivatives designated as hedging instruments |
Balance sheet location |
Fair value | Balance sheet location |
Fair value | ||||||||
Interest rate swap agreements |
Other long- term liabilities |
$ | 23,145 | Other long- term liabilities |
$ | | ||||||
|
|
|
|
|||||||||
Interest rate cap agreements |
Other long- term assets |
$ | 1,381 | Other long- term assets |
$ | | ||||||
|
|
|
|
The following table summarizes the effects of the Companys interest rate swap and cap agreements for the years ended December 31, 2011, 2010 and 2009:
Amount of gains
(losses) recognized in OCI on interest rate swap and cap agreements |
Location of (losses) gains reclassified from accumulated OCI into income |
Amount of gains (losses) reclassified from accumulated OCI into income |
||||||||||||||||||||||||||
Derivatives designated as cash flow hedges |
Years ended December 31, | Years ended December 31, | ||||||||||||||||||||||||||
2011 | 2010 | 2009 | 2011 | 2010 | 2009 | |||||||||||||||||||||||
Interest rate swap agreements |
$ | (35,767 | ) | $ | (217 | ) | $ | (4,220 | ) | Debt expense | $ | (12,622 | ) | $ | (9,093 | ) | $ | (17,253 | ) | |||||||||
Interest rate cap agreements |
(11,777 | ) | | | Debt expense | (3,289 | ) | | | |||||||||||||||||||
Tax benefit |
18,495 | 83 | 1,642 | 6,190 | 3,536 | 6,711 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total |
$ | (29,049 | ) | $ | (134 | ) | $ | (2,578 | ) | $ | (9,721 | ) | $ | (5,557 | ) | $ | (10,542 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
F-25
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The Companys overall weighted average effective interest rate in 2011 was 5.28% and as of December 31, 2011 was 5.27%.
Debt expense
Debt expense consisted of interest expense of $230,953, $172,265 and $176,100, including the amortization and accretion of debt discounts and premiums and the amortization of deferred financing costs of $10,137, $9,342 and $9,655 for 2011, 2010 and 2009, respectively. The interest expense amounts are net of capitalized interest.
14. | Leases |
The majority of the Companys facilities are leased under non-cancelable operating leases, ranging in terms from five to 15 years, which contain renewal options of five to ten years at the fair rental value at the time of renewal. The Company leases are generally subject to periodic consumer price index increases or contain fixed escalation clauses. The Company also leases certain facilities and equipment under capital leases.
Future minimum lease payments under non-cancelable operating leases and capital leases are as follows:
Operating leases |
Capital leases |
|||||||
2012 |
258,336 | 4,620 | ||||||
2013 |
232,569 | 4,656 | ||||||
2014 |
211,544 | 4,510 | ||||||
2015 |
193,874 | 4,260 | ||||||
2016 |
176,063 | 4,239 | ||||||
Thereafter |
635,608 | 42,335 | ||||||
|
|
|
|
|||||
$ | 1,707,994 | 64,620 | ||||||
|
|
|||||||
Less portion representing interest |
(21,256 | ) | ||||||
|
|
|||||||
Total capital lease obligations, including current portion |
$ | 43,364 | ||||||
|
|
Rent expense under all operating leases for 2011, 2010, and 2009 was $296,051, $266,849 and $248,154, respectively. Rent expense is recorded on a straight-line basis, over the term of the lease, for leases that contain fixed escalation clauses or include abatement provisions. Leasehold improvement incentives are deferred and amortized to rent expense over the term of the lease. The net book value of property and equipment under capital leases was $41,514 and $7,579 at December 31, 2011 and 2010, respectively. Capital lease obligations are included in long-term debt. See Note 13 to the consolidated financial statements.
15. | Employee benefit plans |
The Company has a savings plan for substantially all employees which has been established pursuant to the provisions of Section 401(k) of the Internal Revenue Code, or IRC. The plan allows for employees to contribute a percentage of their base annual salaries on a tax-deferred basis not to exceed IRC limitations. The Company does not provide any matching contributions.
F-26
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The Company also maintains a voluntary compensation deferral plan, the DaVita Voluntary Deferral Plan. This plan is non-qualified and permits certain employees whose annualized base salary equals or exceeds a minimum annual threshold amount as set by the Company to elect to defer all or a portion of their annual bonus payment and up to 50% of their base salary into a deferral account maintained by the Company. Total contributions to this plan in 2011, 2010 and 2009 were $2,416, $1,125 and $2,062, respectively. Deferred amounts are generally paid out in cash at the participants election either in the first or second year following retirement or in a specified future period at least three to four years after the deferral election was effective. During 2011, 2010 and 2009 the Company distributed $955, $701 and $601, respectively, to participants. Participants are credited with their proportional amount of annual earnings from the plan. The assets of this plan are held in a rabbi trust and as such are subject to the claims of the Companys general creditors in the event of its bankruptcy. As of December 31, 2011 and 2010, the total fair value of assets held in trust were $9,796 and $8,547, respectively.
As part of the acquisition of DVA Renal Healthcare on October 5, 2005, the Company acquired an Executive Retirement Plan for certain members of management. This plan is non-qualified and contributions to the plan were made at the discretion of DVA Renal Healthcare based upon a pre-determined percentage of a participants base salary. Effective November 2005, all contributions to this plan were discontinued and the balance of the plan assets will be paid out upon termination of each individual participant. During 2011, 2010 and 2009, the Company distributed $194, $198 and $241, respectively, to participants. As of December 31, 2011 and 2010, the total fair value of assets held in trust was $1,294 and $1,501, respectively.
The fair value of all of the assets held in plan trusts as of December 31, 2011, and 2010 totaled $11,090 and $10,048, respectively. These assets are available for sale and as such are recorded at fair market value with changes in the fair market values being recorded in other comprehensive income. Any fair market value changes to the corresponding liability balance will be recorded as compensation expense. See Note 9 to the consolidated financial statements.
Most of the Companys outstanding employee stock plan awards include a provision accelerating the vesting of the award in the event of a change of control. The Company also maintains a change of control protection program for its employees who do not have a significant number of stock awards, which has been in place since 2001, and which provides for cash bonuses to employees in the event of a change of control. Based on the market price of the Companys common stock and shares outstanding on December 31, 2011, these cash bonuses would total approximately $277,000 if a control transaction occurred at that price and the Companys Board of Directors did not modify the program. This amount has not been accrued at December 31, 2011, and would only be accrued upon a change of control. These change of control provisions may affect the price an acquirer would be willing to pay for the Company.
16. | Contingencies |
The majority of the Companys revenues are from government programs and may be subject to adjustment as a result of: (1) examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (2) differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (3) differing opinions regarding a patients medical diagnosis or the medical necessity of services provided; and (4) retroactive applications or interpretations of governmental requirements. In addition, the Companys revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.
F-27
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Inquiries by the Federal Government and Certain Related Civil Proceedings
2005 U.S. Attorney Investigation: In March 2005, the Company received a subpoena from the U.S. Attorneys Office for the Eastern District of Missouri in St. Louis. The subpoena required production of a wide range of documents relating to the Companys operations, including documents related to, among other things, pharmaceutical and other services provided to patients, relationships with pharmaceutical companies, and financial relationships with physicians and joint ventures. The subpoena covers the period from December 1, 1996 through March 2005. In October 2005, the Company received a follow-up request for additional documents related to specific medical director and joint venture arrangements. In February 2006, the Company received an additional subpoena for documents, including certain patient records relating to the administration and billing of EPO. In May 2007, the Company received a request for documents related to durable medical equipment and supply companies owned and operated by the Company. The Company cooperated with the inquiry and has produced the requested records. The subpoenas were issued in connection with a joint civil and criminal investigation. It is possible that criminal proceedings may be initiated against the Company in connection with this investigation. The Company has not received a communication from the St. Louis U.S. Attorneys Office on this matter in over two years.
Woodard Private Civil Suit: In February 2007, the Company received a request for information from the Office of Inspector General, U.S. Department of Health and Human Services, or OIG, for records relating to EPO claims submitted to Medicare. In August 2007, the Company received a subpoena from the OIG seeking similar documents. The requested documents relate to services provided from 2001 to 2004 by a number of the Companys centers. The request and subpoena were sent from the OIGs offices in Houston and Dallas, Texas. The Company cooperated with the inquiry and has produced all previously requested records to date. The Company was contacted by the U.S. Attorneys Office for the Eastern District of Texas, which stated that this was a civil investigation related to EPO claims. On July 6, 2009, the United States District Court for the Eastern District of Texas lifted the seal on the civil qui tam complaint related to these previous requests for information. The Company was subsequently served with a complaint by the relator, Ivey Woodard, purportedly on behalf of the federal government, under the qui tam provisions of the federal False Claims Act. The government did not intervene and is not actively pursuing this matter. The relator is pursuing the claims independently and the parties are engaged in active litigation. The complaint contains allegations relating to the Companys EPO practices for the period from 1992 through 2010 and seeks monetary damages and civil penalties as well as costs and expenses. The court has ruled that claims earlier than 1996 are beyond the statute of limitations. The Company believes that there is some overlap between the subject of this complaint and the review of EPO utilization in the 2005 U.S. Attorney investigation described above. The Company is vigorously defending this matter and intends to continue to do so. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
Vainer Private Civil Suit: In December 2008, the Company received a subpoena for documents from the OIG relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlecit and EPO, as well as other related matters. The subpoena covers the period from January 2003 to December 2008. The Company was in contact with the U.S. Attorneys Office for the Northern District of Georgia and the U.S. Department of Justice in Washington, DC, since November 2008 relating to this matter, and was advised that this was a civil inquiry. On June 17, 2009, the Company learned that the allegations underlying this inquiry were made as part of a civil complaint filed by individuals and brought pursuant to the qui tam provisions of the federal False Claims Act. On April 1, 2011, the United States District Court for the Northern District of Georgia ordered the case to be unsealed. At that time, the Department of Justice and U.S. Attorneys Office filed a notice of declination stating that the United States would not be intervening and not pursuing the relators allegation in litigation. On July 25, 2011, the relators, Daniel Barbir and Dr. Alon Vainer, filed their amended complaint in the United States District
F-28
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Court for the Northern District of Georgia, purportedly on behalf of the federal government. The allegations in the complaint relate to the Companys drug administration practices for Vitamin D and iron agents for a period from 2003 through 2010. The complaint seeks monetary damages and civil penalties as well as costs and expenses. The Company is vigorously defending this matter and intends to continue to do so. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
2010 U.S. Attorney Physician Relationship Investigation: In May 2010, the Company received a subpoena from the OIGs office in Dallas, Texas. The subpoena covers the period from January 1, 2005 to May 2010, and seeks production of a wide range of documents relating to the Companys operations, including documents related to, among other things, financial relationships with physicians and joint ventures. The general subject matter of the inquiry appears to overlap with the 2005 U.S. Attorney Investigation described above. The Company met with representatives of the government to discuss the scope of the subpoena and the production of responsive documents. The Company has been advised that this is a civil investigation. The Company is cooperating with the inquiry and is producing the requested records. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
2011 U.S. Attorney Physician Relationship Investigation: In August 2011, the Company announced it had learned that the U.S. Attorneys Office for the District of Colorado would be looking into certain activities of the Company in connection with information being provided to a grand jury. The Company announced further that it understood that this investigation was at a very preliminary stage, and while its precise scope was unclear, it appeared to overlap, at least in part, with the 2005 U.S. Attorney Investigation and 2010 U.S. Attorney Physician Relationship Investigation described above. Subsequent to the Companys announcement of this 2011 U.S. Attorney Physician Relationship Investigation, it received a subpoena for documents which substantially overlaps with the subpoena in the 2010 U.S. Attorney Physician Relationship Investigation described above and covers the period from January 2006 to September 2011. The Company is cooperating with the government and is producing the requested records. Certain current and former members of the Board and executives received subpoenas in November 2011 and thereafter to testify before the grand jury, and other Company representatives may also receive subpoenas for testimony related to this matter. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.
2011 U.S. Attorney Medicaid Investigation: In October 2011, the Company announced that it would be receiving a request for documents, which could include an administrative subpoena from the Office of Inspector General for the U.S. Department of Health and Human Services. Subsequent to the Companys announcement of this 2011 U.S. Attorney Medicaid Investigation, the Company received a request for documents in connection with the inquiry by the United States Attorneys Office for the Eastern District of New York. The request relates to payments for infusion drugs covered by Medicaid composite payments for dialysis. The Company believes this inquiry is civil in nature. The Company does not know the time period or scope. The Company understands that certain other providers that operate dialysis clinics in New York may be receiving or have received a similar request for documents. The Company intends to cooperate with the government to provide responsive documents.
Except for the private civil complaints filed by the relators as described above, to the Companys knowledge, no proceedings have been initiated against the Company at this time in connection with any of the inquiries by the federal government. Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved, it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators. Responding to the subpoenas or inquiries and defending the Company in the relator
F-29
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
proceedings will continue to require managements attention and significant legal expense. Any negative findings in the inquiries or relator proceedings could result in substantial financial penalties or awards against the Company, exclusion from future participation in the Medicare and Medicaid programs and, to the extent criminal proceedings may be initiated against the Company, possible criminal penalties. At this time, the Company cannot predict the ultimate outcome of these inquiries, or the potential outcome of the relators claims, or the potential range of damages, if any.
Other
The Company has received several notices of claims from commercial payors and other third parties related to historical billing practices and claims against DVA Renal Healthcare (formerly known as Gambro Healthcare), a subsidiary of the Company, related to historical Gambro Healthcare billing practices and other matters covered by its 2004 settlement agreement with the Department of Justice and certain agencies of the U.S. government. The Company has received no further indication that any of these claims are active, and some of them may be barred by applicable statutes of limitations. To the extent any of these claims might proceed, the Company intends to defend against them vigorously; however, the Company may not be successful and these claims may lead to litigation and any such litigation may be resolved unfavorably. At this time, the Company cannot predict the ultimate outcome of this matter or the potential range of damages, if any.
A wage and hour claim, which has been styled as a class action, is pending against the Company in the Superior Court of California. The Company was served with the complaint in this lawsuit in April 2008, and it has been amended since that time. The lawsuit, as amended, alleges that the Company failed to provide meal periods, failed to pay compensation in lieu of providing rest or meal periods, failed to pay overtime, and failed to comply with certain other California Labor Code requirements. In September 2011, the court denied the plaintiffs motion for class certification. Plaintiffs have appealed that decision. The Company intends to continue to vigorously defend against these claims. Any potential settlement of these claims is not anticipated to be material to the Companys consolidated financial statements.
In October 2007, the Company was contacted by the Attorney Generals Office for the State of Nevada. The Attorney Generals Office informed the Company that it was conducting a civil and criminal investigation of the Companys operations in Nevada and that the investigation related to the billing of pharmaceuticals, including EPO. In February 2008, the Attorney Generals Office informed the Company that the civil and criminal investigation had been discontinued. The Attorney Generals Office further advised the Company that Nevada Medicaid intended to conduct audits of end stage renal disease (ESRD) dialysis providers in Nevada and such audits would relate to the issues that were the subjects of the investigation. To the Companys knowledge, no court proceedings have been initiated against the Company at this time. Any negative audit findings could result in a substantial repayment by the Company. At this time, the Company cannot predict the ultimate outcome of this matter or the potential range of damages, if any.
In June 2004, DVA Renal Healthcare was served with a complaint filed in the Superior Court of California by one of its former employees who worked for its California acute services program. The complaint, which is styled as a class action, alleges, among other things, that DVA Renal Healthcare failed to provide overtime wages, defined rest periods and meal periods, or compensation in lieu of such provisions and failed to comply with certain other California Labor Code requirements. The parties have reached an agreement, subject to approval by the court, which fully resolves this matter for an amount that did not materially impact the Companys financial results.
F-30
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
In addition to the foregoing, the Company is subject to claims and suits, including from time to time, contractual disputes and professional and general liability claims, as well as audits and investigations by various government entities, in the ordinary course of business. The Company believes that the ultimate resolution of any such pending proceedings, whether the underlying claims are covered by insurance or not, will not have a material adverse effect on its financial condition, results of operations or cash flows.
17. | DaVita Inc. stock-based compensation and shareholders equity |
Stock-based compensation
Stock-based compensation recognized in a period represents the straight-line amortization during that period of the estimated grant-date fair value of stock-based awards over their vesting terms, adjusted for expected forfeitures. Shares issued upon exercise of stock awards are generally issued from shares held in treasury.
Stock-based compensation plans
On June 6, 2011, the Companys stockholders approved the DaVita Inc. 2011 Incentive Award Plan (the 2011 Plan), which constituted an amendment and restatement of the DaVita Inc. 2002 Equity Compensation Plan (the 2002 Plan, and jointly the Plan).
The 2011 Plan is the Companys omnibus equity compensation plan and provides for grants of stock-based awards to employees, directors and other individuals providing services to the Company, except that incentive stock options may only be awarded to employees. The 2011 Plan authorizes the Company to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock units, restricted stock, and certain other performance-based awards, and is designed to enable the Company to grant equity and cash awards that qualify as performance-based compensation under Section 162(m) of the Internal Revenue Code. The 2011 Plan does not increase the number of shares authorized under the 2002 Plan, continues to mandate a maximum award term of five years, and continues to stipulate that stock appreciation rights and stock options be granted with prices not less than the fair market value on the date of grant. The 2011 Plan also continues to require that full share awards such as restricted stock units reduce shares available under the Plan at a rate of 3.0:1. The Companys nonqualified stock appreciation rights and stock units awarded under the Plan generally vest over 48 to 60 months from the date of grant. At December 31, 2011, there were 10,205,564 stock-settled stock appreciation rights, 10,000 cash-settled stock appreciation rights, 513,108 stock units outstanding under the Plan, and 8,405,431 shares available for future grants under the Plan.
On June 7, 2010, the Companys stockholders had previously approved an amendment and restatement of the 2002 Plan to increase the number of shares reserved to the Plan by 10,000,000 shares.
In connection with this 2010 amendment, the Board of Directors has committed to the Companys stockholders that over the three-year period commencing on April 1, 2010 it will not grant a number of shares subject to stock awards under the Plan, including stock options, stock appreciation rights, restricted stock units or other stock awards, at an average annual rate greater than 4.02% of the number of shares of the Companys common stock that management believes will be outstanding over such three-year period. This 4.02% rate is the average of the 2009 and 2010 three-year average median grant rate plus one standard deviation as published by RiskMetrics Group for the Russell 3000 companies in the GICS 3510 industry segment. Awards that are settled in cash, awards that are granted pursuant to stockholder approved exchange programs, awards sold under the Companys employee stock purchase plan and awards assumed or substituted in business combination transactions will be excluded from the Companys grant rate calculation. For purposes of calculating the number
F-31
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
of shares granted, any full-value awards (i.e., restricted stock, restricted stock unit, performance share or any other award that does not have an exercise price per share at least equal to the per share fair market value of the Companys common stock on the grant date) will count as equivalent to 3.0 shares. The Company will publicly report its compliance with this three-year average annual grant rate commitment, and the data necessary to independently confirm it, in a public filing shortly after March 31, 2013.
Predecessor plans. Various prior stock-based compensation plans were terminated upon original shareholder approval of the 2002 Plan in 2002 and the 1999 Non-Executive Officer and Non-Director Equity Compensation Plan expired in 2009, both except with respect to option awards then outstanding. Stock options granted under these terminated plans were generally issued with exercise prices equal to the market price of the stock on the date of grant, vested over four years from the date of grant, and bore maximum award terms of five to 10 years. There were no stock awards remaining outstanding under these terminated plans as of December 31, 2011.
A combined summary of the status of awards under the Companys stock-based compensation plans, including base shares for stock-settled stock appreciation rights and shares subject to stock option and stock unit awards, is as follows:
Year ended December 31, 2011 | ||||||||||||||||||||
Stock appreciation rights and stock options | Stock units | |||||||||||||||||||
Awards | Weighted average exercise price |
Weighted average remaining contractual life |
Awards | Weighted average remaining contractual life |
||||||||||||||||
Outstanding at beginning of year |
11,013,487 | $ | 51.94 | 501,564 | ||||||||||||||||
Granted |
2,707,500 | 82.17 | 150,246 | |||||||||||||||||
Exercised |
(3,032,329 | ) | 51.46 | (78,106 | ) | |||||||||||||||
Cancelled |
(483,094 | ) | 59.59 | (60,596 | ) | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Outstanding at end of period |
10,205,564 | $ | 59.74 | 2.6 | 513,108 | 1.5 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Awards exercisable at end of period |
4,348,803 | $ | 50.62 | 1.7 | 3,446 | 0.6 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted-average fair value of awards granted during 2011 |
$ | 21.93 | $ | 85.28 | ||||||||||||||||
|
|
|
|
|||||||||||||||||
Weighted-average fair value of awards granted during 2010 |
$ | 15.87 | $ | 62.85 | ||||||||||||||||
|
|
|
|
|||||||||||||||||
Weighted-average fair value of awards granted during 2009 |
$ | 12.08 | $ | 54.31 | ||||||||||||||||
|
|
|
|
Range of exercise prices |
Awards outstanding |
Weighted average exercise price |
Awards exercisable |
Weighted average exercise price |
||||||||||||
$ 0.00$ 0.01 |
513,108 | $ | | 3,446 | $ | | ||||||||||
$40.01$50.00 |
3,856,250 | 45.69 | 2,254,496 | 45.54 | ||||||||||||
$50.01$60.00 |
1,868,878 | 52.43 | 1,453,292 | 52.47 | ||||||||||||
$60.01$70.00 |
1,993,936 | 64.40 | 621,015 | 64.04 | ||||||||||||
$70.01$80.00 |
397,500 | 74.20 | 20,000 | 72.52 | ||||||||||||
$80.01$90.00 |
2,089,000 | 85.01 | | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
10,718,672 | $ | 56.88 | 4,352,249 | $ | 50.58 | ||||||||||
|
|
|
|
|
|
|
|
F-32
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The Company also granted 10,000 cash-settled stock appreciation rights in 2011 at a base price of $79.57. These liability-classified awards remain outstanding but unvested at December 31, 2011, have no intrinsic value at that date, and have contributed $0 to total stock-based compensation for 2011.
For the years ended December 31, 2011, 2010, and 2009, the aggregate intrinsic value of stock awards exercised was $98,235, $67,935 and $46,896, respectively. At December 31, 2011, the aggregate intrinsic value of stock awards outstanding was $222,347 and the aggregate intrinsic value of stock awards exercisable was $109,791.
Estimated fair value of stock-based compensation awards
The Company has estimated the grant-date fair value of stock-settled stock appreciation rights awards and stock options using the Black-Scholes-Merton valuation model and stock unit awards at intrinsic value on the date of grant. The following assumptions were used in estimating these values and determining the total stock-based compensation attributable to the current period:
Expected term of the awards: The expected term of awards granted represents the period of time that they are expected to remain outstanding from the date of grant. The Company determines the expected term of its stock awards based on its historical experience with similar awards, considering the Companys historical exercise and post-vesting termination patterns, and the terms expected by peer companies in near industries.
Expected volatility: Expected volatility represents the volatility anticipated over the expected term of the award. The Company determines the expected volatility for its awards based on the volatility of the price of its common stock over the most recent retrospective period commensurate with the expected term of the award, considering the volatility expectations implied by the market price of its exchange-traded options and the volatilities expected by peer companies in near industries.
Expected dividend yield: The Company has not paid dividends on its common stock and does not currently expect to pay dividends during the term of stock awards granted.
Risk-free interest rate: The Company bases the expected risk-free interest rate on the implied yield currently available on stripped interest coupons of U.S. Treasury issues with a remaining term equivalent to the expected term of the award.
A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of stock options and stock-settled stock appreciation rights granted in the periods indicated is as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Expected term |
4.2 years | 3.5 years | 3.5 years | |||||||||
Expected volatility |
30 | % | 30 | % | 32 | % | ||||||
Expected dividend yield |
0.0 | % | 0.0 | % | 0.0 | % | ||||||
Risk-free interest rate |
1.6 | % | 1.7 | % | 1.8 | % |
The Company estimates expected forfeitures based upon historical experience with separate groups of employees that have exhibited similar forfeiture behavior in the past. Stock-based compensation expense is recorded only for awards that are expected to vest.
F-33
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Employee stock purchase plan
The Employee Stock Purchase Plan entitles qualifying employees to purchase up to $25 of the Companys common stock during each calendar year. The amounts used to purchase stock are accumulated through payroll withholdings or through optional lump sum payments made in advance of the first day of the purchase right period. This compensatory plan allows employees to purchase stock for the lesser of 100% of the fair market value on the first day of the purchase right period or 85% of the fair market value on the last day of the purchase right period. Purchase right periods begin on January 1 and July 1, and end on December 31. Payroll withholdings and lump-sum payments related to the plan, included in accrued compensation and benefits and used to purchase the Companys common stock for 2011, 2010 and 2009 participation periods, were $5,889, $4,933, and $4,280, respectively. Shares purchased pursuant to the plans 2011, 2010 and 2009 participation periods were 91,353, 83,865, and 86,213, respectively. At December 31, 2011, there were 787,497 shares remaining available for future grants under this plan.
The fair value of employees purchase rights was estimated as of the beginning dates of the purchase right periods using the Black-Scholes-Merton valuation model with the following weighted average assumptions for purchase right periods in 2011, 2010 and 2009, respectively: expected volatility of 22%, 22% and 34%; risk-free interest rate of 0.5%, 0.3% and 0.2%, and no dividends. Using these assumptions, the weighted average estimated fair value of these purchase rights was $17.20, $13.80 and $13.90 for 2011, 2010 and 2009, respectively.
Stock-based compensation expense and proceeds
For the years ended December 31, 2011, 2010 and 2009, the Company recognized $48,718, $45,551 and $44,422, respectively, in stock-based compensation expense for stock settled-stock appreciation rights, stock options, stock units and discounted employee stock plan purchases, which is primarily included in general and administrative expenses. The estimated tax benefits recorded for this stock-based compensation in 2011, 2010 and 2009 were $18,424, $17,273 and $16,810, respectively. As of December 31, 2011, there was $91,305 of total estimated unrecognized compensation cost related to nonvested stock-settled compensation arrangements under the Companys equity compensation and stock purchase plans. The Company expects to recognize this cost over a weighted average remaining period of 1.4 years.
During the years ended December 31, 2011, 2010 and 2009, the Company received $5,443, $48,686 and $63,653 in cash proceeds from stock option exercises and $38,199, $26,706 and $18,241 in total actual tax benefits upon the exercise of stock awards, respectively.
Stock repurchases
During 2011 and 2010, the Company repurchased a total of 3,794,686 and 8,918,760 shares of its common stock for $323,348 and $618,496, or an average price of $85.21 and $69.35 per share, respectively, pursuant to previously announced authorizations by the Board of Directors. On November 3, 2010, the Companys Board of Directors authorized an additional $800,000 of share repurchases of its common stock. As a result of these transactions, the total outstanding authorization for share repurchases as of December 31, 2011 was approximately $358,200. The Company has not repurchased any additional shares of its common stock from January 1, 2012 through February 24, 2012. This stock repurchase program has no expiration date.
Shareholder rights plan
The Companys Board of Directors approved a shareholder rights plan on November 14, 2002. This plan provided a mechanism whereby the Board of Directors could take certain actions to dilute the ownership stake of a person or group which acquired, or announced a tender offer for, 15% or more of DaVita Inc.s outstanding common stock.
F-34
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
On March 10, 2011, the Company and The Bank of New York Mellon Trust Company, N.A., as rights agent, entered into an amendment to this plan. This amendment accelerated the expiration of the rights issued under the plan from the close of business on November 14, 2012 to the close of business on March 10, 2011. Accordingly, as of the close of business on March 10, 2011, the rights issued under this plan expired and are no longer outstanding.
Charter documents & Delaware law
The Companys charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice of stockholder proposals or nominations to the Board of Directors and granting the Board of Directors the authority to issue up to five million shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval.
The Company is also subject to Section 203 of the Delaware General Corporation Law that, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. These restrictions may discourage, delay or prevent a change in the control of the Company.
Changes in DaVita Inc.s ownership interest in consolidated subsidiaries
The effects of changes in DaVita Inc.s ownership interest on the Companys equity are as follows:
Year ended December 31, 2011 |
Year ended December 31, 2010 |
Year ended December 31, 2009 |
||||||||||
Net income attributable to DaVita Inc. |
$ | 478,001 | $ | 405,683 | $ | 422,684 | ||||||
|
|
|
|
|
|
|||||||
Decrease in paid-in capital for sales of noncontrolling interest in several joint ventures |
(1,299 | ) | (298 | ) | (529 | ) | ||||||
Decrease in paid-in capital for the purchase of a noncontrolling interest in several joint ventures |
(9,486 | ) | (5,537 | ) | (3,721 | ) | ||||||
|
|
|
|
|
|
|||||||
Net transfer to noncontrolling interests |
(10,785 | ) | (5,835 | ) | (4,250 | ) | ||||||
|
|
|
|
|
|
|||||||
Change from net income attributable to DaVita Inc. and transfers to noncontrolling interests |
$ | 467,216 | $ | 399,848 | $ | 418,434 | ||||||
|
|
|
|
|
|
In addition in 2011, 2010 and 2009, the Company also acquired additional ownership interests in several existing majority-owned joint ventures for $13,689, $14,214 and $6,859, respectively.
F-35
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
18. | Other comprehensive income |
Charges and credits to other comprehensive income have been as follows:
2009 | ||||||||||||
Before tax amount |
Tax (expense) benefit |
Net-of-tax amount |
||||||||||
Unrealized losses on interest rate swaps |
$ | (4,220 | ) | $ | 1,642 | $ | (2,578 | ) | ||||
Less reclassification of net swap realized losses into net income |
17,253 | (6,711 | ) | 10,542 | ||||||||
|
|
|
|
|
|
|||||||
Net swap activity |
13,033 | (5,069 | ) | 7,964 | ||||||||
|
|
|
|
|
|
|||||||
Unrealized gains on investments |
1,614 | (628 | ) | 986 | ||||||||
Less reclassification of net investment realized gains into net income |
(261 | ) | 102 | (159 | ) | |||||||
|
|
|
|
|
|
|||||||
Net investment activity |
1,353 | (526 | ) | 827 | ||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 14,386 | $ | (5,595 | ) | $ | 8,791 | |||||
|
|
|
|
|
|
2010 | ||||||||||||
Before tax amount |
Tax (expense) benefit |
Net-of-tax amount |
||||||||||
Unrealized losses on interest rate swaps |
$ | (217 | ) | $ | 83 | $ | (134 | ) | ||||
Less reclassification of net swap realized losses into net income |
9,093 | (3,536 | ) | 5,557 | ||||||||
|
|
|
|
|
|
|||||||
Net swap activity |
8,876 | (3,453 | ) | 5,423 | ||||||||
|
|
|
|
|
|
|||||||
Unrealized gains on investments |
1,007 | (392 | ) | 615 | ||||||||
Less reclassification of net investment realized losses into net income |
22 | (9 | ) | 13 | ||||||||
|
|
|
|
|
|
|||||||
Net investment activity |
1,029 | (401 | ) | 628 | ||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 9,905 | $ | (3,854 | ) | $ | 6,051 | |||||
|
|
|
|
|
|
2011 | ||||||||||||
Before tax amount |
Tax (expense) benefit |
Net-of-tax amount |
||||||||||
Unrealized losses on interest rate swap and cap agreements |
$ | (47,544 | ) | $ | 18,495 | $ | (29,049 | ) | ||||
Less reclassification of net swap and cap agreements realized losses into net income |
15,911 | (6,190 | ) | 9,721 | ||||||||
|
|
|
|
|
|
|||||||
Net swap and cap agreements activity |
(31,633 | ) | 12,305 | (19,328 | ) | |||||||
|
|
|
|
|
|
|||||||
Unrealized losses on investments |
(986 | ) | 384 | (602 | ) | |||||||
Less reclassification of net investment realized gains into net income |
(93 | ) | 36 | (57 | ) | |||||||
|
|
|
|
|
|
|||||||
Net investment activity |
(1,079 | ) | 420 | (659 | ) | |||||||
|
|
|
|
|
|
|||||||
Total |
$ | (32,712 | ) | $ | 12,725 | $ | (19,987 | ) | ||||
|
|
|
|
|
|
F-36
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Changes in accumulated other comprehensive income (loss) has been as follows:
Interest rate swap and cap agreements |
Investment securities |
Accumulated other comprehensive income |
||||||||||
Balance December 31, 2009 |
$ | (5,423 | ) | $ | (125 | ) | $ | (5,548 | ) | |||
Net activity |
5,423 | 628 | 6,051 | |||||||||
|
|
|
|
|
|
|||||||
Balance December 31, 2010 |
$ | | $ | 503 | $ | 503 | ||||||
Net activity |
(19,328 | ) | (659 | ) | (19,987 | ) | ||||||
|
|
|
|
|
|
|||||||
Balance December 31, 2011 |
$ | (19,328 | ) | $ | (156 | ) | $ | (19,484 | ) | |||
|
|
|
|
|
|
19. | Acquisitions |
During 2011, 2010, and 2009, the Company acquired total dialysis and other businesses as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Cash paid, net of cash acquired |
$ | 1,077,442 | $ | 188,502 | $ | 87,617 | ||||||
Deferred purchase price and other acquisition obligations |
19,010 | 449 | 338 | |||||||||
|
|
|
|
|
|
|||||||
Aggregate purchase cost |
$ | 1,096,452 | $ | 188,951 | $ | 87,955 | ||||||
|
|
|
|
|
|
|||||||
Number of chronic dialysis centers acquired |
178 | 41 | 19 | |||||||||
|
|
|
|
|
|
The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Companys financial statements and operating results from the effective dates of the acquisitions.
Acquisition of DSI Renal Inc.
On September 2, 2011, the Company completed its acquisition of all of the outstanding common stock of CDSI I Holding Company, Inc., the parent company of dialysis provider DSI Renal Inc. (DSI), pursuant to an agreement and plan of merger for approximately $723,012 in net cash, plus the assumption of certain liabilities totaling approximately $6,541, subject to certain post-closing adjustments. DSI had 113 outpatient dialysis centers that provide services to approximately 8,000 patients in 23 states. The Company also incurred approximately $21,700 in transaction and integration costs during 2011 associated with this acquisition that are included in general and administrative expenses in the consolidated statements of income.
The initial purchase price allocation for the DSI acquisition is recorded at estimated fair values based upon the best information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending issuance of the final tax returns.
F-37
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The following table summarizes the assets acquired and liabilities assumed in the transaction and recognized at the acquisition date at their estimated fair values, as well as the estimated fair value of the noncontrolling interests in DSI at that date:
Current assets |
$ | 164,227 | ||
Property and equipment |
67,080 | |||
Amortizable intangible and other long-term assets |
6,523 | |||
Goodwill |
500,662 | |||
Long-term deferred income taxes |
79,420 | |||
Current liabilities assumed |
(54,046 | ) | ||
Other long-term liabilities |
(11,213 | ) | ||
Noncontrolling interests |
(23,100 | ) | ||
|
|
|||
$ | 729,553 | |||
|
|
Amortizable intangible assets acquired in this acquisition had weighted average estimated useful lives of nine years.
Of the goodwill recognized in this acquisition, approximately $262,000 is expected to be deductible for tax purposes over the next 15 years.
The noncontrolling interests acquired as part of the acquisition are stated at fair value based upon a third-party appraisal that was informed by implied multiples used in conjunction with the acquisition of the DSI group, as well as the Companys overall experience and contractual multiples typical for such arrangements.
The operating results of DSI are included in the Companys consolidated financial statements effective September 1, 2011.
Other acquisitions
During 2011, the Company acquired other dialysis related and other ancillary businesses consisting of 57 dialysis centers in the U.S., eight dialysis centers outside of the U.S. and one vascular access center for a total of $354,430 in net cash and deferred purchase price of $12,469. During 2010 and 2009, the Company acquired other dialysis businesses consisting of 41 centers and 19 centers for a total of $188,951 and $87,955, respectively, in cash and deferred purchase price obligations. The assets and liabilities for all acquisitions were recorded at their estimated fair market values at the dates of the acquisitions and are included in the Companys financial statements and operating results from the effective dates of the acquisitions.
The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of the noncontrolling interests assumed in these transactions:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Tangible assets, principally leasehold improvements and equipment |
$ | 32,649 | $ | 21,257 | $ | 11,140 | ||||||
Amortizable intangible assets |
19,804 | 18,300 | 6,703 | |||||||||
Goodwill |
388,844 | 152,252 | 78,199 | |||||||||
Noncontrolling interests assumed |
(70,821 | ) | (1,171 | ) | (7,567 | ) | ||||||
Liabilities assumed |
(3,577 | ) | (1,687 | ) | (520 | ) | ||||||
|
|
|
|
|
|
|||||||
Aggregate purchase cost |
$ | 366,899 | $ | 188,951 | $ | 87,955 | ||||||
|
|
|
|
|
|
F-38
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Amortizable intangible assets acquired during 2011, 2010 and 2009 had weighted-average estimated useful lives of nine, nine and seven years, respectively. In 2011, 2010 and 2009, $352,674, $152,252 and $78,199 of goodwill was associated with the dialysis and related lab services business. In addition, in 2011 $36,170 of goodwill was associated with the other ancillary services and strategic initiatives. The total amount of goodwill deductible for tax purposes associated with these acquisitions for 2011, 2010, and 2009 was approximately $298,000, $154,000 and $72,000, respectively.
Discontinued operations
Pursuant to a consent order issued by the Federal Trade Commission on September 2, 2011, the Company agreed to divest a total of 30 outpatient dialysis centers and several home-based dialysis programs in order to complete the acquisition of DSI. In conjunction with the consent order, on September 30, 2011, the Company completed the sale of 28 outpatient dialysis centers to Dialysis Newco, Inc. (Dialysis Newco), a portfolio company of Frazier Healthcare VI, L.P. and New Enterprise Associates 13, Limited Partnership pursuant to an asset purchase agreement dated August 26, 2011. Effective October 31, 2011, the Company also completed the sale of two additional outpatient dialysis centers to Dialysis Newco that were previously pending state regulatory approval. The Company anticipates receiving total net cash consideration of approximately $82,000 for all of the outpatient dialysis centers that were divested. As part of this transaction, Dialysis Newco assumed specific liabilities related to the centers it acquired. All other liabilities were retained by the Company. The Company recorded a loss of approximately $4,756, net of tax, during the year ended December 31, 2011 related to the divestiture of its historical DaVita centers.
The operating results of the historical DaVita divested centers are reflected as discontinued operations for all periods presented. In addition, the operating results of the DSI divested centers are reflected as discontinued operations in the consolidated financial statements beginning September 1, 2011.
The results from discontinued operations related to the dialysis and related lab services segment were as follows:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Net operating revenues |
$ | 16,648 | $ | 9,341 | $ | 8,152 | ||||||
|
|
|
|
|
|
|||||||
Income before income taxes |
1,896 | 468 | 645 | |||||||||
Income tax expense |
675 | 187 | 252 | |||||||||
|
|
|
|
|
|
|||||||
Income from discontinued operations |
$ | 1,221 | $ | 281 | $ | 393 | ||||||
|
|
|
|
|
|
Net assets of discontinued operations related to the dialysis and related lab services segment as of September 30, 2011, were as follows:
Current assets |
$ | 71,384 | ||
Property and equipment, net |
5,183 | |||
Goodwill |
7,999 | |||
Liabilities and noncontrolling interests |
(836 | ) | ||
|
|
|||
Net assets from discontinued operations |
$ | 83,730 | ||
|
|
F-39
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Pro forma financial information
The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions and divestitures in 2011 and 2010 had been consummated as of the beginning of 2010, after including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.
Year ended December 31, | ||||||||
2011 | 2010 | |||||||
(unaudited) | ||||||||
Pro forma net revenues |
$ | 7,309,901 | $ | 6,983,641 | ||||
Pro forma net income attributable to DaVita Inc. |
520,625 | 471,635 | ||||||
Pro forma income from continuing operations attributable to DaVita Inc. |
524,379 | 471,354 | ||||||
Pro forma basic net income per share attributable to DaVita Inc. |
5.50 | 4.65 | ||||||
Pro forma diluted net income per share attributable to DaVita Inc. |
5.39 | 4.58 |
20. | Variable interest entities |
The Company is required to consolidate each entity determined to be a variable interest entity for which the Company is the primary beneficiary. Variable interest entities (VIEs) typically include those for which the entitys equity is not sufficient to finance its activities without additional subordinated financial support; those for which the equity holders as a group lack the power to direct the activities that most significantly influence the entitys economic performance, the obligation to absorb the entitys expected losses, or the right to receive the entitys expected returns; or those for which the voting rights of some investors are not proportional to their obligations to absorb the entitys losses.
The Company is deemed to be the primary beneficiary of all the variable interest entities it is associated with. These VIEs are principally operating subsidiaries owned by related party nominee owners for the Companys benefit in jurisdictions in which the Company does not qualify for direct ownership under applicable regulations or joint ventures that require subordinated support in addition to their equity capital to finance operations. These include both dialysis operations and physician practice management entities.
Under the terms of the applicable arrangement, the Company bears substantially all of the economic risks and rewards of ownership for these operating VIEs. In some cases, the Company has contractual arrangements with its respective related party nominee owners which indemnify them from the economic losses, and entitle the Company to the economic benefits, that may result from ownership of these VIEs. DaVita Inc. manages these VIEs and provides operating and capital funding as necessary to accomplish their operational and strategic objectives.
Accordingly, since the Company bears the majority of the risks and rewards attendant to their ownership, the Company consolidates these VIEs as their primary beneficiary. Total assets of these consolidated operating VIEs were approximately $7,000 and their liabilities to unrelated third parties were approximately $5,000 at December 31, 2011.
The Company also sponsors certain deferred compensation plans whose trusts qualify as VIEs and as their primary beneficiary the Company consolidates each of these plans. The assets of these plans are recorded in short-term or long-term investments with matching offsetting liabilities in accrued compensation and benefits and other long-term liabilities. See Note 9 for disclosures on the assets of these consolidated non-qualified deferred compensation plans.
F-40
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
21. | Concentrations |
Approximately 66% of the Companys total dialysis and related lab services revenues in 2011, 66% in 2010 and 65% in 2009 are from government-based programs, principally Medicare and Medicaid. Accounts receivable and other receivables, from Medicare, including Medicare-assigned plans, and Medicaid, including Medicaid-assigned plans, were approximately $617,200 and $554,300, respectively as of December 31, 2011 and 2010. No other single payor accounted for more than 5% of total accounts receivable.
EPO is a significant physician-prescribed pharmaceutical that is administered during dialysis and is provided by a sole supplier. The amount of EPO that is separately billable accounted for approximately 3% and 18% of the dialysis and related lab services net operating revenues in 2011 and 2010, respectively. As long as certain conditions are met by the Company, the agreement with Amgen limits their ability to unilaterally decide to increase the price it charges the Company for EPO.
22. | Noncontrolling interests subject to put provisions and other commitments |
Noncontrolling interests subject to put provisions
The Company has potential obligations to purchase the noncontrolling interests held by third parties in several of its joint ventures and non-wholly-owned subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Company would be required to purchase the third-party owners noncontrolling interests at either the appraised fair market value or a predetermined multiple of earnings or cash flow attributable to the noncontrolling interests put to the Company, which is intended to approximate fair value. The methodology the Company uses to estimate the fair values of noncontrolling interests subject to put provisions assumes either the higher of a liquidation value of net assets or an average multiple of earnings, based on historical earnings, patient mix and other performance indicators, as well as other factors. During the second quarter of 2010, the Company refined its methodology used to estimate the fair value of noncontrolling interests subject to put provisions by eliminating an annual inflation factor that was previously applied to the put provisions until they became exercisable. The Company believes that eliminating an annual inflation factor will result in a better representation of the estimated actual fair value of the noncontrolling interests subject to put provisions as of the reporting date. The estimated fair values of the noncontrolling interests subject to put provisions can fluctuate and the implicit multiple of earnings at which these noncontrolling interests obligations may be settled will vary significantly depending upon market conditions including potential purchasers access to the capital markets, which can impact the level of competition for dialysis and non-dialysis related businesses, the economic performance of these businesses and the restricted marketability of the third-party owners noncontrolling interests. The amount of noncontrolling interests subject to put provisions that contractually employ a predetermined multiple of earnings rather than fair value are immaterial.
Additionally, the Company has certain other potential commitments to provide operating capital to several dialysis centers that are wholly-owned by third parties or centers in which the Company owns a minority equity investment as well as to physician-owned vascular access clinics that the Company operates under management and administrative service agreements of approximately $4,000.
Certain consolidated joint ventures are contractually scheduled to dissolve after terms ranging from ten to fifty years. Accordingly, the noncontrolling interests in these joint ventures are considered mandatorily redeemable instruments, for which the classification and measurement requirements have been indefinitely deferred. Future distributions upon dissolution of these entities would be valued below the related noncontrolling interest carrying balances in the consolidated balance sheet.
F-41
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Other commitments
In November 2011, the Company entered into a seven year Sourcing and Supply Agreement with Amgen USA Inc. that expires on December 31, 2018. Under terms of the agreement, the Company will purchase EPO in amounts necessary to meet no less than 90% of its requirements for erythropoiesis stimulations agents. The agreement replaces in its entirety the prior one-year supply agreement between the Company and Amgen that expired on December 31, 2011, and among other things, provides for discounted pricing and rebates for EPO. Some of the rebates are subject to various conditions including future pricing levels of EPO by Amgen and data submission by the Company. In the initial years of the agreement the total rebate opportunity is less than what was provided for in the agreement that expired at the end of 2011, however, the opportunity for the Company to earn discounts and rebates increases over the term of the agreement. The actual amount of EPO that the Company will purchase from Amgen will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that the Company serves.
In January 2010, the Company entered into an agreement with Fresenius which committed the Company to purchase a certain amount of dialysis equipment, parts and supplies from them through 2013. During 2011 and 2010, the Company purchased $107,977 and $103,183, respectively, of certain equipment, parts and supplies from Fresenius.
In July 2010, the Company announced that it will construct a new corporate headquarters in Denver, Colorado. In July 2010, the Company acquired the land and existing improvements for approximately $12,000. Effective December 18, 2010, the Company entered into a construction agreement for the construction of the new building. The Company currently estimates the total construction costs and other project costs of the building will be approximately $95,000. Construction began in early 2011, and is estimated to be completed in the second half of 2012. In 2011 and 2010, the Company paid construction costs and architecture and other design costs totaling approximately $44,000 and $5,000, respectively.
In conjunction with the acquisition of DVA Renal Healthcare, Inc., formerly known as Gambro Healthcare, Inc., which occurred in October 2005, the Company entered into an Alliance and Product Supply Agreement (the Product Supply Agreement) with Gambro AB and Gambro Renal Products, Inc (Gambro Renal Products). Because the Product Supply Agreement results in higher costs for most of the products covered by the Product Supply Agreement than would otherwise be available to the Company, the Product Supply Agreement represented an intangible liability initially valued at $162,100 as of the acquisition date.
The Product Supply Agreement committed the Company to purchase a significant majority of its hemodialysis products, supplies and equipment at fixed prices through 2015. The agreement was amended in 2006 (the Amended Product Supply Agreement) to reduce the Companys purchase obligations for certain hemodialysis product supplies and equipment, and in 2007, the Company terminated its obligation to purchase certain dialysis machines under the Amended Product Supply Agreement. However, the Company continues to be subject to the Product Supply Agreements requirements to purchase a majority of its hemodialysis non-equipment product supplies, such as dialyzers, from Gambro at fixed prices.
During 2011, 2010 and 2009, the Company purchased $120,938, $115,682 and $87,983 of hemodialysis product supplies from Gambro Renal Products, representing 2% of the Companys total operating costs, for all years presented.
Other than operating leases disclosed in Note 14 to the consolidated financial statements, the letters of credit disclosed in Note 13 to the consolidated financial statements, and the arrangements as described above, the Company has no off balance sheet financing arrangements as of December 31, 2011.
F-42
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
23. | Fair values of financial instruments |
The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company also has classified certain assets, liabilities and temporary equity that are measured at fair value into the appropriate fair value hierarchy levels as defined by FASB.
The following tables summarize the Companys assets, liabilities and temporary equity measured at fair value on a recurring basis as of December 31, 2011 and 2010:
December 31, 2011 | ||||||||||||||||
Total | Quoted prices in active markets for identical assets (Level 1) |
Significant other observable inputs (Level 2) |
Significant unobservable inputs (Level 3) |
|||||||||||||
Assets |
||||||||||||||||
Available for sale securities |
$ | 15,535 | $ | 15,535 | $ | | $ | | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest rate cap agreements |
$ | 1,381 | $ | | $ | 1,381 | $ | | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities |
||||||||||||||||
Interest rate swap agreements |
$ | 23,145 | $ | | $ | 23,145 | $ | | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Temporary equity |
||||||||||||||||
Noncontrolling interests subject to put provisions |
$ | 478,216 | $ | | $ | | $ | 478,216 | ||||||||
|
|
|
|
|
|
|
|
December 31, 2010 | ||||||||||||||||
Total | Quoted prices in active markets for identical assets (Level 1) |
Significant other observable inputs (Level 2) |
Significant unobservable inputs (Level 3) |
|||||||||||||
Assets |
||||||||||||||||
Available for sale securities |
$ | 10,048 | $ | 10,048 | $ | | $ | | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Temporary equity |
||||||||||||||||
Noncontrolling interests subject to put provisions |
$ | 383,052 | $ | | $ | | $ | 383,052 | ||||||||
|
|
|
|
|
|
|
|
The available for sale securities represent investments in various open-ended registered investment companies, or mutual funds, and are recorded at fair value based upon quoted prices reported by each mutual fund. The available for sale securities also include the fair value of NxStage common stock based upon quoted market prices as reported by NASDAQ. See Note 9 to the consolidated financial statements for further discussion.
The interest rate swap and cap agreements are recorded at fair value based upon valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate swap and cap agreements would be materially different than the fair values as currently reported. See Note 13 to the consolidated financial statements for further discussion.
F-43
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
See Note 22 to the consolidated financial statements for a discussion of the Companys methodology for estimating the fair value of noncontrolling interests subject to put obligations.
Other financial instruments consist primarily of cash, accounts receivable, accounts payable, other accrued liabilities and debt. The balances of the non-debt financial instruments are presented in the consolidated financial statements at December 31, 2011 and 2010 at their approximate fair values due to the short-term nature of their settlements. The carrying balance of the Companys Senior Secured Credit Facilities totaled $2,874,158 as of December 31, 2011, and the fair value was $2,860,465 based upon quoted market prices. The fair value of the Companys senior notes was approximately $1,565,500 at December 31, 2011 based upon quoted market prices, as compared to the carrying amount of $1,550,000.
24. | Segment reporting |
The Company operates principally as a dialysis and related lab services business but also operates other ancillary services and strategic initiatives. These ancillary services and strategic initiatives consist primarily of pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs, physician services and the Companys international dialysis operations. For internal management reporting the dialysis and related lab services business and each of the ancillary services and strategic initiatives have been defined as separate operating segments by management since separate financial information is regularly produced and reviewed by the Companys chief operating decision maker in making decisions about allocating resources and assessing financial results. The Companys chief operating decision maker is its Chief Executive Officer. The U.S. dialysis and related lab services business qualifies as a separately reportable segment and all of the other ancillary services and strategic initiatives operating segments have been combined and disclosed in the other segments category.
The Companys operating segment financial information is prepared on an internal management reporting basis that the Chief Executive Officer uses to allocate resources and analyze the performance of the operating segments. For internal management reporting, segment operations include direct segment operating expenses with the exception of stock-based compensation expense and equity investment income. In addition, beginning in 2011, the ancillary services and strategic initiatives segment operations also include an allocation of corporate general and administrative expenses.
F-44
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Segment revenues: |
||||||||||||
Dialysis and related lab services (1) |
||||||||||||
External sources |
$ | 6,473,829 | $ | 6,054,252 | $ | 5,766,795 | ||||||
Intersegment revenues |
11,141 | 9,300 | 16,782 | |||||||||
|
|
|
|
|
|
|||||||
Total dialysis and related lab services |
6,484,970 | 6,063,552 | 5,783,577 | |||||||||
|
|
|
|
|
|
|||||||
Other Ancillary services and strategic initiatives |
||||||||||||
External sources (2) |
$ | 508,385 | $ | 383,798 | $ | 333,853 | ||||||
Intersegment revenues |
5,796 | | | |||||||||
|
|
|
|
|
|
|||||||
Total ancillary services and strategic initiatives |
514,181 | 383,798 | 333,853 | |||||||||
Total segment revenues |
6,999,151 | 6,447,350 | 6,117,430 | |||||||||
Elimination of intersegment revenues |
(16,937 | ) | (9,300 | ) | (16,782 | ) | ||||||
|
|
|
|
|
|
|||||||
Consolidated revenues |
$ | 6,982,214 | $ | 6,438,050 | $ | 6,100,648 | ||||||
|
|
|
|
|
|
|||||||
Segment operating margin (loss): (3) |
||||||||||||
Dialysis and related lab services |
$ | 1,224,672 | $ | 1,038,698 | $ | 993,834 | ||||||
OtherAncillary services and strategic initiatives |
(53,948 | ) | (5,586 | ) | (12,226 | ) | ||||||
|
|
|
|
|
|
|||||||
Total segment margin |
1,170,724 | 1,033,112 | 981,608 | |||||||||
Reconciliation of segment operating margin to consolidated income before income taxes: |
||||||||||||
Stock-based compensation |
(48,718 | ) | (45,551 | ) | (44,422 | ) | ||||||
Equity investment income |
8,776 | 8,999 | 2,442 | |||||||||
|
|
|
|
|
|
|||||||
Consolidated operating income |
1,130,782 | 996,560 | 939,628 | |||||||||
Debt expense |
(241,090 | ) | (181,607 | ) | (185,755 | ) | ||||||
Debt refinancing and redemption charges |
| (74,382 | ) | | ||||||||
Other income |
2,982 | 3,419 | 3,706 | |||||||||
|
|
|
|
|
|
|||||||
Consolidated income from continuing operations before income taxes |
$ | 892,674 | $ | 743,990 | $ | 757,579 | ||||||
|
|
|
|
|
|
(1) | Includes management fees for providing management and administrative services to dialysis centers in which the Company either owns a minority equity investment or are wholly-owned by third parties. |
(2) | Revenues from external sources in 2010 and 2009 that were previously eliminated within the ancillary services and strategic initiatives segment have now been reported as a component of revenue from external sources to conform to current year presentations. |
(3) | Certain costs previously reported in the Ancillary Services and Strategic Initiatives have been reclassified to the dialysis and related lab services to conform to the current year presentation. |
Depreciation and amortization expense for the dialysis and related lab services for 2011, 2010 and 2009 were $259,685, $227,029 and $221,317, respectively, and were $6,943, $6,701 and $7,079, respectively, for the ancillary services and strategic initiatives.
F-45
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Summary of assets by segment is as follows:
December 31, | ||||||||
2011 | 2010 | |||||||
Segment assets |
||||||||
Dialysis and related lab services |
$ | 8,588,671 | $ | 7,862,882 | ||||
OtherAncillary services and strategic initiatives |
276,176 | 225,624 | ||||||
Equity investments |
27,325 | 25,918 | ||||||
|
|
|
|
|||||
Consolidated assets |
$ | 8,892,172 | $ | 8,114,424 | ||||
|
|
|
|
In 2011 and 2010, the total amount of expenditures for property and equipment for the dialysis and related lab services were $425,228 and $271,559, respectively, and were $10,692 and $7,226, respectively, for the ancillary services and strategic initiatives.
25. | Supplemental cash flow information |
The table below provides supplemental cash flow information:
Year ended December 31, | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
Cash paid: |
||||||||||||
Income taxes |
$ | 145,687 | $ | 207,265 | $ | 161,671 | ||||||
Interest |
236,446 | 190,949 | 186,280 | |||||||||
Non-cash investing and financing activities: |
||||||||||||
Fixed assets under capital lease obligations |
35,764 | 3,983 | | |||||||||
Assets exchanged for equity investments |
| | 2,618 | |||||||||
Assets received for additional noncontrolling interests |
| | 51 | |||||||||
Issuance of noncontrolling interests |
| 1,139 | |
F-46
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
26. | Selected quarterly financial data (unaudited) |
2011 | 2010 | |||||||||||||||||||||||||||||||
December 31 | September 30 | June 30 | March 31 | December 31 | September 30 | June 30 | March 31 | |||||||||||||||||||||||||
Net operating revenues |
$ | 1,862,318 | $ | 1,807,869 | $ | 1,708,643 | $ | 1,603,384 | $ | 1,646,924 | $ | 1,649,557 | $ | 1,584,821 | $ | 1,556,748 | ||||||||||||||||
Operating income |
330,112 | 318,712 | 246,624 | 235,334 | 255,258 | 256,745 | 242,512 | 242,045 | ||||||||||||||||||||||||
Income from continuing operations before income taxes |
269,149 | 258,662 | 187,283 | 177,580 | 132,215 | 218,014 | 195,469 | 198,292 | ||||||||||||||||||||||||
Discontinued operations, net of tax. |
(1,307 | ) | (2,612 | ) | 253 | 131 | 93 | (95 | ) | (89 | ) | 372 | ||||||||||||||||||||
Net income attributable to DaVita Inc. |
$ | 148,123 | $ | 135,361 | $ | 100,015 | $ | 94,502 | $ | 69,020 | $ | 119,387 | $ | 107,853 | $ | 109,423 | ||||||||||||||||
Basic income from continuing operations per share attributable to DaVita Inc. |
1.60 | 1.48 | 1.05 | 0.98 | 0.71 | 1.16 | 1.06 | 1.05 | ||||||||||||||||||||||||
Basic net income per share attributable to DaVita Inc. |
1.59 | 1.45 | 1.05 | 0.98 | 0.71 | 1.16 | 1.05 | 1.05 | ||||||||||||||||||||||||
Diluted income from continuing operations per share attributable to DaVita Inc. |
$ | 1.58 | $ | 1.45 | $ | 1.02 | $ | 0.96 | $ | 0.70 | $ | 1.15 | $ | 1.04 | $ | 1.04 | ||||||||||||||||
Diluted net income per share attributable to DaVita Inc. |
$ | 1.56 | $ | 1.42 | $ | 1.03 | $ | 0.96 | $ | 0.70 | $ | 1.15 | $ | 1.04 | $ | 1.04 |
F-47
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
27. | Consolidating financial statements |
The following information is presented in accordance with Rule 3-10 of Regulation S-X. The operating and investing activities of the separate legal entities included in the Companys consolidated financial statements are fully interdependent and integrated. Revenues and operating expenses of the separate legal entities include intercompany charges for management and other services. The senior notes were issued by the Company on October 20, 2010 and are guaranteed by substantially all of its direct and indirect domestic wholly-owned subsidiaries. Each of the guarantor subsidiaries has guaranteed the notes on a joint and several basis. However, the guarantor subsidiaries can be released from their obligations in the event of a sale or other disposition of all or substantially all of the assets of such subsidiary, if such subsidiary guarantor is designated as an unrestricted subsidiary or otherwise ceases to be a restricted subsidiary, and if such subsidiary guarantor no longer guaranties any other indebtedness of the Company. Non-wholly-owned subsidiaries, certain wholly-owned subsidiaries, foreign subsidiaries, joint ventures, partnerships and third parties are not guarantors of these obligations.
F-48
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Consolidating Statements of Income
DaVita Inc. | Guarantor Subsidiaries |
Non- Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated Total |
||||||||||||||||
For the year ended December 31, 2011 |
||||||||||||||||||||
Net operating revenues |
$ | 457,460 | $ | 5,527,588 | $ | 1,541,618 | $ | (544,452 | ) | $ | 6,982,214 | |||||||||
Operating expenses |
301,255 | 4,827,005 | 1,267,624 | (544,452 | ) | 5,851,432 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating income |
156,205 | 700,583 | 273,994 | | 1,130,782 | |||||||||||||||
Debt (expense) |
(242,730 | ) | (218,182 | ) | (9,215 | ) | 229,037 | (241,090 | ) | |||||||||||
Other income, net |
229,658 | 1,583 | 778 | (229,037 | ) | 2,982 | ||||||||||||||
Income tax expense |
56,681 | 248,139 | 10,924 | | 315,744 | |||||||||||||||
Equity earnings in subsidiaries |
391,549 | 184,404 | | (575,953 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
478,001 | 420,249 | 254,633 | (575,953 | ) | 576,930 | ||||||||||||||
Discontinued operations net of (loss) gain on disposal of discontinued operations |
| (4,191 | ) | 656 | | (3,535 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
478,001 | 416,058 | 255,289 | (575,953 | ) | 573,395 | ||||||||||||||
Less: Net income attributable to noncontrolling interests |
| | | (95,394 | ) | (95,394 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income attributable to DaVita Inc. |
$ | 478,001 | $ | 416,058 | $ | 255,289 | $ | (671,347 | ) | $ | 478,001 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
For the year ended December 31, 2010 |
||||||||||||||||||||
Net operating revenues |
$ | 431,780 | $ | 5,195,449 | $ | 1,288,259 | $ | (477,438 | ) | $ | 6,438,050 | |||||||||
Operating expenses |
259,302 | 4,615,716 | 1,043,910 | (477,438 | ) | 5,441,490 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating income |
172,478 | 579,733 | 244,349 | | 996,560 | |||||||||||||||
Debt (expense) |
(257,243 | ) | (163,034 | ) | (1,277 | ) | 165,565 | (255,989 | ) | |||||||||||
Other income, net |
165,934 | 1,837 | 1,213 | (165,565 | ) | 3,419 | ||||||||||||||
Income tax expense |
31,656 | 220,867 | 7,529 | | 260,052 | |||||||||||||||
Equity earnings in subsidiaries |
356,170 | 157,278 | | (513,448 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
405,683 | 354,947 | 236,756 | (513,448 | ) | 483,938 | ||||||||||||||
Income from operations of discontinued operations net of tax |
| 172 | 109 | | 281 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
405,683 | 355,119 | 236,865 | (513,448 | ) | 484,219 | ||||||||||||||
Less: Net income attributable to noncontrolling interests |
| | | (78,536 | ) | (78,536 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income attributable to DaVita Inc. |
$ | 405,683 | $ | 355,119 | $ | 236,865 | $ | (591,984 | ) | $ | 405,683 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
For the year ended December 31, 2009 |
||||||||||||||||||||
Net operating revenues |
$ | 401,058 | $ | 5,005,839 | $ | 1,147,394 | $ | (453,643 | ) | $ | 6,100,648 | |||||||||
Operating expenses |
246,578 | 4,375,032 | 993,053 | (453,643 | ) | 5,161,020 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating income |
154,480 | 630,807 | 154,341 | | 939,628 | |||||||||||||||
Debt (expense) |
(188,109 | ) | (181,853 | ) | (1,721 | ) | 185,928 | (185,755 | ) | |||||||||||
Other income, net |
186,189 | 2,718 | 727 | (185,928 | ) | 3,706 | ||||||||||||||
Income tax expense |
60,414 | 218,618 | (819 | ) | | 278,213 | ||||||||||||||
Equity earnings in subsidiaries |
330,538 | 94,964 | | (425,502 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
422,684 | 328,018 | 154,166 | (425,502 | ) | 479,366 | ||||||||||||||
Income from operations of discontinued operations net of tax |
| 180 | 213 | | 393 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
422,684 | 328,198 | 154,379 | (425,502 | ) | 479,759 | ||||||||||||||
Less: Net income attributable to noncontrolling interests |
| | | (57,075 | ) | (57,075 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income attributable to DaVita Inc. |
$ | 422,684 | $ | 328,198 | $ | 154,379 | $ | (482,577 | ) | $ | 422,684 | |||||||||
|
|
|
|
|
|
|
|
|
|
F-49
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Consolidating Balance Sheets
DaVita Inc. | Guarantor Subsidiaries |
Non- Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated Total |
||||||||||||||||
As of December 31, 2011 |
||||||||||||||||||||
Cash and cash equivalents |
$ | 365,276 | $ | | $ | 28,476 | $ | | $ | 393,752 | ||||||||||
Accounts receivable, net |
| 926,041 | 269,122 | | 1,195,163 | |||||||||||||||
Other current assets |
14,665 | 598,721 | 79,307 | | 692,693 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total current assets |
379,941 | 1,524,762 | 376,905 | | 2,281,608 | |||||||||||||||
Property and equipment, net |
78,038 | 971,867 | 382,746 | | 1,432,651 | |||||||||||||||
Amortizable intangible assets, net |
53,276 | 95,900 | 10,315 | | 159,491 | |||||||||||||||
Investments in subsidiaries |
6,696,039 | 1,089,920 | | (7,785,959 | ) | | ||||||||||||||
Intercompany receivables |
| 472,200 | 253,447 | (725,647 | ) | | ||||||||||||||
Other long-term assets and investments |
11,388 | 56,134 | 3,924 | | 71,446 | |||||||||||||||
Goodwill |
| 3,903,542 | 1,043,434 | | 4,946,976 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 7,218,682 | $ | 8,114,325 | $ | 2,070,771 | $ | (8,511,606 | ) | $ | 8,892,172 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Current liabilities |
$ | 148,994 | $ | 889,172 | $ | 114,950 | $ | | $ | 1,153,116 | ||||||||||
Intercompany payables |
271,890 | | 453,757 | (725,647 | ) | | ||||||||||||||
Long-term debt and other long-term liabilities |
4,351,346 | 585,675 | 55,694 | | 4,992,715 | |||||||||||||||
Noncontrolling interests subject to put provisions |
305,377 | | | 172,839 | 478,216 | |||||||||||||||
Total DaVita Inc. shareholders equity |
2,141,075 | 6,639,478 | 1,146,481 | (7,785,959 | ) | 2,141,075 | ||||||||||||||
Noncontrolling interest not subject to put provisions |
| | 299,889 | (172,839 | ) | 127,050 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
2,141,075 | 6,639,478 | 1,446,370 | (7,958,798 | ) | 2,268,125 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 7,218,682 | $ | 8,114,325 | $ | 2,070,771 | $ | (8,511,606 | ) | $ | 8,892,172 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
As of December 31, 2010 |
||||||||||||||||||||
Cash and cash equivalents |
$ | 856,803 | $ | | $ | 3,314 | $ | | $ | 860,117 | ||||||||||
Accounts receivable, net |
| 895,955 | 153,021 | | 1,048,976 | |||||||||||||||
Other current assets |
11,231 | 653,670 | 48,860 | | 713,761 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total current assets |
868,034 | 1,549,625 | 205,195 | | 2,622,854 | |||||||||||||||
Property and equipment, net |
30,409 | 888,927 | 251,472 | | 1,170,808 | |||||||||||||||
Amortizable intangible assets, net |
58,967 | 98,795 | 4,873 | | 162,635 | |||||||||||||||
Investments in subsidiaries |
6,154,398 | 555,579 | | (6,709,977 | ) | | ||||||||||||||
Intercompany receivables |
| 516,286 | 208,030 | (724,316 | ) | | ||||||||||||||
Other long-term assets and investments |
8,951 | 56,996 | 873 | | 66,820 | |||||||||||||||
Goodwill |
| 3,731,983 | 359,324 | | 4,091,307 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 7,120,759 | $ | 7,398,191 | $ | 1,029,767 | $ | (7,434,293 | ) | $ | 8,114,424 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Current liabilities |
$ | 61,384 | $ | 786,114 | $ | 76,847 | $ | | $ | 924,345 | ||||||||||
Intercompany payables |
611,919 | | 112,397 | (724,316 | ) | | ||||||||||||||
Long-term debt and other long-term liabilities |
4,210,703 | 539,620 | 19,570 | | 4,769,893 | |||||||||||||||
Noncontrolling interests subject to put provisions |
258,331 | | | 124,721 | 383,052 | |||||||||||||||
Total DaVita Inc. shareholders equity |
1,978,422 | 6,072,457 | 637,520 | (6,709,977 | ) | 1,978,422 | ||||||||||||||
Noncontrolling interest not subject to put provisions |
| | 183,433 | (124,721 | ) | 58,712 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
1,978,422 | 6,072,457 | 820,953 | (6,834,698 | ) | 2,037,134 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 7,120,759 | $ | 7,398,191 | $ | 1,029,767 | $ | (7,434,293 | ) | $ | 8,114,424 | |||||||||
|
|
|
|
|
|
|
|
|
|
F-50
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Consolidating Statements of Cash Flows
DaVita Inc. | Guarantor Subsidiaries |
Non-Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated Total |
||||||||||||||||
For the year ended December 31, 2011 |
||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income. |
$ | 478,001 | $ | 416,058 | $ | 255,289 | $ | (575,953 | ) | $ | 573,395 | |||||||||
Changes in operating assets and liabilities and non cash items included in net income |
(268,798 | ) | 325,807 | (26,311 | ) | 575,953 | 606,651 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash provided by operating activities |
209,203 | 741,865 | 228,978 | | 1,180,046 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from investing activities: |
||||||||||||||||||||
Additions of property and equipment, net |
(52,653 | ) | (232,540 | ) | (114,963 | ) | | (400,156 | ) | |||||||||||
Acquisitions |
| (1,048,136 | ) | (29,306 | ) | | (1,077,442 | ) | ||||||||||||
Proceeds from asset sales |
| 75,183 | | | 75,183 | |||||||||||||||
Proceeds from investment sales and other items |
(6,077 | ) | 9,264 | | | 3,187 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash used in by investing activities |
(58,730 | ) | (1,196,229 | ) | (144,269 | ) | | (1,399,228 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from financing activities: |
||||||||||||||||||||
Long-term debt and related financing costs, net |
113,762 | (1,896 | ) | 15,794 | | 127,660 | ||||||||||||||
Intercompany borrowing |
(464,564 | ) | 460,262 | 4,302 | | | ||||||||||||||
Other items |
(291,198 | ) | (4,002 | ) | (79,643 | ) | | (374,843 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash (used in) provided by financing activities |
(642,000 | ) | 454,364 | (59,547 | ) | | (247,183 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net (decrease) increase in cash and cash equivalents |
(491,527 | ) | | 25,162 | | (466,365 | ) | |||||||||||||
Cash and cash equivalents at beginning of the year |
856,803 | | 3,314 | | 860,117 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at the end of the year |
$ | 365,276 | $ | | $ | 28,476 | $ | | $ | 393,752 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
For the year ended December 31, 2010 |
||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income. |
$ | 405,683 | $ | 355,119 | $ | 236,865 | $ | (513,448 | ) | $ | 484,219 | |||||||||
Changes in operating assets and liabilities and non cash items included in net income |
(319,090 | ) | 136,348 | 24,758 | 513,448 | 355,464 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash provided by operating activities |
86,593 | 491,467 | 261,623 | | 839,683 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from investing activities: |
||||||||||||||||||||
Additions of property and equipment, net |
(24,118 | ) | (199,147 | ) | (50,337 | ) | | (273,602 | ) | |||||||||||
Acquisitions |
| (188,502 | ) | | | (188,502 | ) | |||||||||||||
Proceeds from asset sales |
| 22,727 | | | 22,727 | |||||||||||||||
Proceeds from investment sales and other items |
(470 | ) | 3,214 | | | 2,744 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash used in investing activities |
(24,588 | ) | (361,708 | ) | (50,337 | ) | | (436,633 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
F-51
DAVITA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(dollars in thousands, except per share data)
Consolidating Statements of Cash Flows
DaVita Inc. | Guarantor Subsidiaries |
Non-Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated Total |
||||||||||||||||
For the year ended December 31, 2010 |
||||||||||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||
Long-term debt and related financing costs, net |
563,350 | 1,987 | (4,391 | ) | | 560,946 | ||||||||||||||
Intercompany borrowing |
255,351 | (121,887 | ) | (133,464 | ) | | | |||||||||||||
Other items |
(558,453 | ) | (9,859 | ) | (75,026 | ) | | (643,338 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash provided by (used in) financing activities |
260,248 | (129,759 | ) | (212,881 | ) | | (82,392 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) in cash and cash equivalents |
322,253 | | (1,595 | ) | | 320,658 | ||||||||||||||
Cash and cash equivalents at beginning of the year |
534,550 | | 4,909 | | 539,459 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at the end of the year |
$ | 856,803 | $ | | $ | 3,314 | $ | | $ | 860,117 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
For the year ended December 31, 2009 |
||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income. |
$ | 422,684 | $ | 328,198 | $ | 154,379 | $ | (425,502 | ) | $ | 479,759 | |||||||||
Changes in operating assets and liabilities and non cash items included in net income |
(257,591 | ) | (58,813 | ) | 77,853 | 425,502 | 186,951 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash provided by operating activities |
165,093 | 269,385 | 232,232 | | 666,710 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from investing activities: |
||||||||||||||||||||
Additions of property and equipment, net |
(1,748 | ) | (207,738 | ) | (65,119 | ) | | (274,605 | ) | |||||||||||
Acquisitions |
| (87,617 | ) | | | (87,617 | ) | |||||||||||||
Proceeds from asset sales |
| 7,697 | | | 7,697 | |||||||||||||||
Proceeds from investment sales and other items |
11,631 | (3,166 | ) | | | 8,465 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash provided by (used in) investing activities |
9,883 | (290,824 | ) | (65,119 | ) | | (346,060 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from financing activities: |
||||||||||||||||||||
Long-term debt |
(60,619 | ) | (1,962 | ) | 1,307 | | (61,274 | ) | ||||||||||||
Intercompany borrowing |
101,254 | 20,885 | (122,139 | ) | | | ||||||||||||||
Other items |
(78,637 | ) | 2,516 | (54,677 | ) | | (130,798 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash (used in) provided by financing activities |
(38,002 | ) | 21,439 | (175,509 | ) | | (192,072 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) in cash and cash equivalents |
136,974 | | (8,396 | ) | | 128,578 | ||||||||||||||
Cash and cash equivalents at beginning of the year |
397,576 | | 13,305 | | 410,881 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at the end of the year |
$ | 534,550 | $ | | $ | 4,909 | $ | | $ | 539,459 | ||||||||||
|
|
|
|
|
|
|
|
|
|
F-52
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, we have duly caused this Annual Report on Form 10-K to be signed on our behalf by the undersigned, thereunto duly authorized, in the City of Denver, State of Colorado, on February 24, 2012.
DAVITA INC. | ||
By: | /S/ KENT J. THIRY | |
Kent J. Thiry Chairman and Chief Executive Officer |
KNOW ALL MEN BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Kent J. Thiry, Luis A. Borgen, and Kim M. Rivera, and each of them his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature |
Title |
Date | ||
/s/ KENT J. THIRY Kent J. Thiry |
Chairman and Chief Executive Officer (Principal Executive Officer) | February 24, 2012 | ||
/s/ LUIS A. BORGEN Luis A. Borgen |
Chief Financial Officer (Principal Financial Officer) | February 24, 2012 | ||
/S/ JAMES K. HILGER James K. Hilger |
Chief Accounting Officer (Principal Accounting Officer) | February 24, 2012 | ||
/S/ PAMELA M. ARWAY Pamela M. Arway |
Director | February 24, 2012 | ||
/s/ CHARLES G. BERG Charles G. Berg |
Director | February 24, 2012 | ||
/s/ WILLARD W. BRITTAIN Willard W. Brittain |
Director | February 24, 2012 | ||
/s/ CAROL A. DAVIDSON Carol A. Davidson |
Director | February 24, 2012 | ||
/s/ PAUL J. DIAZ Paul J. Diaz |
Director | February 24, 2012 |
II-1
Signature |
Title |
Date | ||
/s/ PETER T. GRAUER Peter T. Grauer |
Director | February 24, 2012 | ||
/s/ JOHN M. NEHRA John M. Nehra |
Director | February 24, 2012 | ||
/s/ WILLIAM L. ROPER William L. Roper |
Director | February 24, 2012 | ||
/S/ ROGER J. VALINE Roger J. Valine |
Director | February 24, 2012 |
II-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
DaVita Inc.:
Under date of February 24, 2012, we reported on the consolidated balance sheets of DaVita Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, which are included in the Annual Report on Form 10-K. In connection with our audits of the aforementioned consolidated financial statements, we also audited the related consolidated financial statement Schedule II-Valuation and Qualifying Accounts included in the Annual Report on Form 10-K. This financial statement schedule is the responsibility of the Companys management. Our responsibility is to express an opinion on this financial statement schedule based on our audits.
In our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
/s/ KPMG LLP
Seattle, Washington
February 24, 2012
S-1
DAVITA INC.
SCHEDULE IIVALUATION AND QUALIFYING ACCOUNTS
Description |
Balance at beginning of year |
DSI Renal Inc. Acquisition |
Amounts charged to income |
Amounts written off |
Balance at end of year |
|||||||||||||||
(in thousands) | ||||||||||||||||||||
Allowance for uncollectible accounts: |
||||||||||||||||||||
Year ended December 31, 2009 |
$ | 211,222 | $ | | $ | 161,786 | $ | 143,691 | $ | 229,317 | ||||||||||
Year ended December 31, 2010 |
$ | 229,317 | $ | | $ | 171,250 | $ | 164,938 | $ | 235,629 | ||||||||||
Year ended December 31, 2011 |
$ | 235,629 | $ | 16,193 | $ | 198,750 | $ | 200,229 | $ | 250,343 |
S-2
EXHIBIT INDEX
2.1 | Stock Purchase Agreement dated as of December 6, 2004, among Gambro AB, Gambro, Inc. and DaVita Inc.(9) | |
2.2 | Amended and Restated Asset Purchase Agreement effective as of July 28, 2005, by and among DaVita Inc., Gambro Healthcare, Inc. and Renal Advantage Inc., a Delaware corporation, formerly known as RenalAmerica, Inc.(12) | |
2.3 | Agreement and Plan of Merger by and among DaVita Inc., DVA Acquisition Company, CDSI I Holding Company, Inc. and CDSI Representative LLC, dated as of February 4, 2011.(47) | |
3.1 | Amended and Restated Certificate of Incorporation of Total Renal Care Holdings, Inc., or TRCH, dated December 4, 1995.(1) | |
3.2 | Certificate of Amendment of Certificate of Incorporation of TRCH, dated February 26, 1998.(2) | |
3.3 | Certificate of Amendment of Certificate of Incorporation of DaVita Inc. (formerly Total Renal Care Holdings, Inc.), dated October 5, 2000.(4) | |
3.4 | Certificate of Amendment of Amended and Restated Certificate of Incorporation of DaVita Inc., as amended dated May 30, 2007.(23) | |
3.5 | Amended and Restated Bylaws for DaVita Inc. dated as of March 10, 2011.(25) | |
4.1 | Indenture for the 6 5/8% Senior Notes due 2013 dated as of March 22, 2005.(3) | |
4.2 | Indenture for the 7 1/4% Senior Subordinated Notes due 2015 dated as of March 22, 2005.(3) | |
4.3 | First Supplemental Indenture, dated October 5, 2005, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(11) | |
4.4 | First Supplemental Indenture, dated October 5, 2005, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(13) | |
4.5 | Rights Agreement, dated as of November 14, 2002, between DaVita Inc. and the Bank of New York, as Rights Agent.(21) | |
4.6 | Second Supplemental Indenture (Senior), dated February 9, 2007, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(22) | |
4.7 | Second Supplemental Indenture (Senior Subordinated), dated February 9, 2007, by and among DaVita Inc., the Guarantors, the persons named as Additional Guarantors and The Bank of New York Trust Company, N.A., as Trustee.(22) | |
4.8 | Registration Rights Agreement for the 6 5/8% Senior Notes due 2013 dated as of February 23, 2007.(26) | |
4.9 | Third Supplemental Indenture, dated October 14, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(38) | |
4.10 | Third Supplemental Indenture, dated October 14, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(38) | |
4.11 | Indenture, dated October 20, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(39) | |
4.12 | Indenture, dated October 20, 2010, by and among DaVita Inc., the guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as Trustee.(39) |
1 of 7
4.13 | First Amendment to Rights Agreement, dated as of March 10, 2011, between DaVita Inc. and The Bank of New York Mellon Trust Company, N.A., as Rights Agent.(42) | |
10.1 | Employment Agreement, dated as of October 19, 2009, by and between DaVita Inc. and Kim M. Rivera.(40)* | |
10.2 | Employment Agreement, dated as of June 15, 2000, by and between DaVita Inc. and Joseph C. Mello.(6)* | |
10.3 | Second Amendment to Mr. Mellos Employment Agreement, effective December 12, 2008.(33)* | |
10.4 | Employment Agreement, effective as of August 16, 2004, by and between DaVita Inc. and Tom Usilton.(7)* | |
10.5 | Amendment to Mr. Usiltons Employment Agreement, dated February 12, 2007.(24)* | |
10.6 | Second Amendment to Mr. Usiltons Employment Agreement, effective December 12, 2008.(32)* | |
10.7 | Employment Agreement, effective as of November 18, 2004, by and between DaVita Inc. and Joseph Schohl.(14)* | |
10.8 | Amendment to Mr. Schohls Employment Agreement, effective December 30, 2008.(32)* | |
10.9 | Employment Agreement, dated as of October 31, 2005, effective October 24, 2005, by and between DaVita Inc. and Dennis Kogod.(13)* | |
10.10 | Amendment to Mr. Kogods Employment Agreement, effective December 12, 2008.(32)* | |
10.11 | Employment Agreement, effective September 22, 2005, by and between DaVita Inc. and James Hilger.(15)* | |
10.12 | Amendment to Mr. Hilgers Employment Agreement, effective December 12, 2008.(32)* | |
10.13 | Employment Agreement effective February 13, 2008, by and between DaVita Inc. and Richard K. Whitney.(28)* | |
10.14 | Amendment to Equity Award Agreement, entered into on December 11, 2009, between DaVita Inc. and Richard K. Whitney.(40)* | |
10.15 | Amendment to Stock Appreciation Rights Agreements, effective November 2008, by and between DaVita Inc. and Richard K. Whitney.(36)* | |
10.16 | Employment Agreement, effective July 25, 2008, between DaVita Inc. and Kent J. Thiry.(29)* | |
10.17 | Employment Agreement, effective August 1, 2008, between DaVita Inc. and Allen Nissenson.(30)* | |
10.18 | Employment Agreement, effective March 3, 2008, between DaVita Inc. and David Shapiro.(32)* | |
10.19 | Amendment to Mr. Shapiros Employment Agreement, effective December 4, 2008.(32)* | |
10.20 | Employment Agreement, effective March 17, 2010, by and between DaVita Inc. and Javier Rodriguez.(35)* | |
10.21 | Employment Agreement, effective February 26, 2010, by and between DaVita Inc. and Luis Borgen.(36)* | |
10.22 | Amendment to Mr. Borgens Employment Agreement, effective March 18, 2010.(36)* | |
10.23 | Memorandum Relating to Bonus Structure for Kent J. Thiry.(36)* | |
10.24 | Memorandum Relating to Bonus Structure for Dennis L. Kogod.(36)* | |
10.25 | Memorandum Relating to Bonus Structure for Thomas O. Usilton, Jr.(36)* |
2 of 7
10.26 | Form of Indemnity Agreement.(20)* | |
10.27 | Form of Indemnity Agreement.(14)* | |
10.28 | Executive Incentive Plan (as Amended and Restated effective January 1, 2009).(34)* | |
10.29 | Executive Retirement Plan.(32)* | |
10.30 | Post-Retirement Deferred Compensation Arrangement.(14)* | |
10.31 | Amendment No. 1 to Post Retirement Deferred Compensation Arrangement.(32)* | |
10.32 | DaVita Voluntary Deferral Plan.(11)* | |
10.33 | Deferred Bonus Plan (Prosperity Plan).(31)* | |
10.34 | Amendment No. 1 to Deferred Bonus Plan (Prosperity Plan).(32)* | |
10.35 | Amended and Restated Employee Stock Purchase Plan.(27)* | |
10.36 | Severance Plan.(36)* | |
10.37 | Change in Control Bonus Program.(32)* | |
10.38 | First Amended and Restated Total Renal Care Holdings, Inc. 1999 Non-Executive Officer and Non-Director Equity Compensation Plan.(5) | |
10.39 | Non-Management Director Compensation Philosophy and Plan.(28)* | |
10.40 | Amended and Restated 2002 Equity Compensation Plan.(10)* | |
10.41 | Amended and Restated 2002 Equity Compensation Plan.(19)* | |
10.42 | Amended and Restated 2002 Equity Compensation Plan.(27)* | |
10.43 | Amended and Restated 2002 Equity Compensation Plan.(32)* | |
10.44 | DaVita Inc. 2002 Equity Compensation Plan.(37)* | |
10.45 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 1999 Non-Executive Officer and Non-Director Equity Compensation Plan.(18)* | |
10.46 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(7)* | |
10.47 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* | |
10.48 | Form of Non-Qualified Stock Option AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.49 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(7)* | |
10.50 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* | |
10.51 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.52 | Form of Restricted Stock Units AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(32)* | |
10.53 | Form of Stock Appreciation Rights AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(16)* |
3 of 7
10.54 | Form of Stock Appreciation Rights AgreementEmployee (DaVita Inc. 2002 Equity Compensation Plan).(18)* | |
10.55 | Form of Stock Appreciation Rights AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.56 | Form of Stock Appreciation Rights AgreementBoard members (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.57 | Form of Restricted Stock Units AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.58 | Form of Restricted Stock Units AgreementBoard members (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.59 | Form of Non-Qualified Stock Option AgreementBoard (DaVita Inc. 2002 Equity Compensation Plan).(30)* | |
10.60 | Form of Stock Appreciation Rights AgreementExecutives (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.61 | Form of Restricted Stock Units AgreementExecutives (DaVita Inc. 2011 Incentive Award Plan).(44)* | |
10.62 | Credit Agreement, dated as of October 5, 2005, among DaVita Inc., the Guarantors party thereto, the Lenders party thereto, Bank of America, N.A., Wachovia Bank, National Association, Bear Stearns Corporate Lending Inc., The Bank of New York, The Bank of Nova Scotia, The Royal Bank of Scotland plc, WestLB AG, New York Branch as Co-Documentation Agents, Credit Suisse, Cayman Islands Branch, as Syndication Agent, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, JPMorgan Securities Inc., as Sole Lead Arranger and Bookrunner and Credit Suisse, Cayman Islands Branch, as Co-Arranger.(11) | |
10.63 | Credit Agreement, dated as of October 5, 2005, as Amended and Restated as of February 23, 2007, by and among DaVita Inc., the Guarantors party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A.(26) | |
10.64 | Amendment Agreement, dated February 23, 2007, by and among DaVita Inc., the Guarantors party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A.(26) | |
10.65 | Security Agreement, dated as of October 5, 2005, by DaVita Inc., the Guarantors party thereto and JPMorgan Chase Bank, N.A., as Collateral Agent.(11) | |
10.66 | Credit Agreement, dated as of October 20, 2010, by and among DaVita Inc., the guarantors party thereto, the lenders party thereto, Credit Suisse AG, Barclays Bank PLC, Goldman Sachs Bank USA, Wells Fargo Bank, National Association, Credit Agricole Corporate and Investment Bank, RBC Capital Markets, Scotia Capital (USA) Inc., SunTrust Robinson Humphrey, Inc. and Union Bank, N.A., as Co-Documentation Agents, Bank of America, N.A., as Syndication Agent, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC, Banc of America Securities LLC, Credit Suisse Securities (USA) LLC, Barclays Capital, Goldman Sachs Bank USA and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Joint Bookrunners.(46)** | |
10.67 | Perfection Certificate executed as of October 20, 2010 and delivered in connection with the closing of the Credit Agreement filed as Exhibit 10.66.(46)** | |
10.68 | Corporate Integrity Agreement between the Office of Inspector General of the Department of Health and Human Services and Gambro Healthcare, Inc. effective as of December 1, 2004.(11) | |
10.69 | Amended and Restated Alliance and Product Supply Agreement, dated as of August 25, 2006, among Gambro Renal Products, Inc., DaVita Inc. and Gambro AB.(17)** |
4 of 7
10.70 | Letter dated March 19, 2007 from Willard W. Brittain, Jr. to Peter T. Grauer, Lead Independent Director of the Company.(22) | |
10.71 | Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. dated December 20, 2007.(31)** | |
10.72 | Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. dated December 17, 2010.(41)** | |
10.73 | DaVita Inc. 2011 Incentive Award Plan.(43)* | |
10.74 | Amendment No. 2 to Dialysis Organization Agreement between DaVita Inc. and Amgen USA Inc. effective as of July 1, 2011.(45)** | |
10.75 | Sourcing and Supply Agreement between DaVita Inc. and Amgen USA Inc. effective as of January 1, 2012.ü** | |
12.1 | Computation of Ratio of Earnings to Fixed Charges.ü | |
14.1 | DaVita Inc. Corporate Governance Code of Ethics.(8) | |
21.1 | List of our subsidiaries.ü | |
23.1 | Consent of KPMG LLP, independent registered public accounting firm.ü | |
24.1 | Powers of Attorney with respect to DaVita. (Included on Page II-1). | |
31.1 | Certification of the Chief Executive Officer, dated February 24, 2012, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.ü | |
31.2 | Certification of the Chief Financial Officer, dated February 24, 2012, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.ü | |
32.1 | Certification of the Chief Executive Officer, dated February 24, 2012, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.ü | |
32.2 | Certification of the Chief Financial Officer, dated February 24, 2012, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.ü | |
101.INS | XBRL Instance Document. | |
101.SCH | XBRL Taxonomy Extension Schema Document. | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. |
ü | Included in this filing. |
* | Management contract or executive compensation plan or arrangement. |
** | Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the SEC. |
(1) | Filed on March 18, 1996 as an exhibit to the Companys Transitional Report on Form 10-K for the transition period from June 1, 1995 to December 31, 1995. |
(2) | Filed on March 31, 1998 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 1997. |
(3) | Filed on March 25, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(4) | Filed on March 20, 2001 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2000. |
5 of 7
(5) | Filed on February 28, 2003 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2002. |
(6) | Filed on August 15, 2001 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2001. |
(7) | Filed on November 8, 2004 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. |
(8) | Filed on February 27, 2004 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2003. |
(9) | Filed on December 8, 2004 as an exhibit to the Companys Current Report on Form 8-K. |
(10) | Filed on May 4, 2005 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2005. |
(11) | Filed on November 8, 2005 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2005. |
(12) | Filed on October 11, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(13) | Filed on November 4, 2005 as an exhibit to the Companys Current Report on Form 8-K. |
(14) | Filed on March 3, 2005 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2004. |
(15) | Filed on August 7, 2006 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ending June 30, 2006. |
(16) | Filed on July 6, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(17) | Filed on November 3, 2006 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2006. |
(18) | Filed on October 18, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(19) | Filed on July 31, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(20) | Filed on December 20, 2006 as an exhibit to the Companys Current Report on Form 8-K. |
(21) | Filed on November 19, 2002 as an exhibit to the Companys Current Report on Form 8-K. |
(22) | Filed on May 3, 2007 as an exhibit to the Companys Quarterly Report as Form 10-Q for the quarter ended March 31, 2007. |
(23) | Filed on August 6, 2007 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. |
(24) | Filed on February 16, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(25) | Filed on March 17, 2011 as an exhibit to the Companys Current Report on Form 8-K/A. |
(26) | Filed on February 28, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(27) | Filed on June 4, 2007 as an exhibit to the Companys Current Report on Form 8-K. |
(28) | Filed on May 8, 2008 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. |
(29) | Filed on July 31, 2008 as an exhibit to the Companys Current Report on Form 8-K. |
(30) | Filed on November 6, 2008 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. |
(31) | Filed on February 29, 2008 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2007. |
(32) | Filed on February 27, 2009 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2008 |
(33) | Filed on May 7, 2009 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2009. |
(34) | Filed on June 18, 2009 as an exhibit to the Companys Current Report on Form 8-K. |
(35) | Filed on April 14, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
(36) | Filed on May 3, 2010 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2010. |
(37) | Filed on April 28, 2010 as Appendix A to the Companys Definitive Proxy Statement on Schedule 14A. |
(38) | Filed on October 19, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
(39) | Filed on October 21, 2010 as an exhibit to the Companys Current Report on Form 8-K. |
6 of 7
(40) | Filed on February 25, 2010 as an exhibit to the Companys Annual Report on Form 10-K for the year ended December 31, 2009. |
(41) | Filed on December 29, 2011 as an exhibit to the Companys Annual Report on Form 10-K/A for the year ended December 31, 2010. |
(42) | Filed on May 6, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2011. |
(43) | Filed on April 27, 2011 as Appendix A to the Companys Definitive Proxy Statement on Schedule 14A. |
(44) | Filed on August 4, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2011. |
(45) | Filed on December 29, 2011 as an exhibit to the Companys Quarterly Report on Form 10-Q/A for the quarter ended June 30, 2011. |
(46) | Filed on January 17, 2012 as an exhibit to the Companys Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2011. |
(47) | Filed on February 10, 2011 as an exhibit to the Companys Current Report on Form 8-K. |
7 of 7
Exhibit 10.75
SOURCING AND SUPPLY AGREEMENT
This Sourcing and Supply Agreement (this Agreement) is made by and between Amgen USA Inc. (Amgen), a wholly-owned subsidiary of Amgen Inc., and DaVita Inc. (Dialysis Center) to set forth the terms and conditions upon which Dialysis Center Purchasers shall purchase EPOGEN® (Epoetin alfa) and Amgen shall provide discounts and pay rebates to Dialysis Center on EPOGEN. Each of Amgen and Dialysis Center are referred to herein as a Party and together as the Parties. Amgen Inc. is a party to this Agreement for the purposes set forth in Sections 3.1, 8.2, 9.4, 9.5.1, and 11.14 of this Agreement. Capitalized terms used herein and not otherwise defined herein shall have the meaning set forth in Section 1.
RECITALS
WHEREAS, Amgen is a leading innovator in the field of ESAs with expertise in the field of anemia management and the ability to manufacture and supply safe and efficacious ESAs for the treatment of dialysis patients;
WHEREAS, Dialysis Center is a leading provider of dialysis services in the Territory with expertise in establishing and delivering state-of-the-art, quality-of-care standards, practices and procedures for the care of patients undergoing dialysis;
WHEREAS, Dialysis Center desires to select one ESA supplier to meet its primary ESA needs on a long term basis for patients undergoing dialysis;
WHEREAS, Dialysis Center has evaluated the ESAs available for commercial use and those in clinical development, including potential [DELETED] ESAs, and has determined that EPOGEN® (Epoetin alfa) will be its preferred ESA for managing anemia for patients undergoing dialysis;
WHEREAS, the Parties wish to enter into this Agreement to, among other things, provide for Dialysis Centers selection of Amgen as the Dialysis Center Purchasers supplier of EPOGEN to meet the Dialysis Center Purchasers requirements for EPOGEN for the treatment of dialysis patients during the Term, on all of the terms provided herein;
WHEREAS, Dialysis Center seeks stable, predictable and competitive pricing over a seven year period, which it can achieve through the discounts, rebates and other price concessions set forth herein;
WHEREAS, in order to provide Dialysis Center with such pricing over a seven year period, Amgen will make substantial long-term investments and forego other potential opportunities to scale and schedule its manufacturing capacity and supply of EPOGEN for Dialysis Center Purchasers in accordance with Dialysis Center Purchasers anticipated demand for EPOGEN for use in the Territory as provided under this Agreement;
NOW THEREFORE, in consideration of the foregoing recitals and of the mutual promises and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound, each Party hereby agrees as follows:
1. | DEFINITIONS |
When used with initial capitals herein, the following terms shall have the meaning ascribed to them below:
1.1. | Actual Supply Shortfall has the meaning set forth in Section 2.5. |
[DELETED] = Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the Securities and Exchange Commission.
Page 1 of 123
1.2. | Added Dialysis Center Purchaser has the meaning set forth in Section 2.8.2. |
1.3. | Added Dialysis Center Purchaser Effective Date has the meaning set forth in Section 2.8.2. |
1.4. | Added Dialysis Center Purchaser Transaction Date means with respect to each Added Dialysis Center Purchaser: (a) in the case of a new Dialysis Center Affiliate, the effective date of the acquisition or establishment of the new Dialysis Center Affiliate; or (b) in the case of a new Managed Center, the earlier of (i) the effective date of the contract pursuant to which a dialysis facility becomes a Managed Center or (ii) the date Dialysis Center first provides services to a dialysis facility that results in such facility becoming a Managed Center, in each case after the Term Start Date. |
1.5. | Administrator has the meaning set forth in Section 9.2.1. |
1.6. | Affiliate of a given entity shall mean an entity that controls, is controlled by, or under common control with such given entity. Control shall mean ownership of more than fifty percent (50%) of the voting stock of an entity or, for non-stock entities, the right to more than fifty percent (50%) of the profits of such entity. |
1.7. | [DELETED] has the meaning set forth in Section 2.5.1. |
1.8. | Alternative ESA means an ESA that is available for use in the Territory that is not EPOGEN or Aranesp. |
1.9. | Alternative ESA Purchase Amount has the meaning set forth in Section 2.1.1. |
1.10. | Alternative ESA Purchase Event has the meaning set forth in Section 2.1.1. |
1.11. | Alternative ESA Purchase Event Share of Sales shall be calculated as follows |
[DELETED] | ||||
A | = | Committed Unit Purchases of Amgen ESAs during the [DELETED] which an Alternative ESA Purchase Event has occurred | ||
B | = | Committed Unit Purchases of Amgen ESAs during the [DELETED] which such Alternative ESA Purchase Event has occurred | ||
C | = | Committed Unit Purchases of Alternative ESAs during the [DELETED] which an Alternative ESA Purchase Event has occurred | ||
D | = | Committed Unit Purchases of Alternative ESAs during the [DELETED] which such Alternative ESA Purchase Event has occurred |
1.12. | Amgen Business Representative has the meaning set forth in Section 4.1. |
1.13. | [DELETED] means [DELETED] for use with patients receiving Dialysis Services, which [DELETED] is the subject of a written agreement between the Parties or their Affiliates. |
1.14. | Amgen ESA Risk Evaluation Program has the meaning set forth in Section 11.18. |
1.15. | Amgen ESAs Share of Sales shall mean Committed [DELETED] Purchases of Amgen ESAs during the Quarter divided by the sum of Committed [DELETED] Purchases of Amgen ESAs and Committed [DELETED] Purchases of Alternative ESAs during the Quarter. |
Page 2 of 123
Amgen ESAs Share of Sales Illustration:
Committed [DELETED]Purchases of Amgen ESAs
÷
Committed [DELETED] Purchases of Amgen ESAs + Committed [DELETED]Purchases
of Alternative ESAs
1.16. | Amgen Indemnitees has the meaning set forth in Section 9.5.2. |
1.17. | Appeal Procedures has the meaning set forth in Section 9.2.3. |
1.18. | Aranesp means Amgens proprietary darbepoetin alfa product that is marketed by Amgen in the Territory under the trademark Aranesp®. |
1.19. | Arbitrator has the meaning set forth in Section 9.2.1. |
1.20. | Authorized Removal Occurrence has the meaning set forth in Section 2.8.3. |
1.21. | Authorized Wholesalers shall mean those wholesalers listed on Exhibit B, as such list may be modified pursuant to Section 2.7. |
1.22. | Authorized Wholesaler List has the meaning set forth in Section 2.7. |
1.23. | Available EPOGEN SKUs have the meaning set forth in Section 2.4.5. |
1.24. | Award has the meaning set forth in Section 9.2.3. |
1.25. | Base Invoice Discount means the base invoice discount described in Section 2.1 of Exhibit A. |
1.26. | Base Rate Rebate means the base rebate described in Section 3.1 of Exhibit A. |
1.27. | Baseline [DELETED] has the meaning set forth in Section 2.1.2. |
1.28. | [DELETED] Rebate means the [DELETED] rebate described in Section 3.2 of Exhibit A. |
1.29. | Best Price has the meaning set forth in Section 3.6. |
1.30. | [DELETED] Rebate means the [DELETED] rebate described in Section 3.3 of Exhibit A. |
1.31. | Business Representatives has the meaning set forth in Section 4.1. |
1.32. | Certification has the meaning set forth in Section 5.2. |
1.33. | Committed [DELETED] Purchases of Amgen ESAs means, for any period, the aggregate amounts in [DELETED] of EPOGEN and Aranesp purchased by all Dialysis Center Committed Purchasers during such period for use in providing Dialysis Services, net of product returns and adjustments, which aggregate [DELETED] data have been independently confirmed by Amgen through the Relevant Information. |
1.34. | Committed [DELETED] Purchases of Alternative ESAs means, for any period, the aggregate amounts in [DELETED] of all Alternative ESAs purchased by all Dialysis Center Committed Purchasers from any source during such period for use in providing Dialysis Services, (provided that any Alternative ESA provided to a Dialysis Center Committed Purchaser at no or nominal cost from any source shall be considered a purchase), adjusted to be an equivalent [DELETED] of EPOGEN (in [DELETED]) based on the [DELETED] (if the [DELETED] is clearly set forth therein) or otherwise as reasonably determined pursuant to Section 2.1.2, and which aggregate [DELETED] data have been independently confirmed by Amgen through the Relevant Information. |
Page 3 of 123
1.35. | Compensation Data has the meaning set forth in Section 6.1. |
1.36. | Confidential Information has the meaning set forth in Section 11.14. |
1.37. | Data means the data set forth on Schedule 1 provided by Dialysis Center to Amgen pursuant to the terms and conditions of Section 5 and Exhibit A. |
1.38. | Debarred Party has the meaning set forth in Section 10.2.3. |
1.39. | Designated Affiliates shall mean any Affiliate of Dialysis Center listed on Exhibit C, as such list may be modified pursuant to Section 2.8.1. |
1.40. | Designated Affiliates List has the meaning set forth in Section 2.8.1. |
1.41. | Dialysis Center Business Representative has the meaning set forth in Section 4.1. |
1.42. | Dialysis Center Committed Purchasers has the meaning set forth in Section 2.8.5. |
1.43. | Dialysis Center Committed Purchasers List has the meaning set forth in Section 2.8.5. |
1.44. | Dialysis Center Indemnitees has the meaning set forth in Section 9.5.1. |
1.45. | Dialysis Center Purchasers shall mean Dialysis Center, the Designated Affiliates, and the Managed Centers. Dialysis Center Purchasers include Added Dialysis Center Purchasers from and after the Added Dialysis Center Purchaser Effective Date. |
1.46. | Dialysis Services means services related to the treatment of patients receiving renal dialysis, including hemodialysis, peritoneal dialysis, nocturnal dialysis, and home hemodialysis in the Territory during the Term. |
1.47. | Disclosing Party has the meaning set forth in Section 11.14. |
1.48. | Discounts means all rebates and discounts set forth on Exhibit A that may be earned by the Dialysis Center Purchasers pursuant to the terms and conditions set forth in this Agreement, which shall be earned, calculated and vested as provided in Exhibit A. |
1.49. | Disputes has the meaning set forth in Section 9.1. |
1.50. | [DELETED] has the meaning set forth in Section 2.1.2. |
1.51. | EPOGEN means Amgens proprietary epoetin alfa product that is marketed by Amgen in the Territory under the trademark EPOGEN®. |
1.52. | EPOGEN Equivalent Quantity has the meaning set forth in Section 2.1.1. |
1.53. | ESAs shall mean agents that stimulate erythropoiesis. |
1.54. | FDA has the meaning set forth in Section 8.3. |
1.55. | FDA Website has the meaning set forth in Section 11.18. |
1.56. | Firm has the meaning set forth in Section 3.2. |
1.57. | Forecast Shortfall has the meaning set forth in Section 2.4.2. |
1.58. | Forecast Shortfall Amount has the meaning set forth in Section 2.4.2. |
1.59. | Force Majeure Event has the meaning set forth in Section 11.8. |
1.60. | Governmental Authority shall mean in respect of any individual or entity, any government administrative agency, commission or other governmental authority, body or instrumentality, or any federal, state, or local governmental regulatory body having legal jurisdiction over that individual or entity. |
Page 4 of 123
1.61. | Gross Purchases of Amgen ESAs means, for any period, the aggregate gross amounts paid for purchases of EPOGEN and Aranesp by all Dialysis Center Purchasers during such period for use in providing Dialysis Services, calculated by using [DELETED] in effect on each date of purchase, net of product returns and adjustments, which aggregate sales data have been independently confirmed by Amgen through the Relevant Information. |
1.62. | Hearing has the meaning set forth in Section 9.2.3. |
1.63. | HIPAA shall mean the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations, each as may be amended. |
1.64. | IMS means IMS Health Incorporated, a Delaware corporation and its Affiliates. |
1.65. | Indemnified Party has the meaning set forth in Section 9.6.1. |
1.66. | Indemnifying Party has the meaning set forth in Section 9.6.1. |
1.67. | Individually Identifiable Health Information shall have the meaning specified in HIPAA. |
1.68. | Initial [DELETED] has the meaning set forth in Section 2.1.2. |
1.69. | [DELETED] means an [DELETED] for EPOGEN, Aranesp or an Alternative ESA, as applicable, based on its measured biological activity or effect. |
1.70. | Joint Project has the meaning set forth in Section 7.1. |
1.71. | Joint Project Committee has the meaning set forth in Section 7.1. |
1.72. | Law means, individually and collectively, any and all applicable laws, ordinances, rules, regulations, directives, administrative circulars, guidances and other pronouncements having the effect of law of any Governmental Authority. |
1.73. | Liquidated Damages has the meaning set forth in Section 10.3. |
1.74. | Managed Center shall mean a dialysis facility that is not an Affiliate of Dialysis Center but for which Dialysis Center or an Affiliate of Dialysis Center provides management services or administrative services in which it controls the selection or procurement of ESAs. |
1.75. | Managed Centers List has the meaning set forth in Section 2.8.1. |
1.76. | Material Label Change means a material amendment, change, revision, and/or modification to the Chronic Kidney Disease section of the Boxed Warning of the US prescribing information for EPOGEN as it relates to dialysis use. |
1.77. | Minimum Forecast Commitment has the meaning set forth in Section 2.4.2. |
1.78. | [DELETED] Rebate means the [DELETED] rebate described in Section 3.4 of Exhibit A. |
1.79. | Non-Disclosing Party has the meaning set forth in Section 11.14. |
1.80. | Notice of Added Dialysis Center Purchaser has the meaning set forth in Section 2.8.2. |
1.81. | Objection Notice has the meaning set forth in Section 3.2. |
1.82. | Other Agreement(s) has the meaning set forth in Section 2.2. |
1.83. | Other Agreement Early Termination Date has the meaning set forth in Section 2.2. |
1.84. | Party and Parties have the meaning set forth in the preamble hereto. |
1.85. | [DELETED] has the meaning set forth in Section 5.5. |
Page 5 of 123
1.86. | Permitted Percentage Variances has the meaning set forth in Section 2.4.3. |
1.87. | Permitted Variance Period has the meaning set forth in Section 2.4.3. |
1.88. | Policies and Procedures has the meaning set forth in Section 2.8.6. |
1.89. | Project Plan has the meaning set forth in Section 7.1. |
1.90. | Project Proposal has the meaning set forth in Section 7.1. |
1.91. | Purchase Commitment has the meaning set forth in Section 2.1. |
1.92. | Qualified Gross Purchases of EPOGEN shall mean the amount of EPOGEN purchased by Dialysis Center Purchasers during the Term from an Authorized Wholesaler (or from Amgen pursuant to Section 2.7) for use in providing Dialysis Services, and confirmed by Amgen through sales tracking data. Qualified Gross Purchases of EPOGEN shall be calculated using the [DELETED] in effect at the time of the relevant purchase, net of product returns and adjustments. |
1.93. | Quarter shall mean each calendar quarter during the Term (i.e., January 1 through March 31, April 1 through June 30, July 1 through September 30, and/or October 1 through December 31, as applicable). |
1.94. | Recall has the meaning set forth in Section 11.19. |
1.95. | Relevant Information means the Data, all sales tracking data, Self-Reported Purchase Data, Compensation Data and other relevant information, including relevant Third Party reporting agency data. |
1.96. | Research Study has the meaning set forth in Section 5.5. |
1.97. | Rolling Forecast has the meaning set forth in Section 2.4.1. |
1.98. | Rolling Forecasts has the meaning set forth in Section 2.4.1. |
1.99. | Rules has the meaning set forth in Section 9.2.1. |
1.100. | Self-Reported Purchase Data means all [DELETED] purchased of each ESA and the number of patients who received each such ESA from Dialysis Center Purchasers and such other related data as may be specified on Exhibit SR-1. |
1.101. | [DELETED] has the meaning set forth in Section 5.5. |
1.102. | Supply Commitment has the meaning set forth in Section 2.1. |
1.103. | Supply Shortfall has the meaning set forth in Section 2.5. |
1.104. | Supply Shortfall Notice has the meaning set forth in Section 2.5. |
1.105. | Supply Shortfall Quarter has the meaning set forth in Section 2.5. |
1.106. | Term means the period commencing on the Term Start Date and ending on the Term End Date. |
1.107. | Term End Date shall mean December 31, 2018. |
1.108. | Term Start Date shall mean January 1, 2012. |
1.109. | Termination Date means the date upon which this Agreement shall have been terminated in accordance with the terms and conditions of this Agreement pursuant to Section 10.2. |
1.110. | Territory means the United States, and its territories and possessions, including Puerto Rico. |
Page 6 of 123
1.111. | Third Party means any individual or entity other than a Party or an Affiliate of a Party (or, in the case of Dialysis Center, a Managed Center). |
1.112. | Third Party Claim(s) has the meaning set forth in Section 9.5.1. |
1.113. | [DELETED] shall mean the [DELETED] for EPOGEN to [DELETED] as established by [DELETED] in its [DELETED] from time to time, not including prompt pay or other discounts, rebates, or reductions in [DELETED]. |
2. | PURCHASE AND SUPPLY COMMITMENTS |
2.1. | Purchase and Supply Commitments. Subject to the terms and conditions of this Agreement, (i) the Dialysis Center Committed Purchasers shall purchase from Amgen through one or more Authorized Wholesalers those quantities of EPOGEN that are needed to meet an Amgen ESAs Share of Sales of at least ninety percent (90%) during each Quarter of the Term (the Purchase Commitment), and (ii) Amgen shall ensure that during each Quarter of the Term [DELETED] percent ([DELETED]%) of the [DELETED] for each such Quarter is available for purchase by the Dialysis Center Purchasers from one or more Authorized Wholesalers (the Supply Commitment). Subject to Section 2.3.2 and Section 2.3.3, Amgen acknowledges and agrees that nothing in this Agreement shall prohibit any Dialysis Center Committed Purchaser from purchasing an amount of EPOGEN necessary to satisfy the Purchase Commitment in a particular Quarter regardless of whether such EPOGEN was actually administered by the Dialysis Center Committed Purchasers to their patients for the provision of Dialysis Services during such Quarter. |
2.1.1. | Alternative ESA Purchases. If in any Quarter the Dialysis Center Committed Purchasers do not meet the Purchase Commitment (an Alternative ESA Purchase Event), then Dialysis Center shall (i) within thirty (30) days of the end of any such applicable Quarter provide notice to Amgen of such Alternative ESA Purchase Event, including the Committed [DELETED] Purchases of Alternative ESAs in such Quarter and (ii) within thirty (30) days of the end of the Quarter immediately following the Quarter in which the Alternative ESA Purchase Event occurred, the Committed [DELETED] Purchases of Alternative ESAs in such subsequent Quarter. If Dialysis Center provides such notice pursuant to this Section 2.1.1, or if Amgen, in its sole discretion, through the use of Relevant Information determines that there has been an Alternative ESA Purchase Event, then Amgen shall have the right to deliver to Dialysis Center a notice that sets forth the EPOGEN Equivalent Quantity, which shall be that quantity of EPOGEN (in [DELETED]) [DELETED] but for the Alternative ESA Purchase Event (based on the [DELETED] (if the [DELETED] is clearly set forth therein), or otherwise as reasonably determined by Amgen through the Relevant Information as set forth in Section 2.1.2). In the event the Alternative ESA Purchase Event Share of Sales is equal to or greater than ninety percent (90%), then Dialysis Center shall be deemed to have met the Purchase Commitment for the Quarter in which the Alternative ESA Purchase Event occurred. If the Alternative ESA Purchase Event Share of Sales is less than ninety percent (90%) for any reason, including a Force Majeure Event related to Dialysis Center and/or the Dialysis Center Purchasers, and not the result of a Supply Shortfall, then Amgen shall deliver to Dialysis Center a notice, and Dialysis Center shall pay to Amgen within thirty (30) days of its receipt of such notice, an amount (the Alternative ESA Purchase Amount) indicated by Amgen (as determined by Amgen based on the Relevant Information) in such notice equal to (a) the EPOGEN Equivalent Quantity multiplied by (b) [DELETED] of EPOGEN earned by the Dialysis Center Committed Purchasers during such |
Page 7 of 123
Quarter. At Amgens option, any Alternative ESA Purchase Amount may be offset in whole or in part against any Discounts earned by the Dialysis Center Purchasers on Qualified Gross Purchases of EPOGEN in the applicable Quarter or any subsequent Quarter. |
2.1.2. | If a Party, in its reasonable discretion, feels that the Dialysis Center Committed Purchasers potentially may not meet the Purchase Commitment due to purchases of Alternative ESAs by the Dialysis Center Committed Purchasers in a Quarter, then Amgen shall in consultation with Dialysis Center determine the appropriate methodology to be used to determine the [DELETED] (in [DELETED]) of an Alternative ESA that was used by the Dialysis Center Committed Purchasers patients during the applicable measurement period that is equivalent to a [DELETED] (in [DELETED]) of EPOGEN that was used by the Dialysis Center Committed Purchasers patients during the applicable measurement period (the [DELETED]) and Dialysis Center shall reasonably cooperate with Amgen and provide any other reasonable data, including [DELETED] of ESAs utilized during the applicable measurement period, necessary to complete the determination. If Dialysis Center has a reasonable objection to the methodology proposed by Amgen, the Parties shall appoint a mutually agreeable Third Party to determine the methodology to be used with the costs of such Third Party to be borne equally by the Parties. The initial [DELETED] for any particular Alternative ESA as determined by either the Parties or the Third Party appointed by the Parties, as applicable, pursuant to this Section 2.1.2 (the Initial [DELETED]) shall only apply to the Quarter immediately preceding the Initial [DELETED]. The determination of the [DELETED] for each particular Alternative ESA shall be recalculated for each of the first [DELETED] after the Initial [DELETED] for such Alternative ESA and the calculation of the [DELETED] for such Alternative ESA after each Quarter during such [DELETED] period shall only apply to the immediately preceding Quarter after each such recalculation. The [DELETED] for a particular Alternative ESA for all periods after such [DELETED] period shall be the [DELETED] determined as of the end of the [DELETED] Quarter after the Initial [DELETED] for such Alternative ESA (the Baseline [DELETED]); provided, either Party may, no more frequently than once per calendar year, request a recalculation of the Baseline [DELETED], which recalculation shall be applied prospectively, if such Party reasonably believes that the Baseline [DELETED] has materially changed over time, in which event the requesting Party shall bear the costs of any Third Party appointed by the Parties in connection therewith. |
2.2. | Purchase Commitment Transition Period for Added Dialysis Center Purchasers. If, after the Term Start Date, there is a new Added Dialysis Center Purchaser pursuant to Section 2.8.2, that is a Dialysis Center Committed Purchaser, Dialysis Center shall use its commercially reasonable efforts to cause such Added Dialysis Center Purchaser to meet the Purchase Commitment as soon as practicable, but such Added Dialysis Center Purchaser shall not be obligated to meet the Purchase Commitment until [DELETED] days after the Added Dialysis Center Purchaser Effective Date. If, as of the Added Dialysis Center Purchaser Effective Date regarding an Added Dialysis Center Purchaser, such Added Dialysis Center Purchaser was a party to a written agreement with a Third Party which includes an obligation on the part of such Added Dialysis Center Purchaser to exclusively purchase an Alternative ESA to meet a majority of its ESA requirements for the provision of Dialysis Services in the Territory (an Other Agreement(s)) and Dialysis Center can demonstrate via reasonable evidence to Amgen that such Other Agreement was entered into by such Added Dialysis Center Purchaser at least |
Page 8 of 123
[DELETED] days prior to the Added Dialysis Center Purchaser Transaction Date, then such Added Dialysis Center Purchaser shall not be subject to the Purchase Commitment until [DELETED] days after such time that such Other Agreement(s) can be terminated and/or amended to terminate such obligation with respect to the Alternative ESAs without such Added Dialysis Center Purchaser and/or Dialysis Center and/or any of its Affiliates paying any damages and/or other amounts to such Third Party (the Other Agreement Early Termination Date); provided that Dialysis Center shall use its best efforts to terminate such Other Agreement as soon Dialysis Center can do so without such Added Dialysis Center Purchaser and/or Dialysis Center and/or any of its Affiliates paying any damages and/or other amounts to such Third Party. Amgen shall not be obligated to meet the Supply Commitment for any Added Dialysis Center Purchaser until the expiration of the [DELETED] day period after the Added Dialysis Center Purchaser Effective Date or, in the case of an Added Dialysis Center Purchaser that is a party to an Other Agreement, [DELETED] days after the Other Agreement Early Termination Date. |
2.3. | Eligible Purchases. |
2.3.1. | Purchases from Authorized Wholesaler. Only purchases of EPOGEN made by a Dialysis Center Purchaser from an Authorized Wholesaler shall be eligible to receive the Discounts provided under this Agreement. |
2.3.2. | Own Use. The Dialysis Center Purchasers shall purchase EPOGEN under this Agreement solely for their own use in providing Dialysis Services, and only purchases made by Dialysis Center Purchasers for such use shall be eligible for the Discounts provided under this Agreement and shall be considered Committed [DELETED] Purchases of Amgen ESAs. Dialysis Center on behalf of itself and each other Dialysis Center Purchaser covenants that none of them shall seek to procure any of the Discounts available under this Agreement for any purchases of EPOGEN not for its or their use in providing Dialysis Services, and Dialysis Center shall promptly notify Amgen in the event Amgen shall have provided any Dialysis Center Purchaser with any Discounts hereunder for any EPOGEN that was not used by them for the provision of Dialysis Services. |
2.3.3. | Maximum Quarterly Purchase Increases. Notwithstanding any other provision of this Agreement, no Discounts earned by Dialysis Center shall apply to Qualified Gross Purchases of EPOGEN for any Quarter that exceed [DELETED] percent ([DELETED]%) of the Qualified Gross Purchases of EPOGEN in the immediately preceding Quarter unless Amgen, in its sole discretion, determines that such increase is necessary for Dialysis Center to meet its Purchase Commitment for any such Quarter. Such calculation shall be adjusted to remove from the calculation the effect of any change in [DELETED], or increases/decreases in the number of Dialysis Center Purchasers during the relevant comparison periods. |
2.4. | Quantity Forecasts and Minimum Forecast Commitment. |
2.4.1. | Rolling Forecast. Each Quarter during the Term, Dialysis Center shall submit in writing to Amgen a rolling [DELETED] month forecast setting forth on a month-by-month basis the aggregate quantities in [DELETED] of EPOGEN by Available EPOGEN SKU that Dialysis Center has determined in good faith are required for all Dialysis Center Purchasers for each month in the forecast period, starting with an initial [DELETED] month forecast beginning as of [DELETED] which shall be delivered to Amgen by [DELETED] (each, a Rolling Forecast and collectively the Rolling Forecasts). With the exception of the initial Rolling Forecast, Dialysis Center shall submit each Rolling Forecast by no later than the |
Page 9 of 123
[DELETED] of the [DELETED] of each Quarter during the Term (e.g., by [DELETED] Dialysis Center shall submit a Rolling Forecast for the [DELETED] month period from [DELETED] through [DELETED]). The Rolling Forecasts shall not reflect any EPOGEN requirements for periods after the Term End Date. If Dialysis Center has not timely delivered a Rolling Forecast as provided above, the Rolling Forecast previously in effect shall remain in effect for the periods covered thereby. The purpose of this Section 2.4.1 is to allow Amgen adequate time to adjust its manufacturing planning and operations to properly reflect the anticipated mix of Available EPOGEN SKUs. |
2.4.2. | Minimum Forecast Commitment. Without reducing or limiting the Purchase Commitment set forth in Section 2.1, the forecasted quantities of each Available EPOGEN SKU for months [DELETED] of each Rolling Forecast shall constitute the Dialysis Center Purchasers aggregate minimum purchase commitment of [DELETED] of EPOGEN by Available EPOGEN SKU (the Minimum Forecast Commitment). If the Dialysis Center Purchasers purchase an aggregate quantity in [DELETED] of EPOGEN by Available EPOGEN SKU during any Quarter that is less than the Minimum Forecast Commitment for any such Quarter (the quantity of any such difference, the Forecast Shortfall), then Amgen shall notify Dialysis Center of the Forecast Shortfall in writing. If the Dialysis Center Purchasers purchase a quantity in [DELETED] of EPOGEN by Available EPOGEN SKU during the Quarter in which the Forecast Shortfall occurred and the immediately following Quarter in the aggregate that is less than the aggregate Minimum Forecast Commitments for such two Quarters, Amgen shall notify Dialysis Centers of such failure in writing, and within thirty (30) days of Dialysis Centers receipt of such notice, it shall pay to Amgen an amount equal to [DELETED] percent ([DELETED]%) of (i) the Forecast Shortfall for the applicable Quarter multiplied by (ii) [DELETED] less the Discounts per [DELETED] of EPOGEN for each Available EPOGEN SKU earned by the Dialysis Center Purchasers during such Quarter (the Forecast Shortfall Amount). At Amgens option, any Forecast Shortfall Amount may be offset in whole or in part against any Discounts earned by the Dialysis Center Purchasers on purchases of EPOGEN in the applicable Quarter or any subsequent Quarter. |
2.4.3. | Forecast Variance. Each Rolling Forecast provided by Dialysis Center may [DELETED] quantities of each Available EPOGEN SKU only for new months [DELETED] and may [DELETED] quantities of each Available EPOGEN SKU in the new months [DELETED] from the corresponding months in the immediately prior Rolling Forecast by the Permitted Percentage Variances in the table below. The Permitted Percentage Variances for the months of each Rolling Forecast (the Permitted Variance Period) are as follows: |
Months |
[DELETED] | [DELETED] | [DELETED] | [DELETED] | [DELETED] | |||||||||||||||
Permitted Percentage Variance |
[DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% |
If Dialysis Center submits a Rolling Forecast that contains a forecast for any month therein that is not in compliance with this Section 2.4.3, Amgen shall have the right, in its sole discretion, to either (a) accept such forecast for any month
Page 10 of 123
therein that is not in compliance with this Section; or (b) adjust such non-compliant forecasted quantity for any such month to increase or decrease the amount forecasted for such month by up to the minimum amount necessary to bring such forecasted quantity into compliance with this Section 2.4.3. Dialysis Center may, at any time for any good faith reason, request additional variances to the Permitted Percentage Variances and, in such event, the Parties shall work in good faith to accommodate such request; provided, however, that (i) in no event shall Amgen be liable for any resulting Supply Shortfall or Actual Supply Shortfall and (ii) Dialysis Center shall remain liable for any Forecast Shortfall that may occur. If in any Quarter during the Term, the Dialysis Center Purchasers have a Forecast Shortfall and the Parties have determined, after good faith discussions, that such Forecast Shortfall is the necessary result of a Material Label Change, then the Dialysis Center Purchasers shall not be liable for such Forecast Shortfall.
2.4.4. | Good Faith Estimates. Each Rolling Forecast submitted by Dialysis Center shall represent good faith estimates of the Dialysis Center Purchasers actual anticipated purchases of EPOGEN for the treatment of dialysis patients in the Territory and reasonable inventory requirements for EPOGEN in the Territory during the relevant timeframes. |
2.4.5. | Available EPOGEN SKUs. The Available EPOGEN SKU Schedule attached as Schedule 3 hereto sets forth the Available EPOGEN SKUs as of the Term Start Date. Amgen may add Available EPOGEN SKUs to, or remove Available EPOGEN SKUs (with respect to all purchasers of EPOGEN for free-standing dialysis clinics) from, the Available EPOGEN SKUs Schedule upon at least [DELETED] advance written notice to Dialysis Center; provided that Amgen may not remove any Available EPOGEN SKUs from the Available EPOGEN SKUs Schedule that accounted for [DELETED] percent ([DELETED]%) or more of the Qualified Gross Purchases of EPOGEN during the immediately preceding [DELETED] without the prior written consent of Dialysis Center, which consent may be withheld by Dialysis Center in its sole discretion, unless there is an Available EPOGEN SKU that corresponds to the same dosage, size and potency of the deleted Available EPOGEN SKU; and provided further that, notwithstanding the foregoing, Amgen may immediately remove any Available EPOGEN SKU should Amgen determine, in its sole discretion, that the removal of any such Available EPOGEN SKU is for safety or quality or similar reasons. The Parties shall mutually agree upon (a) the first period for which any such new Available EPOGEN SKU may be ordered by the Dialysis Center Purchasers and (b) any permitted adjustments to the EPOGEN SKU mix contained in Dialysis Centers then applicable Rolling Forecast to reflect any changes in the Available EPOGEN SKUs or as otherwise may be required due to any production shortfall applicable to all EPOGEN customers. |
2.5. | Supply Commitment Shortfalls. Dialysis Center shall promptly notify Amgen in writing (the Supply Shortfall Notice) if a Dialysis Center Purchaser has not been able to purchase from the Authorized Wholesalers a quantity of EPOGEN in [DELETED] for any Available EPOGEN SKU that meets the Minimum Forecast Commitment for any Quarter for any reason, including as a result of a Force Majeure Event related to Amgen (a Supply Shortfall Quarter), setting forth in such notice the quantity of EPOGEN in [DELETED] by Available EPOGEN SKU representing such shortfall, including as a result of a Force Majeure Event related to Amgen (the Supply Shortfall). In the event of a |
Page 11 of 123
Supply Shortfall, Amgen shall not intentionally discriminate against any of the Dialysis Center Purchasers in its allocation of the available quantities of an Available EPOGEN SKU subject to such Supply Shortfall by making its allocation decisions, in whole or in part, on the basis of the prices, Discounts, and/or other financial terms offered to the Dialysis Center Purchasers pursuant to the terms and conditions of this Agreement. In no event shall the inability to obtain a particular Available EPOGEN SKU in a Minimum Forecast Commitment be deemed a Supply Shortfall, if a Dialysis Center Purchaser can purchase (i) the same quantity of EPOGEN in [DELETED] through other Available EPOGEN SKUs or (ii) Aranesp, other than with respect to use by physicians with privileges at a Dialysis Center Purchaser who have obtained approval through Dialysis Centers formulary exception process to use a short-acting Alternative ESA instead of Aranesp. If the Authorized Wholesalers are actually unable to supply the Dialysis Center Purchasers with a quantity of (i) EPOGEN or (ii) Aranesp equal to the Supply Shortfall within the time period reasonably required by the Dialysis Center Purchasers as set forth in the Supply Shortfall Notice, which in no event will be less than five (5) business days after Amgens receipt of the applicable Supply Shortfall Notice, the Purchase Commitment shall be reduced by the quantity of any Supply Shortfall that actually occurs (the Actual Supply Shortfall). |
2.5.1. | In the event of an Actual Supply Shortfall, Dialysis Center shall use good faith efforts to procure any Alternative ESAs from a Third Party at the [DELETED]. Dialysis Center shall deliver to Amgen a statement setting forth the aggregate [DELETED] (i.e., the aggregate [DELETED] less all applicable discounts, rebates, chargebacks and other price adjustments) actually paid by the Dialysis Center Purchasers to any such Third Party for that quantity of Alternative ESAs purchased by such Dialysis Center Purchasers during the Supply Shortfall Quarter solely as a substitute for the Actual Supply Shortfall (the [DELETED]); provided that should Dialysis Center be subject to any confidentiality restrictions that Dialysis Center may have with any Third Party from which it procured Alternative ESAs, then the Parties agree to send such [DELETED] to the Firm to be verified. Amgen shall pay to Dialysis Center an amount of cash equal to the difference, if any, between (a) the [DELETED] and (b) the product of (i) (1) [DELETED] in effect for the Supply Shortfall Quarter less (2) the Discounts per [DELETED] of Available EPOGEN SKU earned by the Dialysis Center Purchasers in such Supply Shortfall Quarter multiplied by (ii) the Actual Supply Shortfall. Amgen shall also pay to Dialysis Center any incremental difference in the aggregate [DELETED] of Aranesp purchased by Dialysis Center Purchasers as a result of the Supply Shortfall compared to the aggregate [DELETED] of EPOGEN unless Amgen shall have notified Dialysis Center in advance that Dialysis Center Purchasers may purchase an Alternative ESA as opposed to Aranesp during the Actual Supply Shortfall. |
2.5.2. | Upon the completion of an Actual Supply Shortfall, the Purchase Commitment, with respect to the quantities of EPOGEN in [DELETED] of the Available EPOGEN SKUs that constitute the Actual Supply Shortfall shall be suspended for a period of [DELETED] days to allow the Dialysis Center Purchasers to transition back from any Alternative ESAs used by the Dialysis Center Purchasers during such Actual Supply Shortfall back to such applicable Available EPOGEN SKU. |
2.5.3. | Provided that Amgen complies with its obligations under Section 2.5.1, then Amgen will not be in breach of Section 2.1 and the Supply Commitment as a result of the Actual Supply Shortfall. |
Page 12 of 123
2.6. | [DELETED]. The Dialysis Center Purchasers shall purchase EPOGEN from an Authorized Wholesaler at the then-prevailing [DELETED] (subject to any wholesaler markup, discount, services fees or other charges), and any Discounts shall be applied in accordance with the schedules and terms set forth in Exhibit A and this Agreement. Amgen reserves the right to change [DELETED] at any time, by any amount, without notice. Amgen shall promptly notify Dialysis Center of any change to [DELETED]. |
2.7. | Authorized Wholesalers. Prior to the Term Start Date, Dialysis Center shall select one or more Authorized Wholesalers from the Authorized Wholesaler list prepared by Amgen and set forth on Exhibit B (as such list may be amended from time to time as provided in this Agreement, the Authorized Wholesaler List), and only such selected Authorized Wholesalers shall be Authorized Wholesalers for purposes of this Agreement. From and after the Term Start Date, Dialysis Center shall have the right to change its selection of Authorized Wholesalers from the Authorized Wholesaler List with thirty (30) days prior written notice to Amgen. Dialysis Center may request Amgen to add wholesalers to the Authorized Wholesaler List, and Amgen, at its sole discretion, shall have the right to determine whether to approve of such addition to the Authorized Wholesaler List. Amgen shall have the right to add or remove wholesalers from the Authorized Wholesaler List set forth on Exhibit B in the exercise of its commercially reasonable discretion by thirty (30) days prior written notice to Dialysis Center, provided that for any removal (a) Amgen removes such Authorized Wholesaler with respect to providing EPOGEN to all purchasers of EPOGEN for free standing dialysis clinics, or (b) such Authorized Wholesaler requests Amgen to remove it as an Authorized Wholesaler for Dialysis Center Purchasers. In the event of any removal of an Authorized Wholesaler from the Authorized Wholesaler List by Amgen, Amgen shall work with Dialysis Center to transition the Dialysis Center Purchasers purchases of EPOGEN to an alternative Authorized Wholesaler, and if no alternative Authorized Wholesaler exists at such time, the Parties shall use reasonable efforts to establish a direct purchasing relationship in any interim period between the removal of the removed Authorized Wholesaler and the initiation of purchases from a new Authorized Wholesaler, if no Authorized Wholesaler exists at such time. Any such direct purchasing relationship shall be subject to credit qualification and the approval by Amgen of an application for direct ship account. If the Dialysis Center Purchasers purchase EPOGEN directly from Amgen as contemplated in this Section 2.7, all purchases of EPOGEN made from Amgen by such Dialysis Center Purchasers shall be deemed Qualified Gross Purchases of EPOGEN and eligible for the Discounts. |
2.8. | Dialysis Center Purchasers |
2.8.1. | Designated Affiliates and Managed Centers. Only the Designated Affiliates listed on Exhibit C (as such list may be amended from time to time as provided in this Agreement, the Designated Affiliates List) and the Managed Centers set forth on Exhibit D (as such list may be amended from time to time as provided in this Agreement, the Managed Centers List) shall be Dialysis Center Purchasers for purposes of this Agreement. Dialysis Center shall promptly update and maintain the accuracy of the Designated Affiliates List and the Managed Centers List throughout the Term, but in no event later than thirty (30) days after the addition or removal of a Dialysis Center Purchaser pursuant to Section 2.8.2 or 2.8.3 below. Dialysis Center shall not acquire, divest, restructure, reorganize or reclassify its Affiliates or Managed Centers, or request any addition or removal of any Dialysis Center Purchaser, with the purpose or intent in whole or in part to avoid or eliminate its obligations or commitments, or the obligations and commitments of each of the Dialysis Center Purchasers set forth in this Agreement. |
Page 13 of 123
2.8.2. | Addition of Dialysis Center Purchasers. After the Term Start Date, subject to Amgens reasonable consent under this Section 2.8.2, all new Affiliates and Managed Centers in the Territory shall be added to this Agreement and become Dialysis Center Purchasers. Dialysis Center shall provide prior written notice to Amgen of each new Affiliate and Managed Center in the Territory (each a Notice of Added Dialysis Center Purchaser), which notice shall include the proposed Added Dialysis Center Purchaser Transaction Date, plus any additional information regarding the proposed Dialysis Center Purchaser that Amgen shall reasonably request. Upon Amgens reasonable consent and subject to the terms and conditions of Section 2.2 with respect to the Purchase Commitment, the Designated Affiliates List and the Managed Centers List shall be amended to include such Affiliates or Managed Centers effective as of the later of (i) thirty (30) days from the date of Amgens receipt of a Notice of Added Dialysis Center Purchaser or (ii) the applicable Added Dialysis Center Purchaser Transaction Date (each such effective date, the Added Dialysis Center Purchaser Effective Date, and each of the Affiliates and Managed Centers added by such amendments, an Added Dialysis Center Purchaser). The Designated Affiliates List and the Managed Centers List shall be amended without further action required of the Parties to reflect additions made in accordance with this Section 2.8.2. |
2.8.3. | Removal of Dialysis Center Purchasers. (A) Dialysis Center may remove Designated Affiliates from the Designated Affiliates List and Managed Centers from the Managed Center List only (i) upon the written consent of Amgen, which consent shall not be unreasonably withheld, conditioned, and/or delayed or (ii) upon thirty (30) days prior written notice to Amgen in the event such removal is a result of a (a) sale of all or substantially all of the assets or equity interests of a Designated Affiliate to a Third Party, whether by reorganization, merger, sales of assets, or sale of equity interests, (b) permanent closure of a Designated Affiliate facility or (c) termination of the relevant management agreement for a Managed Center that has ceased its management relationship with Dialysis Center and/or any Affiliate of Dialysis Center (each of the events described in this clause (ii), an Authorized Removal Occurrence). Dialysis Center shall provide Amgen written notice describing the nature of any requested removal, including the anticipated effective date of any Authorized Removal Occurrence, and such removal shall be effective thirty (30) days after Amgen has provided Dialysis Center with written consent to such removal or such earlier period as may be agreed to by Amgen or, in the event of an Authorized Removal Occurrence, the effective date of the Authorized Removal Occurrence. |
(B) Amgen shall also have the right to remove any Designated Affiliates from the Designated Affiliates List and any Managed Centers from the Managed Centers List upon thirty (30) days (or such shorter /period as may be required by Law or any Governmental Authority) written notice to Dialysis Center (a) that such removal is required by order of a court or Governmental Authority or (b) in instances in which Amgen determines, in its reasonable discretion, that such removal is required (i) to comply with Law or (ii) as a result of any such Designated Affiliates or Managed Centers negligence or willful misconduct in the use or administration of EPOGEN.
Page 14 of 123
(C) The Designated Affiliates List and the Managed Centers List shall be amended without further action required of the Parties to reflect removals made in accordance with this Section 2.8.3.
2.8.4. | Adjustments to Rolling Forecast. Following the addition or removal of an Affiliate to or from the Designated Affiliates List or a Managed Center to or from the Managed Centers List, the Parties shall mutually agree in good faith to implement any reasonable and necessary adjustments to the Rolling Forecast to account for such addition or removal of an Affiliate to or from the Designated Affiliates List or a Managed Center to or from the Managed Centers List; provided, that Amgen shall have no obligation under Section 2.5 for an Actual Supply Shortfall in the event that any increase to the quantities of each Available EPOGEN SKU set forth in such adjusted Rolling Forecast is in excess of the applicable Permitted Percentage Variances. |
2.8.5. | Dialysis Center Committed Purchasers List. The Dialysis Center Purchasers as of the Term Start Date shall constitute the initial list of Dialysis Center Committed Purchasers as listed on Exhibit E (as such list may be amended from time to time as provided in this Agreement, the Dialysis Center Committed Purchasers List). Each Added Dialysis Center Purchaser shall automatically be added to the Dialysis Center Committed Purchasers List as of the Added Dialysis Center Purchaser Effective Date unless Amgen shall have provided notice to the contrary prior to the Added Dialysis Center Purchaser Effective Date. Any Dialysis Center Purchaser removed from the Designated Affiliates List or the Managed Center List in accordance with Section 2.8.3 shall automatically be removed from the Dialysis Center Committed Purchaser List as of the effective date of such removal from the Designated Affiliates List or the Managed Center List. Amgen shall have the right in its sole discretion to add or remove any Dialysis Center Purchasers from the Dialysis Center Committed Purchasers List upon at least fifteen (15) days written notice to Dialysis Center, effective as of the first day of the Quarter after the expiration of the fifteen (15) day notice period; provided, that Amgen shall work together with Dialysis Center to agree as to which specific Dialysis Center Purchasers will be added or removed and, in the event, the Parties are unable to agree in a reasonable time, Amgen may in its discretion add or remove specific Dialysis Center Purchasers that are not disproportionate in their use of Alternative ESAs compared to all Dialysis Center Purchasers. For avoidance of doubt, any Dialysis Center Committed Purchaser that is removed from the Dialysis Center Committed Purchasers List but remains on the Designated Affiliates List or the Managed Center List shall still be considered a Dialysis Center Purchaser. |
2.8.6. | Access to Dialysis Center Facilities. Amgen covenants and agrees that neither it nor any of its employees and/or agents shall have the right to access to any Individually Identifiable Health Information while accessing any of the Dialysis Center Purchasers. The Parties acknowledge and agree that (a) all of Dialysis Centers applicable policies and procedures regarding visitors and any updates thereto (the Policies and Procedures) that will be in effect during the Term are and will be available for viewing by Amgen and its employees and/or agents during the Term at http://www.davita.com/about/vendor-policies and (b) Amgen and its employees and/or agents shall have [DELETED] during [DELETED] to the Dialysis Center Purchasers facilities for the purpose of promoting and providing [DELETED] regarding [DELETED] and shall abide by all the Policies and Procedures during the Term to the extent that such Policies and Procedures have not changed since the |
Page 15 of 123
Term Start Date, other than as required by any applicable Law and/or generally accepted industry guidance covering vendor access to facilities, in a manner that would limit Amgens rights under this Section 2.8.6; provided, however, that, notwithstanding anything contained in the Policies and Procedures, Amgens employees and/or agents shall be permitted to utilize, without any pre-approval or review by Dialysis Center, any Amgen internally approved (i) [DELETED] materials that have been submitted to the FDA, (ii) [DELETED] materials, and (iii) [DELETED] materials, provided, such [DELETED] materials have been previously submitted to Dialysis Centers Vice President of Clinical Management and Vendor Relations for approval and not objected to by Dialysis Centers Vice President of Clinical Management and Vendor Relations within [DELETED] business days of such submission; and provided, further, that Amgen shall provide Dialysis Centers Vice President of Clinical Management and Vendor Relations with copies of all materials to be utilized at the Dialysis Center Purchasers facilities prior to their first use at any facility of the Dialysis Center Purchasers. |
3. | DISCOUNTS |
3.1. | Earning, Calculating, Payment and Vesting of Discounts. All Discounts will be earned, calculated and vested as set forth in Exhibit A. For the purposes of calculating the Discounts hereunder, Qualified Gross Purchases of EPOGEN by any Dialysis Center Purchaser shall be deemed to be made on the date of invoice by an Authorized Wholesaler or Amgen pursuant to Section 2.7 to any such Dialysis Center Purchaser. The Discounts (other than invoice discounts) shall be paid in arrears by electronic funds transfer using information provided to Amgen by Dialysis Center as necessary to enable payment. All Discounts, excluding the Base Rate Rebate and the Base Invoice Discount, shall be conditioned upon material compliance with Section 2.8.6. Amgen Inc. hereby guarantees Amgens obligations to pay all Discounts earned by Dialysis Center hereunder. |
3.2. | Verification and Audit. Discounts (including any qualification criteria for any Discounts) specified herein and/or any other amounts paid by one Party to the other Party pursuant to this Agreement are subject to verification and audit of the relevant purchase and other data (including the Data, the Self-Reported Data and the Compensation Data), as reasonably necessary to calculate any amounts payable hereunder. Dialysis Center Purchasers shall maintain their books and records in accordance with U.S. generally accepted accounting principles, consistently applied. To the extent either Amgen or Dialysis Center, in its reasonable discretion, determines that it is necessary to verify and confirm the calculation of: (a) any Discount described in this Agreement in order to audit and assure compliance with the terms of this Agreement and/or (b) any other amount that one Party must pay to the other Party under this Agreement, the requesting Party shall provide written notice of same to the other Party (an Objection Notice) setting forth in detail any and all items of disagreement related to such computation, statement, and/or amount that must be paid by one Party to the other Party. Amgen and Dialysis Center shall jointly engage (at the requesting Partys sole cost and expense, subject to any reimbursement by the other Party as set forth below) and refer the items in dispute to a nationally recognized firm of independent, certified public accountants as to which Amgen and Dialysis Center mutually agree (the Firm), to resolve any disagreements. Amgen and Dialysis Center will direct the Firm to render a written determination within twenty (20) days of its retention, and Amgen and Dialysis Center and their respective employees and/or agents will cooperate with the Firm during its engagement. The Firm shall keep strictly confidential all data reviewed and information learned or obtained in |
Page 16 of 123
connection with resolving any Objection Notice and shall report to the requesting Party only the conclusion of its review without the disclosure of any Confidential Information. All reports of the Firm shall be made available to both Parties simultaneously, promptly upon completion, and shall be deemed to conclusively and definitively resolve the related Objection Notice, which shall be reimbursed (if applicable) in accordance with this Section 3.2. Any such audit shall be conducted during normal business hours, and so as not to unreasonably interfere with the business of Amgen and/or any of the Dialysis Center Purchasers. In the event any such audit is requested by Amgen and shows that Dialysis Center Purchasers have submitted incorrect information resulting in Dialysis Center receiving in excess of [DELETED] percent ([DELETED]%) of the amount to which it was entitled in any Quarter, Dialysis Center shall reimburse Amgen for the reasonable costs of such audit; otherwise, Amgen shall be responsible for the costs of such audit. In the event any such audit is requested by Dialysis Center and shows that Dialysis Center Purchasers have submitted correct information but have been underpaid by more than [DELETED] percent ([DELETED]%) of the amount to which they were entitled in any Quarter, Amgen shall reimburse Dialysis Center for the reasonable costs of such audit; otherwise, Dialysis Center shall be responsible for the costs of such audit. The determination of the Firm will be conclusive and binding upon Amgen and Dialysis Center. Following any audit that shows any over or underpayment hereunder, the relevant Party shall, within sixty (60) days, make payment to the other Party for the difference between the amount paid hereunder and the amount actually payable hereunder based upon the results of such audit. |
3.3. | Adjustments for Changes. In accordance with Section 2.8.2 and/or 2.8.3 above, in the event of an Affiliates addition to or deletion from the Designated Affiliates List or a Managed Centers addition to or deletion from the Managed Centers List during any Quarter of the Term, Amgen shall adjust Qualified Gross Purchases of EPOGEN to account for such Affiliates addition to or deletion from the Designated Affiliates List or a Managed Centers addition to or deletion from the Managed Centers List by adding or deleting such Designated Affiliates or Managed Centers, as applicable, purchases to or from the relevant Quarter or comparison Quarter (or portion thereof). |
3.4. | Treatment of Discounts and Rebates. |
3.4.1. | Dialysis Center agrees that Dialysis Center Purchasers shall properly disclose and account for all Discounts earned hereunder, in whatever form, in compliance with all applicable federal, state, and local Laws, including §1128B(b) of the Social Security Act, as amended and its implementing regulations. Dialysis Center agrees that, if required by such statutes or regulations, it (together with its Designated Affiliates) shall and it shall cause its Managed Centers to (i) claim the benefit of such Discount received in the fiscal year in which such Discount was earned or the year after, (ii) fully and accurately report the value of such Discount in any cost reports filed under Title XVIII or Title XIX of the Social Security Act, as amended or a state or local health care program, and (iii) provide, upon request by the U.S. Department of Health and Human Services or a state or local agency or any other federally funded state health care program, the information furnished to Dialysis Center Purchasers by Amgen concerning the amount or value of such Discount. |
3.4.2. | In order to assist Dialysis Centers compliance with its obligations as set forth in Section 3.4.1 above, Amgen agrees that it will fully and accurately report all Discounts on the invoices or statements submitted to Dialysis Center and use reasonable efforts to inform Dialysis Center of its obligations to report all such Discounts to the extent specified by 42 C.F.R § 1001.952(h)(2)(ii)(A) or where the |
Page 17 of 123
value of a Discount is not known at the time of sale, Amgen shall fully and accurately report the existence of the Discount program on the invoices or statements submitted to Dialysis Center and use reasonable efforts to inform Dialysis Center of its obligations to report all such Discounts to the extent specified by 42 C.F.R § 1001.952(h)(2)(ii)(B), and when the value of the Discounts become known, provide Dialysis Center with documentation of the calculation of the Discount identifying the specific goods or services purchased to which the Discount will be applied, in accordance with Section 3.5 below. |
3.5. | Reports. Within ninety (90) days of the end of each Quarter, Amgen shall provide to Dialysis Center a statement of the Discounts earned hereunder with the itemization of EPOGEN purchases made in a particular Quarter, broken down for each Dialysis Center Purchaser and any other information that Dialysis Center may reasonably request that is reasonably available to Amgen and necessary for Dialysis Center to obtain in order to comply with its obligations hereunder. Dialysis Center agrees that it will provide such information to its Dialysis Center Purchasers in a timely manner in order to allow such Dialysis Center Purchasers to meet their reporting and other obligations hereunder and under applicable Law. |
3.6. | Best Price Limitation. At any time following the repeal, enactment or modification of any Law, policy, program memorandum, or the interpretation thereof, including a decision by the Centers for Medicare & Medicaid Services, that affects the definition of Best Price (which, for purposes of this Agreement, shall mean the price reported in Amgens Best Price Submission under Title XIX of the Social Security Act) or the methodology by which Best Price must be calculated, Amgen shall have the right, in its sole discretion, to determine the extent to which any [DELETED] to any Third Party due to such repeal, enactment, modification or decision may impact Amgens Best Price calculation under this Agreement alone or in combination with any other [DELETED] in other agreements with Dialysis Center or any Third Party. In the event that Amgen determines reasonably and in good faith that the then-existing [DELETED] under this Agreement establishes or would establish a new Best Price, Amgen shall have the right, in its sole discretion, upon the later of (a) the effective date of such repeal, enactment, modification or decision, or (b) notice to Dialysis Center, to [DELETED] the Discounts offered under this Agreement [DELETED], and shall promptly notify Dialysis Center of the [DELETED]; provided that the [DELETED] as adjusted by Amgen shall result in [DELETED] available to Dialysis Center which would [DELETED] the Best Price prior to the effective date of such repeal, enactment, modification or decision, calculated using the modified definition or methodology by which Best Price is to be calculated. |
4. | GOVERNANCE |
4.1. | Business Representatives. The Business Representatives shall be comprised of: (i) in the case of Amgen, Amgens General Manager of the Nephrology Business Unit (the Amgen Business Representative); and (ii) in the case of Dialysis Center, the Chief Operating Officer of DaVita Inc. (the Dialysis Center Business Representative). Each Business Representative shall be entitled to appoint designees who have been identified to the other Business Representative in writing and have equivalent authority to the Partys Business Representative or have been expressly given all requisite authority by the Partys Business Representative. |
4.2. | Responsibilities of Business Representatives. The Business Representatives shall be responsible for overseeing the Parties activities and conduct under this Agreement generally, and for ensuring an appropriate level of oversight. The Business Representatives shall meet in person, via teleconference or videoconference at such times as may be deemed necessary by the Parties). |
Page 18 of 123
5. | PATIENT AND PRODUCT DATA |
5.1. | Data Submission. Dialysis Center shall deliver all Data to Amgen (or to a data collection vendor specified by Amgen) in the format and manner provided in Exhibit A and subject to the provisions of this Section 5. To the extent Amgen requests that Dialysis Center deliver Data to a data collection vendor, Amgen agrees to cause any such data collection vendor to adhere to and be bound by a substantially similar confidentiality obligation as is applicable to Amgen under this Agreement, and Amgen shall be liable for any failure by any such data collection vendor to act in accordance with such requirements. |
5.2. | HIPAA Compliance. Neither Party has the intent that Dialysis Center will provide Amgen (or any specified data collection vendor) any Data in violation of HIPAA. Accordingly, the Parties shall engage an appropriately qualified statistician, reasonably acceptable to each Party, who meets the requirements set forth in 45 C.F.R. § 164.514(b)(1) to review the Data and deliver a written certification that shall conclude that, subject to any conditions, requirements or assumptions set forth therein, each delivery of Data pursuant to this Agreement will meet the standards for de-identification under HIPAA (the Certification). In connection with the Certification, the Parties agree to use their commercially reasonable best efforts to facilitate the completion and delivery of such Certification to each Party in an expedited manner, and Amgen shall bear the pre-approved costs of such Certification. Notwithstanding anything in this Agreement to the contrary, in order to assure compliance, as determined by either Party in its reasonable discretion, with any existing Law relating to patient privacy of medical records, or at any time following the enactment of any Law relating to patient privacy of medical records that in any manner reforms, modifies, alters, restricts, or otherwise affects any of the Data received or to be received in connection with any of the Discounts contemplated under this Agreement, either Party may, upon thirty (30) days prior written notice, seek to amend this Agreement with respect to the affected Discount. Dialysis Center and Amgen shall meet and in good faith mutually agree to modify this Agreement to accommodate any such change in the Law, with the intent to, if possible, retain the essential terms of this Section 5 and the affected Discount and pricing structure of this Agreement. |
5.3. | Case Identifier. Dialysis Center shall consistently use a unique alpha-numeric code (which shall not be derived from Individually Identifiable Health Information) as a case identifier to track the care rendered to each individual patient over time, and such case identifier shall be included in the Data provided to Amgen. The key or list matching patient identities to their unique case identifiers shall not be provided to Amgen. |
5.4. | Data Use. Amgen and its Affiliates shall have the right to use Data (a) to support verification of the services under this Agreement, (b) for its [DELETED] and [DELETED], development of [DELETED], running [DELETED] analyses, overall analyses of how to improve treatment of patients on dialysis and creating tools by its marketing personnel, (c) in the aggregate for publications as part of a larger data set incorporating comparable clinical data received from other dialysis providers in the Territory and provided that no portion of such data shall be attributed to Dialysis Center or its Affiliates, and (d) for purposes of verifying the Dialysis Center Purchasers performance under this Agreement and the calculation of amounts payable hereunder, including verifying the Dialysis Center Purchasers Purchase Commitment performance under this Agreement and |
Page 19 of 123
calculating or determining the Dialysis Center Purchasers eligibility to receive any Discount. Notwithstanding the foregoing, without Dialysis Centers prior written consent (such consent not to be unreasonably conditioned, withheld or delayed): Amgen and its Affiliates shall not (i) disclose to Third Parties the Data provided by Dialysis Center hereunder except (1) in any publication referenced in clause (c) above, (2) pursuant to public health activities, (3) to agents of Amgen bound by obligations of confidentiality no less restrictive than those contained in Section 11.14 or (4) to other Third Parties as required by Law or regulation as determined in Amgens discretion; and (ii) sell or resell any such data or derivative works thereof to any Third Party. |
5.5. | Clinical Research Studies. Dialysis Center and Amgen acknowledge that Dialysis Center, either directly or through DaVita Clinical Research, Inc., an Affiliate of Dialysis Center, may from time to time be engaged in research studies in which patients of the Dialysis Center Purchasers, may serve as clinical trial subjects (a Research Study). Notwithstanding any obligation of Dialysis Center in this Agreement to the contrary, including any requirement in Section 3.5 of Exhibit A, Dialysis Center shall not be required to submit Data for any patients of the Dialysis Center Purchasers that are participating in a Research Study (a [DELETED]), but shall continue without limitation to be eligible for, and if earned receive, all Discounts granted pursuant to this Agreement, so long as (i) Dialysis Center notifies Amgen of the [DELETED] whose Data will not be delivered by Dialysis Center to Amgen as otherwise required by this Agreement as a result of such patient being a [DELETED], and (ii) the aggregate number of [DELETED] whose Data is excluded by Dialysis Center does not exceed the [DELETED]. For purposes of the foregoing, [DELETED] means [DELETED] percent ([DELETED]%) of the aggregate number of persons receiving treatment from the Dialysis Center Purchasers in any calendar month. |
6. | OTHER DATA |
6.1. | Compensation Data. Dialysis Center agrees that it shall provide the data, with respect to EPOGEN, set forth on Schedule 2 attached hereto (the Compensation Data) to Amgen in the electronic format set forth on Schedule 2 on a calendar [DELETED] basis no later than the fourteenth (14th) day of the following calendar [DELETED] following the [DELETED] for which such Compensation Data is being provided. Amgen acknowledges, agrees and covenants that it shall only use the Compensation Data for sales force targeting and compensation. Dialysis Center and Amgen acknowledge and agree that the Compensation Data does not include and shall never include any Individually Identifiable Health Information of any patient of Dialysis Center Purchasers. Notwithstanding the foregoing, Amgen acknowledges and agrees that Dialysis Center shall only be required to deliver the Compensation Data to Amgen for as long as [DELETED]. Amgen shall indemnify, defend and hold harmless Dialysis Center from and against any and all loss, damage and/or expense (including reasonable attorneys fees) that it may suffer as a result of claims, demands, actions, proceedings, liabilities, costs or judgments, or threats thereof arising out Dialysis Centers supply of the Compensation Data to Amgen. |
6.2. | Self-Reported Purchase Data. Dialysis Center, on behalf of the Dialysis Center Purchasers, acknowledges, covenants and agrees that it shall submit full and complete Self-Reported Purchase Data for each Quarter to Amgen within forty-five (45) days of the end of each such Quarter through a Purchase Data Submission Form attached here to as Exhibit SR-1. Exhibit SR-1 is subject to modification by mutual written agreement of the Parties. Dialysis Center on behalf of the Dialysis Center Purchasers shall submit Exhibit SR-1 in an Excel file format electronically by e-mail to [DELETED] or in such other manner as may be specified by Amgen through written notification to Dialysis Center. |
Page 20 of 123
7. | JOINT PROJECTS |
7.1. | Joint Projects. The Parties shall form a Joint Project Committee comprised of three (3) executives from each Party, one (1) of whom shall be a clinical executive, and shall be led by two (2) co-chairs, one (1) appointed by each of the Parties. During the Term, either Party may present to the Joint Project Committee one or more written proposals (a Project Proposal) for a project or projects to be undertaken jointly by the Parties related to the provision of Dialysis Services (a Joint Project), together with a draft project plan for the Joint Project (a Project Plan) which the Parties shall discuss in good faith. If the Parties agree in writing to undertake a Joint Project, the Parties shall jointly pursue such Joint Project in accordance with the Project Plan without any further approval action required by the Parties. |
7.2. | Joint Project Committee. |
7.2.1. | Joint Project Committee Responsibilities. The Joint Project Committee shall be responsible for the following: |
a) | Reviewing and approving each new Project Proposal prior to adoption of any Joint Projects set forth in such new Project Proposal; |
b) | Reviewing and approving changes to the Project Plans for existing Joint Projects prior to adoption of such changes; |
c) | Providing for communication and discussion between the Parties to, as appropriate, coordinate and optimize the development activities of the Parties under each Joint Project; |
d) | Reviewing and monitoring the activities and progress of the Parties against the Joint Projects; |
e) | Communicating with the Business Representatives regarding all of the foregoing; and |
f) | Such other matters as are appropriate to make operational the terms of this Agreement in respect of Joint Projects and as the Parties shall agree in writing. |
7.2.2. | Meetings. The Joint Project Committee shall meet in person, via teleconference or videoconference or otherwise, as frequently as deemed necessary by the Joint Project Committee. All Joint Project Committee meetings shall have at least one (1) member appointed by each Party in attendance. |
7.2.3. | Decision Making. The Joint Project Committee shall make decisions by a unanimous vote. The Parties shall use good faith, reasonable efforts to come to a complete agreement. In the event the Joint Project Committee fails to reach unanimity with respect to any matter, such matter shall be escalated to the Business Representatives. |
8. | WARRANTIES, REPRESENTATIONS AND COVENANTS |
8.1. | Power and Authority. Each Party represents and warrants to the other that this Agreement: (a) has been duly authorized, executed, and delivered by it, (b) constitutes a valid, legal, and binding agreement enforceable against it in accordance with the terms |
Page 21 of 123
contained herein, and (c) does not and shall not conflict with or violate any of its other contractual obligations, expressed or implied, to which it is a party or by which it may be bound. |
8.2. | Compliance with Law and Regulation. Amgen and Amgen Inc. shall, and Dialysis Center shall, comply with all applicable Laws related to the performance of their respective obligations under this Agreement. Each Party represents and warrants that (which representations and warranties shall be ongoing representations and warranties during the Term): (i) it is not currently named on any of the following lists: (A) HHS/OIG List of Excluded Individuals/Entities, (B) GSA List of Parties Excluded from Federal Programs, or (C) OFAC SDN and Blocked Individuals and (ii) it shall promptly notify the other Party in the event it becomes named on any of the following lists: (x) HHS/OIG List of Excluded Individuals/Entities, (y) GSA List of Parties Excluded from Federal Programs, or (z) OFAC SDN and Blocked Individuals. |
8.3. | Product. Amgen covenants and agrees that EPOGEN is not and will not be adulterated or misbranded within the meaning of the Federal Food, Drug and Cosmetic Act, as amended, or within the meaning of any applicable Law, or is or will be a product which may not be introduced in to interstate commerce. Amgen warrants that EPOGEN purchased pursuant to this Agreement (a) is manufactured, and up to the time of its receipt by Authorized Wholesalers is handled, stored, and transported in accordance with all applicable Laws, and meet all specifications for effectiveness and reliability as required by the United States Food and Drug Administration (the FDA), and (b) when used in accordance with the directions in its labeling is fit for the purposes and indications described in its labeling. Amgen warrants that the use of EPOGEN by Dialysis Center Purchasers shall not infringe upon any ownership rights of any other individual or entity or upon any patent, copyright, trademark or other intellectual property or proprietary right or trade secret of any individual or entity. Amgen agrees that as soon as practicable it will notify Dialysis Center of any material defect in EPOGEN delivered to any Dialysis Center Purchasers in accordance with applicable Law. |
8.4. | Data. Dialysis Center represents and warrants to Amgen that: (a) the Data, the Compensation Data, and the Self-Reported Purchase Data that the Dialysis Center Purchasers deliver to Amgen pursuant to Section 5 and Section 6 shall be: (i) prepared and delivered in accordance with the provisions of Section 5, Section 6 and Exhibit A and (ii) as complete and accurate as is reasonably obtainable in view of the Dialysis Center Purchasers customary method of compilation and the nature and accuracy of the Dialysis Center Purchasers resources; (b) the Dialysis Center Purchasers shall not knowingly and intentionally misrepresent any of the Data, the Compensation Data, and/or the Self-Reported Purchase Data provided by the Dialysis Center Purchasers to Amgen; and (c) Dialysis Center shall promptly notify Amgen in the event it has actual knowledge that any of the Data, the Compensation Data, and/or the Self-Reported Purchase Data is not complete and/or accurate. |
8.5. | Designated Affiliates List and Managed Centers List. Dialysis Center represents and warrants that the Designated Affiliates List and the Managed Centers List, as each of them is attached to this Agreement as of the Term Start Date (and as of any subsequent date that such lists are updated in accordance with the terms hereof) are complete and accurate lists of all Affiliates of Dialysis Center and Managed Centers of Dialysis Center providing Dialysis Services in the Territory as of the Term Start Date (and as of each such subsequent date). |
8.6. | Adverse Claims. Each Party represents and warrants to the other Party that, as of the execution of this Agreement, such Party has no actual knowledge of any legal claim or right to be asserted against the other Party or its Affiliates related to the negotiation or execution of this Agreement. |
Page 22 of 123
8.7. | NO OTHER WARRANTIES. OTHER THAN THE WARRANTIES EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES, AND EACH PARTY EXPRESSLY DISCLAIMS, ALL OTHER WARRANTIES, STATUTORY, EXPRESS, AND/OR IMPLIED, INCLUDING THOSE OF MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE. EACH PARTY HEREBY EXPRESSLY WAIVES ANY AND ALL OTHER WARRANTIES, STATUTORY, EXPRESS, AND/OR IMPLIED, INCLUDING THOSE OF MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE. |
9. | DISPUTE RESOLUTION, INSURANCE and INDEMNITY |
9.1. | Escalation of Disputes to Business Representatives. The Parties recognize that claims, disputes or controversies arising out of or relating to this Agreement (Disputes) may occur from time to time. It is the objective of the Parties to establish procedures to facilitate the resolution of Disputes arising under this Agreement in an expedient manner by mutual cooperation and, if possible, without resort to litigation. |
In the event of any Dispute, and prior to either Party (a) commencing any action in a court of law or under any Governmental Authority, or (b) taking any action to terminate this Agreement as provided in Section 10, the Parties shall first undertake that the employees of each Party with relevant expertise and authority with respect to a Dispute shall meet to discuss such Dispute within five (5) business days of a Party receiving notice of a Dispute (except in the case where delay in resolving any such Dispute would be materially prejudicial to a Party, in which case the Dispute will be referred directly to the Business Representatives). In the event the Parties are unable to resolve any such Dispute within thirty (30) business days of the initial meeting between the Parties, it shall be referred to the Business Representatives, who shall negotiate with one another in good faith to reach a good faith resolution of the Dispute; provided, that the Parties shall use commercially reasonable best efforts to expedite the resolution of any Disputes which by their nature need to be made quickly by the Business Representatives. In the event the Dispute cannot be resolved by the Business Representatives within fifteen (15) business days of the initial meeting between the Business Representatives or such other period of time as is mutually agreed to by the Parties, then, upon the written demand of either Party, the Dispute shall be subject to arbitration, as provided in Section 9.2. Pending resolution of any Dispute, both Parties will continue their performance under this Agreement of all obligations that are not the subject of any such Dispute. If there is a Dispute relating to any amount owed by either Party to the other Party, the undisputed portion of such amount shall be paid to the other Party in accordance with the terms hereof, and the Parties shall first attempt to resolve the disputed balance in accordance with this Section 9.1.
9.2. | Arbitration. |
9.2.1. | Claims. Subject to Section 9.3 below, any Dispute that is not resolved under Section 9.1 within thirty (30) days after a Partys initial written request for resolution, shall be resolved by final and binding arbitration administered by JAMS (the Administrator) in accordance with its Comprehensive Arbitration Rules and Procedures (the Rules), except to the extent any such Rule conflicts with the express provisions of this Section 9.2. (capitalized terms in this Section 9.2 used but not otherwise defined in this Agreement shall have the meanings provided in the Rules.) For Disputes valued at less than Five Million Dollars ($5,000,000), the |
Page 23 of 123
Arbitration shall be conducted by one (1) neutral arbitrator (Arbitrator) selected in accordance with the Rules, provided that such Arbitrator shall not be a current or former employee or director, or a current stockholder, of either Party or any of their respective Affiliates. For Disputes valued at or more than Five Million Dollars ($5,000,000), the Arbitration shall be conducted by a panel of three (3) neutral Arbitrators selected in accordance with the Rules, provided that any such Arbitrator shall not be a current or former employee or director, or a current stockholder, of either Party or any of their respective Affiliates. The Arbitration shall be held in Los Angeles, California. |
9.2.2. | Discovery. Within forty-five (45) days after selection of the Arbitrator(s), the Arbitrator(s) shall conduct the Preliminary Conference. In addressing any of the subjects within the scope of the Preliminary Conference, the Arbitrator(s) shall take into account both the needs of the Parties for an understanding of any legitimate issue raised in the Arbitration and the desirability of making discovery efficient and cost-effective. In that regard, the Parties agree to the application of the E-Discovery procedures set forth in Rule 16.2(c) of JAMS Expedited Procedures; provided that the Parties agree that the time limitations identified in Rule 16.2 of JAMS Expedited Procedures shall not be binding and the Arbitrator(s) shall set time limitations for discovery and depositions that are reasonable and necessary in light of the issues and matters raised in the Preliminary Conference. In no event shall the time limitations set by the Arbitrator(s) for discovery and depositions be shorter than the time periods for discovery and depositions that are set forth in Rule 16.2 of JAMS Expedited Procedures. |
9.2.3. | Hearing; Decision. The hearing (Hearing) shall commence within a reasonable time after the discovery cutoff. The Arbitrator(s) shall require that each Party submit concise written statements of position and shall permit the submission of rebuttal statements, subject to reasonable limitations on the length of such statements to be established by the Arbitrator(s). The Arbitrator(s) shall also permit the submission of expert reports. The Arbitrator(s) shall render the award (Award) within thirty (30) days after the Arbitrator(s) declares the Hearing closed, and the Award shall include a written statement describing the essential findings and conclusions on which the Award is based, including the calculation of any damages awarded. The Arbitrator(s) will, in rendering his, her or their decision, apply the substantive law of the State of California, without giving effect to its principles of conflicts of law, and without giving effect to any rules or laws relating to arbitration. The Award rendered by the Arbitrator(s) shall be final, binding and non-appealable, and judgment may be entered upon it in any court of competent jurisdiction. However, the Parties agree that the JAMS Optional Arbitration Appeal Procedures (Appeal Procedures) shall apply to the Arbitration, at the request by either Party in accordance with such Appeal Procedures. If a Party appeals the Award rendered by the Arbitrator(s), the Award issued by the Appeal Panel (as defined in such Appeal Procedures) shall be final, binding and non-appealable, and judgment may be entered upon it in any court of competent jurisdiction. |
9.2.4. | Costs. Each Party shall bear its own attorneys fees, costs, and disbursements arising out of the Arbitration, and shall pay an equal share of the fees and costs of the Arbitrator(s); provided, however, the Arbitrator(s) shall be authorized to determine whether a Party is the prevailing party, and if so, to award to that prevailing party reimbursement for any or all of its reasonable attorneys fees, costs and disbursements (including, for example, expert witness fees and expenses, photocopy charges, travel expenses, etc.), and/or the fees and costs of the Administrator and the Arbitrator(s). |
Page 24 of 123
9.2.5. | Confidentiality. Each Party acknowledges and agrees that: (a) any discovery pursuant to this Section 9.2, (b) the Hearing, (c) any and all documents exchanged or delivered in connection with the Hearing, settlement negotiations, and/or settlement terms, including the statements of position, rebuttal statements, and expert reports, (d) settlement negotiations and/or settlement terms, and (e) the Award shall be treated as Confidential Information and subject to the terms and conditions of Section 11.14. |
9.3. | Court Actions. Nothing contained in this Agreement shall deny either Party the right to seek injunctive or other equitable relief from a court of competent jurisdiction in the context of a bona fide emergency or prospective irreparable harm, and such an action may be filed and maintained notwithstanding any ongoing discussions between the Parties or any ongoing arbitration proceeding. |
9.4. | Insurance. Each Party shall secure and maintain in full force and effect throughout the Term (and following termination, to the extent necessary to cover any claims arising from this Agreement) commercial general liability insurance and product liability (in the case of Amgen only) which include contractual liability with limits of no less than [DELETED] dollars ($[DELETED] USD); professional liability insurance (in the case of Dialysis Center only) with limits of no less than [DELETED] dollars ($[DELETED] USD), and workers compensation with statutory limits. Any limits on each of a Partys insurance coverage shall not be construed to create any limit on such Partys liability with respect to its obligations under this Agreement or otherwise. Each of the Parties shall have the right to satisfy its obligations under this Section 9.4 through self-insurance. Amgen Inc. hereby guarantees the performance of Amgens obligations as set forth in this Section 9.4. |
9.5. | Indemnity. |
9.5.1. | By Amgen. Amgen agrees to indemnify, defend, and hold Dialysis Center, its officers, directors, agents and employees (collectively, the Dialysis Center Indemnitees) harmless from and against any and all loss, damage and/or expense (including reasonable attorneys fees) that they may suffer as a result of Third Party claims, demands, actions, proceedings, liabilities, costs or judgments, or threats thereof (Third Party Claim(s)) arising out of (i) any defect in the design and/or manufacture of EPOGEN or the storage and/or transportation of EPOGEN in Amgens possession, including claims for property damage, loss of life, and/or bodily injury; and/or (ii) the breach by Amgen or Amgen Inc. of any of their respective warranties, representations, and/or covenants contained in this Agreement. Notwithstanding anything to the contrary contained herein, Amgen and Amgen Inc. shall not have any obligation to defend, indemnify, and/or hold the Dialysis Center Indemnitees harmless from any Third Party Claims arising out of the negligent acts and/or omissions and/or willful misconduct of the Dialysis Center Indemnitees. This indemnification shall survive the termination or expiration of this Agreement. Amgen Inc. hereby guarantees the performance of Amgens obligations as set forth in this Section 9.5.1. |
9.5.2. | By Dialysis Center. Dialysis Center agrees to indemnify, defend, and hold Amgen, its officers, directors, agents and employees (collectively, the Amgen Indemnitees) harmless from and against any and all Third Party Claims arising out of (i) any Dialysis Center Purchasers administration, promotion or use of EPOGEN |
Page 25 of 123
purchased under this Agreement to its patients; (ii) any Dialysis Center Purchasers failure to store and/or transport any EPOGEN in its possession in accordance with any applicable Law and/or labeling information; and/or (iii) the breach by Dialysis Center of any of its warranties, representations, and/or covenants contained in this Agreement. For purposes of the foregoing, the administration of EPOGEN by Dialysis Center shall mean the dispensing and handling by Dialysis Center and its employees of EPOGEN and the actual administration of EPOGEN to patients by Dialysis Center and its employees, but shall exclude physician prescriptions of EPOGEN to patients. Notwithstanding anything to the contrary contained herein, Dialysis Center shall not have any obligation to defend, indemnify, and/or hold the Amgen Indemnitees harmless from any Third Party Claims arising out of the negligent acts and/or omissions and/or willful misconduct of the Amgen Indemnitees. This indemnification shall survive the termination or expiration of this Agreement. |
9.6. | Procedure for Third Party Claims. |
9.6.1. | Notice. The Party receiving indemnification hereunder (the Indemnified Party) shall give the Party providing indemnification hereunder (the Indemnifying Party) written notice within fifteen (15) business days after the Indemnified Party receives notice of any Third Party Claim, subject to indemnification hereunder upon which such Indemnified Party intends to base a request for indemnification under Section 9.5.1 or Section 9.5.2. Failure to give any such notice shall not constitute a waiver of any right to indemnification or reduce in any way the indemnification available hereunder, except and only to the extent that as a result of such failure the Indemnifying Party demonstrates that it was directly and materially damaged as a result of such failure to give timely notice. |
9.6.2. | Control of Defense. The Indemnifying Party, at its expense, shall assume control of the defense and resolution of each Third Party Claim using legal counsel reasonably approved by the Indemnified Party and shall keep the Indemnified Party fully and timely informed of the progress of such defense and resolution. With respect to each Third Party Claim, the Indemnified Party shall have the right to retain independent legal counsel at its cost and monitor such Third Party Claims defense and resolution. In such a case, the Indemnifying Party and its legal counsel shall fully cooperate with the Indemnified Party and its legal counsel in providing such information as the Indemnified Party may reasonably request. Notwithstanding this Section 9.6.2, the Indemnifying Party shall not be entitled to control, but may participate in, and the Indemnified Party shall be entitled to have sole control over and select counsel to conduct, the defense or settlement of each Third Party Claim that: (i) seeks a temporary restraining order, a preliminary or permanent injunction, and/or specific performance against the Indemnified Party, (ii) involves criminal allegations against the Indemnified Party, (iii) if unsuccessful, would set a precedent that would materially interfere with and/or have a material adverse effect on the business and/or financial condition of the Indemnified Party, and/or (iv) imposes liability on the part of the Indemnified Party for which the Indemnified Party is not entitled to indemnification hereunder. In such an event, the Indemnifying Party will still have all of its obligations hereunder with respect to any such affected Third Party Claims; provided that the Indemnified Party will not settle any such affected Third Party Claims without the prior written consent of the Indemnifying Party, which consent will not be unreasonably withheld, conditioned, and/or delayed by the Indemnifying Party. |
Page 26 of 123
9.6.3. | Representation. If both the Indemnifying Party and the Indemnified Party are named parties in any Third Party Claim and representation of both Parties by the same legal counsel would be inappropriate due to the actual or potential differing interests between them, then the Indemnified Party, at the Indemnifying Partys expense, shall have the right to be represented by separate counsel of the Indemnified Partys choosing. |
9.6.4. | Resolution. The Indemnifying Party shall not settle, compromise or resolve any Third Party Claim without the written consent of the Indemnified Party; provided that, the Indemnifying Party may, without such consent, enter into any such judgment, settlement, compromise or resolution that relates solely to the payment of money damages, involves a full release of the Indemnified Party and does not result in any admission of any fault of the Indemnified Party with respect to such Third Party Claim. |
9.6.5. | Payment. Any final judgment entered or settlement agreed upon in the manner provided in this Section 9.6, as applicable, shall be binding upon the Indemnifying Party and shall conclusively be deemed to be an obligation with respect to which the Indemnified Party is entitled to prompt indemnification hereunder, if applicable. Payment of all amounts owing by the Indemnifying Party under this Section 9.6, as applicable, shall be made promptly upon a final settlement between the Indemnifying Party and the Indemnified Party or upon a final adjudication determined by the Arbitrator(s) that an indemnification obligation is owed by the Indemnifying Party to the Indemnified Party. |
10. | TERM AND TERMINATION |
10.1. | Term. This Agreement shall come into effect as of the Term Start Date and shall expire on the earlier of the Term End Date, or the Termination Date. |
10.2. | Termination for Cause. Amgen or Dialysis Center may terminate this Agreement only in the event of the following: |
10.2.1. | Breach of Purchase Commitment. The Parties acknowledge and agree that the Purchase Commitment is the principal value expected to be received by Amgen under this Agreement and it is the essential inducement for Amgen to enter into this Agreement, pursuant to which it has agreed, among other things, (a) to provide the Dialysis Center Purchasers for the duration of the Term the economic benefits of the Discounts provided for herein, (b) to make the Supply Commitment, which requires that Amgen commit facilities to the manufacture of EPOGEN at the expense of other Amgen uses and allocate significant resources to maintain its manufacturing capabilities and capacity at a commensurate level, (c) to assume the business risks and financial liability in respect of the representations, warranties and covenants made by it hereunder and (d) to forego potential other commercial opportunities in respect of its nephrology business. In the event that the Dialysis Center Committed Purchasers do not meet an Amgen ESAs Share of Sales of (i) at least [DELETED] percent ([DELETED]%) for [DELETED] or more [DELETED] during the Term with respect to which the Dialysis Center is required to pay the Alternative ESA Purchase Amount with respect to each of such [DELETED] in any [DELETED] period during the Term, or (ii) at least [DELETED] percent ([DELETED]%) in any [DELETED], then Amgen shall be entitled to terminate this Agreement immediately |
Page 27 of 123
upon written notice to Dialysis Center and, notwithstanding any other provision of this Agreement, thereupon either receive the Liquidated Damages defined below or exercise such other rights and remedies as may be allowed at law or in equity under applicable Law. |
10.2.2. | Termination for Failure to Supply. Dialysis Center may terminate this Agreement immediately upon written notice to Amgen in the event that Amgen has not been able to supply to Dialysis Center through one or more Authorized Wholesalers EPOGEN in [DELETED] (or Aranesp subject to the terms of Section 2.5) equal to at least [DELETED] percent ([DELETED]%) of the Minimum Forecast Commitment (other than as a result of one or more Force Majeure Events) for [DELETED]. |
10.2.3. | Termination for Exclusion from Federal Health Care Program. Either Amgen or Dialysis Center may immediately terminate this Agreement upon written notice to the other Party in the event there is change in the other Partys status which excludes it from participation in any Federal health care program (as defined under 42 U.S.C. § 1320a-7b(f)) (a Debarred Party), provided that no Party shall have the right to terminate this Agreement pursuant to this Section 10.2.3 if the Debarred Party can complete its obligations through, or otherwise transfer its obligations to, an Affiliate as permitted by applicable Law. |
10.3. | Liquidated Damages. The Parties acknowledge that Amgens actual damages in the event of a termination by Amgen, pursuant to Section 10.2.1 or Section 10.2.3, would be difficult to ascertain, and that the payment of the Liquidated Damages represents the best estimate of the amount of such damages by the Parties at this time. The Parties further expressly acknowledge and agree that the Liquidated Damages are intended not as a penalty, but as full liquidated damages, in the event of Amgens termination of this Agreement pursuant to Section 10.2.1 or Section 10.2.3 and as compensation for Amgens losses and other expenses associated with this Agreement. |
For purposes of this Agreement, Liquidated Damages means, in addition to any amounts owed to Amgen under this Agreement, including for breach of the Purchase Commitment under Section 2.1, an amount in cash equal to [DELETED] percent ([DELETED] %) of the [DELETED] of Amgens projected [DELETED] for each remaining Quarter (including any fractional Quarters) in the Term, with such [DELETED] equal to A B, grown Quarterly at a [DELETED] percent ([DELETED]%) annual rate and discounted on a Quarterly basis, at a rate equal to the average annual increase in [DELETED] for EPOGEN on an [DELETED] basis for all calendar years during the Term prior to the related [DELETED] calculation, where:
A | = | The average [DELETED] for the [DELETED] most recent Quarters prior to the Termination Date in which Dialysis Center satisfied the Purchase Commitment in full (or, if less than [DELETED] such Quarters exist, then A shall equal the average of the sum of (i) [DELETED] plus (ii) the [DELETED], for the [DELETED] most recent Quarters prior to the Termination Date); and | ||||
B | = | The average aggregate [DELETED] (other than the [DELETED] Rebate, the [DELETED] Rebate and the [DELETED] Rebate) earned by Dialysis Center Purchasers during the [DELETED] most recent Quarters prior to the Termination Date, regardless of whether Dialysis Center satisfied the Purchase Commitment in such Quarters. |
10.4. | Effect of Termination. Upon any termination or expiration of this Agreement, (a) any earned and vested Discounts shall be paid in accordance with the terms set forth in |
Page 28 of 123
Exhibit A, (b) any Alternative ESA Purchase Amounts shall be paid pursuant to Section 2.1.1, (c) any payments by Amgen owing to Dialysis Center under Section 2.5.1 shall be paid, (d) any payment by Dialysis Center owing to Amgen under Section 2.4.2 shall be paid and (e) the Liquidated Damages pursuant to Section 10.3 shall be paid. All Discounts available to Dialysis Center in the particular Quarter in which such termination occurs shall be paid to Dialysis Center based on an achievement of the eligibility and vesting requirements set forth in Exhibit A. |
10.5. | Survival. Any provision that, either expressly or by its nature is intended to survive this Agreement, shall survive any expiration or termination of this Agreement, including Sections 1, 3, 8, 9, 10, and 11. |
11. | MISCELLANEOUS |
11.1. | Amendment. Except as expressly set forth herein, no amendment of this Agreement shall be effective unless expressed in a writing signed by a duly authorized representative of each Party. |
11.2. | Assignment. Neither Party shall have the right to assign or otherwise transfer this Agreement, or any of its rights and obligations hereunder, in whole or in part, without the other Partys prior written consent, and any attempted assignment or transfer without such consent shall be void; provided, however, that Amgen may assign or otherwise transfer this Agreement and its rights and obligations hereunder to any of its Affiliates that is not in the business of providing Dialysis Services in the Territory. Notwithstanding the foregoing, each Party shall be obligated to assign and transfer this Agreement, without any required consent, to any Person to whom either such Party has transferred all or substantially all of its business relating to this Agreement, and the Parties agree that they shall take all reasonable and necessary actions in respect thereof including the execution and delivery of all appropriate instruments to effectuate such assignment and transfer of this Agreement; provided that any assignment and transfer of this Agreement by Amgen to any Person, a substantial portion of whose business consists of providing Dialysis Services in the Territory, shall require the prior written consent of Dialysis Center, which consent may be withheld by Dialysis Center in its sole and absolute discretion. This Agreement and the provisions hereof shall be binding upon, and inure to the benefit of, the Parties permitted successors and assigns. |
11.3. | Modification of Law. If at any time following the Term Start Date, the enactment or modification of any Law occurs and, as a result, either Partys performance of its obligations under this Agreement would not comply with such Law, either Party may, upon notice to the other Party, recommend an amendment to modify this Agreement to address those provisions of the Agreement that may not comply with such Law. The Parties agree to use their commercially reasonable best efforts to modify this Agreement as necessary to bring it into compliance with the Law if that can be done while retaining, in all material respects, the essential rights and benefits of each Party under this Agreement, including the Purchase Commitment, the Supply Commitment, the collection, exchange and use of the Data and the ability for Dialysis Center Purchasers to earn the Discounts that the Dialysis Center Purchasers are eligible to receive hereunder. Promptly following the delivery of such notice describing the Law at issue and the proposed modifications to bring this Agreement into compliance with such Law, Dialysis Center and Amgen shall meet and in good faith seek to mutually agree to amend this Agreement to accommodate any such Law in accordance with this Section 11.3. |
Page 29 of 123
11.4. | Conflicting Provisions. To the extent that any provisions of Amgens general or customary policies and procedures or any terms of any purchase order conflict with or are in addition to the terms of this Agreement or any Exhibit or Schedule attached hereto, the terms of this Agreement and its Exhibits and Schedules shall govern. |
11.5. | Construction. This Agreement shall be deemed to have been jointly drafted by the Parties, and no rule of strict construction shall apply against either Party. As used herein, the word including shall mean including, without limitation. |
11.6. | Counterparts; Facsimile/PDF Signatures. This Agreement may be executed in one or more counterparts, each of which shall be considered an original. The Parties agree that facsimile or PDF transmission of original signatures shall constitute and be accepted as original signatures. |
11.7. | Currency. All amounts herein are set forth in United States Dollars. |
11.8. | Force Majeure. Except as provided in Section 2.1.1 or Section 2.5, neither Party will be liable for delays in performance or nonperformance of this Agreement or any covenant contained herein if such delay or nonperformance is a result of acts of God, acts of civil or military authority, acts of any Governmental Authority, civil disobedience or commotion, epidemics, war, terrorist acts, failure or default of public utilities or common carriers, destruction of production facilities or materials by fire, earthquake, storm or like catastrophe, inability to procure necessary raw materials in a commercially reasonable manner or default of suppliers or subcontractors or any events beyond the reasonable control and without the fault or negligence of a Party (all of the foregoing, a Force Majeure Event). Force Majeure Events shall not adversely affect Dialysis Centers eligibility for any Discounts. |
11.9. | Further Assurances. Each Party shall perform all further acts reasonably requested by the other to effectuate the purposes of this Agreement, including obtaining the Certifications under Section 5 or obtaining purchase data necessary from third parties to calculate any amounts payable pursuant to Exhibit A. |
11.10. | Governing Law. This Agreement shall be governed by the laws of the State of California (without regard to its conflict of law rules) and, except as otherwise set forth in this Agreement, the Parties submit to the jurisdiction of the California courts, both state and federal. |
11.11. | Merger/No Reliance. This Agreement, together with the Schedules, and the Exhibits constitutes the entire agreement, written or oral, of the Parties as of the Term Start Date concerning the subject matter hereof. The Parties acknowledge that, in making the determination to enter into this Agreement or otherwise, they have not relied, in whole or in part, on any promise, information, understanding, guarantees, discussions, representation, or warranty, expressed or implied, not contained specifically in this Agreement. Without limiting the generality of the foregoing, the Parties agree that neither Party makes or has made any representation or warranty with respect to any potential changes in the dialysis segment or the use or pricing of ESAs in dialysis, including as a result of the introduction of Alternative ESAs (including [DELETED]) including the timing of such introduction(s), the pricing of such Alternative ESAs and their potential physician acceptance and impact on prescribing practices. |
11.12. | No Partnership. The relationship between Amgen and Dialysis Center is that of independent contractors, and not a partnership or an agency, franchise or other relationship. Neither Party shall have the authority to bind the other. |
Page 30 of 123
11.13. | Notices. Any notice or other communication required or permitted hereunder (excluding purchase orders) shall be in writing and shall be deemed given or made five (5) days after deposit in the United States mail with proper postage for first-class registered or certified mail prepaid, return receipt requested, or when delivered personally or by facsimile (as shown by concurrent written transmission confirmation and confirmed by overnight mail), or one (1) day following traceable delivery to a nationally recognized overnight delivery service with instructions for overnight delivery, in each case addressed to the address set forth below, or at such designated address that either Party shall have furnished to the other in accordance with this Section 11.13: |
If to Amgen: |
||
Amgen USA Inc. | ||
One Amgen Center Drive, [DELETED] | ||
Thousand Oaks, CA 91320-1789 | ||
Attn: Specialist, Contracts & Pricing Nephrology Business Unit | ||
Fax: [DELETED] | ||
with a copy to: |
||
Amgen USA Inc. | ||
One Amgen Center Drive, [DELETED] | ||
Thousand Oaks, CA 91320-1789 | ||
Attn: General Counsel | ||
Fax: [DELETED] | ||
If to Amgen Inc.: |
Amgen Inc. | |
One Amgen Center Drive, [DELETED] | ||
Thousand Oaks, CA 91320-1789 | ||
Attn: General Counsel | ||
Fax No.: [DELETED] | ||
If to Dialysis Center: | ||
DaVita Inc. | ||
1350 Old Bayshore Highway, Suite 777 | ||
Burlingame, California 94010 | ||
Attn: Vice-President of Purchasing | ||
Fax No.: [DELETED] | ||
with a copy to: |
||
DaVita Inc. | ||
1551 Wewatta Street | ||
Denver, CO 80202 | ||
Attn: Chief Legal Officer | ||
Fax No.: [DELETED] |
11.14. | Confidentiality. Confidential Information means any and all information provided by one Party and/or any of its Affiliates (including Managed Centers in the case of Dialysis Center) (the Disclosing Party) to the other Party and/or any of its Affiliates (including Managed Centers in the case of Dialysis Center) (the Non-Disclosing Party) which is identified in writing or orally as confidential by the Disclosing Party to the Non-Disclosing Party or given the nature of the information or circumstances surrounding its disclosure |
Page 31 of 123
reasonably should be considered as confidential, whether in written, computerized, oral, tangible or intangible, and/or other form. Nothing in this Section 11.14 shall prohibit, Amgen from using the Data, the Compensation Data, and/or the Self-Reported Purchase Data as provided in Section 5 and Section 6. |
11.14.1. | Confidentiality Covenants. Except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the Parties, the Non-Disclosing Party agrees that for the Term, and for a period of five (5) years following the Term, the Non-Disclosing Party will keep confidential and not publish or otherwise disclose to any Third Party or use for any purpose, other than in accordance with this Agreement, any Confidential Information, provided, however, that the Non-Disclosing Party may disclose any such Confidential Information to its directors, officers, employees, agents, consultants and advisors as necessary for the Non-Disclosing Party to carry out its rights and obligations under this Agreement on the condition that such directors, officers, employees, agents, consultants and advisors are bound by confidentiality provisions at least as restrictive as those contained in this Agreement. The confidentiality provisions contained in this Section 11.14 shall not apply to the extent that it can be established by the Non-Disclosing Party by competent proof that such Confidential Information: |
(a) | was generally available to the public or otherwise part of the public domain at the time of its disclosure to the Non-Disclosing Party by the Disclosing Party; or |
(b) | became generally available to the public or otherwise part of the public domain after its disclosure to the Non-Disclosing Party by the Disclosing Party and other than through any act or omission of the Non-Disclosing Party in breach of this Agreement; or |
(c) | was independently discovered or developed by the Non-Disclosing Party without the use of or reference to the Confidential Information belonging to the Disclosing Party. |
11.14.2. | Retention and Destruction of Confidential Information. At any time upon the written request of the Disclosing Party the Non-Disclosing Party shall promptly return to the Disclosing Party or destroy all Confidential Information. Notwithstanding the return or destruction of the Confidential Information to the Disclosing Party or such other party as designated by the Disclosing Party to the Non-Disclosing Party, the Non-Disclosing Party covenants and agrees that it will continue to abide by its obligations hereunder with respect to any and all Confidential Information. |
11.14.3. | Disclosures Required By Law. In the event that the Non-Disclosing Party and/or any of its directors, officers, employees, agents, consultants and advisors that have received any Confidential Information is required by Law (e.g., by oral questions, interrogatories, request for information or documents, subpoena, civil investigative demand, or similar process) to disclose any Confidential Information, the Non-Disclosing Party agrees to (and shall cause each of its directors, officers, employees, agents, consultants and advisors that have received any Confidential Information to) provide the Disclosing Party with immediate written notice of any such disclosure of Confidential Information that is required by Law in order to provide the Disclosing Party with an opportunity to seek a protective order or other similar order with respect to such Confidential |
Page 32 of 123
Information. If disclosure of any Confidential Information is required by Law, the Non-Disclosing Party will (and will cause each of its directors, officers, employees, agents, consultants and advisors that have received any Confidential Information to) furnish only that portion of the Confidential Information which it is legally obligated to disclose by Law and consistent with the terms of any protective order or other similar order obtained by the Disclosing Party with respect to such Confidential Information required to be disclosed by Law. |
11.14.4. | Public Announcements; Authorized Disclosure. Neither Party shall make a public announcement or other public disclosure concerning this Agreement without the consent of the other Party, except that either Party may make such announcement or disclosure if it is required by applicable Law, reasonably necessary for any filings with any Governmental Authority or pursuant to the rules of any securities exchange or interdealer quotation system; provided, that the disclosing Party shall give reasonable prior advance notice of the proposed text of such announcement or disclosure to the other Party for its prior review and approval, which review and approval shall not be unreasonably conditioned, withheld or delayed. The proviso in the immediately preceding sentence shall not apply to Relevant Information included in any cost report filed under Title XVIII or Title XIX of the Social Security Act, or health care program of any Governmental Authority. |
11.14.5. | Confidential Terms. Notwithstanding the foregoing, each Party may disclose the terms of this Agreement in confidence under terms and conditions at least as restrictive as set forth herein on a need-to-know basis to its legal and financial advisors to the extent such disclosure shall be reasonably necessary in connection with such Partys activities as expressly permitted by this Agreement. |
11.14.6. | Enforcement. Each Party agrees that money damages alone would not be an adequate remedy for any breach of the terms and conditions of this Section 11.14. Therefore, in the event of a breach or threatened breach of this Section 11.14, the non-breaching Party may, in addition to other rights and remedies existing in its favor, apply to any court of competent jurisdiction for specific performance and/or injunctive and/or other relief in order to enforce and/or prevent any violation of the provisions of this Section 11.14 by the breaching Party (without proving monetary damages and/or posting a bond and/or other security). |
11.15. | Severability. Subject to the provisions of Section 11.3, if any one or more of the provisions of this Agreement is held to be invalid or unenforceable, the provisions shall be considered severed from this Agreement and shall not serve to invalidate any remaining provisions hereof. |
11.16. | Waiver. No Party shall be deemed to have waived any right hereunder, unless such waiver is expressed in a writing signed by such Party. |
11.17. | Open Records. To the extent required by §1861(v)(1)(I) of the Social Security Act, as amended, the Parties will allow the U.S. Department of Health and Human Services, the U.S. Comptroller General and their duly authorized representatives, access to this Agreement and all books, documents and records necessary to certify the nature and extent of costs incurred pursuant to it during the Term and for four (4) years following the last date any EPOGEN or services are furnished under it. If Amgen carries out the duties of this Agreement through a subcontract worth $10,000 or more over a 12-month period with a related organization, the subcontract shall also contain an access clause to |
Page 33 of 123
permit access by the U.S. Department of Health and Human Services, the U.S. Comptroller General, and their duly authorized representatives to the related organizations books and records. |
11.18. | Amgens ESA Risk Evaluation and Mitigation Strategy Program. Dialysis Center and its Designated Affiliates and Managed Centers shall reasonably cooperate and comply with Amgen in Amgens implementation of its ESA Risk Evaluation and Mitigation Strategy program as found at the FDA website: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM200105.pdf (the FDA Website) and which may be modified from time to time by the FDA (the Amgen ESA Risk Evaluation Program). Dialysis Center shall refer to the FDA Website for updates to the Amgen ESA Risk Evaluation Program. |
11.19. | Recall. In the event the FDA initiates a mandatory recall or Amgen initiates a recall, field market withdrawal, stock recovery, or other similar action with respect to EPOGEN (a Recall), the Dialysis Center Purchasers shall cooperate with Amgen in implementing the Recall consistent with applicable Law, any industry guidance issued by the FDA, and the terms or procedures of the Recall, including reasonable cooperation with any Amgen designated Third Party vendors. |
11.20. | Assumption of Risk. Each Party expressly accepts and assumes all risks that may arise out of or result from uncertainties or changes to the dialysis market including those resulting from the introduction of Alternative ESAs (including [DELETED]), including the timing of such introduction(s), the pricing of such Alternative ESAs and their potential physician acceptance and impact on prescribing practices. |
Page 34 of 123
The Parties have executed this Agreement by their designated representatives set forth below.
AMGEN USA INC. | DIALYSIS CENTER | |||||||
By: | /s/ Anthony C. Hooper |
By: | /s/ Dennis Kogod | |||||
Name (print): | Anthony C. Hooper |
Name (print): | Dennis Kogod | |||||
Title: | Executive Vice President |
Title: | Chief Operating Officer | |||||
Date: | November 15, 2011 |
Date: | November 15, 2011 |
Amgen Inc. with respect to certain provisions of this Agreement as set forth herein.
Amgen Inc. | ||
By: | /s/ Anthony C. Hooper | |
Name (print): | Anthony C. Hooper | |
Title: | Executive Vice President | |
Date: | November 15, 2011 |
Page 35 of 123
Exhibit A
Discount Terms and Conditions
1 | DEFINITIONS. In addition to the defined terms set forth in Section 1 of this Agreement, the following terms, as used in this Exhibit A, shall have the meaning ascribed below. |
[DELETED] Rebate Definitions
1.1 | Amgen Dialysis Contract shall mean, as of any determination date, a contract between Amgen or one of its Affiliates and a Qualified Customer in effect as of such date that provides for such Qualified Customer to purchase EPOGEN for its commercial use in providing Dialysis Services in the Territory. |
1.2 | Qualified Customer shall mean a Third Party commercial enterprise collectively with all of its Affiliates and/or any dialysis facility in which a Third Party commercial enterprise and/or any of its Affiliates has an ownership interest of less than fifty percent (50%) but for which the Third Party commercial enterprise and/or any of its Affiliates provides management services or administrative services in which it controls the selection or procurement of ESAs (a) who has entered into an Amgen Dialysis Contract and (b) who is not exempt from consideration in the calculation of Best Price as defined by the Social Security Act at section 1927(c)(1)(C), as amended, and as implemented by regulation (e.g., any hospital participating in 340B Drug Pricing Program, any qualified state pharmaceutical assistance program, or any purchaser under the Federal Supply Schedule would not be a Qualified Customer for purposes of this Agreement). |
1.3 | [DELETED] shall mean for each [DELETED] of EPOGEN purchased by a Qualified Customer in any Quarter under an Amgen Dialysis Contract, the [DELETED] in effect on the date of purchase [DELETED] all of the discounts and rebates per [DELETED] of EPOGEN that, for such Quarter were actually earned by such Qualified Customer pursuant to the terms of such Amgen Dialysis Contract (regardless of the actual Quarter in which such discounts or rebates are actually paid to such Qualified Customer); provided, that if any such discounts and rebates once paid are subsequently returned, revised or withdrawn, including pursuant to any retroactive amendment of the Amgen Dialysis Contract or payment settlement (whether in such Quarter or any subsequent Quarter), the applicable [DELETED] shall be based on the discounts, rebates and chargebacks taking into full account such returns, revisions or withdrawals. |
[DELETED] Rebate Definitions
1.4 | [DELETED] Rebate shall mean the rebate described in Section 3.3 of this Exhibit A. |
Page 36 of 123
1.5 | [DELETED] Percentage shall mean, at any date of determination, an amount equal to |
((A B) if > 0)
C
Where
A equals [DELETED]
B equals [DELETED]
C equals [DELETED] in effect at the time of purchase
For example, a determination of [DELETED] Rebate Percentage would be as follows:
[DELETED] Rebate Percentage Illustration:
(([DELETED] - [DELETED]) if greater than zero)
÷
[DELETED] in effect at the time of purchase
1.6 | [DELETED] shall mean a trial comparing the [DELETED] of patients receiving EPOGEN and the [DELETED] in connection with the provision of Dialysis Services. |
1.7 | [DELETED] Price shall mean the [DELETED] of the [DELETED] for the applicable Quarter as reported by the Centers for Medicare & Medicaid Services as mandated by the Patient Protection and Affordable Care Act, as amended and reconciled by the Healthcare and Education Reconciliation Act and implementing regulations and as adjusted to take into account the [DELETED] agreed to by the Parties or the results of the [DELETED], as applicable. |
1.8 | [DELETED] shall mean a [DELETED] product that has been approved by the FDA both as a [DELETED] and as [DELETED]. [DELETED] shall have the meanings ascribed to such terms in the Public Health Service Act (Title 42 U.S. Code, Chapter 6A), as such terms may be further defined by the FDA. |
Page 37 of 123
1.9 | [DELETED] shall mean for each [DELETED] of EPOGEN purchased by a Dialysis Center Purchaser under this Agreement in any Quarter, the [DELETED] in effect on the date of purchase less for such Quarter (i) the Discounts that Dialysis Center is eligible to earn under this Agreement during the applicable Quarter, including the [DELETED] Rebate, the [DELETED] Rebate, and the [DELETED] Rebate, as applicable, and (ii) any other discount, rebate or other price adjustment received by a Dialysis Center Purchaser per [DELETED] of EPOGEN which is included in the Best Price reported in Amgens Best Price Submission under Title XIX of the Social Security Act in respect of such EPOGEN purchase. |
1.10 | [DELETED] shall mean, for any Quarter in which the [DELETED] Rebate is applied, an amount equal to |
(A * B) + A
Where
A equals the [DELETED] Price during such Quarter
B equals [DELETED]%
For example, a determination of [DELETED] would be as follows:
[DELETED] Illustration:
([DELETED] Price * [DELETED]%) + [DELETED] Price
Dialysis Share of Sales Definitions
1.11 | Dialysis Market [DELETED] Purchases of [DELETED] means, for any period, the aggregate [DELETED] paid for purchases of [DELETED] by all purchasers, including those by all Dialysis Center Purchasers, during such period for use in providing Dialysis Services, from any source measured using the prevailing [DELETED] as set by the product manufacturer in effect at the time of purchase to be determined by Amgen based on DDD data provided by IMS or if IMS DDD data is unavailable, by reliable alternative means to be determined by Amgen in Amgens reasonable discretion, subject to verification by Amgen. |
1.12 | Dialysis Share of Sales shall mean Dialysis Center Qualified [DELETED] Purchases [DELETED] during the Quarter divided by Dialysis Market [DELETED] Purchases of [DELETED] during the Quarter. |
Dialysis Share of Sales Illustration:
Dialysis Center Qualified [DELETED] Purchases of [DELETED]
÷
Dialysis Market [DELETED] Purchases of [DELETED]
1.13 | Dialysis Share of Sales Requirement shall mean, for any Quarter, that Dialysis Center had an aggregate Dialysis Share of Sales for any such Quarter and the immediately preceding Quarter that was equal to or greater than [DELETED] percent ([DELETED]%) in the aggregate for such two (2) Quarter period. It is not the intent of the Parties that a [DELETED] of any Alternative ESA (on a [DELETED] equivalent basis) that is significantly higher than the [DELETED] for EPOGEN should negatively |
Page 38 of 123
affect Dialysis Centers attainment of the Dialysis Share of Sales Requirement. If at any time during a Quarter, an Alternative ESA is introduced with respect to the provision of Dialysis Services which has a [DELETED] for such Alternative ESA to [DELETED] as established by the manufacturer of such Alternative ESA that potentially is significantly greater than (on a [DELETED] equivalent basis) the [DELETED] for EPOGEN (a [DELETED] Event), Dialysis Center shall deliver a written notice to Amgen indicating that there has been a [DELETED] Event (a [DELETED] Event Notice). Within thirty (30) days after Amgens receipt of a [DELETED] Event Notice, the Parties shall meet and discuss in good faith any necessary changes, amendments, and/or adjustments to the calculation of the Dialysis Share of Sales Requirement to account for the impact of such [DELETED] Event on the Parties. |
1.14 | Dialysis Center Qualified [DELETED] Purchases of [DELETED] means, for any period, the aggregate [DELETED] paid for purchases of [DELETED] by all Dialysis Center Purchasers during such period for use in providing Dialysis Services, from any source measured using the prevailing [DELETED] as set by the product manufacturer in effect at the time of purchase to be determined by Amgen based on the DDD data provided by IMS or if IMS DDD data is unavailable, by reliable alternative means to be determined by Amgen in Amgens sole discretion, subject to verification by Amgen. |
1.15 | [DELETED] Event has the meaning set forth in Section 1.13 of this Exhibit A. |
1.16 | [DELETED] Event Notice has the meaning set forth in Section 1.13 of this Exhibit A. |
[DELETED] Share of Sales Definitions
1.17 | Dialysis Market [DELETED] Purchases of [DELETED] for [DELETED] Rebate means, for any period, the aggregate [DELETED] paid for purchases of [DELETED] by all purchasers, but excluding all Dialysis Center Purchasers, during such period for use in providing Dialysis Services, from any source measured using the prevailing [DELETED] as set by the product manufacturer in effect at the time of purchase to be determined by Amgen based on data provided by a third-party reporting agency or if third-party reporting agency data is unavailable, by reliable alternative means to be determined by Amgen in Amgens sole reasonable discretion, subject to verification by the Parties. |
1.18 | [DELETED] Share of Sales shall mean Qualified [DELETED] Purchases of the [DELETED] during the Quarter divided by Dialysis Market [DELETED] Purchases of [DELETED] for [DELETED] Rebate during the Quarter. |
[DELETED] Share of Sales Illustration:
Qualified [DELETED] Purchases of [DELETED]
÷
Dialysis Market [DELETED] Purchases of [DELETED] for [DELETED] Rebate
1.19 | Qualified [DELETED] Purchases of [DELETED] means, for any period the aggregate [DELETED] paid for purchases of the applicable [DELETED] by all purchasers, but excluding all Dialysis Center Purchasers, during such period for use in providing Dialysis Services, from any source measured using the prevailing [DELETED] as set by the product manufacturer in effect at the time of purchase to be |
Page 39 of 123
determined by Amgen based on data provided by a third-party reporting agency or if third-party reporting agency data is unavailable, by some alternative means to be determined by Amgen in Amgens sole discretion, subject to verification by Amgen. |
[DELETED] Rebate Definitions
1.20 | [DELETED] shall mean the applicable [DELETED] per [DELETED] of EPOGEN as set forth in the [DELETED] Table below. |
[DELETED] Table
Calendar Year |
[DELETED] | |
2012 |
$[DELETED] | |
2013 |
$[DELETED] | |
2014 |
$[DELETED] | |
2015 |
$[DELETED] | |
2016 |
$[DELETED] | |
2017 |
$[DELETED] | |
2018 |
$[DELETED] |
1.21 | [DELETED] Rebate Percentage shall mean, at any date of determination, an amount equal to |
((A B) if > 0)
C
Where
A equals [DELETED]
B equals [DELETED]
C equals [DELETED] in effect at the time of purchase
For example, a determination of the [DELETED] Rebate Percentage would be as follows:
[DELETED] Rebate Percentage Illustration:
(([DELETED] - [DELETED]) if greater than zero)
÷
[DELETED] in effect at the time of purchase
[DELETED] Incentive Definitions
1.22 | [DELETED] shall mean the [DELETED] incentive described in Section 3.5 of this Exhibit A. |
1.23 | Other. The Parties acknowledge and agree that (i) the aggregate [DELETED] paid for purchases of [DELETED] by all purchasers for use in providing Dialysis Services in the Territory include purchases by [DELETED] as well as other purchasers of ESAs for use in providing Dialysis Services, (ii) there may not be commercially available data comprising purchases of ESAs by all purchasers for use in providing Dialysis Services |
Page 40 of 123
in the Territory that Dialysis Center could access in order to understand and track the Dialysis Share of Sales on an ongoing basis, (iii) there is commercially available data comprising purchases of ESAs by [DELETED] in the Territory that Dialysis Center could access, (iv) the [DELETED] purchases of ESAs by [DELETED] in the Territory currently represents approximately [DELETED] percent ([DELETED]%) of [DELETED] purchases of ESAs by all purchases for use in providing Dialysis Services in the Territory, (v) for the sole and limited purpose of determining whether Dialysis Center shall have met the Dialysis Share of Sales requirement under Sections 3.2.1 and 3.4.1 of this Exhibit A, the aggregate [DELETED] paid for purchases of [DELETED] by all purchasers for use in providing Dialysis Services in the Territory shall be calculated as [DELETED] percent ([DELETED] %) of the aggregate [DELETED] purchases of ESAs by [DELETED] in the Territory and (vi) for the sole and limited purpose of determining whether the [DELETED] Share of Sales requirement under Section 3.3.1 and Section 3.3.2 of this Exhibit A has been met, (a) the aggregate [DELETED] paid for purchases of [DELETED] by all purchasers, but excluding all Dialysis Center Purchasers, for use in providing Dialysis Services in the Territory shall be calculated as [DELETED] percent ([DELETED] %) of the aggregate [DELETED] purchases of ESAs by [DELETED], but excluding all Dialysis Center Purchasers, in the Territory and (b) the aggregate [DELETED] paid for purchases of the applicable [DELETED] by all purchasers, but excluding all Dialysis Center Purchasers, for use in providing Dialysis Services in the Territory shall be calculated as [DELETED] percent ([DELETED]%) of the aggregate [DELETED] purchases of the applicable [DELETED] by [DELETED], but excluding all Dialysis Center Purchasers, in the Territory. |
2 | PRODUCT INVOICE DISCOUNTS |
2.1 | Base Invoice Discounts. Subject to the terms and conditions contained in the Agreement, Dialysis Center Purchasers shall be entitled to the Base Invoice Discount set forth in the following Base Invoice Discount Table, applied to [DELETED] in effect at the time of purchase of EPOGEN by Dialysis Center Purchasers under the Agreement, exclusive of any wholesaler markup, discount, service fees or other charges: |
Base Invoice Discount Table
|
||||||
PRODUCT |
NDC | INVOICE DISCOUNT | ||||
EPOGEN |
All NDCs | [DELETED | ]% |
3 | PRODUCT REBATES |
3.1 | Base Rate Rebate. Dialysis Center shall earn a non-performance Base Rate Rebate for each Quarter during the Term in the manner described below in this Section 3.1. |
3.1.1 | Base Rate Rebate Calculation. Amgen shall calculate the amount of Dialysis Centers Base Rate Rebate by multiplying Dialysis Centers Qualified Gross Purchases of EPOGEN during a Quarter by the applicable Base Rate Rebate Percentage for the calendar year in which such Quarter occurs, according to the Base Rate Rebate Percentage Table below. |
Page 41 of 123
Base Rate Rebate Percentage Table
|
||||
Calendar Year |
Base Rate Rebate Percentage | |||
2012 |
[DELETED | ]% | ||
2013 |
[DELETED | ]% | ||
2014 |
[DELETED | ]% | ||
2015 |
[DELETED | ]% | ||
2016 |
[DELETED | ]% | ||
2017 |
[DELETED | ]% | ||
2018 |
[DELETED | ]% |
3.1.2 | Payment of Base Rate Rebate. Amgen will pay the Base Rate Rebate within [DELETED] days after the end of the corresponding Quarter, provided Amgen is in receipt of all Relevant Information in a form acceptable to Amgen. |
3.1.3 | Vesting of Base Rate Rebate. The Base Rate Rebate for a given Quarter shall vest on the last day of such Quarter. |
3.2 | [DELETED] Rebate. Dialysis Center shall earn the [DELETED] Rebate, if any, for each Quarter during the Term provided it meets the requirements described below in this Section 3.2. |
3.2.1 | Eligibility for [DELETED] Rebate. Dialysis Center shall be eligible to receive the [DELETED] Rebate for any Quarter during the Term if each of the following shall have occurred in such Quarter: (a) Dialysis Center shall have met the Dialysis Share of Sales Requirement, (b) any Qualified Customer received a [DELETED] under an Amgen Dialysis Contract that is lower than the [DELETED] and (c) either (i) the aggregate net sales for all EPOGEN purchased by any such Qualified Customer who received a [DELETED] under an Amgen Dialysis Contract that is lower than the [DELETED] during such Quarter were greater than [DELETED] percent ([DELETED]%) of the aggregate net sales of EPOGEN to all purchasers in the Territory in such Quarter or (ii) the aggregate net sales for all EPOGEN purchased during such Quarter by all Qualified Customers in the aggregate who received a [DELETED] under an Amgen Dialysis Contract that is lower than the [DELETED] were greater than [DELETED] percent ([DELETED]%) of the aggregate net sales of EPOGEN to all purchasers in the Territory in such Quarter. Amgens calculation of the [DELETED] Rebate shall not take into account any reallocation of discounts for purposes of any reports filed under Title XVIII or Title XIX of the Social Security Act, under any health care program of a Governmental Authority or pursuant to any other Law. |
Page 42 of 123
3.2.2 | Calculation of [DELETED] Rebate. Amgen shall calculate the amount of Dialysis Centers [DELETED] Rebate for any Quarter by taking the total of the [DELETED] minus the [DELETED], multiplied by the number of [DELETED] of EPOGEN purchased by all Dialysis Center Purchasers at a [DELETED] during such Quarter. |
[DELETED] Rebate Illustration:
([DELETED] [DELETED])
x
Number of [DELETED] of EPOGEN purchased at [DELETED]
3.2.3 | Payment of [DELETED] Rebate Amount. Amgen will pay the [DELETED] Rebate within [DELETED] days after the end of the corresponding Quarter, provided Amgen is in receipt of all Relevant Information in a form acceptable to Amgen. |
3.2.4 | Vesting of [DELETED] Rebate. The [DELETED] Rebate for a given Quarter shall vest on the last day of such Quarter. |
3.3 | [DELETED] Rebate. Dialysis Center shall earn a [DELETED] Rebate for each Quarter during the Term in the manner described below in this Section 3.3. |
3.3.1 | Trigger Event for [DELETED] Rebate. In the event that an [DELETED] had an [DELETED] Share of Sales of greater than [DELETED] percent ([DELETED]%) for [DELETED] consecutive Quarters during the Term, the Parties shall work together in good faith to determine a [DELETED] between the [DELETED] and EPOGEN. In the event the Parties are not able to determine a mutually agreed upon [DELETED] between the [DELETED] and EPOGEN within thirty (30) days of the end of the applicable Quarter at which the [DELETED] Rebate is at issue or such longer period of time as mutually agreed to by the Parties, the Parties shall work together in good faith to undertake a [DELETED], which [DELETED] shall be jointly funded by the Parties. If the Parties fail to agree on a design for the [DELETED], the Parties shall jointly appoint a mutually agreeable Third Party to design and undertake the [DELETED]. |
3.3.2 | Qualification Criteria. If for a Quarter during the Term, an [DELETED] had an [DELETED] Share of Sales of greater than [DELETED] percent ([DELETED]%) for such Quarter and the immediately prior Quarter, then Dialysis Center shall be entitled to the [DELETED] Rebate for such Quarter, as calculated in Section 3.3.3 below. |
3.3.3 | [DELETED] Rebate Calculation. Amgen shall calculate the amount of Dialysis Centers [DELETED] Rebate by multiplying the Qualified Gross Purchases of EPOGEN during the applicable Quarters by the applicable [DELETED] Rebate Percentage for such applicable Quarters. |
3.3.4 | Payment of [DELETED] Rebate. Amgen will pay the [DELETED] Rebate within [DELETED] days after the end of the corresponding Quarter, provided Amgen is in receipt of all Relevant Information in a form acceptable to Amgen and provided further, that in the event a final [DELETED] for the applicable [DELETED] has not been determined hereunder within thirty (30) days after the end of the applicable Quarter pursuant to Section 3.3.1 of this Exhibit A, such [DELETED] Rebate will be paid within [DELETED] days after the end of the Quarter in which a final [DELETED] for the applicable [DELETED] has been determined. |
Page 43 of 123
3.3.5 | Vesting of [DELETED] Rebate. The [DELETED] Rebate for a given Quarter shall vest on the last day of such Quarter. |
3.4 | [DELETED] Rebate. Dialysis Center shall earn the [DELETED] Rebate for each Quarter during the Term in the manner described below in this Section 3.4 |
3.4.1 | Qualification Criteria. If, for any Quarter during the Term, the [DELETED] exceeds the [DELETED] ([DELETED] Trigger Event), then Dialysis Center Purchasers shall be entitled to the [DELETED] Rebate as calculated in Section 3.4.2 below, provided that the Dialysis Share of Sales Requirement is met during such Quarter. Such [DELETED] Rebate shall apply to all purchases of EPOGEN by Dialysis Center Purchasers during such Quarter from the date of the [DELETED] Trigger Event until the date (if any) at which the [DELETED] is equal to or greater than the [DELETED]. |
3.4.2 | Calculation of [DELETED] Rebate. Amgen shall calculate the amount of Dialysis Centers [DELETED] Rebate by multiplying the Qualified Gross Purchases of EPOGEN during the applicable Quarter by the [DELETED] Rebate Percentage for such Quarter; provided, however, that in the event of an increase of [DELETED] other than on the first day of a calendar year, then the [DELETED] Rebate shall be reduced by an amount equal to the Qualified Gross Purchases of EPOGEN during such calendar year prior to the increase in [DELETED] multiplied by the [DELETED] minus the [DELETED]. |
3.4.3 | Payment of [DELETED] Rebate. Amgen will pay such [DELETED] Rebate within [DELETED] days after the end of the corresponding Quarter, provided Amgen is in receipt of all Relevant Information in a form reasonably acceptable to Amgen. |
3.4.4 | Vesting of [DELETED] Rebate. The [DELETED] Rebate for a given Quarter shall vest on the last day of such Quarter. |
3.5 | [DELETED] Incentive. Dialysis Center shall earn the [DELETED] for each Quarter during the Term provided all Dialysis Center Purchasers provide to Amgen the Data set forth in Schedule 1 and provided Dialysis Center meets the requirements described below in this Section 3.5. |
3.5.1 | Submission of Data Requirement. Subject to the validity of a Certification as described in Section 5 of this Agreement, Dialysis Center Purchasers must provide to Amgen the Data in a machine readable format acceptable to Amgen (Excel; or text file that is tab delimited, comma delimited, colon delimited or space delimited including a line of column headers identifying the column contents and [DELETED], if applicable). The Data files shall contain record counts for each file contained in the data submission; provided, however, that Dialysis Center shall be required to submit such test results only for those dialysis patients whose test results are actually determined by laboratories owned and operated by Dialysis Center. |
3.5.2 | Calculation of [DELETED]. Provided Dialysis Center has fulfilled all requirements described in this Section 3.5 of this Exhibit A, Dialysis Center shall be eligible to receive a [DELETED] percent ([DELETED]%) [DELETED] payment. The [DELETED] will be calculated as a percentage of the Qualified Gross Purchases of EPOGEN during each Quarter. |
3.5.3 | Payment of [DELETED]. The Data must be submitted, on a calendar monthly basis by the last day of the following calendar month (or the next business day if such last day is not a business day). If the Data is received after such timeframe for any month within a given Quarter, the total Qualified Gross Purchases of EPOGEN during such month will be excluded from the calculation of the [DELETED] for that Quarter. Notwithstanding the |
Page 44 of 123
foregoing, if Amgen receives all required Data from a minimum of [DELETED] percent ([DELETED]%) of all Dialysis Center Purchasers within the time frame referenced above for any calendar month within a given Quarter, the total Qualified Gross Purchases of EPOGEN during such calendar month, will be included in the calculation of the [DELETED] for that Quarter; provided that for purposes of clarity, the [DELETED] percent ([DELETED]%) will not include Dialysis Center Purchasers that are acute facilities. Failure of Dialysis Center to qualify under this Section 3.5 of this Exhibit A during a particular Quarter shall not affect Dialysis Centers eligibility to qualify during any other Quarter, nor shall Dialysis Centers qualification during a particular Quarter automatically result in qualification during any other Quarter. If Amgen receives all required Data from less than [DELETED] percent ([DELETED]%) of Dialysis Center Purchasers for any calendar month within a given Quarter, no Qualified Gross Purchases of EPOGEN during such calendar month will be included in the calculation of the [DELETED] for that Quarter; provided, however, that if such [DELETED] percent ([DELETED]%) threshold is not met in any month due to the inclusion of de novo facilities that have not yet treated patients and/or inactive facilities, Amgen shall exclude any such facilities identified by Amgen and Dialysis Center from such month when calculating Dialysis Centers eligibility for the [DELETED] at the end of each Quarter. However, if Amgen determines that any Dialysis Center Purchaser is consistently not submitting the required Data, Amgen and Dialysis Center will work collaboratively in resolving such inconsistencies. Amgen will use commercially reasonable efforts to notify Dialysis Center in writing, no later than fifteen (15) business days after the receipt and acceptance by Amgen of the Data of the identity of all Dialysis Center Purchasers, if any, which have failed to meet the Data submission requirements for that month. Amgen reserves the right, in its sole discretion, to exclude any Qualified Gross Purchases of EPOGEN of any Dialysis Center Purchaser that is consistently non-reporting from the calculation of the [DELETED] for any relevant Quarter. Amgen will pay such [DELETED] within [DELETED] days after the end of the corresponding Quarter provided Amgen is in receipt of all Data in the form and in the time period described in Section 3.5.1 and this Section 3.5.3 of this Exhibit A. If the failure of Dialysis Center to deliver any of the Data is a result of a Certification not being valid due to Amgens failure to satisfy any conditions, requirements or assumptions set forth in such Certification applicable to Amgen, then the [DELETED] shall still be available to Dialysis Center and payable by Amgen, in which case Dialysis Center shall deliver the Data to Amgen as soon as the Certification becomes valid. Upon a valid Certification being issued, Dialysis Center shall submit to Amgen all Data dating back to the date Dialysis Center stopped submitting the Data to Amgen within thirty (30) days. |
3.5.4 | Vesting of [DELETED]. The [DELETED] for a given Quarter shall vest on the last day of such Quarter. |
Page 45 of 123
4 | SUMMARY OF DISCOUNTS |
Provided Dialysis Center has fulfilled all Discount requirements, the total discount opportunity is as set forth in the Summary of Discounts Table below.
Summary of Discounts Table
|
||||||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | ||||||||||||||||||||||
Base Invoice Discount |
[DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | ||||||||||||||
Base Rate Rebate |
[DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | ||||||||||||||
[DELETED] Rebate |
[DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | ||||||||||||||
Total Discount Opportunity |
[DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% | [DELETED | ]% |
Page 46 of 123
Exhibit B
Authorized Wholesalers
The below represents a list of wholesalers authorized for participation under the attached Agreement. Any changes must be made in accordance with Section 2.7 of the Agreement. Only purchases from wholesalers set forth on this List (as may be modified pursuant to such Section 2.7) shall be eligible for the discounts and fees set forth in the Agreement. Notice(s) regarding pricing and membership alignment for the Agreement shall be sent to the wholesalers that Dialysis Center has designated for such notification below. In the absence of any such designation, Amgen shall send pricing and membership alignment notices for the Agreement to those Authorized Wholesalers as designated by Dialysis Center in its previously executed Agreement.
|
American Medical Distributors, Div. of AmerisourceBergen Corporation | |
|
American Medical Services, Div. of Henry Schein, Inc. | |
|
AmerisourceBergen Corporation | |
|
ASD Healthcare, Div. of AmerisourceBergen Specialty Group | |
|
Bellco Drug Corporation, Div of AmerisourceBergen Corporation | |
|
Besse Medical Supply, Div. of AmerisourceBergen Specialty Group | |
|
Borschow Hospital and Medical Supplies, Inc., Div of Cardinal Health, Inc. | |
|
Cardinal Health Inc. | |
|
Cesar Castillo, Inc. | |
|
CuraScript Specialty Distribution (Priority Healthcare Distribution) | |
|
Dakota Drug Inc. | |
|
Dik Drug Company | |
|
DMS Pharmaceutical Group Inc. | |
|
Drogueria Central, Inc. | |
|
Florida Infusion Services, Inc. | |
|
Frank W. Kerr Company | |
|
General Injectables & Vaccines, Div. of Henry Schein, Inc. | |
|
HD Smith Wholesale Drug Company | |
|
Henry Schein, Inc. | |
|
J.M. Blanco, Div of AmerisourceBergen Corporation | |
|
Kinray, Inc. | |
|
McKesson Corporation | |
|
McKesson Medical-Surgical Maine Inc., Div. of McKesson Medical-Surgical | |
|
McKesson Medical-Surgical Minnesota Supply Inc., Div. of McKesson Medical | |
Surgical | ||
|
McKesson Medical-Surgical, Div. of McKesson Corporation | |
|
McKesson Specialty Care Distribution Corporation, Div. of McKesson Corporation | |
|
Metro Medical Supply Inc. | |
|
Morris & Dickson Company LLC | |
|
N.C. Mutual Wholesale Drug Company | |
|
Oncology Supply, Div. of AmerisourceBergen Specialty Group | |
|
Rochester Drug Corporation (RDC) | |
|
Smith Drug Company | |
|
Value Drug Company |
Page 47 of 123
Exhibit C
Designated Affiliates List
Page 48 of 123
Exhibit C
Designated Affiliates List
Active |
TYPE |
CTR # |
CENTER NAME |
LEGAL NAME |
ADDRESS |
ADDRESS |
CITY |
STATE |
ZIP | |||||||||
1 |
Affiliated | 398 | Los Angeles Dialysis Center | Los Angeles Dialysis Center (LADC) | 3901 S WESTERN AVE | LOS ANGELES | CA | 90062-1112 | ||||||||||
2 |
Affiliated | 613 | Garfield | Garfield Hemodialysis Center | 118 HILLIARD AVE | MONTEREY PARK | CA | 91754-1118 | ||||||||||
3 |
Affiliated | 614 | Lynwood | Kidney Dialysis Care Unit (Lynwood) | 3600 E MARTIN LUTHER KING JR BLVD | LYNWOOD | CA | 90262-2607 | ||||||||||
4 |
Affiliated | 615 | Lakewood Dialysis-CA | Lakewood Dialysis-CA | 4611 SILVA ST | LAKEWOOD | CA | 90712-2512 | ||||||||||
5 |
Affiliated | 616 | Valley Dialysis | Valley Dialysis | 16149 HART ST | VAN NUYS | CA | 91406-3906 | ||||||||||
6 |
Affiliated | 617 | Downey Dialysis | Downey Dialysis | 8630 FLORENCE AVE | STE 1 | DOWNEY | CA | 90240-4017 | |||||||||
7 |
Affiliated | 618 | Covina Dialysis | Covina Dialysis | 1547 W GARVEY AVE N | WEST COVINA | CA | 91790-2139 | ||||||||||
8 |
Affiliated | 625 | Four Corners Farmington | Four Corners Farmington | 801 W BROADWAY | FARMINGTON | NM | 87401-5650 | ||||||||||
9 |
Affiliated | 626 | Tuba City Dialysis | Tuba City Dialysis | 500 EDGEWATER DR | PO BOX 291 | TUBA CITY | AZ | 86045-2905 | |||||||||
10 |
Affiliated | 627 | Camelback Dialysis Center | Camelback Dialysis Center (fka Scottsdale Dialysis Center) | 7321 E OSBORN DR | SCOTTSDALE | AZ | 85251-6418 | ||||||||||
11 |
Affiliated | 630 | Westbank | Westbank Chronic Renal Center | 3631 BEHRMAN PLACE | NEW ORLEANS | LA | 70114 | ||||||||||
12 |
Affiliated | 632 | Fleur de Lis | Fleur de Lis Dialysis (fka Tri-Parish) | 5555 BULLARD AVE | NEW ORLEANS | LA | 70128-3450 | ||||||||||
13 |
Affiliated | 637 | Desert Mountain | Desert Mountain Dialysis | 9220 E MOUNTAIN VIEW RD | STE 15 | SCOTTSDALE | AZ | 85258-5134 | |||||||||
14 |
Affiliated | 638 | Chinle | Chinle Dialysis | US HWY 191 | PO BOX 879 | CHINLE | AZ | 86503-0879 | |||||||||
15 |
Affiliated | 648 | Central City | Central City Dialysis Center | 1300 MURCHISON DR | STE 32 | EL PASO | TX | 79902-4840 | |||||||||
16 |
Affiliated | 651 | Federal Way | Federal Way Community Dialysis Center | 1015 S 348TH ST | FEDERAL WAY | WA | 98003-7078 | ||||||||||
17 |
Affiliated | 663 | Beverly Hills | Beverly Hills Dialysis Center | 50 N LA CIENEGA BLVD | 3RD FLOOR, STE 3 | BEVERLY HILLS | CA | 90211-2205 | |||||||||
18 |
Affiliated | 667 | Walnut Creek | Walnut Creek Dialysis Center | 404 N WIGET LN | WALNUT CREEK | CA | 94598-2408 | ||||||||||
19 |
Affiliated | 672 | Norwalk | Norwalk Dialysis Center | 12375 E IMPERIAL HWY | STE D3 | NORWALK | CA | 90650-3129 | |||||||||
20 |
Affiliated | 673 | El Monte | Greater El Monte Dialysis Center | 1938 TYLER AVE | STE J-168 | SOUTH EL MONTE | CA | 91733-3623 | |||||||||
21 |
Affiliated | 676 | Bayonet Point | Bayonet Point-Hudson Kidney | 14144 NEPHRON LN | HUDSON | FL | 34667-6504 | ||||||||||
22 |
Affiliated | 677 | New Port Richey | New Port Richey Kidney Center | 7421 RIDGE RD | PORT RICHEY | FL | 34668-6933 | ||||||||||
23 |
Affiliated | 678 | Hernando | Hernando Kidney Center, Inc | 2985 LANDOVER BLVD | SPRING HILL | FL | 34608-7258 | ||||||||||
24 |
Affiliated | 681 | Woodbridge | CDC Of Woodbridge | 2751 KILLARNEY DR | WOODBRIDGE | VA | 22192-4119 | ||||||||||
25 |
Affiliated | 682 | Manassas | CDC-Manassas Dialysis | 10655 LOMOND DR | STE 11 | MANASSAS | VA | 20109-2877 | |||||||||
26 |
Affiliated | 683 | Springfield | CDC-Springfield Dialysis | 8350 TRAFORD LN | STE A | SPRINGFIELD | VA | 22152-1671 | |||||||||
27 |
Affiliated | 684 | Sterling | CDC-Sterling | 46396 BENEDICT DR | STE 1 | STERLING | VA | 20164-6626 | |||||||||
28 |
Affiliated | 687 | Alexandria | Springfield-Alexandria | 5999 STEVENSON AVE | STE 1 | ALEXANDRIA | VA | 22304-3302 | |||||||||
29 |
Affiliated | 642 | Statesboro | Nephrology Center of Statesboro fka Statesboro Dialysis | 4B COLLEGE PLZ | STATESBORO | GA | 30458-4928 | ||||||||||
30 |
Affiliated | 643 | Vidalia | Nephrology Center of Vidalia | 1806 EDWINA DR | VIDALIA | GA | 30474-8927 | ||||||||||
31 |
Affiliated | 657 | Papago Dialysis | Papago Dialysis Center (fka PD Central & Squaw Peak) | 1401 N 24TH ST | STE 2 | PHOENIX | AZ | 85008-4638 | |||||||||
32 |
Affiliated | 658 | Boca Raton | Boca Raton Artificial Kidney Center | 998 NW 9TH CT | BOCA RATON | FL | 33486-2214 | ||||||||||
33 |
Affiliated | 644 | Piedmont | Buckhead Dialysis | 1575 NORTHSIDE DR NW | STE 365 | ATLANTA | GA | 30318-4210 | |||||||||
34 |
Affiliated | 311 | Logan Square | Logan Square Dialysis Services | 2659 N MILWAUKEE AVE | 1ST FL | CHICAGO | IL | 60647-1643 | |||||||||
35 |
Affiliated | 312 | Lake County | Lake County Dialysis Services | 918 S MILWAUKEE AVE | LIBERTYVILLE | IL | 60048-3229 | ||||||||||
36 |
Affiliated | 314 | Lincoln Park | Lincoln Park Dialysis fka Lincoln Park Nephrology | 3157 N LINCOLN AVE | CHICAGO | IL | 60657-3111 | ||||||||||
37 |
Affiliated | 318 | Lincoln Pk-PD | Skyline Home Dialysis (fka Lincoln Park PD) | 7009 W BELMONT AVE | CHICAGO | IL | 60634-4533 | ||||||||||
38 |
Affiliated | 670 | West Palm Beach | Dialysis Associates of the Palm Beaches | 2611 POINSETTIA AVE | WEST PALM BEACH | FL | 33407-5919 | ||||||||||
39 |
Affiliated | 693 | Sunrise | Sunrise Dialysis Center | 13039 HAWTHORNE BLVD | HAWTHORNE | CA | 90250-4415 | ||||||||||
40 |
Affiliated | 655 | Kayenta | Kayenta Dialysis | PO BOX 217 | US HWY 163 N | KAYENTA | AZ | 86033-0217 | |||||||||
41 |
Affiliated | 321 | Hyde Park | Emerald Dialysis (fka Hyde Park Kidney Center) | 710 W 43RD ST | CHICAGO | IL | 60609-3435 | ||||||||||
42 |
Affiliated | 322 | Olympia Fields | Olympia Fields Dialysis Center | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2318 | |||||||||
43 |
Affiliated | 351 | CKD | Center for Kidney Disease at North Shore | 1190 NW 95TH ST | STE 28 | MIAMI | FL | 33150-2065 | |||||||||
44 |
Affiliated | 352 | Venture | Center for Kidney Disease at Venture | 16855 NE 2ND AVE | STE 25 | N MIAMI BEACH | FL | 33162-1744 | |||||||||
45 |
Affiliated | 360 | South Broward | South Broward Artifical Kidney | 4401 HOLLYWOOD BLVD | HOLLYWOOD | FL | 33021-6609 | ||||||||||
46 |
Affiliated | 688 | East End | East End Dialysis Center | 2201 E MAIN ST | STE 1 | RICHMOND | VA | 23223-7071 | |||||||||
47 |
Affiliated | 354 | Flamingo Park | Flamingo Park Kidney Cntr, Inc | 901 E 10TH AVE | BAY 17 | HIALEAH | FL | 33010-3762 | |||||||||
48 |
Affiliated | 355 | Interamerican | InterAmerican Dialysis Center | 7815 CORAL WAY | STE 115 | MIAMI | FL | 33155-6541 | |||||||||
49 |
Affiliated | 356 | Coral Gables Dialysis Center | Coral Gables Kidney Center (fka LeJeune) | 3280 PONCE DE LEON BLVD | CORAL GABLES | FL | 33134-7252 | ||||||||||
50 |
Affiliated | 370 | Cielo Vista Dialysis | DaVita East Dialysis dba Cielo Vista Dialysis (fkaTotal Renal Care East Dialysis Center) | 7200 GATEWAY BLVD E | STE B | EL PASO | TX | 79915-1301 | |||||||||
51 |
Affiliated | 371 | West Texas Dialysis | DaVita West Dialysis Center dba West Texas (fkaTotal Renal Care West Dialysis Center) | 5595 ALAMEDA AVE B | STE B | EL PASO | TX | 79905 | |||||||||
52 |
Affiliated | 656 | Shiprock | Shiprock Dialysis | PO BOX 2156 | US HWY 491 N | SHIPROCK | NM | 87420-2156 | |||||||||
53 |
Affiliated | 202 | Arden Hills | Arden Hills Dialysis Unit | 3900 NORTHWOODS DR | STE 11 | ARDEN HILLS | MN | 55112-6911 | |||||||||
54 |
Affiliated | 203 | Burnsville | Burnsville Dialysis Unit | 501 E NICOLLET BLVD | STE 15 | BURNSVILLE | MN | 55337-6784 | |||||||||
55 |
Affiliated | 204 | Coon Rapids | Coon Rapids Dialysis Unit | 3960 COON RAPIDS BLVD NW | STE 39 | COON RAPIDS | MN | 55433-2598 | |||||||||
56 |
Affiliated | 205 | Edina | Edina Dialysis Unit | 6550 YORK AVE S | STE 1 | EDINA | MN | 55435-2332 | |||||||||
57 |
Affiliated | 206 | Maplewood | Maplewood Dialysis Center | 2785 WHITE BEAR AVE N | STE 21 | MAPLEWOOD | MN | 55109-1320 | |||||||||
58 |
Affiliated | 207 | Minneapolis | Minneapolis Dialysis Unit | 825 S EIGHTH ST | STE SL42 | MINNEAPOLIS | MN | 55404-1208 | |||||||||
59 |
Affiliated | 208 | Minnetonka | Minnetonka Dialysis Unit | 17809 HUTCHINS DR | MINNETONKA | MN | 55345-4100 | ||||||||||
60 |
Affiliated | 209 | St. Paul Dialysis | St. Paul Dialysis Unit | 555 PARK ST | STE 18 | SAINT PAUL | MN | 55103-2192 | |||||||||
61 |
Affiliated | 210 | Special Needs | University Dialysis Unit Riverside (Minneapolis-Special Needs Dialysis) | 1045 WESTGATE DR | STE 9 | SAINT PAUL | MN | 55114-1079 |
Page 49 of 123
62 |
Affiliated | 211 | West St. Paul | West St. Paul Dialysis | 1555 LIVINGSTON AVE | WEST ST PAUL | MN | 55118-3411 | ||||||||||
63 |
Affiliated | 213 | Cass Lake | Cass Lake Dialysis Unit | 602 GRANT UTLEY ST | PO BOX 757 | CASS LAKE | MN | 56633-0757 | |||||||||
64 |
Affiliated | 215 | Faribault | Faribault Dialysis Unit | 201 LYNDALE AVE S | STE F | FARIBAULT | MN | 55021-5758 | |||||||||
65 |
Affiliated | 217 | Marshall | Marshall Dialysis Unit | 300 S BRUCE ST | AVERA MARSHALL REGIONAL MEDICAL CENTER | MARSHALL | MN | 56258-1934 | |||||||||
66 |
Affiliated | 218 | Montevideo | Montevideo Dialysis Center | 824 N 11TH ST | MONTEVIDEO HOSPITAL | MONTEVIDEO | MN | 56265-1629 | |||||||||
67 |
Affiliated | 220 | Pine City | TRC-Pine City (fka-Pine City Dialysis Unit) | 129 6TH AVE SE | LAKESIDE MEDICAL CENTER | PINE CITY | MN | 55063-1913 | |||||||||
68 |
Affiliated | 222 | Red Wing | Red Wing Dialysis Unit | 3028 N SERVICE DR | RED WING | MN | 55066-1921 | ||||||||||
69 |
Affiliated | 223 | Redwood Falls | Redwood Falls Dialysis Center | 100 FALLWOOD RD | REDWOOD FALLS | MN | 56283-1828 | ||||||||||
70 |
Affiliated | 240 | Mitchell | Mitchell Dialysis | 525 N FOSTER | QUEEN OF PEACE HOSPITAL | MITCHELL | SD | 57301-2966 | |||||||||
71 |
Affiliated | 242 | Rosebud | Rosebud Dialysis | 1 SOLDIER CREEK RD | ROSEBUD | SD | 57570-0610 | ||||||||||
72 |
Affiliated | 243 | Sioux Falls | Sioux Falls Dialysis Community Unit | 1325 S CLIFF AVE | STE 46 | SIOUX FALLS | SD | 57105-1016 | |||||||||
73 |
Affiliated | 250 | St. Croix Falls | St. Croix Falls Dialysis | 744 E LOUISIANA ST | SAINT CROIX FALLS | WI | 54024-9501 | ||||||||||
74 |
Affiliated | 260 | Hayward | Hayward Dialysis Center | 21615 HESPERIAN BLVD | STE F | HAYWARD | CA | 94541-7026 | |||||||||
75 |
Affiliated | 262 | Pleasanton | Pleasanton Dialysis Center (HEMO) (fka Dublin) | 5720 STONERIDGE MALL RD | STE 16 | PLEASANTON | CA | 94588-2882 | |||||||||
76 |
Affiliated | 263 | Union City | Union City Dialysis Center (aka TRC-Union City) | 32930 ALVARADO NILES RD | STE 3 | UNION CITY | CA | 94587-8101 | |||||||||
77 |
Affiliated | 264 | East Bay - PD | East Bay Peritoneal Dialysis Center | 13939 E 14TH ST | STE 11 | SAN LEANDRO | CA | 94578-2613 | |||||||||
78 |
Affiliated | 383 | Greer | Greer Kidney Center | 211 VILLAGE DR | GREER | SC | 29651-1238 | ||||||||||
79 |
Affiliated | 382 | Upstate | Upstate Dialysis Center | 308 MILLS AVE | GREENVILLE | SC | 29605-4022 | ||||||||||
80 |
Affiliated | 390 | Kenner | Kenner Regional Dialysis Center | 200 W ESPLANADE AVE | STE 1 | KENNER | LA | 70065-2473 | |||||||||
81 |
Affiliated | 689 | Downtown Dialysis | Downtown Dialysis Center | 821 N EUTAW ST | STE 41 | BALTIMORE | MD | 21201-6304 | |||||||||
82 |
Affiliated | 331 | Eaton Canyon | Eaton Canyon Dialysis | 2551 E WASHINGTON BLVD | PASADENA | CA | 91107-1446 | ||||||||||
83 |
Affiliated | 190 | Georgetown | Georgetown on the Potomac | 3223 K ST NW | STE 11 | WASHINGTON | DC | 20007-4412 | |||||||||
84 |
Affiliated | 395 | St. Mary | Newtown Dialysis Center (fka St. Mary Dialysis) | 60 BLACKSMITH RD | NEWTOWN | PA | 18940-1847 | ||||||||||
85 |
Affiliated | 393 | Bertha Sirk | Bertha Sirk Dialysis Center | 5820 YORK RD | STE 1 | BALTIMORE | MD | 21212-3620 | |||||||||
86 |
Affiliated | 394 | Greenspring | Greenspring Dialysis Center | 4701 MOUNT HOPE DR | STE C | BALTIMORE | MD | 21215-3246 | |||||||||
87 |
Affiliated | 378 | Houston Kidney - NW | Northwest Kidney Center (Houston) | 11029 NORTHWEST FWY | HOUSTON | TX | 77092-7311 | ||||||||||
88 |
Affiliated | 379 | NorthStar Dialysis | NorthStar Dialysis Center (fka North Houston Kidney Center) | 380 W LITTLE YORK RD | HOUSTON | TX | 77076-1303 | ||||||||||
89 |
Affiliated | 363 | Port Charlotte | Port Charlotte Artificial Kidney Center | 4300 KINGS HWY STE 406 | PORT CHARLOTTE | FL | 33980 | ||||||||||
90 |
Affiliated | 364 | Gulf Coast PD | Gulf Coast Dialysis | 3300 TAMIAMI TRL | STE 11A | PORT CHARLOTTE | FL | 33952-8054 | |||||||||
91 |
Affiliated | 649 | Loma Vista | Loma Vista Dialysis Center Partnership | 1382 LOMALAND DR | STE A | EL PASO | TX | 79935-5204 | |||||||||
92 |
Affiliated | 332 | Paramount | Paramount Dialysis Center | 8319 ALONDRA BLVD | PARAMOUNT | CA | 90723-4403 | ||||||||||
93 |
Affiliated | 334 | East LA | Doctors Dialysis of East LA (aka East Los Angeles Dialysis) | 950 S EASTERN AVE | LOS ANGELES | CA | 90022-4801 | ||||||||||
94 |
Affiliated | 335 | Montebello | Doctors Dialysis of Montebello | 1721 W WHITTIER BLVD | MONTEBELLO | CA | 90640-4004 | ||||||||||
95 |
Affiliated | 361 | Pine Island | Pine Island Kidney Center | 1871 N PINE ISLAND RD | PLANTATION | FL | 33322-5208 | ||||||||||
96 |
Affiliated | 365 | Complete | Complete Dialysis Care | 7850 W SAMPLE RD | MARGATE | FL | 33065-4710 | ||||||||||
97 |
Affiliated | 122 | Lone Star Dialysis | Lone Star Dialysis (fka Hobby Dialysis) | 8560 MONROE RD | HOUSTON | TX | 77061-4815 | ||||||||||
98 |
Affiliated | 255 | Forest Lake | Forest Lake Dialysis | 1068 S LAKE ST | STE 11 | FOREST LAKE | MN | 55025-2633 | |||||||||
99 |
Affiliated | 690 | USC Phase II | TRC/USC Dialysis Center | 2310 ALCAZAR ST | LOS ANGELES | CA | 90033-5327 | ||||||||||
100 |
Affiliated | 396 | TRC/Union Plaza Ctr | Union Plaza Dialysis Center | 810 1ST ST NE | STE 1 | WASHINGTON | DC | 20002-4227 | |||||||||
101 |
Affiliated | 130 | Mid-Columbia Kidney | Mid Columbia Kidney Center | 6825 BURDEN BLVD | STE A | PASCO | WA | 99301-9584 | |||||||||
102 |
Affiliated | 131 | Mt. Adams Kidney Ctr | Mt. Adams Kidney Center | 3220 PICARD PL | SUNNYSIDE | WA | 98944-8400 | ||||||||||
103 |
Affiliated | 650 | Lakewood | Lakewood Community Dialysis Center | 5919 LAKEWOOD TOWNE CENTER BLVD SW | STE A | LAKEWOOD | WA | 98499-6513 | |||||||||
104 |
Affiliated | 228 | St. Paul Ramsey | St. Paul Capitol Dialysis | 555 PARK ST | STE 23 | SAINT PAUL | MN | 55103-2193 | |||||||||
105 |
Affiliated | 229 | River City Dialysis | River City Dialysis (fka Lakeview Dialysis) | 1970 NORTHWESTERN AVE S | STILLWATER | MN | 55082-6567 | ||||||||||
106 |
Affiliated | 231 | Woodbury | Woodbury Dialysis | 1850 WEIR DR | STE 3 | WOODBURY | MN | 55125-2260 | |||||||||
107 |
Affiliated | 281 | Alhambra | Alhambra Dialysis Center | 1315 ALHAMBRA BLVD | STE 1 | SACRAMENTO | CA | 95816-5245 | |||||||||
108 |
Affiliated | 282 | Antelope | Antelope Dialysis Center | 6406 TUPELO DR | STE A | CITRUS HEIGHTS | CA | 95621-1780 | |||||||||
109 |
Affiliated | 283 | Chico | Chico Dialysis Center (aka Chico Clinic) | 530 COHASSET RD | CHICO | CA | 95926-2212 | ||||||||||
110 |
Affiliated | 285 | North Clinic | Manzanita Dialysis Center (aka North Clinic) | 4005 MANZANITA AVE | STE 17 | CARMICHAEL | CA | 95608-1779 | |||||||||
111 |
Affiliated | 286 | Placerville | Cameron Park Dialysis (fka Placerville) | 3311 COACH LN | STE C | CAMERON PARK | CA | 95682 | |||||||||
112 |
Affiliated | 288 | South Sacramento | South Sacramento Dialysis Center | 7000 FRANKLIN BLVD | STE 88 | SACRAMENTO | CA | 95823-1838 | |||||||||
113 |
Affiliated | 289 | Redding | Redding Dialysis Center | 1876 PARK MARINA DR | REDDING | CA | 96001-0913 | ||||||||||
114 |
Affiliated | 291 | Yuba City | Yuba City Dialysis Center | 1525 PLUMAS CT | STE A | YUBA CITY | CA | 95991-2971 | |||||||||
115 |
Affiliated | 292 | University Clinic | University Dialysis Center | 777 CAMPUS COMMONS RD | STE 1 | SACRAMENTO | CA | 95825-8344 | |||||||||
116 |
Affiliated | 372 | Mesa Vista | Mesa Vista Dialysis Center (El Paso) | 2400 N OREGON ST | STE C | EL PASO | TX | 79902-3135 | |||||||||
117 |
Affiliated | 694 | Hollywood | Hollywood Dialysis Center | 5108 W SUNSET BLVD | LOS ANGELES | CA | 90027-5708 | ||||||||||
118 |
Affiliated | 697 | UCLA Harbor | TRC/Harbor-UCLA MFI Total Renal Dialysis Center | 21602 S VERMONT AVE | TORRANCE | CA | 90502-1940 | ||||||||||
119 |
Affiliated | 325 | Brighton | Brighton Dialysis (fka Michigan Kidney Center of Brighton) | 7960 GRAND RIVER RD | STE 21 | BRIGHTON | MI | 48114-7336 | |||||||||
120 |
Affiliated | 326 | Macomb | Macomb Kidney Center (fka Macomb Dialysis) | 28295 SCHOENHERR RD | STE A | WARREN | MI | 48088-4300 | |||||||||
121 |
Affiliated | 327 | North Oakland | North Oakland Dialysis | 450 N TELEGRAPH RD | STE 6 | PONTIAC | MI | 48341-1037 | |||||||||
122 |
Affiliated | 328 | Novi | Novi Dialysis | 47250 W 10 MILE RD | NOVI | MI | 48374-2932 | ||||||||||
123 |
Affiliated | 329 | Southfield | Cornerstone Dialysis (fka Southfield) | 23857 GREENFIELD RD | SOUTHFIELD | MI | 48075-3122 | ||||||||||
124 |
Affiliated | 319 | Childrens Meml Hosp. | TRC Childrens Dialysis Center aka Childrens Chicago/Childrens Memorial Hospital | 2611 N HALSTED ST | CHICAGO | IL | 60614-2301 | ||||||||||
125 |
Affiliated | 151 | New Center | New Center Dialysis | 3011 W GRAND BLVD | STE 65 | DETROIT | MI | 48202-3012 | |||||||||
126 |
Affiliated | 2003 | Whittier | Whittier Dialysis Center (fka Whittier Hills) | 10055 WHITTWOOD DR | WHITTIER | CA | 90603-2313 | ||||||||||
127 |
Affiliated | 357 | Miami Lakes | Miami Lakes Artificial Kidney Center (ALTHIN) | 14600 NW 60TH AVE | MIAMI LAKES | FL | 33014-2811 | ||||||||||
128 |
Affiliated | 571 | Anson County | Dialysis Care of Anson County | 923 E CASWELL ST | WADESBORO | NC | 28170-2305 |
Page 50 of 123
129 |
Affiliated | 573 | Edgecomb County | Dialysis Care of Edgecomb County | 3206 WESTERN BLVD | TARBORO | NC | 27886-1828 | ||||||||||
130 |
Affiliated | 574 | Franklin County | Dialysis Care of Franklin County | 1706 NC HWY 39 N | LOUISBURG | NC | 27549-8329 | ||||||||||
131 |
Affiliated | 575 | Hoke County | Dialysis Care of Hoke County | 403 S MAIN ST | RAEFORD | NC | 28376-3222 | ||||||||||
132 |
Affiliated | 576 | Martin County | Dialysis Care of Martin County | 100 MEDICAL DR | WILLIAMSTON | NC | 27892-2156 | ||||||||||
133 |
Affiliated | 578 | Montgomery County | Dialysis Care of Montgomery County (aka Montgomery) | 323 W MAIN ST | BISCOE | NC | 27209-9528 | ||||||||||
134 |
Affiliated | 579 | Moore County | Dialysis Care of Moore County (aka Pinehurst) | 16 REGIONAL DR | PINEHURST | NC | 28374-8850 | ||||||||||
135 |
Affiliated | 580 | Richmond County | Dialysis Care of Richmond County | 771 CHERAW RD | HAMLET | NC | 28345-7158 | ||||||||||
136 |
Affiliated | 581 | Rockingham County | Dialysis Care of Rockingham County | 251 W KINGS HWY | EDEN | NC | 27288-5009 | ||||||||||
137 |
Affiliated | 582 | Rowan County | Dialysis Care of Rowan County | 111 DORSETT DR | SALISBURY | NC | 28144-2278 | ||||||||||
138 |
Affiliated | 583 | Rutherford County | Dialysis Care of Rutherford County | 226 COMMERCIAL ST | FOREST CITY | NC | 28043-2851 | ||||||||||
139 |
Affiliated | 399 | Monterey Park | Monterey Park Dialysis Center | 2560 CORPORATE PL | STE 1-11 BLDG D | MONTEREY PARK | CA | 91754-7612 | |||||||||
140 |
Affiliated | 183 | Mason Dixon | Mason-Dixon Baltimore County | 9635-A LIBERTY RD | STE 1 | RANDALLSTOWN | MD | 21133-2436 | |||||||||
141 |
Affiliated | 184 | Carrol County | Carroll County Dialysis Facility | 412 MALCOLM DR | STE 31 | WESTMINSTER | MD | 21157-6167 | |||||||||
142 |
Affiliated | 167 | South Brooklyn | South Brooklyn Nephrology Center | 3915 AVENUE V | STE 14 | BROOKLYN | NY | 11234-5150 | |||||||||
143 |
Affiliated | 843 | Phenix City | Phenix City Dialysis Center | 1900 OPELIKA RD | PHENIX CITY | AL | 36867-3640 | ||||||||||
144 |
Affiliated | 876 | Brea | Brea Dialysis Center | 595 TAMARACK AVE | STE A | BREA | CA | 92821-3125 | |||||||||
145 |
Affiliated | 878 | Hemet | Hemet Dialysis Center | 3050 W FLORIDA AVE | HEMET | CA | 92545-3619 | ||||||||||
146 |
Affiliated | 883 | Temecula | Temecula Dialysis Center | 40945 COUNTY CENTER DR | STE G | TEMECULA | CA | 92591-6006 | |||||||||
147 |
Affiliated | 880 | Riverside | Riverside Dialysis Center | 4361 LATHAM ST | STE 1 | RIVERSIDE | CA | 92501-1767 | |||||||||
148 |
Affiliated | 870 | Napa | Napa Dialysis Center | 3900 BEL AIRE PLZ | STE C | NAPA | CA | 94558-2823 | |||||||||
149 |
Affiliated | 875 | Santa Ana | Santa Ana Dialysis Center | 1820 E DEERE AVE | SANTA ANA | CA | 92705-5721 | ||||||||||
150 |
Affiliated | 879 | Valley View Dialysis Center | Valley View Dialysis Center (aka Morneo Valley) | 26900 CACTUS AVE | MORENO VALLEY | CA | 92555-3912 | ||||||||||
151 |
Affiliated | 884 | Orange | Mainplace Dialysis Center (fka Orange Dialysis Center) | 972 W TOWN AND COUNTRY RD | ORANGE | CA | 92868-4714 | ||||||||||
152 |
Affiliated | 882 | San Bernadino | Mountain Vista Dialysis Center (fka San Bernadino Dailysis Center (Mountain Vista)) | 4041 NORTH UNIVERSITY PKWY | SAN BERNARDINO | CA | 92407-1823 | ||||||||||
153 |
Affiliated | 871 | Lakeport | Lakeport Dialysis Center | 804 11TH ST | STE 2 | LAKEPORT | CA | 95453-4102 | |||||||||
154 |
Affiliated | 873 | Vacaville | Vacaville Dialysis Center | 941 MERCHANT ST | VACAVILLE | CA | 95688-5315 | ||||||||||
155 |
Affiliated | 877 | Corona | Corona Dialysis Center | 1820 FULLERTON AVE | STE 18 | CORONA | CA | 92881-3147 | |||||||||
156 |
Affiliated | 872 | Fairfield | Fairfield Dialysis Center | 4660 CENTRAL WAY | FAIRFIELD | CA | 94534-1803 | ||||||||||
157 |
Affiliated | 902 | Westminster | Westminster Dialysis Center (Federal Heights) | 9053 HARLAN ST | STE 9 | WESTMINSTER | CO | 80031-2908 | |||||||||
158 |
Affiliated | 901 | Aurora | Aurora Dialysis Center | 1411 S POTOMAC ST | AMC II STE 1 | AURORA | CO | 80012-4536 | |||||||||
159 |
Affiliated | 900 | Denver | Denver Dialysis Center | 2900 DOWNING ST | STE C | DENVER | CO | 80205-4699 | |||||||||
160 |
Affiliated | 903 | Littleton | Littleton Dialysis Center | 209 W COUNTY LINE RD | LITTLETON | CO | 80129-1901 | ||||||||||
161 |
Affiliated | 904 | South Denver | South Denver Dialysis Center | 850 E HARVARD AVE | STE 6 | DENVER | CO | 80210-5030 | |||||||||
162 |
Affiliated | 946 | Lee Street Dialysis | Lee Street Dialysis (fka Grant Park Dialysis Center) | 5155 LEE ST NE | WASHINGTON | DC | 20019-4051 | ||||||||||
163 |
Affiliated | 868 | Leesburg | Leesburg Dialysis Center | 801 E DIXIE AVE | STE 18A | LEESBURG | FL | 34748-7699 | |||||||||
164 |
Affiliated | 866 | Panama City | Panama City Dialysis Center | 615 HIGHWAY 231 | PANAMA CITY | FL | 32405-4704 | ||||||||||
165 |
Affiliated | 867 | Marianna | Marianna Dialysis Center | 2930 OPTIMIST DR | MARIANNA | FL | 32448-7703 | ||||||||||
166 |
Affiliated | 864 | Venice | Venice Dialysis Center | 816 PINEBROOK RD | VENICE | FL | 34285-7103 | ||||||||||
167 |
Affiliated | 827 | Buena Vista | Buena Vista Dialysis Center | 349 GENEVA RD | BUENA VISTA | GA | 31803-1701 | ||||||||||
168 |
Affiliated | 828 | Decatur | Decatur Dialysis Center | 1987 CANDLER RD | DECATUR | GA | 30032-4212 | ||||||||||
169 |
Affiliated | 825 | Moultrie | Moultrie Dialysis Center | 2419 S MAIN ST | MOULTRIE | GA | 31768-6531 | ||||||||||
170 |
Affiliated | 820 | SW Atlanta | Southwest Atlanta Dialysis Center | 3620 MARTIN LUTHER KING DR SW | ATLANTA | GA | 30331-3711 | ||||||||||
171 |
Affiliated | 818 | Griffin | Griffin Dialysis Center | 731 S 8TH ST | GRIFFIN | GA | 30224-4818 | ||||||||||
172 |
Affiliated | 826 | Columbus | Columbus Dialysis Center | 6228 BRADLEY PARK DR | STE B | COLUMBUS | GA | 31904-3604 | |||||||||
173 |
Affiliated | 829 | East Macon | East Macon Dialysis Center | 165 EMERY HWY | STE 11 | MACON | GA | 31217-3666 | |||||||||
174 |
Affiliated | 817 | Jonesboro | Jonesboro Dialysis Center | 129 KING ST | JONESBORO | GA | 30236-3656 | ||||||||||
175 |
Affiliated | 824 | Milledgeville | Milledgeville Dialysis Center | 400 S WAYNE ST | MILLEDGEVILLE | GA | 31061-3446 | ||||||||||
176 |
Affiliated | 823 | Fort Valley | Fort Valley Dialysis Center | 557 BLUEBIRD BLVD | FORT VALLEY | GA | 31030-5083 | ||||||||||
177 |
Affiliated | 821 | Midtown | Linden Dialysis (fka Midtown-Atlanta) | 121 LINDEN AVE NE | ATLANTA | GA | 30308-2432 | ||||||||||
178 |
Affiliated | 953 | E. St. Louis | Sauget Dialysis (fka East St. Louis Dialysis Center) | 2061 GOOSE LAKE RD | SAUGET | IL | 62206-2822 | ||||||||||
179 |
Affiliated | 952 | Granite City | Granite City Dialysis Center | 9 AMERICAN VLG | GRANITE CITY | IL | 62040-3706 | ||||||||||
180 |
Affiliated | 937 | Batesville | Batesville Dialysis Center Aka Renal Treatment Centers-Batesville | 232 STATE ROAD 129 S | BATESVILLE | IN | 47006-7694 | ||||||||||
181 |
Affiliated | 938 | Lawrenceburg | Lawrenceburg Dialysis Center | 721 RUDOLPH WAY | GREENDALE | IN | 47025-8378 | ||||||||||
182 |
Affiliated | 939 | Madison | Madison Dialysis Center | 220 CLIFTY DR | UNIT K | MADISON | IN | 47250-1669 | |||||||||
183 |
Affiliated | 836 | Newton | Renal Treatment Center-Newton aka-Newton Dialysis Center | 1223 WASHINGTON RD | NEWTON | KS | 67114-4855 | ||||||||||
184 |
Affiliated | 837 | Derby | Renal Treatment Center-Derby aka Derby Dialysis Center | 250 W RED POWELL DR | DERBY | KS | 67037-2626 | ||||||||||
185 |
Affiliated | 834 | Winfield | Renal Treatment Center-Winfield aka, Winfield Dialysis Center | 1315 E 4TH AVE | WINFIELD | KS | 67156-2457 | ||||||||||
186 |
Affiliated | 830 | Wichita | Wichita Dialysis Center | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | ||||||||||
187 |
Affiliated | 833 | Garden City | Renal Treatment Center-Garden City Aka-Garden City Dialysis Center | 401 N MAIN ST | GARDEN CITY | KS | 67846-5429 | ||||||||||
188 |
Affiliated | 831 | E. Wichita | East Wichita Dialysis Center | 320 N HILLSIDE ST | WICHITA | KS | 67214-4918 | ||||||||||
189 |
Affiliated | 832 | Independance | Independence Dialysis Center | 801 W MYRTLE ST | INDEPENDENCE | KS | 67301-3239 | ||||||||||
190 |
Affiliated | 835 | Parson, KS | Parsons Dialysis Center | 1902 S US HWY 59 | BLDG B | PARSONS | KS | 67357-4948 | |||||||||
191 |
Affiliated | 814 | Wheaton | Wheaton Dialysis Center | 11941 GEORGIA AVE | WHEATON | MD | 20902 | ||||||||||
192 |
Affiliated | 812 | Rockville | Rockville Dialysis Center | 14915 BROSCHART RD | STE 1 | ROCKVILLE | MD | 20850-3367 | |||||||||
193 |
Affiliated | 815 | Owing Mills | Owings Mills Dialysis Center (fka-Renal Treatment Center-Owings Mills) | 10 CROSSROADS DR | STE 11 | OWINGS MILLS | MD | 21117-5463 | |||||||||
194 |
Affiliated | 811 | Berlin | Berlin Dialysis Center | 314 FRANKLIN AVE | STE 36 | BERLIN | MD | 21811-1238 | |||||||||
195 |
Affiliated | 810 | Easton | Easton Dialysis Center | 402 MARVEL CT | EASTON | MD | 21601-4052 |
Page 51 of 123
196 |
Affiliated | 813 | Chestertown | Chestertown Dialysis Center (fka Renal Treatment Centers-Chestertown) | 100 BROWN ST | CHESTERTOWN | MD | 21620 | ||||||||||
197 |
Affiliated | 951 | Hope Again | Hope Again Dialysis Center- fka Kennett Dialysis Center | 1207 STATE ROUTE VV | KENNETT | MO | 63857-3823 | ||||||||||
198 |
Affiliated | 950 | Poplar Bluff | Bluff City Dialysis Center | 2400 LUCY LEE PKWY | STE E | POPLAR BLUFF | MO | 63901-2429 | |||||||||
199 |
Affiliated | 949 | Crystal City | Crystal City Dialysis Center | 960 SO TRUMAN BLVD | CRYSTAL CITY | MO | 63019-1329 | ||||||||||
200 |
Affiliated | 947 | St. Louis | St. Louis Dialysis Center (fka Renal Treatment Center-St. Louis) | 2610 CLARK AVE | SAINT LOUIS | MO | 63103-2502 | ||||||||||
201 |
Affiliated | 944 | Burlington | Burlington Dialysis | 873 HEATHER RD | BURLINGTON | NC | 27215-6288 | ||||||||||
202 |
Affiliated | 838 | Scottsbluff | Scottsbluff Dialysis Center | 3812 AVENUE B | SCOTTSBLUFF | NE | 69361-4780 | ||||||||||
203 |
Affiliated | 802 | Bridgewater | Bridgewater Dialysis Center (fka Renal Treatment Center-Bridgewater) | 2121 US HWY 22 | BOUND BROOK | NJ | 08805-1546 | ||||||||||
204 |
Affiliated | 845 | West Las Vegas | Las Vegas Dialysis Center | 150 S VALLEY VIEW BLVD | LAS VEGAS | NV | 89107 | ||||||||||
205 |
Affiliated | 846 | North Las Vegas | North Las Vegas Dialysis Center | 2300 MCDANIEL ST | NORTH LAS VEGAS | NV | 89030-6318 | ||||||||||
206 |
Affiliated | 940 | Cincinnati | Eastgate Dialysis (fka Cincinnati) | 4435 AICHOLTZ RD | CINCINNATI | OH | 45245-1690 | ||||||||||
207 |
Affiliated | 885 | Tulsa | Tulsa Dialysis | 4436 S HARVARD AVE | TULSA | OK | 74135-2605 | ||||||||||
208 |
Affiliated | 897 | NW Bethany | Northwest Bethany Dialysis Center | 7800 NW 23RD ST | STE A | BETHANY | OK | 73008-4948 | |||||||||
209 |
Affiliated | 890 | Duncan | Duncan Dialysis Center | 2645 W ELK AVE | DUNCAN | OK | 73533-1572 | ||||||||||
210 |
Affiliated | 893 | Shawnee | Shawnee Dialysis Center | 4409 N KICKAPOO AVE | STE 113 | SHAWNEE | OK | 74804-1224 | |||||||||
211 |
Affiliated | 895 | Stillwater | Stillwater Dialysis Center | 406 E HALL OF FAME AVE | STE 3 | STILLWATER | OK | 74075-5447 | |||||||||
212 |
Affiliated | 955 | Midwest City | Midwest City Dialysis Center | 7221 E RENO AVE | MIDWEST CITY | OK | 73110-4474 | ||||||||||
213 |
Affiliated | 886 | Broken Arrow | Broken Arrow Dialysis Center | 1700 N 9TH ST | BROKEN ARROW | OK | 74012 | ||||||||||
214 |
Affiliated | 888 | Tahlequah | Tahlequah Dialysis Center | 1373 E BOONE ST | TAHLEQUAH | OK | 74464-3330 | ||||||||||
215 |
Affiliated | 899 | Edmund | Edmond Dialysis | 50 S BAUMANN AVE | EDMOND | OK | 73034-5676 | ||||||||||
216 |
Affiliated | 889 | Altus | Altus Dialysis Center | 205 S PARK LN | STE 13 | ALTUS | OK | 73521-5756 | |||||||||
217 |
Affiliated | 896 | Elk City | Elk City Dialysis Center | 1601 W 2ND ST | ELK CITY | OK | 73644-4427 | ||||||||||
218 |
Affiliated | 887 | Claremore | Claremore Dialysis Center | 202 E BLUE STARR DR | CLAREMORE | OK | 74017-4223 | ||||||||||
219 |
Affiliated | 891 | Norman | Norman Dialysis Center | 1818 W LINDSEY ST | STE 14 BLDG B | NORMAN | OK | 73069-4159 | |||||||||
220 |
Affiliated | 862 | Pocono | Pocono Dialysis Center | 100 PLAZA CT | STE B | EAST STROUDSBURG | PA | 18301-8258 | |||||||||
221 |
Affiliated | 861 | Palmerton | Palmerton Dialysis Center | 185 DELAWARE AVE | STE C | PALMERTON | PA | 18071-1716 | |||||||||
222 |
Affiliated | 860 | Jennersville | Jennersville Dialysis Center | 1011 W BALTIMORE PIKE | WEST GROVE | PA | 19390-9446 | ||||||||||
223 |
Affiliated | 858 | Lewistown | Lewistown Dialysis Center | 611 ELECTRIC AVE | LEWISTOWN | PA | 17044-1128 | ||||||||||
224 |
Affiliated | 854 | Lemoyne | Camp Hill Dialysis Center (fka Lemoyne Dialysis Center (York Hospital Acutes)) | 425 N 21ST ST | LOWER LEVEL | CAMP HILL | PA | 17011-2223 | |||||||||
225 |
Affiliated | 856 | Upland | Upland Dialysis Center | 1 MEDICAL CENTER BLVD | STE 12 | CHESTER | PA | 19013-3902 | |||||||||
226 |
Affiliated | 848 | South Philadelphia | So. Philadelphia Dialysis Center | 109 DICKINSON ST | PHILADELPHIA | PA | 19147-6107 | ||||||||||
227 |
Affiliated | 857 | Exton | Exton Dialysis Center | 710 SPRINGDALE DR | EXTON | PA | 19341-2828 | ||||||||||
228 |
Affiliated | 847 | Northeast Philadelphia | NE Philadelphia Dialysis Center | 518 KNORR ST | PHILADELPHIA | PA | 19111-4604 | ||||||||||
229 |
Affiliated | 934 | Longview | Longview Dialysis Center | 425 N FREDONIA ST | LONGVIEW | TX | 75601-6464 | ||||||||||
230 |
Affiliated | 935 | Marshall-RTC | Marshall Dialysis Center | 1301 S WASHINGTON AVE | MARSHALL | TX | 75670-6215 | ||||||||||
231 |
Affiliated | 933 | Conroe | Conroe Dialysis Center | 500 MEDICAL CENTER BLVD | STE 175 | CONROE | TX | 77304-2899 | |||||||||
232 |
Affiliated | 928 | San Marcos | Hill Country Dialysis Center Of San Marcos | 1820 PETER GARZA DR | SAN MARCOS | TX | 78666-7407 | ||||||||||
233 |
Affiliated | 923 | Sherman | Sherman Dialysis Center | 205 W LAMBERTH RD | SHERMAN | TX | 75092-2659 | ||||||||||
234 |
Affiliated | 932 | Tomball | Tomball Dialysis Center | 27720A TOMBALL PKWY | TOMBALL | TX | 77375- | ||||||||||
235 |
Affiliated | 919 | Cleveland | Cleveland Dialysis Center | 600 E HOUSTON | STE 63 | CLEVELAND | TX | 77327-4689 | |||||||||
236 |
Affiliated | 921 | Livingston | Livingston Dialysis Center | 209 W PARK | LIVINGSTON | TX | 77351-7020 | ||||||||||
237 |
Affiliated | 920 | Kingwood | Kingwood Dialysis Center | 2300 GREEN OAK DR | STE 5 | KINGWOOD | TX | 77339-2053 | |||||||||
238 |
Affiliated | 930 | North Houston | North Houston Dialysis Center | 129 LITTLE YORK RD | HOUSTON | TX | 77076-1020 | ||||||||||
239 |
Affiliated | 926 | Omni | Omni Dialysis Center (fka Hamilton Dialysis Center) | 9350 KIRBY DR | STE 11 | HOUSTON | TX | 77054-2528 | |||||||||
240 |
Affiliated | 925 | Victoria | Victoria Dialysis Center | 1405 VICTORIA STATION DR | VICTORIA | TX | 77901-3092 | ||||||||||
241 |
Affiliated | 922 | Lufkin | Lufkin Dialysis Center | 700 S JOHN REDDITT DR | LUFKIN | TX | 75904-3145 | ||||||||||
242 |
Affiliated | 927 | Gonzales | Gonzales Dialysis Center | 1406 N SARAH DEWITT DR | GONZALES | TX | 78629-2702 | ||||||||||
243 |
Affiliated | 924 | Denison | Denison Dialysis Center | 1220 REBA MCENTIRE LANE | DENISON | TX | 75020-9057 | ||||||||||
244 |
Affiliated | 918 | South San Antonio | South San Antonio Dialysis Center | 1313 SE MILITARY DR | STE 111 | SAN ANTONIO | TX | 78214-2850 | |||||||||
245 |
Affiliated | 913 | Austin | Waterloo Dialysis Center (fka Austin Dialysis Center) | 5310 BURNET RD | UNIT 122 | AUSTIN | TX | 78756-2003 | |||||||||
246 |
Affiliated | 916 | S. Austin | El Milagro Dialysis Unit (fka South Austin Dialysis Center) | 2800 S INTERSTATE HWY 35 | STE 12 | AUSTIN | TX | 78704-5700 | |||||||||
247 |
Affiliated | 929 | SW San Antonio | Southwest San Antonio Dialysis Center | 7515 BARLITE BLVD | SAN ANTONIO | TX | 78224-1311 | ||||||||||
248 |
Affiliated | 936 | Bedford | HEB Dialysis Center (Bedford) | 1401 BROWN TRL | STE A | BEDFORD | TX | 76022-6416 | |||||||||
249 |
Affiliated | 917 | TRC Med Cntr | Med-Center Dialysis, fka Plaza Dialysis Center & Houston Kidney Center #376 | 5610 ALMEDA RD | HOUSTON | TX | 77004-7515 | ||||||||||
250 |
Affiliated | 908 | Chesapeake | Chesapeake Dialysis Center | 1400 CROSSWAYS BLVD | CROSSWAYS II STE 16 | CHESAPEAKE | VA | 23320-2839 | |||||||||
251 |
Affiliated | 912 | Hopewell | Hopewell Dialysis Center | 301 W BROADWAY AVE | HOPEWELL | VA | 23860-2645 | ||||||||||
252 |
Affiliated | 911 | Newport News | Newport News Dialysis Center | 711 79TH ST | NEWPORT NEWS | VA | 23605-2767 | ||||||||||
253 |
Affiliated | 907 | Norfolk | Norfolk Dialysis Center | 962 NORFOLK SQ | NORFOLK | VA | 23502-3235 | ||||||||||
254 |
Affiliated | 909 | Virginia Beach | Virginia Beach Dialysis Center | 740 INDEPENDENCE CIR | VIRGINIA BEACH | VA | 23455-6438 | ||||||||||
255 |
Affiliated | 171 | Palmer | Palmer Dialysis Center | 30 COMMUNITY DR | EASTON | PA | 18045-2658 | ||||||||||
256 |
Affiliated | 589 | Burgaw | SEDC (NC II) Burgaw Dialysis Center | 704 S DICKERSON ST | PO BOX 1391 | BURGAW | NC | 28425-4904 | |||||||||
257 |
Affiliated | 590 | Elizabethtown | SEDC (NC II) Elizabethtown Dialysis Center | 101 DIALYSIS DR | ELIZABETHTOWN | NC | 28337-9048 | ||||||||||
258 |
Affiliated | 591 | Jacksonville | SEDC (NC II) Jacksonville Dialysis Center | 14 OFFICE PARK DR | JACKSONVILLE | NC | 28546-7325 | ||||||||||
259 |
Affiliated | 592 | Kenansville | SEDC (NC II) Kenansville Dialysis Center | 305 BEASLEY ST | KENANSVILLE | NC | 28349-8798 | ||||||||||
260 |
Affiliated | 593 | Shallotte | SEDC (NC II) Shallotte Dialysis Center | 4770 SHALLOTTE AVE | SHALLOTTE | NC | 28470-6596 | ||||||||||
261 |
Affiliated | 594 | Whiteville | SEDC (NC II) Whiteville Dialysis Center | 608 PECAN LN | WHITEVILLE | NC | 28472-2949 | ||||||||||
262 |
Affiliated | 595 | Wilmington | SEDC (NC II) Wilmington Dialysis Center | 2215 YAUPON DR | WILMINGTON | NC | 28401-7334 |
Page 52 of 123
263 |
Affiliated | 175 | Deerfield | Deerfield Beach Artificial Kidney Center | 1983 W HILLSBORO BLVD | DEERFIELD BEACH | FL | 33442-1418 | ||||||||||
264 |
Affiliated | 176 | Pampano Beach | Pompano Beach Artificial Kidney Center | 600 SW 3RD ST | STE 11 | POMPANO BEACH | FL | 33060-6936 | |||||||||
265 |
Affiliated | 177 | Tamarack | Tamarac Artificial Kidney Center | 7140 W MCNAB RD | TAMARAC | FL | 33321-5306 | ||||||||||
266 |
Affiliated | 168 | Atlantic AKC | Atlantic Artificial Kidney Center | 6 INDUSTRIAL WAY W | STE B | EATONTOWN | NJ | 07724-2258 | |||||||||
267 |
Affiliated | 587 | Rowan/Kannapolis | Dialysis Care of Kannapolis | 1607 N MAIN ST | KANNAPOLIS | NC | 28081-2317 | ||||||||||
268 |
Affiliated | 654 | Cortez | Cortez Dialysis | 610 E MAIN ST | STE C | CORTEZ | CO | 81321-3308 | |||||||||
269 |
Affiliated | 142 | West Bountiful 4/6/98 | West Bountiful Dialysis | 724 W 500 S | STE 3 | WEST BOUNTIFUL | UT | 84087-1471 | |||||||||
270 |
Affiliated | 187 | Meherrin | Meherrin Dialysis Center | 201A WEAVER AVE | EMPORIA | VA | 23847-1248 | ||||||||||
271 |
Affiliated | 436 | Montclair | Montclair Dialysis Center | 5050 PALO VERDE ST | STE 1 | MONTCLAIR | CA | 91763-2329 | |||||||||
272 |
Affiliated | 259 | Pipestone | Pipestone Dialysis | 916 4TH AVE SW | PIPESTONE | MN | 56164-1054 | ||||||||||
273 |
Affiliated | 236 | Washington | Washington Dialysis Center | 154 WASHINGTON PLZ | WASHINGTON | GA | 30673-2074 | ||||||||||
274 |
Affiliated | 235 | Elberton | Elberton Dialysis Center | 894 ELBERT ST | ELBERTON | GA | 30635-2628 | ||||||||||
275 |
Affiliated | 174 | Gulf Breeze | Gulf Breeze Dialysis Center | 1519 MAIN ST | DUNEDIN | FL | 34698-4650 | ||||||||||
276 |
Affiliated | 526 | Asheville | Asheville Kidney Center | 1600 CENTRE PARK DR | ASHEVILLE | NC | 28805-6206 | ||||||||||
277 |
Affiliated | 528 | Sylva | Sylva Dialysis Center | 655 ASHEVILLE HWY | SYLVA | NC | 28779-2747 | ||||||||||
278 |
Affiliated | 527 | Hendersonville | Hendersonville Dialysis Center | 500 BEVERLY HANKS CTR | HWY 25 N | HENDERSONVILLE | NC | 28792 | |||||||||
279 |
Affiliated | 389 | Memorial | Memorial Dialysis | 4427 S ROBERTSON ST | NEW ORLEANS | LA | 70115-6308 | ||||||||||
280 |
Affiliated | 127 | Warner Robbins | Dialysis Center of Middle Georgia-Warner Robins | 509 N HOUSTON RD | WARNER ROBINS | GA | 31093-8844 | ||||||||||
281 |
Affiliated | 126 | Macon - Middle Georgia | Dialysis Center of Middle Georgia-Macon | 747 2ND ST | MACON | GA | 31201-6835 | ||||||||||
282 |
Affiliated | 344 | Oakland PD | Oakland Peritoneal Dialysis Center (Piedmont PD) | 5352 CLAREMONT AVE | OAKLAND | CA | 94618 | ||||||||||
283 |
Affiliated | 384 | Fairfax | Fairfax Dialysis Center | 8501 ARLINGTON BLVD | STE 1 | FAIRFAX | VA | 22031-4625 | |||||||||
284 |
Affiliated | 374 | Houston SW | Houston Kidney Center Southwest | 11111 BROOKLET DR | STE 1 BLDG 1 | HOUSTON | TX | 77099-3555 | |||||||||
285 |
Affiliated | 545 | Pikes Peak | Pikes Peak Dialysis Center | 2002 LELARAY ST | STE 13 | COLORADO SPRINGS | CO | 80909-2804 | |||||||||
286 |
Affiliated | 546 | Printers Place | Printers Place Dialysis | 2802 INTERNATIONAL CIR | COLORADO SPRINGS | CO | 80910-3127 | ||||||||||
287 |
Affiliated | 541 | Lakewood Colorado | Lakewood Dialysis Center | 1750 PIERCE ST | LAKEWOOD | CO | 80214-1434 | ||||||||||
288 |
Affiliated | 543 | Boulder | Boulder Dialysis Center | 2880 FOLSOM ST | STE 11 | BOULDER | CO | 80304-3769 | |||||||||
289 |
Affiliated | 542 | Thornton | Thornton Dialysis Center | 8800 FOX DR | THORNTON | CO | 80260-6880 | ||||||||||
290 |
Affiliated | 544 | Arvada | Arvada Dialysis Center | 9950 W 80TH AVE | STE 25 | ARVADA | CO | 80005-3914 | |||||||||
291 |
Affiliated | 173 | Ft. Lauderdale | CDC South-Ft Lauderdale Renal Associates | 6264 N FEDERAL HWY | FORT LAUDERDALE | FL | 33308-1904 | ||||||||||
292 |
Affiliated | 380 | Houston Cypress Station | Houston Kidney Center Cypress Station | 221 FM 1960 RD W | STE H | HOUSTON | TX | 77090-3537 | |||||||||
293 |
Affiliated | 169 | Erie County | Cleve Hill Dialysis Center (Fka Cleve Hill Limited Partnership-Erie Dialysis &ECMC Dialysis Center At Cleve Hill ) | 1461 KENSINGTON AVE | BUFFALO | NY | 14215-1436 | ||||||||||
294 |
Affiliated | 430 | UCLA Pediatrics | Century City Dialysis (fka UCLA, DaVita Westwood UCLA) | 10630 SANTA MONICA BLVD | LOS ANGELES | CA | 90025-4837 | ||||||||||
295 |
Affiliated | 501 | Bronx | Bronx Dialysis Center | 1615 EASTCHESTER RD | BRONX | NY | 10461-2603 | ||||||||||
296 |
Affiliated | 502 | Catskill | Catskill Dialysis Center | 139 FORESTBURGH RD | MONTICELLO | NY | 12701-2364 | ||||||||||
297 |
Affiliated | 505 | Riverdale | Riverdale Dialysis Center | 170 W 233RD ST | BRONX | NY | 10463-5639 | ||||||||||
298 |
Affiliated | 506 | South Bronx | South Bronx Dialysis Center | 1940 WEBSTER AVE | BRONX | NY | 10457-4261 | ||||||||||
299 |
Affiliated | 507 | Stanten Island | Richmond Kidney Center (Staten Island) | 1366 VICTORY BLVD | STATEN ISLAND | NY | 10301-3907 | ||||||||||
300 |
Affiliated | 238 | McDonough | McDonough Dialysis Center | 114 DUNN ST | MCDONOUGH | GA | 30253-2347 | ||||||||||
301 |
Affiliated | 192 | Milford | Delaware Valley Dialysis Center (fka Milford) | 102 DAVITA DR | MILFORD | PA | 18337-9390 | ||||||||||
302 |
Affiliated | 191 | Honesdale | Honesdale Dialysis Center-NE Regional | RR 6 BOX 6636 | STOURBRIDGE MALL | HONESDALE | PA | 18431-9649 | |||||||||
303 |
Affiliated | 247 | Memorial | Memorial Dialysis Center | 11621 KATY FWY | HOUSTON | TX | 77079-1801 | ||||||||||
304 |
Affiliated | 246 | Katy Dialysis Center | Grand Parkway Dialysis Center | 403 W GRAND PKWY S | STE T | KATY | TX | 77494-8358 | |||||||||
305 |
Affiliated | 245 | Cyfair Dialysis Center | Cyfair Dialysis Center | 9110 JONES RD | STE 11 | HOUSTON | TX | 77065-4489 | |||||||||
306 |
Affiliated | 165 | Port Chester | Port Chester Dialysis and Renal Center | 38 BULKLEY AVE | PORT CHESTER | NY | 10573-3902 | ||||||||||
307 |
Affiliated | 193 | Franklin Dialysis | Franklin Dialysis Center | 150 SOUTH INDEPENDENCE WEST | 11 PUBLIC LEDGER BLDG | PHILADELPHIA | PA | 19106-3413 | |||||||||
308 |
Affiliated | 156 | Grand Blanc | Grand Blanc Dialysis Center | 3625 GENESYS PKWY | GRAND BLANC | MI | 48439-8070 | ||||||||||
309 |
Affiliated | 397 | Oxford Court | Oxford Court Dialysis | 930 TOWN CENTER DR | STE G1 | LANGHORNE | PA | 19047-4260 | |||||||||
310 |
Affiliated | 348 | Antioch | Antioch Dialysis | 3100 DELTA FAIR BLVD | ANTIOCH | CA | 94509-4001 | ||||||||||
311 |
Affiliated | 401 | North Palm Beach | North Palm Beach Dialysis Center | 2841 PGA BLVD | PALM BEACH GARDENS | FL | 33410-2910 | ||||||||||
312 |
Affiliated | 277 | Lodi | Lodi Dialysis Center | 1610 W KETTLEMAN LN | STE D | LODI | CA | 95242-4210 | |||||||||
313 |
Affiliated | 438 | United | United Dialysis Center | 3111 LONG BEACH BLVD | LONG BEACH | CA | 90807-5015 | ||||||||||
314 |
Affiliated | 437 | Premier | Premier Dialysis Center | 7612 ATLANTIC AVE | CUDAHY | CA | 90201-5020 | ||||||||||
315 |
Affiliated | 349 | Salinas | Salinas Dialysis Center | 955 BLANCO CIR | STE C | SALINAS | CA | 93901-4452 | |||||||||
316 |
Affiliated | 428 | Lowry I | Lowry Dialysis Center | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | |||||||||
317 |
Affiliated | 154 | Ypsilanti | Ypsilanti Dialysis | 2766 WASHTENAW RD | YPSILANTI | MI | 48197-1506 | ||||||||||
318 |
Affiliated | 237 | Eastpoint | East Point Dialysis | 2669 CHURCH ST | EAST POINT | GA | 30344-3115 | ||||||||||
319 |
Affiliated | 520 | Celia Dill | Celia Dill Dialysis Center | 667 STONELEIGH AVE | STE 123 BARNS OFFICE CENTER | CARMEL | NY | 10512-2454 | |||||||||
320 |
Affiliated | 248 | Elmbrook | Brookriver Dialysis | 8101 BROOKRIVER DR | DALLAS | TX | 75247-4003 | ||||||||||
321 |
Affiliated | 402 | Ocala East | OCALA Regional Kidney Center-East | 2870 SE 1ST AVE | OCALA | FL | 34471-0406 | ||||||||||
322 |
Affiliated | 403 | Ocala West | OCALA Regional Kidney Center-West | 9401 SW HWY 200 | BLDG 6 | OCALA | FL | 34481-9612 | |||||||||
323 |
Affiliated | 404 | Ocala South | OCALA Regional Kidney Center-South | 13940 N US HWY 441 | BLDG 4 | LADY LAKE | FL | 32159-8908 | |||||||||
324 |
Affiliated | 417 | Delta Sierra Dialysis | Delta-Sierra Dialysis Center | 555 W BENJAMIN HOLT DR | STE 2 | STOCKTON | CA | 95207-3839 | |||||||||
325 |
Affiliated | 552 | Olympic View | Olympic View Dialysis Center | 125 16TH AVE E CSB | 5TH FL | SEATTLE | WA | 98112 | |||||||||
326 |
Affiliated | 148 | Pratt | Pratt Dialysis Center | 203 WATSON ST | STE 11 | PRATT | KS | 67124-3092 | |||||||||
327 |
Affiliated | 196 | Buffalo | Renal Care of Buffalo | 550 ORCHARD PARK RD | WEST SENECA | NY | 14224-2646 | ||||||||||
328 |
Affiliated | 555 | Woodland | Woodland Dialysis Center | 912 WOODLAND DR | STE B | ELIZABETHTOWN | KY | 42701-2795 | |||||||||
329 |
Affiliated | 556 | Taylor | Taylor County Dialysis Center | 101 KINGSWOOD DR | CAMPBELLSVILLE | KY | 42718-9634 |
Page 53 of 123
330 |
Affiliated | 491 | Gary | Comprehensive Renal Care (CRC)-Gary | 4802 BROADWAY | GARY | IN | 46408-4509 | ||||||||||
331 |
Affiliated | 492 | Hammond | Comprehensive Renal Care (CRC)-Hammond | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 | ||||||||||
332 |
Affiliated | 493 | Valparaiso | Comprehensive Renal Care (CRC)-Valparaiso | 606 E LINCOLNWAY | VALPARAISO | IN | 46383-5728 | ||||||||||
333 |
Affiliated | 494 | Michigan City | Comprehensive Renal Care (CRC)-Michigan City | 9836 WEST 400 NORTH | MICHIGAN CITY | IN | 46360-2910 | ||||||||||
334 |
Affiliated | 495 | Munster | Comprehensive Renal Care (CRC)-Munster | 9100 CALUMET AVE | MUNSTER | IN | 46321-1737 | ||||||||||
335 |
Affiliated | 497 | South County-Deaconess | South County Dialysis (Deaconess) | 4145 UNION RD | SAINT LOUIS | MO | 63129-1064 | ||||||||||
336 |
Affiliated | 266 | South Hayward | South Hayward Dialysis Center | 254 JACKSON ST | HAYWARD | CA | 94544-1907 | ||||||||||
337 |
Affiliated | 164 | Dyker Heights | Dyker Heights Dialysis Center | 1435 86TH ST | BROOKLYN | NY | 11228-3435 | ||||||||||
338 |
Affiliated | 152 | Clarkston | Clarkston Dialysis Center | 6770 DIXIE HWY | STE 25 | CLARKSTON | MI | 48346-2089 | |||||||||
339 |
Affiliated | 534 | Hudson Valley | Hudson Valley Dialysis Center | 155 WHITE PLAINS RD | TARRYTOWN | NY | 10591-5523 | ||||||||||
340 |
Affiliated | 971 | Central Tulsa | Central Tulsa Dialysis Center | 1124 S SAINT LOUIS AVE | TULSA | OK | 74120-5413 | ||||||||||
341 |
Affiliated | 972 | Okmulgee | Okmulgee Dialysis Center | 201 SO DELAWARE AVE | OKMULGEE | OK | 74447-5528 | ||||||||||
342 |
Affiliated | 974 | Muskogee | Muskogee Community Dialysis | 2316 W SHAWNEE ST | MUSKOGEE | OK | 74401-2228 | ||||||||||
343 |
Affiliated | 975 | Miami-Oklahoma | Tri-State Dialysis Center (fka Miami Dialysis Center (OK)) | 2510 N MAIN ST | MIAMI | OK | 74354-1602 | ||||||||||
344 |
Affiliated | 977 | Stilwell | Stilwell Dialysis Center | 80851 HWY 59 | STILWELL | OK | 74960 | ||||||||||
345 |
Affiliated | 496 | East Chicago | Comprehensive Renal Care (CRC)-East Chicago | 4320 FIR ST | UNIT 44 | EAST CHICAGO | IN | 46312-3078 | |||||||||
346 |
Affiliated | 549 | Bright Dialysis | Bright Dialysis (fka Fort Pierce Artificial Kidney Center, TRC of Fort Pierce-AKC) | 1801 S 23RD ST | STE 1 | FORT PIERCE | FL | 34950-4830 | |||||||||
347 |
Affiliated | 153 | Detroit | Detroit Dialysis Center (Eastern Market, Brewery Park Development) | 2674 E JEFFERSON AVE | DETROIT | MI | 48207-4129 | ||||||||||
348 |
Affiliated | 166 | White Plains | White Plains Dialysis Center | 200 HAMILTON AVE | STE 13B | WHITE PLAINS | NY | 10601-1859 | |||||||||
349 |
Affiliated | 337 | Crescent Heights | Crescent Heights Dialysis Center | 8151 BEVERLY BLVD | LOS ANGELES | CA | 90048-4514 | ||||||||||
350 |
Affiliated | 547 | Pahrump Dialysis | Pahrump Dialysis Center | 330 S LOLA LN | STE 1 | PAHRUMP | NV | 89048-0884 | |||||||||
351 |
Affiliated | 598 | Cherokee Dialysis Center | Cherokee Dialysis Center | 53 ECHOTA CHURCH RD | CHEROKEE | NC | 28719-9702 | ||||||||||
352 |
Affiliated | 444 | Utah Valley | Utah Valley Dialysis Center | 1055 N 500 W | STE 221 | PROVO | UT | 84604-3305 | |||||||||
353 |
Affiliated | 439 | Washington Plaza | Washington Plaza Dialysis Center | 516 E WASHINGTON BLVD | # 522 | LOS ANGELES | CA | 90015-3723 | |||||||||
354 |
Affiliated | 539 | Commerce City | Commerce City Dialysis Center | 6320 HOLLY ST | COMMERCE CITY | CO | 80022-3325 | ||||||||||
355 |
Affiliated | 251 | Bloomington Dialysis | Bloomington Dialysis Unit of TRC (fka Richfield) | 8591 LYNDALE AVE S | BLOOMINGTON | MN | 55420-2237 | ||||||||||
356 |
Affiliated | 133 | Kent Community Dialysis | Kent Dialysis Center | 21501 84TH AVE S | KENT | WA | 98032-1960 | ||||||||||
357 |
Affiliated | 278 | Florin Dialyis | Florin Dialysis Center | 7000 STOCKTON BLVD | SACRAMENTO | CA | 95823-2312 | ||||||||||
358 |
Affiliated | 540 | South Las Vegas Dialysis | South Las Vegas Dialysis Center (Palms) | 2250 S RANCHO DR | STE 115 | LAS VEGAS | NV | 89102-4456 | |||||||||
359 |
Affiliated | 538 | Longmont Dialysis | Longmont Dialysis Center | 1715 IRON HORSE DR | STE 17 | LONGMONT | CO | 80501-9617 | |||||||||
360 |
Affiliated | 500 | Great Bridge | Great Bridge Dialysis (fka Chesapeake II) | 745 BATTLEFIELD BLVD N | STE 1 | CHESAPEAKE | VA | 23320-0305 | |||||||||
361 |
Affiliated | 569 | Weaverville Dialysis | Weaverville Dialysis Facility | 329 MERRIMON AVE | WEAVERVILLE | NC | 28787-9253 | ||||||||||
362 |
Affiliated | 427 | Lakewood Crossing | Lakewood Crossing Dialysis | 1057 S WADSWORTH BLVD | STE 1 | LAKEWOOD | CO | 80226-4361 | |||||||||
363 |
Affiliated | 155 | Jackson | Jackson Dialysis Center | 234 W LOUIS GLICK HWY | JACKSON | MI | 49201-1326 | ||||||||||
364 |
Affiliated | 429 | Englewood | Englewood Dialysis Center | 3247 S LINCOLN ST | ENGLEWOOD | CO | 80113-2505 | ||||||||||
365 |
Affiliated | 387 | Harford Road Dialysis | Harford Road Dialysis Center | 5800 HARFORD RD | BALTIMORE | MD | 21214-1847 | ||||||||||
366 |
Affiliated | 179 | Arcadia | Arcadia Dialysis Center | 1341 E OAK ST | ARCADIA | FL | 34266-8902 | ||||||||||
367 |
Affiliated | 388 | Richmond Community | Richmond Community Hospital Dialysis (fkaTRC @ Richmond Community/Richmond II) | 1510 N 28TH ST | STE 11 | RICHMOND | VA | 23223-5311 | |||||||||
368 |
Affiliated | 119 | Henderson | Henderson Dialysis Center | 1002 US HWY 79 N | HENDERSON | TX | 75652-6008 | ||||||||||
369 |
Affiliated | 253 | Augusta | Nephrology Center of South Augusta | 1631 GORDON HWY STE 1B | AUGUSTA | GA | 30906 | ||||||||||
370 |
Affiliated | 510 | Boston Post Road | Boston Post Road Dialysis Center fka Co Op City Dialysis | 4026 BOSTON RD | BRONX | NY | 10475-1122 | ||||||||||
371 |
Affiliated | 512 | Peekskill | Peekskill Cortlandt Dialysis Center | 2050 E MAIN ST | STE 15 | CORTLANDT MANOR | NY | 10567-2502 | |||||||||
372 |
Affiliated | 513 | Queens | Queens Dialysis Center | 11801 GUY R BREWER BLVD | JAMAICA | NY | 11434-2101 | ||||||||||
373 |
Affiliated | 517 | Soundview | Soundview Dialysis Center | 1622 BRUCKNER BLVD | STE 24 | BRONX | NY | 10473-4553 | |||||||||
374 |
Affiliated | 516 | Port Washington | Port Washington Dialysis Center | 50 SEAVIEW BLVD | PORT WASHINGTON | NY | 11050-4615 | ||||||||||
375 |
Affiliated | 515 | Lynbrook | Lynbrook Dialysis Center | 147 SCRANTON AVE | LYNBROOK | NY | 11563-2808 | ||||||||||
376 |
Affiliated | 518 | Yonkers Dialysis Center | Yonkers Dialysis | 575 YONKERS AVE | YONKERS | NY | 10704-2601 | ||||||||||
377 |
Affiliated | 537 | IHS - Queens Village | Queens Village Dialysis Center | 22202 HEMPSTEAD AVE | STE 17 | QUEENS VILLAGE | NY | 11429-2123 | |||||||||
378 |
Affiliated | 536 | Coney Island - IHS | Sheepshead Bay Renal Care Center (fka Coney Island) | 26 BRIGHTON 11TH ST | BROOKLYN | NY | 11235-5304 | ||||||||||
379 |
Affiliated | 521 | Garden City I.H.S | Garden City Dialysis Center | 1100 STEWART AVE | STE 2 | GARDEN CITY | NY | 11530-4839 | |||||||||
380 |
Affiliated | 267 | Kenneth Hahn- I.R.A | Kenneth Hahn Plaza Dialysis Center (Willowbrook) | 11854 S WILMINGTON AVE | LOS ANGELES | CA | 90059-3016 | ||||||||||
381 |
Affiliated | 279 | North Highland | North Highlands Dialysis Center | 4986 WATT AVE | STE F | NORTH HIGHLANDS | CA | 95660-5182 | |||||||||
382 |
Affiliated | 294 | TRC Orangevale | Orangevale Dialysis Center | 9267 GREENBACK LN | STE A2 | ORANGEVALE | CA | 95662-4864 | |||||||||
383 |
Affiliated | 554 | Forest Park Dialysis Center | Forest Park Dialysis Center | 380 FOREST PKWY | STE C | FOREST PARK | GA | 30297-2107 | |||||||||
384 |
Affiliated | 446 | Grant Park Nursing Home Dialysis | Grant Park Dialysis (fka Grants Park Nursing Home) | 5000 NANNIE HELEN BURROUGHS AVE NE | WASHINGTON | DC | 20019-5506 | ||||||||||
385 |
Affiliated | 455 | Fourth Street Dialysis | Fourth Street Dialysis | 3101 N 4TH ST | STE B | LONGVIEW | TX | 75605-5146 | |||||||||
386 |
Affiliated | 274 | Bay Breeze | Bay Breeze Dialysis | 11465 ULMERTON RD | LARGO | FL | 33778-1602 | ||||||||||
387 |
Affiliated | 416 | Hopi | Hopi Dialysis Center- fka First Mesa | PO BOX 964 | HWY 264 | POLACCA | AZ | 86042 | |||||||||
388 |
Affiliated | 178 | Orlando Dialysis | Orlando Dialysis | 14050 TOWN LOOP BLVD | STE 14A | ORLANDO | FL | 32837-6190 | |||||||||
389 |
Affiliated | 170 | Celebration Dialysis | Celebration Dialysis | 1154 CELEBRATION BLVD | CELEBRATION | FL | 34747-4605 | ||||||||||
390 |
Affiliated | 1500 | Mt. Dora Dialysis | Mt. Dora Dialysis | 2735 W OLD US HIGHWAY 441 | MOUNT DORA | FL | 32757-3526 | ||||||||||
391 |
Affiliated | 1501 | Lake Dialysis | Lake Dialysis | 221 N 1ST ST | LEESBURG | FL | 34748-5150 | ||||||||||
392 |
Affiliated | 146 | Puyallup Community Dialysis | Puyallup Dialysis Center | 716 SOUTH HILL PARK DR | STE C | PUYALLUP | WA | 98373-1445 | |||||||||
393 |
Affiliated | 562 | Towson Dialysis | Dulaney Towson Dialysis Center | 113 WEST RD | STE 21 | TOWSON | MD | 21204-2318 | |||||||||
394 |
Affiliated | 188 | Purcellville | Purcellville Dialysis Center | 280 N HATCHER AVE | PURCELLVILLE | VA | 20132-3193 | ||||||||||
395 |
Affiliated | 476 | Iris City | Iris City Dialysis (aka Griffin) | 521 N EXPRESSWAY | STE 159 | GRIFFIN | GA | 30223-2073 | |||||||||
396 |
Affiliated | 1521 | Slidell Kidney Care | Slidell Kidney Care | 1150 ROBERT BLVD | STE 24 | SLIDELL | LA | 70458-2005 |
Page 54 of 123
397 |
Affiliated | 385 | Rivertowne Dialysis | Rivertowne Dialysis (fka Oxon Hill Dialysis) | 6192 OXON HILL RD | 1ST FL | OXON HILL | MD | 20745-3114 | |||||||||
398 |
Affiliated | 477 | Pearland Dialysis | Pearland Dialysis | 6516 BROADWAY ST | STE 122 | PEARLAND | TX | 77581-7879 | |||||||||
399 |
Affiliated | 419 | East Aurora Dialysis | East Aurora Dialysis (aka Aurora II) | 482 S CHAMBERS RD | AURORA | CO | 80017-2092 | ||||||||||
400 |
Affiliated | 1507 | Merrillville Dialysis | CRC-Merrillville Dialysis Center | 9223 TAFT ST | MERRILLVILLE | IN | 46410-6911 | ||||||||||
401 |
Affiliated | 563 | Bricktown Dialysis | Bricktown Dialysis Center | 525 JACK MARTIN BLVD | FL 2 | BRICK | NJ | 08724-7735 | |||||||||
402 |
Affiliated | 423 | Sapulpa | Sapulpa Dialysis (fka Jenks-Sapulpa) | 9647 RIDGEVIEW ST | TULSA | OK | 74131-6205 | ||||||||||
403 |
Affiliated | 1526 | Ellijay Dialysis | Ellijay Dialysis | 449 INDUSTRIAL BLVD | STE 24 | ELLIJAY | GA | 30540-6724 | |||||||||
404 |
Affiliated | 1527 | Gainesville Dialysis | Gainesville Dialysis | 2545 FLINTRIDGE RD | STE 13 | GAINESVILLE | GA | 30501-7428 | |||||||||
405 |
Affiliated | 1528 | Newnan Dialysis | Newnan Dialysis | 1565 E HWY 34 | STE 13 | NEWNAN | GA | 30265 | |||||||||
406 |
Affiliated | 405 | Ocala Regional Kidney Center - North | OCALA North Dialysis Center | 2620 W HWY 316 | CITRA | FL | 32113-3555 | ||||||||||
407 |
Affiliated | 1516 | Pin Oak Dialysis | Pin Oak Dialysis Center (aka Katy II) | 1302 PIN OAK RD | KATY | TX | 77494-6848 | ||||||||||
408 |
Affiliated | 1523 | Imperial Care Dialysis | Imperial Care Dialysis Center | 4345 E IMPERIAL HWY | LYNWOOD | CA | 90262-2318 | ||||||||||
409 |
Affiliated | 1533 | St. Louis Park Dialysis | St. Louis Park Dialysis Center | 3505 LOUISIANA AVE S | ST LOUIS PARK | MN | 55426-4121 | ||||||||||
410 |
Affiliated | 1517 | Minneapolis NE Dialysis | Minneapolis NE Dialysis | 1049 10TH AVE SE | MINNEAPOLIS | MN | 55414-1312 | ||||||||||
411 |
Affiliated | 298 | Flushing Dialysis | Flushing Dialysis Center | 3469 PIERSON PL | STE A | FLUSHING | MI | 48433-2413 | |||||||||
412 |
Affiliated | 1535 | Dialysis Systems of Covington | Dialysis Systems of Covington | 210 GREENBRIAR BLVD | COVINGTON | LA | 70433-7235 | ||||||||||
413 |
Affiliated | 1536 | Dialysis Systems of Hammond | Dialysis Systems of Hammond | 15799 PROFESSIONAL PLZ | HAMMOND | LA | 70403-1452 | ||||||||||
414 |
Affiliated | 433 | Soledad Dialysis | Soledad Dialysis Center | 901 LOS COCHES DR | SOLEDAD | CA | 93960-2995 | ||||||||||
415 |
Affiliated | 443 | Lake Elsinore Dialysis | Lake Elsinore Dialysis | 32291 MISSION TRL | BLDG S | LAKE ELSINORE | CA | 92530 | |||||||||
416 |
Affiliated | 1511 | Clinton Dialysis Center | Clinton Dialysis Center | 150 S 31ST ST | CLINTON | OK | 73601-9118 | ||||||||||
417 |
Affiliated | 456 | Bakers Ferry | Bakers Ferry Dialysis | 3645 BAKERS FERRY RD SW | ATLANTA | GA | 30331-3712 | ||||||||||
418 |
Affiliated | 1509 | Hermiston | Hermiston Community Dialysis Center | 1155 W LINDA AVE | HERMISTON | OR | 97838-9601 | ||||||||||
419 |
Affiliated | 1539 | Yakima | Yakima Dialysis Center | 1221 N 16TH AVE | YAKIMA | WA | 98902-1347 | ||||||||||
420 |
Affiliated | 409 | Madison | Madison Dialysis Center | 302 HIGHWAY ST | MADISON | NC | 27025-1672 | ||||||||||
421 |
Affiliated | 1508 | Swannanoa Dialysis | Swannanoa Dialysis Center (fka Black Mountain, NC) | 2305 US HIGHWAY 70 | SWANNANOA | NC | 28778-8207 | ||||||||||
422 |
Affiliated | 2009 | NE Wichita Dialysis | NE Wichita Dialysis Center | 2630 N WEBB RD | STE 1 BLDG 1 | WICHITA | KS | 67226-8174 | |||||||||
423 |
Affiliated | 2005 | Chadbourn Dialysis | Chadbourn Dialysis Center (fkaColumbus County) | 210 STRAWBERRY BLVD | CHADBOURN | NC | 28431-1418 | ||||||||||
424 |
Affiliated | 1506 | Western Home Dialysis | Mile High Home Dialysis PD (fka Western Home) | 1750 PIERCE ST | STE A | LAKEWOOD | CO | 80214-1434 | |||||||||
425 |
Affiliated | 2019 | Tustin Dialysis | Tustin Dialysis (aka Santa Ana) | 2090 N TUSTIN AVE | STE 1 | SANTA ANA | CA | 92705-7869 | |||||||||
426 |
Affiliated | 182 | Appomatox | Appomattox Dialysis (Petersburg) | 15 W OLD ST | PETERSBURG | VA | 23803-3221 | ||||||||||
427 |
Affiliated | 2002 | Maryville Dialysis | Maryville Dialysis | 2130 VADALABENE DR | MARYVILLE | IL | 62062-5632 | ||||||||||
428 |
Affiliated | 2001 | Mission Hills | Mission Hills Dialysis (aka Cristo Rey) | 2700 N STANTON ST | EL PASO | TX | 79902-2500 | ||||||||||
429 |
Affiliated | 125 | Moncrief | Moncrief Dialysis Partners | 800 W 34TH ST | STE 11 | AUSTIN | TX | 78705-1144 | |||||||||
430 |
Affiliated | 295 | Southfield West Dialysis | Southfield West Dialysis | 21900 MELROSE AVE | STE 4 | SOUTHFIELD | MI | 48075-7967 | |||||||||
431 |
Affiliated | 525 | Neptune Dialysis | Neptune Dialysis Center | 2180 BRADLEY AVE | NEPTUNE | NJ | 07753-4427 | ||||||||||
432 |
Affiliated | 2014 | Portsmouth Dialysis | Portsmouth Dialysis Center | 2000 HIGH ST | PORTSMOUTH | VA | 23704-3012 | ||||||||||
433 |
Affiliated | 2016 | Tokay Dialysis | Tokay Dialysis Center (fka East Lodi, CA) | 312 S FAIRMONT AVE | STE A | LODI | CA | 95240-3840 | |||||||||
434 |
Affiliated | 1504 | Mt. Pocono Dialysis | Mt. Pocono Dialysis | 100 COMMUNITY DR | STE 16 | TOBYHANNA | PA | 18466-8986 | |||||||||
435 |
Affiliated | 1544 | Greater Portsmouth | Greater Portsmouth (aka Bon View Dialysis & Mid Town Hampton Road Dialysis) | 3516 QUEEN ST | PORTSMOUTH | VA | 23707-3238 | ||||||||||
436 |
Affiliated | 1545 | Peninsula Dialysis | Peninsula Dialysis Center (aka Immaculate Dialysis) | 716 DENBIGH BLVD | STE D1 AND D2 | NEWPORT NEWS | VA | 23608-4414 | |||||||||
437 |
Affiliated | 1540 | Saginaw Dialysis | Saginaw Dialysis | 1527 E GENESEE AVE | SAGINAW | MI | 48607-1755 | ||||||||||
438 |
Affiliated | 1560 | Churchview Dialysis | Churchview Dialysis | 5970 CHURCHVIEW DR | ROCKFORD | IL | 61107-2574 | ||||||||||
439 |
Affiliated | 1562 | Freeport Dialysis | Freeport Dialysis | 1028 S KUNKLE BLVD | FREEPORT | IL | 61032-6914 | ||||||||||
440 |
Affiliated | 1563 | Rockford Dialysis | Rockford Dialysis | 3339 N ROCKTON AVE | ROCKFORD | IL | 61103-2839 | ||||||||||
441 |
Affiliated | 1564 | Whiteside Dialysis | Whiteside Dialysis | 2600 N LOCUST | STE D | STERLING | IL | 61081-4602 | |||||||||
442 |
Affiliated | 2021 | Pikesville Dialysis | Pikesville Dialysis | 1500 REISTERSTOWN RD | STE 22 | PIKESVILLE | MD | 21208-3836 | |||||||||
443 |
Affiliated | 2000 | Waynesville Dialysis | Waynesville Dialysis Center (fka Haywood, NC) | 11 PARK TERRACE DR | CLYDE | NC | 28721-7445 | ||||||||||
444 |
Affiliated | 296 | Davison Dialysis | Davison Dialysis | 1011 S STATE RD | DAVISON | MI | 48423-1903 | ||||||||||
445 |
Affiliated | 1557 | Flint Dialysis | Flint Dialysis Center | 2 HURLEY PLZ | STE 115 | FLINT | MI | 48503-5904 | |||||||||
446 |
Affiliated | 1558 | Hallwood Dialysis | Hallwood Dialysis Center | 4929 CLIO RD | STE B | FLINT | MI | 48504-1886 | |||||||||
447 |
Affiliated | 1559 | Park Plaza Dialysis | Park Plaza Dialysis | G1075 N BALLENGER HWY | FLINT | MI | 48504-4431 | ||||||||||
448 |
Affiliated | 1518 | Rosemead Springs Dialysis | Rosemead Springs Dialysis Center | 3212 ROSEMEAD BLVD | EL MONTE | CA | 91731-2807 | ||||||||||
449 |
Affiliated | 2022 | Scottsdale Dialysis | Scottsdale Dialysis Center | 4725 N SCOTTSDALE RD | STE 1 | SCOTTSDALE | AZ | 85251-7621 | |||||||||
450 |
Affiliated | 1570 | Washington Parish Dialysis | Washington Parish Dialysis | 724 WASHINGTON ST | FRANKLINTON | LA | 70438-1790 | ||||||||||
451 |
Affiliated | 2027 | Brookhollow Dialysis | Brookhollow Dialysis | 4918 W 34TH ST | HOUSTON | TX | 77092-6606 | ||||||||||
452 |
Affiliated | 2017 | Creekside | Creekside Dialysis Center (fka So. Vacaville, CA) | 141 PARKER ST | VACAVILLE | CA | 95688-3921 | ||||||||||
453 |
Affiliated | 529 | Middletown | Middletown Dialysis Center (fka-Red Bank) | 500 STATE ROUTE 35 | UNION SQUARE PLAZA | RED BANK | NJ | 07701-5038 | |||||||||
454 |
Affiliated | 1541 | Southwest Ohio Dialysis | Southwest Ohio Dialysis (Xenia-SWORC) | 215 S ALLISON AVE | XENIA | OH | 45385-3694 | ||||||||||
455 |
Affiliated | 369 | Oak Park | Oak Park Dialysis Center | 13481 W 10 MILE RD | OAK PARK | MI | 48237-4633 | ||||||||||
456 |
Affiliated | 2042 | Eden Prairie | Eden Prairie Dialysis | 14852 SCENIC HEIGHTS RD | STE 255 BLDG B | EDEN PRAIRIE | MN | 55344-2320 | |||||||||
457 |
Affiliated | 1530 | Owensboro Dialysis | Owensboro Dialysis Center | 1930 E PARRISH AVE | OWENSBORO | KY | 42303-1443 | ||||||||||
458 |
Affiliated | 1531 | Tell City Dialysis | CRC-Tell City Dialysis Center | 1602 MAIN ST | TELL CITY | IN | 47586-1310 | ||||||||||
459 |
Affiliated | 1576 | Crestwood Dialysis | Crestwood Dialysis (fka Health Research Group-St. Louis (HRG)) | 9901 WATSON RD | STE 125 | SAINT LOUIS | MO | 63126-1855 | |||||||||
460 |
Affiliated | 2004 | Copperfield Dialysis | Copperfield Dialysis (fka Cabarrus County-NC, and Concord) | 1030 VINEHAVEN DR | CONCORD | NC | 28025-2438 | ||||||||||
461 |
Affiliated | 1572 | Grand Island Dialysis | Grand Island Dialysis | 603 S WEBB RD | GRAND ISLAND | NE | 68803-5141 | ||||||||||
462 |
Affiliated | 1573 | Harlan Dialysis | Harlan Dialysis | 1213 GARFIELD AVE | HARLAN | IA | 51537-2057 | ||||||||||
463 |
Affiliated | 1574 | Shenandoah Dialysis | Shenandoah Dialysis | 300 PERSHING AVE | SHENANDOAH | IA | 51601-2355 |
Page 55 of 123
464 |
Affiliated | 2053 | Germantown Dialysis | Germantown Dialysis | 20111 CENTURY BLVD | STE C | GERMANTOWN | MD | 20874-9165 | |||||||||
465 |
Affiliated | 2051 | Lamplighter Dialysis | Lamplighter Dialysis | 12654 LAMPLIGHTER SQUARE | ST LOUIS | MO | 63128 | ||||||||||
466 |
Affiliated | 1578 | Kidney Care of Largo | Kidney Care of Largo | 1300 MERCANTILE LN | STE 194 | UPPER MARLBORO | MD | 20774 | |||||||||
467 |
Affiliated | 1579 | Kidney Care of Laurel | Kidney Care of Laurel | 14631 LAUREL BOWIE ROAD | UNITS 1-15 | LAUREL | MD | 20707 | |||||||||
468 |
Affiliated | 2024 | Durant Dialysis | Durant Dialysis Center | 411 WESTSIDE DR | DURANT | OK | 74701-2932 | ||||||||||
469 |
Affiliated | 2038 | Palm Brook Dialysis | Palm Brook Dialysis Center | 14664 N DEL WEBB BLVD | SUN CITY | AZ | 85351-2137 | ||||||||||
470 |
Affiliated | 2043 | Cambridge Dialysis | Cambridge Dialysis Center | 300 BYRN ST | CAMBRIDGE | MD | 21613-1908 | ||||||||||
471 |
Affiliated | 2059 | Reston Dialysis Center | Reston Dialysis Center | 1875 CAMPUS COMMONS DR | STE 11 | RESTON | VA | 20191-1564 | |||||||||
472 |
Affiliated | 2040 | Franconia Dialysis | Franconia Dialysis Centre | 5695 KING CENTRE DRIVE | ALEXANDRIA | VA | 22315-5744 | ||||||||||
473 |
Affiliated | 2041 | Eagan Dialysis | Eagan Dialysis Unit | 2750 BLUE WATER RD | SUITE 3 | EAGAN | MN | 55121-1400 | |||||||||
474 |
Affiliated | 1594 | Central Des Moines Dialysis | Central Des Moines Dialysis | 1215 PLEASANT ST | STE 16 | DES MOINES | IA | 50309-1409 | |||||||||
475 |
Affiliated | 1595 | West Des Moines Dialysis | West Des Moines Dialysis | 6800 LAKE DR | STE 185 | WEST DES MOINES | IA | 50266-2544 | |||||||||
476 |
Affiliated | 1596 | Creston Dialysis | Creston Dialysis | 1700 W TOWNLINE ST | CRESTON | IA | 50801-1054 | ||||||||||
477 |
Affiliated | 1597 | Atlantic Dialysis | Atlantic Dialysis | 1500 E 10TH ST | ATLANTIC | IA | 50022-1935 | ||||||||||
478 |
Affiliated | 1598 | Newton Dialysis | Newton Dialysis | 204 N 4TH AVE E | STE 134 | NEWTON | IA | 50208-3135 | |||||||||
479 |
Affiliated | 2046 | Dialysis of Des Moines | Riverpoint Dialysis Unit | 501 SW 7TH ST | STE B | DES MOINES | IA | 50309-4538 | |||||||||
480 |
Affiliated | 2060 | Bellevue Dialysis | Bellevue Dialysis Center | 3535 FACTORIA BLVD SE | STE 15 | BELLEVUE | WA | 98006-1293 | |||||||||
481 |
Affiliated | 414 | Somerset Dialysis | Somerset Dialysis Center | 240 CHURCHILL AVE | SOMERSET | NJ | 08873-3451 | ||||||||||
482 |
Affiliated | 2031 | East Ft. Lauderdale Dialysis | East Ft. Lauderdale Dialysis Center (fka No. Broward) | 1301 S ANDREWS AVE | STE 11 | FT LAUDERDALE | FL | 33316-1823 | |||||||||
483 |
Affiliated | 1593 | Spring Branch Dialysis | Spring Branch Dialysis | 1425 BLALOCK | STE 1 | HOUSTON | TX | 77055-4446 | |||||||||
484 |
Affiliated | 1599 | Battle Creek Dialysis | Battle Creek Dialysis | 220 E GOODALE AVE | BATTLE CREEK | MI | 49037-2728 | ||||||||||
485 |
Affiliated | 2025 | Hampton Avenue Dialysis | Hampton Avenue Dialysis-MO (Forest Park) | 1425 HAMPTON AVE | SAINT LOUIS | MO | 63139-3115 | ||||||||||
486 |
Affiliated | 1605 | Bogalusa Kidney Care | Bogalusa Kidney Care | 2108 SOUTH AVE F | BOGALUSA | LA | 70427 | ||||||||||
487 |
Affiliated | 2055 | Bardstown Dialysis | Bardstown Dialysis Center | 210 W JOHN FITCH AVE | BARDSTOWN | KY | 40004-1115 | ||||||||||
488 |
Affiliated | 2050 | Southern Pines | Southern Pines Dialysis Center | 209 WINDSTAR PL | SOUTHERN PINES | NC | 28387-7086 | ||||||||||
489 |
Affiliated | 2030 | Montclare Dialysis | Montclare Dialysis Center (aka Belmont Ave) | 7009 W BELMONT AVE | CHICAGO | IL | 60634-4533 | ||||||||||
490 |
Affiliated | 2048 | Southern Hills | Southern Hills Dialysis Center | 9280 W SUNSET RD | STE 11 | LAS VEGAS | NV | 89148-4861 | |||||||||
491 |
Affiliated | 2068 | Kilgore Dialysis | Kilgore Dialysis Center | 209 HWY 42 NORTH | KILGORE | TX | 75662-5019 | ||||||||||
492 |
Affiliated | 2067 | Brighton Dialysis | Brighton Dialysis | 4700 E BROMLEY LN | STE 13 | BRIGHTON | CO | 80601-7821 | |||||||||
493 |
Affiliated | 2023 | Union Gap | Union Gap Dialysis (aka Yakima) | 1236 AHTANUM RIDGE DR | AHTANUM RIDGE BUSINESS PARK | UNION GAP | WA | 98903-1813 | |||||||||
494 |
Affiliated | 2039 | Dallas North Dialysis | Dallas North Dialysis Center (aka Greenville) | 11886 GREENVILLE AVE | STE 1B | DALLAS | TX | 75243-9743 | |||||||||
495 |
Affiliated | 2061 | Grovepark Dialysis | Grovepark Dialysis Center (fka Jackson Dialysis) | 794 MCDONOUGH RD | JACKSON | GA | 30233-1572 | ||||||||||
496 |
Affiliated | 1583 | Eastern Kentucky Dialysis | Eastern Kentucky Dialysis | 167 WEDDINGTON BRANCH RD | PIKEVILLE | KY | 41501-3204 | ||||||||||
497 |
Affiliated | 1584 | Paintsville Dialysis | Paintsville Dialysis | 4750 S KY ROUTE 321 | HAGERHILL | KY | 41222 | ||||||||||
498 |
Affiliated | 1582 | West Virginia Dialysis | West Virginia Dialysis | 300 PROSPERITY LANE | STE 15 | LOGAN | WV | 25601-3494 | |||||||||
499 |
Affiliated | 2049 | Reidsville Dialysis | Reidsville Dialysis | 1307 FREEWAY DR | REIDSVILLE | NC | 27320-7104 | ||||||||||
500 |
Affiliated | 2034 | Elk Grove Dialysis | Elk Grove Dialysis | 9281 OFFICE PARK CIR | STE 15 | ELK GROVE | CA | 95758-8069 | |||||||||
501 |
Affiliated | 2035 | Weston Dialysis | Weston Dialysis Center (fka Cleveland Clinic ) | 2685 EXECUTIVE PARK DR | STE 1 | WESTON | FL | 33331-3651 | |||||||||
502 |
Affiliated | 1600 | McCook Dialysis | McCook Dialysis Center | 801 W C ST | MCCOOK | NE | 69001-3591 | ||||||||||
503 |
Affiliated | 1601 | Hastings Dialysis | Hastings Dialysis Center | 1900 N SAINT JOSEPH AVE | HASTINGS | NE | 68901-2652 | ||||||||||
504 |
Affiliated | 1602 | Capital City Dialysis | Capital City Dialysis | 307 N 46TH ST | LINCOLN | NE | 68503-3714 | ||||||||||
505 |
Affiliated | 1616 | Renal Care of Bowie | Renal Care of Bowie | 4861 TELSA DRIVE | STES G-H | BOWIE | MD | 20715-4318 | |||||||||
506 |
Affiliated | 1617 | Renal Care of Takoma Park | Takoma Park Dialysis (fka Renal Care of Takoma Park) | 1502 UNIVERSITY BLVD E | HYATTSVILLE | MD | 20783 | ||||||||||
507 |
Affiliated | 1618 | Renal Care of Lanham | Renal Care of Lanham | 8855 ANNAPOLIS RD | STE 2 | LANHAM | MD | 20706-2942 | |||||||||
508 |
Affiliated | 1619 | Parma Dialysis | Parma Dialysis Center | 6735 AMES RD | CLEVELAND | OH | 44129-5601 | ||||||||||
509 |
Affiliated | 1620 | Middleburg Heights Dialysis | Middleburg Hts. Dialysis | 7360 ENGLE RD | MIDDLEBURG HTS | OH | 44130 | ||||||||||
510 |
Affiliated | 1621 | Rocky River Dialysis | Rocky River Dialysis | 20220 CENTER RIDGE RD | STE 5 | ROCKY RIVER | OH | 44116-3567 | |||||||||
511 |
Affiliated | 1606 | Diamond Valley Dialysis | Diamond Valley Dialysis | 1030 E FLORIDA AVE | HEMET | CA | 92543-4511 | ||||||||||
512 |
Affiliated | 1607 | Murrieta Dialysis | Murrieta Dialysis | 25100 HANCOCK AVE | STE 11 | MURRIETA | CA | 92562-5973 | |||||||||
513 |
Affiliated | 2057 | South Chico Dialysis | South Chico Dialysis Center | 2345 FOREST AVE | CHICO | CA | 95928-7641 | ||||||||||
514 |
Affiliated | 2099 | Dixon Kidney Center | Dixon Kidney Center | 1131 N GALENA AVE | DIXON | IL | 61021-1015 | ||||||||||
515 |
Affiliated | 1640 | Grand Rapids | PDI-Grand Rapids | 801 CHERRY ST SE | GRAND RAPIDS | MI | 49506-1440 | ||||||||||
516 |
Affiliated | 1641 | Grand Rapids East | PDI-Grand Rapids East | 1230 EKHART ST NE | GRAND RAPIDS | MI | 49503-1372 | ||||||||||
517 |
Affiliated | 1642 | Grand Haven | PDI-Grand Haven | 16964 ROBBINS RD | GRAND HAVEN | MI | 49417-2796 | ||||||||||
518 |
Affiliated | 1644 | Highland Park | PDI-Highland Park | 64 VICTOR ST | HIGHLAND PARK | MI | 48203-3128 | ||||||||||
519 |
Affiliated | 1645 | Cadieux | PDI-Cadieux | 6150 CADIEUX ROAD | DETROIT | MI | 48224-2006 | ||||||||||
520 |
Affiliated | 1646 | Montgomery | PDI-Montgomery | 1001 FOREST AVE | MONTGOMERY | AL | 36106-1181 | ||||||||||
521 |
Affiliated | 1647 | East Montgomery | PDI-East Montgomery | 6890 WINTON BLOUNT BLVD | MONTGOMERY | AL | 36117-3516 | ||||||||||
522 |
Affiliated | 1648 | Prattville | PDI-Prattville | 1815 GLYNWOOD DR | PRATTVILLE | AL | 36066-5584 | ||||||||||
523 |
Affiliated | 1649 | Elmore | PDI-Elmore | 125 HOSPITAL DR | WETUMPKA | AL | 36092-1626 | ||||||||||
524 |
Affiliated | 1650 | Fitchburg | PDI-Fitchburg | 551 ELECTRIC AVE | FITCHBURG | MA | 01420-5371 | ||||||||||
525 |
Affiliated | 1652 | Rocky Hill | PDI-Rocky Hill | 30 WATERCHASE DR | ROCKY HILL | CT | 06067-2110 | ||||||||||
526 |
Affiliated | 1653 | Middlesex | PDI-Middlesex Dialysis Center | 100 MAIN ST | STE A | MIDDLETOWN | CT | 06457-3477 | |||||||||
527 |
Affiliated | 1655 | Johnstown | PDI-Johnstown | 344 BUDFIELD ST | JOHNSTOWN | PA | 15904-3214 | ||||||||||
528 |
Affiliated | 1656 | Ebensburg | PDI-Ebensburg | 236 JAMESWAY RD | EBENSBURG | PA | 15931-4207 | ||||||||||
529 |
Affiliated | 1657 | Walnut Tower | PDI-Walnut Tower | 834 WALNUT ST | PHILADELPHIA | PA | 19107-5109 | ||||||||||
530 |
Affiliated | 1659 | Lancaster | PDI-Lancaster | 1412 E KING ST | LANCASTER | PA | 17602-3240 |
Page 56 of 123
531 |
Affiliated | 1660 | Ephrata | PDI-Ephrata | 67 W CHURCH ST | STEVENS | PA | 17578-9203 | ||||||||||
532 |
Affiliated | 2083 | Pinecrest Dialysis | Pinecrest Dialysis (aka North Marshall-TX) | 913 E PINECREST DR | MARSHALL | TX | 75670-7309 | ||||||||||
533 |
Affiliated | 551 | Westwood Dialysis | Westwood Dialysis Center (aka West Seattle) | 2615 SW TRENTON ST | SEATTLE | WA | 98126-3745 | ||||||||||
534 |
Affiliated | 2107 | Louisville Dialysis | Louisville Dialysis | 8037 DIXIE HWY | LOUISVILLE | KY | 40258-1344 | ||||||||||
535 |
Affiliated | 2018 | Fair Oaks Dialysis | Fair Oaks Dialysis Center (fka Chantilly & Centreville) | 3955 PENDER DR | ONE PENDER BUSINESS PARK | FAIRFAX | VA | 22030-6091 | |||||||||
536 |
Affiliated | 421 | Oak Cliff | Oak Cliff Dialysis | 2000 S LLEWELLYN AVE | DALLAS | TX | 75224-1804 | ||||||||||
537 |
Affiliated | 2126 | Gilmer Dialysis | Gilmer Dialysis Center | 519 N WOOD ST | GILMER | TX | 75644-1746 | ||||||||||
538 |
Affiliated | 1608 | Chicago Heights Dialysis | Chicago Heights Dialysis | 177 W JOE ORR RD | STE B | CHICAGO HEIGHTS | IL | 60411-1733 | |||||||||
539 |
Affiliated | 1623 | East Georgia Dialysis | East Georgia Dialysis | 450 GEORGIA AVE | STE A | STATESBORO | GA | 30458-5590 | |||||||||
540 |
Affiliated | 1639 | Northlake Dialysis | Northlake Dialysis | 1350 MONTREAL RD | STE 2 | TUCKER | GA | 30084-8144 | |||||||||
541 |
Affiliated | 1680 | Down River Dialysis | Downriver Kidney Center | 5600 ALLEN RD | ALLEN PARK | MI | 48101-2604 | ||||||||||
542 |
Affiliated | 2063 | Belcaro | Belcaro Dialysis Center | 755 S COLORADO BLVD | DENVER | CO | 80246-8005 | ||||||||||
543 |
Affiliated | 2076 | Sherwood Dialysis Center | Sherwood Dialysis Center | 21035 SW PACIFIC HWY | SHERWOOD | OR | 97140-8062 | ||||||||||
544 |
Affiliated | 2054 | Lonetree Dialysis | Lonetree Dialysis Center (aka Skyridge) | 9777 MOUNT PYRAMID CT | STE 14 | ENGLEWOOD | CO | 80112-6017 | |||||||||
545 |
Affiliated | 2078 | River Park Dialysis | River Park Dialysis (aka Conroe) | 2010 S LOOP 336 W | STE 2 | CONROE | TX | 77304-3313 | |||||||||
546 |
Affiliated | 2058 | Northshore Dialysis | Northshore Kidney Center (fka Slidell II) | 106 MEDICAL CENTER DR | SLIDELL | LA | 70461-5575 | ||||||||||
547 |
Affiliated | 2036 | Marysville Dialysis | Marysville Dialysis Center | 1015 8TH ST | MARYSVILLE | CA | 95901-5271 | ||||||||||
548 |
Affiliated | 2070 | West Georgia Dialysis | West Georgia Dialysis | 1216 STARK AVE | COLUMBUS | GA | 31906-2500 | ||||||||||
549 |
Affiliated | 2102 | East Dearborn Dialysis | Westland Dialysis (aka Canton) | 36588 FORD RD | WESTLAND | MI | 48185-3769 | ||||||||||
550 |
Affiliated | 2045 | Downtown Houston Dialysis | Downtown Houston Dialysis Center | 2207 CRAWFORD ST | HOUSTON | TX | 77002-8915 | ||||||||||
551 |
Affiliated | 2066 | Concord Dialysis | Concord Dialysis Center | 2300 STANWELL DR | STE C | CONCORD | CA | 94520-4841 | |||||||||
552 |
Affiliated | 2087 | Pendleton Dialysis | Pendleton Dialysis (aka Clemson, Tri-County) | 7703 HIGHWAY 76 | PENDLETON | SC | 29670-1818 | ||||||||||
553 |
Affiliated | 2106 | New Albany Dialysis | New Albany Dialysis | 2669 CHARLESTON RD | NEW ALBANY | IN | 47150-2573 | ||||||||||
554 |
Affiliated | 1585 | Whitesburg Dialysis | Whitesburg Dialysis | 222 HOSPITAL RD | STE D | WHITESBURG | KY | 41858-7627 | |||||||||
555 |
Affiliated | 2047 | Jacinto Dialysis | Jacinto Dialysis Center (aka East Houston) | 11515 MARKET STREET RD | HOUSTON | TX | 77029-2305 | ||||||||||
556 |
Affiliated | 2088 | Transmountain Dialysis | Transmountain Dialysis (aka Northeast El Paso, Rushfair) | 5255 WOODROW BEAN | STE B18 | EL PASO | TX | 79924-3832 | |||||||||
557 |
Affiliated | 2029 | Southcrest Dialysis | Southcrest Dialysis (aka South Creek) | 9001 S 101ST EAST AVE | STE 11 | TULSA | OK | 74133-5799 | |||||||||
558 |
Affiliated | 2071 | Lake Hearn | Lake Hearn Dialysis (aka Dunwoody, Roswell, Northside) | 1150 LAKE HEARN DR NE | STE 1 | ATLANTA | GA | 30342-1566 | |||||||||
559 |
Affiliated | 2118 | Mt. Greenwood | Mt. Greenwood Dialysis | 3401 W 111TH ST | CHICAGO | IL | 60655-3329 | ||||||||||
560 |
Affiliated | 2086 | Citrus Valley Dialysis Center | Citrus Valley Dialysis (aka San Bernadino II) | 894 HARDT STREET | SAN BERNARDINO | CA | 92408-2854 | ||||||||||
561 |
Affiliated | 2095 | McDowell County Dialysis | McDowell County Dialysis Center | 100 SPAULDING RD | STE 2 | MARION | NC | 28752-5116 | |||||||||
562 |
Affiliated | 2115 | Leigh Dialysis Center | Leigh Dialysis Center (aka Leigh-Kempville-VA) | 420 N CENTER DR | STE 128 | NORFOLK | VA | 23502-4019 | |||||||||
563 |
Affiliated | 2120 | Dialysis of Lithonia | Dialysis of Lithonia | 2485 PARK CENTRAL BLVD | DECATUR | GA | 30035-3902 | ||||||||||
564 |
Affiliated | 2114 | Embassy Lake Artificial Kidney Center | Embassy Lake Artificial Kidney Center (fka Davie & South Broward AKC) | 11011 SHERIDAN ST | STE 38 | HOLLYWOOD | FL | 33026-1505 | |||||||||
565 |
Affiliated | 2056 | Sun City Dialysis | Sun City Dialysis (akaTexas Tech II) | 600 NEWMAN ST | EL PASO | TX | 79902-5543 | ||||||||||
566 |
Affiliated | 1651 | PDI Worcester | PDI-Worcester Dialysis | 19 GLENNIE ST | STE A | WORCESTER | MA | 01605-3918 | |||||||||
567 |
Affiliated | 2130 | Davenport Dialysis Center | Davenport Dialysis Center (aka Haines City II) | 45597 HIGHWAY 27 | RIDGEVIEW PLAZA | DAVENPORT | FL | 33897-4519 | |||||||||
568 |
Affiliated | 2081 | Cinema Dialysis | Cinema Dialysis (aka OKC South) | 3909 S WESTERN AVE | OKLAHOMA CITY | OK | 73109-3405 | ||||||||||
569 |
Affiliated | 2037 | Greenwood Dialysis Center | Greenwood Dialysis Center (North Tulsa) | 1345 N LANSING AVE | TULSA | OK | 74106-5911 | ||||||||||
570 |
Affiliated | 1712 | TRC Alamosa Diakysis | Alamosa Dialysis | 612 DEL SOL DR | ALAMOSA | CO | 81101-8548 | ||||||||||
571 |
Affiliated | 1682 | South Austin | South Austin Dialysis | 6114 S 1ST ST | AUSTIN | TX | 78745-4008 | ||||||||||
572 |
Affiliated | 2109 | Durango Dialysis Center | Durango Dialysis Center | 72 SUTTLE STREET | STE D | DURANGO | CO | 81303-6829 | |||||||||
573 |
Affiliated | 1700 | Bolivar Dialysis | Bolivar Dialysis | 515 PECAN DR | BOLIVAR | TN | 38008-1611 | ||||||||||
574 |
Affiliated | 1701 | Brownsville Dialysis | Brownsville Dialysis | 380 N DUPREE AVE | BROWNSVILLE | TN | 38012-2332 | ||||||||||
575 |
Affiliated | 1702 | Camden Dialysis | Camden Dialysis | 168 W MAIN ST | STE A | CAMDEN | TN | 38320-1767 | |||||||||
576 |
Affiliated | 1703 | Collierville Dialysis | Collierville Dialysis | 791 W POPLAR AVE | COLLIERVILLE | TN | 38017-2543 | ||||||||||
577 |
Affiliated | 1705 | Galleria Dialysis | Galleria Dialysis | 9160 HIGHWAY 64 | LAKELAND | TN | 38002-4766 | ||||||||||
578 |
Affiliated | 1706 | Humboldt Dialysis | Humboldt Dialysis | 2214 OSBORNE ST | HUMBOLDT | TN | 38343-3044 | ||||||||||
579 |
Affiliated | 1707 | Stonegate Dialysis | North Jackson Dialysis (fka Stonegate) | 217 STERLING FARM DR | JACKSON | TN | 38305-5727 | ||||||||||
580 |
Affiliated | 1708 | Lexington Dialysis | Lexington Dialysis | 317 W CHURCH ST | LEXINGTON | TN | 38351-2096 | ||||||||||
581 |
Affiliated | 1709 | Pickwick Dialysis | Pickwick Dialysis | 121 PICKWICK ST | SAVANNAH | TN | 38372-1953 | ||||||||||
582 |
Affiliated | 1710 | Selmber Dialysis | Selmer Dialysis | 251 OAKGROVE RD | SELMER | TN | 38375-1881 | ||||||||||
583 |
Affiliated | 1713 | Childs Dialysis | Childs Dialysis | 101 MAIN ST | CHILDS | PA | 18407-2614 | ||||||||||
584 |
Affiliated | 1714 | Dunmore Dialysis | Dunmore Dialysis | 1212 ONEIL HWY | DUNMORE | PA | 18512-1717 | ||||||||||
585 |
Affiliated | 1716 | Old Forge Dialysis | Old Forge Dialysis | 325 S MAIN ST | OLD FORGE | PA | 18518-1677 | ||||||||||
586 |
Affiliated | 1717 | Scranton Dialysis | Scranton Dialysis | 475 MORGAN HWY | SCRANTON | PA | 18508-2605 | ||||||||||
587 |
Affiliated | 1718 | Tunkhannock Dialysis | Tunkhannock Dialysis | 5950 SR 6 | TUNKHANNOCK | PA | 18657-7905 | ||||||||||
588 |
Affiliated | 1725 | East Evansville Dialysis | East Evansville Dialysis | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | ||||||||||
589 |
Affiliated | 1726 | North Evansville Dialysis | North Evansville Dialysis | 1151 W BUENA VISTA RD | EVANSVILLE | IN | 47710-3334 | ||||||||||
590 |
Affiliated | 1728 | Jasper Dialysis | Jasper Dialysis | 721 W 13TH ST | STE 15 | JASPER | IN | 47546-1856 | |||||||||
591 |
Affiliated | 1729 | Daviess County Dialysis | Daviess County Dialysis | 310 NE 14TH ST | WASHINGTON | IN | 47501-2137 | ||||||||||
592 |
Affiliated | 1730 | Gardenside Dialysis | Gardenside Dialysis | 70 N GARDENMILE RD | HENDERSON | KY | 42420-5529 | ||||||||||
593 |
Affiliated | 1732 | PD Evansville Dialysis | East Evansville Dialysis PD | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | ||||||||||
594 |
Affiliated | 2098 | Meridian Dialysis Center | Meridian Dialysis Center (aka Bayshore) | 201 W FAIRMONT PKWY | STE A | LA PORTE | TX | 77571-6303 | |||||||||
595 |
Affiliated | 2100 | Sycamore Dialysis | Sycamore Dialysis (aka DeKalb) | 2200 GATEWAY DR | SYCAMORE | IL | 60178-3113 | ||||||||||
596 |
Affiliated | 2104 | Ballenger Pointe Dialysis | Ballenger Pointe Dialysis (aka West Flint) | 2262 S BALLENGER HWY | FLINT | MI | 48503-3447 | ||||||||||
597 |
Affiliated | 2139 | Leitchfield Dialysis | Leitchfield Dialysis | 912 WALLACE AVE | STE 16 | LEITCHFIELD | KY | 42754-2405 |
Page 57 of 123
598 |
Affiliated | 2097 | Roxbury Dialysis Center | Roxbury Dialysis | 622 ROXBURY RD | ROCKFORD | IL | 61107-5089 | ||||||||||
599 |
Affiliated | 2148 | LaGrange Dialysis | La Grange Dialysis | 240 PARKER DR | LA GRANGE | KY | 40031-1200 | ||||||||||
600 |
Affiliated | 2132 | Des Moines East | East Des Moines Dialysis (aka Des Moines II) | 1301 PENNSYLVANIA AVE | STE 28 | DES MOINES | IA | 50316-2365 | |||||||||
601 |
Affiliated | 2119 | Lake Villa Dialysis | Lake Villa Dialysis | 37809 N IL ROUTE 59 | LAKE VILLA | IL | 60046-7332 | ||||||||||
602 |
Affiliated | 159 | Seneca Dialysis | Seneca County Dialysis | 65 SAINT FRANCIS AVE | TIFFIN | OH | 44883-3413 | ||||||||||
603 |
Affiliated | 407 | Perry | Perry Dialysis Center | 1027 KEITH DR | PERRY | GA | 31069-2948 | ||||||||||
604 |
Affiliated | 661 | Wilshire | Wilshire Dialysis | 1212 WILSHIRE BLVD | LOS ANGELES | CA | 90017-1902 | ||||||||||
605 |
Affiliated | 692 | University Park | University Park Dialysis Center | 3986 S FIGUEROA ST | LOS ANGELES | CA | 90037-1222 | ||||||||||
606 |
Affiliated | 1720 | Metro East Dialysis | Metro East Dialysis | 5105 W MAIN ST | BELLEVILLE | IL | 62226-4728 | ||||||||||
607 |
Affiliated | 2196 | Ocala Regional Kidney Centers | Ocala Regional Kidney Centers Home Dialysis Division PD | 2860 SE 1ST AVE | OCALA | FL | 34471-0406 | ||||||||||
608 |
Affiliated | 2133 | Little Village Dialysis | Little Village Dialysis (Chicago) | 2335 W CERMAK RD | CHICAGO | IL | 60608-3811 | ||||||||||
609 |
Affiliated | 2112 | Crossroads | Crossroads Dialysis (aka Fullerton Dialysis) | 3214 YORBA LINDA BLVD | FULLERTON | CA | 92831-1707 | ||||||||||
610 |
Affiliated | 1727 | Vincennes Dialysis | Vincennes Dialysis | 700 WILLOW ST | VINCENNES | IN | 47591-1028 | ||||||||||
611 |
Affiliated | 1723 | Spring Dialysis | Spring Dialysis | 607 TIMBERDALE LN | STE 1 | HOUSTON | TX | 77090-3043 | |||||||||
612 |
Affiliated | 2190 | River Center | Rivercenter Dialysis (aka Central San Antonio) | 1123 N MAIN AVE | STE 15 | SAN ANTONIO | TX | 78212-4738 | |||||||||
613 |
Affiliated | 2193 | Southcross Dialysis Center | Southcross Dialysis (aka SouthEast San Antonio) | 4602 E SOUTHCROSS BLVD | SAN ANTONIO | TX | 78222-4911 | ||||||||||
614 |
Affiliated | 2125 | Bonham Dialysis | Bonham Dialysis | 201 W 5TH ST | BONHAM | TX | 75418-4302 | ||||||||||
615 |
Affiliated | 2192 | Northwest Medical Center Dialysis | NW Medical Center Dialysis (aka NorthWest San Antonio) | 5284 MEDICAL DR | STE 1 | SAN ANTONIO | TX | 78229-4849 | |||||||||
616 |
Affiliated | 2124 | Ontario Dialysis | Ontario Dialysis (aka Dr. Handoko) | 1950 S GROVE AVE | STE 11-15 | ONTARIO | CA | 91761-5693 | |||||||||
617 |
Affiliated | 1750 | Chipley Community Dialysis | Chipley Dialysis | 877 3RD ST | STE 2 | CHIPLEY | FL | 32428-1855 | |||||||||
618 |
Affiliated | 1751 | North Ikaloosa | North Okaloosa Dialysis | 320 REDSTONE AVE W | CRESTVIEW | FL | 32536-6433 | ||||||||||
619 |
Affiliated | 1752 | West Florida Dialysis | West Florida Dialysis | 8333 N DAVIS HWY | 1ST FLOOR ATTN DIALYSIS ROOM | PENSACOLA | FL | 32514-6049 | |||||||||
620 |
Affiliated | 1753 | Santa Rosa Dialysis | Santa Rosa Dialysis | 5819 HIGHWAY 90 | MILTON | FL | 32583-1763 | ||||||||||
621 |
Affiliated | 1755 | Atmore Dialysis | Atmore Dialysis Center | 807 E CRAIG ST | ATMORE | AL | 36502-3017 | ||||||||||
622 |
Affiliated | 1756 | South Baldwin Dialysis | South Baldwin Dialysis Center | 150 W PEACHTREE AVE | FOLEY | AL | 36535-2244 | ||||||||||
623 |
Affiliated | 1731 | Olney Dialysis | Olney Dialysis Center (aka Good Samaritan Hospital) | 117 N BOONE ST | OLNEY | IL | 62450-2109 | ||||||||||
624 |
Affiliated | 2156 | Lancaster Dialysis | Lancaster Dialysis | 2424 W PLEASANT RUN RD | LANCASTER | TX | 75146-4005 | ||||||||||
625 |
Affiliated | 2136 | Columbia Dialysis | RTC-Columbia Dialysis (MO) | 1701 E BROADWAY | STE G12 | COLUMBIA | MO | 65201-8029 | |||||||||
626 |
Affiliated | 2194 | Las Palmas Dialysis Center | Las Palmas Dialysis Center (aka West San Antonio) | 803 CASTROVILLE RD | STE 415 | SAN ANTONIO | TX | 78237-3148 | |||||||||
627 |
Affiliated | 2116 | South Shore Dialysis Center | South Shore Dialysis (aka Horizon) | 212 GULF FWY S | STE G3 | LEAGUE CITY | TX | 77573-3957 | |||||||||
628 |
Affiliated | 2191 | Marymount Dilaysis Center | Marymont Dialysis (aka NorthEast San Antonio) | 2391 NE LOOP 410 | STE 211 | SAN ANTONIO | TX | 78217-5675 | |||||||||
629 |
Affiliated | 1744 | Fox River Dialysis | Fox River Dialysis | 1910 RIVERSIDE DR | GREEN BAY | WI | 54301-2319 | ||||||||||
630 |
Affiliated | 1745 | Titletown Dialysis | Titletown Dialysis | 120 SIEGLER ST | GREEN BAY | WI | 54303-2636 | ||||||||||
631 |
Affiliated | 1746 | Northwoods Dialysis | Green Bay Northwood Dialysis | W 7305 ELM AVENUE | SHAWANO | WI | 54166-1024 | ||||||||||
632 |
Affiliated | 1758 | North Charleston Dialysis | North Charleston Dialysis | 5900 RIVERS AVE | STE E | NORTH CHARLESTON | SC | 29406 | |||||||||
633 |
Affiliated | 1759 | Charleston County Dialysis | Faber Place Dialysis | 3801 FABER PLACE DR | NORTH CHARLESTON | SC | 29405-8533 | ||||||||||
634 |
Affiliated | 1760 | Goose Creek Dialysis | Goose Creek Dialysis | 109 GREENLAND DR | GOOSE CREEK | SC | 29445-5354 | ||||||||||
635 |
Affiliated | 2501 | Bridgeport Dialysis | Bridgeport Dialysis | 900 MADISON AVE | STE 221 | BRIDGEPORT | CT | 06606-5534 | |||||||||
636 |
Affiliated | 2503 | Greater Waterbury Dialysis | Greater Waterbury Dialysis | 209 HIGHLAND AVE | WATERBURY | CT | 06708-3026 | ||||||||||
637 |
Affiliated | 2506 | Shelton Dialysis | Shelton Dialysis | 750 BRIDGEPORT AVE | SHELTON | CT | 06484-4734 | ||||||||||
638 |
Affiliated | 2508 | Yuma Dialysis | Yuma Dialysis | 2130 W 24TH ST | YUMA | AZ | 85364-6122 | ||||||||||
639 |
Affiliated | 2509 | Pittsburgh Dialysis | Pittsburgh Dialysis | 4312 PENN AVE | PITTSBURGH | PA | 15224-1310 | ||||||||||
640 |
Affiliated | 2510 | Elizabeth Dialysis | Elizabeth Dialysis | 201 MCKEESPORT RD | ELIZABETH | PA | 15037-1623 | ||||||||||
641 |
Affiliated | 2511 | Brandon East Dialysis | Brandon East Dialysis | 114 E BRANDON BLVD | BRANDON | FL | 33511-5219 | ||||||||||
642 |
Affiliated | 2513 | North Rolling Road Dialysis | North Rolling Road Dialysis | 1108 N ROLLING RD | BALTIMORE | MD | 21228-3826 | ||||||||||
643 |
Affiliated | 2521 | Memphis South Dialysis | Memphis South Dialysis | 1205 MARLIN RD | MEMPHIS | TN | 38116-5812 | ||||||||||
644 |
Affiliated | 2524 | Hartford Dialysis | Hartford Dialysis | 675 TOWER AVE | RENAL UNIT 2ND FL | HARTFORD | CT | 6112 | |||||||||
645 |
Affiliated | 2538 | New Orleans Uptown Dialysis | New Orleans Uptown Dialysis | 1401 FOUCHER ST | 4TH FLOOR DIALYSIS | NEW ORLEANS | LA | 70115-3515 | |||||||||
646 |
Affiliated | 2540 | Omaha West Dialysis | Omaha West Dialysis | 13014 W DODGE RD | OMAHA | NE | 68154-2148 | ||||||||||
647 |
Affiliated | 2541 | White Memorial Dialysis | East Los Angeles Plaza Dialysis (fka White Memorial) | 1700 E CESAR E CHAVEZ AVE | STE L 1 | LOS ANGELES | CA | 90033-2424 | |||||||||
648 |
Affiliated | 2542 | Imperial Dialysis | Imperial Dialysis | 2738 W IMPERIAL HWY | INGLEWOOD | CA | 90303-3111 | ||||||||||
649 |
Affiliated | 2546 | North Hollywood Dialysis | North Hollywood Dialysis | 12126 VICTORY BLVD | NORTH HOLLYWOOD | CA | 91606-3205 | ||||||||||
650 |
Affiliated | 2555 | Mountain View Dialysis | Mountain View Dialysis | 2881 BUSINESS PARK CT | STE 13 | LAS VEGAS | NV | 89128-9019 | |||||||||
651 |
Affiliated | 2560 | San Juan Capistrano South Dialysis | San Juan Capistrano South Dialysis | 31736 RANCHO VIEJO RD | STE B | SAN JUAN CAPISTRANO | CA | 92675-2783 | |||||||||
652 |
Affiliated | 2564 | Mission Viejo Dialysis | Mission Viejo Dialysis | 27640 MARGUERITE PKWY | MISSION VIEJO | CA | 92692-3604 | ||||||||||
653 |
Affiliated | 2568 | HI-Desert Dialysis | HI-Desert Dialysis | 58457 29 PALMS HWY | STE 12 | YUCCA VALLEY | CA | 92284-5879 | |||||||||
654 |
Affiliated | 2571 | Banning Dialysis | Banning Dialysis | 6090 W RAMSEY ST | BANNING | CA | 92220-3052 | ||||||||||
655 |
Affiliated | 2601 | Rainbow City Dialysis | Rainbow City Dialysis | 2800 RAINBOW DR | RAINBOW CITY | AL | 35906-5811 | ||||||||||
656 |
Affiliated | 2604 | Gadsden Dialysis | Gadsden Dialysis | 409 S 1ST ST | GADSDEN | AL | 35901-5358 | ||||||||||
657 |
Affiliated | 2605 | Chateau Dialysis | Chateau Dialysis | 720 VILLAGE RD | KENNER | LA | 70065-2751 | ||||||||||
658 |
Affiliated | 2606 | Donaldsonville Dialysis | Donaldsonville Dialysis | 101 PLIMSOL DR | DONALDSONVILLE | LA | 70346-4357 | ||||||||||
659 |
Affiliated | 2609 | Dothan Dialysis | Dothan Dialysis | 216 GRACELAND DR | DOTHAN | AL | 36305-7346 | ||||||||||
660 |
Affiliated | 2614 | Birmingham East Dialysis | Birmingham East Dialysis | 1105 E PARK DR | BIRMINGHAM | AL | 35235-2560 | ||||||||||
661 |
Affiliated | 2615 | Tuscaloosa Dialysis | Tuscaloosa Dialysis | 805 OLD MILL ST | TUSCALOOSA | AL | 35401-7132 | ||||||||||
662 |
Affiliated | 2616 | Demopolis Dialysis | Demopolis Dialysis | 511 S CEDAR AVE | DEMOPOLIS | AL | 36732-2235 | ||||||||||
663 |
Affiliated | 2623 | Singing River Dialysis | Singing River Dialysis | 4907 TELEPHONE RD | PASCAGOULA | MS | 39567-1823 | ||||||||||
664 |
Affiliated | 2624 | Ocean Springs Dialysis | Ocean Springs Dialysis | 13150 PONCE DE LEON DR | OCEAN SPRINGS | MS | 39564-2460 |
Page 58 of 123
665 |
Affiliated | 2625 | Lucedale Dialysis | Lucedale Dialysis | 652 MANILA ST | LUCEDALE | MS | 39452-5962 | ||||||||||
666 |
Affiliated | 2707 | Holmdel Dialysis | Holmdel Dialysis | 668 N BEERS ST | HOLMDEL | NJ | 07733-1526 | ||||||||||
667 |
Affiliated | 2855 | Alameda County Dialysis | Alameda County Dialysis | 10700 MACARTHUR BLVD | STE 14 | OAKLAND | CA | 94605-5260 | |||||||||
668 |
Affiliated | 2908 | Elizabeth City Dialysis | Elizabeth City Dialysis | 1840 W CITY DR | ELIZABETH CITY | NC | 27909-9632 | ||||||||||
669 |
Affiliated | 2914 | Cookeville Dialysis | Cookeville Dialysis | 140 W 7TH ST | COOKEVILLE | TN | 38501-1726 | ||||||||||
670 |
Affiliated | 3001 | Inglewood Dialysis | Inglewood Dialysis | 125 E ARBOR VITAE ST | INGLEWOOD | CA | 90301-3839 | ||||||||||
671 |
Affiliated | 3002 | Rome Dialysis | Rome Dialysis | 15 JOHN MADDOX DR NW | ROME | GA | 30165-1413 | ||||||||||
672 |
Affiliated | 3004 | Pomona Dialysis | Pomona Dialysis | 2111 N GAREY AVE | POMONA | CA | 91767-2328 | ||||||||||
673 |
Affiliated | 3005 | Oak Street Dialysis | Oak Street Dialysis (fka Valdosta) | 2704 N OAK ST | BLDG H | VALDOSTA | GA | 31602-1723 | |||||||||
674 |
Affiliated | 3006 | Channelview Dialysis | Channelview Dialysis | 777 SHELDON RD | STE C | CHANNELVIEW | TX | 77530-3509 | |||||||||
675 |
Affiliated | 3007 | Sagemont Dialysis | Sagemont Dialysis | 10851 SCARSDALE BLVD | STE 2 | HOUSTON | TX | 77089-5738 | |||||||||
676 |
Affiliated | 3008 | San Jacinto Dialysis | San Jacinto Dialysis | 11430 EAST FWY | STE 33 | HOUSTON | TX | 77029-1959 | |||||||||
677 |
Affiliated | 3009 | Victor Valley Dialysis | Victor Valley Dialysis | 16049 KAMANA RD | APPLE VALLEY | CA | 92307-1331 | ||||||||||
678 |
Affiliated | 3010 | Delran Dialysis | Delran Dialysis | 8008 ROUTE 130 | DELRAN | NJ | 08075-1869 | ||||||||||
679 |
Affiliated | 3011 | Central Houston Dialysis | Central Houston Dialysis | 610 S WAYSIDE DR | UNIT B | HOUSTON | TX | 77011-4605 | |||||||||
680 |
Affiliated | 3012 | Southern Lane Dialysis | Southern Lane Dialysis | 1840 SOUTHERN LN | DECATUR | GA | 30033-4033 | ||||||||||
681 |
Affiliated | 3013 | Northumberland Dialysis | Northumberland Dialysis | 103 W STATE ROUTE 61 | MOUNT CARMEL | PA | 17851-2539 | ||||||||||
682 |
Affiliated | 3014 | Pryor Dialysis | Pryor Dialysis | 309 E GRAHAM AVE | PRYOR | OK | 74361-2434 | ||||||||||
683 |
Affiliated | 3015 | Oklahoma City South Dialysis | Oklahoma City South Dialysis | 5730 S MAY AVE | OKLAHOMA CITY | OK | 73119-5604 | ||||||||||
684 |
Affiliated | 3016 | Abington Dialysis | Abington Dialysis | 3940A COMMERCE AVE | WILLOW GROVE | PA | 19090-1705 | ||||||||||
685 |
Affiliated | 3017 | Memphis Central Dialysis | Memphis Central Dialysis | 889 LINDEN AVE | MEMPHIS | TN | 38126-2412 | ||||||||||
686 |
Affiliated | 3018 | Memphis East Dialysis | Memphis East Dialysis | 50 HUMPHREYS CTR | STE 42 | MEMPHIS | TN | 38120-2372 | |||||||||
687 |
Affiliated | 3019 | Clarksville Dialysis | Clarksville Dialysis | 231 HILLCREST DR | CLARKSVILLE | TN | 37043-5093 | ||||||||||
688 |
Affiliated | 3020 | Miami Campus Dialysis | Miami Campus Dialysis | 1500 NW 12TH AVE | STE 16 | MIAMI | FL | 33136-1028 | |||||||||
689 |
Affiliated | 3021 | Orlando Dialysis | Orlando Dialysis | 116 STURTEVANT ST | ORLANDO | FL | 32806-2021 | ||||||||||
690 |
Affiliated | 3024 | Durham Dialysis | Durham Dialysis | 601 FAYETTEVILLE ST | DURHAM | NC | 27701-3910 | ||||||||||
691 |
Affiliated | 3025 | Candler County Dialysis | Candler County Dialysis | 325 CEDAR ST | METTER | GA | 30439-4043 | ||||||||||
692 |
Affiliated | 3027 | Kerrville Dialysis | Kerrville Dialysis | 515 GRANADA PL | KERRVILLE | TX | 78028-5992 | ||||||||||
693 |
Affiliated | 3028 | Floresville Dialysis | Floresville Dialysis | 543 10TH ST | FLORESVILLE | TX | 78114-3107 | ||||||||||
694 |
Affiliated | 3029 | Pearsall Dialysis | Pearsall Dialysis | 1305 N OAK ST | PEARSALL | TX | 78061-3414 | ||||||||||
695 |
Affiliated | 3030 | Nogales Dialysis | Nogales Dialysis | 1231 W TARGET RANGE RD | NOGALES | AZ | 85621-2417 | ||||||||||
696 |
Affiliated | 3032 | Wilson Dialysis | Wilson Dialysis | 1605 MEDICAL PARK DR W | WILSON | NC | 27893-2799 | ||||||||||
697 |
Affiliated | 3033 | Goldsboro Dialysis | Goldsboro Dialysis | 2609 HOSPITAL RD | GOLDSBORO | NC | 27534-9424 | ||||||||||
698 |
Affiliated | 3034 | Roxboro Dialysis | Roxboro Dialysis | 718 RIDGE RD | ROXBORO | NC | 27573-4508 | ||||||||||
699 |
Affiliated | 3035 | Boston Dialysis | Boston Dialysis | 660 HARRISON AVE | BOSTON | MA | 02118-2304 | ||||||||||
700 |
Affiliated | 3037 | Jesup Dialysis | Jesup Dialysis | 301 PEACHTREE ST | JESUP | GA | 31545-0245 | ||||||||||
701 |
Affiliated | 3038 | Sheffield Dialysis | Sheffield Dialysis | 1120 S JACKSON HWY | ST 17 | SHEFFIELD | AL | 35660-5777 | |||||||||
702 |
Affiliated | 3039 | Berkeley Dialysis | Berkeley Dialysis | 2920 TELEGRAPH AVE | BERKELEY | CA | 94705-2031 | ||||||||||
703 |
Affiliated | 3040 | Douglas Dialysis | Douglas Dialysis | 190 WESTSIDE DR | STE A | DOUGLAS | GA | 31533-3534 | |||||||||
704 |
Affiliated | 3041 | Hopkinsville Dialysis | Hopkinsville Dialysis | 1914 S VIRGINIA ST | HOPKINSVILLE | KY | 42240-3610 | ||||||||||
705 |
Affiliated | 3042 | Roxborough Dialysis | Roxborough Dialysis | 5003 UMBRIA ST | PHILADELPHIA | PA | 19128-4301 | ||||||||||
706 |
Affiliated | 3043 | New Haven Dialysis | New Haven Dialysis | 100 CHURCH ST S | STE C | NEW HAVEN | CT | 06519-1703 | |||||||||
707 |
Affiliated | 3044 | Ocoee Dialysis | Ocoee Dialysis | 11140 W COLONIAL DR | STE 5 | OCOEE | FL | 34761-3300 | |||||||||
708 |
Affiliated | 3045 | Waverly Dialysis | Waverly Dialysis | 407 E BALTIMORE PIKE | MORTON | PA | 19070-1042 | ||||||||||
709 |
Affiliated | 3046 | Sells Dialysis | Sells Dialysis | PO BOX 3030 | HWY 86 MILEPOST 113 | SELLS | AZ | 85634-3030 | |||||||||
710 |
Affiliated | 3047 | Sierra Vista Dialysis | Sierra Vista Dialysis | 629 N HIGHWAY 90 | STE 6 | SIERRA VISTA | AZ | 85635-2257 | |||||||||
711 |
Affiliated | 3048 | Callaghan Road Dialysis | San Antonio West Dialysis (fka Callaghan Road) | 4530 CALLAGHAN RD | SAN ANTONIO | TX | 78228 | ||||||||||
712 |
Affiliated | 3049 | Houston Dialysis | Houston Dialysis | 7543 SOUTH FWY | HOUSTON | TX | 77021-5928 | ||||||||||
713 |
Affiliated | 3050 | South Yuma Dialysis | South Yuma Dialysis | 7179 E 31ST PLACE | YUMA | AZ | 85365-8392 | ||||||||||
714 |
Affiliated | 3052 | Cherry Hill Dialysis | Cherry Hill Dialysis | 1030 KINGS HWY N | STE 1 | CHERRY HILL | NJ | 08034-1907 | |||||||||
715 |
Affiliated | 3055 | Escondido Dialysis | Escondido Dialysis | 203 E 2ND AVE | ESCONDIDO | CA | 92025-4212 | ||||||||||
716 |
Affiliated | 3056 | Brookline Dialysis | Brookline Dialysis | 322 WASHINGTON ST | BROOKLINE | MA | 02445-6850 | ||||||||||
717 |
Affiliated | 3057 | Reliant Dialysis | Reliant Dialysis | 1335 LA CONCHA LN | HOUSTON | TX | 77054-1809 | ||||||||||
718 |
Affiliated | 3058 | Fullerton Dialysis | Fullerton Dialysis | 238 ORANGEFAIR MALL | FULLERTON | CA | 92832-3037 | ||||||||||
719 |
Affiliated | 3059 | Huntington Beach Dialysis | Huntington Beach Dialysis | 16892 BOLSA CHICA ST | STE 1 | HUNTINGTON BEACH | CA | 92649-3571 | |||||||||
720 |
Affiliated | 3060 | Eastlake Dialysis | Eastlake Dialysis (fka South Dekalb) | 1757 CANDLER RD | DECATUR | GA | 30032-3276 | ||||||||||
721 |
Affiliated | 3061 | Mt. Olive Dialysis | Mt. Olive Dialysis | 105 MICHAEL MARTIN RD | MOUNT OLIVE | NC | 28365-1112 | ||||||||||
722 |
Affiliated | 3062 | Southwest San Antonio Dialysis | Southwest San Antonio Dialysis | 1620 SOMERSET RD | SAN ANTONIO | TX | 78211-3021 | ||||||||||
723 |
Affiliated | 3064 | North Loop East Dialysis | North Loop East Dialysis | 7139 NORTH LOOP E | HOUSTON | TX | 77028-5903 | ||||||||||
724 |
Affiliated | 3065 | Katy Cinco Ranch Dialysis | Katy Cinco Ranch Dialysis | 1265 ROCK CANYON DR | KATY | TX | 77450-3831 | ||||||||||
725 |
Affiliated | 3067 | Palm Springs Dialysis | Palm Springs Dialysis | 1061 N INDIAN CANYON DR | PALM SPRINGS | CA | 92262-4854 | ||||||||||
726 |
Affiliated | 3069 | Muskegon Dialysis | Muskegon Dialysis | 1277 MERCY DR | MUSKEGON | MI | 49444-4605 | ||||||||||
727 |
Affiliated | 3070 | Loomis Road Dialysis | Loomis Road Dialysis | 4120 W LOOMIS RD | GREENFIELD | WI | 53221-2052 | ||||||||||
728 |
Affiliated | 3071 | Ludington Dialysis | Ludington Dialysis | 5 N ATKINSON DR | STE 11 | LUDINGTON | MI | 49431-2918 | |||||||||
729 |
Affiliated | 3073 | Walterboro Dialysis | Walterboro Dialysis | 302 RUBY ST | WALTERBORO | SC | 29488-2758 | ||||||||||
730 |
Affiliated | 3074 | K Street | K Street Dialysis (fka GWU N Street Dialysis) | 2131 K ST NW | WASHINGTON | DC | 20037-1898 | ||||||||||
731 |
Affiliated | 3075 | GWU Southeast Dialysis | GWU Southeast Dialysis | 3857A PENNSYLVANIA AVE SE | WASHINGTON | DC | 20020-1309 |
Page 59 of 123
732 |
Affiliated | 3076 | Lakeside Dialysis | Lakeside Dialysis | 10401 HOSPITAL DR | STE G2 | CLINTON | MD | 20735-3113 | |||||||||
733 |
Affiliated | 3077 | Summit Dialysis | Summit Dialysis | 1139 SPRUCE DR | MOUNTAINSIDE | NJ | 07092-2221 | ||||||||||
734 |
Affiliated | 3078 | Aiken Dialysis | Aiken Dialysis | 775 MEDICAL PARK DR | AIKEN | SC | 29801-6306 | ||||||||||
735 |
Affiliated | 3092 | Ozark Dialysis | Ozark Dialysis | 214 HOSPITAL AVE | OZARK | AL | 36360-2038 | ||||||||||
736 |
Affiliated | 3094 | Wylds Road Dialysis | Wylds Road Dialysis (fka Augusta South) | 1815 WYLDS RD | AUGUSTA | GA | 30909-4430 | ||||||||||
737 |
Affiliated | 3104 | Douglasville Dialysis | Douglasville Dialysis | 3899 LONGVIEW DR | DOUGLASVILLE | GA | 30135-1373 | ||||||||||
738 |
Affiliated | 3106 | Brunswick Dialysis | Brunswick Dialysis | 53 SCRANTON CONNECTOR | BRUNSWICK | GA | 31525-1862 | ||||||||||
739 |
Affiliated | 3109 | Benicia Dialysis | Benicia Dialysis | 560 1ST ST | STE 13 BLDG D | BENICIA | CA | 94510-3295 | |||||||||
740 |
Affiliated | 3111 | Atlanta Dialysis | Atlanta Dialysis | 567 NORTH AVE NE | STE 2 | ATLANTA | GA | 30308-2719 | |||||||||
741 |
Affiliated | 3115 | Rolla Dialysis | Rolla Dialysis | 1503 E 10TH ST | ROLLA | MO | 65401-3696 | ||||||||||
742 |
Affiliated | 3119 | East Atlanta Dialysis | East Atlanta Dialysis | 1308 MORELAND AVE SE | ATLANTA | GA | 30316-3224 | ||||||||||
743 |
Affiliated | 3120 | Brunswick South Dialysis | Brunswick South Dialysis | 2930 SPRINGDALE RD | BRUNSWICK | GA | 31520 | ||||||||||
744 |
Affiliated | 3121 | Thomaston Dialysis | Thomaston Dialysis | 1065 US HIGHWAY 19 NORTH | THOMASTON | GA | 30286-2233 | ||||||||||
745 |
Affiliated | 3128 | Piedmont Dialysis | Piedmont Dialysis | 105 COLLIER RD NW | STE B | ATLANTA | GA | 30309-1730 | |||||||||
746 |
Affiliated | 3130 | Athens West Dialysis | Athens West Dialysis | 2047 PRINCE AVE | STE A | ATHENS | GA | 30606-6033 | |||||||||
747 |
Affiliated | 3131 | Florence Dialysis | Florence Dialysis | 422 E DR HICKS BLVD | STE B | FLORENCE | AL | 35630-5763 | |||||||||
748 |
Affiliated | 3138 | Atwater Dialysis | Atwater Dialysis | 1201 COMMERCE AVE | ATWATER | CA | 95301 | ||||||||||
749 |
Affiliated | 3143 | North Merced Dialysis | Merced Dialysis | 3150 G ST | STE A | MERCED | CA | 95340-1346 | |||||||||
750 |
Affiliated | 3169 | Wisconsin Avenue Dialysis | Wisconsin Avenue Dialysis | 3801 W WISCONSIN AVE | MILWAUKEE | WI | 53208-3155 | ||||||||||
751 |
Affiliated | 3171 | River Center Dialysis | River Center Dialysis | 117 N JEFFERSON ST | MILWAUKEE | WI | 53202-6160 | ||||||||||
752 |
Affiliated | 3175 | South Fulton Dialysis | South Fulton Dialysis | 2685 METROPOLITAN PKWY SW | STE F | ATLANTA | GA | 30315-7926 | |||||||||
753 |
Affiliated | 3201 | Heartland Dialysis | Heartland Dialysis | 925 NE 8TH ST | OKLAHOMA CITY | OK | 73104-5800 | ||||||||||
754 |
Affiliated | 3202 | Hospital Hill Dialysis | Hospital Hill Dialysis | 2250 HOLMES ST | KANSAS CITY | MO | 64108-2639 | ||||||||||
755 |
Affiliated | 3203 | Tucson South Dialysis | Tucson South Dialysis | 3662 S 16TH AVE | TUCSON | AZ | 85713-6001 | ||||||||||
756 |
Affiliated | 3204 | Greene County Dialysis | Greene County Dialysis (AL) | 544 US HIGHWAY 43 | EUTAW | AL | 35462-4017 | ||||||||||
757 |
Affiliated | 3205 | Fayette Dialysis | Fayette Dialysis | 2450 TEMPLE AVE N | FAYETTE | AL | 35555-1160 | ||||||||||
758 |
Affiliated | 3206 | Tuscaloosa University Dialysis | Tuscaloosa University Dialysis | 220 15TH STREET | TUSCALOOSA | AL | 35401 | ||||||||||
759 |
Affiliated | 3207 | Goldsboro South Dialysis | Goldsboro South Dialysis | 1704 WAYNE MEMORIAL DR | GOLDSBORO | NC | 27534-2240 | ||||||||||
760 |
Affiliated | 3208 | Orlando North Dialysis | Orlando North Dialysis | 5135 ADANSON ST | STE 7 | ORLANDO | FL | 32804-1338 | |||||||||
761 |
Affiliated | 3209 | UT Southwestern-Dallas Dialysis | UT Southwestern-Dallas Dialysis | 204 E AIRPORT FREEWAY | IRVING | TX | 75062 | ||||||||||
762 |
Affiliated | 3210 | San Diego South Dialysis | San Diego South Dialysis | 995 GATEWAY CENTER WAY | STE 11 | SAN DIEGO | CA | 92102-4550 | |||||||||
763 |
Affiliated | 3211 | Santa Monica Dialysis | Santa Monica Dialysis | 1260 15TH ST | STE 12 | SANTA MONICA | CA | 90404-1136 | |||||||||
764 |
Affiliated | 3212 | Airport Dialysis | Airport Dialysis | 4632 W CENTURY BLVD | INGLEWOOD | CA | 90304-1456 | ||||||||||
765 |
Affiliated | 3220 | Plantation Dialysis | Plantation Dialysis | 7061 CYPRESS RD | STE 13 | PLANTATION | FL | 33317-2243 | |||||||||
766 |
Affiliated | 3224 | Laurens County Dialysis | Laurens County Dialysis | 2400 BELLEVUE RD | STE 8 | DUBLIN | GA | 31021-2856 | |||||||||
767 |
Affiliated | 3225 | Ford Factory Square Dialysis | Ford Factory Square Dialysis | 567 NORTH AVE NE | STE 1 | ATLANTA | GA | 30308-2719 | |||||||||
768 |
Affiliated | 3226 | North Fulton Dialysis | North Fulton Dialysis | 1250 NORTHMEADOW PKWY | STE 12 | ROSWELL | GA | 30076-4914 | |||||||||
769 |
Affiliated | 3228 | Freehold Dialysis | Freehold Dialysis | 300 CRAIG RD | MANALAPAN | NJ | 07726-8742 | ||||||||||
770 |
Affiliated | 3229 | Neptune Dialysis | Neptune Route 66 Dialysis | 3297 STATE ROUTE 66 | NEPTUNE | NJ | 07753-2762 | ||||||||||
771 |
Affiliated | 3231 | East Orange Dialysis | East Orange Dialysis | 90 WASHINGTON ST | BSMT | EAST ORANGE | NJ | 07017-1050 | |||||||||
772 |
Affiliated | 3234 | UT Southwestern-Oakcliff Dialysis | UT Southwestern-Oakcliff Dialysis | 610 WYNNEWOOD DR | DALLAS | TX | 75224 | ||||||||||
773 |
Affiliated | 3236 | Atlanta West Dialysis | Atlanta West Dialysis | 2538 MARTIN LUTHER KING JR DR SW | ATLANTA | GA | 30311-1779 | ||||||||||
774 |
Affiliated | 3237 | Columbia University Dialysis Center | Columbia University Dialysis Center | 60 HAVEN AVE | NEW YORK | NY | 10032-2604 | ||||||||||
775 |
Affiliated | 3238 | Northeast Cambridge Dialysis | Northeast Cambridge Dialysis | 799 CONCORD AVE | CAMBRIDGE | MA | 02138-1048 | ||||||||||
776 |
Affiliated | 3239 | New Bedford Dialysis | New Bedford Dialysis | 524 UNION ST | NEW BEDFORD | MA | 02740-3546 | ||||||||||
777 |
Affiliated | 3242 | Weymouth Dialysis | Weymouth Dialysis | 330 LIBBEY INDUSTRIAL PARK | STE 9 | WEYMOUTH | MA | 02189-3122 | |||||||||
778 |
Affiliated | 3243 | Woburn Dialysis | Woburn Dialysis | 23 WARREN AVE | WOBURN | MA | 01801-7906 | ||||||||||
779 |
Affiliated | 3248 | Bryan Dialysis | College Station Dialysis (fka Bryan Dialysis) | 701 UNIVERSITY DR E | STE 41 | COLLEGE STATION | TX | 77840-1866 | |||||||||
780 |
Affiliated | 3249 | Brenham Dialysis | Brenham Dialysis | 2815 HIGHWAY 36 SO | BRENHAM | TX | 77833 | ||||||||||
781 |
Affiliated | 3250 | Huntsville Dialysis | Huntsville Dialysis | 521 IH 45S | STE 2 | HUNTSVILLE | TX | 77340-5651 | |||||||||
782 |
Affiliated | 3252 | Utica Avenue Dialysis Center | Utica Avenue Dialysis Center | 1305 UTICA AVE | BROOKLYN | NY | 11203-5911 | ||||||||||
783 |
Affiliated | 3254 | New London Dialysis | New London Dialysis | 5 SHAWS COVE | STE 1 | NEW LONDON | CT | 06320-4974 | |||||||||
784 |
Affiliated | 3258 | Baxley Dialysis | Baxley Dialysis | 539 FAIR ST | BAXLEY | GA | 31513-0112 | ||||||||||
785 |
Affiliated | 3261 | Pascua Yaqui Tribe Dialysis | Pascua Yaqui Tribe Dialysis | 7490 S CAMINO DE OESTE | TUCSON | AZ | 85746-9308 | ||||||||||
786 |
Affiliated | 3262 | JHHS North Bond Street Dialysis | JHHS North Bond Street Dialysis | 409 N CAROLINE ST | BALTIMORE | MD | 21231-1003 | ||||||||||
787 |
Affiliated | 3263 | Syosset Kidney Center | Syosset Kidney Center | 1 LOCUST LN | SYOSSET | NY | 11791-4834 | ||||||||||
788 |
Affiliated | 3264 | Freeport Kidney Center | Freeport Kidney Center | 267 W MERRICK RD | FREEPORT | NY | 11520-3346 | ||||||||||
789 |
Affiliated | 3265 | Huntington Station Dialysis Center | HAKC-Huntington | 256 BROADWAY | HUNTINGTON STATION | NY | 11746-1403 | ||||||||||
790 |
Affiliated | 3266 | Medford Kidney Center | Medford Kidney Center | 1725 N OCEAN AVE | MEDFORD | NY | 11763-2649 | ||||||||||
791 |
Affiliated | 3267 | Blue Ash Dialysis | Blue Ash Dialysis | 10600 MCKINLEY RD | CINCINNATI | OH | 45242-3716 | ||||||||||
792 |
Affiliated | 3269 | Mt. Auburn Dialysis | Mt. Auburn Dialysis | 2109 READING RD | CINCINNATI | OH | 45202-1417 | ||||||||||
793 |
Affiliated | 3272 | Charlottesville Dialysis | Charlottesville Dialysis | 1460 PANTOPS MOUNTAIN PLACE | CHARLOTTESVILLE | VA | 22911 | ||||||||||
794 |
Affiliated | 3273 | Alexandria Dialysis | Alexandria Dialysis | 5150 DUKE ST | ALEXANDRIA | VA | 22304-2906 | ||||||||||
795 |
Affiliated | 3275 | Sebastian Dialysis | Sebastian Dialysis | 1424 US HWY 1 | STE C | SEBASTIAN | FL | 32958-1619 | |||||||||
796 |
Affiliated | 3276 | Crestview Hills Dialysis | Crestview Hills Dialysis | 400 CENTERVIEW BLVD | CRESTVIEW HILLS | KY | 41017-3478 | ||||||||||
797 |
Affiliated | 3278 | Washington Square Dialysis | Washington Square Dialysis | 1112 WASHINGTON SQ | WASHINGTON | MO | 63090-5336 | ||||||||||
798 |
Affiliated | 3279 | Florissant Dialysis | Florissant Dialysis | 11687 W FLORISSANT AVE | FLORISSANT | MO | 63033-6711 |
Page 60 of 123
799 |
Affiliated | 3282 | Ithaca Dialysis Center | Ithaca Dialysis Center | 201 DATES DR | STE 26 | ITHACA | NY | 14850-1345 | |||||||||
800 |
Affiliated | 3289 | Fairfield Dialysis | Fairfield Dialysis | 1210 HICKS BLVD | FAIRFIELD | OH | 45014-1921 | ||||||||||
801 |
Affiliated | 3290 | Fairfield Home Training Dialysis | Fairfield Home Training Dialysis | 1210 HICKS BLVD | FAIRFIELD | OH | 45014-1921 | ||||||||||
802 |
Affiliated | 3291 | South Hill Dialysis | South Hill Dialysis | 525 ALEXANDRIA PIKE | STE 12 | SOUTHGATE | KY | 41071-3243 | |||||||||
803 |
Affiliated | 3292 | Silver Spring Dialysis | Silver Spring Dialysis | 8412 GEORGIA AVE | SILVER SPRING | MD | 20910-4406 | ||||||||||
804 |
Affiliated | 3295 | Philadelphia PMC Dialysis | Philadelphia PMC Dialysis | 51 N 39TH ST | PHILADELPHIA | PA | 19104-2640 | ||||||||||
805 |
Affiliated | 3298 | Tulare Dialysis | Tulare Dialysis | 545 E TULARE AVE | TULARE | CA | 93274-4220 | ||||||||||
806 |
Affiliated | 3300 | Visalia Dialysis | Visalia Dialysis | 5429 W CYPRESS AVE | VISALIA | CA | 93277-8341 | ||||||||||
807 |
Affiliated | 3310 | Falls Road Dialysis | Falls Road Dialysis | 10753 FALLS RD | STE 115 | LUTHERVILLE | MD | 21093-4572 | |||||||||
808 |
Affiliated | 3312 | Malden Dialysis | Wellington Circle Dialysis Center (fka Malden) | 10 CABOT RD | STE 13B | MEDFORD | MA | 02155-5173 | |||||||||
809 |
Affiliated | 3313 | Salem Northeast Dialysis | Salem Northeast Dialysis (MA) | 10 COLONIAL RD | STE 25 | SALEM | MA | 01970-2947 | |||||||||
810 |
Affiliated | 3314 | Lexington | Lexington Prison Unit (OK) | 15151 STATE HWY 39 E | PO BOX 26 | LEXINGTON | OK | 73051-0260 | |||||||||
811 |
Affiliated | 3315 | Macon County Dialysis | Macon County Dialysis | 1090 W MCKINLEY AVE | DECATUR | IL | 62526-3208 | ||||||||||
812 |
Affiliated | 3316 | Effingham Dialysis | Effingham Dialysis | 904 MEDICAL PARK DR | STE 1 | EFFINGHAM | IL | 62401-2193 | |||||||||
813 |
Affiliated | 3317 | Jacksonville Dialysis | Jacksonville Dialysis | 1515 W WALNUT ST | JACKSONVILLE | IL | 62650-1150 | ||||||||||
814 |
Affiliated | 3318 | Litchfield Dialysis | Litchfield Dialysis | 915 ST FRANCES WAY | LITCHFIELD | IL | 62056-1775 | ||||||||||
815 |
Affiliated | 3319 | Mattoon Dialysis | Mattoon Dialysis | 6051 DEVELOPMENT DR | CHARLESTON | IL | 61920-9467 | ||||||||||
816 |
Affiliated | 3320 | Springfield Central Dialysis | Springfield Central Dialysis | 932 N RUTLEDGE ST | SPRINGFIELD | IL | 62702-3721 | ||||||||||
817 |
Affiliated | 3321 | Taylorville Dialysis | Taylorville Dialysis | 901 W SPRESSER ST | TAYLORVILLE | IL | 62568-1831 | ||||||||||
818 |
Affiliated | 3322 | Lincoln Dialysis | Lincoln Dialysis | 2100 WEST FIFTH | LINCOLN | IL | 62656-9115 | ||||||||||
819 |
Affiliated | 3323 | J. B. Zachary Dialysis Center | J. B. Zachary Dialysis Center | 333 CASSELL DR | STE 23 | BALTIMORE | MD | 21224-6815 | |||||||||
820 |
Affiliated | 3324 | Whitesquare Dialysis | Whitesquare Dialysis | 1 NASHUA CT STE E | BALTIMORE | MD | 21221 | ||||||||||
821 |
Affiliated | 3325 | 25th Street Dialysis | 25th Street Dialysis | 920 E 25TH ST | BALTIMORE | MD | 21218-5503 | ||||||||||
822 |
Affiliated | 3326 | Perth Amboy Dialysis | Perth Amboy Dialysis | 530 NEW BRUNSWICK AVE | PERTH AMBOY | NJ | 08861-3654 | ||||||||||
823 |
Affiliated | 3327 | Old Bridge Dialysis | Old Bridge Dialysis | 3 HOSPITAL PLZ | STE 11 | OLD BRIDGE | NJ | 08857-3084 | |||||||||
824 |
Affiliated | 3328 | Pear Tree Dialysis | Pear Tree Dialysis (fka Ukiah) | 126 N ORCHARD AVE | UKIAH | CA | 95482-4502 | ||||||||||
825 |
Affiliated | 3334 | Hubbard Road Dialysis | Hubbard Road Dialysis | 1963 HUBBARD RD | MADISON | OH | 44057-2105 | ||||||||||
826 |
Affiliated | 3335 | St. Charles Dialysis | St. Charles Dialysis | 2125 BLUESTONE DR | SAINT CHARLES | MO | 63303-6704 | ||||||||||
827 |
Affiliated | 3336 | Bel Air Dialysis | Bel Air Dialysis | 2225 OLD EMMORTON RD | STE 15 | BEL AIR | MD | 21015-6122 | |||||||||
828 |
Affiliated | 3339 | Cedarburg Dialysis | Cedarburg Dialysis | N 54 W 6135 MILL ST | CEDARBURG | WI | 53012-2021 | ||||||||||
829 |
Affiliated | 3340 | Western Hills Dialysis | Western Hills Dialysis | 3267 WESTBOURNE DR | CINCINNATI | OH | 45248-5130 | ||||||||||
830 |
Affiliated | 3341 | Winton Road Dialysis | Winton Road Dialysis | 6550 WINTON RD | CINCINNATI | OH | 45224-1327 | ||||||||||
831 |
Affiliated | 3342 | Stamford Dialysis | Stamford Dialysis | 30 COMMERCE RD | STAMFORD | CT | 06902-4550 | ||||||||||
832 |
Affiliated | 3343 | Boaz Dialysis | Boaz Dialysis | 16 CENTRAL HENDERSON RD | BOAZ | AL | 35957-5922 | ||||||||||
833 |
Affiliated | 3344 | Guernsey County Dialysis | Guernsey County Dialysis | 1300 CLARK ST | CAMBRIDGE | OH | 43725-8875 | ||||||||||
834 |
Affiliated | 3345 | Marietta Dialysis | Marietta Dialysis | 1019 PIKE ST | MARIETTA | OH | 45750-3500 | ||||||||||
835 |
Affiliated | 3346 | Zanesville Dialysis | Zanesville Dialysis | 3120 NEWARK RD | ZANESVILLE | OH | 43701-9659 | ||||||||||
836 |
Affiliated | 3351 | Orlando East Dialysis | Orlando East Dialysis | 1160 S SEMORAN BLVD | STE C | ORLANDO | FL | 32807-1461 | |||||||||
837 |
Affiliated | 3352 | Norwich Dialysis | Norwich Dialysis | 113 SALEM TPKE | NORWICH | CT | 06360-6484 | ||||||||||
838 |
Affiliated | 3354 | Columbus Dialysis | Columbus Dialysis | 3830 OLENTANGY RIVER RD | COLUMBUS | OH | 43214-5404 | ||||||||||
839 |
Affiliated | 3362 | Pasadena Dialysis | Pasadena Dialysis | 8894 FORT SMALLWOOD RD | STE 12 | PASADENA | MD | 21122-7608 | |||||||||
840 |
Affiliated | 3369 | Baltimore Geriatric & Rehab Dialysis Center | Baltimore Geriatric & Rehab Dialysis Center | 4940 EASTERN AVE | FLOOR 5 | BALTIMORE | MD | 21224-2735 | |||||||||
841 |
Affiliated | 3373 | Frederick Dialysis | Frederick Dialysis | 140 THOMAS JOHNSON DR | STE 1 | FREDERICK | MD | 21702-4475 | |||||||||
842 |
Affiliated | 3376 | Fayetteville Dialysis | Fayetteville Dialysis | 1279 HIGHWAY 54 W | STE 11 | FAYETTEVILLE | GA | 30214-4551 | |||||||||
843 |
Affiliated | 3377 | Birmingham Central Dialysis | Birmingham Central Dialysis | 728 RICHARD ARRINGTON JR BLVD S | BIRMINGHAM | AL | 35233-2106 | ||||||||||
844 |
Affiliated | 3379 | Birmingham North Dialysis | Birmingham North Dialysis | 1917 32ND AVE N | BIRMINGHAM | AL | 35207-3333 | ||||||||||
845 |
Affiliated | 3380 | Bessemer Dialysis | Bessemer Dialysis | 901 W LAKE MALL | BESSEMER | AL | 35020 | ||||||||||
846 |
Affiliated | 3382 | Ensley Dialysis | Ensley Dialysis | 2630 AVENUE E | BIRMINGHAM | AL | 35218-2163 | ||||||||||
847 |
Affiliated | 3383 | Sylacauga Dialysis | Sylacauga Dialysis | 331 JAMES PAYTON BLVD | SYLACAUGA | AL | 35150 | ||||||||||
848 |
Affiliated | 3385 | Branford Dialysis | Branford Dialysis | 249 W MAIN ST | BRANFORD | CT | 06405-4048 | ||||||||||
849 |
Affiliated | 3386 | Shrewsbury Dialysis | Shrewsbury Dialysis | 7435 WATSON RD | STE 119 | SAINT LOUIS | MO | 63119-4472 | |||||||||
850 |
Affiliated | 3389 | Milford Dialysis | Milford Dialysis | 470 BRIDGEPORT AVE | MILFORD | CT | 06460-4167 | ||||||||||
851 |
Affiliated | 3414 | Cedartown Dialysis | Cedartown Dialysis | 325 WEST AVE | CEDARTOWN | GA | 30125-3439 | ||||||||||
852 |
Affiliated | 3416 | Brookfield Dialysis | Brookfield Dialysis | 19395 W CAPITOL DR | BLDG C | BROOKFIELD | WI | 53045-2736 | |||||||||
853 |
Affiliated | 3417 | Henrico County Dialysis | Henrico County Dialysis | 5270 CHAMBERLAYNE RD | RICHMOND | VA | 23227-2950 | ||||||||||
854 |
Affiliated | 3418 | St. Louis West Dialysis | St. Louis West Dialysis | 400 N LINDBERGH BLVD | SAINT LOUIS | MO | 63141-7814 | ||||||||||
855 |
Affiliated | 3420 | Springfield Montvale Dialysis | Springfield Montvale Dialysis | 2930 MONTVALE DR | STE A | SPRINGFIELD | IL | 62704-5376 | |||||||||
856 |
Affiliated | 3422 | South Norwalk Dialysis | South Norwalk Dialysis | 31 STEVENS ST | NORWALK | CT | 06850-3805 | ||||||||||
857 |
Affiliated | 3425 | Decatur East Wood Dialysis | Decatur East Wood Dialysis | 794 E WOOD ST | DECATUR | IL | 62523-1155 | ||||||||||
858 |
Affiliated | 3426 | Schaeffer Drive Dialysis | Schaeffer Drive Dialysis | 18100 SCHAEFER HWY | DETROIT | MI | 48235-2600 | ||||||||||
859 |
Affiliated | 3427 | Redford Dialysis | Redford Dialysis | 22711 GRAND RIVER AVE | DETROIT | MI | 48219-3113 | ||||||||||
860 |
Affiliated | 3428 | Kresge Dialysis | Kresge Dialysis | 4145 CASS AVE | DETROIT | MI | 48201-1707 | ||||||||||
861 |
Affiliated | 3429 | Motor City Dialysis | Motor City Dialysis | 4727 SAINT ANTOINE ST | STE 11 | DETROIT | MI | 48201-1461 | |||||||||
862 |
Affiliated | 3431 | Whitebridge Dialysis | Whitebridge Dialysis | 103 WHITE BRIDGE PIKE | STE 6 | NASHVILLE | TN | 37209-4539 | |||||||||
863 |
Affiliated | 3432 | Columbia Dialysis | Columbia Dialysis (TN) | 1705 GROVE ST | COLUMBIA | TN | 38401-3517 | ||||||||||
864 |
Affiliated | 3433 | Murfreesboro Dialysis | Murfreesboro Dialysis | 1346 DOW ST | MURFREESBORO | TN | 37130-2470 | ||||||||||
865 |
Affiliated | 3434 | Lawrenceburg Dialysis | Lawrenceburg Dialysis (TN) | 2022 N LOCUST AVE | LAWRENCEBURG | TN | 38464-2336 |
Page 61 of 123
866 |
Affiliated | 3436 | Sumner Dialysis | Sumner Dialysis | 300 STEAM PLANT RD | STE 27 | GALLATIN | TN | 37066-3019 | |||||||||
867 |
Affiliated | 3437 | Cumberland Dialysis | Cumberland Dialysis | 312 HOSPITAL DR | STE 5 | MADISON | TN | 37115-5037 | |||||||||
868 |
Affiliated | 3438 | Williamson County Dialysis | Williamson County Dialysis | 3983 CAROTHERS PKWY | STE E-4 | FRANKLIN | TN | 37067-5936 | |||||||||
869 |
Affiliated | 3441 | Cumming Dialysis | Cumming Dialysis | 911 MARKET PLACE BLVD | STE 3 | CUMMING | GA | 30041-7938 | |||||||||
870 |
Affiliated | 3443 | Silverton Dialysis | Silverton Dialysis | 6929 SILVERTON AVE | CINCINNATI | OH | 45236-3701 | ||||||||||
871 |
Affiliated | 3445 | Atlanta South Dialysis | Atlanta South Dialysis | 3158 EAST MAIN ST | STE A | EAST POINT | GA | 30344-4800 | |||||||||
872 |
Affiliated | 3447 | St. Petersburg Dialysis | St. Petersburg Dialysis | 1117 ARLINGTON AVE N | ST PETERSBURG | FL | 33705-1521 | ||||||||||
873 |
Affiliated | 3449 | Alton Dialysis | Alton Dialysis | 3511 COLLEGE AVE | ALTON | IL | 62002-5009 | ||||||||||
874 |
Affiliated | 3451 | Edison Dialysis | Edison Dialysis | 29 MERIDIAN RD | EDISON | NJ | 08820-2823 | ||||||||||
875 |
Affiliated | 3452 | Dundalk Dialysis | Dundalk Dialysis | 14 COMMERCE ST | DUNDALK | MD | 21222-4307 | ||||||||||
876 |
Affiliated | 3454 | Columbus East Dialysis | Columbus East Dialysis | 299 OUTERBELT ST | COLUMBUS | OH | 43213-1529 | ||||||||||
877 |
Affiliated | 3455 | Dallas East Dialysis | Dallas East Dialysis | 3312 N BUCKNER BLVD | STE 213 | DALLAS | TX | 75228-5642 | |||||||||
878 |
Affiliated | 3456 | San Ysidro Dialysis | San Ysidro Dialysis | 1445 30TH ST | STE A | SAN DIEGO | CA | 92154-3496 | |||||||||
879 |
Affiliated | 3457 | Olathe Dialysis | Olathe Dialysis | 732 W FRONTIER LN | OLATHE | KS | 66061-7202 | ||||||||||
880 |
Affiliated | 3459 | Orange City Dialysis | Orange City Dialysis | 242 TREEMONT DR | BLDG II | ORANGE CITY | FL | 32763-7945 | |||||||||
881 |
Affiliated | 3460 | Miami East Dialysis | Miami East Dialysis | 1250 NW 7TH ST | STE 16 | MIAMI | FL | 33125-3744 | |||||||||
882 |
Affiliated | 3462 | Temple Terrace Dialysis | Temple Terrace Dialysis | 11306 N 53RD ST | TEMPLE TERRACE | FL | 33617-2214 | ||||||||||
883 |
Affiliated | 3463 | Midlothian Dialysis | Midlothian Dialysis | 14281 MIDLOTHIAN TPKE | BLDG B | MIDLOTHIAN | VA | 23113-6560 | |||||||||
884 |
Affiliated | 3464 | Christian County Dialysis | Christian County Dialysis | 200 BURLEY AVE | HOPKINSVILLE | KY | 42240-8725 | ||||||||||
885 |
Affiliated | 3465 | St. Louis West PD Dialysis | St. Louis West PD Dialysis | 450 N LINDBERGH BLVD | STE 1C | CREVE COEUR | MO | 63141-7858 | |||||||||
886 |
Affiliated | 3467 | Atlanta Midtown Dialysis | Atlanta Midtown Dialysis PD | 418 DECATUR ST SE | STE A | ATLANTA | GA | 30312-1801 | |||||||||
887 |
Affiliated | 3468 | Silverton Home Training Dialysis | Silverton Home Training Dialysis | 6929 SILVERTON AVE | CINCINNATI | OH | 45236-3701 | ||||||||||
888 |
Affiliated | 3472 | Philadelphia 42nd Street Dialysis | Philadelphia 42nd Street Dialysis | 4126 WALNUT ST | PHILADELPHIA | PA | 19104-3511 | ||||||||||
889 |
Affiliated | 3473 | Radnor Dialysis | Radnor Dialysis | 250 KING OF PRUSSIA RD | RADNOR | PA | 19087-5220 | ||||||||||
890 |
Affiliated | 3475 | St. Louis Dialysis | St. Louis Dialysis | 324 DE BALIVIERE AVE | SAINT LOUIS | MO | 63112-1804 | ||||||||||
891 |
Affiliated | 3477 | Elkins Park Dialysis | Wyncote Dialysis (fka Elkins Park) | 1000 EASTON RD | STE 25 | WYNCOTE | PA | 19095-2934 | |||||||||
892 |
Affiliated | 3478 | Mainland Dialysis | Mainland Dialysis | 2600 GULF FWY | LA MARQUE | TX | 77568-4922 | ||||||||||
893 |
Affiliated | 3479 | Island Dialysis | Island Dialysis | 5920 BROADWAY ST | GALVESTON | TX | 77551-4305 | ||||||||||
894 |
Affiliated | 3481 | Orlando Home Training Dialysis | Orlando Home Training Dialysis | 116 STURTEVANT ST | STE 2 | ORLANDO | FL | 32806-2021 | |||||||||
895 |
Affiliated | 3482 | Mechanicsville Dialysis | Mechanicsville Dialysis | 8191 ATLEE RD | MECHANICSVILLE | VA | 23116-1807 | ||||||||||
896 |
Affiliated | 3484 | San Diego East Dialysis | San Diego East Dialysis | 292 EUCLID AVE | STE 1 | SAN DIEGO | CA | 92114-3629 | |||||||||
897 |
Affiliated | 3485 | Russellville Dialysis | Russellville Dialysis | 14897 HIGHWAY 43 | RUSSELLVILLE | AL | 35653-1954 | ||||||||||
898 |
Affiliated | 3486 | Encinitas Dialysis | Encinitas Dialysis | 332 SANTA FE DR | STE 1 | ENCINITAS | CA | 92024-5143 | |||||||||
899 |
Affiliated | 3491 | Rushville Dialysis | Rushville Dialysis | 112 SULLIVAN DRIVE | RUSHVILLE | IL | 62681-1293 | ||||||||||
900 |
Affiliated | 3493 | Plainfield Dialysis | Plainfield Dialysis | 1200 RANDOLPH RD | MUHLENBURG CAMPUS | PLAINFIELD | NJ | 07060-3361 | |||||||||
901 |
Affiliated | 3494 | Parkersburg Dialysis | Parkersburg Dialysis | 1824 MURDOCH AVE | STE 44 | PARKERSBURG | WV | 26101-3230 | |||||||||
902 |
Affiliated | 3497 | Tucson South Central Dialysis | Tucson South Central Dialysis | 2024 E IRVINGTON RD | STE 7 | TUCSON | AZ | 85714-1825 | |||||||||
903 |
Affiliated | 3499 | Hazelwood Dialysis | Hazelwood Dialysis | 637 DUNN RD | HAZELWOOD | MO | 63042-1755 | ||||||||||
904 |
Affiliated | 3503 | Durham West Dialysis | Durham West Dialysis | 4307 WESTERN PARK PL | DURHAM | NC | 27705-1204 | ||||||||||
905 |
Affiliated | 3504 | Liberty Dialysis | Liberty Dialysis | 2525 GLEN HENDREN DR | LIBERTY | MO | 64068-9625 | ||||||||||
906 |
Affiliated | 3506 | Chino Dialysis | Chino Dialysis | 4445 RIVERSIDE DR | CHINO | CA | 91710-3961 | ||||||||||
907 |
Affiliated | 3507 | Greenview Dialysis | Greenview Dialysis | 18544 W 8 MILE RD | SOUTHFIELD | MI | 48075-4194 | ||||||||||
908 |
Affiliated | 3508 | Perry Dialysis | Perry Dialysis | 118 W MAIN ST | PERRY | FL | 32347-2656 | ||||||||||
909 |
Affiliated | 3511 | Ashtabula Dialysis | Ashtabula Dialysis | 1614 W 19TH ST | ASHTABULA | OH | 44004-3036 | ||||||||||
910 |
Affiliated | 3513 | Northland Dialysis | Northland Dialysis | 2750 CLAY EDWARDS DR | STE 1 | N KANSAS CITY | MO | 64116-3257 | |||||||||
911 |
Affiliated | 3516 | Lake St. Louis Dialysis | Lake St. Louis Dialysis | 200 BREVCO PLZ | STE 21 | LAKE SAINT LOUIS | MO | 63367-2950 | |||||||||
912 |
Affiliated | 3517 | Wyandotte West Dialysis | Wyandotte West Dialysis | 8919 PARALLEL PKWY | STE 121 | KANSAS CITY | KS | 66112-1655 | |||||||||
913 |
Affiliated | 3518 | Huntingdon Valley Dialysis | Temp CLSD-Huntingdon Valley Dialysis | 769 HUNTINGDON PIKE | STE 18 | HUNTINGDON VALLEY | PA | 19006-8362 | |||||||||
914 |
Affiliated | 3519 | Glendale Dialysis | Glendale Dialysis | 1000 E PALMER AVE | GLENDALE | CA | 91205-3532 | ||||||||||
915 |
Affiliated | 3520 | Toledo Dialysis | Toledo Dialysis | 1614 S BYRNE RD | TOLEDO | OH | 43614-3464 | ||||||||||
916 |
Affiliated | 3523 | Cameron Dialysis | Cameron Dialysis | 1003 W 4TH ST | CAMERON | MO | 64429-1466 | ||||||||||
917 |
Affiliated | 3524 | Omaha Central Dialysis | Omaha Central Dialysis | 144 S 40TH ST | OMAHA | NE | 68131-3004 | ||||||||||
918 |
Affiliated | 3525 | Chillicothe Dialysis | Chillicothe Dialysis | 588 E BUSINESS 36 | CHILLICOTHE | MO | 64601-3721 | ||||||||||
919 |
Affiliated | 4210 | Council Bluffs Dialysis | Council Bluffs Dialysis Center | 300 W BROADWAY | STE 15 | COUNCIL BLUFFS | IA | 51503-9077 | |||||||||
920 |
Affiliated | 3528 | DeRidder Dialysis | DeRidder Dialysis | 239 E 1ST ST | DERIDDER | LA | 70634-4105 | ||||||||||
921 |
Affiliated | 3530 | Dodge County Dialysis | Dodge County Dialysis | 1949 E 23RD AVE S | FREMONT | NE | 68025-2452 | ||||||||||
922 |
Affiliated | 3533 | Omaha North Dialysis | Omaha North Dialysis | 6572 AMES AVE | OMAHA | NE | 68104-1931 | ||||||||||
923 |
Affiliated | 3534 | Omaha South Dialysis | Omaha South Dialysis | 3427 L ST | STE 16 | OMAHA | NE | 68107-2577 | |||||||||
924 |
Affiliated | 3535 | Lake Charles Southwest Dialysis | Lake Charles Southwest Dialysis | 300 W 18th ST | LAKE CHARLES | LA | 70601-7342 | ||||||||||
925 |
Affiliated | 3536 | St. Joseph Dialysis | St. Joseph Dialysis | 5514 CORPORATE DR | STE 1 | SAINT JOSEPH | MO | 64507-7752 | |||||||||
926 |
Affiliated | 3537 | Sulphur Dialysis | Sulphur Dialysis | 944 BEGLIS PKWY | SULPHUR | LA | 70663-5102 | ||||||||||
927 |
Affiliated | 3539 | Tipton County Dialysis | Tipton County Dialysis | 107 TENNESSEE AVE | COVINGTON | TN | 38019-3902 | ||||||||||
928 |
Affiliated | 3540 | Dyersburg Dialysis | Dyersburg Dialysis | 1575 PARR AVE | DYERSBURG | TN | 38024-3151 | ||||||||||
929 |
Affiliated | 3544 | Effingham North Dialysis | Effingham North Dialysis | 301 N PINE ST | SPRINGFIELD | GA | 31329-3076 | ||||||||||
930 |
Affiliated | 3545 | Westminster South Dialysis | Westminster South Dialysis | 14014 MAGNOLIA ST. | WESTMINSTER | CA | 92683-4736 | ||||||||||
931 |
Affiliated | 3546 | Williams Street Dialysis | Williams Street Dialysis | 2812 WILLIAMS ST | SAVANNAH | GA | 31404-4134 | ||||||||||
932 |
Affiliated | 3547 | DeRenne Dialysis | DeRenne Dialysis | 5303 MONTGOMERY ST | SAVANNAH | GA | 31405-5138 |
Page 62 of 123
933 |
Affiliated | 3548 | Abercorn Dialysis | Abercorn Dialysis | 11706 MERCY BLVD | STE 9 | SAVANNAH | GA | 31419-1751 | |||||||||
934 |
Affiliated | 3551 | Fort Myers North Dialysis | Fort Myers North Dialysis | 16101 N CLEVELAND AVE | N FT MYERS | FL | 33903-2148 | ||||||||||
935 |
Affiliated | 3552 | Butler County Dialysis | Butler County Dialysis | 3497 S DIXIE HWY | FRANKLIN | OH | 45005-5717 | ||||||||||
936 |
Affiliated | 3556 | Willingboro | Willingboro Dialysis | 230 VAN SCIVER PKWY | WILLINGBORO | NJ | 08046-1131 | ||||||||||
937 |
Affiliated | 3557 | McKeesport West Dialysis | McKeesport West Dialysis | 101 9TH ST | MCKEESPORT | PA | 15132-3953 | ||||||||||
938 |
Affiliated | 3559 | College Dialysis | College Dialysis | 6535 UNIVERSITY AVE | SAN DIEGO | CA | 92115-5810 | ||||||||||
939 |
Affiliated | 3560 | Montezuma Dialysis | Montezuma Dialysis | 114 DEVAUGHN AVE | MONTEZUMA | GA | 31063-1708 | ||||||||||
940 |
Affiliated | 3561 | Romulus Dialysis | Romulus Dialysis | 31470 ECORSE RD | ROMULUS | MI | 48174-1963 | ||||||||||
941 |
Affiliated | 3564 | Wrightsville Dialysis | Wrightsville Dialysis | 2240 W ELM ST | WRIGHTSVILLE | GA | 31096-2016 | ||||||||||
942 |
Affiliated | 3565 | Tower Dialysis | Tower Dialysis | 8635 W 3RD ST | STE 56W | LOS ANGELES | CA | 90048-6110 | |||||||||
943 |
Affiliated | 3566 | Columbus Downtown Dialysis | Columbus Downtown Dialysis | 415 E MOUND ST | COLUMBUS | OH | 43215-5512 | ||||||||||
944 |
Affiliated | 3568 | Charlotte East Dialysis | Charlotte East Dialysis | 3204 N SHARON AMITY RD | CHARLOTTE | NC | 28205-6541 | ||||||||||
945 |
Affiliated | 3569 | Carmel Mountain Dialysis | Carmel Mountain Dialysis | 9850 CARMEL MOUNTAIN RD | SAN DIEGO | CA | 92129-2892 | ||||||||||
946 |
Affiliated | 3571 | Lenexa Dialysis | Lenexa Dialysis | 8630 HALSEY ST | LENEXA | KS | 66215-2880 | ||||||||||
947 |
Affiliated | 3577 | Nashua Dialysis | Nashua Dialysis | 38 TYLER ST | STE 1 | NASHUA | NH | 03060-2912 | |||||||||
948 |
Affiliated | 3580 | Illini Renal Dialysis | Illini Renal Dialysis | 507 E UNIVERSITY AVE | CHAMPAIGN | IL | 61820-3828 | ||||||||||
949 |
Affiliated | 3586 | Loring Heights Dialysis | Loring Heights Dialysis | 1575 NORTHSIDE DR NW | STE 45 | ATLANTA | GA | 30318-4211 | |||||||||
950 |
Affiliated | 3588 | Forest Hills Dialysis | Forest Hills Dialysis | 2693 FOREST HILLS RD SW | WILSON | NC | 27893-8611 | ||||||||||
951 |
Affiliated | 3589 | St. Peters Dialysis | St. Peters Dialysis | 300 FIRST EXECUTIVE AVE | STE A | SAINT PETERS | MO | 63376-1655 | |||||||||
952 |
Affiliated | 3591 | Platte Woods Dialysis | Platte Woods Dialysis | 7667 NW PRAIRIE VIEW RD | KANSAS CITY | MO | 64151-1544 | ||||||||||
953 |
Affiliated | 3593 | Fresno North Dialysis | Fresno Palm Bluffs Dialysis (fka Fresno North) | 770 W PINEDALE AVE | FRESNO | CA | 93711-5744 | ||||||||||
954 |
Affiliated | 3594 | Middlesex County Dialysis | Burlington Regional Dialysis (fka Middlesex County) | 31 MALL RD | STE 1B | BURLINGTON | MA | 01803-4138 | |||||||||
955 |
Affiliated | 3596 | Clearfield Dialysis | Clearfield Dialysis | 1033 TURNPIKE AVE | STE 1 | CLEARFIELD | PA | 16830-3061 | |||||||||
956 |
Affiliated | 3597 | Papillion Dialysis | Papillion Dialysis | 1502 S WASHINGTON ST | STE 1 | PAPILLION | NE | 68046-3136 | |||||||||
957 |
Affiliated | 3598 | Birmingham Home Training Dialysis | Birmingham Home Training Dialysis | 2101 7TH AVE S | BIRMINGHAM | AL | 35233-3105 | ||||||||||
958 |
Affiliated | 3603 | Bayou Dialysis | Magnolia Dialysis | 210 E SPILLMAN ST | GONZALES | LA | 70737-4604 | ||||||||||
959 |
Affiliated | 3609 | Radford Dialysis | Radford Dialysis | 600 E MAIN ST | STE F | RADFORD | VA | 24141-1826 | |||||||||
960 |
Affiliated | 3610 | Eufaula Dialysis | Eufaula Dialysis | 220 S ORANGE AVE | EUFAULA | AL | 36027-1612 | ||||||||||
961 |
Affiliated | 3612 | Coshocton Dialysis | Coshocton Dialysis | 1404 CHESTNUT ST EAST | COSHOCTON | OH | 43812-1401 | ||||||||||
962 |
Affiliated | 3614 | Costa Mesa Dialysis | Costa Mesa Dialysis | 1590 SCENIC AVE | COSTA MESA | CA | 92626-1400 | ||||||||||
963 |
Affiliated | 3615 | Little Rock Dialysis | Central Little Rock Dialysis | 5800 W 10TH ST | STE 51 | LITTLE ROCK | AR | 72204-1760 | |||||||||
964 |
Affiliated | 3619 | Northport Dialysis | Northport Dialysis | 2401 HOSPITAL DR | NORTHPORT | AL | 35476-3392 | ||||||||||
965 |
Affiliated | 3632 | Pageland Dialysis | Pageland Dialysis | 505A S PEARL ST | PAGELAND | SC | 29728-2222 | ||||||||||
966 |
Affiliated | 3633 | Bakersfield South Dialysis | White Lane Dialysis (fka Bakersfield South) | 7701 WHITE LN | STE D | BAKERSFIELD | CA | 93309-0201 | |||||||||
967 |
Affiliated | 3634 | Newaygo County Dialysis | Newaygo County Dialysis | 1317 W MAIN ST | FREMONT | MI | 49412-1478 | ||||||||||
968 |
Affiliated | 3636 | Cedar Lane Dialysis | Cedar Lane Dialysis | 6334 CEDAR LN | STE 11 | COLUMBIA | MD | 21044-3898 | |||||||||
969 |
Affiliated | 3639 | Torrington Dialysis | Torrington Dialysis | 780 LITCHFIELD ST | STE 1 | TORRINGTON | CT | 06790-6268 | |||||||||
970 |
Affiliated | 3642 | Janesville Dialysis | Janesville Dialysis | 1305 WOODMAN RD | JANESVILLE | WI | 53545-1068 | ||||||||||
971 |
Affiliated | 3643 | Bloomfield Dialysis | Bloomfield Dialysis | 29 GRIFFIN RD S | BLOOMFIELD | CT | 06002-1351 | ||||||||||
972 |
Affiliated | 3645 | Anthem Village Dialysis | Anthem Village Dialysis | 2530 ANTHEM VILLAGE DR | HENDERSON | NV | 89052-5548 | ||||||||||
973 |
Affiliated | 3646 | Glen Burnie Dialysis | Glen Burnie Dialysis | 120 LANGLEY RD N | GLEN BURNIE | MD | 21060-6578 | ||||||||||
974 |
Affiliated | 3655 | Melbourne Dialysis | Melbourne Dialysis | 2235 S BABCOCK ST | MELBOURNE | FL | 32901-5305 | ||||||||||
975 |
Affiliated | 3656 | St. Petersburg South Dialysis | St. Petersburg South Dialysis | 2850 34TH ST S | ST PETERSBURG | FL | 33711-3817 | ||||||||||
976 |
Affiliated | 3663 | Belpre Dialysis | Belpre Dialysis | 2906 WASHINGTON BLVD | BELPRE | OH | 45714-1848 | ||||||||||
977 |
Affiliated | 3666 | Stockton Home Training Dialysis | Stockton Home Training Dialysis | 545 E CLEVELAND ST | STE A | STOCKTON | CA | 95204-5535 | |||||||||
978 |
Affiliated | 3670 | Rock Prairie Road Dialysis | Rock Prairie Road Dialysis | 1605 ROCK PRAIRIE RD | STE 11 | COLLEGE STATION | TX | 77845-8358 | |||||||||
979 |
Affiliated | 3675 | Market Street | Market Street Dialysis | 3701 MARKET ST | STE 1 | PHILADELPHIA | PA | 19104-5503 | |||||||||
980 |
Affiliated | 3677 | Northwood | Northwood Dialysis (aka Toledo East) | 611 LEMOYNE RD | NORTHWOOD | OH | 43619-1811 | ||||||||||
981 |
Affiliated | 3701 | Tysons Corner Dialysis | Tysons Corner Dialysis | 8391 OLD COURTHOUSE RD | STE 16 | VIENNA | VA | 22182-3819 | |||||||||
982 |
Affiliated | 3704 | Southern Maryland Dialysis | Southern Maryland Dialysis | 9211 STUART LN | 4TH FL | CLINTON | MD | 20735-2712 | |||||||||
983 |
Affiliated | 3707 | Brentwood Dialysis | Brentwood Dialysis | 1231 BRENTWOOD RD NE | WASHINGTON | DC | 20018-1019 | ||||||||||
984 |
Affiliated | 3708 | Amelia Dialysis | Amelia Dialysis | 15151 PATRICK HENRY HWY | AMELIA COURT HOUSE | VA | 23002-4700 | ||||||||||
985 |
Affiliated | 3714 | Eighth Street Dialysis | Eighth Street Dialysis | 300 8TH ST NE | WASHINGTON | DC | 20002-6108 | ||||||||||
986 |
Affiliated | 3715 | Chester Dialysis | Chester Dialysis | 10360 IRONBRIDGE RD | CHESTER | VA | 23831-1425 | ||||||||||
987 |
Affiliated | 3716 | Howard County Dialysis | Howard County Dialysis | 5999 HARPERS FARM RD | STE 11E | COLUMBIA | MD | 21044-3023 | |||||||||
988 |
Affiliated | 3717 | Catonsville Dialysis | Catonsville Dialysis | 1581 SULPHUR SPRING RD | STE 112 | BALTIMORE | MD | 21227 | |||||||||
989 |
Affiliated | 3718 | Mercy Dialysis | Mercy Dialysis | 315 N CALVERT ST | STE 3 | BALTIMORE | MD | 21202-3611 | |||||||||
990 |
Affiliated | 3719 | Harbor Park Dialysis | Harbor Park Dialysis | 111 CHERRY HILL RD | BALTIMORE | MD | 21225-1392 | ||||||||||
991 |
Affiliated | 3732 | Dabney Dialysis | Three Chopt Dialysis (fka Dabney) | 8813 THREE CHOPT RD | RICHMOND | VA | 23229 | ||||||||||
992 |
Affiliated | 3733 | Hioaks Dialysis | Hioaks Dialysis | 671 HIOAKS RD | STE A | RICHMOND | VA | 23225-4072 | |||||||||
993 |
Affiliated | 3757 | Arlington Dialysis | Arlington Dialysis | 4805 1st ST N | ARLINGTON | VA | 22203 | ||||||||||
994 |
Affiliated | 3759 | Landover Dialysis | Landover Dialysis | 1200 MERCANTILE LN | STE 15 | UPPER MARLBORO | MD | 20774-5389 | |||||||||
995 |
Affiliated | 3761 | Staunton Dialysis | Staunton Dialysis | 29 IDLEWOOD BLVD | STAUNTON | VA | 24401-9355 | ||||||||||
996 |
Affiliated | 3762 | Covington Dialysis | Covington Dialysis | 2504 VALLEY RIDGE RD | COVINGTON | VA | 24426-6339 | ||||||||||
997 |
Affiliated | 3763 | Culpeper Dialysis | Culpeper Dialysis | 430 SOUTHRIDGE PARKWAY | CULPEPER | VA | 22701-3791 | ||||||||||
998 |
Affiliated | 3764 | Greenbrier Dialysis | Greenbrier Dialysis | 129 SENECA TRL | LEWISBURG | WV | 24901-1564 | ||||||||||
999 |
Affiliated | 3765 | Harrisonburg Dialysis | Harrisonburg Dialysis | 871 CANTRELL AVE | STE 1 | HARRISONBURG | VA | 22801-4323 |
Page 63 of 123
1000 |
Affiliated | 3766 | Lexington Dialysis | Lexington Dialysis | 756 N LEE HWY | LEXINGTON | VA | 24450-3724 | ||||||||||
1001 |
Affiliated | 3802 | Manteca Dialysis | Manteca Dialysis | 1156 S MAIN ST | MANTECA | CA | 95337-9505 | ||||||||||
1002 |
Affiliated | 3804 | Roseburg/Mercy Dialysis | Roseburg/Mercy Dialysis | 2599 NW EDENBOWER BLVD | ROSEBURG | OR | 97471-6220 | ||||||||||
1003 |
Affiliated | 3805 | Daly City Dialysis | Daly City Dialysis | 1498 SOUTHGATE AVE | STE 11 | DALY CITY | CA | 94015-4015 | |||||||||
1004 |
Affiliated | 3806 | Vallejo Dialysis | Vallejo Dialysis | 121 HOSPITAL DR | VALLEJO | CA | 94589-2562 | ||||||||||
1005 |
Affiliated | 3812 | Salem Dialysis | Salem Dialysis (OR) | 3550 LIBERTY RD S | STE 1 | SALEM | OR | 97302-5700 | |||||||||
1006 |
Affiliated | 3817 | Fresno Dialysis | Fresno Dialysis | 1111 E WARNER AVE | FRESNO | CA | 93710-4030 | ||||||||||
1007 |
Affiliated | 3818 | Oakland Dialysis | Oakland Dialysis | 5354 CLAREMONT AVE | OAKLAND | CA | 94618-1035 | ||||||||||
1008 |
Affiliated | 3820 | Bakersfield Dialysis | Bakersfield Brimhall Dialysis (fka California Ave.) | 8501 BRIMHALL RD | BLDG 5 | BAKERSFIELD | CA | 93311-2252 | |||||||||
1009 |
Affiliated | 3821 | Northeast Bakersfield Dialysis | Northeast Dialysis (fka NE Bakersfield) | 3761 MALL VIEW RD | BAKERSFIELD | CA | 93306-3048 | ||||||||||
1010 |
Affiliated | 3830 | San Francisco Dialysis | San Francisco Dialysis | 1499 WEBSTER ST | SAN FRANCISCO | CA | 94115-3705 | ||||||||||
1011 |
Affiliated | 3831 | Hanford Dialysis | Hanford Dialysis | 402 W 8TH ST | HANFORD | CA | 93230-4536 | ||||||||||
1012 |
Affiliated | 3840 | San Pablo Dialysis | San Pablo Dialysis | 14020 SAN PABLO AVE | SAN PABLO | CA | 94806-3604 | ||||||||||
1013 |
Affiliated | 3847 | Chinatown Dialysis | Chinatown Dialysis | 636 CLAY ST | SAN FRANCISCO | CA | 94111-2502 | ||||||||||
1014 |
Affiliated | 3849 | El Cerrito Dialysis | El Cerrito Dialysis | 10690 SAN PABLO AVE | EL CERRITO | CA | 94530-2620 | ||||||||||
1015 |
Affiliated | 3857 | Tracy Dialysis | Tracy Dialysis | 425 W BEVERLY PL | STE A | TRACY | CA | 95376-3086 | |||||||||
1016 |
Affiliated | 3858 | Salem North Dialysis | Salem North Dialysis (OR) | 1220 LIBERTY ST NE | SALEM | OR | 97301-7330 | ||||||||||
1017 |
Affiliated | 3860 | Auburn Dialysis | Auburn Dialysis | 3126 PROFESSIONAL DR | STE 1 | AUBURN | CA | 95603-2411 | |||||||||
1018 |
Affiliated | 3861 | Grass Valley Dialysis | Grass Valley Dialysis | 360 CROWN POINT CIRCLE | STE 21 | GRASS VALLEY | CA | 95945-2543 | |||||||||
1019 |
Affiliated | 3901 | Santee Dialysis | Santee Dialysis | 228 BRADFORD BLVD | SANTEE | SC | 29142-8677 | ||||||||||
1020 |
Affiliated | 3903 | Upland Dialysis | Upland Dialysis | 600 N 13TH AVE | UPLAND | CA | 91786-4957 | ||||||||||
1021 |
Affiliated | 3906 | Vance County Dialysis | Vance County Dialysis | 854 S BECKFORD DR | HENDERSON | NC | 27536-3487 | ||||||||||
1022 |
Affiliated | 3907 | Edenton Dialysis | Edenton Dialysis | 703 LUKE ST | EDENTON | NC | 27932-9694 | ||||||||||
1023 |
Affiliated | 3909 | Ahoskie Dialysis | Ahoskie Dialysis | 129 HERTFORD COUNTY HIGH RD | AHOSKIE | NC | 27910-8131 | ||||||||||
1024 |
Affiliated | 3914 | Allendale County Dialysis | Allendale County Dialysis | 202 HAMPTON AVE N | FAIRFAX | SC | 29827-4510 | ||||||||||
1025 |
Affiliated | 3916 | North Orangeburg Dialysis | North Orangeburg Dialysis | 124 FIRE TOWER RD | ORANGEBURG | SC | 29118-1443 | ||||||||||
1026 |
Affiliated | 3917 | South Orangeburg Dialysis | South Orangeburg Dialysis | 1080 SUMMERS AVE | ORANGEBURG | SC | 29115-4920 | ||||||||||
1027 |
Affiliated | 3931 | Greenwood Dialysis | Greenwood Dialysis | 109 OVERLAND DR | GREENWOOD | SC | 29646-4053 | ||||||||||
1028 |
Affiliated | 3933 | Union County Dialysis | Union County Dialysis | 701 E ROOSEVELT BLVD | STE 4 | MONROE | NC | 28112-4107 | |||||||||
1029 |
Affiliated | 3934 | South Charlotte Dialysis | South Charlotte Dialysis | 6450 BANNINGTON RD | CHARLOTTE | NC | 28226-1327 | ||||||||||
1030 |
Affiliated | 3935 | Lancaster SC Dialysis | Lancaster SC Dialysis | 980 N WOODLAND DR | STE 1 | LANCASTER | SC | 29720-1964 | |||||||||
1031 |
Affiliated | 3952 | Central Bamberg Dialysis | Central Bamberg Dialysis | 67 SUNSET DR | BAMBERG | SC | 29003-1181 | ||||||||||
1032 |
Affiliated | 4001 | West Tallahassee Dialysis | West Tallahassee Dialysis | 2645 W TENNESSEE ST | TALLAHASSEE | FL | 32304-2547 | ||||||||||
1033 |
Affiliated | 4002 | Daytona South Dialysis | Daytona South Dialysis | 1801 S NOVA RD | STE 36 | SOUTH DAYTONA | FL | 32119-1775 | |||||||||
1034 |
Affiliated | 4003 | Daytona Beach Dialysis | Daytona Beach Dialysis | 578 HEALTH BLVD | DAYTONA BEACH | FL | 32114-1492 | ||||||||||
1035 |
Affiliated | 4004 | West Tampa Dialysis | West Tampa Dialysis | 4515 GEORGE RD | STE 3 | TAMPA | FL | 33634-7300 | |||||||||
1036 |
Affiliated | 4005 | Fontana Dialysis | Fontana Dialysis | 17590 FOOTHILL BLVD | FONTANA | CA | 92335-8416 | ||||||||||
1037 |
Affiliated | 4007 | Fort Myers Dialysis | Fort Myers Dialysis | 4220 EXECUTIVE CIRCLE | STE 38 | FORT MYERS | FL | 33916-7993 | |||||||||
1038 |
Affiliated | 4009 | Lehigh Acres Dialysis | Lehigh Acres Dialysis | 2719 4TH ST W | LEHIGH ACRES | FL | 33971-1942 | ||||||||||
1039 |
Affiliated | 4010 | Los Banos Dialysis | Los Banos Dialysis | 222 I ST | LOS BANOS | CA | 93635-4132 | ||||||||||
1040 |
Affiliated | 4013 | Kissimmee Dialysis | Kissimmee Dialysis | 802 N JOHN YOUNG PKWY | KISSIMMEE | FL | 34741-4912 | ||||||||||
1041 |
Affiliated | 4014 | New Smyrna Beach Dialysis | New Smyrna Beach Dialysis | 110 S ORANGE ST | NEW SMYRNA BEACH | FL | 32168-7153 | ||||||||||
1042 |
Affiliated | 4017 | Lake Wales Dialysis | Lake Wales Dialysis | 1125 BRYN MAWR AVE | LAKE WALES | FL | 33853-4333 | ||||||||||
1043 |
Affiliated | 4018 | Dearborn Dialysis | Dearborn Dialysis | 1185 MONROE ST | DEARBORN | MI | 48124-2814 | ||||||||||
1044 |
Affiliated | 4020 | Greater Miami Dialysis | Greater Miami Dialysis | 160 NW 176TH ST | STE 1 | MIAMI | FL | 33169-5023 | |||||||||
1045 |
Affiliated | 4021 | Burbank Dialysis | Burbank Dialysis | 1211 N SAN FERNANDO BLVD | BURBANK | CA | 91504-4234 | ||||||||||
1046 |
Affiliated | 4024 | Lakeland Dialysis | Lakeland Dialysis | 515 E BELLA VISTA ST | LAKELAND | FL | 33805-3005 | ||||||||||
1047 |
Affiliated | 4025 | Burlington North Dialysis | Burlington North Dialysis | 1164 E ROUTE 130 | BURLINGTON | NJ | 08016-2954 | ||||||||||
1048 |
Affiliated | 4026 | Delano Dialysis | Delano Dialysis | 905 MAIN ST | DELANO | CA | 93215-1729 | ||||||||||
1049 |
Affiliated | 4027 | Erie Dialysis | Erie Dialysis | 350 E BAYFRONT PKWY | STE A | ERIE | PA | 16507-2410 | |||||||||
1050 |
Affiliated | 4028 | Homestead Dialysis | Homestead Dialysis | 207 W 7TH AVE | W HOMESTEAD | PA | 15120-1002 | ||||||||||
1051 |
Affiliated | 4029 | Plant City Dialysis | Plant City Dialysis | 1211 W REYNOLDS ST | PLANT CITY | FL | 33563-4321 | ||||||||||
1052 |
Affiliated | 4030 | Winter Haven Dialysis | Winter Haven Dialysis | 1625 UNITY WAY NW | WINTER HAVEN | FL | 33881 | ||||||||||
1053 |
Affiliated | 4032 | Charlotte Dialysis | Charlotte Dialysis | 2321 W MOREHEAD ST | STE 12 | CHARLOTTE | NC | 28208-5145 | |||||||||
1054 |
Affiliated | 4034 | McKeesport Dialysis | McKeesport Dialysis | 2001 LINCOLN WAY | OAK PARK MALL | MCKEESPORT | PA | 15131-2419 | |||||||||
1055 |
Affiliated | 4035 | Broward Dialysis | Broward Dialysis | 1500 N FEDERAL HWY | STE 1 | FT LAUDERDALE | FL | 33304-5600 | |||||||||
1056 |
Affiliated | 4036 | Athens Dialysis | Athens Dialysis | 15953 ATHENS LIMESTONE DR | ATHENS | AL | 35613-2214 | ||||||||||
1057 |
Affiliated | 4038 | Bradenton Dialysis | Bradenton Dialysis | 3501 CORTEZ RD W | STE 14 | BRADENTON | FL | 34210-3104 | |||||||||
1058 |
Affiliated | 4039 | Deland Dialysis | Deland Dialysis | 350 E NEW YORK AVE | DELAND | FL | 32724-5510 | ||||||||||
1059 |
Affiliated | 4040 | Boynton/North Delray Dialysis | Boynton/North Delray Dialysis | 2655 W ATLANTIC AVE | DELRAY BEACH | FL | 33445-4400 | ||||||||||
1060 |
Affiliated | 4041 | Lake Worth Dialysis | Lake Worth Dialysis | 2459 S CONGRESS AVE | STE 1 | PALM SPRINGS | FL | 33406-7616 | |||||||||
1061 |
Affiliated | 4042 | Palm Coast Dialysis | Palm Coast Dialysis | 13 KINGSWOOD DR | STE A | PALM COAST | FL | 32137-4614 | |||||||||
1062 |
Affiliated | 4043 | Fort Myers South Dialysis | Fort Myers South Dialysis | 8570 GRANITE CT | FORT MYERS | FL | 33908-4102 | ||||||||||
1063 |
Affiliated | 4044 | Woodburn Dialysis | Woodburn Dialysis | 1840 NEWBERG HWY | STE 14 | WOODBURN | OR | 97071-3187 | |||||||||
1064 |
Affiliated | 4045 | Four Freedoms | Four Freedoms Dialysis (fka Range Street) | 289 SW RANGE AVE | STE A | MADISON | FL | 32340-2351 | |||||||||
1065 |
Affiliated | 4046 | West Philadelphia Dialysis | West Philadelphia Dialysis | 7609 LINDBERGH BLVD | PHILADELPHIA | PA | 19153-2301 | ||||||||||
1066 |
Affiliated | 4048 | Tucson West Dialysis | Tucson West Dialysis | 1780 W ANKLAM RD | TUCSON | AZ | 85745-2632 |
Page 64 of 123
1067 |
Affiliated | 4049 | Tucson East Dialysis | Tucson East Dialysis | 6420 E BROADWAY BLVD | STE C3 | TUCSON | AZ | 85710-3512 | |||||||||
1068 |
Affiliated | 4053 | Tallahassee South Dialysis | Tallahassee South Dialysis | 2410 S ADAMS ST | TALLAHASSEE | FL | 32301-6325 | ||||||||||
1069 |
Affiliated | 4054 | Selma Dialysis | Selma Dialysis | 2711 CINEMA WAY | STE 111 | SELMA | CA | 93662-2662 | |||||||||
1070 |
Affiliated | 4055 | Hinesville Dialysis | Hinesville Dialysis | 522 ELMA G MILES PKWY | HINESVILLE | GA | 31313-4021 | ||||||||||
1071 |
Affiliated | 4056 | Los Angeles Downtown Dialysis | Los Angeles Downtown Dialysis | 2021 S FLOWER ST | LOS ANGELES | CA | 90007-1342 | ||||||||||
1072 |
Affiliated | 4057 | Anaheim Dialysis | Anaheim Dialysis | 1107 W LA PALMA AVE | ANAHEIM | CA | 92801-2804 | ||||||||||
1073 |
Affiliated | 4058 | Martinsville Dialysis | Martinsville Dialysis | 33 BRIDGE ST S | MARTINSVILLE | VA | 24112-6214 | ||||||||||
1074 |
Affiliated | 4060 | Jefferson Dialysis | Jefferson Dialysis | 14 CLAIRTON BLVD | PITTSBURGH | PA | 15236-3911 | ||||||||||
1075 |
Affiliated | 4061 | Saddleback Dialysis | Saddleback Dialysis | 23141 PLAZA POINTE DR | LAGUNA HILLS | CA | 92653-1425 | ||||||||||
1076 |
Affiliated | 4064 | Sun City Center Dialysis | Sun City Center Dialysis | 783 CORTARO DR | RUSKIN | FL | 33573-6812 | ||||||||||
1077 |
Affiliated | 4065 | Paris Dialysis | Paris Dialysis | 32 STEUBENVILLE PK | PARIS | PA | 15021 | ||||||||||
1078 |
Affiliated | 4066 | Central Tampa Dialysis | Central Tampa Dialysis | 4204 N MACDILL AVE | SOUTH BLDG | TAMPA | FL | 33607-6342 | |||||||||
1079 |
Affiliated | 4068 | Zephyrhills Dialysis | Zephyrhills Dialysis | 6610 STADIUM DR | ZEPHYRHILLS | FL | 33542-7510 | ||||||||||
1080 |
Affiliated | 4069 | Bartow Dialysis | Bartow Dialysis | 1190 E CHURCH ST | BARTOW | FL | 33830-4117 | ||||||||||
1081 |
Affiliated | 4070 | Ormond Beach Dialysis | Ormond Beach Dialysis | 495 S NOVA RD | STE 19 | ORMOND BEACH | FL | 32174-8444 | |||||||||
1082 |
Affiliated | 4071 | Lakeland South Dialysis | Lakeland South Dialysis | 5050 S FLORIDA AVE | LAKELAND | FL | 33813-2501 | ||||||||||
1083 |
Affiliated | 4072 | St. Marys Dialysis | St. Marys Dialysis | 2714 OSBORNE RD | ST MARYS | GA | 31558-4049 | ||||||||||
1084 |
Affiliated | 4073 | Miami North Dialysis | Miami North Dialysis | 860 NE 125TH ST | NORTH MIAMI | FL | 33161-5743 | ||||||||||
1085 |
Affiliated | 4074 | Naples Dialysis | Naples Dialysis | 661 9TH ST N | NAPLES | FL | 34102-8132 | ||||||||||
1086 |
Affiliated | 4075 | Bonita Springs Dialysis | Bonita Springs Dialysis | 9134 BONITA BEACH RD SE | BONITA SPRINGS | FL | 34135-4281 | ||||||||||
1087 |
Affiliated | 4076 | Orlando Southwest Dialysis | Orlando Southwest Dialysis | 6925 LAKE ELLENOR DR | STE 65 | ORLANDO | FL | 32809-4670 | |||||||||
1088 |
Affiliated | 4088 | Quincy Dialysis | Quincy Dialysis | 878 STRONG RD | QUINCY | FL | 32351-5243 | ||||||||||
1089 |
Affiliated | 4089 | Tallahassee Dialysis | Tallahassee Dialysis | 1607 PHYSICIANS DR | TALLAHASSEE | FL | 32308-4620 | ||||||||||
1090 |
Affiliated | 4095 | South Beach Dialysis | South Beach Dialysis | 4701 N MERIDIAN AVE | MIAMI BEACH | FL | 33140-2910 | ||||||||||
1091 |
Affiliated | 4124 | Americus Dialysis | Americus Dialysis | 227 N LEE ST | AMERICUS | GA | 31709-3525 | ||||||||||
1092 |
Affiliated | 4204 | Corry Dialysis | Corry Dialysis | 300 YORK ST | CORRY | PA | 16407-1420 | ||||||||||
1093 |
Affiliated | 4208 | Elizabethtown Dialysis | Elizabethtown Dialysis | 844 N HANOVER ST | ELIZABETHTOWN | PA | 17022-1303 | ||||||||||
1094 |
Affiliated | 4209 | Lumberton Dialysis | Lumberton Dialysis | 668 MAIN ST | LUMBERTON | NJ | 08048-5016 | ||||||||||
1095 |
Affiliated | 4211 | Cobbs Creek Dialysis | Cobbs Creek Dialysis | 1700 S 60TH ST | PHILADELPHIA | PA | 19142-1404 | ||||||||||
1096 |
Affiliated | 4214 | Westland Dialysis | Garden West Dialysis (fka Westland) | 5715 N VENOY RD | WESTLAND | MI | 48185-2830 | ||||||||||
1097 |
Affiliated | 4215 | Meadville Dialysis | Meadville Dialysis | 19050 PARK AVENUE PLZ | MEADVILLE | PA | 16335-4012 | ||||||||||
1098 |
Affiliated | 4217 | Bradford Dialysis | Bradford Dialysis | 665 E MAIN ST | BRADFORD | PA | 16701-1869 | ||||||||||
1099 |
Affiliated | 4219 | Southgate Dialysis | Southgate Dialysis | 14752 NORTHLINE RD | SOUTHGATE | MI | 48195-2467 | ||||||||||
1100 |
Affiliated | 4223 | Waynesburg Dialysis | Waynesburg Dialysis | 248 ELM DR | WAYNESBURG | PA | 15370-8269 | ||||||||||
1101 |
Affiliated | 4224 | Selinsgrove Dialysis | Selinsgrove Dialysis | 1030 N SUSQUEHANNA TRAIL | SELINSGROVE | PA | 17870-7767 | ||||||||||
1102 |
Affiliated | 2153 | Arlington Dialysis | Arlington Dialysis | 1250 E PIONEER PKWY | STE 7 | ARLINGTON | TX | 76010-6423 | |||||||||
1103 |
Affiliated | 2154 | Grapevine Dialysis | Grapevine Dialysis | 1600 W NORTHWEST HWY | STE 1 | GRAPEVINE | TX | 76051-8131 | |||||||||
1104 |
Affiliated | 1740 | Willow Dialysis | Willow Dialysis | 1675 ALEX DR | WILMINGTON | OH | 45177-2446 | ||||||||||
1105 |
Affiliated | 1767 | New Braunfels Dialysis | New Braunfels Dialysis | 900 LOOP 337 | NEW BRAUNFELS | TX | 78130-3555 | ||||||||||
1106 |
Affiliated | 2080 | Chickasha Dialysis | Chickasha Dialysis | 228 S 29TH ST | CHICKASHA | OK | 73018-2502 | ||||||||||
1107 |
Affiliated | 2184 | Sugarloaf | Sugarloaf Dialysis (fka Lawrenceville) | 1705 BELLE MEADE CT | STE 11 | LAWRENCEVILLE | GA | 30043-5895 | |||||||||
1108 |
Affiliated | 2166 | Buford Dialysis | Buford Dialysis | 1550 BUFORD HWY | STE 1E | BUFORD | GA | 30518-3666 | |||||||||
1109 |
Affiliated | 1749 | St. Louis Park PD | St. Louis Park Dialysis Center PD | 3505 LOUISIANA AVE S | ST LOUIS PARK | MN | 55426-4121 | ||||||||||
1110 |
Affiliated | 1769 | Front Royal Dialysis | Front Royal Dialysis | 1077D N SHENANDOAH AVE | FRONT ROYAL | VA | 22630-3546 | ||||||||||
1111 |
Affiliated | 1770 | Winchester Dialysis | Winchester Dialysis | 2301 VALOR DR | WINCHESTER | VA | 22601-6111 | ||||||||||
1112 |
Affiliated | 2200 | New Hope Dialysis | New Hope Dialysis (aka Minneapolis, Golden Valley) | 5640 INTERNATIONAL PKWY | NEW HOPE | MN | 55428-3047 | ||||||||||
1113 |
Affiliated | 2175 | Richfield Dialysis | Richfield Dialysis | 6601 LYNDALE AVE S | STE 15 | RICHFIELD | MN | 55423-2490 | |||||||||
1114 |
Affiliated | 2162 | Fairborne Dialysis | Fairborn Dialysis | 3070 PRESIDENTIAL DR | STE A | FAIRBORN | OH | 45324-6273 | |||||||||
1115 |
Affiliated | 1694 | Benton Dialysis | Benton Dialysis | 1151 ROUTE 14 W | BENTON | IL | 62812-1500 | ||||||||||
1116 |
Affiliated | 1695 | Centralia Dialysis | Centralia Dialysis | 1231 STATE ROUTE 161 | CENTRALIA | IL | 62801-6739 | ||||||||||
1117 |
Affiliated | 1696 | Marion Dialysis | Marion Dialysis | 324 S 4TH ST | MARION | IL | 62959-1241 | ||||||||||
1118 |
Affiliated | 1697 | Mount Vernon Dialysis | Mount Vernon Dialysis | 1800 JEFFERSON AVE | MOUNT VERNON | IL | 62864-4300 | ||||||||||
1119 |
Affiliated | 2121 | Bayou City Dialysis | Bayou City Dialysis (fka Hanson) | 10655 EASTEX FWY | HOUSTON | TX | 77093-4323 | ||||||||||
1120 |
Affiliated | 2117 | Metarie Dialysis Center | Metairie Dialysis | 7100 AIRLINE DR | METAIRIE | LA | 70003-5950 | ||||||||||
1121 |
Affiliated | 1784 | Stony Creek Dialysis | Stony Creek Dialysis | 9115 S CICERO AVE | OAK LAWN | IL | 60453-1895 | ||||||||||
1122 |
Affiliated | 1785 | Beverly Dialysis | Beverly Dialysis | 8109 SOUTH WESTERN AVE | CHICAGO | IL | 60620-5939 | ||||||||||
1123 |
Affiliated | 2089 | Summit Dialysis | Summit Dialysis Center | 3150 POLK ST | HOUSTON | TX | 77003-4631 | ||||||||||
1124 |
Affiliated | 2212 | Upper Valley Dialysis | Upper Valley Dialysis (fka West El Paso) | 7933 N MESA ST | STE H | EL PASO | TX | 79932-1699 | |||||||||
1125 |
Affiliated | 2134 | Dallas County | Perry Dialysis (fka Dallas County) | 610 10TH ST | STE L1 | PERRY | IA | 50220-2221 | |||||||||
1126 |
Affiliated | 1813 | Nampa Dialysis Center | Nampa Dialysis | 846 PARKCENTRE WAY | NAMPA | ID | 83651-1790 | ||||||||||
1127 |
Affiliated | 1814 | Table Rock Dialysis | Table Rock Dialysis | 5610 W GAGE ST | STE B | BOISE | ID | 83706 | |||||||||
1128 |
Affiliated | 1815 | Twin Falls Dialysis | Twin Falls Dialysis | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | ||||||||||
1129 |
Affiliated | 1816 | Burley Dialysis Center | Burley Dialysis | 741 N OVERLAND AVE | BURLEY | ID | 83318-3440 | ||||||||||
1130 |
Affiliated | 1817 | Gate City Dialysis Center | Gate City Dialysis | 2001 BENCH RD | POCATELLO | ID | 83201-2033 | ||||||||||
1131 |
Affiliated | 1818 | Four Rivers Dialysis | Four Rivers Dialysis | 515 EAST LN | ONTARIO | OR | 97914-3953 | ||||||||||
1132 |
Affiliated | 2231 | River Parishes | River Parishes Dialysis (aka La Place) | 2880 W AIRLINE HWY | LA PLACE | LA | 70068-2922 | ||||||||||
1133 |
Affiliated | 2177 | South Lincoln | South Lincoln Dialysis | 3401 PLANTATION DR | STE 14 | LINCOLN | NE | 68516-4712 |
Page 65 of 123
1134 |
Affiliated | 2105 | Rochester Hills | Rochester Hills Dialysis (aka Sterling Heights) | 1886 W AUBURN RD | STE 1 | ROCHESTER HILLS | MI | 48309-3865 | |||||||||
1135 |
Affiliated | 2101 | Willowbrook Dialysis | Willowbrook Dialysis | 12120 JONES RD | STE G | HOUSTON | TX | 77070-5280 | |||||||||
1136 |
Affiliated | 2195 | Springhurst Dialysis | Springhurst Dialysis (aka Louisville) | 10201 CHAMPION FARMS DR | LOUISVILLE | KY | 40241-6150 | ||||||||||
1137 |
Affiliated | 2012 | Magnolia West | Magnolia West Dialysis (aka Riverside II) | 11161 MAGNOLIA AVE | RIVERSIDE | CA | 92505-3605 | ||||||||||
1138 |
Affiliated | 2206 | Garrisonville Dialysis | Garrisonville Dialysis | 70 DOC STONE RD | STE 11 | STAFFORD | VA | 22556-4628 | |||||||||
1139 |
Affiliated | 2152 | Strongsville Dialysis | Strongsville Dialysis | 17792 PEARL RD | STRONGSVILLE | OH | 44136-6909 | ||||||||||
1140 |
Affiliated | 984 | Summerlin Dialysis | Summerlin Dialysis Center, LV | 653 N TOWN CENTER DR | STE 7 BLDG 2 | LAS VEGAS | NV | 89144-0503 | |||||||||
1141 |
Affiliated | 2127 | Red Bluff Dialysis | Red Bluff Dialysis Center | 2455 SISTER MARY COLUMBA DR | RED BLUFF | CA | 96080-4364 | ||||||||||
1142 |
Affiliated | 1638 | Cobb Dialysis | Cobb Dialysis | 3865 MEDICAL PARK DR | AUSTELL | GA | 30106-1109 | ||||||||||
1143 |
Affiliated | 1693 | Paulding Dialysis | Paulding Dialysis | 4019 JOHNS RD | DALLAS | GA | 30132-3420 | ||||||||||
1144 |
Affiliated | 1839 | Sweetwater Dialysis | Sweetwater Dialysis | 7117 S SWEETWATER RD | LITHIA SPRINGS | GA | 30122-2446 | ||||||||||
1145 |
Affiliated | 3671 | Charlottesville North | Charlottesville North Dialysis | 1800 TIMBERWOOD BLVD | STE C | CHARLOTTESVILLE | VA | 22911-7544 | |||||||||
1146 |
Affiliated | 2186 | Southern Crescent | Southern Crescent Dialysis Center (fka Riverdale) | 275 UPPER RIVERDALE RD SW | STE B | RIVERDALE | GA | 30274-2556 | |||||||||
1147 |
Affiliated | 2169 | Meridian Park | Meridian Park Dialysis Center (fka Lake Oswego) | 19255 SW 65TH AVE | STE 1 | TUALATIN | OR | 97062-9712 | |||||||||
1148 |
Affiliated | 1812 | Treasure Valley Dialysis | Treasure Valley Dialysis | 3525 E LOUISE ST | STE 155 | MERIDIAN | ID | 83642-6303 | |||||||||
1149 |
Affiliated | 3637 | White Oak | White Oak Dialysis (Chronic) | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | |||||||||
1150 |
Affiliated | 1786 | Ash Tree | Ash Tree Dialysis | 2666 N GROVE INDUSTRIAL DR | FRESNO | CA | 93727-1552 | ||||||||||
1151 |
Affiliated | 2242 | Madera Dialysis | Almond Wood Dialysis (fka Madera) | 501 E ALMOND AVE | MADERA | CA | 93637-5661 | ||||||||||
1152 |
Affiliated | 2209 | Carrollton | Carrollton Dialysis | 1544 VALWOOD PKWY | STE 114 | CARROLLTON | TX | 75006-8425 | |||||||||
1153 |
Affiliated | 2202 | Edna Dialysis | Edna Dialysis | 1008 N WELLS ST | EDNA | TX | 77957-2153 | ||||||||||
1154 |
Affiliated | 2208 | Bear Creek Dialysis | Bear Creek Dialysis (fka Clay Road) | 4978 HIGHWAY 6 N | STE I | HOUSTON | TX | 77084-5282 | |||||||||
1155 |
Affiliated | 1820 | Windham Dialysis | Windham Dialysis | 375 TUCKIE RD | STE C | NORTH WINDHAM | CT | 06256-1345 | |||||||||
1156 |
Affiliated | 1819 | Vernon Dialysis | Vernon Dialysis | 460 HARTFORD TPKE STE C | VERNON ROCKVILLE | CT | 6066 | ||||||||||
1157 |
Affiliated | 2092 | Fountain Dialysis | Fountain Dialysis (aka Security) | 6910 BANDLEY DR | FOUNTAIN | CO | 80817-2617 | ||||||||||
1158 |
Affiliated | 1846 | Grand Junction | Grand Junction Dialysis Center | 710 WELLINGTON AVE | STE 2 | GRAND JUNCTION | CO | 81501-6100 | |||||||||
1159 |
Affiliated | 2183 | Fort Mill | Fort Mill Dialysis | 1975 CAROLINA PLACE DR | FORT MILL | SC | 29708-6922 | ||||||||||
1160 |
Affiliated | 2215 | Mrytle Beach | JV-Myrtle Beach Dialysis | 3919 MAYFAIR ST | MYRTLE BEACH | SC | 29577-5773 | ||||||||||
1161 |
Affiliated | 2032 | Oakwood | Oakwood Dialysis Center | 148 HECTOR AVE | GRETNA | LA | 70056-2531 | ||||||||||
1162 |
Affiliated | 2168 | SP Hillsboro | Hillsboro Dialysis | 2500 NW 229TH AVE | STE 3 BLDG E | HILLSBORO | OR | 97124-7516 | |||||||||
1163 |
Affiliated | 2269 | Kettering | Kettering Dialysis | 5721 BIGGER RD | KETTERING | OH | 45440-2752 | ||||||||||
1164 |
Affiliated | 2246 | Mansfield | Mansfield Dialysis Center (aka Dallas) | 987 N WALNUT CREEK DR | STE 11 | MANSFIELD | TX | 76063-8016 | |||||||||
1165 |
Affiliated | 2290 | Cottage Grove | Cottage Grove Dialysis | 8800 E POINT DOUGLAS RD S | STE 1 | COTTAGE GROVE | MN | 55016-4160 | |||||||||
1166 |
Affiliated | 2257 | Scott County Dialysis | Scott County Dialysis | 7456 S PARK DR | SAVAGE | MN | 55378 | ||||||||||
1167 |
Affiliated | 1773 | Virginia Beach | Camelot Dialysis Center | 1800 CAMELOT DR | STE 1 | VIRGINIA BEACH | VA | 23454-2440 | |||||||||
1168 |
Affiliated | 1627 | Amelia Island | Amelia Island Dialysis | 1525 LIME ST | STE 12 | FERNANDINA BEACH | FL | 32034-3015 | |||||||||
1169 |
Affiliated | 2179 | Laurel Manor at the Villages | Laurel Manor Dialysis Center at the Villages | 1950 LAUREL MANOR DR | STE 19 | LADY LAKE | FL | 32162-5603 | |||||||||
1170 |
Affiliated | 2160 | East Deerborn | East Dearborn Dialysis | 13200 W WARREN AVE | DEARBORN | MI | 48126-2410 | ||||||||||
1171 |
Affiliated | 1661 | North Houston | PDI-North Houston | 7115 NORTH LOOP E | HOUSTON | TX | 77028-5948 | ||||||||||
1172 |
Affiliated | 1663 | South Houston | PDI-South Houston | 5989 SOUTH LOOP E | HOUSTON | TX | 77033-1017 | ||||||||||
1173 |
Affiliated | 1856 | Ralph McGill Dialysis Center | Ralph McGill Dialysis | 418 DECATUR ST SE | ATLANTA | GA | 30312-1801 | ||||||||||
1174 |
Affiliated | 2144 | Chelsea | Chelsea Dialysis | 1620 COMMERCE PARK DR | STE 2 | CHELSEA | MI | 48118-2136 | |||||||||
1175 |
Affiliated | 2214 | Smokey Mountain | Smoky Mountain Dialysis | 1611 ANDREWS RD | MURPHY | NC | 28906-5100 | ||||||||||
1176 |
Affiliated | 3680 | Miami Gardens | Miami Gardens Dialysis | 3363 NW 167TH ST | MIAMI GARDENS | FL | 33056-4254 | ||||||||||
1177 |
Affiliated | 2222 | Deerbrook | Deerbrook Dialysis | 9660 FM 1960 BYPASS RD W | HUMBLE | TX | 77338-4039 | ||||||||||
1178 |
Affiliated | 2227 | Downtown Dallas | DaVita Downtown Dallas Dialysis Center (fka Grove) | 3515 SWISS AVE | STE A | DALLAS | TX | 75204-6223 | |||||||||
1179 |
Affiliated | 2197 | Henderson | Siena Henderson Dialysis Center | 2865 SIENNA HEIGHTS DR | STE 141 | HENDERSON | NV | 89052-4168 | |||||||||
1180 |
Affiliated | 2292 | Wyandotte | Wyandotte Central Dialysis | 3737 STATE AVE | KANSAS CITY | KS | 66102-3830 | ||||||||||
1181 |
Affiliated | 2235 | Westview | Westview Dialysis | 3749 COMMERCIAL DR | LAFAYETTE PLACE SHOPPING CENTER | INDIANAPOLIS | IN | 46222-1676 | |||||||||
1182 |
Affiliated | 2286 | Garland | Garland Dialysis | 776 E CENTERVILLE RD | GARLAND | TX | 75041-4640 | ||||||||||
1183 |
Affiliated | 2333 | Aberdeen | Aberdeen Dialysis | 780 W BEL AIR AVE | ABERDEEN | MD | 21001-2236 | ||||||||||
1184 |
Affiliated | 2259 | Mountain Park | Mountain Park Dialysis | 5235 MEMORIAL DR | STONE MOUNTAIN | GA | 30083-3112 | ||||||||||
1185 |
Affiliated | 2229 | Downtown San Antonio | Downtown San Antonio Dialysis (Brooklyn St) | 615 E QUINCY ST | SAN ANTONIO | TX | 78215-1600 | ||||||||||
1186 |
Affiliated | 2237 | Medlock Bridge | Medlock Bridge Dialysis (aka Duluth) | 10680 MEDLOCK BRIDGE RD | STE 13 | DULUTH | GA | 30097-8420 | |||||||||
1187 |
Affiliated | 2234 | Greene County Dialysis | Greene County Dialysis Center (NC) | 1025 KINGOLD BLVD | SNOW HILL | NC | 28580-1616 | ||||||||||
1188 |
Affiliated | 2243 | West Broadway Dialysis | West Broadway Dialysis | 720 W BROADWAY | LOUISVILLE | KY | 40202-2240 | ||||||||||
1189 |
Affiliated | 2072 | St. Pauls Dialysis | St. Pauls Dialysis (aka Robeson County) | 564 W MCLEAN ST | SAINT PAULS | NC | 28384-1421 | ||||||||||
1190 |
Affiliated | 2123 | Carquinez Dialyis | Carquinez Dialysis (fka SW Vallejo) | 125 CORPORATE PL | STE C | VALLEJO | CA | 94590-6968 | |||||||||
1191 |
Affiliated | 2159 | DaVita East | DaVita East Dialysis Clinic (fka La Bamba) | 11989 PELLICANO DR | EL PASO | TX | 79936-6287 | ||||||||||
1192 |
Affiliated | 2187 | Natomas | Natomas Dialysis | 30 GOLDEN LAND CT | BLDG G | SACRAMENTO | CA | 95834-2420 | |||||||||
1193 |
Affiliated | 2228 | Tennesse Valley | Tennessee Valley Dialysis Center (aka Johnson City) | 107 WOODLAWN DR | STE 2 | JOHNSON CITY | TN | 37604-6287 | |||||||||
1194 |
Affiliated | 2174 | Turfway Dialysis | Turfway Dialysis (fka Florence) | 11 SPIRAL DR | STE 15 | FLORENCE | KY | 41042-1394 | |||||||||
1195 |
Affiliated | 2291 | Leavenworth | Leavenworth Dialysis | 501 OAK ST | LEAVENWORTH | KS | 66048-2646 | ||||||||||
1196 |
Affiliated | 2270 | Franklin Dialysis | Franklin Dialysis (IN) | 1140 W JEFFERSON ST | STE A | FRANKLIN | IN | 46131-2101 | |||||||||
1197 |
Affiliated | 2011 | Norco | Norco Dialysis (fka Corona II) | 1901 TOWN AND COUNTRY DR | STE 1 | NORCO | CA | 92860-3611 | |||||||||
1198 |
Affiliated | 2240 | Andover | Andover Dialysis | 488 S MAIN ST | ANDOVER | OH | 44003-9602 | ||||||||||
1199 |
Affiliated | 1863 | Little Rock | Jacksonville Central Dialysis Center | 400 T P WHITE DR | JACKSONVILLE | AR | 72076-3287 | ||||||||||
1200 |
Affiliated | 1864 | North Little Rock Dialysis | North Little Rock Center | 4505 E MCCAIN BLVD | NORTH LITTLE ROCK | AR | 72117-2902 |
Page 66 of 123
1201 |
Affiliated | 2233 | Anadarko | Anadarko Dialysis | 412 SE 11TH STREET | ANADARKO | OK | 73005-4442 | ||||||||||
1202 |
Affiliated | 2331 | Desert Springs | Desert Springs Dialysis | 2110 E FLAMINGO RD | STE 18 | LAS VEGAS | NV | 89119-5191 | |||||||||
1203 |
Affiliated | 2213 | Livingston | Vancouver Dialysis Center | 9120 NE VANCOUVER MALL DR | STE 16 | VANCOUVER | WA | 98662-9401 | |||||||||
1204 |
Affiliated | 2300 | Vancouver | Livingston TN Dialysis | 308 OAK ST | LIVINGSTON | TN | 38570-1729 | ||||||||||
1205 |
Affiliated | 2225 | Fenton Dialysis | Fenton Dialysis | 17420 SILVER PKWY | FENTON | MI | 48430-4429 | ||||||||||
1206 |
Affiliated | 2332 | Cold Spring | Cold Springs Dialysis | 430 CROSS ROADS BLVD | COLD SPRING | KY | 41076-2341 | ||||||||||
1207 |
Affiliated | 2094 | Yucaipa | Yucaipa Dialysis | 33487 YUCAIPA BLVD | YUCAIPA | CA | 92399-2064 | ||||||||||
1208 |
Affiliated | 1900 | Florida Renal Center | Florida Renal Center | 3500 NW 7TH ST | MIAMI | FL | 33125-4016 | ||||||||||
1209 |
Affiliated | 2140 | Harbor UCLA | Long Beach Harbor Dialysis (aka UCLA) | 1075 E PACIFIC COAST HWY | LONG BEACH | CA | 90806-5089 | ||||||||||
1210 |
Affiliated | 2210 | Seaton Drive | Seton Drive Dialysis (fka Greensprings II) | 4800 SETON DR | BALTIMORE | MD | 21215-3210 | ||||||||||
1211 |
Affiliated | 1865 | South Valley | South Valley Dialysis | 17815 VENTURA BLVD | STE 1 | ENCINO | CA | 91316-3600 | |||||||||
1212 |
Affiliated | 2305 | West Pensacola | West Pensacola Dialysis | 598 N FAIRFIELD DR | STE 1 | PENSACOLA | FL | 32506-4320 | |||||||||
1213 |
Affiliated | 2073 | Mar Vista | Mar Vista Dialysis Center (UCLA-Santa Monica) | 2020 SANTA MONICA BLVD | STE 1 | SANTA MONICA | CA | 90404-2139 | |||||||||
1214 |
Affiliated | 2082 | Riddle Dialysis | Riddle Dialysis | 100 GRANITE DR | STE 16 | MEDIA | PA | 19063-5134 | |||||||||
1215 |
Affiliated | 2346 | Uptown | Minneapolis Uptown Dialysis | 3601 LYNDALE AVE S | MINNEAPOLIS | MN | 55409-1103 | ||||||||||
1216 |
Affiliated | 1907 | Lake Griffith East Dialysis | Lake Griffin East Dialysis | 401 E NORTH BLVD | LEESBURG | FL | 34748-5256 | ||||||||||
1217 |
Affiliated | 2170 | West Linn | West Linn Dialysis | 19056 WILLAMETTE DR | WEST LINN | OR | 97068-1715 | ||||||||||
1218 |
Affiliated | 2330 | Cape Coral South Dialysis | Cape Coral South Dialysis | 3046 DEL PRADO BLVD S | STE 4A | CAPE CORAL | FL | 33904-7232 | |||||||||
1219 |
Affiliated | 2241 | Ceres | Ceres Dialysis Center | 1768 MITCHELL RD | STE 38 | CERES | CA | 95307-2156 | |||||||||
1220 |
Affiliated | 1862 | Shaker Square | Shaker Square Dialysis | 12800 SHAKER BLVD | STE 1 | CLEVELAND | OH | 44120-2004 | |||||||||
1221 |
Affiliated | 1906 | St. Cloud Dialysis | St. Cloud Dialysis | 4750 OLD CANOE CREEK RD | SAINT CLOUD | FL | 34769-1430 | ||||||||||
1222 |
Affiliated | 1915 | Turlock Dialysis Center | Turlock Dialysis Center | 50 W SYRACUSE AVE | TURLOCK | CA | 95380-3143 | ||||||||||
1223 |
Affiliated | 2268 | Haymarket | Haymarket Dialysis (fka Gainesville) | 14664 GAP WAY | GAINESVILLE | VA | 20155-1683 | ||||||||||
1224 |
Affiliated | 2272 | Hackettstown | Hackettstown Dialysis | 657 WILLOW GROVE ST | WEST WING MEDICAL PLAZA STE 22 | HACKETTSTOWN | NJ | 07840-1713 | |||||||||
1225 |
Affiliated | 2274 | Regency | Regency Dialysis Center (fka Jacksonville) | 9535 REGENCY SQUARE BLVD N | JACKSONVILLE | FL | 32225-8128 | ||||||||||
1226 |
Affiliated | 2149 | Williamsburg | Williamsburg Dialysis (fka Yorktown) | 500 SENTARA CIR | STE 13 | WILLIAMSBURG | VA | 23188-5727 | |||||||||
1227 |
Affiliated | 2141 | Commerce Township | Commerce Township Dialysis | 120 W COMMERCE RD | COMMERCE TOWNSHIP | MI | 48382-3915 | ||||||||||
1228 |
Affiliated | 2147 | Kankakee | Kankakee County Dialysis | 581 WILLIAM R LATHAM SR DR | STE 14 | BOURBONNAIS | IL | 60914-2439 | |||||||||
1229 |
Affiliated | 2283 | Sandusky | Sandusky Dialysis Center | 795 BARDSHAR RD | SANDUSKY | OH | 44870-1505 | ||||||||||
1230 |
Affiliated | 2252 | Ionia | Ionia Dialysis | 2622 HEARTLAND BLVD | IONIA | MI | 48846-8757 | ||||||||||
1231 |
Affiliated | 2289 | Indian River | Indian River Dialysis Center | 2150 45TH ST | UNIT 12 | VERO BEACH | FL | 32967-6281 | |||||||||
1232 |
Affiliated | 2360 | North Henry | North Henry Dialysis (fka Stockbridge) | 5627 N HENRY BLVD | STE I1 | STOCKBRIDGE | GA | 30281-3244 | |||||||||
1233 |
Affiliated | 2077 | Tacoma Dialysis | Tacoma Dialysis Center | 3401 S 19TH ST | TACOMA | WA | 98405-1909 | ||||||||||
1234 |
Affiliated | 1908 | Hileah Kidney Center I | Hialeah Artificial Kidney Center | 2750 W 68TH ST | STE 27 | HIALEAH | FL | 33016-5450 | |||||||||
1235 |
Affiliated | 2315 | St. Francis | Charter Colony Dialysis Center (fka St. Francis Dialysis) | 2312 COLONY CROSSING PL | MIDLOTHIAN | VA | 23112-4280 | ||||||||||
1236 |
Affiliated | 2138 | Bellflower | Bellflower Dialysis Center (aka Widerhorn) | 15736 WOODRUFF AVE | BELLFLOWER | CA | 90706-4018 | ||||||||||
1237 |
Affiliated | 2301 | Smyrna | Smyrna Dialysis | 537 STONECREST PKWY | SMYRNA | TN | 37167-6884 | ||||||||||
1238 |
Affiliated | 2122 | Clearlake | Clearlake Dialysis | 14400 OLYMPIC DR | CLEARLAKE | CA | 95422-8809 | ||||||||||
1239 |
Affiliated | 1853 | Dialysis Center of Erie | Dialysis Center of Erie | 1641 SASSAFRAS ST | ERIE | PA | 16502-1858 | ||||||||||
1240 |
Affiliated | 1854 | Warren Dialysis | Warren Dialysis | 2 W CRESCENT PARK | WARREN | PA | 16365-2111 | ||||||||||
1241 |
Affiliated | 2322 | Maysville | Maysville Dialysis | 489 TUCKER DR | MAYSVILLE | KY | 41056-9111 | ||||||||||
1242 |
Affiliated | 2429 | Fridley | East River Road Dialysis (fka Fridley Dialysis Unit) | 5301 E RIVER RD | STE 117 | FRIDLEY | MN | 55421-3778 | |||||||||
1243 |
Affiliated | 2189 | West Sacramento | West Sacramento Dialysis | 3450 INDUSTRIAL BLVD | STE 1 | WEST SACRAMENTO | CA | 95691-5003 | |||||||||
1244 |
Affiliated | 2293 | Anderson | Anderson Dialysis Center | 7502 STATE RD | STE 116 | CINCINNATI | OH | 45255 | |||||||||
1245 |
Affiliated | 2383 | North County | North St. Louis County Dialysis | 13119 NEW HALLS FERRY RD | FLORISSANT | MO | 63033-3228 | ||||||||||
1246 |
Affiliated | 2439 | Fargo | Fargo Dialysis Center | 4474 23RD AVE S | STE M | FARGO | ND | 58104-8795 | |||||||||
1247 |
Affiliated | 2008 | Eastchester | Eastchester Road Dialysis Center (Bronx II) | 1515 JARRETT PL | BRONX | NY | 10461-2606 | ||||||||||
1248 |
Affiliated | 2224 | Fallon | Fallon Dialysis | 1103 NEW RIVER PKWY | FALLON | NV | 89406-6899 | ||||||||||
1249 |
Affiliated | 2279 | Clarksville North | Clarksville North Dialysis | 3071 CLAY LEWIS RD | CLARKSVILLE | TN | 37040-5141 | ||||||||||
1250 |
Affiliated | 2308 | Eaton | Eaton Dialysis | 105 E WASHINGTON JACKSON RD | EATON | OH | 45320-9789 | ||||||||||
1251 |
Affiliated | 2447 | Wallace | Wallace Dialysis | 5650 S NC 41 HWY | WALLACE | NC | 28466-6094 | ||||||||||
1252 |
Affiliated | 2288 | Central Kalazmazoo | Kalamazoo Central Dialysis | 535 S BURDICK ST | STE 11 | KALAMAZOO | MI | 49007-5261 | |||||||||
1253 |
Affiliated | 2287 | West Kalamazoo | Kalamazoo West Dialysis | 1040 N 10TH ST | KALAMAZOO | MI | 49009-6149 | ||||||||||
1254 |
Affiliated | 1921 | Bakersfield | Bakersfield Dialysis Center | 5143 OFFICE PARK DR | BAKERSFIELD | CA | 93309-0660 | ||||||||||
1255 |
Affiliated | 1930 | Antelope Valley Dialysis | Antelope Valley Dialysis | 1759 W AVENUE J | STE 12 | LANCASTER | CA | 93534-2703 | |||||||||
1256 |
Affiliated | 1931 | Indian Wells Valley Dialysis | Indian Wells Valley Dialysis | 212 S RICHMOND RD | RIDGECREST | CA | 93555-4434 | ||||||||||
1257 |
Affiliated | 1932 | Palmdale Regional Dialysis | Palmdale Regional | 1643 E PALMDALE BLVD | PALMDALE | CA | 93550-4847 | ||||||||||
1258 |
Affiliated | 2185 | South Star / Adamsville | Southstar Adamsville Dialysis (fka Cascade) | 3651 BAKERS FERRY RD SW | ATLANTA | GA | 30331-3712 | ||||||||||
1259 |
Affiliated | 2314 | Union City | Union City Dialysis | 6851 SHANNON PKWY | STE 2 | UNION CITY | GA | 30291-2049 | |||||||||
1260 |
Affiliated | 2345 | Waterbury | Waterbury Dialysis Center | 150 MATTATUCK HEIGHTS RD | WATERBURY | CT | 06705-3893 | ||||||||||
1261 |
Affiliated | 2421 | Butler Farm | Butler Farm Dialysis (Hope II) | 501 BUTLER FARM RD | HAMPTON | VA | 23666-1777 | ||||||||||
1262 |
Affiliated | 2337 | Blue Mtn Kidney Center | Blue Mountain Kidney Center (aka Wild Horse, Pendleton) | 72556 COYOTE RD | PENDLETON | OR | 97801-1002 | ||||||||||
1263 |
Affiliated | 2249 | Talladega | Talladega Dialysis | 726 BATTLE ST E | STE A | TALLADEGA | AL | 35160-2583 | |||||||||
1264 |
Affiliated | 2281 | Athens East | Athens East Dialysis | 2026 S MILLEDGE AVE | STE A2 | ATHENS | GA | 30605-6480 | |||||||||
1265 |
Affiliated | 2412 | Mayland | Mayland Dialysis Center (aka Spruce Pine) | 575 ALTAPASS HWY | SPRUCE PINE | NC | 28777-3012 | ||||||||||
1266 |
Affiliated | 2236 | Salem | Salem Dialysis Center (IN) | 1201 N JIM DAY RD | STE 13 | SALEM | IN | 47167-7219 | |||||||||
1267 |
Affiliated | 2239 | Lake Cliff | Lake Cliff Dialysis Center | 805 N BECKLEY AVE | DALLAS | TX | 75203-1612 |
Page 67 of 123
1268 |
Affiliated | 2363 | DVA Mid Cities Dialysis | Mid Cities Dialysis Center | 117 E HARWOOD RD | HURST | TX | 76054-3043 | ||||||||||
1269 |
Affiliated | 2362 | Boerne | Boerne Dialysis Center | 1369 S MAIN ST | STE 11 | BOERNE | TX | 78006-2860 | |||||||||
1270 |
Affiliated | 2318 | Columbus West | Columbus West Dialysis | 1395 GEORGESVILLE RD | COLUMBUS | OH | 43228-3611 | ||||||||||
1271 |
Affiliated | 2306 | Point Place | Point Place Dialysis | 4747 SUDER AVE | STE 17 | TOLEDO | OH | 43611-2869 | |||||||||
1272 |
Affiliated | 2350 | Delhi Dialysis | Delhi Dialysis | 5040 DELHI AVE | CINCINNATI | OH | 45238-5388 | ||||||||||
1273 |
Affiliated | 2253 | Pataskala | Pataskala Dialysis Center | 642 E BROAD ST | PATASKALA | OH | 43062-7627 | ||||||||||
1274 |
Affiliated | 2384 | Eastland | Eastland Dialysis (fka Independence) | 19101 E VALLEY VIEW PKWY | STE E | INDEPENDENCE | MO | 64055-6907 | |||||||||
1275 |
Affiliated | 2254 | Wauseon | Wauseon Dialysis Center | 721 S SHOOP AVE | WAUSEON | OH | 43567-1729 | ||||||||||
1276 |
Affiliated | 2327 | Lebanon Dialysis | Lebanon Dialysis Center (Chronic Only) | 918B COLUMBUS AVE | LEBANON | OH | 45036- | ||||||||||
1277 |
Affiliated | 2460 | Horton | Horton Dialysis | 1901 EUCLID AVE | HORTON | KS | 66439-1238 | ||||||||||
1278 |
Affiliated | 2280 | Lone Peak Dialysis | Lone Peak Dialysis | 1175 E 50 S | STE 111 | AMERICAN FORK | UT | 84003-2845 | |||||||||
1279 |
Affiliated | 2347 | Mena | Mena Dialysis Center | 1200 CRESTWOOD CIR | MENA | AR | 71953-5516 | ||||||||||
1280 |
Affiliated | 1941 | FAYETTEVILLE DIALYSIS | Fayetteville Dialysis | 509 E MILLSAP RD | STE 111 | FAYETTEVILLE | AR | 72703-4862 | |||||||||
1281 |
Affiliated | 1942 | BENTONVILLE DIALYSIS | Bentonville Dialysis | 1104 SE 30TH ST | BENTONVILLE | AR | 72712-4290 | ||||||||||
1282 |
Affiliated | 1943 | SILOAM SPRINGS DIALYSIS | Siloam Springs Dialysis | 500 S MOUNT OLIVE ST | STE 17 | SILOAM SPRINGS | AR | 72761-3602 | |||||||||
1283 |
Affiliated | 1944 | SPRINGDALE DIALYSIS | Springdale Dialysis | 708 QUANDT AVE | SPRINGDALE | AR | 72764-5309 | ||||||||||
1284 |
Affiliated | 2273 | Grosse Pointe | Grosse Pointe Dialysis | 18000 E WARREN AVE | STE 1 | DETROIT | MI | 48224-1336 | |||||||||
1285 |
Affiliated | 2448 | Indy South Dialysis | Indy South Dialysis | 972 EMERSON PKWY | STE E | GREENWOOD | IN | 46143-6202 | |||||||||
1286 |
Affiliated | 2358 | Greensburg Dialysis | Greensburg Dialysis | 1531 N COMMERCE EAST DR | STE 6 | GREENSBURG | IN | 47240-3259 | |||||||||
1287 |
Affiliated | 2319 | Grove City | Grove City Dialysis | 4155 KELNOR DR | GROVE CITY | OH | 43123-2960 | ||||||||||
1288 |
Affiliated | 2338 | West Beach | West Beach Dialysis Center | 16201 PANAMA CITY BEACH HWY | STE 12 | PANAMA CITY BEACH | FL | 32413-5301 | |||||||||
1289 |
Affiliated | 2371 | Birmingham | Center Point Dialysis (aka Birmingham Center) | 2337 1ST ST NE | CENTER POINT | AL | 35215-3619 | ||||||||||
1290 |
Affiliated | 2445 | Eureka | Eureka Dialysis Center | 419 MERAMEC BLVD | EUREKA | MO | 63025-3906 | ||||||||||
1291 |
Affiliated | 2313 | Tifton | Tifton Dialysis | 624 LOVE AVE | TIFTON | GA | 31794-4406 | ||||||||||
1292 |
Affiliated | 2146 | Woodlands | The Woodlands Dialysis | 9301 PINECROFT DR | STE 13 | SHENANDOAH | TX | 77380-3178 | |||||||||
1293 |
Affiliated | 2266 | Exerter | Exeter Dialysis | 1116 W VISALIA RD | STE 16 | EXETER | CA | 93221-1482 | |||||||||
1294 |
Affiliated | 2396 | Wayne County | Wayne County Dialysis (fka Fairfield) | 303 NW 11TH ST | STE 1 | FAIRFIELD | IL | 62837-1203 | |||||||||
1295 |
Affiliated | 2415 | Cordele Dialysis | Cordele Dialysis | 1013 E 16TH AVE | CORDELE | GA | 31015-1539 | ||||||||||
1296 |
Affiliated | 2304 | Winter Park | Winter Park Dialysis (aka Orlando) | 3727 N GOLDENROD RD | STE 11 | WINTER PARK | FL | 32792-8611 | |||||||||
1297 |
Affiliated | 2449 | Carmel | Carmel Dialysis | 180 E CARMEL DR | CARMEL | IN | 46032-2633 | ||||||||||
1298 |
Affiliated | 2298 | Corydon | Corydon Dialysis | 1937 OLD HWY 135 NW | CORYDON | IN | 47112-2013 | ||||||||||
1299 |
Affiliated | 2382 | Memphis Southeast | Memphis Southeast Dialysis (aka Midtown) | 1805 MORIAH WOODS BLVD | STE 11 | MEMPHIS | TN | 38117-7119 | |||||||||
1300 |
Affiliated | 2399 | Rim Country | Rim Country Dialysis | 809 W LONGHORN RD | PAYSON | AZ | 85541-4280 | ||||||||||
1301 |
Affiliated | 2201 | Cedar Park | Cedar Park Dialysis (fka North Austin) | 1720 E WHITESTONE BLVD | CEDAR PARK | TX | 78613-7640 | ||||||||||
1302 |
Affiliated | 2368 | Ellensburg | Ellensburg Dialysis | 2101 W DOLARWAY RD | STE 1 | ELLENSBURG | WA | 98926-9310 | |||||||||
1303 |
Affiliated | 2260 | Santa Fe Springs | Santa Fe Springs Dialysis | 11147 WASHINGTON BLVD | WHITTIER | CA | 90606-3007 | ||||||||||
1304 |
Affiliated | 1950 | Snapfinger Dialysis | Snapfinger Dialysis | 5255 SNAPFINGER PARK DR | STE 115 | DECATUR | GA | 30035-4066 | |||||||||
1305 |
Affiliated | 1951 | East Dekalb Dialysis | East DeKalb Dialysis | 2801 CANDLER RD | STE 23 | DECATUR | GA | 30034-1429 | |||||||||
1306 |
Affiliated | 2258 | Meadows East | Meadows East Dialysis | 2529 SIX MILE LN | LOUISVILLE | KY | 40220-2934 | ||||||||||
1307 |
Affiliated | 2226 | First Colony | First Colony Dialysis (aka Sugarland, Great Woods) | 1447 HIGHWAY 6 | STE 14 | SUGAR LAND | TX | 77478-5094 | |||||||||
1308 |
Affiliated | 1612 | Coastal Kidney Center | Coastal Kidney Center | 510 N MACARTHUR AVE | PANAMA CITY | FL | 32401-3636 | ||||||||||
1309 |
Affiliated | 2211 | Clinton Township | Clinton Township Dailysis | 15918 19 MILE RD | STE 11 | CLINTON TOWNSHIP | MI | 48038-1101 | |||||||||
1310 |
Affiliated | 2207 | West Brook | Westbrook Dialysis (fka Palm Brook II) | 13907 W CAMINO DEL SOL | STE 13 | SUN CITY WEST | AZ | 85375-4405 | |||||||||
1311 |
Affiliated | 1954 | Johnson County | Johnson County Dialysis | 10453 W 84TH TER | LENEXA | KS | 66214-1641 | ||||||||||
1312 |
Affiliated | 1956 | Wyandotte County | Wyandotte County Dialysis | 5001 STATE AVE | KANSAS CITY | KS | 66102-3459 | ||||||||||
1313 |
Affiliated | 2479 | Maple Grove | Maple Grove Dialysis Unit | 15655 GROVE CIR N | MAPLE GROVE | MN | 55369-4489 | ||||||||||
1314 |
Affiliated | 4336 | East End | East End-Pittsburgh Dialysis (fka Wilkinsburg) | 7714 PENN AVE PARK PLAZA | PITTSBURGH | PA | 15221 | ||||||||||
1315 |
Affiliated | 2493 | Westminster II - North Metro | North Metro Dialysis Center (aka Denver, Westminster II) | 12365 HURON ST | STE 5 | WESTMINSTER | CO | 80234-3498 | |||||||||
1316 |
Affiliated | 1960 | Vidalia | Vidalia First Street Dialysis | 906 E 1ST ST | VIDALIA | GA | 30474-4207 | ||||||||||
1317 |
Affiliated | 2357 | Highland Park | Highland Park Dialysis | 1559 W 7TH ST | SAINT PAUL | MN | 55102-4238 | ||||||||||
1318 |
Affiliated | 2367 | Centennial Parkway | Centennial Dialysis Center | 8775 DEER SPRINGS WAY | LAS VEGAS | NV | 89149-0416 | ||||||||||
1319 |
Affiliated | 2250 | Lord Baltimore | Northwest Dialysis Center (aka Lord Baltimore, N. Rolling Road II, Owings Mills II) | 2245 ROLLING RUN DR | STE 1 | WINDSOR MILL | MD | 21244-1858 | |||||||||
1320 |
Affiliated | 3944 | North Charlotte | North Charlotte Dialysis | 6620 OLD STATESVILLE RD | CHARLOTTE | NC | 28269 | ||||||||||
1321 |
Affiliated | 2410 | Sun Ray Dialysis | Sun Ray Dialysis Unit (fka East St. Paul) | 1758 OLD HUDSON RD | STE 1 | SAINT PAUL | MN | 55106-6161 | |||||||||
1322 |
Affiliated | 2425 | Vandalia | Vandalia Dialysis | 301 MATTES AVE | VANDALIA | IL | 62471-2061 | ||||||||||
1323 |
Affiliated | 2428 | Westwood Hills | Westwood Hills Dialysis (fka Minneapolis, Excelsior) | 7525 WAYZATA BLVD | SAINT LOUIS PARK | MN | 55426-1621 | ||||||||||
1324 |
Affiliated | 4305 | Amery | Amery Dialysis | 970 ELDEN AVE | AMERY | WI | 54001-1448 | ||||||||||
1325 |
Affiliated | 2434 | Wadsworth | Wadsworth Dialysis | 195 WADSWORTH RD | STE 32 | WADSWORTH | OH | 44281-9504 | |||||||||
1326 |
Affiliated | 2419 | Dublin | Dublin Dialysis | 6770 PERIMETER DR | DUBLIN | OH | 43016-8063 | ||||||||||
1327 |
Affiliated | 4314 | Weber Valley | Weber Valley Dialysis (fka Ogden) | 1920 W 250TH N | MARRIOTT-SLATERVILLE | UT | 84404-9233 | ||||||||||
1328 |
Affiliated | 2343 | West Elk Grove | West Elk Grove Dialysis | 2208 KAUSEN DR | STE 1 | ELK GROVE | CA | 95758-7174 | |||||||||
1329 |
Affiliated | 2355 | Bedford Park | Bedford Park Dialysis Center | 3119 WEBSTER AVE | 1ST FLR | BRONX | NY | 10467-4905 | |||||||||
1330 |
Affiliated | 1747 | Cuero Lakeview Dialysis | Cuero Lakeview Dialysis | 1105 E BROADWAY ST | CUERO | TX | 77954 | ||||||||||
1331 |
Affiliated | 1961 | Madisonville Dialysis | Madisonville Dialysis Center | 255 E NORTH ST | MADISONVILLE | KY | 42431 | ||||||||||
1332 |
Affiliated | 2467 | Crescent City | Crescent City Dialysis Center | 3909 BIENVILLE ST | STE B | NEW ORLEANS | LA | 70119-5152 | |||||||||
1333 |
Affiliated | 4318 | Callowhill | Callowhill Dialysis Center | 313 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4103 | ||||||||||
1334 |
Affiliated | 2406 | Oak Creek | Oak Creek Dialysis (fka South Milwaukee) | 8201 S HOWELL AVE | STE 6 | OAK CREEK | WI | 53154-8336 |
Page 68 of 123
1335 |
Affiliated | 4395 | Leesburg Virginia | Leesburg Virginia Dialysis | 224D CORNWALL ST NW | STE 1 | LEESBURG | VA | 20176-2700 | |||||||||
1336 |
Affiliated | 2386 | Joy of Dixon | Joy of Dixon Dialysis Center | 1640 N LINCOLN ST | DIXON | CA | 95620-9255 | ||||||||||
1337 |
Affiliated | 2137 | Long Beach JV -Bixby Knolls | Bixby Knolls Dialysis (fka Long Beach) | 3744 LONG BEACH BLVD | LONG BEACH | CA | 90807-3310 | ||||||||||
1338 |
Affiliated | 1790 | Alliance Community Dialysis | Alliance Community Dialysis | 270 E STATE ST | STE 11 | ALLIANCE | OH | 44601-4309 | |||||||||
1339 |
Affiliated | 1791 | Belden Community Dialysis | Belden Community Dialysis | 4685 FULTON DR NW | CANTON | OH | 44718-2379 | ||||||||||
1340 |
Affiliated | 1792 | Mercy Canton Dialysis | Mercy Canton Dialysis | 1320 MERCY DR NW | CANTON | OH | 44708-2614 | ||||||||||
1341 |
Affiliated | 2294 | Marrero | Marrero Dialysis | 1908 JUTLAND DR | HARVEY | LA | 70058-2359 | ||||||||||
1342 |
Affiliated | 2351 | Miramar | Miramar Kidney Center | 2501 DYKES RD | STE 2 | MIRAMAR | FL | 33027-4217 | |||||||||
1343 |
Affiliated | 2418 | Chesterton | Chesterton Dialysis | 711 PLAZA DR | STE 6 | CHESTERTON | IN | 46304-5506 | |||||||||
1344 |
Affiliated | 4368 | St. John | St. John Dialysis | 10033 WICKER AVE | STE 6 | SAINT JOHN | IN | 46373-8777 | |||||||||
1345 |
Affiliated | 2256 | Princeton | Princeton Dialysis | 2227 SHERMAN DR | PRINCETON | IN | 47670-1062 | ||||||||||
1346 |
Affiliated | 4332 | Black Rock | Black Rock Dialysis (aka Faifield) | 427 STILLSON RD | FAIRFIELD | CT | 06824-3153 | ||||||||||
1347 |
Affiliated | 2422 | Williamstown | Williamstown Dialysis (fka Dry Ridge) | 103 BARNES RD | STE A | WILLIAMSTOWN | KY | 41097-9468 | |||||||||
1348 |
Affiliated | 4376 | Renaissance | Renaissance Dialysis | 1840 DARBY DR | FLORENCE | AL | 35630-2623 | ||||||||||
1349 |
Affiliated | 4360 | Portage | Portage Dialysis | 5823 US HIGHWAY 6 | PORTAGE | IN | 46368-4851 | ||||||||||
1350 |
Affiliated | 2393 | Opelika | Opelika Dialysis Center | 2340 PEPPERELL PKWY | OPELIKA | AL | 36801-6240 | ||||||||||
1351 |
Affiliated | 2435 | Urbana | Urbana Dialysis Center | 1880 E US HIGHWAY 36 | URBANA | OH | 43078-9600 | ||||||||||
1352 |
Affiliated | 1913 | Port Lavaca Dialysis | Port Lavaca Dialysis | 1300 N VIRGINIA ST | STE 12 | PORT LAVACA | TX | 77979-2512 | |||||||||
1353 |
Affiliated | 2276 | Cornerhouse Dialysis | Cornerhouse Dialysis Center (aka Santa Clara) | 2005 NAGLEE AVE | SAN JOSE | CA | 95128-4801 | ||||||||||
1354 |
Affiliated | 2167 | Snellville | Snellville Dialysis | 2135 MAIN ST E | STE 13 | SNELLVILLE | GA | 30078-6424 | |||||||||
1355 |
Affiliated | 4334 | Bloomfield | Bloomfield-Pittsburgh Dialysis | 5171 LIBERTY AVE | STE C | PITTSBURGH | PA | 15224-2254 | |||||||||
1356 |
Affiliated | 2489 | Pennsauken | Pennsauken Dialysis | 7024 KAIGHNS AVE | PENNSAUKEN | NJ | 08109-4417 | ||||||||||
1357 |
Affiliated | 2433 | Logan | Logan Dialysis | 12880 GREY ST | LOGAN | OH | 43138-9638 | ||||||||||
1358 |
Affiliated | 2454 | Forest Fair | Forest Fair Dialysis (fka Forest Park) | 1145 KEMPER MEADOW DR | CINCINNATI | OH | 45240-4118 | ||||||||||
1359 |
Affiliated | 4307 | Knoxville | Knoxville Central Dialysis | 9141 CROSS PARK DR | STE 12 | KNOXVILLE | TN | 37923-4557 | |||||||||
1360 |
Affiliated | 4338 | Kennestone | Kennestone Dialysis (aka Cobb II) | 200 COBB PKWY N | STE 318 BLDG 3 | MARIETTA | GA | 30062-3558 | |||||||||
1361 |
Affiliated | 4343 | Wiregrass Kidney Center | Wiregrass Kidney Center (fka Ross Circle) | 1450 ROSS CLARK CIR | DOTHAN | AL | 36301-4765 | ||||||||||
1362 |
Affiliated | 2432 | Memphis Downtown | Memphis Downtown Dialysis | 2076 UNION AVE | MEMPHIS | TN | 38104-4138 | ||||||||||
1363 |
Affiliated | 3953 | Marshville | Marshville Dialysis Center | 7260 E MARSHVILLE BLVD | MARSHVILLE | NC | 28103-1191 | ||||||||||
1364 |
Affiliated | 4356 | Shamrock | Shamrock Dialysis | 1016 CLAXTON DAIRY RD | STE 1A | DUBLIN | GA | 31021-7971 | |||||||||
1365 |
Affiliated | 4367 | North Colorado Springs | North Colorado Springs Dialysis | 6071 E WOODMEN RD | STE 1 | COLORADO SPRINGS | CO | 80923-2610 | |||||||||
1366 |
Affiliated | 2466 | Oakes | Oakes Dialysis | 413 S 7TH ST | OAKES | ND | 58474-1920 | ||||||||||
1367 |
Affiliated | 1976 | Pinnacle Dialysis of Boca Raton | Pinnacle Dialysis of Boca Raton | 2900 N MILITARY TRL | STE 195 | BOCA RATON | FL | 33431-6308 | |||||||||
1368 |
Affiliated | 1980 | Cedar Valley Dialysis | Cedar Valley Dialysis | 1661 W RIDGEWAY AVE | WATERLOO | IA | 50701-4541 | ||||||||||
1369 |
Affiliated | 1981 | West Union Dialysis | West Union Dialysis | 405 HIGHWAY 150 N | WEST UNION | IA | 52175-1003 | ||||||||||
1370 |
Affiliated | 2161 | Rockside | Rockside Dialysis (aka Independence, Parma II) | 4801 ACORN DR | INDEPENDENCE | OH | 44131-2566 | ||||||||||
1371 |
Affiliated | 2263 | Sunset | Sunset Dialysis Center (fka Sunrise II) | 3071 GOLD CANAL DR | RANCHO CORDOVA | CA | 95670-6129 | ||||||||||
1372 |
Affiliated | 2442 | Yosemite Street | Yosemite Street Dialysis | 1650 W YOSEMITE AVE | MANTECA | CA | 95337-5193 | ||||||||||
1373 |
Affiliated | 2335 | Jedburg | Jedburg Dialysis | 2897 W 5TH NORTH ST | SUMMERVILLE | SC | 29483-9674 | ||||||||||
1374 |
Affiliated | 2441 | Parker Dialysis | Parker Dialysis | 10371 S PARK GLENN WAY | STE 18 | PARKER | CO | 80138-3885 | |||||||||
1375 |
Affiliated | 2296 | Northgate | Northgate Dialysis Center (aka San Rafael-Terra) | 650 LAS GALLINAS AVE | SAN RAFAEL | CA | 94903-3620 | ||||||||||
1376 |
Affiliated | 2271 | The Nevada Center | The Nevada Dialysis Center (fka Warm Springs, Green Valley) | 1510 W WARM SPRINGS RD | STE 1 | HENDERSON | NV | 89014-3586 | |||||||||
1377 |
Affiliated | 2091 | Aventura | Aventura Kidney Center | 22 SW 11TH ST | FLOOR 2 | HALLANDALE BEACH | FL | 33009-7038 | |||||||||
1378 |
Affiliated | 2408 | US Grant Dialysis | US Grant Dialysis (fka Georgetown, Brown County) | 458 HOME ST | GEORGETOWN | OH | 45121-1408 | ||||||||||
1379 |
Affiliated | 4400 | Arbor Place | Arbor Place Dialysis | 9559 HIGHWAY 5 | STE 1 | DOUGLASVILLE | GA | 30135-1573 | |||||||||
1380 |
Affiliated | 4389 | South Jacksonville | Jacksonville South Dialysis Center | 14965 OLD SAINT AUGUSTINE RD | UNIT 114 | JACKSONVILLE | FL | 32258-9481 | |||||||||
1381 |
Affiliated | 2385 | Somerville | Somerville Dialysis | 12475 US HIGHWAY 64 | SOMERVILLE | TN | 38068-6029 | ||||||||||
1382 |
Affiliated | 4321 | District Heights | District Heights Dialysis (aka Pennsylvania Ave) | 5701 SILVER HILL RD | DISTRICT HEIGHTS | MD | 20747-1102 | ||||||||||
1383 |
Affiliated | 2414 | Edwardsville | Edwardsville Dialysis | 235 S BUCHANAN ST | EDWARDSVILLE | IL | 62025-2108 | ||||||||||
1384 |
Affiliated | 2361 | Broad St | South Broad Street Dialysis (aka S. Philadelphia II) | 1172 S BROAD ST | PHILADELPHIA | PA | 19146-3142 | ||||||||||
1385 |
Affiliated | 2342 | Las Vegas Pedidatrics | Las Vegas Pediatrics Dialysis (fka UMC Peds, DaVita Peds) | 7271 W SAHARA AVE | STE 12 | LAS VEGAS | NV | 89117-2862 | |||||||||
1386 |
Affiliated | 1990 | Apopka Dialysis | Apopka Dialysis | 640 EXECUTIVE PARK CT | APOPKA | FL | 32703-6075 | ||||||||||
1387 |
Affiliated | 1991 | Cassellberry Dialysis | Casselberry Dialysis | 4970 S US HWY 17/92 | CASSELBERRY | FL | 32707-3888 | ||||||||||
1388 |
Affiliated | 1992 | Central Orlando Dialysis | Central Orlando Dialysis | 2548 N ORANGE BLOSSOM TRL | STE 4 | ORLANDO | FL | 32804-4863 | |||||||||
1389 |
Affiliated | 1993 | Sanford Dialysis | Sanford Dialysis | 1701 W 1ST ST | SANFORD | FL | 32771-1605 | ||||||||||
1390 |
Affiliated | 1994 | Winter Park Hemo Dialysis | Winter Park Hemo Dialysis | 4100 METRIC DR | STE 3 | WINTER PARK | FL | 32792-6832 | |||||||||
1391 |
Affiliated | 2173 | Graham | Graham Dialysis Center | 10219 196TH ST CT E | STE C | GRAHAM | WA | 98338-7792 | |||||||||
1392 |
Affiliated | 2316 | Batavia | Batavia Dialysis | 4000 GOLDEN AGE DR | BATAVIA | OH | 45103-1913 | ||||||||||
1393 |
Affiliated | 1967 | Klamath Falls | Klamath Falls Dialysis | 2230 N ELDORADO AVE | KLAMATH FALLS | OR | 97601-6418 | ||||||||||
1394 |
Affiliated | 2336 | Longs | Longs Dialysis (fka Conway) | 90 CLOVERLEAF DR | STE 36 | LONGS | SC | 29568-9262 | |||||||||
1395 |
Affiliated | 2452 | Pooler | Pooler Dialysis | 54 TRADERS WAY | POOLER | GA | 31322- | ||||||||||
1396 |
Affiliated | 4380 | Ohio Pike Dialysis | Ohio Pike Dialysis (aka Amelia) | 1761 STATE ROUTE 125 | AMELIA | OH | 45102-2039 | ||||||||||
1397 |
Affiliated | 2285 | Canyon Springs | Canyon Springs Dialysis (aka Moreno Valley) | 22555 ALESSANDRO BLVD | MORENO VALLEY | CA | 92553-8533 | ||||||||||
1398 |
Affiliated | 4306 | Williamson | South Williamson Dialysis | 204 APPALACHIAN PLAZA | SOUTH WILLIAMSON | KY | 41503-9404 | ||||||||||
1399 |
Affiliated | 4402 | Gulf Shores | Gulf Shores Dialysis Center | 3947 GULF SHORES PKWY | UNIT 15 | GULF SHORES | AL | 36542-2737 | |||||||||
1400 |
Affiliated | 2496 | Las Vegas Multi-Care Five Star | Five Star Dialysis Center (fka Las Vegas Multi-Care) | 2400 TECH CENTER CT | LAS VEGAS | NV | 89128-0804 | ||||||||||
1401 |
Affiliated | 4358 | North Vernon | North Vernon Dialysis | 2340 N STATE HWY 7 | NORTH VERNON | IN | 47265-7183 |
Page 69 of 123
1402 |
Affiliated | 4316 | Olympia | Olympia Dialysis Center | 335 COOPER POINT RD NW | STE 15 | OLYMPIA | WA | 98502-4436 | |||||||||
1403 |
Affiliated | 4335 | Monroeville | Monroeville Dialysis | 2690 MONROEVILLE BLVD | MONROEVILLE | PA | 15146-2302 | ||||||||||
1404 |
Affiliated | 2317 | East Galbraith | East Galbraith Dialysis | 3877 E GALBRAITH RD | BLDG C | CINCINNATI | OH | 45236-1500 | |||||||||
1405 |
Affiliated | 2261 | San Marcos | San Marcos Dialysis Center | 2135 MONTIEL RD | BLDG B | SAN MARCOS | CA | 92069-3511 | |||||||||
1406 |
Affiliated | 4408 | Winter Garden | Winter Garden Dialysis | 1222 WINTER GARDEN VINELAND RD | BLDG 3 STE 1 | WINTER GARDEN | FL | 34787 | |||||||||
1407 |
Affiliated | 1926 | Bremer County Dialysis | Relo-Bremer County Dialysis (5022-Cedar Valley Waverly Dialysis) | 220 10th ST SW | WAVERLY | IA | 50677-2930 | ||||||||||
1408 |
Affiliated | 1927 | Black Hawk Dialysis | Black Hawk Dialysis (Waterloo) | 3421 W 9TH ST | WATERLOO | IA | 50702-5401 | ||||||||||
1409 |
Affiliated | 2218 | Downey Landing | Downey Landing Dialysis Center (aka Downey-Kaiser) | 11611 BELLFLOWER BLVD | DOWNEY | CA | 90241-5408 | ||||||||||
1410 |
Affiliated | 2427 | Tucson Central | Tucson Central Dialysis | 2901 E GRANT RD | TUCSON | AZ | 85716-2717 | ||||||||||
1411 |
Affiliated | 4377 | Hamburg | Hamburg Dialysis (fka Lexington) | 1745 ALYSHEBA WAY | LEXINGTON | KY | 40509-9013 | ||||||||||
1412 |
Affiliated | 2150 | Midtown Norfolk | Midtowne Norfolk Dialysis (aka Ghent II) | 2201 COLONIAL AVE | NORFOLK | VA | 23517-1928 | ||||||||||
1413 |
Affiliated | 2394 | Yonkers II | Yonkers East Dialysis Center | 5 ODELL PLZ | STE 131 | YONKERS | NY | 10701-1406 | |||||||||
1414 |
Affiliated | 2364 | Caldwell | Caldwell Dialysis Center | 821 S SMEED PKWY | CALDWELL | ID | 83605-5130 | ||||||||||
1415 |
Affiliated | 2278 | Hesperia | Hesperia Dialysis Center | 14135 MAIN ST | UNIT 51 | HESPERIA | CA | 92345-8097 | |||||||||
1416 |
Affiliated | 2339 | Sealy | Sealy Dialysis | 2242 CHAMPIONSHIP DR | SEALY | TX | 77474-8026 | ||||||||||
1417 |
Affiliated | 2438 | Hearne | Hearne Dialysis Center | 106 CEDAR ST | HEARNE | TX | 77859-2523 | ||||||||||
1418 |
Affiliated | 1998 | Stockton Kidney Center | Stockton Kidney Center | 1523 E MARCH LN | STE 2 | STOCKTON | CA | 95210-5607 | |||||||||
1419 |
Affiliated | 5525 | University of South Florida | USF Dialysis | 10770 N 46TH ST STE A100 | TAMPA | FL | 33617-3465 | ||||||||||
1420 |
Affiliated | 4424 | Westborough | Westborough Dialysis Center (fka South San Francisco, Daly City) | 925 EL CAMINO REAL | SOUTH SAN FRANCISCO | CA | 94080-3203 | ||||||||||
1421 |
Affiliated | 4359 | Rush County | Rush County Dialysis | 1400 N CHERRY ST | RUSHVILLE | IN | 46173-1097 | ||||||||||
1422 |
Affiliated | 4339 | Defuniak Springs | Defuniak Springs Dialysis | 1045 US HWY 331 S | DEFUNIAK SHOPPING PLAZA | DEFUNIAK SPRINGS | FL | 32435-3375 | |||||||||
1423 |
Affiliated | 2181 | Foster city | Foster City Dialysis (fka Belmont) | 1261 E HILLSDALE BLVD | STE 2 | FOSTER CITY | CA | 94404-1236 | |||||||||
1424 |
Affiliated | 4427 | Red Bank | Redbank Village Dialysis (Cincinnati) | 3960 RED BANK RD | STE 16 | CINCINNATI | OH | 45227-3421 | |||||||||
1425 |
Affiliated | 4448 | Southport | Southport Dialysis Center | 1513 N HOWE ST | STE 15 | SOUTHPORT | NC | 28461-2770 | |||||||||
1426 |
Affiliated | 4446 | Orlando Park | Orlando Park Dialysis | 5397 W COLONIAL DR | STE 12 | ORLANDO | FL | 32808-7647 | |||||||||
1427 |
Affiliated | 4431 | Harrisburg | Harrisburg Dialysis Center (aka Concord) | 3310 PERRY ST | CONCORD | NC | 28027-3901 | ||||||||||
1428 |
Affiliated | 2352 | Waycross | Satilla River Dialysis | 308 CARSWELL AVE | WAYCROSS | GA | 31501-4762 | ||||||||||
1429 |
Affiliated | 4455 | Timberlake | Timberlake Dialysis (Kansas City) | 12110 HOLMES RD | KANSAS CITY | MO | 64145-1707 | ||||||||||
1430 |
Affiliated | 4447 | Dexter | Dexter Dialysis | 2010 N OUTER RD | DEXTER | MO | 63841 | ||||||||||
1431 |
Affiliated | 4426 | Norwood | Norwood Dialysis (Cincinnati) | 2300 WALL ST | CINCINNATI | OH | 45212-2781 | ||||||||||
1432 |
Affiliated | 4420 | Peachtree City | Peachtree City Dialysis | 2830 W HWY 54 | BLDG 1 STE J AND K | PEACHTREE CITY | GA | 30269-1026 | |||||||||
1433 |
Affiliated | 5516 | Rogue Valley | Rogue Valley Dialysis | 760 GOLF VIEW DR | UNIT 1 | MEDFORD | OR | 97504-9685 | |||||||||
1434 |
Affiliated | 5517 | Redwood Dialysis | Redwood Dialysis | 201 SW L ST | GRANTS PASS | OR | 97526-2913 | ||||||||||
1435 |
Affiliated | 4410 | Tucker | Tucker Dialysis | 4434 HUGH HOWELL RD | TUCKER | GA | 30084-4905 | ||||||||||
1436 |
Affiliated | 4386 | Shepherdsville | Shepherdsville Dialysis Center | 150 BROOKS WAY | STE 15 | BROOKS | KY | 40109-6105 | |||||||||
1437 |
Affiliated | 4399 | Muscle Shoals | Muscle Shoals Dialysis | 712 STATE ST | MUSCLE SHOALS | AL | 35661-2940 | ||||||||||
1438 |
Affiliated | 2463 | Tel Huron | Tel-Huron Dialysis (fka Waterford) | 225 SUMMIT DR | WATERFORD | MI | 48328-3364 | ||||||||||
1439 |
Affiliated | 2481 | Cherry Valley | Cherry Valley Dialysis (aka Newark) | 1627 W MAIN ST | NEWARK | OH | 43055-1345 | ||||||||||
1440 |
Affiliated | 2437 | Taylor | Taylor Dialysis | 3100 W 2ND ST | TAYLOR | TX | 76574 | ||||||||||
1441 |
Affiliated | 4430 | Forrest City | Forrest City Dialysis | 1501 N WASHINGTON ST | FORREST CITY | AR | 72335-2152 | ||||||||||
1442 |
Affiliated | 4309 | Kaufman | Kaufman Dialysis | 2851 MILLENNIUM DR | KAUFMAN | TX | 75142-8865 | ||||||||||
1443 |
Affiliated | 4348 | Artesia | Artesia Dialysis | 702 N 13TH ST | ARTESIA | NM | 88210-1166 | ||||||||||
1444 |
Affiliated | 2381 | North Hills | North Hills Dialysis | 7927 BOULEVARD 26 | NORTH RICHLAND HILLS | TX | 76180-7103 | ||||||||||
1445 |
Affiliated | 4428 | Millington | Millington Dialysis | 8510 WILKINSVILLE RD | STE 121 | MILLINGTON | TN | 38053-1537 | |||||||||
1446 |
Affiliated | 5519 | Adams County | Adams County Dialysis | 436 N 10TH ST | QUINCY | IL | 62301-4152 | ||||||||||
1447 |
Affiliated | 5518 | Hannibal | Hannibal Dialysis | 3140 PALMYRA ROAD | HANNIBAL | MO | 63401-2204 | ||||||||||
1448 |
Affiliated | 5520 | Pittsfield | Pittsfield Dialysis | 640 W WASHINGTON ST | PITTSFIELD | IL | 62363-1350 | ||||||||||
1449 |
Affiliated | 4463 | Villa of Waterbury | Villa of Waterbury (fka Kissker Microcenter) | 929 WATERBURY FALLS DR | OFALLON | MO | 63368-2202 | ||||||||||
1450 |
Affiliated | 2465 | Washington DC Nursing Facility | Washington DC Nursing Facility | 2425 25TH ST SE | WASHINGTON | DC | 20020-3408 | ||||||||||
1451 |
Affiliated | 4325 | Moscow | Moscow Dialysis Center | 212 RODEO DR | STE 11 | MOSCOW | ID | 83843-9798 | |||||||||
1452 |
Affiliated | 2402 | Chinook Kidney Center | Chinook Kidney Center (aka Richland) | 1315 AARON DR | BLDG C1 | RICHLAND | WA | 99352-4678 | |||||||||
1453 |
Affiliated | 4416 | Rivers Edge | Rivers Edge Dialysis (aka Athens) | 1006 E STATE ST | STE B | ATHENS | OH | 45701-2121 | |||||||||
1454 |
Affiliated | 5530 | North Glendale Dialysis | North Glendale Dialysis | 1505 WILSON TER STE 190 | GLENDALE | CA | 91206-4015 | ||||||||||
1455 |
Affiliated | 4373 | Everett | Everett Dialysis Center (fka Snohomish 2) | 8130 EVERGREEN WAY | EVERETT | WA | 98203-6419 | ||||||||||
1456 |
Affiliated | 2069 | Harbourview | Harbour View Dialysis (aka Churchland, Suffolk) | 1039 CHAMPIONS WAY | BLDG 4 | SUFFOLK | VA | 23435-3761 | |||||||||
1457 |
Affiliated | 4357 | Capelville | Capelville Dialysis Center | 7008 E SHELBY DR | MEMPHIS | TN | 38125-3416 | ||||||||||
1458 |
Affiliated | 4485 | San Leandro | San Leandro Dialysis (Bayfair Mall) | 15555 E 14TH | STE 52 | SAN LEANDRO | CA | 94578-1900 | |||||||||
1459 |
Affiliated | 4317 | Mill Creek | Mill Creek Dialysis Center (Snohomish/Everett) | 18001 BOTHELL EVERETT HWY | STE 112 | BOTHELL | WA | 98012-1661 | |||||||||
1460 |
Affiliated | 2470 | Seaview | Seaview Dialysis Center | 101 18TH ST SE | LONG BEACH | WA | 98631 | ||||||||||
1461 |
Affiliated | 2461 | East Tampa | East Tampa Dialysis (Ybor City) | 1701 E 9TH AVE | YBOR CITY | FL | 33605-3801 | ||||||||||
1462 |
Affiliated | 5522 | Detroit Road Dialysis | Detroit Road Dialysis | 7901 DETROIT AVE | CLEVELAND | OH | 44102-2828 | ||||||||||
1463 |
Affiliated | 5523 | St V Quadrangle Dialysis | St V Quadrangle Dialysis | 2302 COMMUNITY COLLEGE AVE | CLEVELAND | OH | 44115-3117 | ||||||||||
1464 |
Affiliated | 5524 | Westshore Dialysis | Westshore Dialysis | 29000 CENTER RIDGE RD | WESTLAKE | OH | 44145-5293 | ||||||||||
1465 |
Affiliated | 2468 | Magnolia Dialysis Center Texas | Magnolia Dialysis Center | 17649 FM 1488 RD | MAGNOLIA | TX | 77354-5235 | ||||||||||
1466 |
Affiliated | 4471 | Highland County | Highland County Dialysis (Hillsboro) | 120 ROBERTS LN | STE 4 | HILLSBORO | OH | 45133-7608 | |||||||||
1467 |
Affiliated | 4313 | Rockwall | Rockwall Dialysis | 2455 RIDGE RD | STE 11 | ROCKWALL | TX | 75087-5530 | |||||||||
1468 |
Affiliated | 4354 | Great Northern | Villa of Great Northern (fka North Olmsted) | 22710 FAIRVIEW CENTER DR | STE 1 | FAIRVIEW PARK | OH | 44126-3607 |
Page 70 of 123
1469 |
Affiliated | 2440 | Ridgeland | Ridgeland Dialysis | 112 WEATHERSBY ST | RIDGELAND | SC | 29936-9514 | ||||||||||
1470 |
Affiliated | 2334 | Livermore | Livermore Dialysis | 3201 DOOLAN RD | STE 175 | LIVERMORE | CA | 94551-9605 | |||||||||
1471 |
Affiliated | 2265 | Westlake Daly city | Westlake Daly City Dialysis (fka Colma) | 2201 JUNIPERO SERRA BLVD | STE 175 | DALY CITY | CA | 94014-1908 | |||||||||
1472 |
Affiliated | 4488 | 12th Street Covington | 12th Street Covington Dialysis | 1500 JAMES SIMPSON JR WAY | STE 11 | COVINGTON | KY | 41011 | |||||||||
1473 |
Affiliated | 4384 | Bourbon County | Bourbon County Dialysis (fka Paris) | 213 LETTON DR | PARIS TOWNE SQUARE | PARIS | KY | 40361-2251 | |||||||||
1474 |
Affiliated | 2499 | Calverton | Calverton Dialysis | 4780 CORRIDOR PL | STE C | BELTSVILLE | MD | 20705-1165 | |||||||||
1475 |
Affiliated | 2199 | Aborn | Aborn Dialysis (fka East San Jose) | 3162 S WHITE RD | STE 1 | SAN JOSE | CA | 95148-4019 | |||||||||
1476 |
Affiliated | 4438 | Clermont | Clermont County Dialysis (Milford,Goshen) | 5901 MONTCLAIR BLVD | STE 1 | MILFORD | OH | 45150-2547 | |||||||||
1477 |
Affiliated | 4365 | Rita Ranch | Rita Ranch Dialysis (aka Tucson East II) | 7355 S HOUGHTON RD | STE 11 | TUCSON | AZ | 85747-9379 | |||||||||
1478 |
Affiliated | 4333 | Wake Forest | Wake Forest Dialysis Center | 11001 INGLESIDE PL | RALEIGH | NC | 27614-8577 | ||||||||||
1479 |
Affiliated | 4472 | Colonial Springs | Colonial Springs Dialysis (fka Powder Springs) | 2840 EAST WEST CONNECTOR | STE 35 | AUSTELL | GA | 30106-6813 | |||||||||
1480 |
Affiliated | 2474 | Central Dallas | DaVita Central Dallas Dialysis | 9500 N CENTRAL EXPY | DALLAS | TX | 75231-5002 | ||||||||||
1481 |
Affiliated | 2188 | Sanger | Sanger Sequoia Dialysis | 2517 JENSEN AVE | BLDG B | SANGER | CA | 93657-2251 | |||||||||
1482 |
Affiliated | 4421 | Conyers | Conyers Dialysis | 1501 MILSTEAD RD NE | CONYERS | GA | 30012-3838 | ||||||||||
1483 |
Affiliated | 4337 | Duncanville | Duncanville Dialysis (Cedar Hill) | 270 E HIGHWAY 67 | STE 1 | DUNCANVILLE | TX | 75137-4428 | |||||||||
1484 |
Affiliated | 4417 | Gateway | Gateway Dialysis (Ft.Myers) | 5705 LEE BLVD | LEHIGH ACRES | FL | 33971-6342 | ||||||||||
1485 |
Affiliated | 4487 | Derry | Derry Dialysis | 1 ACTION BLVD | STE 2 | LONDONDERRY | NH | 03053-3428 | |||||||||
1486 |
Affiliated | 4461 | Villa of Wentzville Microcenter | Villa of Wentzville (Microcenter) | 1126 W PEARCE BLVD | STE 116 & 118 | WENTZVILLE | MO | 63385-1053 | |||||||||
1487 |
Affiliated | 1925 | Buchanan County Dialysis | Buchanan County Dialysis (Independence) | 1600 1ST ST E | INDEPENDENCE | IA | 50644-3155 | ||||||||||
1488 |
Affiliated | 2450 | Hoosier Hills | Hoosier Hills Dialysis | 143 S KINGSTON DR | BLOOMINGTON | IN | 47408-6342 | ||||||||||
1489 |
Affiliated | 4492 | Palm Breeze | Palm Breeze Dialysis (fka North Port) | 14942 TAMIAMI TRL | STE E | NORTH PORT | FL | 34287-2705 | |||||||||
1490 |
Affiliated | 4362 | Big Oaks | Big Oaks Dialysis | 5623 W TOUHY AVE | NILES | IL | 60714-4019 | ||||||||||
1491 |
Affiliated | 4407 | Pinellas West Shore | Pinellas West Shore Dialysis | 3451 66TH ST N | STE A | ST PETERSBURG | FL | 33710-1568 | |||||||||
1492 |
Affiliated | 2267 | Plano | Plano Dialysis | 481 SHILOH RD | STE 1 | PLANO | TX | 75074-7231 | |||||||||
1493 |
Affiliated | 4350 | Fairview | Villa of Fairview Park (fka Fairview Park Dialysis) | 19050 LORAIN RD | FAIRVIEW PARK | OH | 44126-1915 | ||||||||||
1494 |
Affiliated | 2380 | Ave Marisa | Ave Maria Dialysis (fka Immokalee) | 5340 USEPPA DR | AVE MARIA | FL | 34142-5051 | ||||||||||
1495 |
Affiliated | 5037 | Warminster | Franklin Commons Dialysis (fka Warminster) | 720 JOHNSVILLE BLVD | STE 8 | WARMINSTER | PA | 18974-3546 | |||||||||
1496 |
Affiliated | 2446 | Ripley | Ripley Dialysis Center | 854 HWY 51 S | RIPLEY | TN | 38063-5536 | ||||||||||
1497 |
Affiliated | 5538 | St Charles / Riverbend | River Bend Dialysis (St. Charles Parish) | 1057 PAUL MAILLARD RD | ST B135 | LULING | LA | 70070-4349 | |||||||||
1498 |
Affiliated | 5570 | Midwest Springfield | Midwest Springfield Dialysis | 2200 N LIMESTONE ST STE 104 | SPRINGFIELD | OH | 45503-2692 | ||||||||||
1499 |
Affiliated | 5571 | Midwest Fairborn | Midwest Fairborn Dialysis | 1266 N BROAD ST | FAIRBORN | OH | 45324-5549 | ||||||||||
1500 |
Affiliated | 5572 | Midwest Urbana | Midwest Urbana Dialysis | 1430 E US HIGHWAY 36 | URBANA | OH | 43078-9112 | ||||||||||
1501 |
Affiliated | 5531 | Camarillo | Camarillo Dialysis | 2438 N PONDEROSA DR STE C101 | CAMARILLO | CA | 93010-2465 | ||||||||||
1502 |
Affiliated | 5532 | Thousand Oaks | Thousand Oaks Dialysis | 375 ROLLING OAKS DR STE 100 | THOUSAND OAKS | CA | 91361-1024 | ||||||||||
1503 |
Affiliated | 5533 | Simi Valley | Simi Valley Dialysis | 2950 SYCAMORE DR STE 100 | SIMI VALLEY | CA | 93065-1210 | ||||||||||
1504 |
Affiliated | 5534 | Santa Paula | Santa Paula Dialysis | 253 MARCH ST | SANTA PAULA | CA | 93060-2511 | ||||||||||
1505 |
Affiliated | 5548 | Ventura | Ventura Dialysis | 2705 LOMA VISTA RD STE 101 | VENTURA | CA | 93003-1596 | ||||||||||
1506 |
Affiliated | 4468 | Villa of St. John | Villa of St John (Crossing Microcenter-MO) | 9030 SAINT CHARLES ROCK RD | SAINT LOUIS | MO | 63114-4246 | ||||||||||
1507 |
Affiliated | 4372 | Whidbey Island | Whidbey Island Dialysis Center | 32650 STATE RD 20 | BLDG E STE 18 | OAK HARBOR | WA | 98277-2641 | |||||||||
1508 |
Affiliated | 4437 | Baytown | Baytown Dialysis | 4665 GARTH RD | STE 9 | BAYTOWN | TX | 77521-2261 | |||||||||
1509 |
Affiliated | 2475 | Highland Ranch | Highland Ranch Dialysis Center | 7223 CHURCH ST STE A14 | HIGHLAND | CA | 92346-6837 | ||||||||||
1510 |
Affiliated | 4474 | Tiptonville | Tiptonville Dialysis | 795 HAMRA ST | TIPTONVILLE | TN | 38079-1663 | ||||||||||
1511 |
Affiliated | 1902 | Carabello | Carabello Dialysis Center | 757 E WASHINGTON BLVD | LOS ANGELES | CA | 90021-3016 | ||||||||||
1512 |
Affiliated | 5573 | Palmetto | Palmetto Dialysis | 317 PROFESSIONAL PARK RD | CLINTON | SC | 29325-7625 | ||||||||||
1513 |
Affiliated | 5574 | Greer South | Greer South Dialysis | 3254 BRUSHY CREEK RD | GREER | SC | 29650-1000 | ||||||||||
1514 |
Affiliated | 5575 | Greenville West End | Greenville West End Dialysis | 605 S ACADEMY ST | GREENVILLE | SC | 29601-2407 | ||||||||||
1515 |
Affiliated | 5576 | Fountain Inn | Fountain Inn Dialysis | 298 CHAPMAN RD | FOUNTAIN INN | SC | 29644-6129 | ||||||||||
1516 |
Affiliated | 5558 | Sellersville | Sellersville Dialysis | 1112 OLD BETHLEHEM PIKE | SELLERSVILLE | PA | 18960-1423 | ||||||||||
1517 |
Affiliated | 5564 | Humbolt Ridge | Humboldt Ridge Dialysis | 2211 N HUMBOLDT BLVD | MILWAUKEE | WI | 53212-3507 | ||||||||||
1518 |
Affiliated | 5565 | West Appleton | West Appleton Dialysis | 10130 W APPLETON AVE | STE 5 | MILWAUKEE | WI | 53225-2579 | |||||||||
1519 |
Affiliated | 5566 | Bay Shore | Bay Shore Dialysis | 5650 N GREEN BAY AVE | STE 15 | GLENDALE | WI | 53209-4449 | |||||||||
1520 |
Affiliated | 5567 | South Ridge | South Ridge Dialysis | 4848 S 76TH ST | STE 1 | GREENFIELD | WI | 53220-4361 | |||||||||
1521 |
Affiliated | 5568 | Bluemound | Bluemound Dialysis | 601 N 99TH ST | STE 1 | MILWAUKEE | WI | 53226-4362 | |||||||||
1522 |
Affiliated | 4385 | Versailles | Versailles Dialysis | 480 LEXINGTON RD | VERSAILLES | KY | 40383-1918 | ||||||||||
1523 |
Affiliated | 5035 | Magnolia Oaks | Magnolia Oaks Dialysis (aka Hinesville) | 2377 HWY 196 W | HINESVILLE | GA | 31313-8036 | ||||||||||
1524 |
Affiliated | 4489 | Mesa County | Mesa County Dialysis (Grand Junction) | 561 25 RD | STE D | GRAND JUNCTION | CO | 81505-1303 | |||||||||
1525 |
Affiliated | 297 | West Bloomfield | West Bloomfield Dialysis | 6010 W MAPLE RD | STE 215 | WEST BLOOMFIELD | MI | 48322-4406 | |||||||||
1526 |
Affiliated | 5550 | Crystal Springs Dialysis | Crystal Springs Dialysis | 720 COG CIRCLE | CRYSTAL LAKE | IL | 60014-7301 | ||||||||||
1527 |
Affiliated | 5551 | Cobblestone Dialysis | Cobblestone Dialysis | 934 CENTER ST | STE A | ELGIN | IL | 60120-2125 | |||||||||
1528 |
Affiliated | 5586 | Oak Springs Dialysis | Oak Springs Dialysis | 764 LOCUST AVE | WASHINGTON | PA | 15301-2756 | ||||||||||
1529 |
Affiliated | 5010 | Maple Valley Plaza | Maple Valley Plaza Dialysis (Farmington) | 649 MAPLE VALLEY DR | FARMINGTON | MO | 63640-1993 | ||||||||||
1530 |
Affiliated | 4433 | Floyd Curl | Floyd Curl Dialysis (San Antonio) | 9238 FLOYD CURL DR | STE 12 | SAN ANTONIO | TX | 78240-1691 | |||||||||
1531 |
Affiliated | 2387 | Mission Valley | Mission Valley Dialysis (aka McAllen) | 1203 ST CLAIRE BLVD 9B | MISSION | TX | 78572-6601 | ||||||||||
1532 |
Affiliated | 2180 | Silver Lake | Silver Lake Dialysis | 2723 W TEMPLE ST | LOS ANGELES | CA | 90026-4723 | ||||||||||
1533 |
Affiliated | 5578 | Lake Park Dialysis | Lake Park Dialysis | 1531 E HYDE PARK BLVD | CHICAGO | IL | 60615-3039 | ||||||||||
1534 |
Affiliated | 5579 | Stoney Island Dialysis | Stony Island Dialysis | 8725 S STONY ISLAND AVE | CHICAGO | IL | 60617-2709 | ||||||||||
1535 |
Affiliated | 5580 | Woodlawn Dialysis | Woodlawn Dialysis | 1164 E 55TH ST | CHICAGO | IL | 60615-5115 |
Page 71 of 123
1536 |
Affiliated | 4440 | Jefferson Ave | Jefferson Avenue Dialysis (aka Village Parkway, Hampton) | 11234 JEFFERSON AVE | NEWPORT NEWS | VA | 23601-2207 | ||||||||||
1537 |
Affiliated | 4381 | Robinson | Robinson Dialysis | 1215 N ALLEN ST | STE B | ROBINSON | IL | 62454-1100 | |||||||||
1538 |
Affiliated | 4320 | Gateway Plaza | Gateway Plaza Dialysis (aka Willowbrook) | 1580 W ROSECRANS AVE | COMPTON | CA | 90222-3700 | ||||||||||
1539 |
Affiliated | 4329 | Pasadena Foothills | Pasadena Foothills Dialysis (fka Arcadia) | 3722 E COLORADO BLVD | PASADENA | CA | 91107-3803 | ||||||||||
1540 |
Affiliated | 914 | Live Oak Dialysis | Live Oak Dialysis (fka San Antonio) | 6700 RANDOLPH BLVD | STE 11 | LIVE OAK | TX | 78233-4222 | |||||||||
1541 |
Affiliated | 5031 | Frackville | Frackville Dialysis (aka JV_Pottsville) | 801 SCHUYLKILL MALL | FRACKVILLE | PA | 17931-2524 | ||||||||||
1542 |
Affiliated | 5038 | Castor | Cottman Kidney Center (Castor, NE Philadelphia) | 7198 CASTOR AVE | PHILADELPHIA | PA | 19149-1105 | ||||||||||
1543 |
Affiliated | 4351 | Villa of North Ridgevelle | Villa of North Ridgeville | 35143 CENTER RIDGE RD | NORTH RIDGEVILLE | OH | 44039-3089 | ||||||||||
1544 |
Affiliated | 5503 | Thorn Run Dialysis | Thorn Run Dialysis | 1136 THORN RUN RD | STE J1 | MOON TOWNSHIP | PA | 15108 | |||||||||
1545 |
Affiliated | 5504 | Allegheny Valley | Allegheny Valley Dialysis | 1620 PACIFIC AVE | HEIGHTS PLAZA SHOPPING CENTER | NATRONA HEIGHTS | PA | 15065-2101 | |||||||||
1546 |
Affiliated | 5506 | Northside | Northside Dialysis (fka Allegheny General) | 320 E NORTH AVE | 4TH FL, SOUTH TOWER | PITTSBURGH | PA | 15212-4756 | |||||||||
1547 |
Affiliated | 5507 | Somerset | Somerset County Dialysis | 229 S KIMBERLY AVE | STE 1 | SOMERSET | PA | 15501-2022 | |||||||||
1548 |
Affiliated | 4493 | Carthage | Carthage Dialysis | 165 SAVANNAH GARDENS DR | CARTHAGE | NC | 28327 | ||||||||||
1549 |
Affiliated | 2464 | Riverwood Dialysis | Riverwood Dialysis (fka Nine Mile, Tree City & Southfield) | 24467 W 10 MILE RD | SOUTHFIELD | MI | 48033-2931 | ||||||||||
1550 |
Affiliated | 4415 | Burton | Burton Dialysis (fka Flint Northeast) | 4015 DAVISON RD | BURTON | MI | 48509-1401 | ||||||||||
1551 |
Affiliated | 4490 | Black Canyon | Black Canyon Dialysis (Montrose) | 3421 S RIO GRANDE AVE | UNIT D | MONTROSE | CO | 81401-4840 | |||||||||
1552 |
Affiliated | 4394 | Memphis Midtown | Memphis Midtown Dialysis | 3430 SUMMER AVE | MEMPHIS | TN | 38122-3610 | ||||||||||
1553 |
Affiliated | 5539 | Stonecrest Dialysis | Stonecrest Dialysis | 1302 E STATE ST | ROCKFORD | IL | 61104-2228 | ||||||||||
1554 |
Affiliated | 4412 | West Plano | West Plano Dialysis | 5036 TENNYSON PKWY | PLANO | TX | 75024-3002 | ||||||||||
1555 |
Affiliated | 2217 | Redwood City | Redwood City Dialysis (fka Palo Alto) | 1000 MARSHALL ST | REDWOOD CITY | CA | 94063-2027 | ||||||||||
1556 |
Affiliated | 1592 | State Fair | State Fair Dialysis | 19800 WOODWARD AVE | DETROIT | MI | 48203-5102 | ||||||||||
1557 |
Affiliated | 5589 | ADC of Ft Lauderdale | Advanced Dialysis Center of Fort Lauderdale | 911 E OAKLAND PARK BLVD | OAKLAND PARK | FL | 33334-2725 | ||||||||||
1558 |
Affiliated | 5008 | Dover | Dover Community Dialysis (New Philadelphia) | 899 E IRON AVE | DOVER | OH | 44622-2097 | ||||||||||
1559 |
Affiliated | 5045 | McMinnville | McMinnville Dialysis | 200 NE NORTON LN | MCMINNVILLE | OR | 97128-8470 | ||||||||||
1560 |
Affiliated | 5007 | Sparta | Sparta Dialysis | 150 SAM WALTON DR | STE 8 | SPARTA | TN | 38583-8818 | |||||||||
1561 |
Affiliated | 4409 | Kendall | Kendall Kidney Center (fka Dadeland) | 8364 MILLS DR | STE 174 | MIAMI | FL | 33183-4806 | |||||||||
1562 |
Affiliated | 4397 | Abbeville | Abbeville Dialysis | 904 W GREENWOOD ST | ABBEVILLE | SC | 29620 | ||||||||||
1563 |
Affiliated | 2453 | Delta View | Delta View Dialysis | 1150 E LELAND RD | PITTSBURG | CA | 94565-5319 | ||||||||||
1564 |
Affiliated | 5013 | Wolf River | Wolf River Dialysis (Germantown) | 7990 TRINITY PL | STE 11 | CORDOVA | TN | 38018-7731 | |||||||||
1565 |
Affiliated | 5601 | San Luis Obispo Dialysis | San Luis Obispo Dialysis | 1043 MARSH ST | SAN LUIS OBISPO | CA | 93401-3629 | ||||||||||
1566 |
Affiliated | 5602 | Templeton Dialysis | Templeton Dialysis | 1310 LAS TABLAS RD | STE 11 | TEMPLETON | CA | 93465-9746 | |||||||||
1567 |
Affiliated | 5603 | Pismo Beach Dialysis | Pismo Beach Dialysis | 320 JAMES WAY | STE 11 | PISMO BEACH | CA | 93449-2813 | |||||||||
1568 |
Affiliated | 5583 | Lincoln Way Dialysis | Lincoln Way Dialysis | 1303 LINCOLN WAY STE A | WHITE OAK | PA | 15131-1603 | ||||||||||
1569 |
Affiliated | 5023 | Grundy Center | Grundy Center Dialysis | 101 E J AVENUE | GRUNDY CENTER | IA | 50638-2031 | ||||||||||
1570 |
Affiliated | 3862 | Pickens County | Pickens County Dialysis | 289 WILLIAM E HILL DR. | STE A | CARROLLTON | AL | 35447 | |||||||||
1571 |
Affiliated | 5032 | Willow Grove | Willow Grove Dialysis (Abington-Maplewood) | 1849 DAVISVILLE RD | WILLOW GROVE | PA | 19090-4111 | ||||||||||
1572 |
Affiliated | 2255 | Amherst | Amherst Dialysis (Lorain County) | 3200 COOPER FOSTER PRK RD W | LORAIN | OH | 44053-3654 | ||||||||||
1573 |
Affiliated | 2220 | South Fort Worth | South Fort Worth Dialysis | 6260 SOUTHWEST BLVD | BENBROOK | TX | 76109-6906 | ||||||||||
1574 |
Affiliated | 5521 | Jerseyville Dialysis | Jerseyville Dialysis | 917 S STATE ST | JERSEYVILLE | IL | 62052-2344 | ||||||||||
1575 |
Affiliated | 5605 | Independence County Dialysis | Independence County Dialysis | 1700 HARRISON ST | STE F | BATESVILLE | AR | 72501-7315 | |||||||||
1576 |
Affiliated | 5606 | Jackson County Dialysis | Jackson County Dialysis | 1912 MCLAIN ST | PRATT SQUARE | NEWPORT | AR | 72112-3659 | |||||||||
1577 |
Affiliated | 5607 | Searcy Dialysis | Searcy Dialysis | 3208 LANGLEY DR | SEARCY | AR | 72143-6020 | ||||||||||
1578 |
Affiliated | 5608 | Springhill Dialysis | Springhill Dialysis | 3401 SPRINGHILL DR | STE 19 | NORTH LITTLE ROCK | AR | 72117-2925 | |||||||||
1579 |
Affiliated | 5609 | Pulaski County Dialysis | Pulaski County Dialysis | 202 JOHN HARDEN DR | JACKSONVILLE | AR | 72076-3775 | ||||||||||
1580 |
Affiliated | 5610 | Little Rock Midtown Dialysis | Little Rock Midtown Dialysis | 2 LILE CT | STE 12A | LITTLE ROCK | AR | 72205-6241 | |||||||||
1581 |
Affiliated | 5611 | Saline County Dialysis | Saline County Dialysis | 1200 N MAIN ST | STE 2 | BENTON | AR | 72015-3341 | |||||||||
1582 |
Affiliated | 5612 | Conway Dialysis | Conway Dialysis | 2445 CHRISTINA LANE | CONWAY | AR | 72034 | ||||||||||
1583 |
Affiliated | 5614 | Valley Baptist Harlingen Dialysis | Valley Baptist-Harlingen Dialysis | 2220 HAINE DR STE 40 | HARLINGEN | TX | 78550-8584 | ||||||||||
1584 |
Affiliated | 5615 | Valley Baptist Raymondville Dialysis | Valley Baptist-Raymondville Dialysis | 894 FM 3168 | RAYMONDVILLE | TX | 78580-4519 | ||||||||||
1585 |
Affiliated | 2455 | Hawaiian Gardens | Hawaiian Gardens Dialysis | 12191 226TH ST | HAWAIIAN GARDENS | CA | 90716-1510 | ||||||||||
1586 |
Affiliated | 2310 | Huntington park | Huntington Park Dialysis | 5942 RUGBY AVE | HUNTINGTON PARK | CA | 90255-2803 | ||||||||||
1587 |
Affiliated | 2462 | Poinciana | Poinciana Dialysis | 1002 CYPRESS PKWY | KISSIMMEE | FL | 34758-3328 | ||||||||||
1588 |
Affiliated | 5005 | Southtowns | Southtowns Dialysis (Hamburg) | 4910 CAMP RD | STE 1 | HAMBURG | NY | 14075-2617 | |||||||||
1589 |
Affiliated | 5635 | Parma Heights Dialysis | Parma Heights Dialysis | 9050 N CHURCH DR | PARMA HEIGHTS | OH | 44130-4701 | ||||||||||
1590 |
Affiliated | 5636 | Hillard Dialysis | Hilliard Dialysis | 19133 HILLIARD BLVD | ROCKY RIVER | OH | 44116-2907 | ||||||||||
1591 |
Affiliated | 5546 | Pacific Dialysis | Pacific Dialysis | 2351 CLAY ST | FL 4 | SAN FRANCISCO | CA | 94115-1931 | |||||||||
1592 |
Affiliated | 5547 | Davies Dialysis | Davies Dialysis | 45 CASTRO ST | SOUTH TOWER 2ND FL | SAN FRANCISCO | CA | 94114-1032 | |||||||||
1593 |
Affiliated | 4486 | Newburgh | Newburgh Dialysis | 4311 HIGHWAY 261 | STE A | NEWBURGH | IN | 47630-2653 | |||||||||
1594 |
Affiliated | 5052 | Enterprise | Enterprise Dialysis (fka Geneva) | 6002 BOLL WEEVIL CIRCLE | ENTERPRISE | AL | 36330-9420 | ||||||||||
1595 |
Affiliated | 4387 | State Line | State Line Dialysis | 2049 E SHELBY DR | MEMPHIS | TN | 38116-7639 | ||||||||||
1596 |
Affiliated | 5108 | Cape Coral North | Cape Coral North Dialysis | 1315 SE 8TH TERRACE | CAPE CORAL | FL | 33990-3213 | ||||||||||
1597 |
Affiliated | 5044 | Willard Ave | Willard Avenue Dialysis (Newington) | 445E WILLARD AVE | NEWINGTON | CT | 06111-2318 | ||||||||||
1598 |
Affiliated | 4363 | West Lawn | West Lawn Dialysis (aka Midway) | 7000 S PULASKI RD | CHICAGO | IL | 60629-5842 | ||||||||||
1599 |
Affiliated | 4353 | Villa of Lakewood | Villa of Lakewood (Northcoast) | 14050 MADISON AVE | LAKEWOOD | OH | 44107-4530 | ||||||||||
1600 |
Affiliated | 5054 | North Carrolton | North Carrollton Dialysis (Parkview) | 195 PARKWOOD CIRCLE | CARROLLTON | GA | 30117-8756 | ||||||||||
1601 |
Affiliated | 5620 | Sikeston Jaycee Regional Dialysis | Sikeston Jaycee Regional Dialysis | 135 PLAZA DR STE 101 | SIKESTON | MO | 63801-5148 | ||||||||||
1602 |
Affiliated | 2244 | Radcliff | Radcliff Dialysis | 180 E LINCOLN TRAIL BLVD | RADCLIFF | KY | 40160-1254 |
Page 72 of 123
1603 |
Affiliated | 4452 | McAfee | McAfee Dialysis (Candler Road Decatur) | 1987 CANDLER RD | STE C | DECATUR | GA | 30032-4212 | |||||||||
1604 |
Affiliated | 5036 | Avon | Avon Dialysis (Indy West) | 9210 ROCKVILLE RD | STE D | INDIANAPOLIS | IN | 46234-2669 | |||||||||
1605 |
Affiliated | 2485 | Anaheim West | Anaheim West Dialysis | 1821 W LINCOLN AVE | ANAHEIM | CA | 92801-6731 | ||||||||||
1606 |
Affiliated | 5043 | Port Saint Joe | Port Saint Joe Dialysis | 3871 HIGHWAY 98 E | STE 11 | PORT ST. JOE | FL | 32456-5318 | |||||||||
1607 |
Affiliated | 5056 | Hayward Mission Hills | Hayward Mission Hills Dialysis | 1661 INDUSTRIAL PKWY W | HAYWARD | CA | 94544-7046 | ||||||||||
1608 |
Affiliated | 2472 | Cypress Woods Northwest | Cypress Woods Northwest Dialysis (aka NW Houston) | 20320 NORTHWEST FWY | STE 1 | HOUSTON | TX | 77065- | |||||||||
1609 |
Affiliated | 5641 | Willow Creek Dialysis | Willow Creek Dialysis | 1139 WARWICK WAY | RACINE | WI | 53406-5661 | ||||||||||
1610 |
Affiliated | 5642 | Harbor View Dialysis | Harbor View Dialysis | 818 6TH ST | RACINE | WI | 53403-1176 | ||||||||||
1611 |
Affiliated | 4451 | Red River | Red River Dialysis (fka Shreveport South) | 9205 LINWOOD AVE | SHREVEPORT | LA | 71106-7006 | ||||||||||
1612 |
Affiliated | 2392 | South Dade Kidney Center | South Dade Kidney Center (Coral Reef) | 11040 SW 184TH ST | CUTLER BAY | FL | 33157-6602 | ||||||||||
1613 |
Affiliated | 5604 | Niagara Falls Memorial Dialysis | Niagara Falls Memorial Dialysis (was NF Kidney Care Center) | 621 10TH ST | NIAGARA FALLS | NY | 14301-1813 | ||||||||||
1614 |
Affiliated | 5617 | Silverado Dialysis | Silverado Dialysis | 1100 TRANCAS ST | STE 266 AND 267 | NAPA | CA | 94558-2921 | |||||||||
1615 |
Affiliated | 5621 | Prairie River Dialysis | Prairie River Dialysis | 601 S CENTER AVE | MERRILL | WI | 54452-3404 | ||||||||||
1616 |
Affiliated | 5622 | Stevens Point Dialysis | Stevens Point Dialysis | 900 ILLINOIS AVE | 5th FLR | STEVENS POINT | WI | 54481-2885 | |||||||||
1617 |
Affiliated | 5623 | Grand Seasons Dialysis | Grand Seasons Dialysis | 190 GRAND SEASONS DR | WAUPACA | WI | 54981-8219 | ||||||||||
1618 |
Affiliated | 5624 | Wausau Dialysis | Wausau Dialysis | 2600 STEWART AVE | STE 144 | WAUSAU | WI | 54401-1403 | |||||||||
1619 |
Affiliated | 5625 | Pine Crest Dialysis | Pine Crest Dialysis | 232 S COURTNEY ST | STE 2 | RHINELANDER | WI | 54501-3319 | |||||||||
1620 |
Affiliated | 5626 | Meadow Lane Dialysis | Meadow Lane Dialysis | 1120 PINE ST | STANLEY | WI | 54768-1297 | ||||||||||
1621 |
Affiliated | 5627 | Wisconsin Rapids Dialysis | Wisconsin Rapids Dialysis | 1041B HILL ST | WISCONSIN RAPIDS | WI | 54494-5221 | ||||||||||
1622 |
Affiliated | 5628 | Marshfield Dialysis | Marshfield Dialysis | 123 NORTHRIDGE ST | MARSHFIELD | WI | 54449-8341 | ||||||||||
1623 |
Affiliated | 5629 | Northern Star Dialysis | Northern Star Dialysis | 311 ELM ST | WOODRUFF | WI | 54568-9190 | ||||||||||
1624 |
Affiliated | 5632 | Ames Mary Greeley Dialysis | Ames Mary Greeley Dialysis | 2322 E 13TH ST | AMES | IA | 50010-5669 | ||||||||||
1625 |
Affiliated | 5633 | Marshalltown Mary Greeley Dialysis | Marshalltown Mary Greeley Dialysis | 3120 S 2ND ST | MARSHALLTOWN | IA | 50158-4614 | ||||||||||
1626 |
Affiliated | 5634 | Iowa Falls Mary Greeley Dialysis | Iowa Falls Mary Greeley Dialysis | 701 WASHINGTON AVE | IOWA FALLS | IA | 50126-2100 | ||||||||||
1627 |
Affiliated | 5649 | Dialysis Center of Hutchinson | Dialysis Center of Hutchinson | 1901 N WALDRON ST | HUTCHINSON | KS | 67502-1129 | ||||||||||
1628 |
Affiliated | 5650 | Amarillo Dialysis | Amarillo Dialysis | 8604 S COULTER ST | AMARILLO | TX | 79119-7379 | ||||||||||
1629 |
Affiliated | 4495 | Sagemeadow | Sagemeadow Dialysis (Houston) | 10923 SCARSDALE BLVD | HOUSTON | TX | 77089-6024 | ||||||||||
1630 |
Affiliated | 5009 | McKinney | McKinney Dialysis | 4717 MEDICAL CENTER DR | MCKINNEY | TX | 75069-1870 | ||||||||||
1631 |
Affiliated | 4499 | Scottsburg | Scottsburg Dialysis | 1619 W MCCLAIN AVE | SCOTTSBURG | IN | 47170-1161 | ||||||||||
1632 |
Affiliated | 2108 | Snake River | Snake River Dialysis Center (fka Blackfoot) | 1491 PARKWAY DR | BLACKFOOT | ID | 83221-1667 | ||||||||||
1633 |
Affiliated | 5034 | Southpoint | Southpoint Dialysis (aka Durham South) | 415 W NC HWY 54 | DURHAM | NC | 27713-7516 | ||||||||||
1634 |
Affiliated | 5643 | Burlingame Dialysis | Burlingame Dialysis | 1720 EL CAMINO REAL | STE 12 | BURLINGAME | CA | 94010-3225 | |||||||||
1635 |
Affiliated | 5644 | Mills Dialysis | Mills Dialysis | 100 S SAN MATEO DR | SAN MATEO | CA | 94401-3805 | ||||||||||
1636 |
Affiliated | 5646 | Stuebenville | Steubenville Dialysis | 4000 JOHNSON RD | STEUBENVILLE | OH | 43952-2300 | ||||||||||
1637 |
Affiliated | 5656 | Premiere Kidney Center of Newark | Premiere Kidney Center of Newark | 65 SOUTH TERRACE AVE | NEWARK | OH | 43055-1355 | ||||||||||
1638 |
Affiliated | 5029 | Calvine | Calvine Dialysis (Sacramento) | 8243 E STOCKTON BLVD | STE 1 | SACRAMENTO | CA | 95828-8200 | |||||||||
1639 |
Affiliated | 4445 | Durham Corners dialysis | Durham Corners Dialysis (South Plainfield) | 241 DURHAM AVE | SOUTH PLAINFIELD | NJ | 07080-2504 | ||||||||||
1640 |
Affiliated | 4475 | Mt Morris | Mt Morris Dialysis (aka North Flint) | 6141 N. SAGINAW RD | MOUNT MORRIS | MI | 48458-2403 | ||||||||||
1641 |
Affiliated | 2176 | Grandview | Grandview Dialysis | 13812 S US HIGHWAY 71 | GRANDVIEW | MO | 64030-3685 | ||||||||||
1642 |
Affiliated | 4450 | Lemoore | Lemoore Dialysis | 1345 W BUSH ST | LEMOORE | CA | 93245-3303 | ||||||||||
1643 |
Affiliated | 5663 | Middlebrook Dialysis | Middlebrook Dialysis | 12401 MIDDLEBROOK RD | STE 16 | GERMANTOWN | MD | 20874-1523 | |||||||||
1644 |
Affiliated | 5664 | Catoctin Dialysis | Catoctin Dialysis | 405 W 7TH ST | FREDERICK | MD | 21701-4505 | ||||||||||
1645 |
Affiliated | 5648 | Central New York Dialysis Center | Central New York Dialysis Center | 910 ERIE BLVD E | SYRACUSE | NY | 13210-1060 | ||||||||||
1646 |
Affiliated | 5014 | South Jackson | South Jackson Dialysis | 46 HARTS BRIDGE RD | JACKSON | TN | 38301-7512 | ||||||||||
1647 |
Affiliated | 2344 | Los Alamitos | Los Alamitos Dialysis | 4141 KATELLA AVE | LOS ALAMITOS | CA | 90720-3406 | ||||||||||
1648 |
Affiliated | 5048 | Robbinsdale | Robbinsdale Dialysis | 3461 W BROADWAY AVE | ROBBINSDALE | MN | 55422-2955 | ||||||||||
1649 |
Affiliated | 5557 | Oxnard | Oxnard Dialysis | 1900 OUTLET CENTER DR | OXNARD | CA | 93036-0677 | ||||||||||
1650 |
Affiliated | 4429 | Marked Tree | DNVO-Marked Tree-AR | 216 HESTER PARKER DR | MARKED TREE | AR | 72365-2023 | ||||||||||
1651 |
Affiliated | 5669 | Louisa Dialysis | Louisa Dialysis | 2145 HWY 2565 | LOUISA | KY | 41230 | ||||||||||
1652 |
Affiliated | 5670 | Point Pleasant Dialysis | Point Pleasant Dialysis | 3683 OHIO RIVER DR | POINT PLEASANT | WV | 25550 | ||||||||||
1653 |
Affiliated | 6802 | Marion | Renal Care of Marion (P150) | 2921 HWY 77 | SUITE #8 | MARION | AR | 72364-2368 | |||||||||
1654 |
Affiliated | 6803 | Osceola | Osceola Dialysis (P151) | 1420 W KEISER AVE | OSCEOLA | AR | 72370-2800 | ||||||||||
1655 |
Affiliated | 6805 | Cottonwood | Cottonwood Dialysis (P153) | 203 S CANDY LANE | COTTONWOOD | AZ | 86326-8115 | ||||||||||
1656 |
Affiliated | 6808 | Prescott | Prescott Dialysis (P157) | 980 WILLOW CREEK RD. | SUITE 11 | PRESCOTT | AZ | 86301-1619 | |||||||||
1657 |
Affiliated | 6811 | Naples | Collier County Dialysis (P160) | 6625 HILLWAY CIRCLE | NAPLES | FL | 34112 | ||||||||||
1658 |
Affiliated | 6813 | Catersville | Cartersville Renal Center (P162) | 203 S TENNESSEE ST | CARTERSVILLE | GA | 30120 | ||||||||||
1659 |
Affiliated | 6816 | Arlington Heights Renal Center | Arlington Heights Renal Center (P165) | 17 W GOLF RD | ARLINGTON HEIGHTS | IL | 60006 | ||||||||||
1660 |
Affiliated | 6817 | Hazel Crest Renal Center | Hazel Crest Renal Center (P166) | 3470 W 183RD ST | HAZEL CREST | IL | 60429 | ||||||||||
1661 |
Affiliated | 6818 | Loop Renal Center | Loop Renal Center (P167) | 1101 S CANAL ST | 11TH FLR | CHICAGO | IL | 60607 | |||||||||
1662 |
Affiliated | 6819 | Markham Renal Center | Markham Renal Center (P168) | 3053 W 159TH ST | MARKHAM | IL | 60426 | ||||||||||
1663 |
Affiliated | 6821 | South Holland Renal Center | South Holland Renal Center (P170) | 16136 S PARK AVE. | SOUTH HOLLAND | IL | 60473 | ||||||||||
1664 |
Affiliated | 6822 | Waukegan Renal Center | Waukegan Renal Center (P171) | 1616 GRAND AVE. | STE. C | WAUKEGAN | IL | 60085 | |||||||||
1665 |
Affiliated | 6936 | Waukegan Home Renal Center | Waukegan Home Training (P172) | 1616 GRAND AVE | STE F | WAUKEGAN | IL | 60085 | |||||||||
1666 |
Affiliated | 6825 | Baton Rouge | East Baton Rouge Dialysis (P174) | 1333 ONEAL LANE | BATON ROUGE | LA | 70816 | ||||||||||
1667 |
Affiliated | 6826 | Houma Renal Center | Houma Dialysis (P175) | 108 PICONE RD | HOUMA | LA | 70363 | ||||||||||
1668 |
Affiliated | 6827 | Amesbury | Amesbury Renal Center (P177) | 24 MORRILL PLACE | AMESBURY | MA | 1913 | ||||||||||
1669 |
Affiliated | 6828 | North Andover | North Andover Renal Center (P178) | 201 SUTTON ST | NORTH ANDOVER | MA | 1845 |
Page 73 of 123
1670 |
Affiliated | 6829 | Canton | Canton Renal Center (P179) | 620 E PEACE ST | CANTON | MS | 39046-4729 | ||||||||||
1671 |
Affiliated | 6830 | Hazelhurst | Hazlehurst Dialysis (P180) | 201 N HALEY ST | HAZLEHURST | MS | 39083 | ||||||||||
1672 |
Affiliated | 6831 | Jackson North | Jackson North Dialysis (P181) | 571 BEASLEY RD | SUITE B | JACKSON | MS | 39206-3042 | |||||||||
1673 |
Affiliated | 6832 | Jackson South | Jackson South Dialysis (P182) | 2460 TERRY RD | SUITE 27-J | JACKSON | MS | 39204-5767 | |||||||||
1674 |
Affiliated | 6833 | Jackson Southwest | Jackson Southwest Dialysis (P183) | 1828 RAYMOND RD | JACKSON | MS | 39204-4126 | ||||||||||
1675 |
Affiliated | 6834 | Lexington | Renal Care of Lexington (P184) | 22579 DEPOT STREET | LEXINGTON | MS | 39095 | ||||||||||
1676 |
Affiliated | 6835 | Munroe Falls | Munroe Falls Dialysis (P185) | 265 N MAIN ST | MUNROE FALLS | OH | 44262 | ||||||||||
1677 |
Affiliated | 6836 | Summit | Summit Renal Center (P186) | 73 MASSILLON ROAD | AKRON | OH | 44312 | ||||||||||
1678 |
Affiliated | 6837 | White Ponds | White Ponds Dialysis (P187) | 534 WHITE POND DRIVE | SUITE A | AKRON | OH | 44320 | |||||||||
1679 |
Affiliated | 6838 | Philadelphia | Memphis Street Renal Center (P189) | 3310 24 MEMPHIS ST | PHILADELPHIA | PA | 19134-4510 | ||||||||||
1680 |
Affiliated | 6839 | Memphis Central Renal Center | Renal Care of Central Memphis (P190) | 1331 UNION AVE. | SUITE 11 | MEMPHIS | TN | 38104-7559 | |||||||||
1681 |
Affiliated | 6840 | Memphis Graceland Renal Center | Memphis Graceland Renal Center (P191) | 4180 AUBURN RD | MEMPHIS | TN | 38116-6202 | ||||||||||
1682 |
Affiliated | 6841 | Memphis Midtown Renal Center | Renal Care of Midtown Memphis (P192) | 1166 MONROE AVE. | MEMPHIS | TN | 38104-6614 | ||||||||||
1683 |
Affiliated | 6842 | Memphis North Renal Center | Renal Care of Memphis North (P193) | 4913 RALEIGH COMMON DR. | SUITE 1 | MEMPHIS | TN | 38128-2485 | |||||||||
1684 |
Affiliated | 6844 | Whitehaven Renal Center | Whitehaven Renal Center (P195) | 3420 ELVIS PRESLEY BLVD. | MEMPHIS | TN | 38116-3260 | ||||||||||
1685 |
Affiliated | 6846 | Edinburg | Edinburg Renal Center (P197) | 4302 S SUGAR RD | STE 15 | EDINBURG | TX | 78539-9140 | |||||||||
1686 |
Affiliated | 6847 | Mcallen | Dialysis Care of McAllen (P198) | 411 LINDBERG AVE | MCALLEN | TX | 78501-2921 | ||||||||||
1687 |
Affiliated | 6848 | Weslaco | Weslaco Renal Center (P199) | 910 SOUTH UTAH | WESLACO | TX | 78596-4270 | ||||||||||
1688 |
Affiliated | 6849 | Marlton Dialysis Center | Marlton Dialysis (P200) | 769 E ROUTE 70 | MARLTON | NJ | 08053-2341 | ||||||||||
1689 |
Affiliated | 6850 | Lawrenceville Renal Center | Lawrenceville Renal Center (P201) | 1840 PRINCETON AVE | LAWRENCEVILLE | NJ | 8648 | ||||||||||
1690 |
Affiliated | 6851 | Austell Renal Center | Austell Renal Center (P202) | 3642 MARATHON CIRCLE | AUSTELL | GA | 30106- 6821 | ||||||||||
1691 |
Affiliated | 6852 | Bartlett Renal Center | Bartlett Renal Center (P203_P290_P8203) | 2920 COVINGTON PIKE | MEMPHIS | TN | 38128-6007 | ||||||||||
1692 |
Affiliated | 6854 | Beaverton Dialysis Center | Beaverton Dialysis Center (P206) | 15050 SW KOLL PARKWAY | SUITE J | BEAVERTON | OR | 97006-6002 | |||||||||
1693 |
Affiliated | 6858 | Walker County Dialysis | Walker County Dialysis (P212) | 589 HIGHWAY 78W | JASPER | AL | 35501 | ||||||||||
1694 |
Affiliated | 6861 | Lakewood | Manatee County Dialysis (P215) | 8470 COOPER CREEK BVLD | UNIVERSITY PARK | FL | 34201 | ||||||||||
1695 |
Affiliated | 6862 | Canton | Northwest Georgia Dialysis (P216) | 260 HOSPITAL RD | CANTON | GA | 30114 | ||||||||||
1696 |
Affiliated | 6863 | Buffulo Grove Renal Center | Buffalo Grove Dialysis (P218) | 1291 W DUNDEE RD | BUFFALO GROVE | IL | 60089 | ||||||||||
1697 |
Affiliated | 6864 | Evanston Renal Center | Evanston Renal Center (P219) | 1715 CENTRAL ST | EVANSTON | IL | 60201 | ||||||||||
1698 |
Affiliated | 6865 | Schaumburg Renal Center | Schaumburg Renal Center (P220) | 1156 S. ROSELLE ROAD | SCHAUMBURG | IL | 60193 | ||||||||||
1699 |
Affiliated | 6937 | Schaumburg Home Renal Center | Schaumburg Home Training (P270) | 17 W GOLF RD | ARLINGTON HEIGHTS | IL | 60005 | ||||||||||
1700 |
Affiliated | 6866 | Blue River Valley | Blue River Valley Renal Center (P222) | 2309 S MILLER STREET | SUITE 1 | SHELBYVILLE | IN | 46176-9350 | |||||||||
1701 |
Affiliated | 6867 | Central Fort Wayne | Central Fort Wayne Dialysis (P223) | 1940 BLUFTON RD | FORT WAYNE | IN | 46809-1307 | ||||||||||
1702 |
Affiliated | 6869 | Huntington | Renal Care of Huntington (P225) | 3040 WEST PARK DRIVE | HUNTINGTON | IN | 46750-8956 | ||||||||||
1703 |
Affiliated | 6870 | Lake Avenue Dialysis Renal Center | Lake Avenue Dialysis (P226) | 3525 LAKE AVE | STE 4 | FORT WAYNE | IN | 46805-5545 | |||||||||
1704 |
Affiliated | 6871 | Marion County | Marion County Dialysis (P229) | 3834 S EMERSON AVE | BLDG B | INDIANAPOLIS | IN | 46203-5902 | |||||||||
1705 |
Affiliated | 6873 | Quad Counties Dialysis | Quad Counties Dialysis (P232) | 528 NORTH GRANDSTAFF | AUBURN | IN | 46706-1660 | ||||||||||
1706 |
Affiliated | 6875 | South Anthony | South Anthony Dialysis (P234) | 7017 SOUTH ANTHONY BLVD. | FORT WAYNE | IN | 46816-2016 | ||||||||||
1707 |
Affiliated | 6876 | Brandon | Brandon Renal Center (P235) | 101 CHRISTIAN DR | BRANDON | MS | 39042-2678 | ||||||||||
1708 |
Affiliated | 6877 | Carthage | Renal Care of Carthage (P236) | 312 ELLIS STREET | CARTHAGE | MS | 39051 | ||||||||||
1709 |
Affiliated | 6878 | Las Cruces Renal Center | Las Cruces Renal Center (P237) | 3961 E LOHMAN AVE | STE 29 | LAS CRUCES | NM | 88011-8272 | |||||||||
1710 |
Affiliated | 6879 | Northeast Portland | Northeast Portland Renal Center (P240) | 703 NE HANCOCK ST | PORTLAND | OR | 97212-3955 | ||||||||||
1711 |
Affiliated | 6880 | Oregon Kidney Center | Dialysis Care of Portland (P241) | 5318 NE IRVING | PORTLAND | OR | 97213 | ||||||||||
1712 |
Affiliated | 6881 | Sunnyside | Sunnyside Renal Center (P242) | 6902 SE LAKE ROAD | SUITE 1 | MILWAUKIE | OR | 97267-2148 | |||||||||
1713 |
Affiliated | 6882 | Willamette Valley | Williamette Valley Renal Center (P243) | 1510 DIVISION STREET | SUITE 9 | OREGON CITY | OR | 97045-1572 | |||||||||
1714 |
Affiliated | 6883 | Northern Philadelphia | Northern Philadelphia Dialysis (P244) | 5933 N BROAD ST | PHILADELPHIA | PA | 19141 | ||||||||||
1715 |
Affiliated | 6884 | North Providence Renal Center | North Providence Renal Center (P246) | 1635 MINERAL SPRING AVE | NORTH PROVIDENCE | RI | 02904-4025 | ||||||||||
1716 |
Affiliated | 6889 | Alice Renal Center | Alice Renal Center (P252) | 2345 ALICE REGIONAL BLVD. | ALICE | TX | 78332-7291 | ||||||||||
1717 |
Affiliated | 6890 | Beeville Renal Center | Beeville Renal Center (P253) | 1905 NW FRONTAGE | BEEVILLE | TX | 78102-2954 | ||||||||||
1718 |
Affiliated | 6891 | Brownsville | Brownsville Renal Center (P254) | 2945 CENTRAL BLVD | BROWNSVILLE | TX | 78520-8958 | ||||||||||
1719 |
Affiliated | 6892 | Corpus Christi Renal Center | Corpus Christi Dialysis (P255) | 2733 SWANTNER DR | CORPUS CHRISTI | TX | 78404-2832 | ||||||||||
1720 |
Affiliated | 6893 | Riverside Renal Center | Riverside Renal Center (P256) | 13434 LEOPARD RD. SUITE A17 | CORPUS CHRISTI | TX | 78410-4466 | ||||||||||
1721 |
Affiliated | 6894 | South Texas Renal Center | South Texas Renal Center (P257) | 4301 S PADRE ISLAND DR | CORPUS CHRISTI | TX | 78411-4433 | ||||||||||
1722 |
Affiliated | 6896 | South Central Renal Center | Morgan Avenue Dialysis (P258) | 2222 S MORGAN AVE | SUITE 114 | CORPUS CHRISTI | TX | 78405-1900 | |||||||||
1723 |
Affiliated | 6898 | Northeast Texas | Dialylsis Care of Greenville (P260) | 4805 WESLEY ST | GREENVILLE | TX | 75401-5649 | ||||||||||
1724 |
Affiliated | 6899 | Downtown Spokane | Downtown Spokane Renal Center (P261) | 601 W 5TH ST | SUITE F | SPOKANE | WA | 99205 | |||||||||
1725 |
Affiliated | 6900 | North Spokane | North Spokane Renal Center (P262) | 12610 E MARIBEAU PRKWY | STE 1 | SPOKANE | WA | 99216 | |||||||||
1726 |
Affiliated | 6901 | Spokane Valley | Spokane Valley Renal Center (P263) | 12610 EAST MIRABEAU PKY | SUITE 1 | SPOKANE | WA | 99208-1450 | |||||||||
1727 |
Affiliated | 6902 | Kansas City | Kansas City Renal Center (P264) | 4333 MADISON AVE | KANSAS CITY | MO | 64111-3429 | ||||||||||
1728 |
Affiliated | 6903 | Butler Renal Center | Butler Renal Center (P266) | 601 W NURSERY | BUTLER | MO | 64730 | ||||||||||
1729 |
Affiliated | 6904 | Harrisonville | Harrisonville Renal Center (P267) | 308 GALAXIE AVE | HARRISONVILLE | MO | 64701-2084 | ||||||||||
1730 |
Affiliated | 6905 | Marshall Renal Center | Marshall Renal Center (P268) | 359 W MORGAN | MARSHALL | MO | 65340 | ||||||||||
1731 |
Affiliated | 6907 | Akron Renal Center | Akron Renal Center (P272) | 525 EAST MARKET STREET | AKRON | OH | 44304-1619 | ||||||||||
1732 |
Affiliated | 6908 | Kendallville Renal Center | Kendallville Renal Center (P274) | 602 SAWYER RD | KENDALLVILLE | IN | 46755- 2566 | ||||||||||
1733 |
Affiliated | 6909 | Greenwood Holly Renal Center | Greenwood Holly Renal Center (P276) | 1533 HOLLY RD | CORPUS CHRISTI | TX | 78417-2010 | ||||||||||
1734 |
Affiliated | 6910 | Plainfield Renal Center | Plainfield Renal Center (P278) | 8110 NETWORK DR | PLAINFIELD | IN | 46168-9024 | ||||||||||
1735 |
Affiliated | 6911 | Green Valley Renal Center | Green Valley Dialysis (P279) | 1489 W WARM SPRINGS RD | STE 122 | HENDERSON | NV | 89014-7637 | |||||||||
1736 |
Affiliated | 6912 | Las Vegas Renal Center | Las Vegas Renal Center (P280) | 2333 RENAISSANCE DR | LAS VEGAS | NV | 89119-6191 |
Page 74 of 123
1737 |
Affiliated | 6913 | Lees Summit Renal Center | Lees Summit Renal Center (P281) | 100 NE MISSOURI RD | STE 1 | LEES SUMMIT | MO | 64086-4702 | |||||||||
1738 |
Affiliated | 6914 | Westport Renal Center | Westport Renal Center (P282) | 3947 BROADWAY STREET | KANSAS CITY | MO | 64111-2516 | ||||||||||
1739 |
Affiliated | 6915 | Greensboro Dialysis Center | Greensboro Dialysis Center (P284) | 1220 SILOAM RD | GREENSBORO | GA | 30642-0390 | ||||||||||
1740 |
Affiliated | 5057 | Forest Landing | DNVO-Forest Landing Dialysis (Harford Cty, Havre de Grace)-MD | 2220 COMMERCE AVE | STE 1 | FOREST HILL | MD | 21050 | |||||||||
1741 |
Affiliated | 5033 | University City | DNVO-University City Dialysis (Philadelphia)-PA | 3020 MARKET ST | STE 13 | PHILADELPHIA | PA | 19104-2999 | |||||||||
1742 |
Affiliated | 2411 | Parkland | DNVO-Parkland Dialysis-WA | 311 140TH ST SO | TACOMA | WA | 98444 | ||||||||||
1743 |
Affiliated | 5094 | Shelbyville Road | DNVO JV-Shelbyville Road Dialysis (DuPont, Louisville)-KY | 4600 SHELBYVILLE RD | STE 31 | LOUISVILLE | KY | 40207 | |||||||||
1744 |
Affiliated | 5106 | Fort Wayne West Dialysis | DNVO JV-Fort Wayne South-IN | 302 E PETTIT AVE | FORT WAYNE | IN | 468063007 | ||||||||||
1745 |
Affiliated | 5671 | Suburban Dialysis | ACQ-5671-NY | 1542 MAPLE RD | WILLIAMSVILLE | NY | 14221 | ||||||||||
1746 |
Affiliated | 5672 | Gates Circle Dialysis | ACQ-5672-NY | 3 GATES CIRCLE | 1ST FLR | BUFFALO | NY | 14209 | |||||||||
1747 |
Affiliated | 5673 | Orchard Park Dialysis | ACQ-5673-NY | 3801 TAYLOR RD | ORCHARD PARK | NY | 14127 | ||||||||||
1748 |
Affiliated | 2420 | TC Jester | DNVO-TC Jester-TX | 1800 W 26TH ST | STE 11 | HOUSTON | TX | 77008-1419 | |||||||||
1749 |
Affiliated | 4436 | Champions | DNVO-Champions Dialysis (Houston)-TX | 4427 FM 1960 W | STE D | HOUSTON | TX | 77068-3409 | |||||||||
1750 |
Affiliated | 5083 | Magic City Dialysis MMC | DNVO-Magic City Dialysis (Birmingham)-AL | 300 22ND ST SO | BIRMINGHAM | AL | 35233-2209 | ||||||||||
1751 |
Affiliated | 5084 | Steel City Dialysis | DNVO-Steel City Dialysis (Birmingham)-AL | 1809 AVE H (ENSLEY) | BIRMINGHAM | AL | 35218 | ||||||||||
1752 |
Affiliated | 5081 | Jewel Dialysis | DNVO-Jewel Dialysis (Camellia, Birmingham)-AL | 514 WEST TOWN PLAZA | BESSEMER | AL | 35020 | ||||||||||
1753 |
Affiliated | 660 | Crystal River | Crystal River Dialysis | 7435 W GULF TO LAKE HWY | CRYSTAL RIVER | FL | 34429-7834 | ||||||||||
1754 |
Affiliated | 1936 | Southwest Kidney | Estrella Dialysis Center | 8410 W THOMAS RD | STE 1 BLDG 1 | PHOENIX | AZ | 85037-3356 | |||||||||
1755 |
Affiliated | 1937 | Gilbert Dialysis | Gilbert Dialysis Center | 5222 E BASELINE RD | STE 14 | GILBERT | AZ | 85234-2963 | |||||||||
1756 |
Affiliated | 1938 | Tempe Dialysis | Tempe Dialysis Center | 2149 E WARNER RD | STE 11 | TEMPE | AZ | 85284-3496 | |||||||||
1757 |
Affiliated | 1939 | Phoenix Dialysis | Phoenix Dialysis Center | 337 E CORONADO RD | STE 11 | PHOENIX | AZ | 85004-1582 | |||||||||
1758 |
Affiliated | 1949 | Arrowhead Lakes Dialysis | Arrowhead Lakes Dialysis | 20325 N 51ST AVE | BLDG 11, STE 186 | GLENDALE | AZ | 85308-4625 | |||||||||
1759 |
Affiliated | 1952 | Mountain Vista Dialysis | Mountain Vista Dialysis Center of Arizona | 10238 E HAMPTON AVE | STE 18 | MESA | AZ | 85209-3317 | |||||||||
1760 |
Affiliated | 1977 | South Meadows Dialysis Center | South Meadows Dialysis Center | 10085 DOUBLE R BLVD | STE 16 | RENO | NV | 89521-4867 | |||||||||
1761 |
Affiliated | 1978 | Reno Dialysis Center | Reno Dialysis Center | 1500 E 2ND ST | STE 11 | RENO | NV | 89502-1189 | |||||||||
1762 |
Affiliated | 1979 | Carson City Dialysis Center | Carson City Dialysis Center | 3246 N. CARSON ST | STE 11 | CARSON CITY | NV | 89706-0248 | |||||||||
1763 |
Affiliated | 844 | Sparks | Sparks Dialysis Center | 4860 VISTA BLVD | STE 1 | SPARKS | NV | 89436-2817 | |||||||||
1764 |
Affiliated | 2015 | Sierra Rose Dialysis | Sierra Rose Dialysis Center | 685 SIERRA ROSE DR | RENO | NV | 89511-2060 | ||||||||||
1765 |
Affiliated | 2325 | Northwest Tucson | Northwest Tucson Dialysis | 2945 W INA RD | STE 15 | TUCSON | AZ | 85741-2366 | |||||||||
1766 |
Affiliated | 4355 | Mesa | Central Mesa Dialysis Center | 1134 E UNIVERSITY DR | STE 11 | MESA | AZ | 85203-8048 | |||||||||
1767 |
Affiliated | 4371 | Raven | Raven Dialysis Center | 3540 E BASELINE RD | STE 11 | PHOENIX | AZ | 85042-9628 | |||||||||
1768 |
Affiliated | 4374 | Brookwood | Brookwood Dialysis Center | 8910 N 43RD AVE | STE 17 | GLENDALE | AZ | 85302-5340 | |||||||||
1769 |
Affiliated | 4405 | Ocotillo | Ocotillo Dialysis | 975 W CHANDLER HEIGHTS RD | UNIT 11 | CHANDLER | AZ | 85248-5724 | |||||||||
1770 |
Affiliated | 4364 | Maryvale | Maryvale Dialysis Center | 4845 W MCDOWELL RD | STE 1A, 2A, 3A | PHOENIX | AZ | 85035-4076 | |||||||||
Affiliated | 1995 | Winter Park Home PD Dialysis | Winter Park Home PD Dialysis | 4100 METRIC DR | STE 2 | WINTER PARK | FL | 32792-6832 | ||||||||||
Affiliated | 4302 | Lockport HHD PD At Home | Lockport Home Dialysis-PD | 16626 W 159TH ST | STE 73 | LOCKPORT | IL | 60441-8019 | ||||||||||
Affiliated | 1972 | HHD 6183 and PD 1972 in Shreveport | Shreveport Home Dialysis PD | 1560 IRVING PL | SHREVEPORT | LA | 71101-4604 | |||||||||||
Affiliated | 5618 | Home Dialysis of Dayton South | Home Dialysis of Dayton-South | 4700 SPRINGBORO PIKE | STE 3 | MORAINE | OH | 45439-1964 | ||||||||||
Affiliated | 5619 | Home Dialysis of Dayton | Home Dialysis of Dayton | 627 S EDWIN C MOSES BLVD | STE 2B | DAYTON | OH | 45417-3474 | ||||||||||
Affiliated | 144 | Timpanogos Dialysis Center | Timpanogos Dialysis | 1055 N 500 W | STE 222 | PROVO | UT | 84604-3329 | ||||||||||
Affiliated | 216 | HOME DIALYSIS UNIT | Home Dialysis /CAPD Unit | 825 S 8TH ST STE 1202 | MINNEAPOLIS | MN | 55404 | |||||||||||
Affiliated | 284 | MANZANITA HOME TRAINING CENTER | Manzanita Home Training Center (fka North CAPD) | 4005 MANZANITA AVE | STE 18 | CARMICHAEL | CA | 95608-1779 | ||||||||||
Affiliated | 408 | WICHITA DIALYSIS CENTER | Wichita Dialysis Center-PD Program | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | |||||||||||
Affiliated | 978 | CENTRAL TULSA DIALYSIS CENTER | Central Tulsa PD | 1124 S SAINT LOUIS AVE | TULSA | OK | 74120-5413 | |||||||||||
Affiliated | 1748 | ST PAUL CAPITAL PD | St. Paul Capital Dialysis at Home-PD (fka Capital PD Program) | 555 PARK ST | STE 110 | SAINT PAUL | MN | 55103-2110 | ||||||||||
Affiliated | 1787 | ASH TREE PD | Ash Tree PD | 2666 N GROVE INDUSTRIAL DR | FRESNO | CA | 93727-1552 | |||||||||||
Affiliated | 1821 | EMERALD DIALYSIS | Emerald Dialysis PD (fka Hyde Park PD) | 710 W 43RD ST | CHICAGO | IL | 60609-3435 | |||||||||||
Affiliated | 1822 | OLYMPIA FIELDS DIALYSIS | Olympia Fields PD | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2385 | ||||||||||
Affiliated | 1823 | LAKE COUNTY DIALYSIS | Lake County PD | 918 S MILWAUKEE AVE | LIBERTYVILLE | IL | 60048-3229 | |||||||||||
Affiliated | 1825 | COMPREHENSIVE RENAL CARE-GARY | CRC-Gary PD | 4802 BROADWAY | GARY | IN | 46408-4509 | |||||||||||
Affiliated | 1826 | COMPREHENSIVE RENAL CARE-HAMMOND | CRC-Hammond PD | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 | |||||||||||
Affiliated | 1827 | COMPREHENSIVE RENAL CARE-VALPARAISO | CRC-Valparaiso PD | 606 E LINCOLNWAY | VALPARAISO | IN | 46383-5728 | |||||||||||
Affiliated | 1828 | COMPREHENSIVE RENAL CARE-MICHIGAN CITY | CRC-Michigan City PD | 9836 WEST 400 NORTH | MICHIGAN CITY | IN | 46360-2910 | |||||||||||
Affiliated | 1829 | MERRILLVILLE PD | Merrillville Dialysis PD | 9223 TAFT ST | MERRILLVILLE | IN | 46410-6911 | |||||||||||
Affiliated | 1833 | NAMPA DIALYSIS CENTER | Nampa Dialysis PD | 846 PARKCENTRE WAY | NAMPA | ID | 83651-1790 | |||||||||||
Affiliated | 1834 | TABLE ROCK DIALYSIS CENTER | Table Rock Dialysis PD | 5610 W GAGE ST | BOISE | ID | 83706 | |||||||||||
Affiliated | 1835 | TWIN FALLS DIALYSIS CENTER | Twin Falls Dialysis PD | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | |||||||||||
Affiliated | 1836 | TREASURE VALLEY DIALYSIS CENTER | Treasure Valley Dialysis PD & Home | 3525 E LOUISE DR | STE 155 | MERIDIAN | ID | 83642-6303 | ||||||||||
Affiliated | 1837 | GATE CITY DIALYSIS CENTER | Gate City Dialysis PD | 2001 BENCH RD | POCATELLO | ID | 83201-2033 | |||||||||||
Affiliated | 1838 | FOUR RIVERS DIALYSIS CENTER | Four Rivers Dialysis PD | 515 EAST LN | ONTARIO | OR | 97914-3953 | |||||||||||
Affiliated | 1869 | LOWRY DIALYSIS CENTER | Lowry Dialysis PD | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | ||||||||||
Affiliated | 1905 | BURLEY DIALYSIS CENTER | Burley Dialysis PD | 741 N OVERLAND AVE | BURLEY | ID | 83318-3440 | |||||||||||
Affiliated | 1909 | TURFWAY PD DIALYSIS | Turfway PD Training | 11 SPIRAL DR | STE 15A | FLORENCE | KY | 41042-1394 | ||||||||||
Affiliated | 1910 | MARYVILLE DIALYSIS | Maryville Dialysis PD | 2136B VADALABENE DR | MARYVILLE | IL | 62062-5632 | |||||||||||
Affiliated | 1917 | PDL ANNEX-PD | PDL Annex-PD (PDL=Physician Dialysis Lancaster) | 2110 HARRISBURG PIKE | STE 310 | LANCASTER | PA | 17601-2644 | ||||||||||
Affiliated | 1924 | KANKAKEE COUNTY DIALYSIS | Kankakee County Dialysis PD | 581 WILLIAM R LATHAM SR DR | STE 104 | BOURBONNAIS | IL | 60914-2439 | ||||||||||
Affiliated | 1946 | SNAKE RIVER DIALYSIS PD | DNVO-Snake River Dialysis PD (fka Blackfoot)-ID | 1491 PARKWAY DR | BLACKFOOT | ID | 83221-1667 |
Page 75 of 123
Affiliated | 1953 | NORTH HIGHLANDS DIALYSIS CENTER | North Highlands Dialysis Center PD | 4986 WATT AVE | STE C | NORTH HIGHLANDS | CA | 95660-5182 | ||||||||||
Affiliated | 1966 | AMERY DIALYSIS | Amery Dialysis PD | 970 ELDEN AVE | AMERY | WI | 54001-1448 | |||||||||||
Affiliated | 1975 | KIDNEY HOME CENTER | Kidney HOME (Home Operations & Medical Education) Center PD | 2245 ROLLING RUN DR | STE 4 | WINDSOR MILL | MD | 21244-1858 | ||||||||||
Affiliated | 1988 | MEMPHIS DOWNTOWN DIALYSIS | Memphis Downtown Dialysis PD | 2076 UNION AVE | FL 2 | MEMPHIS | TN | 38104-4138 | ||||||||||
Affiliated | 1989 | PGH HOME MODALITY COE | Pittsburgh Home Modality Center of Excellence PD | 5171 LIBERTY AVE | STE A | PITTSBURGH | PA | 15224-2254 | ||||||||||
Affiliated | 2223 | LAKE VILLA DIALYSIS | Lake Villa Dialysis PD | 37809 N IL RTE 59 | LAKE VILLA | IL | 60046-7332 | |||||||||||
Affiliated | 2232 | RICHFIELD DIALYSIS | Richfield PD Program | 6601 LYNDALE AVE S | STE 150 | RICHFIELD | MN | 55423-2490 | ||||||||||
Affiliated | 2297 | TOKAY HOME DIALYSIS CENTER | Tokay Home Dialysis-PD | 777 S HAM LN | STE L | LODI | CA | 95242-3593 | ||||||||||
Affiliated | 2302 | SPIVEY PERITONEAL AND HOME DIALYSIS CENTER | Spivey Peritoneal Dialysis and Home Dialysis Center | 1423 STOCKBRIDGE RD | STE B | JONESBORO | GA | 30236-3740 | ||||||||||
Affiliated | 2326 | WARRENSVILLE HEIGHTS PD DIALYSIS | Warrensville Heights PD Dialysis | 4200 WARRENSVILLE CENTER RD | STE 210 | WARRENSVILLE HEIGHTS | OH | 44122-7000 | ||||||||||
Affiliated | 2340 | EASTGATE HOME | Eastgate Home Training | 4435 AICHOLTZ RD | STE 800B | CINCINNATI | OH | 45245-1692 | ||||||||||
Affiliated | 2366 | WESLEY CHAPEL DIALYSIS | Wesley Chapel Dialysis (PD ONLY) | 2255 GREEN HEDGES WAY | WESLEY CHAPEL | FL | 33544-8183 | |||||||||||
Affiliated | 2400 | FRESNO PD | Fresno At Home Center-PD Only | 568 E HERNDON AVE | STE 301 | FRESNO | CA | 93720-2989 | ||||||||||
Affiliated | 2456 | GRAND HOME DIALYSIS PD/HHD | Grand Home Dialysis (PD only) | 14674 W MOUNTAIN VIEW BLVD | STE 204 | SURPRISE | AZ | 85374-2708 | ||||||||||
Affiliated | 2458 | WASHINGTON COUNTY DIALYSIS | Washington County Dialysis PD Only (fka Hagerstown) | 1136 OPAL CT | HAGERSTOWN | MD | 21740-5940 | |||||||||||
Affiliated | 2477 | SAN JOSE PD | San Jose At Home-PD Only (Freestanding) | 4400 STEVENS CREEK BLVD | STE 50 | SAN JOSE | CA | 95129-1104 | ||||||||||
Affiliated | 2483 | FREMONT HOME TRAINING JV | DNVO-Fremont At Home PD/HHD-CA | 39355 CALIFORNIA AVE | FREMONT | CA | 94538 | |||||||||||
Affiliated | 2490 | HOME DIALYSIS OPTIONS OF BALDWIN COUNTY | Home Dialysis Options of Baldwin County-PD Only | 27880 N MAIN ST | STE A | DAPHNE | AL | 36526-7080 | ||||||||||
Affiliated | 3299 | TRI COUNTIES HOME TRAINING | Tri Counties Home Dialysis | 433 S BRIDGE ST | VISALIA | CA | 93277-2801 | |||||||||||
Affiliated | 3640 | WHITE OAK HOME TRAINING DIALYSIS | White Oak Home Training | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | ||||||||||
Affiliated | 3683 | BUTLER COUNTY HOME TRAINING DIALYSIS | Butler County Home Training | 3497 S DIXIE HWY | FRANKLIN | OH | 45005-5717 | |||||||||||
Affiliated | 3727 | HANFORD AT HOME DIALYSIS | Hanford Home Dialysis PD | 900 N DOUTY ST | HANFORD | CA | 93230-3918 | |||||||||||
Affiliated | 3735 | HIOAKS DIALYSIS PD | Hioaks Dialysis PD | 681 HIOAKS RD | STE B | RICHMOND | VA | 23225-4043 | ||||||||||
Affiliated | 3891 | MEMPHIS EAST DIALYSIS PD | Memphis East Dialysis PD | 50 HUMPHREYS CTR | STE 28B | MEMPHIS | TN | 38120-2369 | ||||||||||
Affiliated | 3892 | NASHVILLE HOME TRAINING DIALYSIS PD | Nashville Home Training Dialysis PD | 1919 CHARLOTTE AVE | STE 200 | NASHVILLE | TN | 37203-2245 | ||||||||||
Affiliated | 3989 | DEARBORN HOME DIALYSIS | Dearborn Home Dialysis-PD | 22030 PARK ST | DEARBORN | MI | 48124-2854 | |||||||||||
Affiliated | 4308 | GALLERIA HOME TRAINING DIALYSIS | Galleria Home Training Dialysis PD (aka SW Tennessee) | 9045 HIGHWAY 64 | STE 102 | LAKELAND | TN | 38002-8394 | ||||||||||
Affiliated | 4310 | GREATER TAMPA AT HOME | Greater Tampa At Home PD | 4204 N MACDILL AVE | STE 1B NORTH BLDG | TAMPA | FL | 33607-6364 | ||||||||||
Affiliated | 4315 | LORAIN COUNTY HOME DIALYSIS | DNVO-Lorain County Home Dialysis HHD/PD-OH | 824 E BROAD ST | ELYRIA | OH | 44035-6557 | |||||||||||
Affiliated | 4375 | GARFIELD HOME PROGRAM | Garfield Home Program (PD Only) | 228 N GARFIELD AVE | STE 301 | MONTEREY PARK | CA | 91754-1709 | ||||||||||
Affiliated | 4453 | BINZ HOME TRAINING | Binz Home Training - PD only | 1213 HERMANN DR | STE 180 | HOUSTON | TX | 77004-7018 | ||||||||||
Affiliated | 5021 | FRANKLIN AT HOME PD | Franklin At Home PD | 301 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4117 | |||||||||||
Affiliated | 5028 | CALDWELL DIALYSIS CENTER PD | Caldwell Dialysis Center | 821 S SMEED PKWY | CALDWELL | ID | 83605-5130 | |||||||||||
Affiliated | 5170 | FORT WAYNE HOME DIALYSIS | DNVO-Fort Wayne Home Dialysis (PD-HHD)-IN | 3124 E STATE BLVD | STE 5B | FORT WAYNE | IN | 46805-4763 | ||||||||||
Affiliated | 5556 | VISALIA AT HOME | Visalia At Home PD | 1120 N CHINOWTH ST | VISALIA | CA | 93291-7896 | |||||||||||
Affiliated | 5569 | BLUEMOUND PD | Bluemound PD | 601 N 99TH ST STE 300 | WAUWATOSA | WI | 53226-4362 | |||||||||||
Affiliated | 5581 | WOODLAWN HOME PROGRAM PD | Woodlawn Home Program PD Only | 5841 S MARYLAND AVE | RM L-026 | CHICAGO | IL | 60637-1447 | ||||||||||
Affiliated | 5599 | BEVERLY DIALYSIS PD | Beverly PD | 8109 S WESTERN AVE | CHICAGO | IL | 60620-5939 | |||||||||||
Affiliated | 5600 | WOODLAWN PEDIATRIC HOME PROGRAM | Woodlawn Pediatrics Home Program PD Only | 5841 S MARYLAND AVE L026 | CHICAGO | IL | 60615 | |||||||||||
Affiliated | 5616 | SPRINGHILL HOME TRAINING DIALYSIS | Springhill Home Training (PD Only) | 3401 SPRINGHILL DR | STE 330 | NORTH LITTLE ROCK | AR | 72117-2945 | ||||||||||
Affiliated | 5647 | FIRST COLONIAL DAVITA PD | First Colonial DaVita PD | 1157 FIRST COLONIAL RD | STE 200 | VIRGINIA BEACH | VA | 23454-2432 | ||||||||||
Affiliated | 5898 | AMHERST AT HOME | Amherst At Home | 3200 COOPER FOSTER PRK RD W | LORAIN | OH | 44053-3654 | |||||||||||
Affiliated | 5900 | CATHERDRAL CITY AT HOME | DNVO JV-Cathedral City At Home-CA | 30-885 DATE PALM DR | CATHEDRAL CITY | CA | 92234-2958 | |||||||||||
Affiliated | 5904 | ROBBINSDALE AT HOME | Robbinsdale At Home | 3461 WEST BROADWAY AVE | ROBBINSDALE | MN | 55422-2955 | |||||||||||
Affiliated | 5905 | NORTH PALM BEACH AT HOME | North Palm Beach At Home | 2841 PGA BLVD | PALM BEACH GARDENS | FL | 33410-2910 | |||||||||||
Affiliated | 5907 | SOUTHTOWNS AT HOME | Southtowns At Home (Hamburg) | 4910 CAMP RD | STE 100 | HAMBURG | NY | 14075-2617 | ||||||||||
Affiliated | 5909 | FORT WAYNE HOME AT HOME | DNVO-Fort Wayne Home At Home | 3124 E STATE BLVD | STE 5B | FORT WAYNE | IN | 46805-4763 | ||||||||||
Affiliated | 5910 | FORT WAYNE WEST AT HOME | DNVO JV-Fort Wayne West At Home | 4916 ILLINOIS RD | STE 118 | FORT WAYNE | IN | 46804-5116 | ||||||||||
Affiliated | 5913 | WINCHESTER AT HOME | Winchester At Home | 2301 VALOR DR | WINCHESTER | VA | 22601-6111 | |||||||||||
Affiliated | 5914 | MARSHFIELD AT HOME | Marshfield At Home | 123 NORTHRIDGE ST | MARSHFIELD | WI | 54449-8341 | |||||||||||
Affiliated | 5915 | MOSCOW AT HOME | Moscow At Home | 212 RODEO DR | STE 110 | MOSCOW | ID | 83843-9791 | ||||||||||
Affiliated | 5919 | AVON AT HOME | Avon At Home | 9210 ROCKVILLE RD | STE D | INDIANAPOLIS | IN | 46234-2670 | ||||||||||
Affiliated | 5923 | NORTHSIDE AT HOME | Northside At Home | 320 E NORTH AVE | 4TH FLOOR SOUTH TOWER | PITTSBURGH | PA | 15212-4756 | ||||||||||
Affiliated | 5926 | PANAMA CITY AT HOME | Panama City At Home | 615 HIGHWAY 231 | PANAMA CITY | FL | 32405-4704 | |||||||||||
Affiliated | 5927 | MAGNOLIA OAKS AT HOME | Magnolia Oaks At Home (aka Hinesville, Satilla River) | 2377 HIGHWAY 196 W | BLDG A MAGNOLIA OAKS | HINESVILLE | GA | 31313-8036 | ||||||||||
Affiliated | 5928 | WESTBANK AT HOME | Westbank At Home | 3631 BEHRMAN PL | NEW ORLEANS | LA | 70114-0906 | |||||||||||
Affiliated | 5931 | ROCKSIDE AT HOME | Rockside At Home | 4801 ACORN DR | INDEPENDENCE | OH | 44131-2566 | |||||||||||
Affiliated | 5932 | WADSWORTH AT HOME | Wadsworth At Home | 195 WADSWORTH RD STE 302 | FOUNDERS HALL 3RD FLOOR | WADSWORTH | OH | 44281-9504 | ||||||||||
Affiliated | 5933 | WOODLAWN AT HOME HHD | Woodlawn Home Program At Home | 5841 S MARYLAND AVE | RM L-026 | CHICAGO | IL | 60637-1447 | ||||||||||
Affiliated | 5934 | WESLEY CHAPEL AT HOME | Wesley Chapel At Home | 2255 GREEN HEDGES WAY | WESLEY CHAPEL | FL | 33544-8183 | |||||||||||
Affiliated | 5935 | THOUSAND OAKS AT HOME | Thousand Oaks At Home | 375 ROLLING OAKS DR | STE 100 | THOUSAND OAKS | CA | 91361-1024 | ||||||||||
Affiliated | 5936 | SIMI VALLEY AT HOME | Simi Valley At Home | 2950 SYCAMORE DR | STE 100 | SIMI VALLEY | CA | 93065-1210 | ||||||||||
Affiliated | 5937 | MIDWEST FAIRBORN AT HOME | Midwest Fairborn At Home | 1266 N BROAD ST | FAIRBORN | OH | 45324 | |||||||||||
Affiliated | 5938 | NORTH ST LOUIS COUNTY AT HOME | North St. Louis County At Home | 13119 NEW HALLS FERRY RD | FLORISSANT | MO | 63033-3228 | |||||||||||
Affiliated | 5939 | BLUEMOUND AT HOME | Bluemound At Home | 601 N 99TH ST | STE 110 | WAUWATOSA | WI | 53226 | ||||||||||
Affiliated | 5940 | MESA COUNTY AT HOME | Mesa County At Home (Grand Junction) | 561 25 RD | STE D | GRAND JUNCTION | CO | 81505-1303 | ||||||||||
Affiliated | 5942 | PLANO AT HOME | Plano At Home | 481 SHILOH RD | STE 100 | PLANO | TX | 75074-7231 |
Page 76 of 123
Affiliated | 5943 | WEST BLOOMFIELD AT HOME | West Bloomfield At Home | 6010 W MAPLE RD STE 215 | WEST BLOOMFIELD | MI | 48322-4406 | |||||||||||
Affiliated | 5945 | BINZ HOME TRAINING AT HOME | Binz Home Training At Home | 1213 HERMANN DR STE 180 | HOUSTON | TX | 77004-7070 | |||||||||||
Affiliated | 5947 | HANNIBAL AT HOME | Hannibal At Home | 3140 PALMYRA RD | HANNIBAL | MO | 63401-2204 | |||||||||||
Affiliated | 5949 | BEVERLY AT HOME | Beverly At Home | 8109 SOUTH WESTERN AVE | CHICAGO | IL | 60620-5939 | |||||||||||
Affiliated | 5950 | NORTH JACKSON AT HOME | North Jackson At Home (fka Stonegate) | 217 STERLING FARM DR | JACKSON | TN | 38305-5727 | |||||||||||
Affiliated | 5951 | PORTAGE AT HOME | Portage At Home | 5823 US HIGHWAY 6 | PORTAGE | IN | 46368-4851 | |||||||||||
Affiliated | 5952 | ROGUE VALLEY AT HOME | Rogue Valley At Home | 760 GOLF VIEW DR UNIT 100 | MEDFORD | OR | 97504-9685 | |||||||||||
Affiliated | 5953 | EVERETT AT HOME | Everett At Home | 8130 EVERGREEN WAY STE C | EVERETT | WA | 98203-6419 | |||||||||||
Affiliated | 5954 | OLYMPIA AT HOME | Olympia At Home | 335 COOPER POINT ROAD NW | SUITE 105 | OLYMPIA | WA | 98502-4436 | ||||||||||
Affiliated | 5955 | LORAIN COUNTY HOME AT HOME | DNVO-Lorain County Home At Home | 824 EAST BROAD ST | ELYRIA | OH | 44035-6559 | |||||||||||
Affiliated | 5956 | RENAISSANCE AT HOME | Renaissance At Home | 1840 DARBY DR | FLORENCE | AL | 35630-2623 | |||||||||||
Affiliated | 5957 | POOLER AT HOME | Pooler At Home | 54 TRADERS WAY | LIVE OAK PLAZA | POOLER | GA | 31322-4158 | ||||||||||
Affiliated | 5958 | GULF SHORES AT HOME | Gulf Shores At Home | 3947 GULF SHORES PKWY | UNIT 150 | GULF SHORES | AL | 36542-2735 | ||||||||||
Affiliated | 5959 | FRANKLIN AT HOME | Franklin At Home | 301 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4117 | |||||||||||
Affiliated | 5961 | RENO AT HOME | Reno At Home | 1500 EAST 2ND STREET | STE 101, 106 | RENO | NV | 89502-1189 | ||||||||||
Affiliated | 5963 | JACKSONVILLE SOUTH AT HOME | Jacksonville South At Home | 14965 OLD SAINT AUGUSTINE RD | UNIT 114 | JACKSONVILLE | FL | 32258-9481 | ||||||||||
Affiliated | 5964 | LAKE ST LOUIS AT HOME | Lake St. Louis At Home | 200 BREVCO PLZ | STE 202 | LAKE ST LOUIS | MO | 63367-2950 | ||||||||||
Affiliated | 5965 | UNION CITY AT HOME (GA) | Union City At Home (GA) | 6851 SHANNON PARKWAY | STE 200 | UNION CITY | GA | 30291-2049 | ||||||||||
Affiliated | 5966 | WEBER VALLEY AT HOME | Weber Valley At Home | 1920 W 250TH N | MARRIOTT-SLATERVILLE | UT | 84404-9233 | |||||||||||
Affiliated | 5968 | PARKER DIALYSIS CENTER | Parker At Home | 10371 S PARK GLENN WAY | STE 180 | PARKER | CO | 80138-3871 | ||||||||||
Affiliated | 5971 | KENNESTONE AT HOME | Kennestone At Home | 200 COBB PKWY N | STE 318 | MARIETTA | GA | 30062-3558 | ||||||||||
Affiliated | 5973 | NORTH COLORADO SPRINGS AT HOME | North Colorado Springs At Home | 6071 E WOODMEN RD | STE 100 | COLORADO SPRINGS | CO | 80923-2610 | ||||||||||
Affiliated | 5974 | PGH HOME MODALITY COD/HHD | Pittsburgh Home Modality Center of Excellence At Home | 5171 LIBERTY AVE | STE A | PITTSBURGH | PA | 15224-2254 | ||||||||||
Affiliated | 5977 | FRESNO AT HOME CENTER | Fresno At Home Center-HHD Only | 568 E HERNDON AVE | STE 301 | FRESNO | CA | 93720-2989 | ||||||||||
Affiliated | 5978 | BLUFF CITY AT HOME | Bluff City At Home | 2400 LUCY LEE PKWY | STE E | POPLAR BLUFF | MO | 63901-2427 | ||||||||||
Affiliated | 5979 | NORTH METRO AT HOME | North Metro At Home | 12365 HURON ST | STE 500 | WESTMINSTER | CO | 80234-3498 | ||||||||||
Affiliated | 5980 | FIVE STAR AT HOME | Five Star At Home (fka Las Vegas Multi-Care) | 2400 TECH CENTER CT | LAS VEGAS | NV | 89128-0804 | |||||||||||
Affiliated | 5981 | KIDNEY HOME AT HOME | Kidney HOME (Home Operations & Medical Education) At Home | 2245 ROLLING RUN DR | STE 3 | WINDSOR MILL | MD | 21244-1858 | ||||||||||
Affiliated | 5982 | FARGO AT HOME | Fargo At Home | 4474 23RD AVE S | STE M | FARGO | ND | 58104-8795 | ||||||||||
Affiliated | 5983 | GALLERIA HOME TRAINING AT HOME | Galleria Home Training At Home | 9045 HIGHWAY 64 | STE 102 | LAKELAND | TN | 38002-8394 | ||||||||||
Affiliated | 5986 | BELDEN COMMUNITY AT HOME | Belden Community At Home | 4685 FULTON DR NW | CANTON | OH | 44718-2379 | |||||||||||
Affiliated | 5987 | MAINPLACE AT HOME | Mainplace At Home | 972 W TOWN AND COUNTRY RD | ORANGE | CA | 92868-4714 | |||||||||||
Affiliated | 5988 | PENNSAUKEN AT HOME | Pennsauken At Home | 7024 KAIGHNS AVE | PENNSAUKEN | NJ | 08109-4417 | |||||||||||
Affiliated | 5989 | JEDBURG AT HOME | Jedburg At Home | 2897 W 5TH NORTH ST | SUMMERVILLE | SC | 29483-9674 | |||||||||||
Affiliated | 5993 | CAPE CORAL SOUTH AT HOME | Cape Coral South At Home | 3046 DEL PRADO BLVD S | STE 4A | CAPE CORAL | FL | 33904-7232 | ||||||||||
Affiliated | 5994 | GREATER TAMPA HOME AT HOME | Greater Tampa At Home | 4204 N MACDILL AVE | STE 1B NORTH BLDG | TAMPA | FL | 33607-6364 | ||||||||||
Affiliated | 5995 | ATHENS EAST AT HOME | Athens East At Home | 2026 S MILLEDGE AVE | STE A2 | ATHENS | GA | 30605-6480 | ||||||||||
Affiliated | 5996 | UNIVERSITY UNIT RIVERSIDE AT HOME | University Unit Riverside At Home | 1045 WESTGATE DR | STE 90 | SAINT PAUL | MN | 55114-1079 | ||||||||||
Affiliated | 5997 | WOODRIDGE AT HOME | Woodridge Home At Home | 7425 JANES AVE | STE 103 | WOODRIDGE | IL | 60517-2356 | ||||||||||
Affiliated | 5998 | INDY SOUTH AT HOME | Indy South At Home | 972 EMERSON PKWY | STE E | GREENWOOD | IN | 46143-6202 | ||||||||||
Affiliated | 5999 | LOCKPORT HOME AT HOME | Lockport Home Dialysis At Home | 16626 W 159TH ST | STE 703 | LOCKPORT | IL | 60441-8019 | ||||||||||
Affiliated | 6000 | CAMELBACK AT HOME HEMO | Camelback Dialysis At Home | 7321 E OSBORN DR | SCOTTSDALE | AZ | 85251-6418 | |||||||||||
Affiliated | 6002 | WEST BOUNTIFUL DIALYSIS AT HOME | West Bountiful Dialysis At Home | 724 W 500 S | STE 300 | WEST BOUNTIFUL | UT | 84087-1471 | ||||||||||
Affiliated | 6002 | WEST BOUNTIFUL DIALYSIS AT HOME | West Bountiful Dialysis At Home | 724 W 500 S | STE 300 | WEST BOUNTIFUL | UT | 84087-1471 | ||||||||||
Affiliated | 6004 | CORNERSTONE DIALYSIS AT HOME | Cornerstone Dialysis At Home | 23857 GREENFIELD RD | SOUTHFIELD | MI | 48075-3122 | |||||||||||
Affiliated | 6006 | DIALYSIS CARE OF MOORE COUNTY AT HOME | Dialysis Care of Moore County At Home (aka Pinehurst) | 16 REGIONAL DR | PINEHURST | NC | 28374-8850 | |||||||||||
Affiliated | 6007 | HOME DIALYSIS AT HOME | Home Dialysis At Home (Minneapolis) | 825 S 8TH ST | STE 1224 | MINNEAPOLIS | MN | 55404-1223 | ||||||||||
Affiliated | 6009 | ST PAUL CAPITOL DIALYSIS AT HOME | St Paul Capital Dialysis At Home | 555 PARK ST | STE 210 | SAINT PAUL | MN | 55103-2193 | ||||||||||
Affiliated | 6011 | BALLENGER PT AT HOME | Ballenger Pt. At Home | 2262 S BALLENGER HWY | FLINT | MI | 48503-3447 | |||||||||||
Affiliated | 6012 | LAKEWOOD AT HOME | Lakewood At Home | 1750 PIERCE ST | LAKEWOOD | CO | 80214-1434 | |||||||||||
Affiliated | 6013 | MED-CENTER AT HOME | Med-Center at Home | 7580 FANNIN ST | STE 230 | HOUSTON | TX | 77054-1939 | ||||||||||
Affiliated | 6014 | UTAH VALLEY DIALYSIS AT HOME | Utah Valley Dialysis At Home | 1055 N 500 W | STE 221 | PROVO | UT | 84604-3305 | ||||||||||
Affiliated | 6015 | LOWRY AT HOME | Lowry At Home | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | ||||||||||
Affiliated | 6016 | MANZANITA AT HOME | Manzanita At Home | 4005 MANZANITA AVE | STE 17 | CARMICHAEL | CA | 95608-1779 | ||||||||||
Affiliated | 6017 | FIRST COLONIAL DAVITA AT HOME | First Colonial DaVita At Home | 1157 FIRST COLONIAL RD | STE 200 | VIRGINIA BEACH | VA | 23454-2432 | ||||||||||
Affiliated | 6019 | LAKEWOOD WASHINGTON AT HOME | Lakewood Washington At Home | 5919 LAKEWOOD TOWNE CENTER BLVD SW | STE A | LAKEWOOD | WA | 98499-6513 | ||||||||||
Affiliated | 6020 | GRAPEVINE AT HOME | Grapevine At Home | 1600 W NORTHWEST HWY | STE 100 | GRAPEVINE | TX | 76051-8131 | ||||||||||
Affiliated | 6021 | GRAND RAPIDS AT HOME (CHERRY STREET) | Grand Rapids At Home (Cherry Street) | 801 CHERRY ST SE | GRAND RAPIDS | MI | 49506-1440 | |||||||||||
Affiliated | 6022 | FEDERAL WAY AT HOME | Federal Way At Home | 1015 S 348TH ST | FEDERAL WAY | WA | 98003-7078 | |||||||||||
Affiliated | 6023 | CENTURY CITY AT HOME | Century City At Home | 10630 SANTA MONICA BLVD | LOS ANGELES | CA | 90025 | |||||||||||
Affiliated | 6024 | REDDING AT HOME | Redding At Home | 1876 PARK MARINA DR | REDDING | CA | 96001-0913 | |||||||||||
Affiliated | 6025 | OLYMPIA FIELDS AT HOME | Olympia Fields At Home | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2318 | ||||||||||
Affiliated | 6026 | MT VERNON AT HOME | Mount Vernon At Home | 1800 JEFFERSON AVE | MOUNT VERNON | IL | 62864-4300 | |||||||||||
Affiliated | 6028 | YAKIMA AT HOME | Yakima At Home | 1221 N 16TH AVE | YAKIMA | WA | 98902-1347 | |||||||||||
Affiliated | 6029 | MID-COLUMBIA AT HOME | Mid Columbia At Home | 6825 BURDEN BLVD | STE A | PASCO | WA | 99301-9584 | ||||||||||
Affiliated | 6030 | GEORGETOWN ON THE POTOMAC AT HOME | Georgetown on the Potomac At Home | 3323 K STREET NW | SUITE 110 | WASHINGTON | DC | 20007 | ||||||||||
Affiliated | 6031 | SIOUX FALLS AT HOME | Sioux Falls At Home | 800 E 21ST ST | SIOUX FALLS | SD | 57105-1016 |
Page 77 of 123
Affiliated | 6032 | HILLSBORO AT HOME | Hillsboro At Home | 2500 NW 229TH AVE | STE 300 BLDG E | HILLSBORO | OR | 97124-7516 | ||||||||||
Affiliated | 6033 | PIKES PEAK AT HOME | Pikes Peak At Home | 2002 LELARAY ST | STE 130 | COLORADO SPRINGS | CO | 80909-2804 | ||||||||||
Affiliated | 6034 | WALNUT CREEK AT HOME | Walnut Creek At Home | 400 N WIGET LN | WALNUT CREEK | CA | 94598-2408 | |||||||||||
Affiliated | 6035 | SAN ANTONIO AT HOME | San Antonio At Home | 5284 MEDICAL DR | STE 100 | SAN ANTONIO | TX | 78229-4849 | ||||||||||
Affiliated | 6036 | SANTA ROSA AT HOME | Santa Rosa At Home | 5819 HIGHWAY 90 | MILTON | FL | 32583-1763 | |||||||||||
Affiliated | 6037 | DUNMORE AT HOME | Dunmore At Home | 1212 ONEILL HWY | DUNMORE | PA | 18512-1717 | |||||||||||
Affiliated | 6038 | PALMERTON AT HOME | Palmerton At Home | 185 DELAWARE AVE | STE C | PALMERTON | PA | 18071-1716 | ||||||||||
Affiliated | 6039 | LONGVIEW AT HOME | Longview At Home | 425 N FREDONIA ST | LONGVIEW | TX | 75601-6464 | |||||||||||
Affiliated | 6040 | JB ZACHARY AT HOME | JB Zachary At Home | 333 CASSELL DR | STE 2300 | BALTIMORE | MD | 21224-6815 | ||||||||||
Affiliated | 6041 | MEMPHIS EAST AT HOME | Memphis East At Home | 50 HUMPHREYS CTR | STE 28B | MEMPHIS | TN | 38120-2369 | ||||||||||
Affiliated | 6042 | PLAINFIELD AT HOME | Plainfield At Home | 1200 RANDOLPH RD | KENYAN HOUSE | PLAINFIELD | NJ | 07060-3361 | ||||||||||
Affiliated | 6045 | CHARLOTTE AT HOME | Charlotte (NC) At Home | 2321 W MOREHEAD ST | STE 102 | CHARLOTTE | NC | 28208-5145 | ||||||||||
Affiliated | 6046 | DALY CITY AT HOME | Daly City At Home | 1498 SOUTHGATE AVE | STE 101 | DALY CITY | CA | 94015-4015 | ||||||||||
Affiliated | 6047 | SALEM AT HOME | Salem At Home (OR) | 3550 LIBERTY RD S | STE 100 | SALEM | OR | 97302-5700 | ||||||||||
Affiliated | 6048 | OMAHA WEST AT HOME | Omaha West At Home | 13014 W DODGE RD | OMAHA | NE | 68154-2148 | |||||||||||
Affiliated | 6049 | TUCSON EAST AT HOME | Tucson East At Home | 6420 E BROADWAY BLVD | STE C300 | TUCSON | AZ | 85710-3512 | ||||||||||
Affiliated | 6050 | WHITE OAK AT HOME | White Oak At Home | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | ||||||||||
Affiliated | 6051 | BELPRE AT HOME | Belpre At Home | 2906 WASHINGTON BLVD | BELPRE | OH | 45714-1848 | |||||||||||
Affiliated | 6052 | BIRMINGHAM AT HOME | Birmingham At Home | 2101 7TH AVE S | BIRMINGHAM | AL | 35233-3105 | |||||||||||
Affiliated | 6053 | STAMFORD AT HOME | Stamford At Home | 30 COMMERCE RD | STAMFORD | CT | 06902-4506 | |||||||||||
Affiliated | 6054 | WHITEBRIDGE AT HOME | Whitebridge At Home | 103 WHITE BRIDGE PIKE | STE 6 | NASHVILLE | TN | 37209-4539 | ||||||||||
Affiliated | 6055 | ZANESVILLE AT HOME | Zanesville At Home | 3120 NEWARK RD | ZANESVILLE | OH | 43701-9659 | |||||||||||
Affiliated | 6056 | TYSONS CORNER AT HOME | Tysons Corner At Home | 8391 OLD COURTHOUSE RD | STE 160 | VIENNA | VA | 22182-3819 | ||||||||||
Affiliated | 6057 | BRADFORD AT HOME | Bradford At Home | 665 E MAIN ST | BRADFORD | PA | 16701-1869 | |||||||||||
Affiliated | 6059 | NORTHLAND AT HOME | Northland At Home | 2750 CLAY EDWARDS DR | STE 515 | N KANSAS CITY | MO | 64116-3258 | ||||||||||
Affiliated | 6060 | LAKE WORTH AT HOME | Lake Worth At Home | 2459 S CONGRESS AVE | STE 100 | PALM SPRINGS | FL | 33406-7616 | ||||||||||
Affiliated | 6061 | MEADVILLE AT HOME | Meadville At Home | 19050 PARK AVENUE PLZ | MEADVILLE | PA | 16335-4012 | |||||||||||
Affiliated | 6063 | WILLINGBORO AT HOME | Willingboro At Home | 230 VAN SCIVER PKWY | WILLINGBORO | NJ | 08046-1131 | |||||||||||
Affiliated | 6064 | DERENNE AT HOME | DeRenne At Home | 5303 MONTGOMERY ST | SAVANNAH | GA | 31405-5138 | |||||||||||
Affiliated | 6065 | BRUNSWICK AT HOME | Brunswick At Home | 53 SCRANTON CONNECTOR | BRUNSWICK | GA | 31525-1862 | |||||||||||
Affiliated | 6067 | AIKEN AT HOME | Aiken At Home | 775 MEDICAL PARK DR | AIKEN | SC | 29801-6306 | |||||||||||
Affiliated | 6068 | BRIDGEPORT AT HOME | Bridgeport At Home | 900 MADISON AVE | BRIDGEPORT | CT | 06606-5534 | |||||||||||
Affiliated | 6069 | ST PETERSBURG AT HOME | St Petersburg At Home | 2850 34TH ST S | ST PETERSBURG | FL | 33711-3817 | |||||||||||
Affiliated | 6070 | DENISON AT HOME | Denison At Home | 1220 REBA MACENTIRE LN | DENISON | TX | 75020-9057 | |||||||||||
Affiliated | 6072 | ATLANTIC AT HOME | Atlantic At Home | 6 INDUSTRIAL WAY W | STE B | EATONTOWN | NJ | 07724-2258 | ||||||||||
Affiliated | 6073 | NEWTOWN AT HOME | Newtown At Home (fka St. Mary) | 60 BLACKSMITH RD | NEWTOWN | PA | 18940-1847 | |||||||||||
Affiliated | 6075 | FOX RIVER AT HOME | Fox River At Home | 1910 RIVERSIDE DR | GREEN BAY | WI | 54301-2319 | |||||||||||
Affiliated | 6076 | TOKAY AT HOME | Tokay At Home | 777 S HAM LN | STE L | LODI | CA | 95242-3593 | ||||||||||
Affiliated | 6077 | CAPITAL CITY AT HOME | Capital City At Home | 307 N 46TH ST | LINCOLN | NE | 68503-3714 | |||||||||||
Affiliated | 6081 | GREATER MIAMI AT HOME | Greater Miami At Home | 160 NW 176TH ST | STE 100 | MIAMI | FL | 33169-5023 | ||||||||||
Affiliated | 6083 | EFFINGHAM AT HOME | Effingham At Home | 904 MEDICAL PARK DR | STE 1 | EFFINGHAM | IL | 62401-2193 | ||||||||||
Affiliated | 6084 | SPRINGFIELD CENTRAL AT HOME | Springfield Central At Home | 932 N RUTLEDGE ST | SPRINGFIELD | IL | 62702-3721 | |||||||||||
Affiliated | 6085 | DECATUR EAST WOOD AT HOME | Decatur East Wood At Home | 794 E WOOD ST | DECATUR | IL | 62523-1155 | |||||||||||
Affiliated | 6086 | ILLINI AT HOME | Illini At Home | 507 E UNIVERSITY AVE | CHAMPAIGN | IL | 61820-3828 | |||||||||||
Affiliated | 6087 | JANESVILLE AT HOME | Janesville At Home | 1305 WOODMAN RD | JANESVILLE | WI | 53545-1068 | |||||||||||
Affiliated | 6088 | NEW HAVEN AT HOME | New Haven At Home | 100 CHURCH ST S | STE C | NEW HAVEN | CT | 06519-1703 | ||||||||||
Affiliated | 6089 | NASHUA AT HOME | Nashua At Home | 38 TYLER ST | STE 100 | NASHUA | NH | 03060-2912 | ||||||||||
Affiliated | 6090 | EAST EVANSVILLE AT HOME | East Evansville At Home | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | |||||||||||
Affiliated | 6095 | BROOKRIVER AT HOME | Brookriver At Home | 8101 BROOKRIVER DR | DALLAS | TX | 75247-4003 | |||||||||||
Affiliated | 6098 | METRO EAST AT HOME | Metro East At Home | 5105 W MAIN ST | BELLEVILLE | IL | 62226-4728 | |||||||||||
Affiliated | 6099 | MARION AT HOME | Marion At Home | 324 S 4TH ST | MARION | IL | 62959-1241 | |||||||||||
Affiliated | 6100 | ROXBURY AT HOME | Roxbury At Home | 622 ROXBURY RD | ROCKFORD | IL | 61107-5089 | |||||||||||
Affiliated | 6101 | SYCAMORE AT HOME | Sycamore At Home | 2200 GATEWAY DR | SYCAMORE | IL | 60178-3113 | |||||||||||
Affiliated | 6103 | WESTVIEW AT HOME | Westview At Home | 3749 COMMERCIAL DR | STE B | INDIANAPOLIS | IN | 46222-1676 | ||||||||||
Affiliated | 6105 | OCALA AT HOME | Ocala At Home | 2860 SE 1ST AVE | OCALA | FL | 34471-0406 | |||||||||||
Affiliated | 6106 | COMPLETE CARE AT HOME | Complete Care At Home | 7850 W SAMPLE RD | MARGATE | FL | 33065-4710 | |||||||||||
Affiliated | 6107 | INTERAMERICAN AT HOME | InterAmerican At Home | 7815 CORAL WAY | STE 115 | MIAMI | FL | 33155-6541 | ||||||||||
Affiliated | 6109 | PURCELLVILLE AT HOME | Purcellville At Home | 280 N HATCHER AVE | PURCELLVILLE | VA | 20132-3193 | |||||||||||
Affiliated | 6110 | TABLE ROCK AT HOME | Table Rock At Home | 5610 GAGE ST | STE B | BOISE | ID | 83706 | ||||||||||
Affiliated | 6111 | TWIN FALLS AT HOME | Twin Falls At Home | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | |||||||||||
Affiliated | 6113 | FOUR RIVERS AT HOME | Four Rivers At Home | 515 EAST LN | ONTARIO | OR | 97914-3953 | |||||||||||
Affiliated | 6114 | OLYMPIC VIEW AT HOME | Olympic View At Home | 125 16TH AVE E | FL 5 | SEATTLE | WA | 98112-5211 | ||||||||||
Affiliated | 6115 | SPIVEY AT HOME | Spivey At Home | 1423 STOCKBRIDGE RD | STE B | JONESBORO | GA | 30236-3740 | ||||||||||
Affiliated | 6116 | EAST DES MOINES AT HOME | East Des Moines At Home | 1301 PENNSYLVANIA AVE | STE 208 | DES MOINES | IA | 50316-2365 | ||||||||||
Affiliated | 6118 | KETTERING AT HOME | Kettering At Home | 5721 BIGGER RD | KETTERING | OH | 45440-2752 | |||||||||||
Affiliated | 6119 | CITRUS VALLEY AT HOME | Citrus Valley At Home | 894 HARDT ST | SAN BERNARDINO | CA | 92408-2854 | |||||||||||
Affiliated | 6124 | MERIDIAN PARK AT HOME | Meridian Park At Home | 19255 SW 65TH AVE | STE 100 | TUALATIN | OR | 97062-9712 |
Page 78 of 123
Affiliated | 6125 | MARYVILLE AT HOME | Maryville At Home | 2136B VADALABENE DR | MARYVILLE | IL | 62062-5632 | |||||||||||
Affiliated | 6128 | PDI-WORCESTER AT HOME | PDI-Worcester At Home | 19 GLENNIE ST | STE A | WORCESTER | MA | 01605-3918 | ||||||||||
Affiliated | 6129 | PDI-ROCKY HILL AT HOME | PDI-Rocky Hill At Home | 30 WATERCHASE DR | ROCKY HILL | CT | 06067-2110 | |||||||||||
Affiliated | 6133 | WICHITA AT HOME | Wichita At Home | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | |||||||||||
Affiliated | 6134 | ASHEVILLE KIDNEY AT HOME | Asheville Kidney At Home | 1600 CENTERPARK DR | ASHEVILLE | NC | 28805-6206 | |||||||||||
Affiliated | 6136 | STRONGSVILLE AT HOME | Strongsville At Home | 17792 PEARL RD | STRONGSVILLE | OH | 44136-6909 | |||||||||||
Affiliated | 6137 | BATON ROUGE AT HOME | DSI Divest-Baton Rouge At Home | 3888 NORTH BLVD | STE 101 | BATON ROUGE | LA | 70806-3824 | ||||||||||
Affiliated | 6138 | WEST BROADWAY DIALYSIS AT HOME | West Broadway At Home | 720 W BROADWAY | STE 200 | LOUISVILLE | KY | 40202-3245 | ||||||||||
Affiliated | 6140 | BRONX AT HOME | Bronx At Home | 1615 EASTCHESTER RD | BRONX | NY | 10461-2603 | |||||||||||
Affiliated | 6142 | CLEVE HILL AT HOME | Cleve Hill At Home | 1461 KENSINGTON AVE | BUFFALO | NY | 14215-1436 | |||||||||||
Affiliated | 6144 | WHITE PLAINS AT HOME | White Plains At Home | 200 HAMILTON AVE | STE 13B | WHITE PLAINS | NY | 10601-1859 | ||||||||||
Affiliated | 6146 | LAKE VILLA AT HOME | Lake Villa At Home | 37809 N IL ROUTE 59 | LAKE VILLA | IL | 60046-7332 | |||||||||||
Affiliated | 6148 | TULSA AT HOME | Tulsa At Home | 4436 S HARVARD AVE | TULSA | OK | 74135-2605 | |||||||||||
Affiliated | 6151 | LITHONIA AT HOME | Lithonia At Home | 2485 PARK CENTRAL BLVD | DECATUR | GA | 30035-3902 | |||||||||||
Affiliated | 6152 | LANHAM AT HOME | Lanham At Home | 8855 ANNAPOLIS RD | STE 200 | LANHAM | MD | 20706-2919 | ||||||||||
Affiliated | 6153 | HAMMOND AT HOME | Hammond At Home | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 | |||||||||||
Affiliated | 6156 | UNION CITY CENTER AT HOME (CA) | Union City Center At Home (CA) | 32930 ALVARADO NILES RD | STE 300 | UNION CITY | CA | 94587-8101 | ||||||||||
Affiliated | 6157 | CHICO AT HOME | Chico At Home | 530 COHASSET RD | CHICO | CA | 95926-2212 | |||||||||||
Affiliated | 6158 | MONTCLAIR AT HOME | Montclair At Home | 5050 PALO VERDE ST | STE 100 | MONTCLAIR | CA | 91763-2333 | ||||||||||
Affiliated | 6161 | PDI - LANCASTER AT HOME | PDI-Lancaster At Home | 1412 E KING ST | LANCASTER | PA | 17602-3240 | |||||||||||
Affiliated | 6162 | PDI JOHNSTOWN AT HOME | PDI-Johnstown At Home | 344 BUDFIELD ST | JOHNSTOWN | PA | 15904-3214 | |||||||||||
Affiliated | 6163 | CAMP HILL AT HOME | Camp Hill At Home | 425 N 21ST ST | PLAZA 21 BLDG 1ST FL | CAMP HILL | PA | 17011-2202 | ||||||||||
Affiliated |
6164 | PDI MONTGOMERY AT HOME | PDI-Montgomery At Home | 1001 FOREST AVE | MONTGOMERY | AL | 36106-1181 | |||||||||||
Affiliated | 6165 | FAIRFAX AT HOME | Fairfax At Home | 8501 ARLINGTON BLVD | STE 100 | FAIRFAX | VA | 22031-4625 | ||||||||||
Affiliated | 6170 | WEST SACRAMENTO AT HOME | West Sacramento At Home | 3450 INDUSTRIAL BLVD | STE 100 | WEST SACRAMENTO | CA | 95691-5003 | ||||||||||
Affiliated | 6171 | EAST MACON AT HOME | East Macon At Home | 165 EMERY HWY | STE 101 | MACON | GA | 31217-3666 | ||||||||||
Affiliated | 6178 | GERMANTOWN AT HOME | Germantown At Home | 20111 CENTURY BLVD | STE C | GERMANTOWN | MD | 20874-9165 | ||||||||||
Affiliated | 6180 | SEDC-WILMINGTON AT HOME | SEDC-Wilmington (NC) At Home | 2215 YAUPON DR | WILMINGTON | NC | 28401-7334 | |||||||||||
Affiliated | 6182 | HERMISTON COMMUNITY AT HOME | Hermiston Community At Home | 1155 W LINDA AVE | HERMISTON | OR | 97838-9601 | |||||||||||
Affiliated | 6183 | SHREVEPORT HHD LA | Shreveport Home Dialysis At Home | 1560 IRVING PL | SHREVEPORT | LA | 71101-4604 | |||||||||||
Affiliated | 6184 | DOWNTOWN SAN ANTONIO AT HOME | Downtown San Antonio At Home | 615 E QUINCY ST | SAN ANTONIO | TX | 78212 | |||||||||||
Affiliated | 6186 | COLUMBIA MO AT HOME | RTC-Columbia (MO) At Home | 1701 E BROADWAY | STE G102 | COLUMBIA | MO | 65201-8029 | ||||||||||
Affiliated | 6188 | REGENCY AT HOME | Regency At Home (fka Jacksonville) | 9535 REGENCY SQUARE BLVD N | JACKSONVILLE | FL | 32225-8128 | |||||||||||
Affiliated | 6193 | WEST GEORGIA AT HOME | West Georgia At Home (fka Columbus (GA)) | 1216 STARK AVE | COLUMBUS | GA | 31906-2500 | |||||||||||
Affiliated | 6194 | BUFORD AT HOME | Buford At Home | 1550 BUFORD HWY | STE 1E | BUFORD | GA | 30518-3666 | ||||||||||
Affiliated | 6195 | KALAMAZOO WEST AT HOME | Kalamazoo West At Home | 1040 N 10TH ST | KALAMAZOO | MI | 49009-6149 | |||||||||||
Affiliated | 6196 | SOUTH VALLEY AT HOME | South Valley At Home | 17815 VENTURA BLVD | STE 100 | ENCINO | CA | 91316-3600 | ||||||||||
Affiliated | 6204 | QUEENS VILLAGE AT HOME | Queens Village At Home | 22202 HEMPSTEAD AVE | STE 170 | QUEENS VILLAGE | NY | 11429-2123 | ||||||||||
Affiliated | 6207 | LANSING AT HOME-MI | Lansing Home Hemodialysis At Home | 1675 WATERTOWER PL | STE 700 | EAST LANSING | MI | 48823-6397 | ||||||||||
Affiliated | 6208 | SOUTH COUNTY AT HOME | South County At Home (Deaconess) | 4145 UNION RD | SAINT LOUIS | MO | 63129-1064 | |||||||||||
Affiliated | 6211 | TACOMA AT HOME | Tacoma At Home | 3401 S 19TH ST | TACOMA | WA | 98405-1909 | |||||||||||
Affiliated | 6213 | CEDAR PARK AT HOME | Cedar Park At Home (fka North Austin) | 1720 E WHITESTONE BLVD | CEDAR PARK | TX | 78613-7640 | |||||||||||
Affiliated | 6214 | SOUTH FORT WORTH DIALYSIS AT HOME | South Fort Worth At Home | 6260 SOUTHWEST BLVD | BENBROOK | TX | 76109-6906 | |||||||||||
Affiliated | 6215 | THE WOODLANDS AT HOME | DNVO-The Woodlands At Home | 9301 PINECROFT DR | SHENANDOAH | TX | 77380-3179 | |||||||||||
Affiliated | 6218 | ARROWHEAD LAKES AT HOME | Arrowhead Lakes At Home | 20325 N 51ST AVE | STE 184 BLDG 11 | GLENDALE | AZ | 85308-4625 | ||||||||||
Affiliated | 6220 | COLUMBUS WEST HOME TRAINING | Columbus West Home Training At Home | 1391 GEORGESVILLE RD | COLUMBUS | OH | 43228-3611 | |||||||||||
Affiliated | 6221 | RICHMOND KIDNEY CENTER AT HOME | Richmond Kidney Center At Home (Staten Island) | 1366 VICTORY BLVD | STATEN ISLAND | NY | 10301-3907 | |||||||||||
Affiliated | 6225 | DIALYSIS CARE OF KANNAPOLIS AT HOME | Dialysis Care of Kannapolis At Home | 1607 N MAIN ST | KANNAPOLIS | NC | 28081-2317 | |||||||||||
Affiliated | 6226 | BUTLER-FARM AT HOME | Butler Farm At Home | 501 BUTLER FARM RD | STE A | HAMPTON | VA | 23666-1777 | ||||||||||
Affiliated | 6228 | NEW PORT RICHEY AT HOME | New Port Richey Kidney At Home | 7421 RIDGE RD | PORT RICHEY | FL | 34668-6933 | |||||||||||
Affiliated | 6229 | GRAND HOME AT HOME | Grand Home At Home | 14674 W MOUNTAIN VIEW BLVD | STE 204 | SURPRISE | AZ | 85374-2708 | ||||||||||
Affiliated | 6230 | WILLIAMSBURG AT HOME | Williamsburg At Home (fka Yorktown) | 500 SENTARA CIR | STE 103 | WILLIAMSBURG | VA | 23188-5727 | ||||||||||
Affiliated | 6231 | BALDWIN COUNTY AT HOME | Home Dialysis Options of Baldwin County At Home | 27880 N MAIN ST | STE A | DAPHNE | AL | 36526-7080 | ||||||||||
Affiliated | 6232 | CLINTON TOWNSHIP AT HOME | Clinton Township at Home | 15918 19 MILE RD | STE 110 | CLINTON TOWNSHIP | MI | 48038-1101 | ||||||||||
Affiliated | 6233 | GROSSE POINTE AT HOME | Grosse Pointe At Home | 18000 E WARREN AVE | STE 100 | DETROIT | MI | 48224-1336 | ||||||||||
Affiliated | 6234 | GREENSBURG AT HOME | Greensburg At Home | 1531 N COMMERCE EAST DR | STE 6 | GREENSBURG | IN | 47240-3259 | ||||||||||
Affiliated | 6236 | GULF BREEZE AT HOME | Gulf Breeze At Home | 1519 MAIN ST | DUNEDIN | FL | 34698-4650 | |||||||||||
Affiliated | 6237 | JACKSONVILLE CENTRAL AT HOME | Jacksonville Central At Home | 400 T P WHITE DR | JACKSONVILLE | AR | 72076-3287 | |||||||||||
Affiliated | 6238 | SAN JOSE AT HOME | San Jose At Home (Freestanding) | 4400 STEVENS CREEK BLVD | STE 50 | SAN JOSE | CA | 95129-1104 | ||||||||||
Affiliated | 6243 | ORLANDO AT HOME | Orlando At Home (0178) | 14050 TOWN LOOP BLVD | STE 104B | ORLANDO | FL | 32837-6190 | ||||||||||
Affiliated | 6244 | KENNEDY HOME DIALYSIS-AT HOME | Kennedy Home Dialysis-At Home | 5509 N CUMBERLAND AVE | STE 515 | CHICAGO | IL | 60656-4702 | ||||||||||
Affiliated | 6245 | YPSILANTI AT HOME | Ypsilanti At Home | 2762 WASHTENAW RD | YPSILANTI | MI | 48197-1506 | |||||||||||
Affiliated | 6246 | JACKSONVILLE AT HOME | SEDC (NC II) Jacksonville At Home | 14 OFFICE PARK DR | JACKSONVILLE | NC | 28546-7325 | |||||||||||
Affiliated | 6247 | LEBANON AT HOME | Lebanon At Home | 918 COLUMBUS AVE | STE 2 UNIT B | LEBANON | OH | 45036-1402 | ||||||||||
Affiliated | 6248 | SLIDELL KIDNEY CARE AT HOME | Slidell Kidney Care At Home | 1150 ROBERT BLVD | STE 240 | SLIDELL | LA | 70458-2005 | ||||||||||
Affiliated | 6249 | WATERBURY AT HOME | Waterbury At Home | 150 MATTATUCK HEIGHTS RD | WATERBURY | CT | 06705-3893 | |||||||||||
Affiliated | 6251 | WHITE LANE AT HOME | White Lane At Home | 7701 WHITE LN | STE D | BAKERSFIELD | CA | 93309-0201 |
Page 79 of 123
Affiliated | 6253 | HANFORD AT HOME | Hanford At Home | 900 N DOUTY ST | HANFORD | CA | 93230-3918 | |||||||||||
Affiliated | 6254 | ANAHEIM AT HOME | Anaheim At Home | 1107 W LA PALMA AVE | ANAHEIM | CA | 92801-2804 | |||||||||||
Affiliated | 6255 | MERCED AT HOME | Merced At Home | 3150 NORTH G ST | STE B | MERCED | CA | 95340-1346 | ||||||||||
Affiliated | 6257 | ST JOSEPH AT HOME | St. Joseph At Home | 5514 CORPORATE DR | STE 100 | SAINT JOSEPH | MO | 64507-7752 | ||||||||||
Affiliated | 6258 | CENTRAL LITTLE ROCK AT HOME | Central Little Rock At Home | 5800 W 10TH ST | STE 510 | LITTLE ROCK | AR | 72204-1760 | ||||||||||
Affiliated | 6260 | DURHAM WEST AT HOME | Durham West At Home | 4307 WESTERN PARK PL | STE 101 | DURHAM | NC | 27705-1204 | ||||||||||
Affiliated | 6262 | TOLEDO AT HOME | Toledo At Home | 1614 S BYRNE RD | TOLEDO | OH | 43614-3464 | |||||||||||
Affiliated | 6263 | HIOAKS AT HOME | Hioaks At Home | 681 HIOAKS RD | STE D | RICHMOND | VA | 23225-4043 | ||||||||||
Affiliated | 6264 | ELIZABETH AT HOME | Elizabeth At Home | 201 MCKEESPORT RD | ELIZABETH | PA | 15037-1623 | |||||||||||
Affiliated | 6265 | ABINGTON AT HOME | Abington At Home | 3940A COMMERCE AVE | WILLOW GROVE | PA | 19090-1705 | |||||||||||
Affiliated | 6267 | NORTH ORANGEBURG AT HOME | North Orangeburg At Home | 124 FIRE TOWER RD | ORANGEBURG | SC | 29118-1401 | |||||||||||
Affiliated | 6268 | DEARBORN HOME DIALYSIS - AT HOME | Dearborn Home Dialysis-At Home | 22030 PARK ST | DEARBORN | MI | 48124-2854 | |||||||||||
Affiliated | 6269 | OCEAN SPRINGS AT HOME | Ocean Springs At Home | 13150 PONCE DEL LEON | OCEAN SPRINGS | MS | 39564-2460 | |||||||||||
Affiliated | 6270 | HAKC - HUNTINGTON AT HOME | HAKC-Huntington At Home | 256 BROADWAY | HUNTINGTON STATION | NY | 11746-1403 | |||||||||||
Affiliated | 6271 | 42ND ST AT HOME | Philadelphia 42nd Street At Home | 4126 WALNUT ST | PHILADELPHIA | PA | 19104-3511 | |||||||||||
Affiliated | 6275 | CHARLOTTESVILLE NORTH AT HOME | Charlottesville North At Home | 1800 TIMBERWOOD BLVD | STE C | CHARLOTTESVILLE | VA | 22911-7544 | ||||||||||
Affiliated | 6276 | HEARTLAND AT HOME | Heartland At Home | 925 NE 8TH ST | OKLAHOMA CITY | OK | 73104-5800 | |||||||||||
Affiliated | 6278 | LAKELAND SOUTH AT HOME | Lakeland South At Home | 5050 S FLORIDA AVE | STE 1 | LAKELAND | FL | 33813-2501 | ||||||||||
Affiliated | 6282 | RAINBOW CITY AT HOME | Rainbow City At Home | 2800 RAINBOW DR | RAINBOW CITY | AL | 35906-5811 | |||||||||||
Affiliated | 6283 | ATHENS AT HOME | Athens At Home | 15953 ATHENS LIMESTONE DR | STE 15 | ATHENS | AL | 35613-2214 | ||||||||||
Affiliated | 6284 | SYLACAUGA AT HOME | Sylacauga At Home | 331 JAMES PAYTON BLVD | SYLACAUGA | AL | 35150 | |||||||||||
Affiliated | 6287 | PITTSBURGH AT HOME | Pittsburgh At Home | 4312 PENN AVE | PITTSBURGH | PA | 15224-1310 | |||||||||||
Affiliated | 6289 | RADNOR AT HOME | Radnor At Home | 250 KING OF PRUSSIA RD | RADNOR | PA | 19087-5220 | |||||||||||
Affiliated | 6291 | RADFORD AT HOME | Radford At Home | 600 E MAIN ST | STE B | RADFORD | VA | 24141-1826 | ||||||||||
Affiliated | 6292 | HARRISONBURG AT HOME | Harrisonburg At Home | 871 CANTRELL AVE | STE 100 | HARRISONBURG | VA | 22801-4323 | ||||||||||
Affiliated | 6293 | KERRVILLE AT HOME | Kerrville At Home | 515 GRANADA PL | KERRVILLE | TX | 78028-5992 | |||||||||||
Affiliated | 6294 | WEST TALLAHASSEE AT HOME | West Tallahassee At Home | 2645 W TENNESSEE ST | STE 8 | TALLAHASSEE | FL | 32304-2521 | ||||||||||
Affiliated | 6295 | ROME AT HOME | Rome At Home | 15 JOHN MADDOX DR NW | ROME | GA | 30165-1413 | |||||||||||
Affiliated | 6297 | ST LOUIS WEST AT HOME | St. Louis West At Home | 450 N LINDBERGH BLVD | STE 100C | CREVE COEUR | MO | 63141-7858 | ||||||||||
Affiliated | 6298 | COOKEVILLE AT HOME | Cookeville At Home | 140 W 7TH ST | COOKEVILLE | TN | 38501-1726 | |||||||||||
Affiliated | 6300 | DOTHAN AT HOME | Dothan At Home | 216 GRACELAND DR | DOTHAN | AL | 36305-7346 | |||||||||||
Affiliated | 6302 | HENRICO COUNTY AT HOME | Henrico County At Home | 5270 CHAMBERLAYNE RD | RICHMOND | VA | 23227-2950 | |||||||||||
Affiliated | 6303 | WEYMOUTH CLINIC AT HOME | Weymouth At Home | 330 LIBBEY INDUSTRIAL PKWY | STE 900 | WEYMOUTH | MA | 02189-3122 | ||||||||||
Affiliated | 6304 | ERIE AT HOME | Erie At Home | 350 E BAYFRONT PKWY | STE A | ERIE | PA | 16507-2410 | ||||||||||
Affiliated | 6305 | WILSON AT HOME | Wilson At Home | 1605 MEDICAL PARK DR W | WILSON | NC | 27893-2799 | |||||||||||
Affiliated | 6306 | NORTH FULTON AT HOME | North Fulton At Home | 1250 NORTHMEADOW PKWY | STE 120 | ROSWELL | GA | 30076-4914 | ||||||||||
Affiliated | 6311 | BRADENTON AT HOME | Bradenton At Home | 3501 CORTEZ RD W | STE 104 | BRADENTON | FL | 34210-3104 | ||||||||||
Affiliated | 6312 | COLUMBIA UNIVERSITY AT HOME | Columbia University At Home | 60 HAVEN AVENUE | NEW YORK | NY | 10032-2604 | |||||||||||
Affiliated | 6313 | NEW BEDFORD AT HOME | New Bedford At Home | 524 UNION ST | NEW BEDFORD | MA | 02740-3546 | |||||||||||
Affiliated | 6314 | MUSKEGON AT HOME | Muskegon At Home | 1277 MERCY DR | MUSKEGON | MI | 49444-4605 | |||||||||||
Affiliated | 6315 | WELLINGTON CIRCLE AT HOME | Wellington Circle At Home | 10 CABOT RD | STE 103B | MEDFORD | MA | 02155-5173 | ||||||||||
Affiliated | 6316 | FREDERICK AT HOME | Frederick At Home | 140 THOMAS JOHNSON DR | STE 100 | FREDERICK | MD | 21702-4475 | ||||||||||
Affiliated | 6317 | SELINSGROVE AT HOME | Selinsgrove At Home | 1030 N SUSQUEHANNA TRL | SELINSGROVE | PA | 17870-7767 | |||||||||||
Affiliated | 6318 | LAKE CHARLES SOUTHWEST AT HOME | Lake Charles Southwest At Home | 300 18th ST | LAKE CHARLES | LA | 70601-7342 | |||||||||||
Affiliated | 6319 | LENEXA AT HOME | Lenexa At Home | 8630 HALSEY ST | LENEXA | KS | 66215-2880 | |||||||||||
Affiliated | 6321 | NASHVILLE HOME TRAINING AT HOME | Nashville Home Training At Home | 1919 CHARLOTTE AVE | STE 200 | NASHVILLE | TN | 37203-2245 | ||||||||||
Affiliated | 6322 | GOLDSBORO AT HOME | Goldsboro At Home | 2609 HOSPITAL RD | GOLDSBORO | NC | 27534-9424 | |||||||||||
Affiliated | 6323 | MIAMI CAMPUS AT HOME | Miami Campus At Home | 1500 NW 12TH AVE | STE 106 | MIAMI | FL | 33136-1028 | ||||||||||
Affiliated | 6324 | DAYTONA BEACH AT HOME | Daytona Beach At Home | 578 HEALTH BLVD | DAYTONA BEACH | FL | 32114-1492 | |||||||||||
Affiliated | 6325 | GRASS VALLEY AT HOME | Grass Valley At Home | 360 CROWN POINT CIR | STE 210 | GRASS VALLEY | CA | 95945-2543 | ||||||||||
Affiliated | 6326 | POMONA AT HOME | Pomona At Home | 2111 NORTH GAREY AVENUE | POMONA | CA | 91767 | |||||||||||
Affiliated | 6327 | MID ATLANTA HOME AT HOME | MidAtlanta Home At Home | 418 DECATUR ST SE | SUITE B | ATLANTA | GA | 30312-1801 | ||||||||||
Affiliated | 6328 | MARTINSVILLE AT HOME | Martinsville Dialysis | 33 BRIDGE ST S | MARTINSVILLE | VA | 24112-6214 | |||||||||||
Affiliated | 6329 | HUBBARD ROAD AT HOME | Hubbard Road At Home | 1963 HUBBARD RD | MADISON | OH | 44057 | |||||||||||
Affiliated | 6350 | PLAINFIELD RENAL CENTER AT HOME | Plainfield Renal At Home (P278) | 8110 NETWORK DR | PLAINFIELD | IN | 46168-9024 | |||||||||||
Affiliated | 6351 | NORTH ANDOVER RENAL CENTER AT HOME | North Andover Renal At Home (P178) | 201 SUTTON ST | NORTH ANDOVER | MA | 1845 | |||||||||||
Affiliated | 6352 | JACKSON NORTH DIALYSIS AT HOME | Jackson North At Home (P181) | 571 BEASLEY RD | STE B | JACKSON | MS | 39206-3042 | ||||||||||
Affiliated | 6353 | SUMMIT RENAL AT HOME | Summit Renal At Home (P186) | 73 MASSILLON RD | AKRON | OH | 44312-1028 | |||||||||||
Affiliated | 6354 | MARLTON DIALYSIS AT HOME | Marlton At Home (P200) | 769 E RTE 70 | MARLTON | NJ | 08053-2341 | |||||||||||
Affiliated | 6355 | CENTRAL FORT WAYNE DIALYSIS AT HOME | Central Fort Wayne At Home (P223) | 1940 BLUFTON RD | FORT WAYNE | IN | 46809-1307 | |||||||||||
Affiliated | 6356 | LAS CRUCES RENAL CENTER AT HOME | Las Cruces Renal At Home (P237) | 3961 E LOHMAN AVE | STE 29 | LAS CRUCES | NM | 88011-8272 | ||||||||||
Affiliated | 6357 | NORTHEAST PORTLAND RENAL CENTER AT HOME | Northeast Portland Renal At Home (P240) | 703 NE HANCOCK ST | PORTLAND | OR | 97212-3955 | |||||||||||
Affiliated | 6358 | KANSAS CITY RENAL CENTER AT HOME | Kansas City Renal At Home (P264) | 4333 MADISON AVE | KANSAS CITY | MO | 64111-3429 | |||||||||||
Affiliated | 6359 | COASTAL DIALYSIS AT HOME | South Texas Renal At Home (P257) | 4300 S PADRE ISLAND DR | CORPUS CHRISTI | TX | 78411-4433 | |||||||||||
Affiliated | 6360 | NORTH SPOKANE RENAL CENTER AT HOME | North Spokane Renal At Home (P262) | 12610 E MARIBEAU PRKWY | STE 100 | SPOKANE | WA | 99216 | ||||||||||
Affiliated | 5659 | TEMPE DIALYSIS PD | Tempe Dialysis Center PD | 2149 EAST WARNER RD | STE 109 | TEMPE | AZ | 85284-3496 | ||||||||||
Affiliated | 5660 | ARROWHEAD LAKES DIALYSIS PD | Arrowhead Lakes Dialysis PD | 20325 N 51ST AVE | BLDG 11, STE 184 | GLENDALE | AZ | 85308-4625 |
Page 80 of 123
Affiliated | 5916 | SHAKER SQUARE AT HOME | Shaker Square At Home | 12800 SHAKER BLVD | STE 1 | CLEVELAND | OH | 44120-2004 | ||||||||||
Affiliated | 6130 | SIERRA ROSE AT HOME | Sierra Rose At Home | 685 SIERRA ROSE DR | RENO | NV | 89511-2060 | |||||||||||
Affiliated | 6217 | TEMPE AT HOME | Tempe At Home | 2149 E WARNER RD | STE 109 | TEMPE | AZ | 85284-3496 | ||||||||||
Affiliated | 6281 | TUSCALOOSA AT HOME | Tuscaloosa At Home | 805 OLD MILL ST | TUSCALOOSA | AL | 35401-7132 | |||||||||||
TEMPORARY CLOSURES | ||||||||||||||||||
(Included above are several centers that have temporarily suspended operations for a variety of reasons, but are scheduled to resume operations within the coming few months) | ||||||||||||||||||
614 | Lynwood | |||||||||||||||||
643 | Vidalia | |||||||||||||||||
3518 | Huntingdon Valley Dialysis | |||||||||||||||||
626 | Tuba City | |||||||||||||||||
903 | Littleton |
Page 81 of 123
Exhibit D
Managed Centers List
Page 82 of 123
Exhibit D
Managed Centers List
Active |
TYPE |
CTR # |
CENTER NAME |
LEGAL NAME |
ADDRESS |
ADDRESS |
CITY |
STATE |
ZIP | |||||||||
1771 |
Administrative Services | 181 | Childrens Hospital | MGD-Childrens National Medical Center | 111 MICHIGAN AVE NW | WASHINGTON | DC | 20010-2916 | ||||||||||
1772 |
Administrative Services | 1624 | Renal Care Seat Pleasant | MGD-Renal Care of Seat Pleasant | 6274 CENTRAL AVE | SEAT PLEASANT | MD | 20743 | ||||||||||
1773 |
Administrative Services | 1715 | Moses Taylor Hospital Renal Unit | Moses Taylor Hospital Renal Unit | 700 QUINCY AVE | SCRANTON | PA | 18510-1724 | ||||||||||
1774 |
Administrative Services | 3330 | Aurora Medical Group - Fond du Lac | Aurora Medical Group-Fond du Lac | 210 WISCONSIN AMERICAN DR | ATTN DAVITA DIALYSIS (WEST END OF BLDG) | FOND DU LAC | WI | 54937-2999 | |||||||||
1775 |
Administrative Services | 3331 | Aurora Medical Group - Sheboygan | Aurora Medical Group-Sheboygan | 2414 KOHLER MEMORIAL DR | SHEBOYGAN | WI | 53081-3129 | ||||||||||
1776 |
Administrative Services | 3338 | Aurora Medical Group - Lake Geneva | Aurora Medical Group-Lake Geneva | 146 E GENEVA SQ | LAKE GENEVA | WI | 53147-9694 | ||||||||||
1777 |
Administrative Services | 3555 | Aurora Medical Group - Marinette Dialysis | Aurora Medical Group-Marinette Dialysis | 4061 OLD PESHTIGO RD | MARINETTE | WI | 54143 | ||||||||||
1778 |
Administrative Services | 3607 | Aurora Medical Group - Brown County Dialysis | Aurora Medical Group-Brown County Dialysis | 1751 DECKNER AVE | GREEN BAY | WI | 54302-2630 | ||||||||||
1779 |
Administrative Services | 3641 | Aurora Medical Group - Sturgeon Bay Dialysis | Aurora Medical Group-Sturgeon Bay Dialysis | 108 S 10TH AVE | STURGEON BAY | WI | 54235-1802 | ||||||||||
1780 |
Administrative Services | 3653 | Aurora Medical Group - Oshkosh West Dialysis | Aurora Medical Group-Oshkosh West Dialysis | 855 N WESTHAVEN DR | OSHKOSH | WI | 54904-7668 | ||||||||||
1781 |
Administrative Services | 3665 | Aurora Medical Group - Manitowoc Dialysis | Aurora Medical Group-Manitowoc Dialysis | 601 REED AVE | MANITOWOC | WI | 54220-2026 | ||||||||||
1782 |
Administrative Services | 3672 | Aurora Medical Group - Wautoma Dialysis | Aurora Medical Group-Wautoma Dialysis | 900 EAST DIVISION ST | WAUTOMA | WI | 54982-6944 | ||||||||||
1783 |
Administrative Services | 1868 | Maize Dialysis | Maize Dialysis Center | 10001 GRADY AVE | MAIZE | KS | 67101 | ||||||||||
1784 |
Administrative Services | 1912 | Kidney Dialysis Center | MGD-Kidney Dialysis Center, LLC (MMG Macon) | 640 MARTIN LUTHER KING JR BLVD | MACON | GA | 31201-3206 | ||||||||||
Administrative Services | 6079 | MAGNOLIA WEST AT HOME | Magnolia West At Home | 11161 MAGNOLIA AVE | STE B | RIVERSIDE | CA | 92505-3605 | ||||||||||
Administrative Services | 1903 | Riverside PD Central NAMG | Riverside PD Central | 3660 PARK SIERRA DR | STE 18 | RIVERSIDE | CA | 92505-3071 |
Page 83 of 123
Exhibit E
Dialysis Center Committed Purchasers List
Page 84 of 123
Exhibit E
Dialysis Center Committed Purchasers List
Active |
TYPE |
CTR # |
CENTER NAME |
LEGAL NAME |
ADDRESS |
ADDRESS |
CITY |
STATE |
ZIP | |||||||||
1 |
Affiliated | 398 | Los Angeles Dialysis Center | Los Angeles Dialysis Center (LADC) | 3901 S WESTERN AVE | LOS ANGELES | CA | 90062-1112 | ||||||||||
2 |
Affiliated | 613 | Garfield | Garfield Hemodialysis Center | 118 HILLIARD AVE | MONTEREY PARK | CA | 91754-1118 | ||||||||||
3 |
Affiliated | 614 | Lynwood | Kidney Dialysis Care Unit (Lynwood) | 3600 E MARTIN LUTHER KING JR BLVD | LYNWOOD | CA | 90262-2607 | ||||||||||
4 |
Affiliated | 615 | Lakewood Dialysis-CA | Lakewood Dialysis-CA | 4611 SILVA ST | LAKEWOOD | CA | 90712-2512 | ||||||||||
5 |
Affiliated | 616 | Valley Dialysis | Valley Dialysis | 16149 HART ST | VAN NUYS | CA | 91406-3906 | ||||||||||
6 |
Affiliated | 617 | Downey Dialysis | Downey Dialysis | 8630 FLORENCE AVE | STE 1 | DOWNEY | CA | 90240-4017 | |||||||||
7 |
Affiliated | 618 | Covina Dialysis | Covina Dialysis | 1547 W GARVEY AVE N | WEST COVINA | CA | 91790-2139 | ||||||||||
8 |
Affiliated | 625 | Four Corners Farmington | Four Corners Farmington | 801 W BROADWAY | FARMINGTON | NM | 87401-5650 | ||||||||||
9 |
Affiliated | 626 | Tuba City Dialysis | Tuba City Dialysis | 500 EDGEWATER DR | PO BOX 291 | TUBA CITY | AZ | 86045-2905 | |||||||||
10 |
Affiliated | 627 | Camelback Dialysis Center | Camelback Dialysis Center (fka Scottsdale Dialysis Center) | 7321 E OSBORN DR | SCOTTSDALE | AZ | 85251-6418 | ||||||||||
11 |
Affiliated | 630 | Westbank | Westbank Chronic Renal Center | 3631 BEHRMAN PLACE | NEW ORLEANS | LA | 70114 | ||||||||||
12 |
Affiliated | 632 | Fleur de Lis | Fleur de Lis Dialysis (fka Tri-Parish) | 5555 BULLARD AVE | NEW ORLEANS | LA | 70128-3450 | ||||||||||
13 |
Affiliated | 637 | Desert Mountain | Desert Mountain Dialysis | 9220 E MOUNTAIN VIEW RD | STE 15 | SCOTTSDALE | AZ | 85258-5134 | |||||||||
14 |
Affiliated | 638 | Chinle | Chinle Dialysis | US HWY 191 | PO BOX 879 | CHINLE | AZ | 86503-0879 | |||||||||
15 |
Affiliated | 648 | Central City | Central City Dialysis Center | 1300 MURCHISON DR | STE 32 | EL PASO | TX | 79902-4840 | |||||||||
16 |
Affiliated | 651 | Federal Way | Federal Way Community Dialysis Center | 1015 S 348TH ST | FEDERAL WAY | WA | 98003-7078 | ||||||||||
17 |
Affiliated | 663 | Beverly Hills | Beverly Hills Dialysis Center | 50 N LA CIENEGA BLVD | 3RD FLOOR, STE 3 | BEVERLY HILLS | CA | 90211-2205 | |||||||||
18 |
Affiliated | 667 | Walnut Creek | Walnut Creek Dialysis Center | 404 N WIGET LN | WALNUT CREEK | CA | 94598-2408 | ||||||||||
19 |
Affiliated | 672 | Norwalk | Norwalk Dialysis Center | 12375 E IMPERIAL HWY | STE D3 | NORWALK | CA | 90650-3129 | |||||||||
20 |
Affiliated | 673 | El Monte | Greater El Monte Dialysis Center | 1938 TYLER AVE | STE J-168 | SOUTH EL MONTE | CA | 91733-3623 | |||||||||
21 |
Affiliated | 676 | Bayonet Point | Bayonet Point-Hudson Kidney | 14144 NEPHRON LN | HUDSON | FL | 34667-6504 | ||||||||||
22 |
Affiliated | 677 | New Port Richey | New Port Richey Kidney Center | 7421 RIDGE RD | PORT RICHEY | FL | 34668-6933 | ||||||||||
23 |
Affiliated | 678 | Hernando | Hernando Kidney Center, Inc | 2985 LANDOVER BLVD | SPRING HILL | FL | 34608-7258 | ||||||||||
24 |
Affiliated | 681 | Woodbridge | CDC Of Woodbridge | 2751 KILLARNEY DR | WOODBRIDGE | VA | 22192-4119 | ||||||||||
25 |
Affiliated | 682 | Manassas | CDC-Manassas Dialysis | 10655 LOMOND DR | STE 11 | MANASSAS | VA | 20109-2877 | |||||||||
26 |
Affiliated | 683 | Springfield | CDC-Springfield Dialysis | 8350 TRAFORD LN | STE A | SPRINGFIELD | VA | 22152-1671 | |||||||||
27 |
Affiliated | 684 | Sterling | CDC-Sterling | 46396 BENEDICT DR | STE 1 | STERLING | VA | 20164-6626 | |||||||||
28 |
Affiliated | 687 | Alexandria | Springfield-Alexandria | 5999 STEVENSON AVE | STE 1 | ALEXANDRIA | VA | 22304-3302 | |||||||||
29 |
Affiliated | 642 | Statesboro | Nephrology Center of Statesboro fka Statesboro Dialysis | 4B COLLEGE PLZ | STATESBORO | GA | 30458-4928 | ||||||||||
30 |
Affiliated | 643 | Vidalia | Nephrology Center of Vidalia | 1806 EDWINA DR | VIDALIA | GA | 30474-8927 | ||||||||||
31 |
Affiliated | 657 | Papago Dialysis | Papago Dialysis Center (fka PD Central & Squaw Peak) | 1401 N 24TH ST | STE 2 | PHOENIX | AZ | 85008-4638 | |||||||||
32 |
Affiliated | 658 | Boca Raton | Boca Raton Artificial Kidney Center | 998 NW 9TH CT | BOCA RATON | FL | 33486-2214 | ||||||||||
33 |
Affiliated | 644 | Piedmont | Buckhead Dialysis | 1575 NORTHSIDE DR NW | STE 365 | ATLANTA | GA | 30318-4210 | |||||||||
34 |
Affiliated | 311 | Logan Square | Logan Square Dialysis Services | 2659 N MILWAUKEE AVE | 1ST FL | CHICAGO | IL | 60647-1643 | |||||||||
35 |
Affiliated | 312 | Lake County | Lake County Dialysis Services | 918 S MILWAUKEE AVE | LIBERTYVILLE | IL | 60048-3229 | ||||||||||
36 |
Affiliated | 314 | Lincoln Park | Lincoln Park Dialysis fka Lincoln Park Nephrology | 3157 N LINCOLN AVE | CHICAGO | IL | 60657-3111 | ||||||||||
37 |
Affiliated | 318 | Lincoln Pk-PD | Skyline Home Dialysis (fka Lincoln Park PD) | 7009 W BELMONT AVE | CHICAGO | IL | 60634-4533 | ||||||||||
38 |
Affiliated | 670 | West Palm Beach | Dialysis Associates of the Palm Beaches | 2611 POINSETTIA AVE | WEST PALM BEACH | FL | 33407-5919 | ||||||||||
39 |
Affiliated | 693 | Sunrise | Sunrise Dialysis Center | 13039 HAWTHORNE BLVD | HAWTHORNE | CA | 90250-4415 | ||||||||||
40 |
Affiliated | 655 | Kayenta | Kayenta Dialysis | PO BOX 217 | US HWY 163 N | KAYENTA | AZ | 86033-0217 | |||||||||
41 |
Affiliated | 321 | Hyde Park | Emerald Dialysis (fka Hyde Park Kidney Center) | 710 W 43RD ST | CHICAGO | IL | 60609-3435 | ||||||||||
42 |
Affiliated | 322 | Olympia Fields | Olympia Fields Dialysis Center | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2318 | |||||||||
43 |
Affiliated | 351 | CKD | Center for Kidney Disease at North Shore | 1190 NW 95TH ST | STE 28 | MIAMI | FL | 33150-2065 | |||||||||
44 |
Affiliated | 352 | Venture | Center for Kidney Disease at Venture | 16855 NE 2ND AVE | STE 25 | N MIAMI BEACH | FL | 33162-1744 | |||||||||
45 |
Affiliated | 360 | South Broward | South Broward Artifical Kidney | 4401 HOLLYWOOD BLVD | HOLLYWOOD | FL | 33021-6609 | ||||||||||
46 |
Affiliated | 688 | East End | East End Dialysis Center | 2201 E MAIN ST | STE 1 | RICHMOND | VA | 23223-7071 | |||||||||
47 |
Affiliated | 354 | Flamingo Park | Flamingo Park Kidney Cntr, Inc | 901 E 10TH AVE | BAY 17 | HIALEAH | FL | 33010-3762 | |||||||||
48 |
Affiliated | 355 | Interamerican | InterAmerican Dialysis Center | 7815 CORAL WAY | STE 115 | MIAMI | FL | 33155-6541 | |||||||||
49 |
Affiliated | 356 | Coral Gables Dialysis Center | Coral Gables Kidney Center (fka LeJeune) | 3280 PONCE DE LEON BLVD | CORAL GABLES | FL | 33134-7252 | ||||||||||
50 |
Affiliated | 370 | Cielo Vista Dialysis | DaVita East Dialysis dba Cielo Vista Dialysis (fkaTotal Renal Care East Dialysis Center) | 7200 GATEWAY BLVD E | STE B | EL PASO | TX | 79915-1301 | |||||||||
51 |
Affiliated | 371 | West Texas Dialysis | DaVita West Dialysis Center dba West Texas (fkaTotal Renal Care West Dialysis Center) | 5595 ALAMEDA AVE B | STE B | EL PASO | TX | 79905 | |||||||||
52 |
Affiliated | 656 | Shiprock | Shiprock Dialysis | PO BOX 2156 | US HWY 491 N | SHIPROCK | NM | 87420-2156 | |||||||||
53 |
Affiliated | 202 | Arden Hills | Arden Hills Dialysis Unit | 3900 NORTHWOODS DR | STE 11 | ARDEN HILLS | MN | 55112-6911 | |||||||||
54 |
Affiliated | 203 | Burnsville | Burnsville Dialysis Unit | 501 E NICOLLET BLVD | STE 15 | BURNSVILLE | MN | 55337-6784 | |||||||||
55 |
Affiliated | 204 | Coon Rapids | Coon Rapids Dialysis Unit | 3960 COON RAPIDS BLVD NW | STE 39 | COON RAPIDS | MN | 55433-2598 | |||||||||
56 |
Affiliated | 205 | Edina | Edina Dialysis Unit | 6550 YORK AVE S | STE 1 | EDINA | MN | 55435-2332 | |||||||||
57 |
Affiliated | 206 | Maplewood | Maplewood Dialysis Center | 2785 WHITE BEAR AVE N | STE 21 | MAPLEWOOD | MN | 55109-1320 | |||||||||
58 |
Affiliated | 207 | Minneapolis | Minneapolis Dialysis Unit | 825 S EIGHTH ST | STE SL42 | MINNEAPOLIS | MN | 55404-1208 | |||||||||
59 |
Affiliated | 208 | Minnetonka | Minnetonka Dialysis Unit | 17809 HUTCHINS DR | MINNETONKA | MN | 55345-4100 | ||||||||||
60 |
Affiliated | 209 | St. Paul Dialysis | St. Paul Dialysis Unit | 555 PARK ST | STE 18 | SAINT PAUL | MN | 55103-2192 | |||||||||
61 |
Affiliated | 210 | Special Needs | University Dialysis Unit Riverside (Minneapolis-Special Needs Dialysis) | 1045 WESTGATE DR | STE 9 | SAINT PAUL | MN | 55114-1079 |
Page 85 of 123
62 |
Affiliated | 211 | West St. Paul | West St. Paul Dialysis | 1555 LIVINGSTON AVE | WEST ST PAUL | MN | 55118-3411 | ||||||||||
63 |
Affiliated | 213 | Cass Lake | Cass Lake Dialysis Unit | 602 GRANT UTLEY ST | PO BOX 757 | CASS LAKE | MN | 56633-0757 | |||||||||
64 |
Affiliated | 215 | Faribault | Faribault Dialysis Unit | 201 LYNDALE AVE S | STE F | FARIBAULT | MN | 55021-5758 | |||||||||
65 |
Affiliated | 217 | Marshall | Marshall Dialysis Unit | 300 S BRUCE ST | AVERA MARSHALL REGIONAL MEDICAL CENTER | MARSHALL | MN | 56258-1934 | |||||||||
66 |
Affiliated | 218 | Montevideo | Montevideo Dialysis Center | 824 N 11TH ST | MONTEVIDEO HOSPITAL | MONTEVIDEO | MN | 56265-1629 | |||||||||
67 |
Affiliated | 220 | Pine City | TRC-Pine City (fka-Pine City Dialysis Unit) | 129 6TH AVE SE | LAKESIDE MEDICAL CENTER | PINE CITY | MN | 55063-1913 | |||||||||
68 |
Affiliated | 222 | Red Wing | Red Wing Dialysis Unit | 3028 N SERVICE DR | RED WING | MN | 55066-1921 | ||||||||||
69 |
Affiliated | 223 | Redwood Falls | Redwood Falls Dialysis Center | 100 FALLWOOD RD | REDWOOD FALLS | MN | 56283-1828 | ||||||||||
70 |
Affiliated | 240 | Mitchell | Mitchell Dialysis | 525 N FOSTER | QUEEN OF PEACE HOSPITAL | MITCHELL | SD | 57301-2966 | |||||||||
71 |
Affiliated | 242 | Rosebud | Rosebud Dialysis | 1 SOLDIER CREEK RD | ROSEBUD | SD | 57570-0610 | ||||||||||
72 |
Affiliated | 243 | Sioux Falls | Sioux Falls Dialysis Community Unit | 1325 S CLIFF AVE | STE 46 | SIOUX FALLS | SD | 57105-1016 | |||||||||
73 |
Affiliated | 250 | St. Croix Falls | St. Croix Falls Dialysis | 744 E LOUISIANA ST | SAINT CROIX FALLS | WI | 54024-9501 | ||||||||||
74 |
Affiliated | 260 | Hayward | Hayward Dialysis Center | 21615 HESPERIAN BLVD | STE F | HAYWARD | CA | 94541-7026 | |||||||||
75 |
Affiliated | 262 | Pleasanton | Pleasanton Dialysis Center (HEMO) (fka Dublin) | 5720 STONERIDGE MALL RD | STE 16 | PLEASANTON | CA | 94588-2882 | |||||||||
76 |
Affiliated | 263 | Union City | Union City Dialysis Center (aka TRC-Union City) | 32930 ALVARADO NILES RD | STE 3 | UNION CITY | CA | 94587-8101 | |||||||||
77 |
Affiliated | 264 | East Bay - PD | East Bay Peritoneal Dialysis Center | 13939 E 14TH ST | STE 11 | SAN LEANDRO | CA | 94578-2613 | |||||||||
78 |
Affiliated | 383 | Greer | Greer Kidney Center | 211 VILLAGE DR | GREER | SC | 29651-1238 | ||||||||||
79 |
Affiliated | 382 | Upstate | Upstate Dialysis Center | 308 MILLS AVE | GREENVILLE | SC | 29605-4022 | ||||||||||
80 |
Affiliated | 390 | Kenner | Kenner Regional Dialysis Center | 200 W ESPLANADE AVE | STE 1 | KENNER | LA | 70065-2473 | |||||||||
81 |
Affiliated | 689 | Downtown Dialysis | Downtown Dialysis Center | 821 N EUTAW ST | STE 41 | BALTIMORE | MD | 21201-6304 | |||||||||
82 |
Affiliated | 331 | Eaton Canyon | Eaton Canyon Dialysis | 2551 E WASHINGTON BLVD | PASADENA | CA | 91107-1446 | ||||||||||
83 |
Affiliated | 190 | Georgetown | Georgetown on the Potomac | 3223 K ST NW | STE 11 | WASHINGTON | DC | 20007-4412 | |||||||||
84 |
Affiliated | 395 | St. Mary | Newtown Dialysis Center (fka St. Mary Dialysis) | 60 BLACKSMITH RD | NEWTOWN | PA | 18940-1847 | ||||||||||
85 |
Affiliated | 393 | Bertha Sirk | Bertha Sirk Dialysis Center | 5820 YORK RD | STE 1 | BALTIMORE | MD | 21212-3620 | |||||||||
86 |
Affiliated | 394 | Greenspring | Greenspring Dialysis Center | 4701 MOUNT HOPE DR | STE C | BALTIMORE | MD | 21215-3246 | |||||||||
87 |
Affiliated | 378 | Houston Kidney - NW | Northwest Kidney Center (Houston) | 11029 NORTHWEST FWY | HOUSTON | TX | 77092-7311 | ||||||||||
88 |
Affiliated | 379 | NorthStar Dialysis | NorthStar Dialysis Center (fka North Houston Kidney Center) | 380 W LITTLE YORK RD | HOUSTON | TX | 77076-1303 | ||||||||||
89 |
Affiliated | 363 | Port Charlotte | Port Charlotte Artificial Kidney Center | 4300 KINGS HWY STE 406 | PORT CHARLOTTE | FL | 33980 | ||||||||||
90 |
Affiliated | 364 | Gulf Coast PD | Gulf Coast Dialysis | 3300 TAMIAMI TRL | STE 11A | PORT CHARLOTTE | FL | 33952-8054 | |||||||||
91 |
Affiliated | 649 | Loma Vista | Loma Vista Dialysis Center Partnership | 1382 LOMALAND DR | STE A | EL PASO | TX | 79935-5204 | |||||||||
92 |
Affiliated | 332 | Paramount | Paramount Dialysis Center | 8319 ALONDRA BLVD | PARAMOUNT | CA | 90723-4403 | ||||||||||
93 |
Affiliated | 334 | East LA | Doctors Dialysis of East LA (aka East Los Angeles Dialysis) | 950 S EASTERN AVE | LOS ANGELES | CA | 90022-4801 | ||||||||||
94 |
Affiliated | 335 | Montebello | Doctors Dialysis of Montebello | 1721 W WHITTIER BLVD | MONTEBELLO | CA | 90640-4004 | ||||||||||
95 |
Affiliated | 361 | Pine Island | Pine Island Kidney Center | 1871 N PINE ISLAND RD | PLANTATION | FL | 33322-5208 | ||||||||||
96 |
Affiliated | 365 | Complete | Complete Dialysis Care | 7850 W SAMPLE RD | MARGATE | FL | 33065-4710 | ||||||||||
97 |
Affiliated | 122 | Lone Star Dialysis | Lone Star Dialysis (fka Hobby Dialysis) | 8560 MONROE RD | HOUSTON | TX | 77061-4815 | ||||||||||
98 |
Affiliated | 255 | Forest Lake | Forest Lake Dialysis | 1068 S LAKE ST | STE 11 | FOREST LAKE | MN | 55025-2633 | |||||||||
99 |
Affiliated | 690 | USC Phase II | TRC/USC Dialysis Center | 2310 ALCAZAR ST | LOS ANGELES | CA | 90033-5327 | ||||||||||
100 |
Affiliated | 396 | TRC/Union Plaza Ctr | Union Plaza Dialysis Center | 810 1ST ST NE | STE 1 | WASHINGTON | DC | 20002-4227 | |||||||||
101 |
Affiliated | 130 | Mid-Columbia Kidney | Mid Columbia Kidney Center | 6825 BURDEN BLVD | STE A | PASCO | WA | 99301-9584 | |||||||||
102 |
Affiliated | 131 | Mt. Adams Kidney Ctr | Mt. Adams Kidney Center | 3220 PICARD PL | SUNNYSIDE | WA | 98944-8400 | ||||||||||
103 |
Affiliated | 650 | Lakewood | Lakewood Community Dialysis Center | 5919 LAKEWOOD TOWNE CENTER BLVD SW | STE A | LAKEWOOD | WA | 98499-6513 | |||||||||
104 |
Affiliated | 228 | St. Paul Ramsey | St. Paul Capitol Dialysis | 555 PARK ST | STE 23 | SAINT PAUL | MN | 55103-2193 | |||||||||
105 |
Affiliated | 229 | River City Dialysis | River City Dialysis (fka Lakeview Dialysis) | 1970 NORTHWESTERN AVE S | STILLWATER | MN | 55082-6567 | ||||||||||
106 |
Affiliated | 231 | Woodbury | Woodbury Dialysis | 1850 WEIR DR | STE 3 | WOODBURY | MN | 55125-2260 | |||||||||
107 |
Affiliated | 281 | Alhambra | Alhambra Dialysis Center | 1315 ALHAMBRA BLVD | STE 1 | SACRAMENTO | CA | 95816-5245 | |||||||||
108 |
Affiliated | 282 | Antelope | Antelope Dialysis Center | 6406 TUPELO DR | STE A | CITRUS HEIGHTS | CA | 95621-1780 | |||||||||
109 |
Affiliated | 283 | Chico | Chico Dialysis Center (aka Chico Clinic) | 530 COHASSET RD | CHICO | CA | 95926-2212 | ||||||||||
110 |
Affiliated | 285 | North Clinic | Manzanita Dialysis Center (aka North Clinic) | 4005 MANZANITA AVE | STE 17 | CARMICHAEL | CA | 95608-1779 | |||||||||
111 |
Affiliated | 286 | Placerville | Cameron Park Dialysis (fka Placerville) | 3311 COACH LN | STE C | CAMERON PARK | CA | 95682 | |||||||||
112 |
Affiliated | 288 | South Sacramento | South Sacramento Dialysis Center | 7000 FRANKLIN BLVD | STE 88 | SACRAMENTO | CA | 95823-1838 | |||||||||
113 |
Affiliated | 289 | Redding | Redding Dialysis Center | 1876 PARK MARINA DR | REDDING | CA | 96001-0913 | ||||||||||
114 |
Affiliated | 291 | Yuba City | Yuba City Dialysis Center | 1525 PLUMAS CT | STE A | YUBA CITY | CA | 95991-2971 | |||||||||
115 |
Affiliated | 292 | University Clinic | University Dialysis Center | 777 CAMPUS COMMONS RD | STE 1 | SACRAMENTO | CA | 95825-8344 | |||||||||
116 |
Affiliated | 372 | Mesa Vista | Mesa Vista Dialysis Center (El Paso) | 2400 N OREGON ST | STE C | EL PASO | TX | 79902-3135 | |||||||||
117 |
Affiliated | 694 | Hollywood | Hollywood Dialysis Center | 5108 W SUNSET BLVD | LOS ANGELES | CA | 90027-5708 | ||||||||||
118 |
Affiliated | 697 | UCLA Harbor | TRC/Harbor-UCLA MFI Total Renal Dialysis Center | 21602 S VERMONT AVE | TORRANCE | CA | 90502-1940 | ||||||||||
119 |
Affiliated | 325 | Brighton | Brighton Dialysis (fka Michigan Kidney Center of Brighton) | 7960 GRAND RIVER RD | STE 21 | BRIGHTON | MI | 48114-7336 | |||||||||
120 |
Affiliated | 326 | Macomb | Macomb Kidney Center (fka Macomb Dialysis) | 28295 SCHOENHERR RD | STE A | WARREN | MI | 48088-4300 | |||||||||
121 |
Affiliated | 327 | North Oakland | North Oakland Dialysis | 450 N TELEGRAPH RD | STE 6 | PONTIAC | MI | 48341-1037 | |||||||||
122 |
Affiliated | 328 | Novi | Novi Dialysis | 47250 W 10 MILE RD | NOVI | MI | 48374-2932 | ||||||||||
123 |
Affiliated | 329 | Southfield | Cornerstone Dialysis (fka Southfield) | 23857 GREENFIELD RD | SOUTHFIELD | MI | 48075-3122 | ||||||||||
124 |
Affiliated | 319 | Childrens Meml Hosp. | TRC Childrens Dialysis Center aka Childrens Chicago/Childrens Memorial Hospital | 2611 N HALSTED ST | CHICAGO | IL | 60614-2301 | ||||||||||
125 |
Affiliated | 151 | New Center | New Center Dialysis | 3011 W GRAND BLVD | STE 65 | DETROIT | MI | 48202-3012 | |||||||||
126 |
Affiliated | 2003 | Whittier | Whittier Dialysis Center (fka Whittier Hills) | 10055 WHITTWOOD DR | WHITTIER | CA | 90603-2313 | ||||||||||
127 |
Affiliated | 357 | Miami Lakes | Miami Lakes Artificial Kidney Center (ALTHIN) | 14600 NW 60TH AVE | MIAMI LAKES | FL | 33014-2811 | ||||||||||
128 |
Affiliated | 571 | Anson County | Dialysis Care of Anson County | 923 E CASWELL ST | WADESBORO | NC | 28170-2305 |
Page 86 of 123
129 |
Affiliated | 573 | Edgecomb County | Dialysis Care of Edgecomb County | 3206 WESTERN BLVD | TARBORO | NC | 27886-1828 | ||||||||||
130 |
Affiliated | 574 | Franklin County | Dialysis Care of Franklin County | 1706 NC HWY 39 N | LOUISBURG | NC | 27549-8329 | ||||||||||
131 |
Affiliated | 575 | Hoke County | Dialysis Care of Hoke County | 403 S MAIN ST | RAEFORD | NC | 28376-3222 | ||||||||||
132 |
Affiliated | 576 | Martin County | Dialysis Care of Martin County | 100 MEDICAL DR | WILLIAMSTON | NC | 27892-2156 | ||||||||||
133 |
Affiliated | 578 | Montgomery County | Dialysis Care of Montgomery County (aka Montgomery) | 323 W MAIN ST | BISCOE | NC | 27209-9528 | ||||||||||
134 |
Affiliated | 579 | Moore County | Dialysis Care of Moore County (aka Pinehurst) | 16 REGIONAL DR | PINEHURST | NC | 28374-8850 | ||||||||||
135 |
Affiliated | 580 | Richmond County | Dialysis Care of Richmond County | 771 CHERAW RD | HAMLET | NC | 28345-7158 | ||||||||||
136 |
Affiliated | 581 | Rockingham County | Dialysis Care of Rockingham County | 251 W KINGS HWY | EDEN | NC | 27288-5009 | ||||||||||
137 |
Affiliated | 582 | Rowan County | Dialysis Care of Rowan County | 111 DORSETT DR | SALISBURY | NC | 28144-2278 | ||||||||||
138 |
Affiliated | 583 | Rutherford County | Dialysis Care of Rutherford County | 226 COMMERCIAL ST | FOREST CITY | NC | 28043-2851 | ||||||||||
139 |
Affiliated | 399 | Monterey Park | Monterey Park Dialysis Center | 2560 CORPORATE PL | STE 1-11 BLDG D | MONTEREY PARK | CA | 91754-7612 | |||||||||
140 |
Affiliated | 183 | Mason Dixon | Mason-Dixon Baltimore County | 9635-A LIBERTY RD | STE 1 | RANDALLSTOWN | MD | 21133-2436 | |||||||||
141 |
Affiliated | 184 | Carrol County | Carroll County Dialysis Facility | 412 MALCOLM DR | STE 31 | WESTMINSTER | MD | 21157-6167 | |||||||||
142 |
Affiliated | 167 | South Brooklyn | South Brooklyn Nephrology Center | 3915 AVENUE V | STE 14 | BROOKLYN | NY | 11234-5150 | |||||||||
143 |
Affiliated | 843 | Phenix City | Phenix City Dialysis Center | 1900 OPELIKA RD | PHENIX CITY | AL | 36867-3640 | ||||||||||
144 |
Affiliated | 876 | Brea | Brea Dialysis Center | 595 TAMARACK AVE | STE A | BREA | CA | 92821-3125 | |||||||||
145 |
Affiliated | 878 | Hemet | Hemet Dialysis Center | 3050 W FLORIDA AVE | HEMET | CA | 92545-3619 | ||||||||||
146 |
Affiliated | 883 | Temecula | Temecula Dialysis Center | 40945 COUNTY CENTER DR | STE G | TEMECULA | CA | 92591-6006 | |||||||||
147 |
Affiliated | 880 | Riverside | Riverside Dialysis Center | 4361 LATHAM ST | STE 1 | RIVERSIDE | CA | 92501-1767 | |||||||||
148 |
Affiliated | 870 | Napa | Napa Dialysis Center | 3900 BEL AIRE PLZ | STE C | NAPA | CA | 94558-2823 | |||||||||
149 |
Affiliated | 875 | Santa Ana | Santa Ana Dialysis Center | 1820 E DEERE AVE | SANTA ANA | CA | 92705-5721 | ||||||||||
150 |
Affiliated | 879 | Valley View Dialysis Center | Valley View Dialysis Center (aka Morneo Valley) | 26900 CACTUS AVE | MORENO VALLEY | CA | 92555-3912 | ||||||||||
151 |
Affiliated | 884 | Orange | Mainplace Dialysis Center (fka Orange Dialysis Center) | 972 W TOWN AND COUNTRY RD | ORANGE | CA | 92868-4714 | ||||||||||
152 |
Affiliated | 882 | San Bernadino | Mountain Vista Dialysis Center (fka San Bernadino Dailysis Center (Mountain Vista)) | 4041 NORTH UNIVERSITY PKWY | SAN BERNARDINO | CA | 92407-1823 | ||||||||||
153 |
Affiliated | 871 | Lakeport | Lakeport Dialysis Center | 804 11TH ST | STE 2 | LAKEPORT | CA | 95453-4102 | |||||||||
154 |
Affiliated | 873 | Vacaville | Vacaville Dialysis Center | 941 MERCHANT ST | VACAVILLE | CA | 95688-5315 | ||||||||||
155 |
Affiliated | 877 | Corona | Corona Dialysis Center | 1820 FULLERTON AVE | STE 18 | CORONA | CA | 92881-3147 | |||||||||
156 |
Affiliated | 872 | Fairfield | Fairfield Dialysis Center | 4660 CENTRAL WAY | FAIRFIELD | CA | 94534-1803 | ||||||||||
157 |
Affiliated | 902 | Westminster | Westminster Dialysis Center (Federal Heights) | 9053 HARLAN ST | STE 9 | WESTMINSTER | CO | 80031-2908 | |||||||||
158 |
Affiliated | 901 | Aurora | Aurora Dialysis Center | 1411 S POTOMAC ST | AMC II STE 1 | AURORA | CO | 80012-4536 | |||||||||
159 |
Affiliated | 900 | Denver | Denver Dialysis Center | 2900 DOWNING ST | STE C | DENVER | CO | 80205-4699 | |||||||||
160 |
Affiliated | 903 | Littleton | Littleton Dialysis Center | 209 W COUNTY LINE RD | LITTLETON | CO | 80129-1901 | ||||||||||
161 |
Affiliated | 904 | South Denver | South Denver Dialysis Center | 850 E HARVARD AVE | STE 6 | DENVER | CO | 80210-5030 | |||||||||
162 |
Affiliated | 946 | Lee Street Dialysis | Lee Street Dialysis (fka Grant Park Dialysis Center) | 5155 LEE ST NE | WASHINGTON | DC | 20019-4051 | ||||||||||
163 |
Affiliated | 868 | Leesburg | Leesburg Dialysis Center | 801 E DIXIE AVE | STE 18A | LEESBURG | FL | 34748-7699 | |||||||||
164 |
Affiliated | 866 | Panama City | Panama City Dialysis Center | 615 HIGHWAY 231 | PANAMA CITY | FL | 32405-4704 | ||||||||||
165 |
Affiliated | 867 | Marianna | Marianna Dialysis Center | 2930 OPTIMIST DR | MARIANNA | FL | 32448-7703 | ||||||||||
166 |
Affiliated | 864 | Venice | Venice Dialysis Center | 816 PINEBROOK RD | VENICE | FL | 34285-7103 | ||||||||||
167 |
Affiliated | 827 | Buena Vista | Buena Vista Dialysis Center | 349 GENEVA RD | BUENA VISTA | GA | 31803-1701 | ||||||||||
168 |
Affiliated | 828 | Decatur | Decatur Dialysis Center | 1987 CANDLER RD | DECATUR | GA | 30032-4212 | ||||||||||
169 |
Affiliated | 825 | Moultrie | Moultrie Dialysis Center | 2419 S MAIN ST | MOULTRIE | GA | 31768-6531 | ||||||||||
170 |
Affiliated | 820 | SW Atlanta | Southwest Atlanta Dialysis Center | 3620 MARTIN LUTHER KING DR SW | ATLANTA | GA | 30331-3711 | ||||||||||
171 |
Affiliated | 818 | Griffin | Griffin Dialysis Center | 731 S 8TH ST | GRIFFIN | GA | 30224-4818 | ||||||||||
172 |
Affiliated | 826 | Columbus | Columbus Dialysis Center | 6228 BRADLEY PARK DR | STE B | COLUMBUS | GA | 31904-3604 | |||||||||
173 |
Affiliated | 829 | East Macon | East Macon Dialysis Center | 165 EMERY HWY | STE 11 | MACON | GA | 31217-3666 | |||||||||
174 |
Affiliated | 817 | Jonesboro | Jonesboro Dialysis Center | 129 KING ST | JONESBORO | GA | 30236-3656 | ||||||||||
175 |
Affiliated | 824 | Milledgeville | Milledgeville Dialysis Center | 400 S WAYNE ST | MILLEDGEVILLE | GA | 31061-3446 | ||||||||||
176 |
Affiliated | 823 | Fort Valley | Fort Valley Dialysis Center | 557 BLUEBIRD BLVD | FORT VALLEY | GA | 31030-5083 | ||||||||||
177 |
Affiliated | 821 | Midtown | Linden Dialysis (fka Midtown-Atlanta) | 121 LINDEN AVE NE | ATLANTA | GA | 30308-2432 | ||||||||||
178 |
Affiliated | 953 | E. St. Louis | Sauget Dialysis (fka East St. Louis Dialysis Center) | 2061 GOOSE LAKE RD | SAUGET | IL | 62206-2822 | ||||||||||
179 |
Affiliated | 952 | Granite City | Granite City Dialysis Center | 9 AMERICAN VLG | GRANITE CITY | IL | 62040-3706 | ||||||||||
180 |
Affiliated | 937 | Batesville | Batesville Dialysis Center Aka Renal Treatment Centers-Batesville | 232 STATE ROAD 129 S | BATESVILLE | IN | 47006-7694 | ||||||||||
181 |
Affiliated | 938 | Lawrenceburg | Lawrenceburg Dialysis Center | 721 RUDOLPH WAY | GREENDALE | IN | 47025-8378 | ||||||||||
182 |
Affiliated | 939 | Madison | Madison Dialysis Center | 220 CLIFTY DR | UNIT K | MADISON | IN | 47250-1669 | |||||||||
183 |
Affiliated | 836 | Newton | Renal Treatment Center-Newton aka-Newton Dialysis Center | 1223 WASHINGTON RD | NEWTON | KS | 67114-4855 | ||||||||||
184 |
Affiliated | 837 | Derby | Renal Treatment Center-Derby aka Derby Dialysis Center | 250 W RED POWELL DR | DERBY | KS | 67037-2626 | ||||||||||
185 |
Affiliated | 834 | Winfield | Renal Treatment Center-Winfield aka, Winfield Dialysis Center | 1315 E 4TH AVE | WINFIELD | KS | 67156-2457 | ||||||||||
186 |
Affiliated | 830 | Wichita | Wichita Dialysis Center | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | ||||||||||
187 |
Affiliated | 833 | Garden City | Renal Treatment Center-Garden City Aka-Garden City Dialysis Center | 401 N MAIN ST | GARDEN CITY | KS | 67846-5429 | ||||||||||
188 |
Affiliated | 831 | E. Wichita | East Wichita Dialysis Center | 320 N HILLSIDE ST | WICHITA | KS | 67214-4918 | ||||||||||
189 |
Affiliated | 832 | Independance | Independence Dialysis Center | 801 W MYRTLE ST | INDEPENDENCE | KS | 67301-3239 | ||||||||||
190 |
Affiliated | 835 | Parson, KS | Parsons Dialysis Center | 1902 S US HWY 59 | BLDG B | PARSONS | KS | 67357-4948 | |||||||||
191 |
Affiliated | 814 | Wheaton | Wheaton Dialysis Center | 11941 GEORGIA AVE | WHEATON | MD | 20902 | ||||||||||
192 |
Affiliated | 812 | Rockville | Rockville Dialysis Center | 14915 BROSCHART RD | STE 1 | ROCKVILLE | MD | 20850-3367 | |||||||||
193 |
Affiliated | 815 | Owing Mills | Owings Mills Dialysis Center (fka-Renal Treatment Center-Owings Mills) | 10 CROSSROADS DR | STE 11 | OWINGS MILLS | MD | 21117-5463 | |||||||||
194 |
Affiliated | 811 | Berlin | Berlin Dialysis Center | 314 FRANKLIN AVE | STE 36 | BERLIN | MD | 21811-1238 | |||||||||
195 |
Affiliated | 810 | Easton | Easton Dialysis Center | 402 MARVEL CT | EASTON | MD | 21601-4052 |
Page 87 of 123
196 |
Affiliated | 813 | Chestertown | Chestertown Dialysis Center (fka Renal Treatment Centers-Chestertown) | 100 BROWN ST | CHESTERTOWN | MD | 21620 | ||||||||||
197 |
Affiliated | 951 | Hope Again | Hope Again Dialysis Center- fka Kennett Dialysis Center | 1207 STATE ROUTE VV | KENNETT | MO | 63857-3823 | ||||||||||
198 |
Affiliated | 950 | Poplar Bluff | Bluff City Dialysis Center | 2400 LUCY LEE PKWY | STE E | POPLAR BLUFF | MO | 63901-2429 | |||||||||
199 |
Affiliated | 949 | Crystal City | Crystal City Dialysis Center | 960 SO TRUMAN BLVD | CRYSTAL CITY | MO | 63019-1329 | ||||||||||
200 |
Affiliated | 947 | St. Louis | St. Louis Dialysis Center (fka Renal Treatment Center-St. Louis) | 2610 CLARK AVE | SAINT LOUIS | MO | 63103-2502 | ||||||||||
201 |
Affiliated | 944 | Burlington | Burlington Dialysis | 873 HEATHER RD | BURLINGTON | NC | 27215-6288 | ||||||||||
202 |
Affiliated | 838 | Scottsbluff | Scottsbluff Dialysis Center | 3812 AVENUE B | SCOTTSBLUFF | NE | 69361-4780 | ||||||||||
203 |
Affiliated | 802 | Bridgewater | Bridgewater Dialysis Center (fka Renal Treatment Center-Bridgewater) | 2121 US HWY 22 | BOUND BROOK | NJ | 08805-1546 | ||||||||||
204 |
Affiliated | 845 | West Las Vegas | Las Vegas Dialysis Center | 150 S VALLEY VIEW BLVD | LAS VEGAS | NV | 89107 | ||||||||||
205 |
Affiliated | 846 | North Las Vegas | North Las Vegas Dialysis Center | 2300 MCDANIEL ST | NORTH LAS VEGAS | NV | 89030-6318 | ||||||||||
206 |
Affiliated | 940 | Cincinnati | Eastgate Dialysis (fka Cincinnati) | 4435 AICHOLTZ RD | CINCINNATI | OH | 45245-1690 | ||||||||||
207 |
Affiliated | 885 | Tulsa | Tulsa Dialysis | 4436 S HARVARD AVE | TULSA | OK | 74135-2605 | ||||||||||
208 |
Affiliated | 897 | NW Bethany | Northwest Bethany Dialysis Center | 7800 NW 23RD ST | STE A | BETHANY | OK | 73008-4948 | |||||||||
209 |
Affiliated | 890 | Duncan | Duncan Dialysis Center | 2645 W ELK AVE | DUNCAN | OK | 73533-1572 | ||||||||||
210 |
Affiliated | 893 | Shawnee | Shawnee Dialysis Center | 4409 N KICKAPOO AVE | STE 113 | SHAWNEE | OK | 74804-1224 | |||||||||
211 |
Affiliated | 895 | Stillwater | Stillwater Dialysis Center | 406 E HALL OF FAME AVE | STE 3 | STILLWATER | OK | 74075-5447 | |||||||||
212 |
Affiliated | 955 | Midwest City | Midwest City Dialysis Center | 7221 E RENO AVE | MIDWEST CITY | OK | 73110-4474 | ||||||||||
213 |
Affiliated | 886 | Broken Arrow | Broken Arrow Dialysis Center | 1700 N 9TH ST | BROKEN ARROW | OK | 74012 | ||||||||||
214 |
Affiliated | 888 | Tahlequah | Tahlequah Dialysis Center | 1373 E BOONE ST | TAHLEQUAH | OK | 74464-3330 | ||||||||||
215 |
Affiliated | 899 | Edmund | Edmond Dialysis | 50 S BAUMANN AVE | EDMOND | OK | 73034-5676 | ||||||||||
216 |
Affiliated | 889 | Altus | Altus Dialysis Center | 205 S PARK LN | STE 13 | ALTUS | OK | 73521-5756 | |||||||||
217 |
Affiliated | 896 | Elk City | Elk City Dialysis Center | 1601 W 2ND ST | ELK CITY | OK | 73644-4427 | ||||||||||
218 |
Affiliated | 887 | Claremore | Claremore Dialysis Center | 202 E BLUE STARR DR | CLAREMORE | OK | 74017-4223 | ||||||||||
219 |
Affiliated | 891 | Norman | Norman Dialysis Center | 1818 W LINDSEY ST | STE 14 BLDG B | NORMAN | OK | 73069-4159 | |||||||||
220 |
Affiliated | 862 | Pocono | Pocono Dialysis Center | 100 PLAZA CT | STE B | EAST STROUDSBURG | PA | 18301-8258 | |||||||||
221 |
Affiliated | 861 | Palmerton | Palmerton Dialysis Center | 185 DELAWARE AVE | STE C | PALMERTON | PA | 18071-1716 | |||||||||
222 |
Affiliated | 860 | Jennersville | Jennersville Dialysis Center | 1011 W BALTIMORE PIKE | WEST GROVE | PA | 19390-9446 | ||||||||||
223 |
Affiliated | 858 | Lewistown | Lewistown Dialysis Center | 611 ELECTRIC AVE | LEWISTOWN | PA | 17044-1128 | ||||||||||
224 |
Affiliated | 854 | Lemoyne | Camp Hill Dialysis Center (fka Lemoyne Dialysis Center (York Hospital Acutes)) | 425 N 21ST ST | LOWER LEVEL | CAMP HILL | PA | 17011-2223 | |||||||||
225 |
Affiliated | 856 | Upland | Upland Dialysis Center | 1 MEDICAL CENTER BLVD | STE 12 | CHESTER | PA | 19013-3902 | |||||||||
226 |
Affiliated | 848 | South Philadelphia | So. Philadelphia Dialysis Center | 109 DICKINSON ST | PHILADELPHIA | PA | 19147-6107 | ||||||||||
227 |
Affiliated | 857 | Exton | Exton Dialysis Center | 710 SPRINGDALE DR | EXTON | PA | 19341-2828 | ||||||||||
228 |
Affiliated | 847 | Northeast Philadelphia | NE Philadelphia Dialysis Center | 518 KNORR ST | PHILADELPHIA | PA | 19111-4604 | ||||||||||
229 |
Affiliated | 934 | Longview | Longview Dialysis Center | 425 N FREDONIA ST | LONGVIEW | TX | 75601-6464 | ||||||||||
230 |
Affiliated | 935 | Marshall-RTC | Marshall Dialysis Center | 1301 S WASHINGTON AVE | MARSHALL | TX | 75670-6215 | ||||||||||
231 |
Affiliated | 933 | Conroe | Conroe Dialysis Center | 500 MEDICAL CENTER BLVD | STE 175 | CONROE | TX | 77304-2899 | |||||||||
232 |
Affiliated | 928 | San Marcos | Hill Country Dialysis Center Of San Marcos | 1820 PETER GARZA DR | SAN MARCOS | TX | 78666-7407 | ||||||||||
233 |
Affiliated | 923 | Sherman | Sherman Dialysis Center | 205 W LAMBERTH RD | SHERMAN | TX | 75092-2659 | ||||||||||
234 |
Affiliated | 932 | Tomball | Tomball Dialysis Center | 27720A TOMBALL PKWY | TOMBALL | TX | 77375- | ||||||||||
235 |
Affiliated | 919 | Cleveland | Cleveland Dialysis Center | 600 E HOUSTON | STE 63 | CLEVELAND | TX | 77327-4689 | |||||||||
236 |
Affiliated | 921 | Livingston | Livingston Dialysis Center | 209 W PARK | LIVINGSTON | TX | 77351-7020 | ||||||||||
237 |
Affiliated | 920 | Kingwood | Kingwood Dialysis Center | 2300 GREEN OAK DR | STE 5 | KINGWOOD | TX | 77339-2053 | |||||||||
238 |
Affiliated | 930 | North Houston | North Houston Dialysis Center | 129 LITTLE YORK RD | HOUSTON | TX | 77076-1020 | ||||||||||
239 |
Affiliated | 926 | Omni | Omni Dialysis Center (fka Hamilton Dialysis Center) | 9350 KIRBY DR | STE 11 | HOUSTON | TX | 77054-2528 | |||||||||
240 |
Affiliated | 925 | Victoria | Victoria Dialysis Center | 1405 VICTORIA STATION DR | VICTORIA | TX | 77901-3092 | ||||||||||
241 |
Affiliated | 922 | Lufkin | Lufkin Dialysis Center | 700 S JOHN REDDITT DR | LUFKIN | TX | 75904-3145 | ||||||||||
242 |
Affiliated | 927 | Gonzales | Gonzales Dialysis Center | 1406 N SARAH DEWITT DR | GONZALES | TX | 78629-2702 | ||||||||||
243 |
Affiliated | 924 | Denison | Denison Dialysis Center | 1220 REBA MCENTIRE LANE | DENISON | TX | 75020-9057 | ||||||||||
244 |
Affiliated | 918 | South San Antonio | South San Antonio Dialysis Center | 1313 SE MILITARY DR | STE 111 | SAN ANTONIO | TX | 78214-2850 | |||||||||
245 |
Affiliated | 913 | Austin | Waterloo Dialysis Center (fka Austin Dialysis Center) | 5310 BURNET RD | UNIT 122 | AUSTIN | TX | 78756-2003 | |||||||||
246 |
Affiliated | 916 | S. Austin | El Milagro Dialysis Unit (fka South Austin Dialysis Center) | 2800 S INTERSTATE HWY 35 | STE 12 | AUSTIN | TX | 78704-5700 | |||||||||
247 |
Affiliated | 929 | SW San Antonio | Southwest San Antonio Dialysis Center | 7515 BARLITE BLVD | SAN ANTONIO | TX | 78224-1311 | ||||||||||
248 |
Affiliated | 936 | Bedford | HEB Dialysis Center (Bedford) | 1401 BROWN TRL | STE A | BEDFORD | TX | 76022-6416 | |||||||||
249 |
Affiliated | 917 | TRC Med Cntr | Med-Center Dialysis, fka Plaza Dialysis Center & Houston Kidney Center #376 | 5610 ALMEDA RD | HOUSTON | TX | 77004-7515 | ||||||||||
250 |
Affiliated | 908 | Chesapeake | Chesapeake Dialysis Center | 1400 CROSSWAYS BLVD | CROSSWAYS II STE 16 | CHESAPEAKE | VA | 23320-2839 | |||||||||
251 |
Affiliated | 912 | Hopewell | Hopewell Dialysis Center | 301 W BROADWAY AVE | HOPEWELL | VA | 23860-2645 | ||||||||||
252 |
Affiliated | 911 | Newport News | Newport News Dialysis Center | 711 79TH ST | NEWPORT NEWS | VA | 23605-2767 | ||||||||||
253 |
Affiliated | 907 | Norfolk | Norfolk Dialysis Center | 962 NORFOLK SQ | NORFOLK | VA | 23502-3235 | ||||||||||
254 |
Affiliated | 909 | Virginia Beach | Virginia Beach Dialysis Center | 740 INDEPENDENCE CIR | VIRGINIA BEACH | VA | 23455-6438 | ||||||||||
255 |
Affiliated | 171 | Palmer | Palmer Dialysis Center | 30 COMMUNITY DR | EASTON | PA | 18045-2658 | ||||||||||
256 |
Affiliated | 589 | Burgaw | SEDC (NC II) Burgaw Dialysis Center | 704 S DICKERSON ST | PO BOX 1391 | BURGAW | NC | 28425-4904 | |||||||||
257 |
Affiliated | 590 | Elizabethtown | SEDC (NC II) Elizabethtown Dialysis Center | 101 DIALYSIS DR | ELIZABETHTOWN | NC | 28337-9048 | ||||||||||
258 |
Affiliated | 591 | Jacksonville | SEDC (NC II) Jacksonville Dialysis Center | 14 OFFICE PARK DR | JACKSONVILLE | NC | 28546-7325 | ||||||||||
259 |
Affiliated | 592 | Kenansville | SEDC (NC II) Kenansville Dialysis Center | 305 BEASLEY ST | KENANSVILLE | NC | 28349-8798 | ||||||||||
260 |
Affiliated | 593 | Shallotte | SEDC (NC II) Shallotte Dialysis Center | 4770 SHALLOTTE AVE | SHALLOTTE | NC | 28470-6596 | ||||||||||
261 |
Affiliated | 594 | Whiteville | SEDC (NC II) Whiteville Dialysis Center | 608 PECAN LN | WHITEVILLE | NC | 28472-2949 | ||||||||||
262 |
Affiliated | 595 | Wilmington | SEDC (NC II) Wilmington Dialysis Center | 2215 YAUPON DR | WILMINGTON | NC | 28401-7334 |
Page 88 of 123
263 |
Affiliated | 175 | Deerfield | Deerfield Beach Artificial Kidney Center | 1983 W HILLSBORO BLVD | DEERFIELD BEACH | FL | 33442-1418 | ||||||||||
264 |
Affiliated | 176 | Pampano Beach | Pompano Beach Artificial Kidney Center | 600 SW 3RD ST | STE 11 | POMPANO BEACH | FL | 33060-6936 | |||||||||
265 |
Affiliated | 177 | Tamarack | Tamarac Artificial Kidney Center | 7140 W MCNAB RD | TAMARAC | FL | 33321-5306 | ||||||||||
266 |
Affiliated | 168 | Atlantic AKC | Atlantic Artificial Kidney Center | 6 INDUSTRIAL WAY W | STE B | EATONTOWN | NJ | 07724-2258 | |||||||||
267 |
Affiliated | 587 | Rowan/Kannapolis | Dialysis Care of Kannapolis | 1607 N MAIN ST | KANNAPOLIS | NC | 28081-2317 | ||||||||||
268 |
Affiliated | 654 | Cortez | Cortez Dialysis | 610 E MAIN ST | STE C | CORTEZ | CO | 81321-3308 | |||||||||
269 |
Affiliated | 142 | West Bountiful 4/6/98 | West Bountiful Dialysis | 724 W 500 S | STE 3 | WEST BOUNTIFUL | UT | 84087-1471 | |||||||||
270 |
Affiliated | 187 | Meherrin | Meherrin Dialysis Center | 201A WEAVER AVE | EMPORIA | VA | 23847-1248 | ||||||||||
271 |
Affiliated | 436 | Montclair | Montclair Dialysis Center | 5050 PALO VERDE ST | STE 1 | MONTCLAIR | CA | 91763-2329 | |||||||||
272 |
Affiliated | 259 | Pipestone | Pipestone Dialysis | 916 4TH AVE SW | PIPESTONE | MN | 56164-1054 | ||||||||||
273 |
Affiliated | 236 | Washington | Washington Dialysis Center | 154 WASHINGTON PLZ | WASHINGTON | GA | 30673-2074 | ||||||||||
274 |
Affiliated | 235 | Elberton | Elberton Dialysis Center | 894 ELBERT ST | ELBERTON | GA | 30635-2628 | ||||||||||
275 |
Affiliated | 174 | Gulf Breeze | Gulf Breeze Dialysis Center | 1519 MAIN ST | DUNEDIN | FL | 34698-4650 | ||||||||||
276 |
Affiliated | 526 | Asheville | Asheville Kidney Center | 1600 CENTRE PARK DR | ASHEVILLE | NC | 28805-6206 | ||||||||||
277 |
Affiliated | 528 | Sylva | Sylva Dialysis Center | 655 ASHEVILLE HWY | SYLVA | NC | 28779-2747 | ||||||||||
278 |
Affiliated | 527 | Hendersonville | Hendersonville Dialysis Center | 500 BEVERLY HANKS CTR | HWY 25 N | HENDERSONVILLE | NC | 28792 | |||||||||
279 |
Affiliated | 389 | Memorial | Memorial Dialysis | 4427 S ROBERTSON ST | NEW ORLEANS | LA | 70115-6308 | ||||||||||
280 |
Affiliated | 127 | Warner Robbins | Dialysis Center of Middle Georgia-Warner Robins | 509 N HOUSTON RD | WARNER ROBINS | GA | 31093-8844 | ||||||||||
281 |
Affiliated | 126 | Macon - Middle Georgia | Dialysis Center of Middle Georgia-Macon | 747 2ND ST | MACON | GA | 31201-6835 | ||||||||||
282 |
Affiliated | 344 | Oakland PD | Oakland Peritoneal Dialysis Center (Piedmont PD) | 5352 CLAREMONT AVE | OAKLAND | CA | 94618 | ||||||||||
283 |
Affiliated | 384 | Fairfax | Fairfax Dialysis Center | 8501 ARLINGTON BLVD | STE 1 | FAIRFAX | VA | 22031-4625 | |||||||||
284 |
Affiliated | 374 | Houston SW | Houston Kidney Center Southwest | 11111 BROOKLET DR | STE 1 BLDG 1 | HOUSTON | TX | 77099-3555 | |||||||||
285 |
Affiliated | 545 | Pikes Peak | Pikes Peak Dialysis Center | 2002 LELARAY ST | STE 13 | COLORADO SPRINGS | CO | 80909-2804 | |||||||||
286 |
Affiliated | 546 | Printers Place | Printers Place Dialysis | 2802 INTERNATIONAL CIR | COLORADO SPRINGS | CO | 80910-3127 | ||||||||||
287 |
Affiliated | 541 | Lakewood Colorado | Lakewood Dialysis Center | 1750 PIERCE ST | LAKEWOOD | CO | 80214-1434 | ||||||||||
288 |
Affiliated | 543 | Boulder | Boulder Dialysis Center | 2880 FOLSOM ST | STE 11 | BOULDER | CO | 80304-3769 | |||||||||
289 |
Affiliated | 542 | Thornton | Thornton Dialysis Center | 8800 FOX DR | THORNTON | CO | 80260-6880 | ||||||||||
290 |
Affiliated | 544 | Arvada | Arvada Dialysis Center | 9950 W 80TH AVE | STE 25 | ARVADA | CO | 80005-3914 | |||||||||
291 |
Affiliated | 173 | Ft. Lauderdale | CDC South-Ft Lauderdale Renal Associates | 6264 N FEDERAL HWY | FORT LAUDERDALE | FL | 33308-1904 | ||||||||||
292 |
Affiliated | 380 | Houston Cypress Station | Houston Kidney Center Cypress Station | 221 FM 1960 RD W | STE H | HOUSTON | TX | 77090-3537 | |||||||||
293 |
Affiliated | 169 | Erie County | Cleve Hill Dialysis Center (Fka Cleve Hill Limited Partnership-Erie Dialysis &ECMC Dialysis Center At Cleve Hill ) | 1461 KENSINGTON AVE | BUFFALO | NY | 14215-1436 | ||||||||||
294 |
Affiliated | 430 | UCLA Pediatrics | Century City Dialysis (fka UCLA, DaVita Westwood UCLA) | 10630 SANTA MONICA BLVD | LOS ANGELES | CA | 90025-4837 | ||||||||||
295 |
Affiliated | 501 | Bronx | Bronx Dialysis Center | 1615 EASTCHESTER RD | BRONX | NY | 10461-2603 | ||||||||||
296 |
Affiliated | 502 | Catskill | Catskill Dialysis Center | 139 FORESTBURGH RD | MONTICELLO | NY | 12701-2364 | ||||||||||
297 |
Affiliated | 505 | Riverdale | Riverdale Dialysis Center | 170 W 233RD ST | BRONX | NY | 10463-5639 | ||||||||||
298 |
Affiliated | 506 | South Bronx | South Bronx Dialysis Center | 1940 WEBSTER AVE | BRONX | NY | 10457-4261 | ||||||||||
299 |
Affiliated | 507 | Stanten Island | Richmond Kidney Center (Staten Island) | 1366 VICTORY BLVD | STATEN ISLAND | NY | 10301-3907 | ||||||||||
300 |
Affiliated | 238 | McDonough | McDonough Dialysis Center | 114 DUNN ST | MCDONOUGH | GA | 30253-2347 | ||||||||||
301 |
Affiliated | 192 | Milford | Delaware Valley Dialysis Center (fka Milford) | 102 DAVITA DR | MILFORD | PA | 18337-9390 | ||||||||||
302 |
Affiliated | 191 | Honesdale | Honesdale Dialysis Center-NE Regional | RR 6 BOX 6636 | STOURBRIDGE MALL | HONESDALE | PA | 18431-9649 | |||||||||
303 |
Affiliated | 247 | Memorial | Memorial Dialysis Center | 11621 KATY FWY | HOUSTON | TX | 77079-1801 | ||||||||||
304 |
Affiliated | 246 | Katy Dialysis Center | Grand Parkway Dialysis Center | 403 W GRAND PKWY S | STE T | KATY | TX | 77494-8358 | |||||||||
305 |
Affiliated | 245 | Cyfair Dialysis Center | Cyfair Dialysis Center | 9110 JONES RD | STE 11 | HOUSTON | TX | 77065-4489 | |||||||||
306 |
Affiliated | 165 | Port Chester | Port Chester Dialysis and Renal Center | 38 BULKLEY AVE | PORT CHESTER | NY | 10573-3902 | ||||||||||
307 |
Affiliated | 193 | Franklin Dialysis | Franklin Dialysis Center | 150 SOUTH INDEPENDENCE WEST | 11 PUBLIC LEDGER BLDG | PHILADELPHIA | PA | 19106-3413 | |||||||||
308 |
Affiliated | 156 | Grand Blanc | Grand Blanc Dialysis Center | 3625 GENESYS PKWY | GRAND BLANC | MI | 48439-8070 | ||||||||||
309 |
Affiliated | 397 | Oxford Court | Oxford Court Dialysis | 930 TOWN CENTER DR | STE G1 | LANGHORNE | PA | 19047-4260 | |||||||||
310 |
Affiliated | 348 | Antioch | Antioch Dialysis | 3100 DELTA FAIR BLVD | ANTIOCH | CA | 94509-4001 | ||||||||||
311 |
Affiliated | 401 | North Palm Beach | North Palm Beach Dialysis Center | 2841 PGA BLVD | PALM BEACH GARDENS | FL | 33410-2910 | ||||||||||
312 |
Affiliated | 277 | Lodi | Lodi Dialysis Center | 1610 W KETTLEMAN LN | STE D | LODI | CA | 95242-4210 | |||||||||
313 |
Affiliated | 438 | United | United Dialysis Center | 3111 LONG BEACH BLVD | LONG BEACH | CA | 90807-5015 | ||||||||||
314 |
Affiliated | 437 | Premier | Premier Dialysis Center | 7612 ATLANTIC AVE | CUDAHY | CA | 90201-5020 | ||||||||||
315 |
Affiliated | 349 | Salinas | Salinas Dialysis Center | 955 BLANCO CIR | STE C | SALINAS | CA | 93901-4452 | |||||||||
316 |
Affiliated | 428 | Lowry I | Lowry Dialysis Center | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | |||||||||
317 |
Affiliated | 154 | Ypsilanti | Ypsilanti Dialysis | 2766 WASHTENAW RD | YPSILANTI | MI | 48197-1506 | ||||||||||
318 |
Affiliated | 237 | Eastpoint | East Point Dialysis | 2669 CHURCH ST | EAST POINT | GA | 30344-3115 | ||||||||||
319 |
Affiliated | 520 | Celia Dill | Celia Dill Dialysis Center | 667 STONELEIGH AVE | STE 123 BARNS OFFICE CENTER | CARMEL | NY | 10512-2454 | |||||||||
320 |
Affiliated | 248 | Elmbrook | Brookriver Dialysis | 8101 BROOKRIVER DR | DALLAS | TX | 75247-4003 | ||||||||||
321 |
Affiliated | 402 | Ocala East | OCALA Regional Kidney Center-East | 2870 SE 1ST AVE | OCALA | FL | 34471-0406 | ||||||||||
322 |
Affiliated | 403 | Ocala West | OCALA Regional Kidney Center-West | 9401 SW HWY 200 | BLDG 6 | OCALA | FL | 34481-9612 | |||||||||
323 |
Affiliated | 404 | Ocala South | OCALA Regional Kidney Center-South | 13940 N US HWY 441 | BLDG 4 | LADY LAKE | FL | 32159-8908 | |||||||||
324 |
Affiliated | 417 | Delta Sierra Dialysis | Delta-Sierra Dialysis Center | 555 W BENJAMIN HOLT DR | STE 2 | STOCKTON | CA | 95207-3839 | |||||||||
325 |
Affiliated | 552 | Olympic View | Olympic View Dialysis Center | 125 16TH AVE E CSB | 5TH FL | SEATTLE | WA | 98112 | |||||||||
326 |
Affiliated | 148 | Pratt | Pratt Dialysis Center | 203 WATSON ST | STE 11 | PRATT | KS | 67124-3092 | |||||||||
327 |
Affiliated | 196 | Buffalo | Renal Care of Buffalo | 550 ORCHARD PARK RD | WEST SENECA | NY | 14224-2646 | ||||||||||
328 |
Affiliated | 555 | Woodland | Woodland Dialysis Center | 912 WOODLAND DR | STE B | ELIZABETHTOWN | KY | 42701-2795 | |||||||||
329 |
Affiliated | 556 | Taylor | Taylor County Dialysis Center | 101 KINGSWOOD DR | CAMPBELLSVILLE | KY | 42718-9634 |
Page 89 of 123
330 |
Affiliated | 491 | Gary | Comprehensive Renal Care (CRC)-Gary | 4802 BROADWAY | GARY | IN | 46408-4509 | ||||||||||
331 |
Affiliated | 492 | Hammond | Comprehensive Renal Care (CRC)-Hammond | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 | ||||||||||
332 |
Affiliated | 493 | Valparaiso | Comprehensive Renal Care (CRC)-Valparaiso | 606 E LINCOLNWAY | VALPARAISO | IN | 46383-5728 | ||||||||||
333 |
Affiliated | 494 | Michigan City | Comprehensive Renal Care (CRC)-Michigan City | 9836 WEST 400 NORTH | MICHIGAN CITY | IN | 46360-2910 | ||||||||||
334 |
Affiliated | 495 | Munster | Comprehensive Renal Care (CRC)-Munster | 9100 CALUMET AVE | MUNSTER | IN | 46321-1737 | ||||||||||
335 |
Affiliated | 497 | South County-Deaconess | South County Dialysis (Deaconess) | 4145 UNION RD | SAINT LOUIS | MO | 63129-1064 | ||||||||||
336 |
Affiliated | 266 | South Hayward | South Hayward Dialysis Center | 254 JACKSON ST | HAYWARD | CA | 94544-1907 | ||||||||||
337 |
Affiliated | 164 | Dyker Heights | Dyker Heights Dialysis Center | 1435 86TH ST | BROOKLYN | NY | 11228-3435 | ||||||||||
338 |
Affiliated | 152 | Clarkston | Clarkston Dialysis Center | 6770 DIXIE HWY | STE 25 | CLARKSTON | MI | 48346-2089 | |||||||||
339 |
Affiliated | 534 | Hudson Valley | Hudson Valley Dialysis Center | 155 WHITE PLAINS RD | TARRYTOWN | NY | 10591-5523 | ||||||||||
340 |
Affiliated | 971 | Central Tulsa | Central Tulsa Dialysis Center | 1124 S SAINT LOUIS AVE | TULSA | OK | 74120-5413 | ||||||||||
341 |
Affiliated | 972 | Okmulgee | Okmulgee Dialysis Center | 201 SO DELAWARE AVE | OKMULGEE | OK | 74447-5528 | ||||||||||
342 |
Affiliated | 974 | Muskogee | Muskogee Community Dialysis | 2316 W SHAWNEE ST | MUSKOGEE | OK | 74401-2228 | ||||||||||
343 |
Affiliated | 975 | Miami-Oklahoma | Tri-State Dialysis Center (fka Miami Dialysis Center (OK)) | 2510 N MAIN ST | MIAMI | OK | 74354-1602 | ||||||||||
344 |
Affiliated | 977 | Stilwell | Stilwell Dialysis Center | 80851 HWY 59 | STILWELL | OK | 74960 | ||||||||||
345 |
Affiliated | 496 | East Chicago | Comprehensive Renal Care (CRC)-East Chicago | 4320 FIR ST | UNIT 44 | EAST CHICAGO | IN | 46312-3078 | |||||||||
346 |
Affiliated | 549 | Bright Dialysis | Bright Dialysis (fka Fort Pierce Artificial Kidney Center, TRC of Fort Pierce-AKC) | 1801 S 23RD ST | STE 1 | FORT PIERCE | FL | 34950-4830 | |||||||||
347 |
Affiliated | 153 | Detroit | Detroit Dialysis Center (Eastern Market, Brewery Park Development) | 2674 E JEFFERSON AVE | DETROIT | MI | 48207-4129 | ||||||||||
348 |
Affiliated | 166 | White Plains | White Plains Dialysis Center | 200 HAMILTON AVE | STE 13B | WHITE PLAINS | NY | 10601-1859 | |||||||||
349 |
Affiliated | 337 | Crescent Heights | Crescent Heights Dialysis Center | 8151 BEVERLY BLVD | LOS ANGELES | CA | 90048-4514 | ||||||||||
350 |
Affiliated | 547 | Pahrump Dialysis | Pahrump Dialysis Center | 330 S LOLA LN | STE 1 | PAHRUMP | NV | 89048-0884 | |||||||||
351 |
Affiliated | 598 | Cherokee Dialysis Center | Cherokee Dialysis Center | 53 ECHOTA CHURCH RD | CHEROKEE | NC | 28719-9702 | ||||||||||
352 |
Affiliated | 444 | Utah Valley | Utah Valley Dialysis Center | 1055 N 500 W | STE 221 | PROVO | UT | 84604-3305 | |||||||||
353 |
Affiliated | 439 | Washington Plaza | Washington Plaza Dialysis Center | 516 E WASHINGTON BLVD | # 522 | LOS ANGELES | CA | 90015-3723 | |||||||||
354 |
Affiliated | 539 | Commerce City | Commerce City Dialysis Center | 6320 HOLLY ST | COMMERCE CITY | CO | 80022-3325 | ||||||||||
355 |
Affiliated | 251 | Bloomington Dialysis | Bloomington Dialysis Unit of TRC (fka Richfield) | 8591 LYNDALE AVE S | BLOOMINGTON | MN | 55420-2237 | ||||||||||
356 |
Affiliated | 133 | Kent Community Dialysis | Kent Dialysis Center | 21501 84TH AVE S | KENT | WA | 98032-1960 | ||||||||||
357 |
Affiliated | 278 | Florin Dialyis | Florin Dialysis Center | 7000 STOCKTON BLVD | SACRAMENTO | CA | 95823-2312 | ||||||||||
358 |
Affiliated | 540 | South Las Vegas Dialysis | South Las Vegas Dialysis Center (Palms) | 2250 S RANCHO DR | STE 115 | LAS VEGAS | NV | 89102-4456 | |||||||||
359 |
Affiliated | 538 | Longmont Dialysis | Longmont Dialysis Center | 1715 IRON HORSE DR | STE 17 | LONGMONT | CO | 80501-9617 | |||||||||
360 |
Affiliated | 500 | Great Bridge | Great Bridge Dialysis (fka Chesapeake II) | 745 BATTLEFIELD BLVD N | STE 1 | CHESAPEAKE | VA | 23320-0305 | |||||||||
361 |
Affiliated | 569 | Weaverville Dialysis | Weaverville Dialysis Facility | 329 MERRIMON AVE | WEAVERVILLE | NC | 28787-9253 | ||||||||||
362 |
Affiliated | 427 | Lakewood Crossing | Lakewood Crossing Dialysis | 1057 S WADSWORTH BLVD | STE 1 | LAKEWOOD | CO | 80226-4361 | |||||||||
363 |
Affiliated | 155 | Jackson | Jackson Dialysis Center | 234 W LOUIS GLICK HWY | JACKSON | MI | 49201-1326 | ||||||||||
364 |
Affiliated | 429 | Englewood | Englewood Dialysis Center | 3247 S LINCOLN ST | ENGLEWOOD | CO | 80113-2505 | ||||||||||
365 |
Affiliated | 387 | Harford Road Dialysis | Harford Road Dialysis Center | 5800 HARFORD RD | BALTIMORE | MD | 21214-1847 | ||||||||||
366 |
Affiliated | 179 | Arcadia | Arcadia Dialysis Center | 1341 E OAK ST | ARCADIA | FL | 34266-8902 | ||||||||||
367 |
Affiliated | 388 | Richmond Community | Richmond Community Hospital Dialysis (fkaTRC @ Richmond Community/Richmond II) | 1510 N 28TH ST | STE 11 | RICHMOND | VA | 23223-5311 | |||||||||
368 |
Affiliated | 119 | Henderson | Henderson Dialysis Center | 1002 US HWY 79 N | HENDERSON | TX | 75652-6008 | ||||||||||
369 |
Affiliated | 253 | Augusta | Nephrology Center of South Augusta | 1631 GORDON HWY STE 1B | AUGUSTA | GA | 30906 | ||||||||||
370 |
Affiliated | 510 | Boston Post Road | Boston Post Road Dialysis Center fka Co Op City Dialysis | 4026 BOSTON RD | BRONX | NY | 10475-1122 | ||||||||||
371 |
Affiliated | 512 | Peekskill | Peekskill Cortlandt Dialysis Center | 2050 E MAIN ST | STE 15 | CORTLANDT MANOR | NY | 10567-2502 | |||||||||
372 |
Affiliated | 513 | Queens | Queens Dialysis Center | 11801 GUY R BREWER BLVD | JAMAICA | NY | 11434-2101 | ||||||||||
373 |
Affiliated | 517 | Soundview | Soundview Dialysis Center | 1622 BRUCKNER BLVD | STE 24 | BRONX | NY | 10473-4553 | |||||||||
374 |
Affiliated | 516 | Port Washington | Port Washington Dialysis Center | 50 SEAVIEW BLVD | PORT WASHINGTON | NY | 11050-4615 | ||||||||||
375 |
Affiliated | 515 | Lynbrook | Lynbrook Dialysis Center | 147 SCRANTON AVE | LYNBROOK | NY | 11563-2808 | ||||||||||
376 |
Affiliated | 518 | Yonkers Dialysis Center | Yonkers Dialysis | 575 YONKERS AVE | YONKERS | NY | 10704-2601 | ||||||||||
377 |
Affiliated | 537 | IHS - Queens Village | Queens Village Dialysis Center | 22202 HEMPSTEAD AVE | STE 17 | QUEENS VILLAGE | NY | 11429-2123 | |||||||||
378 |
Affiliated | 536 | Coney Island - IHS | Sheepshead Bay Renal Care Center (fka Coney Island) | 26 BRIGHTON 11TH ST | BROOKLYN | NY | 11235-5304 | ||||||||||
379 |
Affiliated | 521 | Garden City I.H.S | Garden City Dialysis Center | 1100 STEWART AVE | STE 2 | GARDEN CITY | NY | 11530-4839 | |||||||||
380 |
Affiliated | 267 | Kenneth Hahn- I.R.A | Kenneth Hahn Plaza Dialysis Center (Willowbrook) | 11854 S WILMINGTON AVE | LOS ANGELES | CA | 90059-3016 | ||||||||||
381 |
Affiliated | 279 | North Highland | North Highlands Dialysis Center | 4986 WATT AVE | STE F | NORTH HIGHLANDS | CA | 95660-5182 | |||||||||
382 |
Affiliated | 294 | TRC Orangevale | Orangevale Dialysis Center | 9267 GREENBACK LN | STE A2 | ORANGEVALE | CA | 95662-4864 | |||||||||
383 |
Affiliated | 554 | Forest Park Dialysis Center | Forest Park Dialysis Center | 380 FOREST PKWY | STE C | FOREST PARK | GA | 30297-2107 | |||||||||
384 |
Affiliated | 446 | Grant Park Nursing Home Dialysis | Grant Park Dialysis (fka Grants Park Nursing Home) | 5000 NANNIE HELEN BURROUGHS AVE NE | WASHINGTON | DC | 20019-5506 | ||||||||||
385 |
Affiliated | 455 | Fourth Street Dialysis | Fourth Street Dialysis | 3101 N 4TH ST | STE B | LONGVIEW | TX | 75605-5146 | |||||||||
386 |
Affiliated | 274 | Bay Breeze | Bay Breeze Dialysis | 11465 ULMERTON RD | LARGO | FL | 33778-1602 | ||||||||||
387 |
Affiliated | 416 | Hopi | Hopi Dialysis Center- fka First Mesa | PO BOX 964 | HWY 264 | POLACCA | AZ | 86042 | |||||||||
388 |
Affiliated | 178 | Orlando Dialysis | Orlando Dialysis | 14050 TOWN LOOP BLVD | STE 14A | ORLANDO | FL | 32837-6190 | |||||||||
389 |
Affiliated | 170 | Celebration Dialysis | Celebration Dialysis | 1154 CELEBRATION BLVD | CELEBRATION | FL | 34747-4605 | ||||||||||
390 |
Affiliated | 1500 | Mt. Dora Dialysis | Mt. Dora Dialysis | 2735 W OLD US HIGHWAY 441 | MOUNT DORA | FL | 32757-3526 | ||||||||||
391 |
Affiliated | 1501 | Lake Dialysis | Lake Dialysis | 221 N 1ST ST | LEESBURG | FL | 34748-5150 | ||||||||||
392 |
Affiliated | 146 | Puyallup Community Dialysis | Puyallup Dialysis Center | 716 SOUTH HILL PARK DR | STE C | PUYALLUP | WA | 98373-1445 | |||||||||
393 |
Affiliated | 562 | Towson Dialysis | Dulaney Towson Dialysis Center | 113 WEST RD | STE 21 | TOWSON | MD | 21204-2318 | |||||||||
394 |
Affiliated | 188 | Purcellville | Purcellville Dialysis Center | 280 N HATCHER AVE | PURCELLVILLE | VA | 20132-3193 | ||||||||||
395 |
Affiliated | 476 | Iris City | Iris City Dialysis (aka Griffin) | 521 N EXPRESSWAY | STE 159 | GRIFFIN | GA | 30223-2073 | |||||||||
396 |
Affiliated | 1521 | Slidell Kidney Care | Slidell Kidney Care | 1150 ROBERT BLVD | STE 24 | SLIDELL | LA | 70458-2005 |
Page 90 of 123
397 |
Affiliated | 385 | Rivertowne Dialysis | Rivertowne Dialysis (fka Oxon Hill Dialysis) | 6192 OXON HILL RD | 1ST FL | OXON HILL | MD | 20745-3114 | |||||||||
398 |
Affiliated | 477 | Pearland Dialysis | Pearland Dialysis | 6516 BROADWAY ST | STE 122 | PEARLAND | TX | 77581-7879 | |||||||||
399 |
Affiliated | 419 | East Aurora Dialysis | East Aurora Dialysis (aka Aurora II) | 482 S CHAMBERS RD | AURORA | CO | 80017-2092 | ||||||||||
400 |
Affiliated | 1507 | Merrillville Dialysis | CRC-Merrillville Dialysis Center | 9223 TAFT ST | MERRILLVILLE | IN | 46410-6911 | ||||||||||
401 |
Affiliated | 563 | Bricktown Dialysis | Bricktown Dialysis Center | 525 JACK MARTIN BLVD | FL 2 | BRICK | NJ | 08724-7735 | |||||||||
402 |
Affiliated | 423 | Sapulpa | Sapulpa Dialysis (fka Jenks-Sapulpa) | 9647 RIDGEVIEW ST | TULSA | OK | 74131-6205 | ||||||||||
403 |
Affiliated | 1526 | Ellijay Dialysis | Ellijay Dialysis | 449 INDUSTRIAL BLVD | STE 24 | ELLIJAY | GA | 30540-6724 | |||||||||
404 |
Affiliated | 1527 | Gainesville Dialysis | Gainesville Dialysis | 2545 FLINTRIDGE RD | STE 13 | GAINESVILLE | GA | 30501-7428 | |||||||||
405 |
Affiliated | 1528 | Newnan Dialysis | Newnan Dialysis | 1565 E HWY 34 | STE 13 | NEWNAN | GA | 30265 | |||||||||
406 |
Affiliated | 405 | Ocala Regional Kidney Center - North | OCALA North Dialysis Center | 2620 W HWY 316 | CITRA | FL | 32113-3555 | ||||||||||
407 |
Affiliated | 1516 | Pin Oak Dialysis | Pin Oak Dialysis Center (aka Katy II) | 1302 PIN OAK RD | KATY | TX | 77494-6848 | ||||||||||
408 |
Affiliated | 1523 | Imperial Care Dialysis | Imperial Care Dialysis Center | 4345 E IMPERIAL HWY | LYNWOOD | CA | 90262-2318 | ||||||||||
409 |
Affiliated | 1533 | St. Louis Park Dialysis | St. Louis Park Dialysis Center | 3505 LOUISIANA AVE S | ST LOUIS PARK | MN | 55426-4121 | ||||||||||
410 |
Affiliated | 1517 | Minneapolis NE Dialysis | Minneapolis NE Dialysis | 1049 10TH AVE SE | MINNEAPOLIS | MN | 55414-1312 | ||||||||||
411 |
Affiliated | 298 | Flushing Dialysis | Flushing Dialysis Center | 3469 PIERSON PL | STE A | FLUSHING | MI | 48433-2413 | |||||||||
412 |
Affiliated | 1535 | Dialysis Systems of Covington | Dialysis Systems of Covington | 210 GREENBRIAR BLVD | COVINGTON | LA | 70433-7235 | ||||||||||
413 |
Affiliated | 1536 | Dialysis Systems of Hammond | Dialysis Systems of Hammond | 15799 PROFESSIONAL PLZ | HAMMOND | LA | 70403-1452 | ||||||||||
414 |
Affiliated | 433 | Soledad Dialysis | Soledad Dialysis Center | 901 LOS COCHES DR | SOLEDAD | CA | 93960-2995 | ||||||||||
415 |
Affiliated | 443 | Lake Elsinore Dialysis | Lake Elsinore Dialysis | 32291 MISSION TRL | BLDG S | LAKE ELSINORE | CA | 92530 | |||||||||
416 |
Affiliated | 1511 | Clinton Dialysis Center | Clinton Dialysis Center | 150 S 31ST ST | CLINTON | OK | 73601-9118 | ||||||||||
417 |
Affiliated | 456 | Bakers Ferry | Bakers Ferry Dialysis | 3645 BAKERS FERRY RD SW | ATLANTA | GA | 30331-3712 | ||||||||||
418 |
Affiliated | 1509 | Hermiston | Hermiston Community Dialysis Center | 1155 W LINDA AVE | HERMISTON | OR | 97838-9601 | ||||||||||
419 |
Affiliated | 1539 | Yakima | Yakima Dialysis Center | 1221 N 16TH AVE | YAKIMA | WA | 98902-1347 | ||||||||||
420 |
Affiliated | 409 | Madison | Madison Dialysis Center | 302 HIGHWAY ST | MADISON | NC | 27025-1672 | ||||||||||
421 |
Affiliated | 1508 | Swannanoa Dialysis | Swannanoa Dialysis Center (fka Black Mountain, NC) | 2305 US HIGHWAY 70 | SWANNANOA | NC | 28778-8207 | ||||||||||
422 |
Affiliated | 2009 | NE Wichita Dialysis | NE Wichita Dialysis Center | 2630 N WEBB RD | STE 1 BLDG 1 | WICHITA | KS | 67226-8174 | |||||||||
423 |
Affiliated | 2005 | Chadbourn Dialysis | Chadbourn Dialysis Center (fkaColumbus County) | 210 STRAWBERRY BLVD | CHADBOURN | NC | 28431-1418 | ||||||||||
424 |
Affiliated | 1506 | Western Home Dialysis | Mile High Home Dialysis PD (fka Western Home) | 1750 PIERCE ST | STE A | LAKEWOOD | CO | 80214-1434 | |||||||||
425 |
Affiliated | 2019 | Tustin Dialysis | Tustin Dialysis (aka Santa Ana) | 2090 N TUSTIN AVE | STE 1 | SANTA ANA | CA | 92705-7869 | |||||||||
426 |
Affiliated | 182 | Appomatox | Appomattox Dialysis (Petersburg) | 15 W OLD ST | PETERSBURG | VA | 23803-3221 | ||||||||||
427 |
Affiliated | 2002 | Maryville Dialysis | Maryville Dialysis | 2130 VADALABENE DR | MARYVILLE | IL | 62062-5632 | ||||||||||
428 |
Affiliated | 2001 | Mission Hills | Mission Hills Dialysis (aka Cristo Rey) | 2700 N STANTON ST | EL PASO | TX | 79902-2500 | ||||||||||
429 |
Affiliated | 125 | Moncrief | Moncrief Dialysis Partners | 800 W 34TH ST | STE 11 | AUSTIN | TX | 78705-1144 | |||||||||
430 |
Affiliated | 295 | Southfield West Dialysis | Southfield West Dialysis | 21900 MELROSE AVE | STE 4 | SOUTHFIELD | MI | 48075-7967 | |||||||||
431 |
Affiliated | 525 | Neptune Dialysis | Neptune Dialysis Center | 2180 BRADLEY AVE | NEPTUNE | NJ | 07753-4427 | ||||||||||
432 |
Affiliated | 2014 | Portsmouth Dialysis | Portsmouth Dialysis Center | 2000 HIGH ST | PORTSMOUTH | VA | 23704-3012 | ||||||||||
433 |
Affiliated | 2016 | Tokay Dialysis | Tokay Dialysis Center (fka East Lodi, CA) | 312 S FAIRMONT AVE | STE A | LODI | CA | 95240-3840 | |||||||||
434 |
Affiliated | 1504 | Mt. Pocono Dialysis | Mt. Pocono Dialysis | 100 COMMUNITY DR | STE 16 | TOBYHANNA | PA | 18466-8986 | |||||||||
435 |
Affiliated | 1544 | Greater Portsmouth | Greater Portsmouth (aka Bon View Dialysis & Mid Town Hampton Road Dialysis) | 3516 QUEEN ST | PORTSMOUTH | VA | 23707-3238 | ||||||||||
436 |
Affiliated | 1545 | Peninsula Dialysis | Peninsula Dialysis Center (aka Immaculate Dialysis) | 716 DENBIGH BLVD | STE D1 AND D2 | NEWPORT NEWS | VA | 23608-4414 | |||||||||
437 |
Affiliated | 1540 | Saginaw Dialysis | Saginaw Dialysis | 1527 E GENESEE AVE | SAGINAW | MI | 48607-1755 | ||||||||||
438 |
Affiliated | 1560 | Churchview Dialysis | Churchview Dialysis | 5970 CHURCHVIEW DR | ROCKFORD | IL | 61107-2574 | ||||||||||
439 |
Affiliated | 1562 | Freeport Dialysis | Freeport Dialysis | 1028 S KUNKLE BLVD | FREEPORT | IL | 61032-6914 | ||||||||||
440 |
Affiliated | 1563 | Rockford Dialysis | Rockford Dialysis | 3339 N ROCKTON AVE | ROCKFORD | IL | 61103-2839 | ||||||||||
441 |
Affiliated | 1564 | Whiteside Dialysis | Whiteside Dialysis | 2600 N LOCUST | STE D | STERLING | IL | 61081-4602 | |||||||||
442 |
Affiliated | 2021 | Pikesville Dialysis | Pikesville Dialysis | 1500 REISTERSTOWN RD | STE 22 | PIKESVILLE | MD | 21208-3836 | |||||||||
443 |
Affiliated | 2000 | Waynesville Dialysis | Waynesville Dialysis Center (fka Haywood, NC) | 11 PARK TERRACE DR | CLYDE | NC | 28721-7445 | ||||||||||
444 |
Affiliated | 296 | Davison Dialysis | Davison Dialysis | 1011 S STATE RD | DAVISON | MI | 48423-1903 | ||||||||||
445 |
Affiliated | 1557 | Flint Dialysis | Flint Dialysis Center | 2 HURLEY PLZ | STE 115 | FLINT | MI | 48503-5904 | |||||||||
446 |
Affiliated | 1558 | Hallwood Dialysis | Hallwood Dialysis Center | 4929 CLIO RD | STE B | FLINT | MI | 48504-1886 | |||||||||
447 |
Affiliated | 1559 | Park Plaza Dialysis | Park Plaza Dialysis | G1075 N BALLENGER HWY | FLINT | MI | 48504-4431 | ||||||||||
448 |
Affiliated | 1518 | Rosemead Springs Dialysis | Rosemead Springs Dialysis Center | 3212 ROSEMEAD BLVD | EL MONTE | CA | 91731-2807 | ||||||||||
449 |
Affiliated | 2022 | Scottsdale Dialysis | Scottsdale Dialysis Center | 4725 N SCOTTSDALE RD | STE 1 | SCOTTSDALE | AZ | 85251-7621 | |||||||||
450 |
Affiliated | 1570 | Washington Parish Dialysis | Washington Parish Dialysis | 724 WASHINGTON ST | FRANKLINTON | LA | 70438-1790 | ||||||||||
451 |
Affiliated | 2027 | Brookhollow Dialysis | Brookhollow Dialysis | 4918 W 34TH ST | HOUSTON | TX | 77092-6606 | ||||||||||
452 |
Affiliated | 2017 | Creekside | Creekside Dialysis Center (fka So. Vacaville, CA) | 141 PARKER ST | VACAVILLE | CA | 95688-3921 | ||||||||||
453 |
Affiliated | 529 | Middletown | Middletown Dialysis Center (fka-Red Bank) | 500 STATE ROUTE 35 | UNION SQUARE PLAZA | RED BANK | NJ | 07701-5038 | |||||||||
454 |
Affiliated | 1541 | Southwest Ohio Dialysis | Southwest Ohio Dialysis (Xenia-SWORC) | 215 S ALLISON AVE | XENIA | OH | 45385-3694 | ||||||||||
455 |
Affiliated | 369 | Oak Park | Oak Park Dialysis Center | 13481 W 10 MILE RD | OAK PARK | MI | 48237-4633 | ||||||||||
456 |
Affiliated | 2042 | Eden Prairie | Eden Prairie Dialysis | 14852 SCENIC HEIGHTS RD | STE 255 BLDG B | EDEN PRAIRIE | MN | 55344-2320 | |||||||||
457 |
Affiliated | 1530 | Owensboro Dialysis | Owensboro Dialysis Center | 1930 E PARRISH AVE | OWENSBORO | KY | 42303-1443 | ||||||||||
458 |
Affiliated | 1531 | Tell City Dialysis | CRC-Tell City Dialysis Center | 1602 MAIN ST | TELL CITY | IN | 47586-1310 | ||||||||||
459 |
Affiliated | 1576 | Crestwood Dialysis | Crestwood Dialysis (fka Health Research Group-St. Louis (HRG)) | 9901 WATSON RD | STE 125 | SAINT LOUIS | MO | 63126-1855 | |||||||||
460 |
Affiliated | 2004 | Copperfield Dialysis | Copperfield Dialysis (fka Cabarrus County-NC, and Concord) | 1030 VINEHAVEN DR | CONCORD | NC | 28025-2438 | ||||||||||
461 |
Affiliated | 1572 | Grand Island Dialysis | Grand Island Dialysis | 603 S WEBB RD | GRAND ISLAND | NE | 68803-5141 | ||||||||||
462 |
Affiliated | 1573 | Harlan Dialysis | Harlan Dialysis | 1213 GARFIELD AVE | HARLAN | IA | 51537-2057 | ||||||||||
463 |
Affiliated | 1574 | Shenandoah Dialysis | Shenandoah Dialysis | 300 PERSHING AVE | SHENANDOAH | IA | 51601-2355 |
Page 91 of 123
464 |
Affiliated | 2053 | Germantown Dialysis | Germantown Dialysis | 20111 CENTURY BLVD | STE C | GERMANTOWN | MD | 20874-9165 | |||||||||
465 |
Affiliated | 2051 | Lamplighter Dialysis | Lamplighter Dialysis | 12654 LAMPLIGHTER SQUARE | ST LOUIS | MO | 63128 | ||||||||||
466 |
Affiliated | 1578 | Kidney Care of Largo | Kidney Care of Largo | 1300 MERCANTILE LN | STE 194 | UPPER MARLBORO | MD | 20774 | |||||||||
467 |
Affiliated | 1579 | Kidney Care of Laurel | Kidney Care of Laurel | 14631 LAUREL BOWIE ROAD | UNITS 1-15 | LAUREL | MD | 20707 | |||||||||
468 |
Affiliated | 2024 | Durant Dialysis | Durant Dialysis Center | 411 WESTSIDE DR | DURANT | OK | 74701-2932 | ||||||||||
469 |
Affiliated | 2038 | Palm Brook Dialysis | Palm Brook Dialysis Center | 14664 N DEL WEBB BLVD | SUN CITY | AZ | 85351-2137 | ||||||||||
470 |
Affiliated | 2043 | Cambridge Dialysis | Cambridge Dialysis Center | 300 BYRN ST | CAMBRIDGE | MD | 21613-1908 | ||||||||||
471 |
Affiliated | 2059 | Reston Dialysis Center | Reston Dialysis Center | 1875 CAMPUS COMMONS DR | STE 11 | RESTON | VA | 20191-1564 | |||||||||
472 |
Affiliated | 2040 | Franconia Dialysis | Franconia Dialysis Centre | 5695 KING CENTRE DRIVE | ALEXANDRIA | VA | 22315-5744 | ||||||||||
473 |
Affiliated | 2041 | Eagan Dialysis | Eagan Dialysis Unit | 2750 BLUE WATER RD | SUITE 3 | EAGAN | MN | 55121-1400 | |||||||||
474 |
Affiliated | 1594 | Central Des Moines Dialysis | Central Des Moines Dialysis | 1215 PLEASANT ST | STE 16 | DES MOINES | IA | 50309-1409 | |||||||||
475 |
Affiliated | 1595 | West Des Moines Dialysis | West Des Moines Dialysis | 6800 LAKE DR | STE 185 | WEST DES MOINES | IA | 50266-2544 | |||||||||
476 |
Affiliated | 1596 | Creston Dialysis | Creston Dialysis | 1700 W TOWNLINE ST | CRESTON | IA | 50801-1054 | ||||||||||
477 |
Affiliated | 1597 | Atlantic Dialysis | Atlantic Dialysis | 1500 E 10TH ST | ATLANTIC | IA | 50022-1935 | ||||||||||
478 |
Affiliated | 1598 | Newton Dialysis | Newton Dialysis | 204 N 4TH AVE E | STE 134 | NEWTON | IA | 50208-3135 | |||||||||
479 |
Affiliated | 2046 | Dialysis of Des Moines | Riverpoint Dialysis Unit | 501 SW 7TH ST | STE B | DES MOINES | IA | 50309-4538 | |||||||||
480 |
Affiliated | 2060 | Bellevue Dialysis | Bellevue Dialysis Center | 3535 FACTORIA BLVD SE | STE 15 | BELLEVUE | WA | 98006-1293 | |||||||||
481 |
Affiliated | 414 | Somerset Dialysis | Somerset Dialysis Center | 240 CHURCHILL AVE | SOMERSET | NJ | 08873-3451 | ||||||||||
482 |
Affiliated | 2031 | East Ft. Lauderdale Dialysis | East Ft. Lauderdale Dialysis Center (fka No. Broward) | 1301 S ANDREWS AVE | STE 11 | FT LAUDERDALE | FL | 33316-1823 | |||||||||
483 |
Affiliated | 1593 | Spring Branch Dialysis | Spring Branch Dialysis | 1425 BLALOCK | STE 1 | HOUSTON | TX | 77055-4446 | |||||||||
484 |
Affiliated | 1599 | Battle Creek Dialysis | Battle Creek Dialysis | 220 E GOODALE AVE | BATTLE CREEK | MI | 49037-2728 | ||||||||||
485 |
Affiliated | 2025 | Hampton Avenue Dialysis | Hampton Avenue Dialysis-MO (Forest Park) | 1425 HAMPTON AVE | SAINT LOUIS | MO | 63139-3115 | ||||||||||
486 |
Affiliated | 1605 | Bogalusa Kidney Care | Bogalusa Kidney Care | 2108 SOUTH AVE F | BOGALUSA | LA | 70427 | ||||||||||
487 |
Affiliated | 2055 | Bardstown Dialysis | Bardstown Dialysis Center | 210 W JOHN FITCH AVE | BARDSTOWN | KY | 40004-1115 | ||||||||||
488 |
Affiliated | 2050 | Southern Pines | Southern Pines Dialysis Center | 209 WINDSTAR PL | SOUTHERN PINES | NC | 28387-7086 | ||||||||||
489 |
Affiliated | 2030 | Montclare Dialysis | Montclare Dialysis Center (aka Belmont Ave) | 7009 W BELMONT AVE | CHICAGO | IL | 60634-4533 | ||||||||||
490 |
Affiliated | 2048 | Southern Hills | Southern Hills Dialysis Center | 9280 W SUNSET RD | STE 11 | LAS VEGAS | NV | 89148-4861 | |||||||||
491 |
Affiliated | 2068 | Kilgore Dialysis | Kilgore Dialysis Center | 209 HWY 42 NORTH | KILGORE | TX | 75662-5019 | ||||||||||
492 |
Affiliated | 2067 | Brighton Dialysis | Brighton Dialysis | 4700 E BROMLEY LN | STE 13 | BRIGHTON | CO | 80601-7821 | |||||||||
493 |
Affiliated | 2023 | Union Gap | Union Gap Dialysis (aka Yakima) | 1236 AHTANUM RIDGE DR | AHTANUM RIDGE BUSINESS PARK | UNION GAP | WA | 98903-1813 | |||||||||
494 |
Affiliated | 2039 | Dallas North Dialysis | Dallas North Dialysis Center (aka Greenville) | 11886 GREENVILLE AVE | STE 1B | DALLAS | TX | 75243-9743 | |||||||||
495 |
Affiliated | 2061 | Grovepark Dialysis | Grovepark Dialysis Center (fka Jackson Dialysis) | 794 MCDONOUGH RD | JACKSON | GA | 30233-1572 | ||||||||||
496 |
Affiliated | 1583 | Eastern Kentucky Dialysis | Eastern Kentucky Dialysis | 167 WEDDINGTON BRANCH RD | PIKEVILLE | KY | 41501-3204 | ||||||||||
497 |
Affiliated | 1584 | Paintsville Dialysis | Paintsville Dialysis | 4750 S KY ROUTE 321 | HAGERHILL | KY | 41222 | ||||||||||
498 |
Affiliated | 1582 | West Virginia Dialysis | West Virginia Dialysis | 300 PROSPERITY LANE | STE 15 | LOGAN | WV | 25601-3494 | |||||||||
499 |
Affiliated | 2049 | Reidsville Dialysis | Reidsville Dialysis | 1307 FREEWAY DR | REIDSVILLE | NC | 27320-7104 | ||||||||||
500 |
Affiliated | 2034 | Elk Grove Dialysis | Elk Grove Dialysis | 9281 OFFICE PARK CIR | STE 15 | ELK GROVE | CA | 95758-8069 | |||||||||
501 |
Affiliated | 2035 | Weston Dialysis | Weston Dialysis Center (fka Cleveland Clinic ) | 2685 EXECUTIVE PARK DR | STE 1 | WESTON | FL | 33331-3651 | |||||||||
502 |
Affiliated | 1600 | McCook Dialysis | McCook Dialysis Center | 801 W C ST | MCCOOK | NE | 69001-3591 | ||||||||||
503 |
Affiliated | 1601 | Hastings Dialysis | Hastings Dialysis Center | 1900 N SAINT JOSEPH AVE | HASTINGS | NE | 68901-2652 | ||||||||||
504 |
Affiliated | 1602 | Capital City Dialysis | Capital City Dialysis | 307 N 46TH ST | LINCOLN | NE | 68503-3714 | ||||||||||
505 |
Affiliated | 1616 | Renal Care of Bowie | Renal Care of Bowie | 4861 TELSA DRIVE | STES G-H | BOWIE | MD | 20715-4318 | |||||||||
506 |
Affiliated | 1617 | Renal Care of Takoma Park | Takoma Park Dialysis (fka Renal Care of Takoma Park) | 1502 UNIVERSITY BLVD E | HYATTSVILLE | MD | 20783 | ||||||||||
507 |
Affiliated | 1618 | Renal Care of Lanham | Renal Care of Lanham | 8855 ANNAPOLIS RD | STE 2 | LANHAM | MD | 20706-2942 | |||||||||
508 |
Affiliated | 1619 | Parma Dialysis | Parma Dialysis Center | 6735 AMES RD | CLEVELAND | OH | 44129-5601 | ||||||||||
509 |
Affiliated | 1620 | Middleburg Heights Dialysis | Middleburg Hts. Dialysis | 7360 ENGLE RD | MIDDLEBURG HTS | OH | 44130 | ||||||||||
510 |
Affiliated | 1621 | Rocky River Dialysis | Rocky River Dialysis | 20220 CENTER RIDGE RD | STE 5 | ROCKY RIVER | OH | 44116-3567 | |||||||||
511 |
Affiliated | 1606 | Diamond Valley Dialysis | Diamond Valley Dialysis | 1030 E FLORIDA AVE | HEMET | CA | 92543-4511 | ||||||||||
512 |
Affiliated | 1607 | Murrieta Dialysis | Murrieta Dialysis | 25100 HANCOCK AVE | STE 11 | MURRIETA | CA | 92562-5973 | |||||||||
513 |
Affiliated | 2057 | South Chico Dialysis | South Chico Dialysis Center | 2345 FOREST AVE | CHICO | CA | 95928-7641 | ||||||||||
514 |
Affiliated | 2099 | Dixon Kidney Center | Dixon Kidney Center | 1131 N GALENA AVE | DIXON | IL | 61021-1015 | ||||||||||
515 |
Affiliated | 1640 | Grand Rapids | PDI-Grand Rapids | 801 CHERRY ST SE | GRAND RAPIDS | MI | 49506-1440 | ||||||||||
516 |
Affiliated | 1641 | Grand Rapids East | PDI-Grand Rapids East | 1230 EKHART ST NE | GRAND RAPIDS | MI | 49503-1372 | ||||||||||
517 |
Affiliated | 1642 | Grand Haven | PDI-Grand Haven | 16964 ROBBINS RD | GRAND HAVEN | MI | 49417-2796 | ||||||||||
518 |
Affiliated | 1644 | Highland Park | PDI-Highland Park | 64 VICTOR ST | HIGHLAND PARK | MI | 48203-3128 | ||||||||||
519 |
Affiliated | 1645 | Cadieux | PDI-Cadieux | 6150 CADIEUX ROAD | DETROIT | MI | 48224-2006 | ||||||||||
520 |
Affiliated | 1646 | Montgomery | PDI-Montgomery | 1001 FOREST AVE | MONTGOMERY | AL | 36106-1181 | ||||||||||
521 |
Affiliated | 1647 | East Montgomery | PDI-East Montgomery | 6890 WINTON BLOUNT BLVD | MONTGOMERY | AL | 36117-3516 | ||||||||||
522 |
Affiliated | 1648 | Prattville | PDI-Prattville | 1815 GLYNWOOD DR | PRATTVILLE | AL | 36066-5584 | ||||||||||
523 |
Affiliated | 1649 | Elmore | PDI-Elmore | 125 HOSPITAL DR | WETUMPKA | AL | 36092-1626 | ||||||||||
524 |
Affiliated | 1650 | Fitchburg | PDI-Fitchburg | 551 ELECTRIC AVE | FITCHBURG | MA | 01420-5371 | ||||||||||
525 |
Affiliated | 1652 | Rocky Hill | PDI-Rocky Hill | 30 WATERCHASE DR | ROCKY HILL | CT | 06067-2110 | ||||||||||
526 |
Affiliated | 1653 | Middlesex | PDI-Middlesex Dialysis Center | 100 MAIN ST | STE A | MIDDLETOWN | CT | 06457-3477 | |||||||||
527 |
Affiliated | 1655 | Johnstown | PDI-Johnstown | 344 BUDFIELD ST | JOHNSTOWN | PA | 15904-3214 | ||||||||||
528 |
Affiliated | 1656 | Ebensburg | PDI-Ebensburg | 236 JAMESWAY RD | EBENSBURG | PA | 15931-4207 | ||||||||||
529 |
Affiliated | 1657 | Walnut Tower | PDI-Walnut Tower | 834 WALNUT ST | PHILADELPHIA | PA | 19107-5109 | ||||||||||
530 |
Affiliated | 1659 | Lancaster | PDI-Lancaster | 1412 E KING ST | LANCASTER | PA | 17602-3240 |
Page 92 of 123
531 |
Affiliated | 1660 | Ephrata | PDI-Ephrata | 67 W CHURCH ST | STEVENS | PA | 17578-9203 | ||||||||||
532 |
Affiliated | 2083 | Pinecrest Dialysis | Pinecrest Dialysis (aka North Marshall-TX) | 913 E PINECREST DR | MARSHALL | TX | 75670-7309 | ||||||||||
533 |
Affiliated | 551 | Westwood Dialysis | Westwood Dialysis Center (aka West Seattle) | 2615 SW TRENTON ST | SEATTLE | WA | 98126-3745 | ||||||||||
534 |
Affiliated | 2107 | Louisville Dialysis | Louisville Dialysis | 8037 DIXIE HWY | LOUISVILLE | KY | 40258-1344 | ||||||||||
535 |
Affiliated | 2018 | Fair Oaks Dialysis | Fair Oaks Dialysis Center (fka Chantilly & Centreville) | 3955 PENDER DR | ONE PENDER BUSINESS PARK | FAIRFAX | VA | 22030-6091 | |||||||||
536 |
Affiliated | 421 | Oak Cliff | Oak Cliff Dialysis | 2000 S LLEWELLYN AVE | DALLAS | TX | 75224-1804 | ||||||||||
537 |
Affiliated | 2126 | Gilmer Dialysis | Gilmer Dialysis Center | 519 N WOOD ST | GILMER | TX | 75644-1746 | ||||||||||
538 |
Affiliated | 1608 | Chicago Heights Dialysis | Chicago Heights Dialysis | 177 W JOE ORR RD | STE B | CHICAGO HEIGHTS | IL | 60411-1733 | |||||||||
539 |
Affiliated | 1623 | East Georgia Dialysis | East Georgia Dialysis | 450 GEORGIA AVE | STE A | STATESBORO | GA | 30458-5590 | |||||||||
540 |
Affiliated | 1639 | Northlake Dialysis | Northlake Dialysis | 1350 MONTREAL RD | STE 2 | TUCKER | GA | 30084-8144 | |||||||||
541 |
Affiliated | 1680 | Down River Dialysis | Downriver Kidney Center | 5600 ALLEN RD | ALLEN PARK | MI | 48101-2604 | ||||||||||
542 |
Affiliated | 2063 | Belcaro | Belcaro Dialysis Center | 755 S COLORADO BLVD | DENVER | CO | 80246-8005 | ||||||||||
543 |
Affiliated | 2076 | Sherwood Dialysis Center | Sherwood Dialysis Center | 21035 SW PACIFIC HWY | SHERWOOD | OR | 97140-8062 | ||||||||||
544 |
Affiliated | 2054 | Lonetree Dialysis | Lonetree Dialysis Center (aka Skyridge) | 9777 MOUNT PYRAMID CT | STE 14 | ENGLEWOOD | CO | 80112-6017 | |||||||||
545 |
Affiliated | 2078 | River Park Dialysis | River Park Dialysis (aka Conroe) | 2010 S LOOP 336 W | STE 2 | CONROE | TX | 77304-3313 | |||||||||
546 |
Affiliated | 2058 | Northshore Dialysis | Northshore Kidney Center (fka Slidell II) | 106 MEDICAL CENTER DR | SLIDELL | LA | 70461-5575 | ||||||||||
547 |
Affiliated | 2036 | Marysville Dialysis | Marysville Dialysis Center | 1015 8TH ST | MARYSVILLE | CA | 95901-5271 | ||||||||||
548 |
Affiliated | 2070 | West Georgia Dialysis | West Georgia Dialysis | 1216 STARK AVE | COLUMBUS | GA | 31906-2500 | ||||||||||
549 |
Affiliated | 2102 | East Dearborn Dialysis | Westland Dialysis (aka Canton) | 36588 FORD RD | WESTLAND | MI | 48185-3769 | ||||||||||
550 |
Affiliated | 2045 | Downtown Houston Dialysis | Downtown Houston Dialysis Center | 2207 CRAWFORD ST | HOUSTON | TX | 77002-8915 | ||||||||||
551 |
Affiliated | 2066 | Concord Dialysis | Concord Dialysis Center | 2300 STANWELL DR | STE C | CONCORD | CA | 94520-4841 | |||||||||
552 |
Affiliated | 2087 | Pendleton Dialysis | Pendleton Dialysis (aka Clemson, Tri-County) | 7703 HIGHWAY 76 | PENDLETON | SC | 29670-1818 | ||||||||||
553 |
Affiliated | 2106 | New Albany Dialysis | New Albany Dialysis | 2669 CHARLESTON RD | NEW ALBANY | IN | 47150-2573 | ||||||||||
554 |
Affiliated | 1585 | Whitesburg Dialysis | Whitesburg Dialysis | 222 HOSPITAL RD | STE D | WHITESBURG | KY | 41858-7627 | |||||||||
555 |
Affiliated | 2047 | Jacinto Dialysis | Jacinto Dialysis Center (aka East Houston) | 11515 MARKET STREET RD | HOUSTON | TX | 77029-2305 | ||||||||||
556 |
Affiliated | 2088 | Transmountain Dialysis | Transmountain Dialysis (aka Northeast El Paso, Rushfair) | 5255 WOODROW BEAN | STE B18 | EL PASO | TX | 79924-3832 | |||||||||
557 |
Affiliated | 2029 | Southcrest Dialysis | Southcrest Dialysis (aka South Creek) | 9001 S 101ST EAST AVE | STE 11 | TULSA | OK | 74133-5799 | |||||||||
558 |
Affiliated | 2071 | Lake Hearn | Lake Hearn Dialysis (aka Dunwoody, Roswell, Northside) | 1150 LAKE HEARN DR NE | STE 1 | ATLANTA | GA | 30342-1566 | |||||||||
559 |
Affiliated | 2118 | Mt. Greenwood | Mt. Greenwood Dialysis | 3401 W 111TH ST | CHICAGO | IL | 60655-3329 | ||||||||||
560 |
Affiliated | 2086 | Citrus Valley Dialysis Center | Citrus Valley Dialysis (aka San Bernadino II) | 894 HARDT STREET | SAN BERNARDINO | CA | 92408-2854 | ||||||||||
561 |
Affiliated | 2095 | McDowell County Dialysis | McDowell County Dialysis Center | 100 SPAULDING RD | STE 2 | MARION | NC | 28752-5116 | |||||||||
562 |
Affiliated | 2115 | Leigh Dialysis Center | Leigh Dialysis Center (aka Leigh-Kempville-VA) | 420 N CENTER DR | STE 128 | NORFOLK | VA | 23502-4019 | |||||||||
563 |
Affiliated | 2120 | Dialysis of Lithonia | Dialysis of Lithonia | 2485 PARK CENTRAL BLVD | DECATUR | GA | 30035-3902 | ||||||||||
564 |
Affiliated | 2114 | Embassy Lake Artificial Kidney Center | Embassy Lake Artificial Kidney Center (fka Davie & South Broward AKC) | 11011 SHERIDAN ST | STE 38 | HOLLYWOOD | FL | 33026-1505 | |||||||||
565 |
Affiliated | 2056 | Sun City Dialysis | Sun City Dialysis (akaTexas Tech II) | 600 NEWMAN ST | EL PASO | TX | 79902-5543 | ||||||||||
566 |
Affiliated | 1651 | PDI Worcester | PDI-Worcester Dialysis | 19 GLENNIE ST | STE A | WORCESTER | MA | 01605-3918 | |||||||||
567 |
Affiliated | 2130 | Davenport Dialysis Center | Davenport Dialysis Center (aka Haines City II) | 45597 HIGHWAY 27 | RIDGEVIEW PLAZA | DAVENPORT | FL | 33897-4519 | |||||||||
568 |
Affiliated | 2081 | Cinema Dialysis | Cinema Dialysis (aka OKC South) | 3909 S WESTERN AVE | OKLAHOMA CITY | OK | 73109-3405 | ||||||||||
569 |
Affiliated | 2037 | Greenwood Dialysis Center | Greenwood Dialysis Center (North Tulsa) | 1345 N LANSING AVE | TULSA | OK | 74106-5911 | ||||||||||
570 |
Affiliated | 1712 | TRC Alamosa Diakysis | Alamosa Dialysis | 612 DEL SOL DR | ALAMOSA | CO | 81101-8548 | ||||||||||
571 |
Affiliated | 1682 | South Austin | South Austin Dialysis | 6114 S 1ST ST | AUSTIN | TX | 78745-4008 | ||||||||||
572 |
Affiliated | 2109 | Durango Dialysis Center | Durango Dialysis Center | 72 SUTTLE STREET | STE D | DURANGO | CO | 81303-6829 | |||||||||
573 |
Affiliated | 1700 | Bolivar Dialysis | Bolivar Dialysis | 515 PECAN DR | BOLIVAR | TN | 38008-1611 | ||||||||||
574 |
Affiliated | 1701 | Brownsville Dialysis | Brownsville Dialysis | 380 N DUPREE AVE | BROWNSVILLE | TN | 38012-2332 | ||||||||||
575 |
Affiliated | 1702 | Camden Dialysis | Camden Dialysis | 168 W MAIN ST | STE A | CAMDEN | TN | 38320-1767 | |||||||||
576 |
Affiliated | 1703 | Collierville Dialysis | Collierville Dialysis | 791 W POPLAR AVE | COLLIERVILLE | TN | 38017-2543 | ||||||||||
577 |
Affiliated | 1705 | Galleria Dialysis | Galleria Dialysis | 9160 HIGHWAY 64 | LAKELAND | TN | 38002-4766 | ||||||||||
578 |
Affiliated | 1706 | Humboldt Dialysis | Humboldt Dialysis | 2214 OSBORNE ST | HUMBOLDT | TN | 38343-3044 | ||||||||||
579 |
Affiliated | 1707 | Stonegate Dialysis | North Jackson Dialysis (fka Stonegate) | 217 STERLING FARM DR | JACKSON | TN | 38305-5727 | ||||||||||
580 |
Affiliated | 1708 | Lexington Dialysis | Lexington Dialysis | 317 W CHURCH ST | LEXINGTON | TN | 38351-2096 | ||||||||||
581 |
Affiliated | 1709 | Pickwick Dialysis | Pickwick Dialysis | 121 PICKWICK ST | SAVANNAH | TN | 38372-1953 | ||||||||||
582 |
Affiliated | 1710 | Selmber Dialysis | Selmer Dialysis | 251 OAKGROVE RD | SELMER | TN | 38375-1881 | ||||||||||
583 |
Affiliated | 1713 | Childs Dialysis | Childs Dialysis | 101 MAIN ST | CHILDS | PA | 18407-2614 | ||||||||||
584 |
Affiliated | 1714 | Dunmore Dialysis | Dunmore Dialysis | 1212 ONEIL HWY | DUNMORE | PA | 18512-1717 | ||||||||||
585 |
Affiliated | 1716 | Old Forge Dialysis | Old Forge Dialysis | 325 S MAIN ST | OLD FORGE | PA | 18518-1677 | ||||||||||
586 |
Affiliated | 1717 | Scranton Dialysis | Scranton Dialysis | 475 MORGAN HWY | SCRANTON | PA | 18508-2605 | ||||||||||
587 |
Affiliated | 1718 | Tunkhannock Dialysis | Tunkhannock Dialysis | 5950 SR 6 | TUNKHANNOCK | PA | 18657-7905 | ||||||||||
588 |
Affiliated | 1725 | East Evansville Dialysis | East Evansville Dialysis | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | ||||||||||
589 |
Affiliated | 1726 | North Evansville Dialysis | North Evansville Dialysis | 1151 W BUENA VISTA RD | EVANSVILLE | IN | 47710-3334 | ||||||||||
590 |
Affiliated | 1728 | Jasper Dialysis | Jasper Dialysis | 721 W 13TH ST | STE 15 | JASPER | IN | 47546-1856 | |||||||||
591 |
Affiliated | 1729 | Daviess County Dialysis | Daviess County Dialysis | 310 NE 14TH ST | WASHINGTON | IN | 47501-2137 | ||||||||||
592 |
Affiliated | 1730 | Gardenside Dialysis | Gardenside Dialysis | 70 N GARDENMILE RD | HENDERSON | KY | 42420-5529 | ||||||||||
593 |
Affiliated | 1732 | PD Evansville Dialysis | East Evansville Dialysis PD | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | ||||||||||
594 |
Affiliated | 2098 | Meridian Dialysis Center | Meridian Dialysis Center (aka Bayshore) | 201 W FAIRMONT PKWY | STE A | LA PORTE | TX | 77571-6303 | |||||||||
595 |
Affiliated | 2100 | Sycamore Dialysis | Sycamore Dialysis (aka DeKalb) | 2200 GATEWAY DR | SYCAMORE | IL | 60178-3113 | ||||||||||
596 |
Affiliated | 2104 | Ballenger Pointe Dialysis | Ballenger Pointe Dialysis (aka West Flint) | 2262 S BALLENGER HWY | FLINT | MI | 48503-3447 | ||||||||||
597 |
Affiliated | 2139 | Leitchfield Dialysis | Leitchfield Dialysis | 912 WALLACE AVE | STE 16 | LEITCHFIELD | KY | 42754-2405 |
Page 93 of 123
598 |
Affiliated | 2097 | Roxbury Dialysis Center | Roxbury Dialysis | 622 ROXBURY RD | ROCKFORD | IL | 61107-5089 | ||||||||||
599 |
Affiliated | 2148 | LaGrange Dialysis | La Grange Dialysis | 240 PARKER DR | LA GRANGE | KY | 40031-1200 | ||||||||||
600 |
Affiliated | 2132 | Des Moines East | East Des Moines Dialysis (aka Des Moines II) | 1301 PENNSYLVANIA AVE | STE 28 | DES MOINES | IA | 50316-2365 | |||||||||
601 |
Affiliated | 2119 | Lake Villa Dialysis | Lake Villa Dialysis | 37809 N IL ROUTE 59 | LAKE VILLA | IL | 60046-7332 | ||||||||||
602 |
Affiliated | 159 | Seneca Dialysis | Seneca County Dialysis | 65 SAINT FRANCIS AVE | TIFFIN | OH | 44883-3413 | ||||||||||
603 |
Affiliated | 407 | Perry | Perry Dialysis Center | 1027 KEITH DR | PERRY | GA | 31069-2948 | ||||||||||
604 |
Affiliated | 661 | Wilshire | Wilshire Dialysis | 1212 WILSHIRE BLVD | LOS ANGELES | CA | 90017-1902 | ||||||||||
605 |
Affiliated | 692 | University Park | University Park Dialysis Center | 3986 S FIGUEROA ST | LOS ANGELES | CA | 90037-1222 | ||||||||||
606 |
Affiliated | 1720 | Metro East Dialysis | Metro East Dialysis | 5105 W MAIN ST | BELLEVILLE | IL | 62226-4728 | ||||||||||
607 |
Affiliated | 2196 | Ocala Regional Kidney Centers | Ocala Regional Kidney Centers Home Dialysis Division PD | 2860 SE 1ST AVE | OCALA | FL | 34471-0406 | ||||||||||
608 |
Affiliated | 2133 | Little Village Dialysis | Little Village Dialysis (Chicago) | 2335 W CERMAK RD | CHICAGO | IL | 60608-3811 | ||||||||||
609 |
Affiliated | 2112 | Crossroads | Crossroads Dialysis (aka Fullerton Dialysis) | 3214 YORBA LINDA BLVD | FULLERTON | CA | 92831-1707 | ||||||||||
610 |
Affiliated | 1727 | Vincennes Dialysis | Vincennes Dialysis | 700 WILLOW ST | VINCENNES | IN | 47591-1028 | ||||||||||
611 |
Affiliated | 1723 | Spring Dialysis | Spring Dialysis | 607 TIMBERDALE LN | STE 1 | HOUSTON | TX | 77090-3043 | |||||||||
612 |
Affiliated | 2190 | River Center | Rivercenter Dialysis (aka Central San Antonio) | 1123 N MAIN AVE | STE 15 | SAN ANTONIO | TX | 78212-4738 | |||||||||
613 |
Affiliated | 2193 | Southcross Dialysis Center | Southcross Dialysis (aka SouthEast San Antonio) | 4602 E SOUTHCROSS BLVD | SAN ANTONIO | TX | 78222-4911 | ||||||||||
614 |
Affiliated | 2125 | Bonham Dialysis | Bonham Dialysis | 201 W 5TH ST | BONHAM | TX | 75418-4302 | ||||||||||
615 |
Affiliated | 2192 | Northwest Medical Center Dialysis | NW Medical Center Dialysis (aka NorthWest San Antonio) | 5284 MEDICAL DR | STE 1 | SAN ANTONIO | TX | 78229-4849 | |||||||||
616 |
Affiliated | 2124 | Ontario Dialysis | Ontario Dialysis (aka Dr. Handoko) | 1950 S GROVE AVE | STE 11-15 | ONTARIO | CA | 91761-5693 | |||||||||
617 |
Affiliated | 1750 | Chipley Community Dialysis | Chipley Dialysis | 877 3RD ST | STE 2 | CHIPLEY | FL | 32428-1855 | |||||||||
618 |
Affiliated | 1751 | North Ikaloosa | North Okaloosa Dialysis | 320 REDSTONE AVE W | CRESTVIEW | FL | 32536-6433 | ||||||||||
619 |
Affiliated | 1752 | West Florida Dialysis | West Florida Dialysis | 8333 N DAVIS HWY | 1ST FLOOR ATTN DIALYSIS ROOM | PENSACOLA | FL | 32514-6049 | |||||||||
620 |
Affiliated | 1753 | Santa Rosa Dialysis | Santa Rosa Dialysis | 5819 HIGHWAY 90 | MILTON | FL | 32583-1763 | ||||||||||
621 |
Affiliated | 1755 | Atmore Dialysis | Atmore Dialysis Center | 807 E CRAIG ST | ATMORE | AL | 36502-3017 | ||||||||||
622 |
Affiliated | 1756 | South Baldwin Dialysis | South Baldwin Dialysis Center | 150 W PEACHTREE AVE | FOLEY | AL | 36535-2244 | ||||||||||
623 |
Affiliated | 1731 | Olney Dialysis | Olney Dialysis Center (aka Good Samaritan Hospital) | 117 N BOONE ST | OLNEY | IL | 62450-2109 | ||||||||||
624 |
Affiliated | 2156 | Lancaster Dialysis | Lancaster Dialysis | 2424 W PLEASANT RUN RD | LANCASTER | TX | 75146-4005 | ||||||||||
625 |
Affiliated | 2136 | Columbia Dialysis | RTC-Columbia Dialysis (MO) | 1701 E BROADWAY | STE G12 | COLUMBIA | MO | 65201-8029 | |||||||||
626 |
Affiliated | 2194 | Las Palmas Dialysis Center | Las Palmas Dialysis Center (aka West San Antonio) | 803 CASTROVILLE RD | STE 415 | SAN ANTONIO | TX | 78237-3148 | |||||||||
627 |
Affiliated | 2116 | South Shore Dialysis Center | South Shore Dialysis (aka Horizon) | 212 GULF FWY S | STE G3 | LEAGUE CITY | TX | 77573-3957 | |||||||||
628 |
Affiliated | 2191 | Marymount Dilaysis Center | Marymont Dialysis (aka NorthEast San Antonio) | 2391 NE LOOP 410 | STE 211 | SAN ANTONIO | TX | 78217-5675 | |||||||||
629 |
Affiliated | 1744 | Fox River Dialysis | Fox River Dialysis | 1910 RIVERSIDE DR | GREEN BAY | WI | 54301-2319 | ||||||||||
630 |
Affiliated | 1745 | Titletown Dialysis | Titletown Dialysis | 120 SIEGLER ST | GREEN BAY | WI | 54303-2636 | ||||||||||
631 |
Affiliated | 1746 | Northwoods Dialysis | Green Bay Northwood Dialysis | W 7305 ELM AVENUE | SHAWANO | WI | 54166-1024 | ||||||||||
632 |
Affiliated | 1758 | North Charleston Dialysis | North Charleston Dialysis | 5900 RIVERS AVE | STE E | NORTH CHARLESTON | SC | 29406 | |||||||||
633 |
Affiliated | 1759 | Charleston County Dialysis | Faber Place Dialysis | 3801 FABER PLACE DR | NORTH CHARLESTON | SC | 29405-8533 | ||||||||||
634 |
Affiliated | 1760 | Goose Creek Dialysis | Goose Creek Dialysis | 109 GREENLAND DR | GOOSE CREEK | SC | 29445-5354 | ||||||||||
635 |
Affiliated | 2501 | Bridgeport Dialysis | Bridgeport Dialysis | 900 MADISON AVE | STE 221 | BRIDGEPORT | CT | 06606-5534 | |||||||||
636 |
Affiliated | 2503 | Greater Waterbury Dialysis | Greater Waterbury Dialysis | 209 HIGHLAND AVE | WATERBURY | CT | 06708-3026 | ||||||||||
637 |
Affiliated | 2506 | Shelton Dialysis | Shelton Dialysis | 750 BRIDGEPORT AVE | SHELTON | CT | 06484-4734 | ||||||||||
638 |
Affiliated | 2508 | Yuma Dialysis | Yuma Dialysis | 2130 W 24TH ST | YUMA | AZ | 85364-6122 | ||||||||||
639 |
Affiliated | 2509 | Pittsburgh Dialysis | Pittsburgh Dialysis | 4312 PENN AVE | PITTSBURGH | PA | 15224-1310 | ||||||||||
640 |
Affiliated | 2510 | Elizabeth Dialysis | Elizabeth Dialysis | 201 MCKEESPORT RD | ELIZABETH | PA | 15037-1623 | ||||||||||
641 |
Affiliated | 2511 | Brandon East Dialysis | Brandon East Dialysis | 114 E BRANDON BLVD | BRANDON | FL | 33511-5219 | ||||||||||
642 |
Affiliated | 2513 | North Rolling Road Dialysis | North Rolling Road Dialysis | 1108 N ROLLING RD | BALTIMORE | MD | 21228-3826 | ||||||||||
643 |
Affiliated | 2521 | Memphis South Dialysis | Memphis South Dialysis | 1205 MARLIN RD | MEMPHIS | TN | 38116-5812 | ||||||||||
644 |
Affiliated | 2524 | Hartford Dialysis | Hartford Dialysis | 675 TOWER AVE | RENAL UNIT 2ND FL | HARTFORD | CT | 6112 | |||||||||
645 |
Affiliated | 2538 | New Orleans Uptown Dialysis | New Orleans Uptown Dialysis | 1401 FOUCHER ST | 4TH FLOOR DIALYSIS | NEW ORLEANS | LA | 70115-3515 | |||||||||
646 |
Affiliated | 2540 | Omaha West Dialysis | Omaha West Dialysis | 13014 W DODGE RD | OMAHA | NE | 68154-2148 | ||||||||||
647 |
Affiliated | 2541 | White Memorial Dialysis | East Los Angeles Plaza Dialysis (fka White Memorial) | 1700 E CESAR E CHAVEZ AVE | STE L 1 | LOS ANGELES | CA | 90033-2424 | |||||||||
648 |
Affiliated | 2542 | Imperial Dialysis | Imperial Dialysis | 2738 W IMPERIAL HWY | INGLEWOOD | CA | 90303-3111 | ||||||||||
649 |
Affiliated | 2546 | North Hollywood Dialysis | North Hollywood Dialysis | 12126 VICTORY BLVD | NORTH HOLLYWOOD | CA | 91606-3205 | ||||||||||
650 |
Affiliated | 2555 | Mountain View Dialysis | Mountain View Dialysis | 2881 BUSINESS PARK CT | STE 13 | LAS VEGAS | NV | 89128-9019 | |||||||||
651 |
Affiliated | 2560 | San Juan Capistrano South Dialysis | San Juan Capistrano South Dialysis | 31736 RANCHO VIEJO RD | STE B | SAN JUAN CAPISTRANO | CA | 92675-2783 | |||||||||
652 |
Affiliated | 2564 | Mission Viejo Dialysis | Mission Viejo Dialysis | 27640 MARGUERITE PKWY | MISSION VIEJO | CA | 92692-3604 | ||||||||||
653 |
Affiliated | 2568 | HI-Desert Dialysis | HI-Desert Dialysis | 58457 29 PALMS HWY | STE 12 | YUCCA VALLEY | CA | 92284-5879 | |||||||||
654 |
Affiliated | 2571 | Banning Dialysis | Banning Dialysis | 6090 W RAMSEY ST | BANNING | CA | 92220-3052 | ||||||||||
655 |
Affiliated | 2601 | Rainbow City Dialysis | Rainbow City Dialysis | 2800 RAINBOW DR | RAINBOW CITY | AL | 35906-5811 | ||||||||||
656 |
Affiliated | 2604 | Gadsden Dialysis | Gadsden Dialysis | 409 S 1ST ST | GADSDEN | AL | 35901-5358 | ||||||||||
657 |
Affiliated | 2605 | Chateau Dialysis | Chateau Dialysis | 720 VILLAGE RD | KENNER | LA | 70065-2751 | ||||||||||
658 |
Affiliated | 2606 | Donaldsonville Dialysis | Donaldsonville Dialysis | 101 PLIMSOL DR | DONALDSONVILLE | LA | 70346-4357 | ||||||||||
659 |
Affiliated | 2609 | Dothan Dialysis | Dothan Dialysis | 216 GRACELAND DR | DOTHAN | AL | 36305-7346 | ||||||||||
660 |
Affiliated | 2614 | Birmingham East Dialysis | Birmingham East Dialysis | 1105 E PARK DR | BIRMINGHAM | AL | 35235-2560 | ||||||||||
661 |
Affiliated | 2615 | Tuscaloosa Dialysis | Tuscaloosa Dialysis | 805 OLD MILL ST | TUSCALOOSA | AL | 35401-7132 | ||||||||||
662 |
Affiliated | 2616 | Demopolis Dialysis | Demopolis Dialysis | 511 S CEDAR AVE | DEMOPOLIS | AL | 36732-2235 | ||||||||||
663 |
Affiliated | 2623 | Singing River Dialysis | Singing River Dialysis | 4907 TELEPHONE RD | PASCAGOULA | MS | 39567-1823 | ||||||||||
664 |
Affiliated | 2624 | Ocean Springs Dialysis | Ocean Springs Dialysis | 13150 PONCE DE LEON DR | OCEAN SPRINGS | MS | 39564-2460 |
Page 94 of 123
665 |
Affiliated | 2625 | Lucedale Dialysis | Lucedale Dialysis | 652 MANILA ST | LUCEDALE | MS | 39452-5962 | ||||||||||
666 |
Affiliated | 2707 | Holmdel Dialysis | Holmdel Dialysis | 668 N BEERS ST | HOLMDEL | NJ | 07733-1526 | ||||||||||
667 |
Affiliated | 2855 | Alameda County Dialysis | Alameda County Dialysis | 10700 MACARTHUR BLVD | STE 14 | OAKLAND | CA | 94605-5260 | |||||||||
668 |
Affiliated | 2908 | Elizabeth City Dialysis | Elizabeth City Dialysis | 1840 W CITY DR | ELIZABETH CITY | NC | 27909-9632 | ||||||||||
669 |
Affiliated | 2914 | Cookeville Dialysis | Cookeville Dialysis | 140 W 7TH ST | COOKEVILLE | TN | 38501-1726 | ||||||||||
670 |
Affiliated | 3001 | Inglewood Dialysis | Inglewood Dialysis | 125 E ARBOR VITAE ST | INGLEWOOD | CA | 90301-3839 | ||||||||||
671 |
Affiliated | 3002 | Rome Dialysis | Rome Dialysis | 15 JOHN MADDOX DR NW | ROME | GA | 30165-1413 | ||||||||||
672 |
Affiliated | 3004 | Pomona Dialysis | Pomona Dialysis | 2111 N GAREY AVE | POMONA | CA | 91767-2328 | ||||||||||
673 |
Affiliated | 3005 | Oak Street Dialysis | Oak Street Dialysis (fka Valdosta) | 2704 N OAK ST | BLDG H | VALDOSTA | GA | 31602-1723 | |||||||||
674 |
Affiliated | 3006 | Channelview Dialysis | Channelview Dialysis | 777 SHELDON RD | STE C | CHANNELVIEW | TX | 77530-3509 | |||||||||
675 |
Affiliated | 3007 | Sagemont Dialysis | Sagemont Dialysis | 10851 SCARSDALE BLVD | STE 2 | HOUSTON | TX | 77089-5738 | |||||||||
676 |
Affiliated | 3008 | San Jacinto Dialysis | San Jacinto Dialysis | 11430 EAST FWY | STE 33 | HOUSTON | TX | 77029-1959 | |||||||||
677 |
Affiliated | 3009 | Victor Valley Dialysis | Victor Valley Dialysis | 16049 KAMANA RD | APPLE VALLEY | CA | 92307-1331 | ||||||||||
678 |
Affiliated | 3010 | Delran Dialysis | Delran Dialysis | 8008 ROUTE 130 | DELRAN | NJ | 08075-1869 | ||||||||||
679 |
Affiliated | 3011 | Central Houston Dialysis | Central Houston Dialysis | 610 S WAYSIDE DR | UNIT B | HOUSTON | TX | 77011-4605 | |||||||||
680 |
Affiliated | 3012 | Southern Lane Dialysis | Southern Lane Dialysis | 1840 SOUTHERN LN | DECATUR | GA | 30033-4033 | ||||||||||
681 |
Affiliated | 3013 | Northumberland Dialysis | Northumberland Dialysis | 103 W STATE ROUTE 61 | MOUNT CARMEL | PA | 17851-2539 | ||||||||||
682 |
Affiliated | 3014 | Pryor Dialysis | Pryor Dialysis | 309 E GRAHAM AVE | PRYOR | OK | 74361-2434 | ||||||||||
683 |
Affiliated | 3015 | Oklahoma City South Dialysis | Oklahoma City South Dialysis | 5730 S MAY AVE | OKLAHOMA CITY | OK | 73119-5604 | ||||||||||
684 |
Affiliated | 3016 | Abington Dialysis | Abington Dialysis | 3940A COMMERCE AVE | WILLOW GROVE | PA | 19090-1705 | ||||||||||
685 |
Affiliated | 3017 | Memphis Central Dialysis | Memphis Central Dialysis | 889 LINDEN AVE | MEMPHIS | TN | 38126-2412 | ||||||||||
686 |
Affiliated | 3018 | Memphis East Dialysis | Memphis East Dialysis | 50 HUMPHREYS CTR | STE 42 | MEMPHIS | TN | 38120-2372 | |||||||||
687 |
Affiliated | 3019 | Clarksville Dialysis | Clarksville Dialysis | 231 HILLCREST DR | CLARKSVILLE | TN | 37043-5093 | ||||||||||
688 |
Affiliated | 3020 | Miami Campus Dialysis | Miami Campus Dialysis | 1500 NW 12TH AVE | STE 16 | MIAMI | FL | 33136-1028 | |||||||||
689 |
Affiliated | 3021 | Orlando Dialysis | Orlando Dialysis | 116 STURTEVANT ST | ORLANDO | FL | 32806-2021 | ||||||||||
690 |
Affiliated | 3024 | Durham Dialysis | Durham Dialysis | 601 FAYETTEVILLE ST | DURHAM | NC | 27701-3910 | ||||||||||
691 |
Affiliated | 3025 | Candler County Dialysis | Candler County Dialysis | 325 CEDAR ST | METTER | GA | 30439-4043 | ||||||||||
692 |
Affiliated | 3027 | Kerrville Dialysis | Kerrville Dialysis | 515 GRANADA PL | KERRVILLE | TX | 78028-5992 | ||||||||||
693 |
Affiliated | 3028 | Floresville Dialysis | Floresville Dialysis | 543 10TH ST | FLORESVILLE | TX | 78114-3107 | ||||||||||
694 |
Affiliated | 3029 | Pearsall Dialysis | Pearsall Dialysis | 1305 N OAK ST | PEARSALL | TX | 78061-3414 | ||||||||||
695 |
Affiliated | 3030 | Nogales Dialysis | Nogales Dialysis | 1231 W TARGET RANGE RD | NOGALES | AZ | 85621-2417 | ||||||||||
696 |
Affiliated | 3032 | Wilson Dialysis | Wilson Dialysis | 1605 MEDICAL PARK DR W | WILSON | NC | 27893-2799 | ||||||||||
697 |
Affiliated | 3033 | Goldsboro Dialysis | Goldsboro Dialysis | 2609 HOSPITAL RD | GOLDSBORO | NC | 27534-9424 | ||||||||||
698 |
Affiliated | 3034 | Roxboro Dialysis | Roxboro Dialysis | 718 RIDGE RD | ROXBORO | NC | 27573-4508 | ||||||||||
699 |
Affiliated | 3035 | Boston Dialysis | Boston Dialysis | 660 HARRISON AVE | BOSTON | MA | 02118-2304 | ||||||||||
700 |
Affiliated | 3037 | Jesup Dialysis | Jesup Dialysis | 301 PEACHTREE ST | JESUP | GA | 31545-0245 | ||||||||||
701 |
Affiliated | 3038 | Sheffield Dialysis | Sheffield Dialysis | 1120 S JACKSON HWY | ST 17 | SHEFFIELD | AL | 35660-5777 | |||||||||
702 |
Affiliated | 3039 | Berkeley Dialysis | Berkeley Dialysis | 2920 TELEGRAPH AVE | BERKELEY | CA | 94705-2031 | ||||||||||
703 |
Affiliated | 3040 | Douglas Dialysis | Douglas Dialysis | 190 WESTSIDE DR | STE A | DOUGLAS | GA | 31533-3534 | |||||||||
704 |
Affiliated | 3041 | Hopkinsville Dialysis | Hopkinsville Dialysis | 1914 S VIRGINIA ST | HOPKINSVILLE | KY | 42240-3610 | ||||||||||
705 |
Affiliated | 3042 | Roxborough Dialysis | Roxborough Dialysis | 5003 UMBRIA ST | PHILADELPHIA | PA | 19128-4301 | ||||||||||
706 |
Affiliated | 3043 | New Haven Dialysis | New Haven Dialysis | 100 CHURCH ST S | STE C | NEW HAVEN | CT | 06519-1703 | |||||||||
707 |
Affiliated | 3044 | Ocoee Dialysis | Ocoee Dialysis | 11140 W COLONIAL DR | STE 5 | OCOEE | FL | 34761-3300 | |||||||||
708 |
Affiliated | 3045 | Waverly Dialysis | Waverly Dialysis | 407 E BALTIMORE PIKE | MORTON | PA | 19070-1042 | ||||||||||
709 |
Affiliated | 3046 | Sells Dialysis | Sells Dialysis | PO BOX 3030 | HWY 86 MILEPOST 113 | SELLS | AZ | 85634-3030 | |||||||||
710 |
Affiliated | 3047 | Sierra Vista Dialysis | Sierra Vista Dialysis | 629 N HIGHWAY 90 | STE 6 | SIERRA VISTA | AZ | 85635-2257 | |||||||||
711 |
Affiliated | 3048 | Callaghan Road Dialysis | San Antonio West Dialysis (fka Callaghan Road) | 4530 CALLAGHAN RD | SAN ANTONIO | TX | 78228 | ||||||||||
712 |
Affiliated | 3049 | Houston Dialysis | Houston Dialysis | 7543 SOUTH FWY | HOUSTON | TX | 77021-5928 | ||||||||||
713 |
Affiliated | 3050 | South Yuma Dialysis | South Yuma Dialysis | 7179 E 31ST PLACE | YUMA | AZ | 85365-8392 | ||||||||||
714 |
Affiliated | 3052 | Cherry Hill Dialysis | Cherry Hill Dialysis | 1030 KINGS HWY N | STE 1 | CHERRY HILL | NJ | 08034-1907 | |||||||||
715 |
Affiliated | 3055 | Escondido Dialysis | Escondido Dialysis | 203 E 2ND AVE | ESCONDIDO | CA | 92025-4212 | ||||||||||
716 |
Affiliated | 3056 | Brookline Dialysis | Brookline Dialysis | 322 WASHINGTON ST | BROOKLINE | MA | 02445-6850 | ||||||||||
717 |
Affiliated | 3057 | Reliant Dialysis | Reliant Dialysis | 1335 LA CONCHA LN | HOUSTON | TX | 77054-1809 | ||||||||||
718 |
Affiliated | 3058 | Fullerton Dialysis | Fullerton Dialysis | 238 ORANGEFAIR MALL | FULLERTON | CA | 92832-3037 | ||||||||||
719 |
Affiliated | 3059 | Huntington Beach Dialysis | Huntington Beach Dialysis | 16892 BOLSA CHICA ST | STE 1 | HUNTINGTON BEACH | CA | 92649-3571 | |||||||||
720 |
Affiliated | 3060 | Eastlake Dialysis | Eastlake Dialysis (fka South Dekalb) | 1757 CANDLER RD | DECATUR | GA | 30032-3276 | ||||||||||
721 |
Affiliated | 3061 | Mt. Olive Dialysis | Mt. Olive Dialysis | 105 MICHAEL MARTIN RD | MOUNT OLIVE | NC | 28365-1112 | ||||||||||
722 |
Affiliated | 3062 | Southwest San Antonio Dialysis | Southwest San Antonio Dialysis | 1620 SOMERSET RD | SAN ANTONIO | TX | 78211-3021 | ||||||||||
723 |
Affiliated | 3064 | North Loop East Dialysis | North Loop East Dialysis | 7139 NORTH LOOP E | HOUSTON | TX | 77028-5903 | ||||||||||
724 |
Affiliated | 3065 | Katy Cinco Ranch Dialysis | Katy Cinco Ranch Dialysis | 1265 ROCK CANYON DR | KATY | TX | 77450-3831 | ||||||||||
725 |
Affiliated | 3067 | Palm Springs Dialysis | Palm Springs Dialysis | 1061 N INDIAN CANYON DR | PALM SPRINGS | CA | 92262-4854 | ||||||||||
726 |
Affiliated | 3069 | Muskegon Dialysis | Muskegon Dialysis | 1277 MERCY DR | MUSKEGON | MI | 49444-4605 | ||||||||||
727 |
Affiliated | 3070 | Loomis Road Dialysis | Loomis Road Dialysis | 4120 W LOOMIS RD | GREENFIELD | WI | 53221-2052 | ||||||||||
728 |
Affiliated | 3071 | Ludington Dialysis | Ludington Dialysis | 5 N ATKINSON DR | STE 11 | LUDINGTON | MI | 49431-2918 | |||||||||
729 |
Affiliated | 3073 | Walterboro Dialysis | Walterboro Dialysis | 302 RUBY ST | WALTERBORO | SC | 29488-2758 | ||||||||||
730 |
Affiliated | 3074 | K Street | K Street Dialysis (fka GWU N Street Dialysis) | 2131 K ST NW | WASHINGTON | DC | 20037-1898 | ||||||||||
731 |
Affiliated | 3075 | GWU Southeast Dialysis | GWU Southeast Dialysis | 3857A PENNSYLVANIA AVE SE | WASHINGTON | DC | 20020-1309 |
Page 95 of 123
732 |
Affiliated | 3076 | Lakeside Dialysis | Lakeside Dialysis | 10401 HOSPITAL DR | STE G2 | CLINTON | MD | 20735-3113 | |||||||||
733 |
Affiliated | 3077 | Summit Dialysis | Summit Dialysis | 1139 SPRUCE DR | MOUNTAINSIDE | NJ | 07092-2221 | ||||||||||
734 |
Affiliated | 3078 | Aiken Dialysis | Aiken Dialysis | 775 MEDICAL PARK DR | AIKEN | SC | 29801-6306 | ||||||||||
735 |
Affiliated | 3092 | Ozark Dialysis | Ozark Dialysis | 214 HOSPITAL AVE | OZARK | AL | 36360-2038 | ||||||||||
736 |
Affiliated | 3094 | Wylds Road Dialysis | Wylds Road Dialysis (fka Augusta South) | 1815 WYLDS RD | AUGUSTA | GA | 30909-4430 | ||||||||||
737 |
Affiliated | 3104 | Douglasville Dialysis | Douglasville Dialysis | 3899 LONGVIEW DR | DOUGLASVILLE | GA | 30135-1373 | ||||||||||
738 |
Affiliated | 3106 | Brunswick Dialysis | Brunswick Dialysis | 53 SCRANTON CONNECTOR | BRUNSWICK | GA | 31525-1862 | ||||||||||
739 |
Affiliated | 3109 | Benicia Dialysis | Benicia Dialysis | 560 1ST ST | STE 13 BLDG D | BENICIA | CA | 94510-3295 | |||||||||
740 |
Affiliated | 3111 | Atlanta Dialysis | Atlanta Dialysis | 567 NORTH AVE NE | STE 2 | ATLANTA | GA | 30308-2719 | |||||||||
741 |
Affiliated | 3115 | Rolla Dialysis | Rolla Dialysis | 1503 E 10TH ST | ROLLA | MO | 65401-3696 | ||||||||||
742 |
Affiliated | 3119 | East Atlanta Dialysis | East Atlanta Dialysis | 1308 MORELAND AVE SE | ATLANTA | GA | 30316-3224 | ||||||||||
743 |
Affiliated | 3120 | Brunswick South Dialysis | Brunswick South Dialysis | 2930 SPRINGDALE RD | BRUNSWICK | GA | 31520 | ||||||||||
744 |
Affiliated | 3121 | Thomaston Dialysis | Thomaston Dialysis | 1065 US HIGHWAY 19 NORTH | THOMASTON | GA | 30286-2233 | ||||||||||
745 |
Affiliated | 3128 | Piedmont Dialysis | Piedmont Dialysis | 105 COLLIER RD NW | STE B | ATLANTA | GA | 30309-1730 | |||||||||
746 |
Affiliated | 3130 | Athens West Dialysis | Athens West Dialysis | 2047 PRINCE AVE | STE A | ATHENS | GA | 30606-6033 | |||||||||
747 |
Affiliated | 3131 | Florence Dialysis | Florence Dialysis | 422 E DR HICKS BLVD | STE B | FLORENCE | AL | 35630-5763 | |||||||||
748 |
Affiliated | 3138 | Atwater Dialysis | Atwater Dialysis | 1201 COMMERCE AVE | ATWATER | CA | 95301 | ||||||||||
749 |
Affiliated | 3143 | North Merced Dialysis | Merced Dialysis | 3150 G ST | STE A | MERCED | CA | 95340-1346 | |||||||||
750 |
Affiliated | 3169 | Wisconsin Avenue Dialysis | Wisconsin Avenue Dialysis | 3801 W WISCONSIN AVE | MILWAUKEE | WI | 53208-3155 | ||||||||||
751 |
Affiliated | 3171 | River Center Dialysis | River Center Dialysis | 117 N JEFFERSON ST | MILWAUKEE | WI | 53202-6160 | ||||||||||
752 |
Affiliated | 3175 | South Fulton Dialysis | South Fulton Dialysis | 2685 METROPOLITAN PKWY SW | STE F | ATLANTA | GA | 30315-7926 | |||||||||
753 |
Affiliated | 3201 | Heartland Dialysis | Heartland Dialysis | 925 NE 8TH ST | OKLAHOMA CITY | OK | 73104-5800 | ||||||||||
754 |
Affiliated | 3202 | Hospital Hill Dialysis | Hospital Hill Dialysis | 2250 HOLMES ST | KANSAS CITY | MO | 64108-2639 | ||||||||||
755 |
Affiliated | 3203 | Tucson South Dialysis | Tucson South Dialysis | 3662 S 16TH AVE | TUCSON | AZ | 85713-6001 | ||||||||||
756 |
Affiliated | 3204 | Greene County Dialysis | Greene County Dialysis (AL) | 544 US HIGHWAY 43 | EUTAW | AL | 35462-4017 | ||||||||||
757 |
Affiliated | 3205 | Fayette Dialysis | Fayette Dialysis | 2450 TEMPLE AVE N | FAYETTE | AL | 35555-1160 | ||||||||||
758 |
Affiliated | 3206 | Tuscaloosa University Dialysis | Tuscaloosa University Dialysis | 220 15TH STREET | TUSCALOOSA | AL | 35401 | ||||||||||
759 |
Affiliated | 3207 | Goldsboro South Dialysis | Goldsboro South Dialysis | 1704 WAYNE MEMORIAL DR | GOLDSBORO | NC | 27534-2240 | ||||||||||
760 |
Affiliated | 3208 | Orlando North Dialysis | Orlando North Dialysis | 5135 ADANSON ST | STE 7 | ORLANDO | FL | 32804-1338 | |||||||||
761 |
Affiliated | 3209 | UT Southwestern-Dallas Dialysis | UT Southwestern-Dallas Dialysis | 204 E AIRPORT FREEWAY | IRVING | TX | 75062 | ||||||||||
762 |
Affiliated | 3210 | San Diego South Dialysis | San Diego South Dialysis | 995 GATEWAY CENTER WAY | STE 11 | SAN DIEGO | CA | 92102-4550 | |||||||||
763 |
Affiliated | 3211 | Santa Monica Dialysis | Santa Monica Dialysis | 1260 15TH ST | STE 12 | SANTA MONICA | CA | 90404-1136 | |||||||||
764 |
Affiliated | 3212 | Airport Dialysis | Airport Dialysis | 4632 W CENTURY BLVD | INGLEWOOD | CA | 90304-1456 | ||||||||||
765 |
Affiliated | 3220 | Plantation Dialysis | Plantation Dialysis | 7061 CYPRESS RD | STE 13 | PLANTATION | FL | 33317-2243 | |||||||||
766 |
Affiliated | 3224 | Laurens County Dialysis | Laurens County Dialysis | 2400 BELLEVUE RD | STE 8 | DUBLIN | GA | 31021-2856 | |||||||||
767 |
Affiliated | 3225 | Ford Factory Square Dialysis | Ford Factory Square Dialysis | 567 NORTH AVE NE | STE 1 | ATLANTA | GA | 30308-2719 | |||||||||
768 |
Affiliated | 3226 | North Fulton Dialysis | North Fulton Dialysis | 1250 NORTHMEADOW PKWY | STE 12 | ROSWELL | GA | 30076-4914 | |||||||||
769 |
Affiliated | 3228 | Freehold Dialysis | Freehold Dialysis | 300 CRAIG RD | MANALAPAN | NJ | 07726-8742 | ||||||||||
770 |
Affiliated | 3229 | Neptune Dialysis | Neptune Route 66 Dialysis | 3297 STATE ROUTE 66 | NEPTUNE | NJ | 07753-2762 | ||||||||||
771 |
Affiliated | 3231 | East Orange Dialysis | East Orange Dialysis | 90 WASHINGTON ST | BSMT | EAST ORANGE | NJ | 07017-1050 | |||||||||
772 |
Affiliated | 3234 | UT Southwestern-Oakcliff Dialysis | UT Southwestern-Oakcliff Dialysis | 610 WYNNEWOOD DR | DALLAS | TX | 75224 | ||||||||||
773 |
Affiliated | 3236 | Atlanta West Dialysis | Atlanta West Dialysis | 2538 MARTIN LUTHER KING JR DR SW | ATLANTA | GA | 30311-1779 | ||||||||||
774 |
Affiliated | 3237 | Columbia University Dialysis Center | Columbia University Dialysis Center | 60 HAVEN AVE | NEW YORK | NY | 10032-2604 | ||||||||||
775 |
Affiliated | 3238 | Northeast Cambridge Dialysis | Northeast Cambridge Dialysis | 799 CONCORD AVE | CAMBRIDGE | MA | 02138-1048 | ||||||||||
776 |
Affiliated | 3239 | New Bedford Dialysis | New Bedford Dialysis | 524 UNION ST | NEW BEDFORD | MA | 02740-3546 | ||||||||||
777 |
Affiliated | 3242 | Weymouth Dialysis | Weymouth Dialysis | 330 LIBBEY INDUSTRIAL PARK | STE 9 | WEYMOUTH | MA | 02189-3122 | |||||||||
778 |
Affiliated | 3243 | Woburn Dialysis | Woburn Dialysis | 23 WARREN AVE | WOBURN | MA | 01801-7906 | ||||||||||
779 |
Affiliated | 3248 | Bryan Dialysis | College Station Dialysis (fka Bryan Dialysis) | 701 UNIVERSITY DR E | STE 41 | COLLEGE STATION | TX | 77840-1866 | |||||||||
780 |
Affiliated | 3249 | Brenham Dialysis | Brenham Dialysis | 2815 HIGHWAY 36 SO | BRENHAM | TX | 77833 | ||||||||||
781 |
Affiliated | 3250 | Huntsville Dialysis | Huntsville Dialysis | 521 IH 45S | STE 2 | HUNTSVILLE | TX | 77340-5651 | |||||||||
782 |
Affiliated | 3252 | Utica Avenue Dialysis Center | Utica Avenue Dialysis Center | 1305 UTICA AVE | BROOKLYN | NY | 11203-5911 | ||||||||||
783 |
Affiliated | 3254 | New London Dialysis | New London Dialysis | 5 SHAWS COVE | STE 1 | NEW LONDON | CT | 06320-4974 | |||||||||
784 |
Affiliated | 3258 | Baxley Dialysis | Baxley Dialysis | 539 FAIR ST | BAXLEY | GA | 31513-0112 | ||||||||||
785 |
Affiliated | 3261 | Pascua Yaqui Tribe Dialysis | Pascua Yaqui Tribe Dialysis | 7490 S CAMINO DE OESTE | TUCSON | AZ | 85746-9308 | ||||||||||
786 |
Affiliated | 3262 | JHHS North Bond Street Dialysis | JHHS North Bond Street Dialysis | 409 N CAROLINE ST | BALTIMORE | MD | 21231-1003 | ||||||||||
787 |
Affiliated | 3263 | Syosset Kidney Center | Syosset Kidney Center | 1 LOCUST LN | SYOSSET | NY | 11791-4834 | ||||||||||
788 |
Affiliated | 3264 | Freeport Kidney Center | Freeport Kidney Center | 267 W MERRICK RD | FREEPORT | NY | 11520-3346 | ||||||||||
789 |
Affiliated | 3265 | Huntington Station Dialysis Center | HAKC-Huntington | 256 BROADWAY | HUNTINGTON STATION | NY | 11746-1403 | ||||||||||
790 |
Affiliated | 3266 | Medford Kidney Center | Medford Kidney Center | 1725 N OCEAN AVE | MEDFORD | NY | 11763-2649 | ||||||||||
791 |
Affiliated | 3267 | Blue Ash Dialysis | Blue Ash Dialysis | 10600 MCKINLEY RD | CINCINNATI | OH | 45242-3716 | ||||||||||
792 |
Affiliated | 3269 | Mt. Auburn Dialysis | Mt. Auburn Dialysis | 2109 READING RD | CINCINNATI | OH | 45202-1417 | ||||||||||
793 |
Affiliated | 3272 | Charlottesville Dialysis | Charlottesville Dialysis | 1460 PANTOPS MOUNTAIN PLACE | CHARLOTTESVILLE | VA | 22911 | ||||||||||
794 |
Affiliated | 3273 | Alexandria Dialysis | Alexandria Dialysis | 5150 DUKE ST | ALEXANDRIA | VA | 22304-2906 | ||||||||||
795 |
Affiliated | 3275 | Sebastian Dialysis | Sebastian Dialysis | 1424 US HWY 1 | STE C | SEBASTIAN | FL | 32958-1619 | |||||||||
796 |
Affiliated | 3276 | Crestview Hills Dialysis | Crestview Hills Dialysis | 400 CENTERVIEW BLVD | CRESTVIEW HILLS | KY | 41017-3478 | ||||||||||
797 |
Affiliated | 3278 | Washington Square Dialysis | Washington Square Dialysis | 1112 WASHINGTON SQ | WASHINGTON | MO | 63090-5336 | ||||||||||
798 |
Affiliated | 3279 | Florissant Dialysis | Florissant Dialysis | 11687 W FLORISSANT AVE | FLORISSANT | MO | 63033-6711 |
Page 96 of 123
799 |
Affiliated | 3282 | Ithaca Dialysis Center | Ithaca Dialysis Center | 201 DATES DR | STE 26 | ITHACA | NY | 14850-1345 | |||||||||
800 |
Affiliated | 3289 | Fairfield Dialysis | Fairfield Dialysis | 1210 HICKS BLVD | FAIRFIELD | OH | 45014-1921 | ||||||||||
801 |
Affiliated | 3290 | Fairfield Home Training Dialysis | Fairfield Home Training Dialysis | 1210 HICKS BLVD | FAIRFIELD | OH | 45014-1921 | ||||||||||
802 |
Affiliated | 3291 | South Hill Dialysis | South Hill Dialysis | 525 ALEXANDRIA PIKE | STE 12 | SOUTHGATE | KY | 41071-3243 | |||||||||
803 |
Affiliated | 3292 | Silver Spring Dialysis | Silver Spring Dialysis | 8412 GEORGIA AVE | SILVER SPRING | MD | 20910-4406 | ||||||||||
804 |
Affiliated | 3295 | Philadelphia PMC Dialysis | Philadelphia PMC Dialysis | 51 N 39TH ST | PHILADELPHIA | PA | 19104-2640 | ||||||||||
805 |
Affiliated | 3298 | Tulare Dialysis | Tulare Dialysis | 545 E TULARE AVE | TULARE | CA | 93274-4220 | ||||||||||
806 |
Affiliated | 3300 | Visalia Dialysis | Visalia Dialysis | 5429 W CYPRESS AVE | VISALIA | CA | 93277-8341 | ||||||||||
807 |
Affiliated | 3310 | Falls Road Dialysis | Falls Road Dialysis | 10753 FALLS RD | STE 115 | LUTHERVILLE | MD | 21093-4572 | |||||||||
808 |
Affiliated | 3312 | Malden Dialysis | Wellington Circle Dialysis Center (fka Malden) | 10 CABOT RD | STE 13B | MEDFORD | MA | 02155-5173 | |||||||||
809 |
Affiliated | 3313 | Salem Northeast Dialysis | Salem Northeast Dialysis (MA) | 10 COLONIAL RD | STE 25 | SALEM | MA | 01970-2947 | |||||||||
810 |
Affiliated | 3314 | Lexington | Lexington Prison Unit (OK) | 15151 STATE HWY 39 E | PO BOX 26 | LEXINGTON | OK | 73051-0260 | |||||||||
811 |
Affiliated | 3315 | Macon County Dialysis | Macon County Dialysis | 1090 W MCKINLEY AVE | DECATUR | IL | 62526-3208 | ||||||||||
812 |
Affiliated | 3316 | Effingham Dialysis | Effingham Dialysis | 904 MEDICAL PARK DR | STE 1 | EFFINGHAM | IL | 62401-2193 | |||||||||
813 |
Affiliated | 3317 | Jacksonville Dialysis | Jacksonville Dialysis | 1515 W WALNUT ST | JACKSONVILLE | IL | 62650-1150 | ||||||||||
814 |
Affiliated | 3318 | Litchfield Dialysis | Litchfield Dialysis | 915 ST FRANCES WAY | LITCHFIELD | IL | 62056-1775 | ||||||||||
815 |
Affiliated | 3319 | Mattoon Dialysis | Mattoon Dialysis | 6051 DEVELOPMENT DR | CHARLESTON | IL | 61920-9467 | ||||||||||
816 |
Affiliated | 3320 | Springfield Central Dialysis | Springfield Central Dialysis | 932 N RUTLEDGE ST | SPRINGFIELD | IL | 62702-3721 | ||||||||||
817 |
Affiliated | 3321 | Taylorville Dialysis | Taylorville Dialysis | 901 W SPRESSER ST | TAYLORVILLE | IL | 62568-1831 | ||||||||||
818 |
Affiliated | 3322 | Lincoln Dialysis | Lincoln Dialysis | 2100 WEST FIFTH | LINCOLN | IL | 62656-9115 | ||||||||||
819 |
Affiliated | 3323 | J. B. Zachary Dialysis Center | J. B. Zachary Dialysis Center | 333 CASSELL DR | STE 23 | BALTIMORE | MD | 21224-6815 | |||||||||
820 |
Affiliated | 3324 | Whitesquare Dialysis | Whitesquare Dialysis | 1 NASHUA CT STE E | BALTIMORE | MD | 21221 | ||||||||||
821 |
Affiliated | 3325 | 25th Street Dialysis | 25th Street Dialysis | 920 E 25TH ST | BALTIMORE | MD | 21218-5503 | ||||||||||
822 |
Affiliated | 3326 | Perth Amboy Dialysis | Perth Amboy Dialysis | 530 NEW BRUNSWICK AVE | PERTH AMBOY | NJ | 08861-3654 | ||||||||||
823 |
Affiliated | 3327 | Old Bridge Dialysis | Old Bridge Dialysis | 3 HOSPITAL PLZ | STE 11 | OLD BRIDGE | NJ | 08857-3084 | |||||||||
824 |
Affiliated | 3328 | Pear Tree Dialysis | Pear Tree Dialysis (fka Ukiah) | 126 N ORCHARD AVE | UKIAH | CA | 95482-4502 | ||||||||||
825 |
Affiliated | 3334 | Hubbard Road Dialysis | Hubbard Road Dialysis | 1963 HUBBARD RD | MADISON | OH | 44057-2105 | ||||||||||
826 |
Affiliated | 3335 | St. Charles Dialysis | St. Charles Dialysis | 2125 BLUESTONE DR | SAINT CHARLES | MO | 63303-6704 | ||||||||||
827 |
Affiliated | 3336 | Bel Air Dialysis | Bel Air Dialysis | 2225 OLD EMMORTON RD | STE 15 | BEL AIR | MD | 21015-6122 | |||||||||
828 |
Affiliated | 3339 | Cedarburg Dialysis | Cedarburg Dialysis | N 54 W 6135 MILL ST | CEDARBURG | WI | 53012-2021 | ||||||||||
829 |
Affiliated | 3340 | Western Hills Dialysis | Western Hills Dialysis | 3267 WESTBOURNE DR | CINCINNATI | OH | 45248-5130 | ||||||||||
830 |
Affiliated | 3341 | Winton Road Dialysis | Winton Road Dialysis | 6550 WINTON RD | CINCINNATI | OH | 45224-1327 | ||||||||||
831 |
Affiliated | 3342 | Stamford Dialysis | Stamford Dialysis | 30 COMMERCE RD | STAMFORD | CT | 06902-4550 | ||||||||||
832 |
Affiliated | 3343 | Boaz Dialysis | Boaz Dialysis | 16 CENTRAL HENDERSON RD | BOAZ | AL | 35957-5922 | ||||||||||
833 |
Affiliated | 3344 | Guernsey County Dialysis | Guernsey County Dialysis | 1300 CLARK ST | CAMBRIDGE | OH | 43725-8875 | ||||||||||
834 |
Affiliated | 3345 | Marietta Dialysis | Marietta Dialysis | 1019 PIKE ST | MARIETTA | OH | 45750-3500 | ||||||||||
835 |
Affiliated | 3346 | Zanesville Dialysis | Zanesville Dialysis | 3120 NEWARK RD | ZANESVILLE | OH | 43701-9659 | ||||||||||
836 |
Affiliated | 3351 | Orlando East Dialysis | Orlando East Dialysis | 1160 S SEMORAN BLVD | STE C | ORLANDO | FL | 32807-1461 | |||||||||
837 |
Affiliated | 3352 | Norwich Dialysis | Norwich Dialysis | 113 SALEM TPKE | NORWICH | CT | 06360-6484 | ||||||||||
838 |
Affiliated | 3354 | Columbus Dialysis | Columbus Dialysis | 3830 OLENTANGY RIVER RD | COLUMBUS | OH | 43214-5404 | ||||||||||
839 |
Affiliated | 3362 | Pasadena Dialysis | Pasadena Dialysis | 8894 FORT SMALLWOOD RD | STE 12 | PASADENA | MD | 21122-7608 | |||||||||
840 |
Affiliated | 3369 | Baltimore Geriatric & Rehab Dialysis Center | Baltimore Geriatric & Rehab Dialysis Center | 4940 EASTERN AVE | FLOOR 5 | BALTIMORE | MD | 21224-2735 | |||||||||
841 |
Affiliated | 3373 | Frederick Dialysis | Frederick Dialysis | 140 THOMAS JOHNSON DR | STE 1 | FREDERICK | MD | 21702-4475 | |||||||||
842 |
Affiliated | 3376 | Fayetteville Dialysis | Fayetteville Dialysis | 1279 HIGHWAY 54 W | STE 11 | FAYETTEVILLE | GA | 30214-4551 | |||||||||
843 |
Affiliated | 3377 | Birmingham Central Dialysis | Birmingham Central Dialysis | 728 RICHARD ARRINGTON JR BLVD S | BIRMINGHAM | AL | 35233-2106 | ||||||||||
844 |
Affiliated | 3379 | Birmingham North Dialysis | Birmingham North Dialysis | 1917 32ND AVE N | BIRMINGHAM | AL | 35207-3333 | ||||||||||
845 |
Affiliated | 3380 | Bessemer Dialysis | Bessemer Dialysis | 901 W LAKE MALL | BESSEMER | AL | 35020 | ||||||||||
846 |
Affiliated | 3382 | Ensley Dialysis | Ensley Dialysis | 2630 AVENUE E | BIRMINGHAM | AL | 35218-2163 | ||||||||||
847 |
Affiliated | 3383 | Sylacauga Dialysis | Sylacauga Dialysis | 331 JAMES PAYTON BLVD | SYLACAUGA | AL | 35150 | ||||||||||
848 |
Affiliated | 3385 | Branford Dialysis | Branford Dialysis | 249 W MAIN ST | BRANFORD | CT | 06405-4048 | ||||||||||
849 |
Affiliated | 3386 | Shrewsbury Dialysis | Shrewsbury Dialysis | 7435 WATSON RD | STE 119 | SAINT LOUIS | MO | 63119-4472 | |||||||||
850 |
Affiliated | 3389 | Milford Dialysis | Milford Dialysis | 470 BRIDGEPORT AVE | MILFORD | CT | 06460-4167 | ||||||||||
851 |
Affiliated | 3414 | Cedartown Dialysis | Cedartown Dialysis | 325 WEST AVE | CEDARTOWN | GA | 30125-3439 | ||||||||||
852 |
Affiliated | 3416 | Brookfield Dialysis | Brookfield Dialysis | 19395 W CAPITOL DR | BLDG C | BROOKFIELD | WI | 53045-2736 | |||||||||
853 |
Affiliated | 3417 | Henrico County Dialysis | Henrico County Dialysis | 5270 CHAMBERLAYNE RD | RICHMOND | VA | 23227-2950 | ||||||||||
854 |
Affiliated | 3418 | St. Louis West Dialysis | St. Louis West Dialysis | 400 N LINDBERGH BLVD | SAINT LOUIS | MO | 63141-7814 | ||||||||||
855 |
Affiliated | 3420 | Springfield Montvale Dialysis | Springfield Montvale Dialysis | 2930 MONTVALE DR | STE A | SPRINGFIELD | IL | 62704-5376 | |||||||||
856 |
Affiliated | 3422 | South Norwalk Dialysis | South Norwalk Dialysis | 31 STEVENS ST | NORWALK | CT | 06850-3805 | ||||||||||
857 |
Affiliated | 3425 | Decatur East Wood Dialysis | Decatur East Wood Dialysis | 794 E WOOD ST | DECATUR | IL | 62523-1155 | ||||||||||
858 |
Affiliated | 3426 | Schaeffer Drive Dialysis | Schaeffer Drive Dialysis | 18100 SCHAEFER HWY | DETROIT | MI | 48235-2600 | ||||||||||
859 |
Affiliated | 3427 | Redford Dialysis | Redford Dialysis | 22711 GRAND RIVER AVE | DETROIT | MI | 48219-3113 | ||||||||||
860 |
Affiliated | 3428 | Kresge Dialysis | Kresge Dialysis | 4145 CASS AVE | DETROIT | MI | 48201-1707 | ||||||||||
861 |
Affiliated | 3429 | Motor City Dialysis | Motor City Dialysis | 4727 SAINT ANTOINE ST | STE 11 | DETROIT | MI | 48201-1461 | |||||||||
862 |
Affiliated | 3431 | Whitebridge Dialysis | Whitebridge Dialysis | 103 WHITE BRIDGE PIKE | STE 6 | NASHVILLE | TN | 37209-4539 | |||||||||
863 |
Affiliated | 3432 | Columbia Dialysis | Columbia Dialysis (TN) | 1705 GROVE ST | COLUMBIA | TN | 38401-3517 | ||||||||||
864 |
Affiliated | 3433 | Murfreesboro Dialysis | Murfreesboro Dialysis | 1346 DOW ST | MURFREESBORO | TN | 37130-2470 | ||||||||||
865 |
Affiliated | 3434 | Lawrenceburg Dialysis | Lawrenceburg Dialysis (TN) | 2022 N LOCUST AVE | LAWRENCEBURG | TN | 38464-2336 |
Page 97 of 123
866 |
Affiliated | 3436 | Sumner Dialysis | Sumner Dialysis | 300 STEAM PLANT RD | STE 27 | GALLATIN | TN | 37066-3019 | |||||||||
867 |
Affiliated | 3437 | Cumberland Dialysis | Cumberland Dialysis | 312 HOSPITAL DR | STE 5 | MADISON | TN | 37115-5037 | |||||||||
868 |
Affiliated | 3438 | Williamson County Dialysis | Williamson County Dialysis | 3983 CAROTHERS PKWY | STE E-4 | FRANKLIN | TN | 37067-5936 | |||||||||
869 |
Affiliated | 3441 | Cumming Dialysis | Cumming Dialysis | 911 MARKET PLACE BLVD | STE 3 | CUMMING | GA | 30041-7938 | |||||||||
870 |
Affiliated | 3443 | Silverton Dialysis | Silverton Dialysis | 6929 SILVERTON AVE | CINCINNATI | OH | 45236-3701 | ||||||||||
871 |
Affiliated | 3445 | Atlanta South Dialysis | Atlanta South Dialysis | 3158 EAST MAIN ST | STE A | EAST POINT | GA | 30344-4800 | |||||||||
872 |
Affiliated | 3447 | St. Petersburg Dialysis | St. Petersburg Dialysis | 1117 ARLINGTON AVE N | ST PETERSBURG | FL | 33705-1521 | ||||||||||
873 |
Affiliated | 3449 | Alton Dialysis | Alton Dialysis | 3511 COLLEGE AVE | ALTON | IL | 62002-5009 | ||||||||||
874 |
Affiliated | 3451 | Edison Dialysis | Edison Dialysis | 29 MERIDIAN RD | EDISON | NJ | 08820-2823 | ||||||||||
875 |
Affiliated | 3452 | Dundalk Dialysis | Dundalk Dialysis | 14 COMMERCE ST | DUNDALK | MD | 21222-4307 | ||||||||||
876 |
Affiliated | 3454 | Columbus East Dialysis | Columbus East Dialysis | 299 OUTERBELT ST | COLUMBUS | OH | 43213-1529 | ||||||||||
877 |
Affiliated | 3455 | Dallas East Dialysis | Dallas East Dialysis | 3312 N BUCKNER BLVD | STE 213 | DALLAS | TX | 75228-5642 | |||||||||
878 |
Affiliated | 3456 | San Ysidro Dialysis | San Ysidro Dialysis | 1445 30TH ST | STE A | SAN DIEGO | CA | 92154-3496 | |||||||||
879 |
Affiliated | 3457 | Olathe Dialysis | Olathe Dialysis | 732 W FRONTIER LN | OLATHE | KS | 66061-7202 | ||||||||||
880 |
Affiliated | 3459 | Orange City Dialysis | Orange City Dialysis | 242 TREEMONT DR | BLDG II | ORANGE CITY | FL | 32763-7945 | |||||||||
881 |
Affiliated | 3460 | Miami East Dialysis | Miami East Dialysis | 1250 NW 7TH ST | STE 16 | MIAMI | FL | 33125-3744 | |||||||||
882 |
Affiliated | 3462 | Temple Terrace Dialysis | Temple Terrace Dialysis | 11306 N 53RD ST | TEMPLE TERRACE | FL | 33617-2214 | ||||||||||
883 |
Affiliated | 3463 | Midlothian Dialysis | Midlothian Dialysis | 14281 MIDLOTHIAN TPKE | BLDG B | MIDLOTHIAN | VA | 23113-6560 | |||||||||
884 |
Affiliated | 3464 | Christian County Dialysis | Christian County Dialysis | 200 BURLEY AVE | HOPKINSVILLE | KY | 42240-8725 | ||||||||||
885 |
Affiliated | 3465 | St. Louis West PD Dialysis | St. Louis West PD Dialysis | 450 N LINDBERGH BLVD | STE 1C | CREVE COEUR | MO | 63141-7858 | |||||||||
886 |
Affiliated | 3467 | Atlanta Midtown Dialysis | Atlanta Midtown Dialysis PD | 418 DECATUR ST SE | STE A | ATLANTA | GA | 30312-1801 | |||||||||
887 |
Affiliated | 3468 | Silverton Home Training Dialysis | Silverton Home Training Dialysis | 6929 SILVERTON AVE | CINCINNATI | OH | 45236-3701 | ||||||||||
888 |
Affiliated | 3472 | Philadelphia 42nd Street Dialysis | Philadelphia 42nd Street Dialysis | 4126 WALNUT ST | PHILADELPHIA | PA | 19104-3511 | ||||||||||
889 |
Affiliated | 3473 | Radnor Dialysis | Radnor Dialysis | 250 KING OF PRUSSIA RD | RADNOR | PA | 19087-5220 | ||||||||||
890 |
Affiliated | 3475 | St. Louis Dialysis | St. Louis Dialysis | 324 DE BALIVIERE AVE | SAINT LOUIS | MO | 63112-1804 | ||||||||||
891 |
Affiliated | 3477 | Elkins Park Dialysis | Wyncote Dialysis (fka Elkins Park) | 1000 EASTON RD | STE 25 | WYNCOTE | PA | 19095-2934 | |||||||||
892 |
Affiliated | 3478 | Mainland Dialysis | Mainland Dialysis | 2600 GULF FWY | LA MARQUE | TX | 77568-4922 | ||||||||||
893 |
Affiliated | 3479 | Island Dialysis | Island Dialysis | 5920 BROADWAY ST | GALVESTON | TX | 77551-4305 | ||||||||||
894 |
Affiliated | 3481 | Orlando Home Training Dialysis | Orlando Home Training Dialysis | 116 STURTEVANT ST | STE 2 | ORLANDO | FL | 32806-2021 | |||||||||
895 |
Affiliated | 3482 | Mechanicsville Dialysis | Mechanicsville Dialysis | 8191 ATLEE RD | MECHANICSVILLE | VA | 23116-1807 | ||||||||||
896 |
Affiliated | 3484 | San Diego East Dialysis | San Diego East Dialysis | 292 EUCLID AVE | STE 1 | SAN DIEGO | CA | 92114-3629 | |||||||||
897 |
Affiliated | 3485 | Russellville Dialysis | Russellville Dialysis | 14897 HIGHWAY 43 | RUSSELLVILLE | AL | 35653-1954 | ||||||||||
898 |
Affiliated | 3486 | Encinitas Dialysis | Encinitas Dialysis | 332 SANTA FE DR | STE 1 | ENCINITAS | CA | 92024-5143 | |||||||||
899 |
Affiliated | 3491 | Rushville Dialysis | Rushville Dialysis | 112 SULLIVAN DRIVE | RUSHVILLE | IL | 62681-1293 | ||||||||||
900 |
Affiliated | 3493 | Plainfield Dialysis | Plainfield Dialysis | 1200 RANDOLPH RD | MUHLENBURG CAMPUS | PLAINFIELD | NJ | 07060-3361 | |||||||||
901 |
Affiliated | 3494 | Parkersburg Dialysis | Parkersburg Dialysis | 1824 MURDOCH AVE | STE 44 | PARKERSBURG | WV | 26101-3230 | |||||||||
902 |
Affiliated | 3497 | Tucson South Central Dialysis | Tucson South Central Dialysis | 2024 E IRVINGTON RD | STE 7 | TUCSON | AZ | 85714-1825 | |||||||||
903 |
Affiliated | 3499 | Hazelwood Dialysis | Hazelwood Dialysis | 637 DUNN RD | HAZELWOOD | MO | 63042-1755 | ||||||||||
904 |
Affiliated | 3503 | Durham West Dialysis | Durham West Dialysis | 4307 WESTERN PARK PL | DURHAM | NC | 27705-1204 | ||||||||||
905 |
Affiliated | 3504 | Liberty Dialysis | Liberty Dialysis | 2525 GLEN HENDREN DR | LIBERTY | MO | 64068-9625 | ||||||||||
906 |
Affiliated | 3506 | Chino Dialysis | Chino Dialysis | 4445 RIVERSIDE DR | CHINO | CA | 91710-3961 | ||||||||||
907 |
Affiliated | 3507 | Greenview Dialysis | Greenview Dialysis | 18544 W 8 MILE RD | SOUTHFIELD | MI | 48075-4194 | ||||||||||
908 |
Affiliated | 3508 | Perry Dialysis | Perry Dialysis | 118 W MAIN ST | PERRY | FL | 32347-2656 | ||||||||||
909 |
Affiliated | 3511 | Ashtabula Dialysis | Ashtabula Dialysis | 1614 W 19TH ST | ASHTABULA | OH | 44004-3036 | ||||||||||
910 |
Affiliated | 3513 | Northland Dialysis | Northland Dialysis | 2750 CLAY EDWARDS DR | STE 1 | N KANSAS CITY | MO | 64116-3257 | |||||||||
911 |
Affiliated | 3516 | Lake St. Louis Dialysis | Lake St. Louis Dialysis | 200 BREVCO PLZ | STE 21 | LAKE SAINT LOUIS | MO | 63367-2950 | |||||||||
912 |
Affiliated | 3517 | Wyandotte West Dialysis | Wyandotte West Dialysis | 8919 PARALLEL PKWY | STE 121 | KANSAS CITY | KS | 66112-1655 | |||||||||
913 |
Affiliated | 3518 | Huntingdon Valley Dialysis | Temp CLSD-Huntingdon Valley Dialysis | 769 HUNTINGDON PIKE | STE 18 | HUNTINGDON VALLEY | PA | 19006-8362 | |||||||||
914 |
Affiliated | 3519 | Glendale Dialysis | Glendale Dialysis | 1000 E PALMER AVE | GLENDALE | CA | 91205-3532 | ||||||||||
915 |
Affiliated | 3520 | Toledo Dialysis | Toledo Dialysis | 1614 S BYRNE RD | TOLEDO | OH | 43614-3464 | ||||||||||
916 |
Affiliated | 3523 | Cameron Dialysis | Cameron Dialysis | 1003 W 4TH ST | CAMERON | MO | 64429-1466 | ||||||||||
917 |
Affiliated | 3524 | Omaha Central Dialysis | Omaha Central Dialysis | 144 S 40TH ST | OMAHA | NE | 68131-3004 | ||||||||||
918 |
Affiliated | 3525 | Chillicothe Dialysis | Chillicothe Dialysis | 588 E BUSINESS 36 | CHILLICOTHE | MO | 64601-3721 | ||||||||||
919 |
Affiliated | 4210 | Council Bluffs Dialysis | Council Bluffs Dialysis Center | 300 W BROADWAY | STE 15 | COUNCIL BLUFFS | IA | 51503-9077 | |||||||||
920 |
Affiliated | 3528 | DeRidder Dialysis | DeRidder Dialysis | 239 E 1ST ST | DERIDDER | LA | 70634-4105 | ||||||||||
921 |
Affiliated | 3530 | Dodge County Dialysis | Dodge County Dialysis | 1949 E 23RD AVE S | FREMONT | NE | 68025-2452 | ||||||||||
922 |
Affiliated | 3533 | Omaha North Dialysis | Omaha North Dialysis | 6572 AMES AVE | OMAHA | NE | 68104-1931 | ||||||||||
923 |
Affiliated | 3534 | Omaha South Dialysis | Omaha South Dialysis | 3427 L ST | STE 16 | OMAHA | NE | 68107-2577 | |||||||||
924 |
Affiliated | 3535 | Lake Charles Southwest Dialysis | Lake Charles Southwest Dialysis | 300 W 18th ST | LAKE CHARLES | LA | 70601-7342 | ||||||||||
925 |
Affiliated | 3536 | St. Joseph Dialysis | St. Joseph Dialysis | 5514 CORPORATE DR | STE 1 | SAINT JOSEPH | MO | 64507-7752 | |||||||||
926 |
Affiliated | 3537 | Sulphur Dialysis | Sulphur Dialysis | 944 BEGLIS PKWY | SULPHUR | LA | 70663-5102 | ||||||||||
927 |
Affiliated | 3539 | Tipton County Dialysis | Tipton County Dialysis | 107 TENNESSEE AVE | COVINGTON | TN | 38019-3902 | ||||||||||
928 |
Affiliated | 3540 | Dyersburg Dialysis | Dyersburg Dialysis | 1575 PARR AVE | DYERSBURG | TN | 38024-3151 | ||||||||||
929 |
Affiliated | 3544 | Effingham North Dialysis | Effingham North Dialysis | 301 N PINE ST | SPRINGFIELD | GA | 31329-3076 | ||||||||||
930 |
Affiliated | 3545 | Westminster South Dialysis | Westminster South Dialysis | 14014 MAGNOLIA ST. | WESTMINSTER | CA | 92683-4736 | ||||||||||
931 |
Affiliated | 3546 | Williams Street Dialysis | Williams Street Dialysis | 2812 WILLIAMS ST | SAVANNAH | GA | 31404-4134 | ||||||||||
932 |
Affiliated | 3547 | DeRenne Dialysis | DeRenne Dialysis | 5303 MONTGOMERY ST | SAVANNAH | GA | 31405-5138 |
Page 98 of 123
933 |
Affiliated | 3548 | Abercorn Dialysis | Abercorn Dialysis | 11706 MERCY BLVD | STE 9 | SAVANNAH | GA | 31419-1751 | |||||||||
934 |
Affiliated | 3551 | Fort Myers North Dialysis | Fort Myers North Dialysis | 16101 N CLEVELAND AVE | N FT MYERS | FL | 33903-2148 | ||||||||||
935 |
Affiliated | 3552 | Butler County Dialysis | Butler County Dialysis | 3497 S DIXIE HWY | FRANKLIN | OH | 45005-5717 | ||||||||||
936 |
Affiliated | 3556 | Willingboro | Willingboro Dialysis | 230 VAN SCIVER PKWY | WILLINGBORO | NJ | 08046-1131 | ||||||||||
937 |
Affiliated | 3557 | McKeesport West Dialysis | McKeesport West Dialysis | 101 9TH ST | MCKEESPORT | PA | 15132-3953 | ||||||||||
938 |
Affiliated | 3559 | College Dialysis | College Dialysis | 6535 UNIVERSITY AVE | SAN DIEGO | CA | 92115-5810 | ||||||||||
939 |
Affiliated | 3560 | Montezuma Dialysis | Montezuma Dialysis | 114 DEVAUGHN AVE | MONTEZUMA | GA | 31063-1708 | ||||||||||
940 |
Affiliated | 3561 | Romulus Dialysis | Romulus Dialysis | 31470 ECORSE RD | ROMULUS | MI | 48174-1963 | ||||||||||
941 |
Affiliated | 3564 | Wrightsville Dialysis | Wrightsville Dialysis | 2240 W ELM ST | WRIGHTSVILLE | GA | 31096-2016 | ||||||||||
942 |
Affiliated | 3565 | Tower Dialysis | Tower Dialysis | 8635 W 3RD ST | STE 56W | LOS ANGELES | CA | 90048-6110 | |||||||||
943 |
Affiliated | 3566 | Columbus Downtown Dialysis | Columbus Downtown Dialysis | 415 E MOUND ST | COLUMBUS | OH | 43215-5512 | ||||||||||
944 |
Affiliated | 3568 | Charlotte East Dialysis | Charlotte East Dialysis | 3204 N SHARON AMITY RD | CHARLOTTE | NC | 28205-6541 | ||||||||||
945 |
Affiliated | 3569 | Carmel Mountain Dialysis | Carmel Mountain Dialysis | 9850 CARMEL MOUNTAIN RD | SAN DIEGO | CA | 92129-2892 | ||||||||||
946 |
Affiliated | 3571 | Lenexa Dialysis | Lenexa Dialysis | 8630 HALSEY ST | LENEXA | KS | 66215-2880 | ||||||||||
947 |
Affiliated | 3577 | Nashua Dialysis | Nashua Dialysis | 38 TYLER ST | STE 1 | NASHUA | NH | 03060-2912 | |||||||||
948 |
Affiliated | 3580 | Illini Renal Dialysis | Illini Renal Dialysis | 507 E UNIVERSITY AVE | CHAMPAIGN | IL | 61820-3828 | ||||||||||
949 |
Affiliated | 3586 | Loring Heights Dialysis | Loring Heights Dialysis | 1575 NORTHSIDE DR NW | STE 45 | ATLANTA | GA | 30318-4211 | |||||||||
950 |
Affiliated | 3588 | Forest Hills Dialysis | Forest Hills Dialysis | 2693 FOREST HILLS RD SW | WILSON | NC | 27893-8611 | ||||||||||
951 |
Affiliated | 3589 | St. Peters Dialysis | St. Peters Dialysis | 300 FIRST EXECUTIVE AVE | STE A | SAINT PETERS | MO | 63376-1655 | |||||||||
952 |
Affiliated | 3591 | Platte Woods Dialysis | Platte Woods Dialysis | 7667 NW PRAIRIE VIEW RD | KANSAS CITY | MO | 64151-1544 | ||||||||||
953 |
Affiliated | 3593 | Fresno North Dialysis | Fresno Palm Bluffs Dialysis (fka Fresno North) | 770 W PINEDALE AVE | FRESNO | CA | 93711-5744 | ||||||||||
954 |
Affiliated | 3594 | Middlesex County Dialysis | Burlington Regional Dialysis (fka Middlesex County) | 31 MALL RD | STE 1B | BURLINGTON | MA | 01803-4138 | |||||||||
955 |
Affiliated | 3596 | Clearfield Dialysis | Clearfield Dialysis | 1033 TURNPIKE AVE | STE 1 | CLEARFIELD | PA | 16830-3061 | |||||||||
956 |
Affiliated | 3597 | Papillion Dialysis | Papillion Dialysis | 1502 S WASHINGTON ST | STE 1 | PAPILLION | NE | 68046-3136 | |||||||||
957 |
Affiliated | 3598 | Birmingham Home Training Dialysis | Birmingham Home Training Dialysis | 2101 7TH AVE S | BIRMINGHAM | AL | 35233-3105 | ||||||||||
958 |
Affiliated | 3603 | Bayou Dialysis | Magnolia Dialysis | 210 E SPILLMAN ST | GONZALES | LA | 70737-4604 | ||||||||||
959 |
Affiliated | 3609 | Radford Dialysis | Radford Dialysis | 600 E MAIN ST | STE F | RADFORD | VA | 24141-1826 | |||||||||
960 |
Affiliated | 3610 | Eufaula Dialysis | Eufaula Dialysis | 220 S ORANGE AVE | EUFAULA | AL | 36027-1612 | ||||||||||
961 |
Affiliated | 3612 | Coshocton Dialysis | Coshocton Dialysis | 1404 CHESTNUT ST EAST | COSHOCTON | OH | 43812-1401 | ||||||||||
962 |
Affiliated | 3614 | Costa Mesa Dialysis | Costa Mesa Dialysis | 1590 SCENIC AVE | COSTA MESA | CA | 92626-1400 | ||||||||||
963 |
Affiliated | 3615 | Little Rock Dialysis | Central Little Rock Dialysis | 5800 W 10TH ST | STE 51 | LITTLE ROCK | AR | 72204-1760 | |||||||||
964 |
Affiliated | 3619 | Northport Dialysis | Northport Dialysis | 2401 HOSPITAL DR | NORTHPORT | AL | 35476-3392 | ||||||||||
965 |
Affiliated | 3632 | Pageland Dialysis | Pageland Dialysis | 505A S PEARL ST | PAGELAND | SC | 29728-2222 | ||||||||||
966 |
Affiliated | 3633 | Bakersfield South Dialysis | White Lane Dialysis (fka Bakersfield South) | 7701 WHITE LN | STE D | BAKERSFIELD | CA | 93309-0201 | |||||||||
967 |
Affiliated | 3634 | Newaygo County Dialysis | Newaygo County Dialysis | 1317 W MAIN ST | FREMONT | MI | 49412-1478 | ||||||||||
968 |
Affiliated | 3636 | Cedar Lane Dialysis | Cedar Lane Dialysis | 6334 CEDAR LN | STE 11 | COLUMBIA | MD | 21044-3898 | |||||||||
969 |
Affiliated | 3639 | Torrington Dialysis | Torrington Dialysis | 780 LITCHFIELD ST | STE 1 | TORRINGTON | CT | 06790-6268 | |||||||||
970 |
Affiliated | 3642 | Janesville Dialysis | Janesville Dialysis | 1305 WOODMAN RD | JANESVILLE | WI | 53545-1068 | ||||||||||
971 |
Affiliated | 3643 | Bloomfield Dialysis | Bloomfield Dialysis | 29 GRIFFIN RD S | BLOOMFIELD | CT | 06002-1351 | ||||||||||
972 |
Affiliated | 3645 | Anthem Village Dialysis | Anthem Village Dialysis | 2530 ANTHEM VILLAGE DR | HENDERSON | NV | 89052-5548 | ||||||||||
973 |
Affiliated | 3646 | Glen Burnie Dialysis | Glen Burnie Dialysis | 120 LANGLEY RD N | GLEN BURNIE | MD | 21060-6578 | ||||||||||
974 |
Affiliated | 3655 | Melbourne Dialysis | Melbourne Dialysis | 2235 S BABCOCK ST | MELBOURNE | FL | 32901-5305 | ||||||||||
975 |
Affiliated | 3656 | St. Petersburg South Dialysis | St. Petersburg South Dialysis | 2850 34TH ST S | ST PETERSBURG | FL | 33711-3817 | ||||||||||
976 |
Affiliated | 3663 | Belpre Dialysis | Belpre Dialysis | 2906 WASHINGTON BLVD | BELPRE | OH | 45714-1848 | ||||||||||
977 |
Affiliated | 3666 | Stockton Home Training Dialysis | Stockton Home Training Dialysis | 545 E CLEVELAND ST | STE A | STOCKTON | CA | 95204-5535 | |||||||||
978 |
Affiliated | 3670 | Rock Prairie Road Dialysis | Rock Prairie Road Dialysis | 1605 ROCK PRAIRIE RD | STE 11 | COLLEGE STATION | TX | 77845-8358 | |||||||||
979 |
Affiliated | 3675 | Market Street | Market Street Dialysis | 3701 MARKET ST | STE 1 | PHILADELPHIA | PA | 19104-5503 | |||||||||
980 |
Affiliated | 3677 | Northwood | Northwood Dialysis (aka Toledo East) | 611 LEMOYNE RD | NORTHWOOD | OH | 43619-1811 | ||||||||||
981 |
Affiliated | 3701 | Tysons Corner Dialysis | Tysons Corner Dialysis | 8391 OLD COURTHOUSE RD | STE 16 | VIENNA | VA | 22182-3819 | |||||||||
982 |
Affiliated | 3704 | Southern Maryland Dialysis | Southern Maryland Dialysis | 9211 STUART LN | 4TH FL | CLINTON | MD | 20735-2712 | |||||||||
983 |
Affiliated | 3707 | Brentwood Dialysis | Brentwood Dialysis | 1231 BRENTWOOD RD NE | WASHINGTON | DC | 20018-1019 | ||||||||||
984 |
Affiliated | 3708 | Amelia Dialysis | Amelia Dialysis | 15151 PATRICK HENRY HWY | AMELIA COURT HOUSE | VA | 23002-4700 | ||||||||||
985 |
Affiliated | 3714 | Eighth Street Dialysis | Eighth Street Dialysis | 300 8TH ST NE | WASHINGTON | DC | 20002-6108 | ||||||||||
986 |
Affiliated | 3715 | Chester Dialysis | Chester Dialysis | 10360 IRONBRIDGE RD | CHESTER | VA | 23831-1425 | ||||||||||
987 |
Affiliated | 3716 | Howard County Dialysis | Howard County Dialysis | 5999 HARPERS FARM RD | STE 11E | COLUMBIA | MD | 21044-3023 | |||||||||
988 |
Affiliated | 3717 | Catonsville Dialysis | Catonsville Dialysis | 1581 SULPHUR SPRING RD | STE 112 | BALTIMORE | MD | 21227 | |||||||||
989 |
Affiliated | 3718 | Mercy Dialysis | Mercy Dialysis | 315 N CALVERT ST | STE 3 | BALTIMORE | MD | 21202-3611 | |||||||||
990 |
Affiliated | 3719 | Harbor Park Dialysis | Harbor Park Dialysis | 111 CHERRY HILL RD | BALTIMORE | MD | 21225-1392 | ||||||||||
991 |
Affiliated | 3732 | Dabney Dialysis | Three Chopt Dialysis (fka Dabney) | 8813 THREE CHOPT RD | RICHMOND | VA | 23229 | ||||||||||
992 |
Affiliated | 3733 | Hioaks Dialysis | Hioaks Dialysis | 671 HIOAKS RD | STE A | RICHMOND | VA | 23225-4072 | |||||||||
993 |
Affiliated | 3757 | Arlington Dialysis | Arlington Dialysis | 4805 1st ST N | ARLINGTON | VA | 22203 | ||||||||||
994 |
Affiliated | 3759 | Landover Dialysis | Landover Dialysis | 1200 MERCANTILE LN | STE 15 | UPPER MARLBORO | MD | 20774-5389 | |||||||||
995 |
Affiliated | 3761 | Staunton Dialysis | Staunton Dialysis | 29 IDLEWOOD BLVD | STAUNTON | VA | 24401-9355 | ||||||||||
996 |
Affiliated | 3762 | Covington Dialysis | Covington Dialysis | 2504 VALLEY RIDGE RD | COVINGTON | VA | 24426-6339 | ||||||||||
997 |
Affiliated | 3763 | Culpeper Dialysis | Culpeper Dialysis | 430 SOUTHRIDGE PARKWAY | CULPEPER | VA | 22701-3791 | ||||||||||
998 |
Affiliated | 3764 | Greenbrier Dialysis | Greenbrier Dialysis | 129 SENECA TRL | LEWISBURG | WV | 24901-1564 | ||||||||||
999 |
Affiliated | 3765 | Harrisonburg Dialysis | Harrisonburg Dialysis | 871 CANTRELL AVE | STE 1 | HARRISONBURG | VA | 22801-4323 |
Page 99 of 123
1000 |
Affiliated | 3766 | Lexington Dialysis | Lexington Dialysis | 756 N LEE HWY | LEXINGTON | VA | 24450-3724 | ||||||||||
1001 |
Affiliated | 3802 | Manteca Dialysis | Manteca Dialysis | 1156 S MAIN ST | MANTECA | CA | 95337-9505 | ||||||||||
1002 |
Affiliated | 3804 | Roseburg/Mercy Dialysis | Roseburg/Mercy Dialysis | 2599 NW EDENBOWER BLVD | ROSEBURG | OR | 97471-6220 | ||||||||||
1003 |
Affiliated | 3805 | Daly City Dialysis | Daly City Dialysis | 1498 SOUTHGATE AVE | STE 11 | DALY CITY | CA | 94015-4015 | |||||||||
1004 |
Affiliated | 3806 | Vallejo Dialysis | Vallejo Dialysis | 121 HOSPITAL DR | VALLEJO | CA | 94589-2562 | ||||||||||
1005 |
Affiliated | 3812 | Salem Dialysis | Salem Dialysis (OR) | 3550 LIBERTY RD S | STE 1 | SALEM | OR | 97302-5700 | |||||||||
1006 |
Affiliated | 3817 | Fresno Dialysis | Fresno Dialysis | 1111 E WARNER AVE | FRESNO | CA | 93710-4030 | ||||||||||
1007 |
Affiliated | 3818 | Oakland Dialysis | Oakland Dialysis | 5354 CLAREMONT AVE | OAKLAND | CA | 94618-1035 | ||||||||||
1008 |
Affiliated | 3820 | Bakersfield Dialysis | Bakersfield Brimhall Dialysis (fka California Ave.) | 8501 BRIMHALL RD | BLDG 5 | BAKERSFIELD | CA | 93311-2252 | |||||||||
1009 |
Affiliated | 3821 | Northeast Bakersfield Dialysis | Northeast Dialysis (fka NE Bakersfield) | 3761 MALL VIEW RD | BAKERSFIELD | CA | 93306-3048 | ||||||||||
1010 |
Affiliated | 3830 | San Francisco Dialysis | San Francisco Dialysis | 1499 WEBSTER ST | SAN FRANCISCO | CA | 94115-3705 | ||||||||||
1011 |
Affiliated | 3831 | Hanford Dialysis | Hanford Dialysis | 402 W 8TH ST | HANFORD | CA | 93230-4536 | ||||||||||
1012 |
Affiliated | 3840 | San Pablo Dialysis | San Pablo Dialysis | 14020 SAN PABLO AVE | SAN PABLO | CA | 94806-3604 | ||||||||||
1013 |
Affiliated | 3847 | Chinatown Dialysis | Chinatown Dialysis | 636 CLAY ST | SAN FRANCISCO | CA | 94111-2502 | ||||||||||
1014 |
Affiliated | 3849 | El Cerrito Dialysis | El Cerrito Dialysis | 10690 SAN PABLO AVE | EL CERRITO | CA | 94530-2620 | ||||||||||
1015 |
Affiliated | 3857 | Tracy Dialysis | Tracy Dialysis | 425 W BEVERLY PL | STE A | TRACY | CA | 95376-3086 | |||||||||
1016 |
Affiliated | 3858 | Salem North Dialysis | Salem North Dialysis (OR) | 1220 LIBERTY ST NE | SALEM | OR | 97301-7330 | ||||||||||
1017 |
Affiliated | 3860 | Auburn Dialysis | Auburn Dialysis | 3126 PROFESSIONAL DR | STE 1 | AUBURN | CA | 95603-2411 | |||||||||
1018 |
Affiliated | 3861 | Grass Valley Dialysis | Grass Valley Dialysis | 360 CROWN POINT CIRCLE | STE 21 | GRASS VALLEY | CA | 95945-2543 | |||||||||
1019 |
Affiliated | 3901 | Santee Dialysis | Santee Dialysis | 228 BRADFORD BLVD | SANTEE | SC | 29142-8677 | ||||||||||
1020 |
Affiliated | 3903 | Upland Dialysis | Upland Dialysis | 600 N 13TH AVE | UPLAND | CA | 91786-4957 | ||||||||||
1021 |
Affiliated | 3906 | Vance County Dialysis | Vance County Dialysis | 854 S BECKFORD DR | HENDERSON | NC | 27536-3487 | ||||||||||
1022 |
Affiliated | 3907 | Edenton Dialysis | Edenton Dialysis | 703 LUKE ST | EDENTON | NC | 27932-9694 | ||||||||||
1023 |
Affiliated | 3909 | Ahoskie Dialysis | Ahoskie Dialysis | 129 HERTFORD COUNTY HIGH RD | AHOSKIE | NC | 27910-8131 | ||||||||||
1024 |
Affiliated | 3914 | Allendale County Dialysis | Allendale County Dialysis | 202 HAMPTON AVE N | FAIRFAX | SC | 29827-4510 | ||||||||||
1025 |
Affiliated | 3916 | North Orangeburg Dialysis | North Orangeburg Dialysis | 124 FIRE TOWER RD | ORANGEBURG | SC | 29118-1443 | ||||||||||
1026 |
Affiliated | 3917 | South Orangeburg Dialysis | South Orangeburg Dialysis | 1080 SUMMERS AVE | ORANGEBURG | SC | 29115-4920 | ||||||||||
1027 |
Affiliated | 3931 | Greenwood Dialysis | Greenwood Dialysis | 109 OVERLAND DR | GREENWOOD | SC | 29646-4053 | ||||||||||
1028 |
Affiliated | 3933 | Union County Dialysis | Union County Dialysis | 701 E ROOSEVELT BLVD | STE 4 | MONROE | NC | 28112-4107 | |||||||||
1029 |
Affiliated | 3934 | South Charlotte Dialysis | South Charlotte Dialysis | 6450 BANNINGTON RD | CHARLOTTE | NC | 28226-1327 | ||||||||||
1030 |
Affiliated | 3935 | Lancaster SC Dialysis | Lancaster SC Dialysis | 980 N WOODLAND DR | STE 1 | LANCASTER | SC | 29720-1964 | |||||||||
1031 |
Affiliated | 3952 | Central Bamberg Dialysis | Central Bamberg Dialysis | 67 SUNSET DR | BAMBERG | SC | 29003-1181 | ||||||||||
1032 |
Affiliated | 4001 | West Tallahassee Dialysis | West Tallahassee Dialysis | 2645 W TENNESSEE ST | TALLAHASSEE | FL | 32304-2547 | ||||||||||
1033 |
Affiliated | 4002 | Daytona South Dialysis | Daytona South Dialysis | 1801 S NOVA RD | STE 36 | SOUTH DAYTONA | FL | 32119-1775 | |||||||||
1034 |
Affiliated | 4003 | Daytona Beach Dialysis | Daytona Beach Dialysis | 578 HEALTH BLVD | DAYTONA BEACH | FL | 32114-1492 | ||||||||||
1035 |
Affiliated | 4004 | West Tampa Dialysis | West Tampa Dialysis | 4515 GEORGE RD | STE 3 | TAMPA | FL | 33634-7300 | |||||||||
1036 |
Affiliated | 4005 | Fontana Dialysis | Fontana Dialysis | 17590 FOOTHILL BLVD | FONTANA | CA | 92335-8416 | ||||||||||
1037 |
Affiliated | 4007 | Fort Myers Dialysis | Fort Myers Dialysis | 4220 EXECUTIVE CIRCLE | STE 38 | FORT MYERS | FL | 33916-7993 | |||||||||
1038 |
Affiliated | 4009 | Lehigh Acres Dialysis | Lehigh Acres Dialysis | 2719 4TH ST W | LEHIGH ACRES | FL | 33971-1942 | ||||||||||
1039 |
Affiliated | 4010 | Los Banos Dialysis | Los Banos Dialysis | 222 I ST | LOS BANOS | CA | 93635-4132 | ||||||||||
1040 |
Affiliated | 4013 | Kissimmee Dialysis | Kissimmee Dialysis | 802 N JOHN YOUNG PKWY | KISSIMMEE | FL | 34741-4912 | ||||||||||
1041 |
Affiliated | 4014 | New Smyrna Beach Dialysis | New Smyrna Beach Dialysis | 110 S ORANGE ST | NEW SMYRNA BEACH | FL | 32168-7153 | ||||||||||
1042 |
Affiliated | 4017 | Lake Wales Dialysis | Lake Wales Dialysis | 1125 BRYN MAWR AVE | LAKE WALES | FL | 33853-4333 | ||||||||||
1043 |
Affiliated | 4018 | Dearborn Dialysis | Dearborn Dialysis | 1185 MONROE ST | DEARBORN | MI | 48124-2814 | ||||||||||
1044 |
Affiliated | 4020 | Greater Miami Dialysis | Greater Miami Dialysis | 160 NW 176TH ST | STE 1 | MIAMI | FL | 33169-5023 | |||||||||
1045 |
Affiliated | 4021 | Burbank Dialysis | Burbank Dialysis | 1211 N SAN FERNANDO BLVD | BURBANK | CA | 91504-4234 | ||||||||||
1046 |
Affiliated | 4024 | Lakeland Dialysis | Lakeland Dialysis | 515 E BELLA VISTA ST | LAKELAND | FL | 33805-3005 | ||||||||||
1047 |
Affiliated | 4025 | Burlington North Dialysis | Burlington North Dialysis | 1164 E ROUTE 130 | BURLINGTON | NJ | 08016-2954 | ||||||||||
1048 |
Affiliated | 4026 | Delano Dialysis | Delano Dialysis | 905 MAIN ST | DELANO | CA | 93215-1729 | ||||||||||
1049 |
Affiliated | 4027 | Erie Dialysis | Erie Dialysis | 350 E BAYFRONT PKWY | STE A | ERIE | PA | 16507-2410 | |||||||||
1050 |
Affiliated | 4028 | Homestead Dialysis | Homestead Dialysis | 207 W 7TH AVE | W HOMESTEAD | PA | 15120-1002 | ||||||||||
1051 |
Affiliated | 4029 | Plant City Dialysis | Plant City Dialysis | 1211 W REYNOLDS ST | PLANT CITY | FL | 33563-4321 | ||||||||||
1052 |
Affiliated | 4030 | Winter Haven Dialysis | Winter Haven Dialysis | 1625 UNITY WAY NW | WINTER HAVEN | FL | 33881 | ||||||||||
1053 |
Affiliated | 4032 | Charlotte Dialysis | Charlotte Dialysis | 2321 W MOREHEAD ST | STE 12 | CHARLOTTE | NC | 28208-5145 | |||||||||
1054 |
Affiliated | 4034 | McKeesport Dialysis | McKeesport Dialysis | 2001 LINCOLN WAY | OAK PARK MALL | MCKEESPORT | PA | 15131-2419 | |||||||||
1055 |
Affiliated | 4035 | Broward Dialysis | Broward Dialysis | 1500 N FEDERAL HWY | STE 1 | FT LAUDERDALE | FL | 33304-5600 | |||||||||
1056 |
Affiliated | 4036 | Athens Dialysis | Athens Dialysis | 15953 ATHENS LIMESTONE DR | ATHENS | AL | 35613-2214 | ||||||||||
1057 |
Affiliated | 4038 | Bradenton Dialysis | Bradenton Dialysis | 3501 CORTEZ RD W | STE 14 | BRADENTON | FL | 34210-3104 | |||||||||
1058 |
Affiliated | 4039 | Deland Dialysis | Deland Dialysis | 350 E NEW YORK AVE | DELAND | FL | 32724-5510 | ||||||||||
1059 |
Affiliated | 4040 | Boynton/North Delray Dialysis | Boynton/North Delray Dialysis | 2655 W ATLANTIC AVE | DELRAY BEACH | FL | 33445-4400 | ||||||||||
1060 |
Affiliated | 4041 | Lake Worth Dialysis | Lake Worth Dialysis | 2459 S CONGRESS AVE | STE 1 | PALM SPRINGS | FL | 33406-7616 | |||||||||
1061 |
Affiliated | 4042 | Palm Coast Dialysis | Palm Coast Dialysis | 13 KINGSWOOD DR | STE A | PALM COAST | FL | 32137-4614 | |||||||||
1062 |
Affiliated | 4043 | Fort Myers South Dialysis | Fort Myers South Dialysis | 8570 GRANITE CT | FORT MYERS | FL | 33908-4102 | ||||||||||
1063 |
Affiliated | 4044 | Woodburn Dialysis | Woodburn Dialysis | 1840 NEWBERG HWY | STE 14 | WOODBURN | OR | 97071-3187 | |||||||||
1064 |
Affiliated | 4045 | Four Freedoms | Four Freedoms Dialysis (fka Range Street) | 289 SW RANGE AVE | STE A | MADISON | FL | 32340-2351 | |||||||||
1065 |
Affiliated | 4046 | West Philadelphia Dialysis | West Philadelphia Dialysis | 7609 LINDBERGH BLVD | PHILADELPHIA | PA | 19153-2301 | ||||||||||
1066 |
Affiliated | 4048 | Tucson West Dialysis | Tucson West Dialysis | 1780 W ANKLAM RD | TUCSON | AZ | 85745-2632 |
Page 100 of 123
1067 |
Affiliated | 4049 | Tucson East Dialysis | Tucson East Dialysis | 6420 E BROADWAY BLVD | STE C3 | TUCSON | AZ | 85710-3512 | |||||||||
1068 |
Affiliated | 4053 | Tallahassee South Dialysis | Tallahassee South Dialysis | 2410 S ADAMS ST | TALLAHASSEE | FL | 32301-6325 | ||||||||||
1069 |
Affiliated | 4054 | Selma Dialysis | Selma Dialysis | 2711 CINEMA WAY | STE 111 | SELMA | CA | 93662-2662 | |||||||||
1070 |
Affiliated | 4055 | Hinesville Dialysis | Hinesville Dialysis | 522 ELMA G MILES PKWY | HINESVILLE | GA | 31313-4021 | ||||||||||
1071 |
Affiliated | 4056 | Los Angeles Downtown Dialysis | Los Angeles Downtown Dialysis | 2021 S FLOWER ST | LOS ANGELES | CA | 90007-1342 | ||||||||||
1072 |
Affiliated | 4057 | Anaheim Dialysis | Anaheim Dialysis | 1107 W LA PALMA AVE | ANAHEIM | CA | 92801-2804 | ||||||||||
1073 |
Affiliated | 4058 | Martinsville Dialysis | Martinsville Dialysis | 33 BRIDGE ST S | MARTINSVILLE | VA | 24112-6214 | ||||||||||
1074 |
Affiliated | 4060 | Jefferson Dialysis | Jefferson Dialysis | 14 CLAIRTON BLVD | PITTSBURGH | PA | 15236-3911 | ||||||||||
1075 |
Affiliated | 4061 | Saddleback Dialysis | Saddleback Dialysis | 23141 PLAZA POINTE DR | LAGUNA HILLS | CA | 92653-1425 | ||||||||||
1076 |
Affiliated | 4064 | Sun City Center Dialysis | Sun City Center Dialysis | 783 CORTARO DR | RUSKIN | FL | 33573-6812 | ||||||||||
1077 |
Affiliated | 4065 | Paris Dialysis | Paris Dialysis | 32 STEUBENVILLE PK | PARIS | PA | 15021 | ||||||||||
1078 |
Affiliated | 4066 | Central Tampa Dialysis | Central Tampa Dialysis | 4204 N MACDILL AVE | SOUTH BLDG | TAMPA | FL | 33607-6342 | |||||||||
1079 |
Affiliated | 4068 | Zephyrhills Dialysis | Zephyrhills Dialysis | 6610 STADIUM DR | ZEPHYRHILLS | FL | 33542-7510 | ||||||||||
1080 |
Affiliated | 4069 | Bartow Dialysis | Bartow Dialysis | 1190 E CHURCH ST | BARTOW | FL | 33830-4117 | ||||||||||
1081 |
Affiliated | 4070 | Ormond Beach Dialysis | Ormond Beach Dialysis | 495 S NOVA RD | STE 19 | ORMOND BEACH | FL | 32174-8444 | |||||||||
1082 |
Affiliated | 4071 | Lakeland South Dialysis | Lakeland South Dialysis | 5050 S FLORIDA AVE | LAKELAND | FL | 33813-2501 | ||||||||||
1083 |
Affiliated | 4072 | St. Marys Dialysis | St. Marys Dialysis | 2714 OSBORNE RD | ST MARYS | GA | 31558-4049 | ||||||||||
1084 |
Affiliated | 4073 | Miami North Dialysis | Miami North Dialysis | 860 NE 125TH ST | NORTH MIAMI | FL | 33161-5743 | ||||||||||
1085 |
Affiliated | 4074 | Naples Dialysis | Naples Dialysis | 661 9TH ST N | NAPLES | FL | 34102-8132 | ||||||||||
1086 |
Affiliated | 4075 | Bonita Springs Dialysis | Bonita Springs Dialysis | 9134 BONITA BEACH RD SE | BONITA SPRINGS | FL | 34135-4281 | ||||||||||
1087 |
Affiliated | 4076 | Orlando Southwest Dialysis | Orlando Southwest Dialysis | 6925 LAKE ELLENOR DR | STE 65 | ORLANDO | FL | 32809-4670 | |||||||||
1088 |
Affiliated | 4088 | Quincy Dialysis | Quincy Dialysis | 878 STRONG RD | QUINCY | FL | 32351-5243 | ||||||||||
1089 |
Affiliated | 4089 | Tallahassee Dialysis | Tallahassee Dialysis | 1607 PHYSICIANS DR | TALLAHASSEE | FL | 32308-4620 | ||||||||||
1090 |
Affiliated | 4095 | South Beach Dialysis | South Beach Dialysis | 4701 N MERIDIAN AVE | MIAMI BEACH | FL | 33140-2910 | ||||||||||
1091 |
Affiliated | 4124 | Americus Dialysis | Americus Dialysis | 227 N LEE ST | AMERICUS | GA | 31709-3525 | ||||||||||
1092 |
Affiliated | 4204 | Corry Dialysis | Corry Dialysis | 300 YORK ST | CORRY | PA | 16407-1420 | ||||||||||
1093 |
Affiliated | 4208 | Elizabethtown Dialysis | Elizabethtown Dialysis | 844 N HANOVER ST | ELIZABETHTOWN | PA | 17022-1303 | ||||||||||
1094 |
Affiliated | 4209 | Lumberton Dialysis | Lumberton Dialysis | 668 MAIN ST | LUMBERTON | NJ | 08048-5016 | ||||||||||
1095 |
Affiliated | 4211 | Cobbs Creek Dialysis | Cobbs Creek Dialysis | 1700 S 60TH ST | PHILADELPHIA | PA | 19142-1404 | ||||||||||
1096 |
Affiliated | 4214 | Westland Dialysis | Garden West Dialysis (fka Westland) | 5715 N VENOY RD | WESTLAND | MI | 48185-2830 | ||||||||||
1097 |
Affiliated | 4215 | Meadville Dialysis | Meadville Dialysis | 19050 PARK AVENUE PLZ | MEADVILLE | PA | 16335-4012 | ||||||||||
1098 |
Affiliated | 4217 | Bradford Dialysis | Bradford Dialysis | 665 E MAIN ST | BRADFORD | PA | 16701-1869 | ||||||||||
1099 |
Affiliated | 4219 | Southgate Dialysis | Southgate Dialysis | 14752 NORTHLINE RD | SOUTHGATE | MI | 48195-2467 | ||||||||||
1100 |
Affiliated | 4223 | Waynesburg Dialysis | Waynesburg Dialysis | 248 ELM DR | WAYNESBURG | PA | 15370-8269 | ||||||||||
1101 |
Affiliated | 4224 | Selinsgrove Dialysis | Selinsgrove Dialysis | 1030 N SUSQUEHANNA TRAIL | SELINSGROVE | PA | 17870-7767 | ||||||||||
1102 |
Affiliated | 2153 | Arlington Dialysis | Arlington Dialysis | 1250 E PIONEER PKWY | STE 7 | ARLINGTON | TX | 76010-6423 | |||||||||
1103 |
Affiliated | 2154 | Grapevine Dialysis | Grapevine Dialysis | 1600 W NORTHWEST HWY | STE 1 | GRAPEVINE | TX | 76051-8131 | |||||||||
1104 |
Affiliated | 1740 | Willow Dialysis | Willow Dialysis | 1675 ALEX DR | WILMINGTON | OH | 45177-2446 | ||||||||||
1105 |
Affiliated | 1767 | New Braunfels Dialysis | New Braunfels Dialysis | 900 LOOP 337 | NEW BRAUNFELS | TX | 78130-3555 | ||||||||||
1106 |
Affiliated | 2080 | Chickasha Dialysis | Chickasha Dialysis | 228 S 29TH ST | CHICKASHA | OK | 73018-2502 | ||||||||||
1107 |
Affiliated | 2184 | Sugarloaf | Sugarloaf Dialysis (fka Lawrenceville) | 1705 BELLE MEADE CT | STE 11 | LAWRENCEVILLE | GA | 30043-5895 | |||||||||
1108 |
Affiliated | 2166 | Buford Dialysis | Buford Dialysis | 1550 BUFORD HWY | STE 1E | BUFORD | GA | 30518-3666 | |||||||||
1109 |
Affiliated | 1749 | St. Louis Park PD | St. Louis Park Dialysis Center PD | 3505 LOUISIANA AVE S | ST LOUIS PARK | MN | 55426-4121 | ||||||||||
1110 |
Affiliated | 1769 | Front Royal Dialysis | Front Royal Dialysis | 1077D N SHENANDOAH AVE | FRONT ROYAL | VA | 22630-3546 | ||||||||||
1111 |
Affiliated | 1770 | Winchester Dialysis | Winchester Dialysis | 2301 VALOR DR | WINCHESTER | VA | 22601-6111 | ||||||||||
1112 |
Affiliated | 2200 | New Hope Dialysis | New Hope Dialysis (aka Minneapolis, Golden Valley) | 5640 INTERNATIONAL PKWY | NEW HOPE | MN | 55428-3047 | ||||||||||
1113 |
Affiliated | 2175 | Richfield Dialysis | Richfield Dialysis | 6601 LYNDALE AVE S | STE 15 | RICHFIELD | MN | 55423-2490 | |||||||||
1114 |
Affiliated | 2162 | Fairborne Dialysis | Fairborn Dialysis | 3070 PRESIDENTIAL DR | STE A | FAIRBORN | OH | 45324-6273 | |||||||||
1115 |
Affiliated | 1694 | Benton Dialysis | Benton Dialysis | 1151 ROUTE 14 W | BENTON | IL | 62812-1500 | ||||||||||
1116 |
Affiliated | 1695 | Centralia Dialysis | Centralia Dialysis | 1231 STATE ROUTE 161 | CENTRALIA | IL | 62801-6739 | ||||||||||
1117 |
Affiliated | 1696 | Marion Dialysis | Marion Dialysis | 324 S 4TH ST | MARION | IL | 62959-1241 | ||||||||||
1118 |
Affiliated | 1697 | Mount Vernon Dialysis | Mount Vernon Dialysis | 1800 JEFFERSON AVE | MOUNT VERNON | IL | 62864-4300 | ||||||||||
1119 |
Affiliated | 2121 | Bayou City Dialysis | Bayou City Dialysis (fka Hanson) | 10655 EASTEX FWY | HOUSTON | TX | 77093-4323 | ||||||||||
1120 |
Affiliated | 2117 | Metarie Dialysis Center | Metairie Dialysis | 7100 AIRLINE DR | METAIRIE | LA | 70003-5950 | ||||||||||
1121 |
Affiliated | 1784 | Stony Creek Dialysis | Stony Creek Dialysis | 9115 S CICERO AVE | OAK LAWN | IL | 60453-1895 | ||||||||||
1122 |
Affiliated | 1785 | Beverly Dialysis | Beverly Dialysis | 8109 SOUTH WESTERN AVE | CHICAGO | IL | 60620-5939 | ||||||||||
1123 |
Affiliated | 2089 | Summit Dialysis | Summit Dialysis Center | 3150 POLK ST | HOUSTON | TX | 77003-4631 | ||||||||||
1124 |
Affiliated | 2212 | Upper Valley Dialysis | Upper Valley Dialysis (fka West El Paso) | 7933 N MESA ST | STE H | EL PASO | TX | 79932-1699 | |||||||||
1125 |
Affiliated | 2134 | Dallas County | Perry Dialysis (fka Dallas County) | 610 10TH ST | STE L1 | PERRY | IA | 50220-2221 | |||||||||
1126 |
Affiliated | 1813 | Nampa Dialysis Center | Nampa Dialysis | 846 PARKCENTRE WAY | NAMPA | ID | 83651-1790 | ||||||||||
1127 |
Affiliated | 1814 | Table Rock Dialysis | Table Rock Dialysis | 5610 W GAGE ST | STE B | BOISE | ID | 83706 | |||||||||
1128 |
Affiliated | 1815 | Twin Falls Dialysis | Twin Falls Dialysis | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | ||||||||||
1129 |
Affiliated | 1816 | Burley Dialysis Center | Burley Dialysis | 741 N OVERLAND AVE | BURLEY | ID | 83318-3440 | ||||||||||
1130 |
Affiliated | 1817 | Gate City Dialysis Center | Gate City Dialysis | 2001 BENCH RD | POCATELLO | ID | 83201-2033 | ||||||||||
1131 |
Affiliated | 1818 | Four Rivers Dialysis | Four Rivers Dialysis | 515 EAST LN | ONTARIO | OR | 97914-3953 | ||||||||||
1132 |
Affiliated | 2231 | River Parishes | River Parishes Dialysis (aka La Place) | 2880 W AIRLINE HWY | LA PLACE | LA | 70068-2922 | ||||||||||
1133 |
Affiliated | 2177 | South Lincoln | South Lincoln Dialysis | 3401 PLANTATION DR | STE 14 | LINCOLN | NE | 68516-4712 |
Page 101 of 123
1134 |
Affiliated | 2105 | Rochester Hills | Rochester Hills Dialysis (aka Sterling Heights) | 1886 W AUBURN RD | STE 1 | ROCHESTER HILLS | MI | 48309-3865 | |||||||||
1135 |
Affiliated | 2101 | Willowbrook Dialysis | Willowbrook Dialysis | 12120 JONES RD | STE G | HOUSTON | TX | 77070-5280 | |||||||||
1136 |
Affiliated | 2195 | Springhurst Dialysis | Springhurst Dialysis (aka Louisville) | 10201 CHAMPION FARMS DR | LOUISVILLE | KY | 40241-6150 | ||||||||||
1137 |
Affiliated | 2012 | Magnolia West | Magnolia West Dialysis (aka Riverside II) | 11161 MAGNOLIA AVE | RIVERSIDE | CA | 92505-3605 | ||||||||||
1138 |
Affiliated | 2206 | Garrisonville Dialysis | Garrisonville Dialysis | 70 DOC STONE RD | STE 11 | STAFFORD | VA | 22556-4628 | |||||||||
1139 |
Affiliated | 2152 | Strongsville Dialysis | Strongsville Dialysis | 17792 PEARL RD | STRONGSVILLE | OH | 44136-6909 | ||||||||||
1140 |
Affiliated | 984 | Summerlin Dialysis | Summerlin Dialysis Center, LV | 653 N TOWN CENTER DR | STE 7 BLDG 2 | LAS VEGAS | NV | 89144-0503 | |||||||||
1141 |
Affiliated | 2127 | Red Bluff Dialysis | Red Bluff Dialysis Center | 2455 SISTER MARY COLUMBA DR | RED BLUFF | CA | 96080-4364 | ||||||||||
1142 |
Affiliated | 1638 | Cobb Dialysis | Cobb Dialysis | 3865 MEDICAL PARK DR | AUSTELL | GA | 30106-1109 | ||||||||||
1143 |
Affiliated | 1693 | Paulding Dialysis | Paulding Dialysis | 4019 JOHNS RD | DALLAS | GA | 30132-3420 | ||||||||||
1144 |
Affiliated | 1839 | Sweetwater Dialysis | Sweetwater Dialysis | 7117 S SWEETWATER RD | LITHIA SPRINGS | GA | 30122-2446 | ||||||||||
1145 |
Affiliated | 3671 | Charlottesville North | Charlottesville North Dialysis | 1800 TIMBERWOOD BLVD | STE C | CHARLOTTESVILLE | VA | 22911-7544 | |||||||||
1146 |
Affiliated | 2186 | Southern Crescent | Southern Crescent Dialysis Center (fka Riverdale) | 275 UPPER RIVERDALE RD SW | STE B | RIVERDALE | GA | 30274-2556 | |||||||||
1147 |
Affiliated | 2169 | Meridian Park | Meridian Park Dialysis Center (fka Lake Oswego) | 19255 SW 65TH AVE | STE 1 | TUALATIN | OR | 97062-9712 | |||||||||
1148 |
Affiliated | 1812 | Treasure Valley Dialysis | Treasure Valley Dialysis | 3525 E LOUISE ST | STE 155 | MERIDIAN | ID | 83642-6303 | |||||||||
1149 |
Affiliated | 3637 | White Oak | White Oak Dialysis (Chronic) | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | |||||||||
1150 |
Affiliated | 1786 | Ash Tree | Ash Tree Dialysis | 2666 N GROVE INDUSTRIAL DR | FRESNO | CA | 93727-1552 | ||||||||||
1151 |
Affiliated | 2242 | Madera Dialysis | Almond Wood Dialysis (fka Madera) | 501 E ALMOND AVE | MADERA | CA | 93637-5661 | ||||||||||
1152 |
Affiliated | 2209 | Carrollton | Carrollton Dialysis | 1544 VALWOOD PKWY | STE 114 | CARROLLTON | TX | 75006-8425 | |||||||||
1153 |
Affiliated | 2202 | Edna Dialysis | Edna Dialysis | 1008 N WELLS ST | EDNA | TX | 77957-2153 | ||||||||||
1154 |
Affiliated | 2208 | Bear Creek Dialysis | Bear Creek Dialysis (fka Clay Road) | 4978 HIGHWAY 6 N | STE I | HOUSTON | TX | 77084-5282 | |||||||||
1155 |
Affiliated | 1820 | Windham Dialysis | Windham Dialysis | 375 TUCKIE RD | STE C | NORTH WINDHAM | CT | 06256-1345 | |||||||||
1156 |
Affiliated | 1819 | Vernon Dialysis | Vernon Dialysis | 460 HARTFORD TPKE STE C | VERNON ROCKVILLE | CT | 6066 | ||||||||||
1157 |
Affiliated | 2092 | Fountain Dialysis | Fountain Dialysis (aka Security) | 6910 BANDLEY DR | FOUNTAIN | CO | 80817-2617 | ||||||||||
1158 |
Affiliated | 1846 | Grand Junction | Grand Junction Dialysis Center | 710 WELLINGTON AVE | STE 2 | GRAND JUNCTION | CO | 81501-6100 | |||||||||
1159 |
Affiliated | 2183 | Fort Mill | Fort Mill Dialysis | 1975 CAROLINA PLACE DR | FORT MILL | SC | 29708-6922 | ||||||||||
1160 |
Affiliated | 2215 | Mrytle Beach | JV-Myrtle Beach Dialysis | 3919 MAYFAIR ST | MYRTLE BEACH | SC | 29577-5773 | ||||||||||
1161 |
Affiliated | 2032 | Oakwood | Oakwood Dialysis Center | 148 HECTOR AVE | GRETNA | LA | 70056-2531 | ||||||||||
1162 |
Affiliated | 2168 | SP Hillsboro | Hillsboro Dialysis | 2500 NW 229TH AVE | STE 3 BLDG E | HILLSBORO | OR | 97124-7516 | |||||||||
1163 |
Affiliated | 2269 | Kettering | Kettering Dialysis | 5721 BIGGER RD | KETTERING | OH | 45440-2752 | ||||||||||
1164 |
Affiliated | 2246 | Mansfield | Mansfield Dialysis Center (aka Dallas) | 987 N WALNUT CREEK DR | STE 11 | MANSFIELD | TX | 76063-8016 | |||||||||
1165 |
Affiliated | 2290 | Cottage Grove | Cottage Grove Dialysis | 8800 E POINT DOUGLAS RD S | STE 1 | COTTAGE GROVE | MN | 55016-4160 | |||||||||
1166 |
Affiliated | 2257 | Scott County Dialysis | Scott County Dialysis | 7456 S PARK DR | SAVAGE | MN | 55378 | ||||||||||
1167 |
Affiliated | 1773 | Virginia Beach | Camelot Dialysis Center | 1800 CAMELOT DR | STE 1 | VIRGINIA BEACH | VA | 23454-2440 | |||||||||
1168 |
Affiliated | 1627 | Amelia Island | Amelia Island Dialysis | 1525 LIME ST | STE 12 | FERNANDINA BEACH | FL | 32034-3015 | |||||||||
1169 |
Affiliated | 2179 | Laurel Manor at the Villages | Laurel Manor Dialysis Center at the Villages | 1950 LAUREL MANOR DR | STE 19 | LADY LAKE | FL | 32162-5603 | |||||||||
1170 |
Affiliated | 2160 | East Deerborn | East Dearborn Dialysis | 13200 W WARREN AVE | DEARBORN | MI | 48126-2410 | ||||||||||
1171 |
Affiliated | 1661 | North Houston | PDI-North Houston | 7115 NORTH LOOP E | HOUSTON | TX | 77028-5948 | ||||||||||
1172 |
Affiliated | 1663 | South Houston | PDI-South Houston | 5989 SOUTH LOOP E | HOUSTON | TX | 77033-1017 | ||||||||||
1173 |
Affiliated | 1856 | Ralph McGill Dialysis Center | Ralph McGill Dialysis | 418 DECATUR ST SE | ATLANTA | GA | 30312-1801 | ||||||||||
1174 |
Affiliated | 2144 | Chelsea | Chelsea Dialysis | 1620 COMMERCE PARK DR | STE 2 | CHELSEA | MI | 48118-2136 | |||||||||
1175 |
Affiliated | 2214 | Smokey Mountain | Smoky Mountain Dialysis | 1611 ANDREWS RD | MURPHY | NC | 28906-5100 | ||||||||||
1176 |
Affiliated | 3680 | Miami Gardens | Miami Gardens Dialysis | 3363 NW 167TH ST | MIAMI GARDENS | FL | 33056-4254 | ||||||||||
1177 |
Affiliated | 2222 | Deerbrook | Deerbrook Dialysis | 9660 FM 1960 BYPASS RD W | HUMBLE | TX | 77338-4039 | ||||||||||
1178 |
Affiliated | 2227 | Downtown Dallas | DaVita Downtown Dallas Dialysis Center (fka Grove) | 3515 SWISS AVE | STE A | DALLAS | TX | 75204-6223 | |||||||||
1179 |
Affiliated | 2197 | Henderson | Siena Henderson Dialysis Center | 2865 SIENNA HEIGHTS DR | STE 141 | HENDERSON | NV | 89052-4168 | |||||||||
1180 |
Affiliated | 2292 | Wyandotte | Wyandotte Central Dialysis | 3737 STATE AVE | KANSAS CITY | KS | 66102-3830 | ||||||||||
1181 |
Affiliated | 2235 | Westview | Westview Dialysis | 3749 COMMERCIAL DR | LAFAYETTE PLACE SHOPPING CENTER | INDIANAPOLIS | IN | 46222-1676 | |||||||||
1182 |
Affiliated | 2286 | Garland | Garland Dialysis | 776 E CENTERVILLE RD | GARLAND | TX | 75041-4640 | ||||||||||
1183 |
Affiliated | 2333 | Aberdeen | Aberdeen Dialysis | 780 W BEL AIR AVE | ABERDEEN | MD | 21001-2236 | ||||||||||
1184 |
Affiliated | 2259 | Mountain Park | Mountain Park Dialysis | 5235 MEMORIAL DR | STONE MOUNTAIN | GA | 30083-3112 | ||||||||||
1185 |
Affiliated | 2229 | Downtown San Antonio | Downtown San Antonio Dialysis (Brooklyn St) | 615 E QUINCY ST | SAN ANTONIO | TX | 78215-1600 | ||||||||||
1186 |
Affiliated | 2237 | Medlock Bridge | Medlock Bridge Dialysis (aka Duluth) | 10680 MEDLOCK BRIDGE RD | STE 13 | DULUTH | GA | 30097-8420 | |||||||||
1187 |
Affiliated | 2234 | Greene County Dialysis | Greene County Dialysis Center (NC) | 1025 KINGOLD BLVD | SNOW HILL | NC | 28580-1616 | ||||||||||
1188 |
Affiliated | 2243 | West Broadway Dialysis | West Broadway Dialysis | 720 W BROADWAY | LOUISVILLE | KY | 40202-2240 | ||||||||||
1189 |
Affiliated | 2072 | St. Pauls Dialysis | St. Pauls Dialysis (aka Robeson County) | 564 W MCLEAN ST | SAINT PAULS | NC | 28384-1421 | ||||||||||
1190 |
Affiliated | 2123 | Carquinez Dialyis | Carquinez Dialysis (fka SW Vallejo) | 125 CORPORATE PL | STE C | VALLEJO | CA | 94590-6968 | |||||||||
1191 |
Affiliated | 2159 | DaVita East | DaVita East Dialysis Clinic (fka La Bamba) | 11989 PELLICANO DR | EL PASO | TX | 79936-6287 | ||||||||||
1192 |
Affiliated | 2187 | Natomas | Natomas Dialysis | 30 GOLDEN LAND CT | BLDG G | SACRAMENTO | CA | 95834-2420 | |||||||||
1193 |
Affiliated | 2228 | Tennesse Valley | Tennessee Valley Dialysis Center (aka Johnson City) | 107 WOODLAWN DR | STE 2 | JOHNSON CITY | TN | 37604-6287 | |||||||||
1194 |
Affiliated | 2174 | Turfway Dialysis | Turfway Dialysis (fka Florence) | 11 SPIRAL DR | STE 15 | FLORENCE | KY | 41042-1394 | |||||||||
1195 |
Affiliated | 2291 | Leavenworth | Leavenworth Dialysis | 501 OAK ST | LEAVENWORTH | KS | 66048-2646 | ||||||||||
1196 |
Affiliated | 2270 | Franklin Dialysis | Franklin Dialysis (IN) | 1140 W JEFFERSON ST | STE A | FRANKLIN | IN | 46131-2101 | |||||||||
1197 |
Affiliated | 2011 | Norco | Norco Dialysis (fka Corona II) | 1901 TOWN AND COUNTRY DR | STE 1 | NORCO | CA | 92860-3611 | |||||||||
1198 |
Affiliated | 2240 | Andover | Andover Dialysis | 488 S MAIN ST | ANDOVER | OH | 44003-9602 | ||||||||||
1199 |
Affiliated | 1863 | Little Rock | Jacksonville Central Dialysis Center | 400 T P WHITE DR | JACKSONVILLE | AR | 72076-3287 | ||||||||||
1200 |
Affiliated | 1864 | North Little Rock Dialysis | North Little Rock Center | 4505 E MCCAIN BLVD | NORTH LITTLE ROCK | AR | 72117-2902 |
Page 102 of 123
1201 |
Affiliated | 2233 | Anadarko | Anadarko Dialysis | 412 SE 11TH STREET | ANADARKO | OK | 73005-4442 | ||||||||||
1202 |
Affiliated | 2331 | Desert Springs | Desert Springs Dialysis | 2110 E FLAMINGO RD | STE 18 | LAS VEGAS | NV | 89119-5191 | |||||||||
1203 |
Affiliated | 2213 | Livingston | Vancouver Dialysis Center | 9120 NE VANCOUVER MALL DR | STE 16 | VANCOUVER | WA | 98662-9401 | |||||||||
1204 |
Affiliated | 2300 | Vancouver | Livingston TN Dialysis | 308 OAK ST | LIVINGSTON | TN | 38570-1729 | ||||||||||
1205 |
Affiliated | 2225 | Fenton Dialysis | Fenton Dialysis | 17420 SILVER PKWY | FENTON | MI | 48430-4429 | ||||||||||
1206 |
Affiliated | 2332 | Cold Spring | Cold Springs Dialysis | 430 CROSS ROADS BLVD | COLD SPRING | KY | 41076-2341 | ||||||||||
1207 |
Affiliated | 2094 | Yucaipa | Yucaipa Dialysis | 33487 YUCAIPA BLVD | YUCAIPA | CA | 92399-2064 | ||||||||||
1208 |
Affiliated | 1900 | Florida Renal Center | Florida Renal Center | 3500 NW 7TH ST | MIAMI | FL | 33125-4016 | ||||||||||
1209 |
Affiliated | 2140 | Harbor UCLA | Long Beach Harbor Dialysis (aka UCLA) | 1075 E PACIFIC COAST HWY | LONG BEACH | CA | 90806-5089 | ||||||||||
1210 |
Affiliated | 2210 | Seaton Drive | Seton Drive Dialysis (fka Greensprings II) | 4800 SETON DR | BALTIMORE | MD | 21215-3210 | ||||||||||
1211 |
Affiliated | 1865 | South Valley | South Valley Dialysis | 17815 VENTURA BLVD | STE 1 | ENCINO | CA | 91316-3600 | |||||||||
1212 |
Affiliated | 2305 | West Pensacola | West Pensacola Dialysis | 598 N FAIRFIELD DR | STE 1 | PENSACOLA | FL | 32506-4320 | |||||||||
1213 |
Affiliated | 2073 | Mar Vista | Mar Vista Dialysis Center (UCLA-Santa Monica) | 2020 SANTA MONICA BLVD | STE 1 | SANTA MONICA | CA | 90404-2139 | |||||||||
1214 |
Affiliated | 2082 | Riddle Dialysis | Riddle Dialysis | 100 GRANITE DR | STE 16 | MEDIA | PA | 19063-5134 | |||||||||
1215 |
Affiliated | 2346 | Uptown | Minneapolis Uptown Dialysis | 3601 LYNDALE AVE S | MINNEAPOLIS | MN | 55409-1103 | ||||||||||
1216 |
Affiliated | 1907 | Lake Griffith East Dialysis | Lake Griffin East Dialysis | 401 E NORTH BLVD | LEESBURG | FL | 34748-5256 | ||||||||||
1217 |
Affiliated | 2170 | West Linn | West Linn Dialysis | 19056 WILLAMETTE DR | WEST LINN | OR | 97068-1715 | ||||||||||
1218 |
Affiliated | 2330 | Cape Coral South Dialysis | Cape Coral South Dialysis | 3046 DEL PRADO BLVD S | STE 4A | CAPE CORAL | FL | 33904-7232 | |||||||||
1219 |
Affiliated | 2241 | Ceres | Ceres Dialysis Center | 1768 MITCHELL RD | STE 38 | CERES | CA | 95307-2156 | |||||||||
1220 |
Affiliated | 1862 | Shaker Square | Shaker Square Dialysis | 12800 SHAKER BLVD | STE 1 | CLEVELAND | OH | 44120-2004 | |||||||||
1221 |
Affiliated | 1906 | St. Cloud Dialysis | St. Cloud Dialysis | 4750 OLD CANOE CREEK RD | SAINT CLOUD | FL | 34769-1430 | ||||||||||
1222 |
Affiliated | 1915 | Turlock Dialysis Center | Turlock Dialysis Center | 50 W SYRACUSE AVE | TURLOCK | CA | 95380-3143 | ||||||||||
1223 |
Affiliated | 2268 | Haymarket | Haymarket Dialysis (fka Gainesville) | 14664 GAP WAY | GAINESVILLE | VA | 20155-1683 | ||||||||||
1224 |
Affiliated | 2272 | Hackettstown | Hackettstown Dialysis | 657 WILLOW GROVE ST | WEST WING MEDICAL PLAZA STE 22 | HACKETTSTOWN | NJ | 07840-1713 | |||||||||
1225 |
Affiliated | 2274 | Regency | Regency Dialysis Center (fka Jacksonville) | 9535 REGENCY SQUARE BLVD N | JACKSONVILLE | FL | 32225-8128 | ||||||||||
1226 |
Affiliated | 2149 | Williamsburg | Williamsburg Dialysis (fka Yorktown) | 500 SENTARA CIR | STE 13 | WILLIAMSBURG | VA | 23188-5727 | |||||||||
1227 |
Affiliated | 2141 | Commerce Township | Commerce Township Dialysis | 120 W COMMERCE RD | COMMERCE TOWNSHIP | MI | 48382-3915 | ||||||||||
1228 |
Affiliated | 2147 | Kankakee | Kankakee County Dialysis | 581 WILLIAM R LATHAM SR DR | STE 14 | BOURBONNAIS | IL | 60914-2439 | |||||||||
1229 |
Affiliated | 2283 | Sandusky | Sandusky Dialysis Center | 795 BARDSHAR RD | SANDUSKY | OH | 44870-1505 | ||||||||||
1230 |
Affiliated | 2252 | Ionia | Ionia Dialysis | 2622 HEARTLAND BLVD | IONIA | MI | 48846-8757 | ||||||||||
1231 |
Affiliated | 2289 | Indian River | Indian River Dialysis Center | 2150 45TH ST | UNIT 12 | VERO BEACH | FL | 32967-6281 | |||||||||
1232 |
Affiliated | 2360 | North Henry | North Henry Dialysis (fka Stockbridge) | 5627 N HENRY BLVD | STE I1 | STOCKBRIDGE | GA | 30281-3244 | |||||||||
1233 |
Affiliated | 2077 | Tacoma Dialysis | Tacoma Dialysis Center | 3401 S 19TH ST | TACOMA | WA | 98405-1909 | ||||||||||
1234 |
Affiliated | 1908 | Hileah Kidney Center I | Hialeah Artificial Kidney Center | 2750 W 68TH ST | STE 27 | HIALEAH | FL | 33016-5450 | |||||||||
1235 |
Affiliated | 2315 | St. Francis | Charter Colony Dialysis Center (fka St. Francis Dialysis) | 2312 COLONY CROSSING PL | MIDLOTHIAN | VA | 23112-4280 | ||||||||||
1236 |
Affiliated | 2138 | Bellflower | Bellflower Dialysis Center (aka Widerhorn) | 15736 WOODRUFF AVE | BELLFLOWER | CA | 90706-4018 | ||||||||||
1237 |
Affiliated | 2301 | Smyrna | Smyrna Dialysis | 537 STONECREST PKWY | SMYRNA | TN | 37167-6884 | ||||||||||
1238 |
Affiliated | 2122 | Clearlake | Clearlake Dialysis | 14400 OLYMPIC DR | CLEARLAKE | CA | 95422-8809 | ||||||||||
1239 |
Affiliated | 1853 | Dialysis Center of Erie | Dialysis Center of Erie | 1641 SASSAFRAS ST | ERIE | PA | 16502-1858 | ||||||||||
1240 |
Affiliated | 1854 | Warren Dialysis | Warren Dialysis | 2 W CRESCENT PARK | WARREN | PA | 16365-2111 | ||||||||||
1241 |
Affiliated | 2322 | Maysville | Maysville Dialysis | 489 TUCKER DR | MAYSVILLE | KY | 41056-9111 | ||||||||||
1242 |
Affiliated | 2429 | Fridley | East River Road Dialysis (fka Fridley Dialysis Unit) | 5301 E RIVER RD | STE 117 | FRIDLEY | MN | 55421-3778 | |||||||||
1243 |
Affiliated | 2189 | West Sacramento | West Sacramento Dialysis | 3450 INDUSTRIAL BLVD | STE 1 | WEST SACRAMENTO | CA | 95691-5003 | |||||||||
1244 |
Affiliated | 2293 | Anderson | Anderson Dialysis Center | 7502 STATE RD | STE 116 | CINCINNATI | OH | 45255 | |||||||||
1245 |
Affiliated | 2383 | North County | North St. Louis County Dialysis | 13119 NEW HALLS FERRY RD | FLORISSANT | MO | 63033-3228 | ||||||||||
1246 |
Affiliated | 2439 | Fargo | Fargo Dialysis Center | 4474 23RD AVE S | STE M | FARGO | ND | 58104-8795 | |||||||||
1247 |
Affiliated | 2008 | Eastchester | Eastchester Road Dialysis Center (Bronx II) | 1515 JARRETT PL | BRONX | NY | 10461-2606 | ||||||||||
1248 |
Affiliated | 2224 | Fallon | Fallon Dialysis | 1103 NEW RIVER PKWY | FALLON | NV | 89406-6899 | ||||||||||
1249 |
Affiliated | 2279 | Clarksville North | Clarksville North Dialysis | 3071 CLAY LEWIS RD | CLARKSVILLE | TN | 37040-5141 | ||||||||||
1250 |
Affiliated | 2308 | Eaton | Eaton Dialysis | 105 E WASHINGTON JACKSON RD | EATON | OH | 45320-9789 | ||||||||||
1251 |
Affiliated | 2447 | Wallace | Wallace Dialysis | 5650 S NC 41 HWY | WALLACE | NC | 28466-6094 | ||||||||||
1252 |
Affiliated | 2288 | Central Kalazmazoo | Kalamazoo Central Dialysis | 535 S BURDICK ST | STE 11 | KALAMAZOO | MI | 49007-5261 | |||||||||
1253 |
Affiliated | 2287 | West Kalamazoo | Kalamazoo West Dialysis | 1040 N 10TH ST | KALAMAZOO | MI | 49009-6149 | ||||||||||
1254 |
Affiliated | 1921 | Bakersfield | Bakersfield Dialysis Center | 5143 OFFICE PARK DR | BAKERSFIELD | CA | 93309-0660 | ||||||||||
1255 |
Affiliated | 1930 | Antelope Valley Dialysis | Antelope Valley Dialysis | 1759 W AVENUE J | STE 12 | LANCASTER | CA | 93534-2703 | |||||||||
1256 |
Affiliated | 1931 | Indian Wells Valley Dialysis | Indian Wells Valley Dialysis | 212 S RICHMOND RD | RIDGECREST | CA | 93555-4434 | ||||||||||
1257 |
Affiliated | 1932 | Palmdale Regional Dialysis | Palmdale Regional | 1643 E PALMDALE BLVD | PALMDALE | CA | 93550-4847 | ||||||||||
1258 |
Affiliated | 2185 | South Star / Adamsville | Southstar Adamsville Dialysis (fka Cascade) | 3651 BAKERS FERRY RD SW | ATLANTA | GA | 30331-3712 | ||||||||||
1259 |
Affiliated | 2314 | Union City | Union City Dialysis | 6851 SHANNON PKWY | STE 2 | UNION CITY | GA | 30291-2049 | |||||||||
1260 |
Affiliated | 2345 | Waterbury | Waterbury Dialysis Center | 150 MATTATUCK HEIGHTS RD | WATERBURY | CT | 06705-3893 | ||||||||||
1261 |
Affiliated | 2421 | Butler Farm | Butler Farm Dialysis (Hope II) | 501 BUTLER FARM RD | HAMPTON | VA | 23666-1777 | ||||||||||
1262 |
Affiliated | 2337 | Blue Mtn Kidney Center | Blue Mountain Kidney Center (aka Wild Horse, Pendleton) | 72556 COYOTE RD | PENDLETON | OR | 97801-1002 | ||||||||||
1263 |
Affiliated | 2249 | Talladega | Talladega Dialysis | 726 BATTLE ST E | STE A | TALLADEGA | AL | 35160-2583 | |||||||||
1264 |
Affiliated | 2281 | Athens East | Athens East Dialysis | 2026 S MILLEDGE AVE | STE A2 | ATHENS | GA | 30605-6480 | |||||||||
1265 |
Affiliated | 2412 | Mayland | Mayland Dialysis Center (aka Spruce Pine) | 575 ALTAPASS HWY | SPRUCE PINE | NC | 28777-3012 | ||||||||||
1266 |
Affiliated | 2236 | Salem | Salem Dialysis Center (IN) | 1201 N JIM DAY RD | STE 13 | SALEM | IN | 47167-7219 | |||||||||
1267 |
Affiliated | 2239 | Lake Cliff | Lake Cliff Dialysis Center | 805 N BECKLEY AVE | DALLAS | TX | 75203-1612 |
Page 103 of 123
1268 |
Affiliated | 2363 | DVA Mid Cities Dialysis | Mid Cities Dialysis Center | 117 E HARWOOD RD | HURST | TX | 76054-3043 | ||||||||||
1269 |
Affiliated | 2362 | Boerne | Boerne Dialysis Center | 1369 S MAIN ST | STE 11 | BOERNE | TX | 78006-2860 | |||||||||
1270 |
Affiliated | 2318 | Columbus West | Columbus West Dialysis | 1395 GEORGESVILLE RD | COLUMBUS | OH | 43228-3611 | ||||||||||
1271 |
Affiliated | 2306 | Point Place | Point Place Dialysis | 4747 SUDER AVE | STE 17 | TOLEDO | OH | 43611-2869 | |||||||||
1272 |
Affiliated | 2350 | Delhi Dialysis | Delhi Dialysis | 5040 DELHI AVE | CINCINNATI | OH | 45238-5388 | ||||||||||
1273 |
Affiliated | 2253 | Pataskala | Pataskala Dialysis Center | 642 E BROAD ST | PATASKALA | OH | 43062-7627 | ||||||||||
1274 |
Affiliated | 2384 | Eastland | Eastland Dialysis (fka Independence) | 19101 E VALLEY VIEW PKWY | STE E | INDEPENDENCE | MO | 64055-6907 | |||||||||
1275 |
Affiliated | 2254 | Wauseon | Wauseon Dialysis Center | 721 S SHOOP AVE | WAUSEON | OH | 43567-1729 | ||||||||||
1276 |
Affiliated | 2327 | Lebanon Dialysis | Lebanon Dialysis Center (Chronic Only) | 918B COLUMBUS AVE | LEBANON | OH | 45036- | ||||||||||
1277 |
Affiliated | 2460 | Horton | Horton Dialysis | 1901 EUCLID AVE | HORTON | KS | 66439-1238 | ||||||||||
1278 |
Affiliated | 2280 | Lone Peak Dialysis | Lone Peak Dialysis | 1175 E 50 S | STE 111 | AMERICAN FORK | UT | 84003-2845 | |||||||||
1279 |
Affiliated | 2347 | Mena | Mena Dialysis Center | 1200 CRESTWOOD CIR | MENA | AR | 71953-5516 | ||||||||||
1280 |
Affiliated | 1941 | FAYETTEVILLE DIALYSIS | Fayetteville Dialysis | 509 E MILLSAP RD | STE 111 | FAYETTEVILLE | AR | 72703-4862 | |||||||||
1281 |
Affiliated | 1942 | BENTONVILLE DIALYSIS | Bentonville Dialysis | 1104 SE 30TH ST | BENTONVILLE | AR | 72712-4290 | ||||||||||
1282 |
Affiliated | 1943 | SILOAM SPRINGS DIALYSIS | Siloam Springs Dialysis | 500 S MOUNT OLIVE ST | STE 17 | SILOAM SPRINGS | AR | 72761-3602 | |||||||||
1283 |
Affiliated | 1944 | SPRINGDALE DIALYSIS | Springdale Dialysis | 708 QUANDT AVE | SPRINGDALE | AR | 72764-5309 | ||||||||||
1284 |
Affiliated | 2273 | Grosse Pointe | Grosse Pointe Dialysis | 18000 E WARREN AVE | STE 1 | DETROIT | MI | 48224-1336 | |||||||||
1285 |
Affiliated | 2448 | Indy South Dialysis | Indy South Dialysis | 972 EMERSON PKWY | STE E | GREENWOOD | IN | 46143-6202 | |||||||||
1286 |
Affiliated | 2358 | Greensburg Dialysis | Greensburg Dialysis | 1531 N COMMERCE EAST DR | STE 6 | GREENSBURG | IN | 47240-3259 | |||||||||
1287 |
Affiliated | 2319 | Grove City | Grove City Dialysis | 4155 KELNOR DR | GROVE CITY | OH | 43123-2960 | ||||||||||
1288 |
Affiliated | 2338 | West Beach | West Beach Dialysis Center | 16201 PANAMA CITY BEACH HWY | STE 12 | PANAMA CITY BEACH | FL | 32413-5301 | |||||||||
1289 |
Affiliated | 2371 | Birmingham | Center Point Dialysis (aka Birmingham Center) | 2337 1ST ST NE | CENTER POINT | AL | 35215-3619 | ||||||||||
1290 |
Affiliated | 2445 | Eureka | Eureka Dialysis Center | 419 MERAMEC BLVD | EUREKA | MO | 63025-3906 | ||||||||||
1291 |
Affiliated | 2313 | Tifton | Tifton Dialysis | 624 LOVE AVE | TIFTON | GA | 31794-4406 | ||||||||||
1292 |
Affiliated | 2146 | Woodlands | The Woodlands Dialysis | 9301 PINECROFT DR | STE 13 | SHENANDOAH | TX | 77380-3178 | |||||||||
1293 |
Affiliated | 2266 | Exerter | Exeter Dialysis | 1116 W VISALIA RD | STE 16 | EXETER | CA | 93221-1482 | |||||||||
1294 |
Affiliated | 2396 | Wayne County | Wayne County Dialysis (fka Fairfield) | 303 NW 11TH ST | STE 1 | FAIRFIELD | IL | 62837-1203 | |||||||||
1295 |
Affiliated | 2415 | Cordele Dialysis | Cordele Dialysis | 1013 E 16TH AVE | CORDELE | GA | 31015-1539 | ||||||||||
1296 |
Affiliated | 2304 | Winter Park | Winter Park Dialysis (aka Orlando) | 3727 N GOLDENROD RD | STE 11 | WINTER PARK | FL | 32792-8611 | |||||||||
1297 |
Affiliated | 2449 | Carmel | Carmel Dialysis | 180 E CARMEL DR | CARMEL | IN | 46032-2633 | ||||||||||
1298 |
Affiliated | 2298 | Corydon | Corydon Dialysis | 1937 OLD HWY 135 NW | CORYDON | IN | 47112-2013 | ||||||||||
1299 |
Affiliated | 2382 | Memphis Southeast | Memphis Southeast Dialysis (aka Midtown) | 1805 MORIAH WOODS BLVD | STE 11 | MEMPHIS | TN | 38117-7119 | |||||||||
1300 |
Affiliated | 2399 | Rim Country | Rim Country Dialysis | 809 W LONGHORN RD | PAYSON | AZ | 85541-4280 | ||||||||||
1301 |
Affiliated | 2201 | Cedar Park | Cedar Park Dialysis (fka North Austin) | 1720 E WHITESTONE BLVD | CEDAR PARK | TX | 78613-7640 | ||||||||||
1302 |
Affiliated | 2368 | Ellensburg | Ellensburg Dialysis | 2101 W DOLARWAY RD | STE 1 | ELLENSBURG | WA | 98926-9310 | |||||||||
1303 |
Affiliated | 2260 | Santa Fe Springs | Santa Fe Springs Dialysis | 11147 WASHINGTON BLVD | WHITTIER | CA | 90606-3007 | ||||||||||
1304 |
Affiliated | 1950 | Snapfinger Dialysis | Snapfinger Dialysis | 5255 SNAPFINGER PARK DR | STE 115 | DECATUR | GA | 30035-4066 | |||||||||
1305 |
Affiliated | 1951 | East Dekalb Dialysis | East DeKalb Dialysis | 2801 CANDLER RD | STE 23 | DECATUR | GA | 30034-1429 | |||||||||
1306 |
Affiliated | 2258 | Meadows East | Meadows East Dialysis | 2529 SIX MILE LN | LOUISVILLE | KY | 40220-2934 | ||||||||||
1307 |
Affiliated | 2226 | First Colony | First Colony Dialysis (aka Sugarland, Great Woods) | 1447 HIGHWAY 6 | STE 14 | SUGAR LAND | TX | 77478-5094 | |||||||||
1308 |
Affiliated | 1612 | Coastal Kidney Center | Coastal Kidney Center | 510 N MACARTHUR AVE | PANAMA CITY | FL | 32401-3636 | ||||||||||
1309 |
Affiliated | 2211 | Clinton Township | Clinton Township Dailysis | 15918 19 MILE RD | STE 11 | CLINTON TOWNSHIP | MI | 48038-1101 | |||||||||
1310 |
Affiliated | 2207 | West Brook | Westbrook Dialysis (fka Palm Brook II) | 13907 W CAMINO DEL SOL | STE 13 | SUN CITY WEST | AZ | 85375-4405 | |||||||||
1311 |
Affiliated | 1954 | Johnson County | Johnson County Dialysis | 10453 W 84TH TER | LENEXA | KS | 66214-1641 | ||||||||||
1312 |
Affiliated | 1956 | Wyandotte County | Wyandotte County Dialysis | 5001 STATE AVE | KANSAS CITY | KS | 66102-3459 | ||||||||||
1313 |
Affiliated | 2479 | Maple Grove | Maple Grove Dialysis Unit | 15655 GROVE CIR N | MAPLE GROVE | MN | 55369-4489 | ||||||||||
1314 |
Affiliated | 4336 | East End | East End-Pittsburgh Dialysis (fka Wilkinsburg) | 7714 PENN AVE PARK PLAZA | PITTSBURGH | PA | 15221 | ||||||||||
1315 |
Affiliated | 2493 | Westminster II - North Metro | North Metro Dialysis Center (aka Denver, Westminster II) | 12365 HURON ST | STE 5 | WESTMINSTER | CO | 80234-3498 | |||||||||
1316 |
Affiliated | 1960 | Vidalia | Vidalia First Street Dialysis | 906 E 1ST ST | VIDALIA | GA | 30474-4207 | ||||||||||
1317 |
Affiliated | 2357 | Highland Park | Highland Park Dialysis | 1559 W 7TH ST | SAINT PAUL | MN | 55102-4238 | ||||||||||
1318 |
Affiliated | 2367 | Centennial Parkway | Centennial Dialysis Center | 8775 DEER SPRINGS WAY | LAS VEGAS | NV | 89149-0416 | ||||||||||
1319 |
Affiliated | 2250 | Lord Baltimore | Northwest Dialysis Center (aka Lord Baltimore, N. Rolling Road II, Owings Mills II) | 2245 ROLLING RUN DR | STE 1 | WINDSOR MILL | MD | 21244-1858 | |||||||||
1320 |
Affiliated | 3944 | North Charlotte | North Charlotte Dialysis | 6620 OLD STATESVILLE RD | CHARLOTTE | NC | 28269 | ||||||||||
1321 |
Affiliated | 2410 | Sun Ray Dialysis | Sun Ray Dialysis Unit (fka East St. Paul) | 1758 OLD HUDSON RD | STE 1 | SAINT PAUL | MN | 55106-6161 | |||||||||
1322 |
Affiliated | 2425 | Vandalia | Vandalia Dialysis | 301 MATTES AVE | VANDALIA | IL | 62471-2061 | ||||||||||
1323 |
Affiliated | 2428 | Westwood Hills | Westwood Hills Dialysis (fka Minneapolis, Excelsior) | 7525 WAYZATA BLVD | SAINT LOUIS PARK | MN | 55426-1621 | ||||||||||
1324 |
Affiliated | 4305 | Amery | Amery Dialysis | 970 ELDEN AVE | AMERY | WI | 54001-1448 | ||||||||||
1325 |
Affiliated | 2434 | Wadsworth | Wadsworth Dialysis | 195 WADSWORTH RD | STE 32 | WADSWORTH | OH | 44281-9504 | |||||||||
1326 |
Affiliated | 2419 | Dublin | Dublin Dialysis | 6770 PERIMETER DR | DUBLIN | OH | 43016-8063 | ||||||||||
1327 |
Affiliated | 4314 | Weber Valley | Weber Valley Dialysis (fka Ogden) | 1920 W 250TH N | MARRIOTT-SLATERVILLE | UT | 84404-9233 | ||||||||||
1328 |
Affiliated | 2343 | West Elk Grove | West Elk Grove Dialysis | 2208 KAUSEN DR | STE 1 | ELK GROVE | CA | 95758-7174 | |||||||||
1329 |
Affiliated | 2355 | Bedford Park | Bedford Park Dialysis Center | 3119 WEBSTER AVE | 1ST FLR | BRONX | NY | 10467-4905 | |||||||||
1330 |
Affiliated | 1747 | Cuero Lakeview Dialysis | Cuero Lakeview Dialysis | 1105 E BROADWAY ST | CUERO | TX | 77954 | ||||||||||
1331 |
Affiliated | 1961 | Madisonville Dialysis | Madisonville Dialysis Center | 255 E NORTH ST | MADISONVILLE | KY | 42431 | ||||||||||
1332 |
Affiliated | 2467 | Crescent City | Crescent City Dialysis Center | 3909 BIENVILLE ST | STE B | NEW ORLEANS | LA | 70119-5152 | |||||||||
1333 |
Affiliated | 4318 | Callowhill | Callowhill Dialysis Center | 313 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4103 | ||||||||||
1334 |
Affiliated | 2406 | Oak Creek | Oak Creek Dialysis (fka South Milwaukee) | 8201 S HOWELL AVE | STE 6 | OAK CREEK | WI | 53154-8336 |
Page 104 of 123
1335 |
Affiliated | 4395 | Leesburg Virginia | Leesburg Virginia Dialysis | 224D CORNWALL ST NW | STE 1 | LEESBURG | VA | 20176-2700 | |||||||||
1336 |
Affiliated | 2386 | Joy of Dixon | Joy of Dixon Dialysis Center | 1640 N LINCOLN ST | DIXON | CA | 95620-9255 | ||||||||||
1337 |
Affiliated | 2137 | Long Beach JV -Bixby Knolls | Bixby Knolls Dialysis (fka Long Beach) | 3744 LONG BEACH BLVD | LONG BEACH | CA | 90807-3310 | ||||||||||
1338 |
Affiliated | 1790 | Alliance Community Dialysis | Alliance Community Dialysis | 270 E STATE ST | STE 11 | ALLIANCE | OH | 44601-4309 | |||||||||
1339 |
Affiliated | 1791 | Belden Community Dialysis | Belden Community Dialysis | 4685 FULTON DR NW | CANTON | OH | 44718-2379 | ||||||||||
1340 |
Affiliated | 1792 | Mercy Canton Dialysis | Mercy Canton Dialysis | 1320 MERCY DR NW | CANTON | OH | 44708-2614 | ||||||||||
1341 |
Affiliated | 2294 | Marrero | Marrero Dialysis | 1908 JUTLAND DR | HARVEY | LA | 70058-2359 | ||||||||||
1342 |
Affiliated | 2351 | Miramar | Miramar Kidney Center | 2501 DYKES RD | STE 2 | MIRAMAR | FL | 33027-4217 | |||||||||
1343 |
Affiliated | 2418 | Chesterton | Chesterton Dialysis | 711 PLAZA DR | STE 6 | CHESTERTON | IN | 46304-5506 | |||||||||
1344 |
Affiliated | 4368 | St. John | St. John Dialysis | 10033 WICKER AVE | STE 6 | SAINT JOHN | IN | 46373-8777 | |||||||||
1345 |
Affiliated | 2256 | Princeton | Princeton Dialysis | 2227 SHERMAN DR | PRINCETON | IN | 47670-1062 | ||||||||||
1346 |
Affiliated | 4332 | Black Rock | Black Rock Dialysis (aka Faifield) | 427 STILLSON RD | FAIRFIELD | CT | 06824-3153 | ||||||||||
1347 |
Affiliated | 2422 | Williamstown | Williamstown Dialysis (fka Dry Ridge) | 103 BARNES RD | STE A | WILLIAMSTOWN | KY | 41097-9468 | |||||||||
1348 |
Affiliated | 4376 | Renaissance | Renaissance Dialysis | 1840 DARBY DR | FLORENCE | AL | 35630-2623 | ||||||||||
1349 |
Affiliated | 4360 | Portage | Portage Dialysis | 5823 US HIGHWAY 6 | PORTAGE | IN | 46368-4851 | ||||||||||
1350 |
Affiliated | 2393 | Opelika | Opelika Dialysis Center | 2340 PEPPERELL PKWY | OPELIKA | AL | 36801-6240 | ||||||||||
1351 |
Affiliated | 2435 | Urbana | Urbana Dialysis Center | 1880 E US HIGHWAY 36 | URBANA | OH | 43078-9600 | ||||||||||
1352 |
Affiliated | 1913 | Port Lavaca Dialysis | Port Lavaca Dialysis | 1300 N VIRGINIA ST | STE 12 | PORT LAVACA | TX | 77979-2512 | |||||||||
1353 |
Affiliated | 2276 | Cornerhouse Dialysis | Cornerhouse Dialysis Center (aka Santa Clara) | 2005 NAGLEE AVE | SAN JOSE | CA | 95128-4801 | ||||||||||
1354 |
Affiliated | 2167 | Snellville | Snellville Dialysis | 2135 MAIN ST E | STE 13 | SNELLVILLE | GA | 30078-6424 | |||||||||
1355 |
Affiliated | 4334 | Bloomfield | Bloomfield-Pittsburgh Dialysis | 5171 LIBERTY AVE | STE C | PITTSBURGH | PA | 15224-2254 | |||||||||
1356 |
Affiliated | 2489 | Pennsauken | Pennsauken Dialysis | 7024 KAIGHNS AVE | PENNSAUKEN | NJ | 08109-4417 | ||||||||||
1357 |
Affiliated | 2433 | Logan | Logan Dialysis | 12880 GREY ST | LOGAN | OH | 43138-9638 | ||||||||||
1358 |
Affiliated | 2454 | Forest Fair | Forest Fair Dialysis (fka Forest Park) | 1145 KEMPER MEADOW DR | CINCINNATI | OH | 45240-4118 | ||||||||||
1359 |
Affiliated | 4307 | Knoxville | Knoxville Central Dialysis | 9141 CROSS PARK DR | STE 12 | KNOXVILLE | TN | 37923-4557 | |||||||||
1360 |
Affiliated | 4338 | Kennestone | Kennestone Dialysis (aka Cobb II) | 200 COBB PKWY N | STE 318 BLDG 3 | MARIETTA | GA | 30062-3558 | |||||||||
1361 |
Affiliated | 4343 | Wiregrass Kidney Center | Wiregrass Kidney Center (fka Ross Circle) | 1450 ROSS CLARK CIR | DOTHAN | AL | 36301-4765 | ||||||||||
1362 |
Affiliated | 2432 | Memphis Downtown | Memphis Downtown Dialysis | 2076 UNION AVE | MEMPHIS | TN | 38104-4138 | ||||||||||
1363 |
Affiliated | 3953 | Marshville | Marshville Dialysis Center | 7260 E MARSHVILLE BLVD | MARSHVILLE | NC | 28103-1191 | ||||||||||
1364 |
Affiliated | 4356 | Shamrock | Shamrock Dialysis | 1016 CLAXTON DAIRY RD | STE 1A | DUBLIN | GA | 31021-7971 | |||||||||
1365 |
Affiliated | 4367 | North Colorado Springs | North Colorado Springs Dialysis | 6071 E WOODMEN RD | STE 1 | COLORADO SPRINGS | CO | 80923-2610 | |||||||||
1366 |
Affiliated | 2466 | Oakes | Oakes Dialysis | 413 S 7TH ST | OAKES | ND | 58474-1920 | ||||||||||
1367 |
Affiliated | 1976 | Pinnacle Dialysis of Boca Raton | Pinnacle Dialysis of Boca Raton | 2900 N MILITARY TRL | STE 195 | BOCA RATON | FL | 33431-6308 | |||||||||
1368 |
Affiliated | 1980 | Cedar Valley Dialysis | Cedar Valley Dialysis | 1661 W RIDGEWAY AVE | WATERLOO | IA | 50701-4541 | ||||||||||
1369 |
Affiliated | 1981 | West Union Dialysis | West Union Dialysis | 405 HIGHWAY 150 N | WEST UNION | IA | 52175-1003 | ||||||||||
1370 |
Affiliated | 2161 | Rockside | Rockside Dialysis (aka Independence, Parma II) | 4801 ACORN DR | INDEPENDENCE | OH | 44131-2566 | ||||||||||
1371 |
Affiliated | 2263 | Sunset | Sunset Dialysis Center (fka Sunrise II) | 3071 GOLD CANAL DR | RANCHO CORDOVA | CA | 95670-6129 | ||||||||||
1372 |
Affiliated | 2442 | Yosemite Street | Yosemite Street Dialysis | 1650 W YOSEMITE AVE | MANTECA | CA | 95337-5193 | ||||||||||
1373 |
Affiliated | 2335 | Jedburg | Jedburg Dialysis | 2897 W 5TH NORTH ST | SUMMERVILLE | SC | 29483-9674 | ||||||||||
1374 |
Affiliated | 2441 | Parker Dialysis | Parker Dialysis | 10371 S PARK GLENN WAY | STE 18 | PARKER | CO | 80138-3885 | |||||||||
1375 |
Affiliated | 2296 | Northgate | Northgate Dialysis Center (aka San Rafael-Terra) | 650 LAS GALLINAS AVE | SAN RAFAEL | CA | 94903-3620 | ||||||||||
1376 |
Affiliated | 2271 | The Nevada Center | The Nevada Dialysis Center (fka Warm Springs, Green Valley) | 1510 W WARM SPRINGS RD | STE 1 | HENDERSON | NV | 89014-3586 | |||||||||
1377 |
Affiliated | 2091 | Aventura | Aventura Kidney Center | 22 SW 11TH ST | FLOOR 2 | HALLANDALE BEACH | FL | 33009-7038 | |||||||||
1378 |
Affiliated | 2408 | US Grant Dialysis | US Grant Dialysis (fka Georgetown, Brown County) | 458 HOME ST | GEORGETOWN | OH | 45121-1408 | ||||||||||
1379 |
Affiliated | 4400 | Arbor Place | Arbor Place Dialysis | 9559 HIGHWAY 5 | STE 1 | DOUGLASVILLE | GA | 30135-1573 | |||||||||
1380 |
Affiliated | 4389 | South Jacksonville | Jacksonville South Dialysis Center | 14965 OLD SAINT AUGUSTINE RD | UNIT 114 | JACKSONVILLE | FL | 32258-9481 | |||||||||
1381 |
Affiliated | 2385 | Somerville | Somerville Dialysis | 12475 US HIGHWAY 64 | SOMERVILLE | TN | 38068-6029 | ||||||||||
1382 |
Affiliated | 4321 | District Heights | District Heights Dialysis (aka Pennsylvania Ave) | 5701 SILVER HILL RD | DISTRICT HEIGHTS | MD | 20747-1102 | ||||||||||
1383 |
Affiliated | 2414 | Edwardsville | Edwardsville Dialysis | 235 S BUCHANAN ST | EDWARDSVILLE | IL | 62025-2108 | ||||||||||
1384 |
Affiliated | 2361 | Broad St | South Broad Street Dialysis (aka S. Philadelphia II) | 1172 S BROAD ST | PHILADELPHIA | PA | 19146-3142 | ||||||||||
1385 |
Affiliated | 2342 | Las Vegas Pedidatrics | Las Vegas Pediatrics Dialysis (fka UMC Peds, DaVita Peds) | 7271 W SAHARA AVE | STE 12 | LAS VEGAS | NV | 89117-2862 | |||||||||
1386 |
Affiliated | 1990 | Apopka Dialysis | Apopka Dialysis | 640 EXECUTIVE PARK CT | APOPKA | FL | 32703-6075 | ||||||||||
1387 |
Affiliated | 1991 | Cassellberry Dialysis | Casselberry Dialysis | 4970 S US HWY 17/92 | CASSELBERRY | FL | 32707-3888 | ||||||||||
1388 |
Affiliated | 1992 | Central Orlando Dialysis | Central Orlando Dialysis | 2548 N ORANGE BLOSSOM TRL | STE 4 | ORLANDO | FL | 32804-4863 | |||||||||
1389 |
Affiliated | 1993 | Sanford Dialysis | Sanford Dialysis | 1701 W 1ST ST | SANFORD | FL | 32771-1605 | ||||||||||
1390 |
Affiliated | 1994 | Winter Park Hemo Dialysis | Winter Park Hemo Dialysis | 4100 METRIC DR | STE 3 | WINTER PARK | FL | 32792-6832 | |||||||||
1391 |
Affiliated | 2173 | Graham | Graham Dialysis Center | 10219 196TH ST CT E | STE C | GRAHAM | WA | 98338-7792 | |||||||||
1392 |
Affiliated | 2316 | Batavia | Batavia Dialysis | 4000 GOLDEN AGE DR | BATAVIA | OH | 45103-1913 | ||||||||||
1393 |
Affiliated | 1967 | Klamath Falls | Klamath Falls Dialysis | 2230 N ELDORADO AVE | KLAMATH FALLS | OR | 97601-6418 | ||||||||||
1394 |
Affiliated | 2336 | Longs | Longs Dialysis (fka Conway) | 90 CLOVERLEAF DR | STE 36 | LONGS | SC | 29568-9262 | |||||||||
1395 |
Affiliated | 2452 | Pooler | Pooler Dialysis | 54 TRADERS WAY | POOLER | GA | 31322- | ||||||||||
1396 |
Affiliated | 4380 | Ohio Pike Dialysis | Ohio Pike Dialysis (aka Amelia) | 1761 STATE ROUTE 125 | AMELIA | OH | 45102-2039 | ||||||||||
1397 |
Affiliated | 2285 | Canyon Springs | Canyon Springs Dialysis (aka Moreno Valley) | 22555 ALESSANDRO BLVD | MORENO VALLEY | CA | 92553-8533 | ||||||||||
1398 |
Affiliated | 4306 | Williamson | South Williamson Dialysis | 204 APPALACHIAN PLAZA | SOUTH WILLIAMSON | KY | 41503-9404 | ||||||||||
1399 |
Affiliated | 4402 | Gulf Shores | Gulf Shores Dialysis Center | 3947 GULF SHORES PKWY | UNIT 15 | GULF SHORES | AL | 36542-2737 | |||||||||
1400 |
Affiliated | 2496 | Las Vegas Multi-Care Five Star | Five Star Dialysis Center (fka Las Vegas Multi-Care) | 2400 TECH CENTER CT | LAS VEGAS | NV | 89128-0804 | ||||||||||
1401 |
Affiliated | 4358 | North Vernon | North Vernon Dialysis | 2340 N STATE HWY 7 | NORTH VERNON | IN | 47265-7183 |
Page 105 of 123
1402 |
Affiliated | 4316 | Olympia | Olympia Dialysis Center | 335 COOPER POINT RD NW | STE 15 | OLYMPIA | WA | 98502-4436 | |||||||||
1403 |
Affiliated | 4335 | Monroeville | Monroeville Dialysis | 2690 MONROEVILLE BLVD | MONROEVILLE | PA | 15146-2302 | ||||||||||
1404 |
Affiliated | 2317 | East Galbraith | East Galbraith Dialysis | 3877 E GALBRAITH RD | BLDG C | CINCINNATI | OH | 45236-1500 | |||||||||
1405 |
Affiliated | 2261 | San Marcos | San Marcos Dialysis Center | 2135 MONTIEL RD | BLDG B | SAN MARCOS | CA | 92069-3511 | |||||||||
1406 |
Affiliated | 4408 | Winter Garden | Winter Garden Dialysis | 1222 WINTER GARDEN VINELAND RD | BLDG 3 STE 1 | WINTER GARDEN | FL | 34787 | |||||||||
1407 |
Affiliated | 1926 | Bremer County Dialysis | Relo-Bremer County Dialysis (5022-Cedar Valley Waverly Dialysis) | 220 10th ST SW | WAVERLY | IA | 50677-2930 | ||||||||||
1408 |
Affiliated | 1927 | Black Hawk Dialysis | Black Hawk Dialysis (Waterloo) | 3421 W 9TH ST | WATERLOO | IA | 50702-5401 | ||||||||||
1409 |
Affiliated | 2218 | Downey Landing | Downey Landing Dialysis Center (aka Downey-Kaiser) | 11611 BELLFLOWER BLVD | DOWNEY | CA | 90241-5408 | ||||||||||
1410 |
Affiliated | 2427 | Tucson Central | Tucson Central Dialysis | 2901 E GRANT RD | TUCSON | AZ | 85716-2717 | ||||||||||
1411 |
Affiliated | 4377 | Hamburg | Hamburg Dialysis (fka Lexington) | 1745 ALYSHEBA WAY | LEXINGTON | KY | 40509-9013 | ||||||||||
1412 |
Affiliated | 2150 | Midtown Norfolk | Midtowne Norfolk Dialysis (aka Ghent II) | 2201 COLONIAL AVE | NORFOLK | VA | 23517-1928 | ||||||||||
1413 |
Affiliated | 2394 | Yonkers II | Yonkers East Dialysis Center | 5 ODELL PLZ | STE 131 | YONKERS | NY | 10701-1406 | |||||||||
1414 |
Affiliated | 2364 | Caldwell | Caldwell Dialysis Center | 821 S SMEED PKWY | CALDWELL | ID | 83605-5130 | ||||||||||
1415 |
Affiliated | 2278 | Hesperia | Hesperia Dialysis Center | 14135 MAIN ST | UNIT 51 | HESPERIA | CA | 92345-8097 | |||||||||
1416 |
Affiliated | 2339 | Sealy | Sealy Dialysis | 2242 CHAMPIONSHIP DR | SEALY | TX | 77474-8026 | ||||||||||
1417 |
Affiliated | 2438 | Hearne | Hearne Dialysis Center | 106 CEDAR ST | HEARNE | TX | 77859-2523 | ||||||||||
1418 |
Affiliated | 1998 | Stockton Kidney Center | Stockton Kidney Center | 1523 E MARCH LN | STE 2 | STOCKTON | CA | 95210-5607 | |||||||||
1419 |
Affiliated | 5525 | University of South Florida | USF Dialysis | 10770 N 46TH ST STE A100 | TAMPA | FL | 33617-3465 | ||||||||||
1420 |
Affiliated | 4424 | Westborough | Westborough Dialysis Center (fka South San Francisco, Daly City) | 925 EL CAMINO REAL | SOUTH SAN FRANCISCO | CA | 94080-3203 | ||||||||||
1421 |
Affiliated | 4359 | Rush County | Rush County Dialysis | 1400 N CHERRY ST | RUSHVILLE | IN | 46173-1097 | ||||||||||
1422 |
Affiliated | 4339 | Defuniak Springs | Defuniak Springs Dialysis | 1045 US HWY 331 S | DEFUNIAK SHOPPING PLAZA | DEFUNIAK SPRINGS | FL | 32435-3375 | |||||||||
1423 |
Affiliated | 2181 | Foster city | Foster City Dialysis (fka Belmont) | 1261 E HILLSDALE BLVD | STE 2 | FOSTER CITY | CA | 94404-1236 | |||||||||
1424 |
Affiliated | 4427 | Red Bank | Redbank Village Dialysis (Cincinnati) | 3960 RED BANK RD | STE 16 | CINCINNATI | OH | 45227-3421 | |||||||||
1425 |
Affiliated | 4448 | Southport | Southport Dialysis Center | 1513 N HOWE ST | STE 15 | SOUTHPORT | NC | 28461-2770 | |||||||||
1426 |
Affiliated | 4446 | Orlando Park | Orlando Park Dialysis | 5397 W COLONIAL DR | STE 12 | ORLANDO | FL | 32808-7647 | |||||||||
1427 |
Affiliated | 4431 | Harrisburg | Harrisburg Dialysis Center (aka Concord) | 3310 PERRY ST | CONCORD | NC | 28027-3901 | ||||||||||
1428 |
Affiliated | 2352 | Waycross | Satilla River Dialysis | 308 CARSWELL AVE | WAYCROSS | GA | 31501-4762 | ||||||||||
1429 |
Affiliated | 4455 | Timberlake | Timberlake Dialysis (Kansas City) | 12110 HOLMES RD | KANSAS CITY | MO | 64145-1707 | ||||||||||
1430 |
Affiliated | 4447 | Dexter | Dexter Dialysis | 2010 N OUTER RD | DEXTER | MO | 63841 | ||||||||||
1431 |
Affiliated | 4426 | Norwood | Norwood Dialysis (Cincinnati) | 2300 WALL ST | CINCINNATI | OH | 45212-2781 | ||||||||||
1432 |
Affiliated | 4420 | Peachtree City | Peachtree City Dialysis | 2830 W HWY 54 | BLDG 1 STE J AND K | PEACHTREE CITY | GA | 30269-1026 | |||||||||
1433 |
Affiliated | 5516 | Rogue Valley | Rogue Valley Dialysis | 760 GOLF VIEW DR | UNIT 1 | MEDFORD | OR | 97504-9685 | |||||||||
1434 |
Affiliated | 5517 | Redwood Dialysis | Redwood Dialysis | 201 SW L ST | GRANTS PASS | OR | 97526-2913 | ||||||||||
1435 |
Affiliated | 4410 | Tucker | Tucker Dialysis | 4434 HUGH HOWELL RD | TUCKER | GA | 30084-4905 | ||||||||||
1436 |
Affiliated | 4386 | Shepherdsville | Shepherdsville Dialysis Center | 150 BROOKS WAY | STE 15 | BROOKS | KY | 40109-6105 | |||||||||
1437 |
Affiliated | 4399 | Muscle Shoals | Muscle Shoals Dialysis | 712 STATE ST | MUSCLE SHOALS | AL | 35661-2940 | ||||||||||
1438 |
Affiliated | 2463 | Tel Huron | Tel-Huron Dialysis (fka Waterford) | 225 SUMMIT DR | WATERFORD | MI | 48328-3364 | ||||||||||
1439 |
Affiliated | 2481 | Cherry Valley | Cherry Valley Dialysis (aka Newark) | 1627 W MAIN ST | NEWARK | OH | 43055-1345 | ||||||||||
1440 |
Affiliated | 2437 | Taylor | Taylor Dialysis | 3100 W 2ND ST | TAYLOR | TX | 76574 | ||||||||||
1441 |
Affiliated | 4430 | Forrest City | Forrest City Dialysis | 1501 N WASHINGTON ST | FORREST CITY | AR | 72335-2152 | ||||||||||
1442 |
Affiliated | 4309 | Kaufman | Kaufman Dialysis | 2851 MILLENNIUM DR | KAUFMAN | TX | 75142-8865 | ||||||||||
1443 |
Affiliated | 4348 | Artesia | Artesia Dialysis | 702 N 13TH ST | ARTESIA | NM | 88210-1166 | ||||||||||
1444 |
Affiliated | 2381 | North Hills | North Hills Dialysis | 7927 BOULEVARD 26 | NORTH RICHLAND HILLS | TX | 76180-7103 | ||||||||||
1445 |
Affiliated | 4428 | Millington | Millington Dialysis | 8510 WILKINSVILLE RD | STE 121 | MILLINGTON | TN | 38053-1537 | |||||||||
1446 |
Affiliated | 5519 | Adams County | Adams County Dialysis | 436 N 10TH ST | QUINCY | IL | 62301-4152 | ||||||||||
1447 |
Affiliated | 5518 | Hannibal | Hannibal Dialysis | 3140 PALMYRA ROAD | HANNIBAL | MO | 63401-2204 | ||||||||||
1448 |
Affiliated | 5520 | Pittsfield | Pittsfield Dialysis | 640 W WASHINGTON ST | PITTSFIELD | IL | 62363-1350 | ||||||||||
1449 |
Affiliated | 4463 | Villa of Waterbury | Villa of Waterbury (fka Kissker Microcenter) | 929 WATERBURY FALLS DR | OFALLON | MO | 63368-2202 | ||||||||||
1450 |
Affiliated | 2465 | Washington DC Nursing Facility | Washington DC Nursing Facility | 2425 25TH ST SE | WASHINGTON | DC | 20020-3408 | ||||||||||
1451 |
Affiliated | 4325 | Moscow | Moscow Dialysis Center | 212 RODEO DR | STE 11 | MOSCOW | ID | 83843-9798 | |||||||||
1452 |
Affiliated | 2402 | Chinook Kidney Center | Chinook Kidney Center (aka Richland) | 1315 AARON DR | BLDG C1 | RICHLAND | WA | 99352-4678 | |||||||||
1453 |
Affiliated | 4416 | Rivers Edge | Rivers Edge Dialysis (aka Athens) | 1006 E STATE ST | STE B | ATHENS | OH | 45701-2121 | |||||||||
1454 |
Affiliated | 5530 | North Glendale Dialysis | North Glendale Dialysis | 1505 WILSON TER STE 190 | GLENDALE | CA | 91206-4015 | ||||||||||
1455 |
Affiliated | 4373 | Everett | Everett Dialysis Center (fka Snohomish 2) | 8130 EVERGREEN WAY | EVERETT | WA | 98203-6419 | ||||||||||
1456 |
Affiliated | 2069 | Harbourview | Harbour View Dialysis (aka Churchland, Suffolk) | 1039 CHAMPIONS WAY | BLDG 4 | SUFFOLK | VA | 23435-3761 | |||||||||
1457 |
Affiliated | 4357 | Capelville | Capelville Dialysis Center | 7008 E SHELBY DR | MEMPHIS | TN | 38125-3416 | ||||||||||
1458 |
Affiliated | 4485 | San Leandro | San Leandro Dialysis (Bayfair Mall) | 15555 E 14TH | STE 52 | SAN LEANDRO | CA | 94578-1900 | |||||||||
1459 |
Affiliated | 4317 | Mill Creek | Mill Creek Dialysis Center (Snohomish/Everett) | 18001 BOTHELL EVERETT HWY | STE 112 | BOTHELL | WA | 98012-1661 | |||||||||
1460 |
Affiliated | 2470 | Seaview | Seaview Dialysis Center | 101 18TH ST SE | LONG BEACH | WA | 98631 | ||||||||||
1461 |
Affiliated | 2461 | East Tampa | East Tampa Dialysis (Ybor City) | 1701 E 9TH AVE | YBOR CITY | FL | 33605-3801 | ||||||||||
1462 |
Affiliated | 5522 | Detroit Road Dialysis | Detroit Road Dialysis | 7901 DETROIT AVE | CLEVELAND | OH | 44102-2828 | ||||||||||
1463 |
Affiliated | 5523 | St V Quadrangle Dialysis | St V Quadrangle Dialysis | 2302 COMMUNITY COLLEGE AVE | CLEVELAND | OH | 44115-3117 | ||||||||||
1464 |
Affiliated | 5524 | Westshore Dialysis | Westshore Dialysis | 29000 CENTER RIDGE RD | WESTLAKE | OH | 44145-5293 | ||||||||||
1465 |
Affiliated | 2468 | Magnolia Dialysis Center Texas | Magnolia Dialysis Center | 17649 FM 1488 RD | MAGNOLIA | TX | 77354-5235 | ||||||||||
1466 |
Affiliated | 4471 | Highland County | Highland County Dialysis (Hillsboro) | 120 ROBERTS LN | STE 4 | HILLSBORO | OH | 45133-7608 | |||||||||
1467 |
Affiliated | 4313 | Rockwall | Rockwall Dialysis | 2455 RIDGE RD | STE 11 | ROCKWALL | TX | 75087-5530 | |||||||||
1468 |
Affiliated | 4354 | Great Northern | Villa of Great Northern (fka North Olmsted) | 22710 FAIRVIEW CENTER DR | STE 1 | FAIRVIEW PARK | OH | 44126-3607 |
Page 106 of 123
1469 |
Affiliated | 2440 | Ridgeland | Ridgeland Dialysis | 112 WEATHERSBY ST | RIDGELAND | SC | 29936-9514 | ||||||||||
1470 |
Affiliated | 2334 | Livermore | Livermore Dialysis | 3201 DOOLAN RD | STE 175 | LIVERMORE | CA | 94551-9605 | |||||||||
1471 |
Affiliated | 2265 | Westlake Daly city | Westlake Daly City Dialysis (fka Colma) | 2201 JUNIPERO SERRA BLVD | STE 175 | DALY CITY | CA | 94014-1908 | |||||||||
1472 |
Affiliated | 4488 | 12th Street Covington | 12th Street Covington Dialysis | 1500 JAMES SIMPSON JR WAY | STE 11 | COVINGTON | KY | 41011 | |||||||||
1473 |
Affiliated | 4384 | Bourbon County | Bourbon County Dialysis (fka Paris) | 213 LETTON DR | PARIS TOWNE SQUARE | PARIS | KY | 40361-2251 | |||||||||
1474 |
Affiliated | 2499 | Calverton | Calverton Dialysis | 4780 CORRIDOR PL | STE C | BELTSVILLE | MD | 20705-1165 | |||||||||
1475 |
Affiliated | 2199 | Aborn | Aborn Dialysis (fka East San Jose) | 3162 S WHITE RD | STE 1 | SAN JOSE | CA | 95148-4019 | |||||||||
1476 |
Affiliated | 4438 | Clermont | Clermont County Dialysis (Milford,Goshen) | 5901 MONTCLAIR BLVD | STE 1 | MILFORD | OH | 45150-2547 | |||||||||
1477 |
Affiliated | 4365 | Rita Ranch | Rita Ranch Dialysis (aka Tucson East II) | 7355 S HOUGHTON RD | STE 11 | TUCSON | AZ | 85747-9379 | |||||||||
1478 |
Affiliated | 4333 | Wake Forest | Wake Forest Dialysis Center | 11001 INGLESIDE PL | RALEIGH | NC | 27614-8577 | ||||||||||
1479 |
Affiliated | 4472 | Colonial Springs | Colonial Springs Dialysis (fka Powder Springs) | 2840 EAST WEST CONNECTOR | STE 35 | AUSTELL | GA | 30106-6813 | |||||||||
1480 |
Affiliated | 2474 | Central Dallas | DaVita Central Dallas Dialysis | 9500 N CENTRAL EXPY | DALLAS | TX | 75231-5002 | ||||||||||
1481 |
Affiliated | 2188 | Sanger | Sanger Sequoia Dialysis | 2517 JENSEN AVE | BLDG B | SANGER | CA | 93657-2251 | |||||||||
1482 |
Affiliated | 4421 | Conyers | Conyers Dialysis | 1501 MILSTEAD RD NE | CONYERS | GA | 30012-3838 | ||||||||||
1483 |
Affiliated | 4337 | Duncanville | Duncanville Dialysis (Cedar Hill) | 270 E HIGHWAY 67 | STE 1 | DUNCANVILLE | TX | 75137-4428 | |||||||||
1484 |
Affiliated | 4417 | Gateway | Gateway Dialysis (Ft.Myers) | 5705 LEE BLVD | LEHIGH ACRES | FL | 33971-6342 | ||||||||||
1485 |
Affiliated | 4487 | Derry | Derry Dialysis | 1 ACTION BLVD | STE 2 | LONDONDERRY | NH | 03053-3428 | |||||||||
1486 |
Affiliated | 4461 | Villa of Wentzville Microcenter | Villa of Wentzville (Microcenter) | 1126 W PEARCE BLVD | STE 116 & 118 | WENTZVILLE | MO | 63385-1053 | |||||||||
1487 |
Affiliated | 1925 | Buchanan County Dialysis | Buchanan County Dialysis (Independence) | 1600 1ST ST E | INDEPENDENCE | IA | 50644-3155 | ||||||||||
1488 |
Affiliated | 2450 | Hoosier Hills | Hoosier Hills Dialysis | 143 S KINGSTON DR | BLOOMINGTON | IN | 47408-6342 | ||||||||||
1489 |
Affiliated | 4492 | Palm Breeze | Palm Breeze Dialysis (fka North Port) | 14942 TAMIAMI TRL | STE E | NORTH PORT | FL | 34287-2705 | |||||||||
1490 |
Affiliated | 4362 | Big Oaks | Big Oaks Dialysis | 5623 W TOUHY AVE | NILES | IL | 60714-4019 | ||||||||||
1491 |
Affiliated | 4407 | Pinellas West Shore | Pinellas West Shore Dialysis | 3451 66TH ST N | STE A | ST PETERSBURG | FL | 33710-1568 | |||||||||
1492 |
Affiliated | 2267 | Plano | Plano Dialysis | 481 SHILOH RD | STE 1 | PLANO | TX | 75074-7231 | |||||||||
1493 |
Affiliated | 4350 | Fairview | Villa of Fairview Park (fka Fairview Park Dialysis) | 19050 LORAIN RD | FAIRVIEW PARK | OH | 44126-1915 | ||||||||||
1494 |
Affiliated | 2380 | Ave Marisa | Ave Maria Dialysis (fka Immokalee) | 5340 USEPPA DR | AVE MARIA | FL | 34142-5051 | ||||||||||
1495 |
Affiliated | 5037 | Warminster | Franklin Commons Dialysis (fka Warminster) | 720 JOHNSVILLE BLVD | STE 8 | WARMINSTER | PA | 18974-3546 | |||||||||
1496 |
Affiliated | 2446 | Ripley | Ripley Dialysis Center | 854 HWY 51 S | RIPLEY | TN | 38063-5536 | ||||||||||
1497 |
Affiliated | 5538 | St Charles / Riverbend | River Bend Dialysis (St. Charles Parish) | 1057 PAUL MAILLARD RD | ST B135 | LULING | LA | 70070-4349 | |||||||||
1498 |
Affiliated | 5570 | Midwest Springfield | Midwest Springfield Dialysis | 2200 N LIMESTONE ST STE 104 | SPRINGFIELD | OH | 45503-2692 | ||||||||||
1499 |
Affiliated | 5571 | Midwest Fairborn | Midwest Fairborn Dialysis | 1266 N BROAD ST | FAIRBORN | OH | 45324-5549 | ||||||||||
1500 |
Affiliated | 5572 | Midwest Urbana | Midwest Urbana Dialysis | 1430 E US HIGHWAY 36 | URBANA | OH | 43078-9112 | ||||||||||
1501 |
Affiliated | 5531 | Camarillo | Camarillo Dialysis | 2438 N PONDEROSA DR STE C101 | CAMARILLO | CA | 93010-2465 | ||||||||||
1502 |
Affiliated | 5532 | Thousand Oaks | Thousand Oaks Dialysis | 375 ROLLING OAKS DR STE 100 | THOUSAND OAKS | CA | 91361-1024 | ||||||||||
1503 |
Affiliated | 5533 | Simi Valley | Simi Valley Dialysis | 2950 SYCAMORE DR STE 100 | SIMI VALLEY | CA | 93065-1210 | ||||||||||
1504 |
Affiliated | 5534 | Santa Paula | Santa Paula Dialysis | 253 MARCH ST | SANTA PAULA | CA | 93060-2511 | ||||||||||
1505 |
Affiliated | 5548 | Ventura | Ventura Dialysis | 2705 LOMA VISTA RD STE 101 | VENTURA | CA | 93003-1596 | ||||||||||
1506 |
Affiliated | 4468 | Villa of St. John | Villa of St John (Crossing Microcenter-MO) | 9030 SAINT CHARLES ROCK RD | SAINT LOUIS | MO | 63114-4246 | ||||||||||
1507 |
Affiliated | 4372 | Whidbey Island | Whidbey Island Dialysis Center | 32650 STATE RD 20 | BLDG E STE 18 | OAK HARBOR | WA | 98277-2641 | |||||||||
1508 |
Affiliated | 4437 | Baytown | Baytown Dialysis | 4665 GARTH RD | STE 9 | BAYTOWN | TX | 77521-2261 | |||||||||
1509 |
Affiliated | 2475 | Highland Ranch | Highland Ranch Dialysis Center | 7223 CHURCH ST STE A14 | HIGHLAND | CA | 92346-6837 | ||||||||||
1510 |
Affiliated | 4474 | Tiptonville | Tiptonville Dialysis | 795 HAMRA ST | TIPTONVILLE | TN | 38079-1663 | ||||||||||
1511 |
Affiliated | 1902 | Carabello | Carabello Dialysis Center | 757 E WASHINGTON BLVD | LOS ANGELES | CA | 90021-3016 | ||||||||||
1512 |
Affiliated | 5573 | Palmetto | Palmetto Dialysis | 317 PROFESSIONAL PARK RD | CLINTON | SC | 29325-7625 | ||||||||||
1513 |
Affiliated | 5574 | Greer South | Greer South Dialysis | 3254 BRUSHY CREEK RD | GREER | SC | 29650-1000 | ||||||||||
1514 |
Affiliated | 5575 | Greenville West End | Greenville West End Dialysis | 605 S ACADEMY ST | GREENVILLE | SC | 29601-2407 | ||||||||||
1515 |
Affiliated | 5576 | Fountain Inn | Fountain Inn Dialysis | 298 CHAPMAN RD | FOUNTAIN INN | SC | 29644-6129 | ||||||||||
1516 |
Affiliated | 5558 | Sellersville | Sellersville Dialysis | 1112 OLD BETHLEHEM PIKE | SELLERSVILLE | PA | 18960-1423 | ||||||||||
1517 |
Affiliated | 5564 | Humbolt Ridge | Humboldt Ridge Dialysis | 2211 N HUMBOLDT BLVD | MILWAUKEE | WI | 53212-3507 | ||||||||||
1518 |
Affiliated | 5565 | West Appleton | West Appleton Dialysis | 10130 W APPLETON AVE | STE 5 | MILWAUKEE | WI | 53225-2579 | |||||||||
1519 |
Affiliated | 5566 | Bay Shore | Bay Shore Dialysis | 5650 N GREEN BAY AVE | STE 15 | GLENDALE | WI | 53209-4449 | |||||||||
1520 |
Affiliated | 5567 | South Ridge | South Ridge Dialysis | 4848 S 76TH ST | STE 1 | GREENFIELD | WI | 53220-4361 | |||||||||
1521 |
Affiliated | 5568 | Bluemound | Bluemound Dialysis | 601 N 99TH ST | STE 1 | MILWAUKEE | WI | 53226-4362 | |||||||||
1522 |
Affiliated | 4385 | Versailles | Versailles Dialysis | 480 LEXINGTON RD | VERSAILLES | KY | 40383-1918 | ||||||||||
1523 |
Affiliated | 5035 | Magnolia Oaks | Magnolia Oaks Dialysis (aka Hinesville) | 2377 HWY 196 W | HINESVILLE | GA | 31313-8036 | ||||||||||
1524 |
Affiliated | 4489 | Mesa County | Mesa County Dialysis (Grand Junction) | 561 25 RD | STE D | GRAND JUNCTION | CO | 81505-1303 | |||||||||
1525 |
Affiliated | 297 | West Bloomfield | West Bloomfield Dialysis | 6010 W MAPLE RD | STE 215 | WEST BLOOMFIELD | MI | 48322-4406 | |||||||||
1526 |
Affiliated | 5550 | Crystal Springs Dialysis | Crystal Springs Dialysis | 720 COG CIRCLE | CRYSTAL LAKE | IL | 60014-7301 | ||||||||||
1527 |
Affiliated | 5551 | Cobblestone Dialysis | Cobblestone Dialysis | 934 CENTER ST | STE A | ELGIN | IL | 60120-2125 | |||||||||
1528 |
Affiliated | 5586 | Oak Springs Dialysis | Oak Springs Dialysis | 764 LOCUST AVE | WASHINGTON | PA | 15301-2756 | ||||||||||
1529 |
Affiliated | 5010 | Maple Valley Plaza | Maple Valley Plaza Dialysis (Farmington) | 649 MAPLE VALLEY DR | FARMINGTON | MO | 63640-1993 | ||||||||||
1530 |
Affiliated | 4433 | Floyd Curl | Floyd Curl Dialysis (San Antonio) | 9238 FLOYD CURL DR | STE 12 | SAN ANTONIO | TX | 78240-1691 | |||||||||
1531 |
Affiliated | 2387 | Mission Valley | Mission Valley Dialysis (aka McAllen) | 1203 ST CLAIRE BLVD 9B | MISSION | TX | 78572-6601 | ||||||||||
1532 |
Affiliated | 2180 | Silver Lake | Silver Lake Dialysis | 2723 W TEMPLE ST | LOS ANGELES | CA | 90026-4723 | ||||||||||
1533 |
Affiliated | 5578 | Lake Park Dialysis | Lake Park Dialysis | 1531 E HYDE PARK BLVD | CHICAGO | IL | 60615-3039 | ||||||||||
1534 |
Affiliated | 5579 | Stoney Island Dialysis | Stony Island Dialysis | 8725 S STONY ISLAND AVE | CHICAGO | IL | 60617-2709 | ||||||||||
1535 |
Affiliated | 5580 | Woodlawn Dialysis | Woodlawn Dialysis | 1164 E 55TH ST | CHICAGO | IL | 60615-5115 |
Page 107 of 123
1536 |
Affiliated | 4440 | Jefferson Ave | Jefferson Avenue Dialysis (aka Village Parkway, Hampton) | 11234 JEFFERSON AVE | NEWPORT NEWS | VA | 23601-2207 | ||||||||||
1537 |
Affiliated | 4381 | Robinson | Robinson Dialysis | 1215 N ALLEN ST | STE B | ROBINSON | IL | 62454-1100 | |||||||||
1538 |
Affiliated | 4320 | Gateway Plaza | Gateway Plaza Dialysis (aka Willowbrook) | 1580 W ROSECRANS AVE | COMPTON | CA | 90222-3700 | ||||||||||
1539 |
Affiliated | 4329 | Pasadena Foothills | Pasadena Foothills Dialysis (fka Arcadia) | 3722 E COLORADO BLVD | PASADENA | CA | 91107-3803 | ||||||||||
1540 |
Affiliated | 914 | Live Oak Dialysis | Live Oak Dialysis (fka San Antonio) | 6700 RANDOLPH BLVD | STE 11 | LIVE OAK | TX | 78233-4222 | |||||||||
1541 |
Affiliated | 5031 | Frackville | Frackville Dialysis (aka JV_Pottsville) | 801 SCHUYLKILL MALL | FRACKVILLE | PA | 17931-2524 | ||||||||||
1542 |
Affiliated | 5038 | Castor | Cottman Kidney Center (Castor, NE Philadelphia) | 7198 CASTOR AVE | PHILADELPHIA | PA | 19149-1105 | ||||||||||
1543 |
Affiliated | 4351 | Villa of North Ridgevelle | Villa of North Ridgeville | 35143 CENTER RIDGE RD | NORTH RIDGEVILLE | OH | 44039-3089 | ||||||||||
1544 |
Affiliated | 5503 | Thorn Run Dialysis | Thorn Run Dialysis | 1136 THORN RUN RD | STE J1 | MOON TOWNSHIP | PA | 15108 | |||||||||
1545 |
Affiliated | 5504 | Allegheny Valley | Allegheny Valley Dialysis | 1620 PACIFIC AVE | HEIGHTS PLAZA SHOPPING CENTER | NATRONA HEIGHTS | PA | 15065-2101 | |||||||||
1546 |
Affiliated | 5506 | Northside | Northside Dialysis (fka Allegheny General) | 320 E NORTH AVE | 4TH FL, SOUTH TOWER | PITTSBURGH | PA | 15212-4756 | |||||||||
1547 |
Affiliated | 5507 | Somerset | Somerset County Dialysis | 229 S KIMBERLY AVE | STE 1 | SOMERSET | PA | 15501-2022 | |||||||||
1548 |
Affiliated | 4493 | Carthage | Carthage Dialysis | 165 SAVANNAH GARDENS DR | CARTHAGE | NC | 28327 | ||||||||||
1549 |
Affiliated | 2464 | Riverwood Dialysis | Riverwood Dialysis (fka Nine Mile, Tree City & Southfield) | 24467 W 10 MILE RD | SOUTHFIELD | MI | 48033-2931 | ||||||||||
1550 |
Affiliated | 4415 | Burton | Burton Dialysis (fka Flint Northeast) | 4015 DAVISON RD | BURTON | MI | 48509-1401 | ||||||||||
1551 |
Affiliated | 4490 | Black Canyon | Black Canyon Dialysis (Montrose) | 3421 S RIO GRANDE AVE | UNIT D | MONTROSE | CO | 81401-4840 | |||||||||
1552 |
Affiliated | 4394 | Memphis Midtown | Memphis Midtown Dialysis | 3430 SUMMER AVE | MEMPHIS | TN | 38122-3610 | ||||||||||
1553 |
Affiliated | 5539 | Stonecrest Dialysis | Stonecrest Dialysis | 1302 E STATE ST | ROCKFORD | IL | 61104-2228 | ||||||||||
1554 |
Affiliated | 4412 | West Plano | West Plano Dialysis | 5036 TENNYSON PKWY | PLANO | TX | 75024-3002 | ||||||||||
1555 |
Affiliated | 2217 | Redwood City | Redwood City Dialysis (fka Palo Alto) | 1000 MARSHALL ST | REDWOOD CITY | CA | 94063-2027 | ||||||||||
1556 |
Affiliated | 1592 | State Fair | State Fair Dialysis | 19800 WOODWARD AVE | DETROIT | MI | 48203-5102 | ||||||||||
1557 |
Affiliated | 5589 | ADC of Ft Lauderdale | Advanced Dialysis Center of Fort Lauderdale | 911 E OAKLAND PARK BLVD | OAKLAND PARK | FL | 33334-2725 | ||||||||||
1558 |
Affiliated | 5008 | Dover | Dover Community Dialysis (New Philadelphia) | 899 E IRON AVE | DOVER | OH | 44622-2097 | ||||||||||
1559 |
Affiliated | 5045 | McMinnville | McMinnville Dialysis | 200 NE NORTON LN | MCMINNVILLE | OR | 97128-8470 | ||||||||||
1560 |
Affiliated | 5007 | Sparta | Sparta Dialysis | 150 SAM WALTON DR | STE 8 | SPARTA | TN | 38583-8818 | |||||||||
1561 |
Affiliated | 4409 | Kendall | Kendall Kidney Center (fka Dadeland) | 8364 MILLS DR | STE 174 | MIAMI | FL | 33183-4806 | |||||||||
1562 |
Affiliated | 4397 | Abbeville | Abbeville Dialysis | 904 W GREENWOOD ST | ABBEVILLE | SC | 29620 | ||||||||||
1563 |
Affiliated | 2453 | Delta View | Delta View Dialysis | 1150 E LELAND RD | PITTSBURG | CA | 94565-5319 | ||||||||||
1564 |
Affiliated | 5013 | Wolf River | Wolf River Dialysis (Germantown) | 7990 TRINITY PL | STE 11 | CORDOVA | TN | 38018-7731 | |||||||||
1565 |
Affiliated | 5601 | San Luis Obispo Dialysis | San Luis Obispo Dialysis | 1043 MARSH ST | SAN LUIS OBISPO | CA | 93401-3629 | ||||||||||
1566 |
Affiliated | 5602 | Templeton Dialysis | Templeton Dialysis | 1310 LAS TABLAS RD | STE 11 | TEMPLETON | CA | 93465-9746 | |||||||||
1567 |
Affiliated | 5603 | Pismo Beach Dialysis | Pismo Beach Dialysis | 320 JAMES WAY | STE 11 | PISMO BEACH | CA | 93449-2813 | |||||||||
1568 |
Affiliated | 5583 | Lincoln Way Dialysis | Lincoln Way Dialysis | 1303 LINCOLN WAY STE A | WHITE OAK | PA | 15131-1603 | ||||||||||
1569 |
Affiliated | 5023 | Grundy Center | Grundy Center Dialysis | 101 E J AVENUE | GRUNDY CENTER | IA | 50638-2031 | ||||||||||
1570 |
Affiliated | 3862 | Pickens County | Pickens County Dialysis | 289 WILLIAM E HILL DR. | STE A | CARROLLTON | AL | 35447 | |||||||||
1571 |
Affiliated | 5032 | Willow Grove | Willow Grove Dialysis (Abington-Maplewood) | 1849 DAVISVILLE RD | WILLOW GROVE | PA | 19090-4111 | ||||||||||
1572 |
Affiliated | 2255 | Amherst | Amherst Dialysis (Lorain County) | 3200 COOPER FOSTER PRK RD W | LORAIN | OH | 44053-3654 | ||||||||||
1573 |
Affiliated | 2220 | South Fort Worth | South Fort Worth Dialysis | 6260 SOUTHWEST BLVD | BENBROOK | TX | 76109-6906 | ||||||||||
1574 |
Affiliated | 5521 | Jerseyville Dialysis | Jerseyville Dialysis | 917 S STATE ST | JERSEYVILLE | IL | 62052-2344 | ||||||||||
1575 |
Affiliated | 5605 | Independence County Dialysis | Independence County Dialysis | 1700 HARRISON ST | STE F | BATESVILLE | AR | 72501-7315 | |||||||||
1576 |
Affiliated | 5606 | Jackson County Dialysis | Jackson County Dialysis | 1912 MCLAIN ST | PRATT SQUARE | NEWPORT | AR | 72112-3659 | |||||||||
1577 |
Affiliated | 5607 | Searcy Dialysis | Searcy Dialysis | 3208 LANGLEY DR | SEARCY | AR | 72143-6020 | ||||||||||
1578 |
Affiliated | 5608 | Springhill Dialysis | Springhill Dialysis | 3401 SPRINGHILL DR | STE 19 | NORTH LITTLE ROCK | AR | 72117-2925 | |||||||||
1579 |
Affiliated | 5609 | Pulaski County Dialysis | Pulaski County Dialysis | 202 JOHN HARDEN DR | JACKSONVILLE | AR | 72076-3775 | ||||||||||
1580 |
Affiliated | 5610 | Little Rock Midtown Dialysis | Little Rock Midtown Dialysis | 2 LILE CT | STE 12A | LITTLE ROCK | AR | 72205-6241 | |||||||||
1581 |
Affiliated | 5611 | Saline County Dialysis | Saline County Dialysis | 1200 N MAIN ST | STE 2 | BENTON | AR | 72015-3341 | |||||||||
1582 |
Affiliated | 5612 | Conway Dialysis | Conway Dialysis | 2445 CHRISTINA LANE | CONWAY | AR | 72034 | ||||||||||
1583 |
Affiliated | 5614 | Valley Baptist Harlingen Dialysis | Valley Baptist-Harlingen Dialysis | 2220 HAINE DR STE 40 | HARLINGEN | TX | 78550-8584 | ||||||||||
1584 |
Affiliated | 5615 | Valley Baptist Raymondville Dialysis | Valley Baptist-Raymondville Dialysis | 894 FM 3168 | RAYMONDVILLE | TX | 78580-4519 | ||||||||||
1585 |
Affiliated | 2455 | Hawaiian Gardens | Hawaiian Gardens Dialysis | 12191 226TH ST | HAWAIIAN GARDENS | CA | 90716-1510 | ||||||||||
1586 |
Affiliated | 2310 | Huntington park | Huntington Park Dialysis | 5942 RUGBY AVE | HUNTINGTON PARK | CA | 90255-2803 | ||||||||||
1587 |
Affiliated | 2462 | Poinciana | Poinciana Dialysis | 1002 CYPRESS PKWY | KISSIMMEE | FL | 34758-3328 | ||||||||||
1588 |
Affiliated | 5005 | Southtowns | Southtowns Dialysis (Hamburg) | 4910 CAMP RD | STE 1 | HAMBURG | NY | 14075-2617 | |||||||||
1589 |
Affiliated | 5635 | Parma Heights Dialysis | Parma Heights Dialysis | 9050 N CHURCH DR | PARMA HEIGHTS | OH | 44130-4701 | ||||||||||
1590 |
Affiliated | 5636 | Hillard Dialysis | Hilliard Dialysis | 19133 HILLIARD BLVD | ROCKY RIVER | OH | 44116-2907 | ||||||||||
1591 |
Affiliated | 5546 | Pacific Dialysis | Pacific Dialysis | 2351 CLAY ST | FL 4 | SAN FRANCISCO | CA | 94115-1931 | |||||||||
1592 |
Affiliated | 5547 | Davies Dialysis | Davies Dialysis | 45 CASTRO ST | SOUTH TOWER 2ND FL | SAN FRANCISCO | CA | 94114-1032 | |||||||||
1593 |
Affiliated | 4486 | Newburgh | Newburgh Dialysis | 4311 HIGHWAY 261 | STE A | NEWBURGH | IN | 47630-2653 | |||||||||
1594 |
Affiliated | 5052 | Enterprise | Enterprise Dialysis (fka Geneva) | 6002 BOLL WEEVIL CIRCLE | ENTERPRISE | AL | 36330-9420 | ||||||||||
1595 |
Affiliated | 4387 | State Line | State Line Dialysis | 2049 E SHELBY DR | MEMPHIS | TN | 38116-7639 | ||||||||||
1596 |
Affiliated | 5108 | Cape Coral North | Cape Coral North Dialysis | 1315 SE 8TH TERRACE | CAPE CORAL | FL | 33990-3213 | ||||||||||
1597 |
Affiliated | 5044 | Willard Ave | Willard Avenue Dialysis (Newington) | 445E WILLARD AVE | NEWINGTON | CT | 06111-2318 | ||||||||||
1598 |
Affiliated | 4363 | West Lawn | West Lawn Dialysis (aka Midway) | 7000 S PULASKI RD | CHICAGO | IL | 60629-5842 | ||||||||||
1599 |
Affiliated | 4353 | Villa of Lakewood | Villa of Lakewood (Northcoast) | 14050 MADISON AVE | LAKEWOOD | OH | 44107-4530 | ||||||||||
1600 |
Affiliated | 5054 | North Carrolton | North Carrollton Dialysis (Parkview) | 195 PARKWOOD CIRCLE | CARROLLTON | GA | 30117-8756 | ||||||||||
1601 |
Affiliated | 5620 | Sikeston Jaycee Regional Dialysis | Sikeston Jaycee Regional Dialysis | 135 PLAZA DR STE 101 | SIKESTON | MO | 63801-5148 | ||||||||||
1602 |
Affiliated | 2244 | Radcliff | Radcliff Dialysis | 180 E LINCOLN TRAIL BLVD | RADCLIFF | KY | 40160-1254 |
Page 108 of 123
1603 |
Affiliated | 4452 | McAfee | McAfee Dialysis (Candler Road Decatur) | 1987 CANDLER RD | STE C | DECATUR | GA | 30032-4212 | |||||||||
1604 |
Affiliated | 5036 | Avon | Avon Dialysis (Indy West) | 9210 ROCKVILLE RD | STE D | INDIANAPOLIS | IN | 46234-2669 | |||||||||
1605 |
Affiliated | 2485 | Anaheim West | Anaheim West Dialysis | 1821 W LINCOLN AVE | ANAHEIM | CA | 92801-6731 | ||||||||||
1606 |
Affiliated | 5043 | Port Saint Joe | Port Saint Joe Dialysis | 3871 HIGHWAY 98 E | STE 11 | PORT ST. JOE | FL | 32456-5318 | |||||||||
1607 |
Affiliated | 5056 | Hayward Mission Hills | Hayward Mission Hills Dialysis | 1661 INDUSTRIAL PKWY W | HAYWARD | CA | 94544-7046 | ||||||||||
1608 |
Affiliated | 2472 | Cypress Woods Northwest | Cypress Woods Northwest Dialysis (aka NW Houston) | 20320 NORTHWEST FWY | STE 1 | HOUSTON | TX | 77065- | |||||||||
1609 |
Affiliated | 5641 | Willow Creek Dialysis | Willow Creek Dialysis | 1139 WARWICK WAY | RACINE | WI | 53406-5661 | ||||||||||
1610 |
Affiliated | 5642 | Harbor View Dialysis | Harbor View Dialysis | 818 6TH ST | RACINE | WI | 53403-1176 | ||||||||||
1611 |
Affiliated | 4451 | Red River | Red River Dialysis (fka Shreveport South) | 9205 LINWOOD AVE | SHREVEPORT | LA | 71106-7006 | ||||||||||
1612 |
Affiliated | 2392 | South Dade Kidney Center | South Dade Kidney Center (Coral Reef) | 11040 SW 184TH ST | CUTLER BAY | FL | 33157-6602 | ||||||||||
1613 |
Affiliated | 5604 | Niagara Falls Memorial Dialysis | Niagara Falls Memorial Dialysis (was NF Kidney Care Center) | 621 10TH ST | NIAGARA FALLS | NY | 14301-1813 | ||||||||||
1614 |
Affiliated | 5617 | Silverado Dialysis | Silverado Dialysis | 1100 TRANCAS ST | STE 266 AND 267 | NAPA | CA | 94558-2921 | |||||||||
1615 |
Affiliated | 5621 | Prairie River Dialysis | Prairie River Dialysis | 601 S CENTER AVE | MERRILL | WI | 54452-3404 | ||||||||||
1616 |
Affiliated | 5622 | Stevens Point Dialysis | Stevens Point Dialysis | 900 ILLINOIS AVE | 5th FLR | STEVENS POINT | WI | 54481-2885 | |||||||||
1617 |
Affiliated | 5623 | Grand Seasons Dialysis | Grand Seasons Dialysis | 190 GRAND SEASONS DR | WAUPACA | WI | 54981-8219 | ||||||||||
1618 |
Affiliated | 5624 | Wausau Dialysis | Wausau Dialysis | 2600 STEWART AVE | STE 144 | WAUSAU | WI | 54401-1403 | |||||||||
1619 |
Affiliated | 5625 | Pine Crest Dialysis | Pine Crest Dialysis | 232 S COURTNEY ST | STE 2 | RHINELANDER | WI | 54501-3319 | |||||||||
1620 |
Affiliated | 5626 | Meadow Lane Dialysis | Meadow Lane Dialysis | 1120 PINE ST | STANLEY | WI | 54768-1297 | ||||||||||
1621 |
Affiliated | 5627 | Wisconsin Rapids Dialysis | Wisconsin Rapids Dialysis | 1041B HILL ST | WISCONSIN RAPIDS | WI | 54494-5221 | ||||||||||
1622 |
Affiliated | 5628 | Marshfield Dialysis | Marshfield Dialysis | 123 NORTHRIDGE ST | MARSHFIELD | WI | 54449-8341 | ||||||||||
1623 |
Affiliated | 5629 | Northern Star Dialysis | Northern Star Dialysis | 311 ELM ST | WOODRUFF | WI | 54568-9190 | ||||||||||
1624 |
Affiliated | 5632 | Ames Mary Greeley Dialysis | Ames Mary Greeley Dialysis | 2322 E 13TH ST | AMES | IA | 50010-5669 | ||||||||||
1625 |
Affiliated | 5633 | Marshalltown Mary Greeley Dialysis | Marshalltown Mary Greeley Dialysis | 3120 S 2ND ST | MARSHALLTOWN | IA | 50158-4614 | ||||||||||
1626 |
Affiliated | 5634 | Iowa Falls Mary Greeley Dialysis | Iowa Falls Mary Greeley Dialysis | 701 WASHINGTON AVE | IOWA FALLS | IA | 50126-2100 | ||||||||||
1627 |
Affiliated | 5649 | Dialysis Center of Hutchinson | Dialysis Center of Hutchinson | 1901 N WALDRON ST | HUTCHINSON | KS | 67502-1129 | ||||||||||
1628 |
Affiliated | 5650 | Amarillo Dialysis | Amarillo Dialysis | 8604 S COULTER ST | AMARILLO | TX | 79119-7379 | ||||||||||
1629 |
Affiliated | 4495 | Sagemeadow | Sagemeadow Dialysis (Houston) | 10923 SCARSDALE BLVD | HOUSTON | TX | 77089-6024 | ||||||||||
1630 |
Affiliated | 5009 | McKinney | McKinney Dialysis | 4717 MEDICAL CENTER DR | MCKINNEY | TX | 75069-1870 | ||||||||||
1631 |
Affiliated | 4499 | Scottsburg | Scottsburg Dialysis | 1619 W MCCLAIN AVE | SCOTTSBURG | IN | 47170-1161 | ||||||||||
1632 |
Affiliated | 2108 | Snake River | Snake River Dialysis Center (fka Blackfoot) | 1491 PARKWAY DR | BLACKFOOT | ID | 83221-1667 | ||||||||||
1633 |
Affiliated | 5034 | Southpoint | Southpoint Dialysis (aka Durham South) | 415 W NC HWY 54 | DURHAM | NC | 27713-7516 | ||||||||||
1634 |
Affiliated | 5643 | Burlingame Dialysis | Burlingame Dialysis | 1720 EL CAMINO REAL | STE 12 | BURLINGAME | CA | 94010-3225 | |||||||||
1635 |
Affiliated | 5644 | Mills Dialysis | Mills Dialysis | 100 S SAN MATEO DR | SAN MATEO | CA | 94401-3805 | ||||||||||
1636 |
Affiliated | 5646 | Stuebenville | Steubenville Dialysis | 4000 JOHNSON RD | STEUBENVILLE | OH | 43952-2300 | ||||||||||
1637 |
Affiliated | 5656 | Premiere Kidney Center of Newark | Premiere Kidney Center of Newark | 65 SOUTH TERRACE AVE | NEWARK | OH | 43055-1355 | ||||||||||
1638 |
Affiliated | 5029 | Calvine | Calvine Dialysis (Sacramento) | 8243 E STOCKTON BLVD | STE 1 | SACRAMENTO | CA | 95828-8200 | |||||||||
1639 |
Affiliated | 4445 | Durham Corners dialysis | Durham Corners Dialysis (South Plainfield) | 241 DURHAM AVE | SOUTH PLAINFIELD | NJ | 07080-2504 | ||||||||||
1640 |
Affiliated | 4475 | Mt Morris | Mt Morris Dialysis (aka North Flint) | 6141 N. SAGINAW RD | MOUNT MORRIS | MI | 48458-2403 | ||||||||||
1641 |
Affiliated | 2176 | Grandview | Grandview Dialysis | 13812 S US HIGHWAY 71 | GRANDVIEW | MO | 64030-3685 | ||||||||||
1642 |
Affiliated | 4450 | Lemoore | Lemoore Dialysis | 1345 W BUSH ST | LEMOORE | CA | 93245-3303 | ||||||||||
1643 |
Affiliated | 5663 | Middlebrook Dialysis | Middlebrook Dialysis | 12401 MIDDLEBROOK RD | STE 16 | GERMANTOWN | MD | 20874-1523 | |||||||||
1644 |
Affiliated | 5664 | Catoctin Dialysis | Catoctin Dialysis | 405 W 7TH ST | FREDERICK | MD | 21701-4505 | ||||||||||
1645 |
Affiliated | 5648 | Central New York Dialysis Center | Central New York Dialysis Center | 910 ERIE BLVD E | SYRACUSE | NY | 13210-1060 | ||||||||||
1646 |
Affiliated | 5014 | South Jackson | South Jackson Dialysis | 46 HARTS BRIDGE RD | JACKSON | TN | 38301-7512 | ||||||||||
1647 |
Affiliated | 2344 | Los Alamitos | Los Alamitos Dialysis | 4141 KATELLA AVE | LOS ALAMITOS | CA | 90720-3406 | ||||||||||
1648 |
Affiliated | 5048 | Robbinsdale | Robbinsdale Dialysis | 3461 W BROADWAY AVE | ROBBINSDALE | MN | 55422-2955 | ||||||||||
1649 |
Affiliated | 5557 | Oxnard | Oxnard Dialysis | 1900 OUTLET CENTER DR | OXNARD | CA | 93036-0677 | ||||||||||
1650 |
Affiliated | 4429 | Marked Tree | DNVO-Marked Tree-AR | 216 HESTER PARKER DR | MARKED TREE | AR | 72365-2023 | ||||||||||
1651 |
Affiliated | 5669 | Louisa Dialysis | Louisa Dialysis | 2145 HWY 2565 | LOUISA | KY | 41230 | ||||||||||
1652 |
Affiliated | 5670 | Point Pleasant Dialysis | Point Pleasant Dialysis | 3683 OHIO RIVER DR | POINT PLEASANT | WV | 25550 | ||||||||||
1653 |
Affiliated | 6802 | Marion | Renal Care of Marion (P150) | 2921 HWY 77 | SUITE #8 | MARION | AR | 72364-2368 | |||||||||
1654 |
Affiliated | 6803 | Osceola | Osceola Dialysis (P151) | 1420 W KEISER AVE | OSCEOLA | AR | 72370-2800 | ||||||||||
1655 |
Affiliated | 6805 | Cottonwood | Cottonwood Dialysis (P153) | 203 S CANDY LANE | COTTONWOOD | AZ | 86326-8115 | ||||||||||
1656 |
Affiliated | 6808 | Prescott | Prescott Dialysis (P157) | 980 WILLOW CREEK RD. | SUITE 11 | PRESCOTT | AZ | 86301-1619 | |||||||||
1657 |
Affiliated | 6811 | Naples | Collier County Dialysis (P160) | 6625 HILLWAY CIRCLE | NAPLES | FL | 34112 | ||||||||||
1658 |
Affiliated | 6813 | Catersville | Cartersville Renal Center (P162) | 203 S TENNESSEE ST | CARTERSVILLE | GA | 30120 | ||||||||||
1659 |
Affiliated | 6816 | Arlington Heights Renal Center | Arlington Heights Renal Center (P165) | 17 W GOLF RD | ARLINGTON HEIGHTS | IL | 60006 | ||||||||||
1660 |
Affiliated | 6817 | Hazel Crest Renal Center | Hazel Crest Renal Center (P166) | 3470 W 183RD ST | HAZEL CREST | IL | 60429 | ||||||||||
1661 |
Affiliated | 6818 | Loop Renal Center | Loop Renal Center (P167) | 1101 S CANAL ST | 11TH FLR | CHICAGO | IL | 60607 | |||||||||
1662 |
Affiliated | 6819 | Markham Renal Center | Markham Renal Center (P168) | 3053 W 159TH ST | MARKHAM | IL | 60426 | ||||||||||
1663 |
Affiliated | 6821 | South Holland Renal Center | South Holland Renal Center (P170) | 16136 S PARK AVE. | SOUTH HOLLAND | IL | 60473 | ||||||||||
1664 |
Affiliated | 6822 | Waukegan Renal Center | Waukegan Renal Center (P171) | 1616 GRAND AVE. | STE. C | WAUKEGAN | IL | 60085 | |||||||||
1665 |
Affiliated | 6936 | Waukegan Home Renal Center | Waukegan Home Training (P172) | 1616 GRAND AVE | STE F | WAUKEGAN | IL | 60085 | |||||||||
1666 |
Affiliated | 6825 | Baton Rouge | East Baton Rouge Dialysis (P174) | 1333 ONEAL LANE | BATON ROUGE | LA | 70816 | ||||||||||
1667 |
Affiliated | 6826 | Houma Renal Center | Houma Dialysis (P175) | 108 PICONE RD | HOUMA | LA | 70363 | ||||||||||
1668 |
Affiliated | 6827 | Amesbury | Amesbury Renal Center (P177) | 24 MORRILL PLACE | AMESBURY | MA | 1913 | ||||||||||
1669 |
Affiliated | 6828 | North Andover | North Andover Renal Center (P178) | 201 SUTTON ST | NORTH ANDOVER | MA | 1845 |
Page 109 of 123
1670 |
Affiliated | 6829 | Canton | Canton Renal Center (P179) | 620 E PEACE ST | CANTON | MS | 39046-4729 | ||||||||||
1671 |
Affiliated | 6830 | Hazelhurst | Hazlehurst Dialysis (P180) | 201 N HALEY ST | HAZLEHURST | MS | 39083 | ||||||||||
1672 |
Affiliated | 6831 | Jackson North | Jackson North Dialysis (P181) | 571 BEASLEY RD | SUITE B | JACKSON | MS | 39206-3042 | |||||||||
1673 |
Affiliated | 6832 | Jackson South | Jackson South Dialysis (P182) | 2460 TERRY RD | SUITE 27-J | JACKSON | MS | 39204-5767 | |||||||||
1674 |
Affiliated | 6833 | Jackson Southwest | Jackson Southwest Dialysis (P183) | 1828 RAYMOND RD | JACKSON | MS | 39204-4126 | ||||||||||
1675 |
Affiliated | 6834 | Lexington | Renal Care of Lexington (P184) | 22579 DEPOT STREET | LEXINGTON | MS | 39095 | ||||||||||
1676 |
Affiliated | 6835 | Munroe Falls | Munroe Falls Dialysis (P185) | 265 N MAIN ST | MUNROE FALLS | OH | 44262 | ||||||||||
1677 |
Affiliated | 6836 | Summit | Summit Renal Center (P186) | 73 MASSILLON ROAD | AKRON | OH | 44312 | ||||||||||
1678 |
Affiliated | 6837 | White Ponds | White Ponds Dialysis (P187) | 534 WHITE POND DRIVE | SUITE A | AKRON | OH | 44320 | |||||||||
1679 |
Affiliated | 6838 | Philadelphia | Memphis Street Renal Center (P189) | 3310 24 MEMPHIS ST | PHILADELPHIA | PA | 19134-4510 | ||||||||||
1680 |
Affiliated | 6839 | Memphis Central Renal Center | Renal Care of Central Memphis (P190) | 1331 UNION AVE. | SUITE 11 | MEMPHIS | TN | 38104-7559 | |||||||||
1681 |
Affiliated | 6840 | Memphis Graceland Renal Center | Memphis Graceland Renal Center (P191) | 4180 AUBURN RD | MEMPHIS | TN | 38116-6202 | ||||||||||
1682 |
Affiliated | 6841 | Memphis Midtown Renal Center | Renal Care of Midtown Memphis (P192) | 1166 MONROE AVE. | MEMPHIS | TN | 38104-6614 | ||||||||||
1683 |
Affiliated | 6842 | Memphis North Renal Center | Renal Care of Memphis North (P193) | 4913 RALEIGH COMMON DR. | SUITE 1 | MEMPHIS | TN | 38128-2485 | |||||||||
1684 |
Affiliated | 6844 | Whitehaven Renal Center | Whitehaven Renal Center (P195) | 3420 ELVIS PRESLEY BLVD. | MEMPHIS | TN | 38116-3260 | ||||||||||
1685 |
Affiliated | 6846 | Edinburg | Edinburg Renal Center (P197) | 4302 S SUGAR RD | STE 15 | EDINBURG | TX | 78539-9140 | |||||||||
1686 |
Affiliated | 6847 | Mcallen | Dialysis Care of McAllen (P198) | 411 LINDBERG AVE | MCALLEN | TX | 78501-2921 | ||||||||||
1687 |
Affiliated | 6848 | Weslaco | Weslaco Renal Center (P199) | 910 SOUTH UTAH | WESLACO | TX | 78596-4270 | ||||||||||
1688 |
Affiliated | 6849 | Marlton Dialysis Center | Marlton Dialysis (P200) | 769 E ROUTE 70 | MARLTON | NJ | 08053-2341 | ||||||||||
1689 |
Affiliated | 6850 | Lawrenceville Renal Center | Lawrenceville Renal Center (P201) | 1840 PRINCETON AVE | LAWRENCEVILLE | NJ | 8648 | ||||||||||
1690 |
Affiliated | 6851 | Austell Renal Center | Austell Renal Center (P202) | 3642 MARATHON CIRCLE | AUSTELL | GA | 30106- 6821 | ||||||||||
1691 |
Affiliated | 6852 | Bartlett Renal Center | Bartlett Renal Center (P203_P290_P8203) | 2920 COVINGTON PIKE | MEMPHIS | TN | 38128-6007 | ||||||||||
1692 |
Affiliated | 6854 | Beaverton Dialysis Center | Beaverton Dialysis Center (P206) | 15050 SW KOLL PARKWAY | SUITE J | BEAVERTON | OR | 97006-6002 | |||||||||
1693 |
Affiliated | 6858 | Walker County Dialysis | Walker County Dialysis (P212) | 589 HIGHWAY 78W | JASPER | AL | 35501 | ||||||||||
1694 |
Affiliated | 6861 | Lakewood | Manatee County Dialysis (P215) | 8470 COOPER CREEK BVLD | UNIVERSITY PARK | FL | 34201 | ||||||||||
1695 |
Affiliated | 6862 | Canton | Northwest Georgia Dialysis (P216) | 260 HOSPITAL RD | CANTON | GA | 30114 | ||||||||||
1696 |
Affiliated | 6863 | Buffulo Grove Renal Center | Buffalo Grove Dialysis (P218) | 1291 W DUNDEE RD | BUFFALO GROVE | IL | 60089 | ||||||||||
1697 |
Affiliated | 6864 | Evanston Renal Center | Evanston Renal Center (P219) | 1715 CENTRAL ST | EVANSTON | IL | 60201 | ||||||||||
1698 |
Affiliated | 6865 | Schaumburg Renal Center | Schaumburg Renal Center (P220) | 1156 S. ROSELLE ROAD | SCHAUMBURG | IL | 60193 | ||||||||||
1699 |
Affiliated | 6937 | Schaumburg Home Renal Center | Schaumburg Home Training (P270) | 17 W GOLF RD | ARLINGTON HEIGHTS | IL | 60005 | ||||||||||
1700 |
Affiliated | 6866 | Blue River Valley | Blue River Valley Renal Center (P222) | 2309 S MILLER STREET | SUITE 1 | SHELBYVILLE | IN | 46176-9350 | |||||||||
1701 |
Affiliated | 6867 | Central Fort Wayne | Central Fort Wayne Dialysis (P223) | 1940 BLUFTON RD | FORT WAYNE | IN | 46809-1307 | ||||||||||
1702 |
Affiliated | 6869 | Huntington | Renal Care of Huntington (P225) | 3040 WEST PARK DRIVE | HUNTINGTON | IN | 46750-8956 | ||||||||||
1703 |
Affiliated | 6870 | Lake Avenue Dialysis Renal Center | Lake Avenue Dialysis (P226) | 3525 LAKE AVE | STE 4 | FORT WAYNE | IN | 46805-5545 | |||||||||
1704 |
Affiliated | 6871 | Marion County | Marion County Dialysis (P229) | 3834 S EMERSON AVE | BLDG B | INDIANAPOLIS | IN | 46203-5902 | |||||||||
1705 |
Affiliated | 6873 | Quad Counties Dialysis | Quad Counties Dialysis (P232) | 528 NORTH GRANDSTAFF | AUBURN | IN | 46706-1660 | ||||||||||
1706 |
Affiliated | 6875 | South Anthony | South Anthony Dialysis (P234) | 7017 SOUTH ANTHONY BLVD. | FORT WAYNE | IN | 46816-2016 | ||||||||||
1707 |
Affiliated | 6876 | Brandon | Brandon Renal Center (P235) | 101 CHRISTIAN DR | BRANDON | MS | 39042-2678 | ||||||||||
1708 |
Affiliated | 6877 | Carthage | Renal Care of Carthage (P236) | 312 ELLIS STREET | CARTHAGE | MS | 39051 | ||||||||||
1709 |
Affiliated | 6878 | Las Cruces Renal Center | Las Cruces Renal Center (P237) | 3961 E LOHMAN AVE | STE 29 | LAS CRUCES | NM | 88011-8272 | |||||||||
1710 |
Affiliated | 6879 | Northeast Portland | Northeast Portland Renal Center (P240) | 703 NE HANCOCK ST | PORTLAND | OR | 97212-3955 | ||||||||||
1711 |
Affiliated | 6880 | Oregon Kidney Center | Dialysis Care of Portland (P241) | 5318 NE IRVING | PORTLAND | OR | 97213 | ||||||||||
1712 |
Affiliated | 6881 | Sunnyside | Sunnyside Renal Center (P242) | 6902 SE LAKE ROAD | SUITE 1 | MILWAUKIE | OR | 97267-2148 | |||||||||
1713 |
Affiliated | 6882 | Willamette Valley | Williamette Valley Renal Center (P243) | 1510 DIVISION STREET | SUITE 9 | OREGON CITY | OR | 97045-1572 | |||||||||
1714 |
Affiliated | 6883 | Northern Philadelphia | Northern Philadelphia Dialysis (P244) | 5933 N BROAD ST | PHILADELPHIA | PA | 19141 | ||||||||||
1715 |
Affiliated | 6884 | North Providence Renal Center | North Providence Renal Center (P246) | 1635 MINERAL SPRING AVE | NORTH PROVIDENCE | RI | 02904-4025 | ||||||||||
1716 |
Affiliated | 6889 | Alice Renal Center | Alice Renal Center (P252) | 2345 ALICE REGIONAL BLVD. | ALICE | TX | 78332-7291 | ||||||||||
1717 |
Affiliated | 6890 | Beeville Renal Center | Beeville Renal Center (P253) | 1905 NW FRONTAGE | BEEVILLE | TX | 78102-2954 | ||||||||||
1718 |
Affiliated | 6891 | Brownsville | Brownsville Renal Center (P254) | 2945 CENTRAL BLVD | BROWNSVILLE | TX | 78520-8958 | ||||||||||
1719 |
Affiliated | 6892 | Corpus Christi Renal Center | Corpus Christi Dialysis (P255) | 2733 SWANTNER DR | CORPUS CHRISTI | TX | 78404-2832 | ||||||||||
1720 |
Affiliated | 6893 | Riverside Renal Center | Riverside Renal Center (P256) | 13434 LEOPARD RD. SUITE A17 | CORPUS CHRISTI | TX | 78410-4466 | ||||||||||
1721 |
Affiliated | 6894 | South Texas Renal Center | South Texas Renal Center (P257) | 4301 S PADRE ISLAND DR | CORPUS CHRISTI | TX | 78411-4433 | ||||||||||
1722 |
Affiliated | 6896 | South Central Renal Center | Morgan Avenue Dialysis (P258) | 2222 S MORGAN AVE | SUITE 114 | CORPUS CHRISTI | TX | 78405-1900 | |||||||||
1723 |
Affiliated | 6898 | Northeast Texas | Dialylsis Care of Greenville (P260) | 4805 WESLEY ST | GREENVILLE | TX | 75401-5649 | ||||||||||
1724 |
Affiliated | 6899 | Downtown Spokane | Downtown Spokane Renal Center (P261) | 601 W 5TH ST | SUITE F | SPOKANE | WA | 99205 | |||||||||
1725 |
Affiliated | 6900 | North Spokane | North Spokane Renal Center (P262) | 12610 E MARIBEAU PRKWY | STE 1 | SPOKANE | WA | 99216 | |||||||||
1726 |
Affiliated | 6901 | Spokane Valley | Spokane Valley Renal Center (P263) | 12610 EAST MIRABEAU PKY | SUITE 1 | SPOKANE | WA | 99208-1450 | |||||||||
1727 |
Affiliated | 6902 | Kansas City | Kansas City Renal Center (P264) | 4333 MADISON AVE | KANSAS CITY | MO | 64111-3429 | ||||||||||
1728 |
Affiliated | 6903 | Butler Renal Center | Butler Renal Center (P266) | 601 W NURSERY | BUTLER | MO | 64730 | ||||||||||
1729 |
Affiliated | 6904 | Harrisonville | Harrisonville Renal Center (P267) | 308 GALAXIE AVE | HARRISONVILLE | MO | 64701-2084 | ||||||||||
1730 |
Affiliated | 6905 | Marshall Renal Center | Marshall Renal Center (P268) | 359 W MORGAN | MARSHALL | MO | 65340 | ||||||||||
1731 |
Affiliated | 6907 | Akron Renal Center | Akron Renal Center (P272) | 525 EAST MARKET STREET | AKRON | OH | 44304-1619 | ||||||||||
1732 |
Affiliated | 6908 | Kendallville Renal Center | Kendallville Renal Center (P274) | 602 SAWYER RD | KENDALLVILLE | IN | 46755- 2566 | ||||||||||
1733 |
Affiliated | 6909 | Greenwood Holly Renal Center | Greenwood Holly Renal Center (P276) | 1533 HOLLY RD | CORPUS CHRISTI | TX | 78417-2010 | ||||||||||
1734 |
Affiliated | 6910 | Plainfield Renal Center | Plainfield Renal Center (P278) | 8110 NETWORK DR | PLAINFIELD | IN | 46168-9024 | ||||||||||
1735 |
Affiliated | 6911 | Green Valley Renal Center | Green Valley Dialysis (P279) | 1489 W WARM SPRINGS RD | STE 122 | HENDERSON | NV | 89014-7637 | |||||||||
1736 |
Affiliated | 6912 | Las Vegas Renal Center | Las Vegas Renal Center (P280) | 2333 RENAISSANCE DR | LAS VEGAS | NV | 89119-6191 |
Page 110 of 123
1737 |
Affiliated | 6913 | Lees Summit Renal Center | Lees Summit Renal Center (P281) | 100 NE MISSOURI RD | STE 1 | LEES SUMMIT | MO | 64086-4702 | |||||||||
1738 |
Affiliated | 6914 | Westport Renal Center | Westport Renal Center (P282) | 3947 BROADWAY STREET | KANSAS CITY | MO | 64111-2516 | ||||||||||
1739 |
Affiliated | 6915 | Greensboro Dialysis Center | Greensboro Dialysis Center (P284) | 1220 SILOAM RD | GREENSBORO | GA | 30642-0390 | ||||||||||
1740 |
Affiliated | 5057 | Forest Landing | DNVO-Forest Landing Dialysis (Harford Cty, Havre de Grace)-MD | 2220 COMMERCE AVE | STE 1 | FOREST HILL | MD | 21050 | |||||||||
1741 |
Affiliated | 5033 | University City | DNVO-University City Dialysis (Philadelphia)-PA | 3020 MARKET ST | STE 13 | PHILADELPHIA | PA | 19104-2999 | |||||||||
1742 |
Affiliated | 2411 | Parkland | DNVO-Parkland Dialysis-WA | 311 140TH ST SO | TACOMA | WA | 98444 | ||||||||||
1743 |
Affiliated | 5094 | Shelbyville Road | DNVO JV-Shelbyville Road Dialysis (DuPont, Louisville)-KY | 4600 SHELBYVILLE RD | STE 31 | LOUISVILLE | KY | 40207 | |||||||||
1744 |
Affiliated | 5106 | Fort Wayne West Dialysis | DNVO JV-Fort Wayne South-IN | 302 E PETTIT AVE | FORT WAYNE | IN | 468063007 | ||||||||||
1745 |
Affiliated | 5671 | Suburban Dialysis | ACQ-5671-NY | 1542 MAPLE RD | WILLIAMSVILLE | NY | 14221 | ||||||||||
1746 |
Affiliated | 5672 | Gates Circle Dialysis | ACQ-5672-NY | 3 GATES CIRCLE | 1ST FLR | BUFFALO | NY | 14209 | |||||||||
1747 |
Affiliated | 5673 | Orchard Park Dialysis | ACQ-5673-NY | 3801 TAYLOR RD | ORCHARD PARK | NY | 14127 | ||||||||||
1748 |
Affiliated | 2420 | TC Jester | DNVO-TC Jester-TX | 1800 W 26TH ST | STE 11 | HOUSTON | TX | 77008-1419 | |||||||||
1749 |
Affiliated | 4436 | Champions | DNVO-Champions Dialysis (Houston)-TX | 4427 FM 1960 W | STE D | HOUSTON | TX | 77068-3409 | |||||||||
1750 |
Affiliated | 5083 | Magic City Dialysis MMC | DNVO-Magic City Dialysis (Birmingham)-AL | 300 22ND ST SO | BIRMINGHAM | AL | 35233-2209 | ||||||||||
1751 |
Affiliated | 5084 | Steel City Dialysis | DNVO-Steel City Dialysis (Birmingham)-AL | 1809 AVE H (ENSLEY) | BIRMINGHAM | AL | 35218 | ||||||||||
1752 |
Affiliated | 5081 | Jewel Dialysis | DNVO-Jewel Dialysis (Camellia, Birmingham)-AL | 514 WEST TOWN PLAZA | BESSEMER | AL | 35020 | ||||||||||
1753 |
Affiliated | 660 | Crystal River | Crystal River Dialysis | 7435 W GULF TO LAKE HWY | CRYSTAL RIVER | FL | 34429-7834 | ||||||||||
1754 |
Affiliated | 1936 | Southwest Kidney | Estrella Dialysis Center | 8410 W THOMAS RD | STE 1 BLDG 1 | PHOENIX | AZ | 85037-3356 | |||||||||
1755 |
Affiliated | 1937 | Gilbert Dialysis | Gilbert Dialysis Center | 5222 E BASELINE RD | STE 14 | GILBERT | AZ | 85234-2963 | |||||||||
1756 |
Affiliated | 1938 | Tempe Dialysis | Tempe Dialysis Center | 2149 E WARNER RD | STE 11 | TEMPE | AZ | 85284-3496 | |||||||||
1757 |
Affiliated | 1939 | Phoenix Dialysis | Phoenix Dialysis Center | 337 E CORONADO RD | STE 11 | PHOENIX | AZ | 85004-1582 | |||||||||
1758 |
Affiliated | 1949 | Arrowhead Lakes Dialysis | Arrowhead Lakes Dialysis | 20325 N 51ST AVE | BLDG 11, STE 186 | GLENDALE | AZ | 85308-4625 | |||||||||
1759 |
Affiliated | 1952 | Mountain Vista Dialysis | Mountain Vista Dialysis Center of Arizona | 10238 E HAMPTON AVE | STE 18 | MESA | AZ | 85209-3317 | |||||||||
1760 |
Affiliated | 1977 | South Meadows Dialysis Center | South Meadows Dialysis Center | 10085 DOUBLE R BLVD | STE 16 | RENO | NV | 89521-4867 | |||||||||
1761 |
Affiliated | 1978 | Reno Dialysis Center | Reno Dialysis Center | 1500 E 2ND ST | STE 11 | RENO | NV | 89502-1189 | |||||||||
1762 |
Affiliated | 1979 | Carson City Dialysis Center | Carson City Dialysis Center | 3246 N. CARSON ST | STE 11 | CARSON CITY | NV | 89706-0248 | |||||||||
1763 |
Affiliated | 844 | Sparks | Sparks Dialysis Center | 4860 VISTA BLVD | STE 1 | SPARKS | NV | 89436-2817 | |||||||||
1764 |
Affiliated | 2015 | Sierra Rose Dialysis | Sierra Rose Dialysis Center | 685 SIERRA ROSE DR | RENO | NV | 89511-2060 | ||||||||||
1765 |
Affiliated | 2325 | Northwest Tucson | Northwest Tucson Dialysis | 2945 W INA RD | STE 15 | TUCSON | AZ | 85741-2366 | |||||||||
1766 |
Affiliated | 4355 | Mesa | Central Mesa Dialysis Center | 1134 E UNIVERSITY DR | STE 11 | MESA | AZ | 85203-8048 | |||||||||
1767 |
Affiliated | 4371 | Raven | Raven Dialysis Center | 3540 E BASELINE RD | STE 11 | PHOENIX | AZ | 85042-9628 | |||||||||
1768 |
Affiliated | 4374 | Brookwood | Brookwood Dialysis Center | 8910 N 43RD AVE | STE 17 | GLENDALE | AZ | 85302-5340 | |||||||||
1769 |
Affiliated | 4405 | Ocotillo | Ocotillo Dialysis | 975 W CHANDLER HEIGHTS RD | UNIT 11 | CHANDLER | AZ | 85248-5724 | |||||||||
1770 |
Affiliated | 4364 | Maryvale | Maryvale Dialysis Center | 4845 W MCDOWELL RD | STE 1A, 2A, 3A | PHOENIX | AZ | 85035-4076 | |||||||||
1771 |
Administrative Services | 181 | Childrens Hospital | MGD-Childrens National Medical Center | 111 MICHIGAN AVE NW | WASHINGTON | DC | 20010-2916 | ||||||||||
1772 |
Administrative Services | 1624 | Renal Care Seat Pleasant | MGD-Renal Care of Seat Pleasant | 6274 CENTRAL AVE | SEAT PLEASANT | MD | 20743 | ||||||||||
1773 |
Administrative Services | 1715 | Moses Taylor Hospital Renal Unit | Moses Taylor Hospital Renal Unit | 700 QUINCY AVE | SCRANTON | PA | 18510-1724 | ||||||||||
1774 |
Administrative Services | 3330 | Aurora Medical Group - Fond du Lac | Aurora Medical Group-Fond du Lac | 210 WISCONSIN AMERICAN DR | ATTN DAVITA DIALYSIS (WEST END OF BLDG) | FOND DU LAC | WI | 54937-2999 | |||||||||
1775 |
Administrative Services | 3331 | Aurora Medical Group - Sheboygan | Aurora Medical Group-Sheboygan | 2414 KOHLER MEMORIAL DR | SHEBOYGAN | WI | 53081-3129 | ||||||||||
1776 |
Administrative Services | 3338 | Aurora Medical Group - Lake Geneva | Aurora Medical Group-Lake Geneva | 146 E GENEVA SQ | LAKE GENEVA | WI | 53147-9694 | ||||||||||
1777 |
Administrative Services | 3555 | Aurora Medical Group - Marinette Dialysis | Aurora Medical Group-Marinette Dialysis | 4061 OLD PESHTIGO RD | MARINETTE | WI | 54143 | ||||||||||
1778 |
Administrative Services | 3607 | Aurora Medical Group - Brown County Dialysis | Aurora Medical Group-Brown County Dialysis | 1751 DECKNER AVE | GREEN BAY | WI | 54302-2630 | ||||||||||
1779 |
Administrative Services | 3641 | Aurora Medical Group - Sturgeon Bay Dialysis | Aurora Medical Group-Sturgeon Bay Dialysis | 108 S 10TH AVE | STURGEON BAY | WI | 54235-1802 | ||||||||||
1780 |
Administrative Services | 3653 | Aurora Medical Group - Oshkosh West Dialysis | Aurora Medical Group-Oshkosh West Dialysis | 855 N WESTHAVEN DR | OSHKOSH | WI | 54904-7668 | ||||||||||
1781 |
Administrative Services | 3665 | Aurora Medical Group - Manitowoc Dialysis | Aurora Medical Group-Manitowoc Dialysis | 601 REED AVE | MANITOWOC | WI | 54220-2026 | ||||||||||
1782 |
Administrative Services | 3672 | Aurora Medical Group - Wautoma Dialysis | Aurora Medical Group-Wautoma Dialysis | 900 EAST DIVISION ST | WAUTOMA | WI | 54982-6944 | ||||||||||
1783 |
Administrative Services | 1868 | Maize Dialysis | Maize Dialysis Center | 10001 GRADY AVE | MAIZE | KS | 67101 | ||||||||||
1784 |
Administrative Services | 1912 | Kidney Dialysis Center | MGD-Kidney Dialysis Center, LLC (MMG Macon) | 640 MARTIN LUTHER KING JR BLVD | MACON | GA | 31201-3206 | ||||||||||
Administrative Services | 6079 | MAGNOLIA WEST AT HOME | Magnolia West At Home | 11161 MAGNOLIA AVE | STE B | RIVERSIDE | CA | 92505-3605 | ||||||||||
Administrative Services | 1903 | Riverside PD Central NAMG | Riverside PD Central | 3660 PARK SIERRA DR | STE 18 | RIVERSIDE | CA | 92505-3071 | ||||||||||
Affiliated | 1995 | Winter Park Home PD Dialysis | Winter Park Home PD Dialysis | 4100 METRIC DR | STE 2 | WINTER PARK | FL | 32792-6832 | ||||||||||
Affiliated | 4302 | Lockport HHD PD At Home | Lockport Home Dialysis-PD | 16626 W 159TH ST | STE 73 | LOCKPORT | IL | 60441-8019 | ||||||||||
Affiliated | 1972 | HHD 6183 and PD 1972 in Shreveport | Shreveport Home Dialysis PD | 1560 IRVING PL | SHREVEPORT | LA | 71101-4604 | |||||||||||
Affiliated | 5618 | Home Dialysis of Dayton South | Home Dialysis of Dayton-South | 4700 SPRINGBORO PIKE | STE 3 | MORAINE | OH | 45439-1964 | ||||||||||
Affiliated | 5619 | Home Dialysis of Dayton | Home Dialysis of Dayton | 627 S EDWIN C MOSES BLVD | STE 2B | DAYTON | OH | 45417-3474 | ||||||||||
Affiliated | 144 | Timpanogos Dialysis Center | Timpanogos Dialysis | 1055 N 500 W | STE 222 | PROVO | UT | 84604-3329 | ||||||||||
Affiliated | 216 | HOME DIALYSIS UNIT | Home Dialysis /CAPD Unit | 825 S 8TH ST STE 1202 | MINNEAPOLIS | MN | 55404 | |||||||||||
Affiliated | 284 | MANZANITA HOME TRAINING CENTER | Manzanita Home Training Center (fka North CAPD) | 4005 MANZANITA AVE | STE 18 | CARMICHAEL | CA | 95608-1779 | ||||||||||
Affiliated | 408 | WICHITA DIALYSIS CENTER | Wichita Dialysis Center-PD Program | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | |||||||||||
Affiliated | 978 | CENTRAL TULSA DIALYSIS CENTER | Central Tulsa PD | 1124 S SAINT LOUIS AVE | TULSA | OK | 74120-5413 | |||||||||||
Affiliated | 1748 | ST PAUL CAPITAL PD | St. Paul Capital Dialysis at Home-PD (fka Capital PD Program) | 555 PARK ST | STE 110 | SAINT PAUL | MN | 55103-2110 | ||||||||||
Affiliated | 1787 | ASH TREE PD | Ash Tree PD | 2666 N GROVE INDUSTRIAL DR | FRESNO | CA | 93727-1552 | |||||||||||
Affiliated | 1821 | EMERALD DIALYSIS | Emerald Dialysis PD (fka Hyde Park PD) | 710 W 43RD ST | CHICAGO | IL | 60609-3435 | |||||||||||
Affiliated | 1822 | OLYMPIA FIELDS DIALYSIS | Olympia Fields PD | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2385 | ||||||||||
Affiliated | 1823 | LAKE COUNTY DIALYSIS | Lake County PD | 918 S MILWAUKEE AVE | LIBERTYVILLE | IL | 60048-3229 | |||||||||||
Affiliated | 1825 | COMPREHENSIVE RENAL CARE-GARY | CRC-Gary PD | 4802 BROADWAY | GARY | IN | 46408-4509 | |||||||||||
Affiliated | 1826 | COMPREHENSIVE RENAL CARE-HAMMOND | CRC-Hammond PD | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 |
Page 111 of 123
Affiliated |
1827 | COMPREHENSIVE RENAL CARE-VALPARAISO | CRC-Valparaiso PD | 606 E LINCOLNWAY | VALPARAISO | IN | 46383-5728 | |||||||||||
Affiliated |
1828 | COMPREHENSIVE RENAL CARE-MICHIGAN CITY | CRC-Michigan City PD | 9836 WEST 400 NORTH | MICHIGAN CITY | IN | 46360-2910 | |||||||||||
Affiliated |
1829 | MERRILLVILLE PD | Merrillville Dialysis PD | 9223 TAFT ST | MERRILLVILLE | IN | 46410-6911 | |||||||||||
Affiliated |
1833 | NAMPA DIALYSIS CENTER | Nampa Dialysis PD | 846 PARKCENTRE WAY | NAMPA | ID | 83651-1790 | |||||||||||
Affiliated |
1834 | TABLE ROCK DIALYSIS CENTER | Table Rock Dialysis PD | 5610 W GAGE ST | BOISE | ID | 83706 | |||||||||||
Affiliated |
1835 | TWIN FALLS DIALYSIS CENTER | Twin Falls Dialysis PD | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | |||||||||||
Affiliated |
1836 | TREASURE VALLEY DIALYSIS CENTER | Treasure Valley Dialysis PD & Home | 3525 E LOUISE DR | STE 155 | MERIDIAN | ID | 83642-6303 | ||||||||||
Affiliated |
1837 | GATE CITY DIALYSIS CENTER | Gate City Dialysis PD | 2001 BENCH RD | POCATELLO | ID | 83201-2033 | |||||||||||
Affiliated |
1838 | FOUR RIVERS DIALYSIS CENTER | Four Rivers Dialysis PD | 515 EAST LN | ONTARIO | OR | 97914-3953 | |||||||||||
Affiliated |
1869 | LOWRY DIALYSIS CENTER | Lowry Dialysis PD | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | ||||||||||
Affiliated |
1905 | BURLEY DIALYSIS CENTER | Burley Dialysis PD | 741 N OVERLAND AVE | BURLEY | ID | 83318-3440 | |||||||||||
Affiliated |
1909 | TURFWAY PD DIALYSIS | Turfway PD Training | 11 SPIRAL DR | STE 15A | FLORENCE | KY | 41042-1394 | ||||||||||
Affiliated |
1910 | MARYVILLE DIALYSIS | Maryville Dialysis PD | 2136B VADALABENE DR | MARYVILLE | IL | 62062-5632 | |||||||||||
Affiliated |
1917 | PDL ANNEX-PD | PDL Annex-PD (PDL=Physician Dialysis Lancaster) | 2110 HARRISBURG PIKE | STE 310 | LANCASTER | PA | 17601-2644 | ||||||||||
Affiliated |
1924 | KANKAKEE COUNTY DIALYSIS | Kankakee County Dialysis PD | 581 WILLIAM R LATHAM SR DR | STE 104 | BOURBONNAIS | IL | 60914-2439 | ||||||||||
Affiliated |
1946 | SNAKE RIVER DIALYSIS PD | DNVO-Snake River Dialysis PD (fka Blackfoot)-ID | 1491 PARKWAY DR | BLACKFOOT | ID | 83221-1667 | |||||||||||
Affiliated |
1953 | NORTH HIGHLANDS DIALYSIS CENTER | North Highlands Dialysis Center PD | 4986 WATT AVE | STE C | NORTH HIGHLANDS | CA | 95660-5182 | ||||||||||
Affiliated |
1966 | AMERY DIALYSIS | Amery Dialysis PD | 970 ELDEN AVE | AMERY | WI | 54001-1448 | |||||||||||
Affiliated |
1975 | KIDNEY HOME CENTER | Kidney HOME (Home Operations & Medical Education) Center PD | 2245 ROLLING RUN DR | STE 4 | WINDSOR MILL | MD | 21244-1858 | ||||||||||
Affiliated |
1988 | MEMPHIS DOWNTOWN DIALYSIS | Memphis Downtown Dialysis PD | 2076 UNION AVE | FL 2 | MEMPHIS | TN | 38104-4138 | ||||||||||
Affiliated |
1989 | PGH HOME MODALITY COE | Pittsburgh Home Modality Center of Excellence PD | 5171 LIBERTY AVE | STE A | PITTSBURGH | PA | 15224-2254 | ||||||||||
Affiliated |
2223 | LAKE VILLA DIALYSIS | Lake Villa Dialysis PD | 37809 N IL RTE 59 | LAKE VILLA | IL | 60046-7332 | |||||||||||
Affiliated |
2232 | RICHFIELD DIALYSIS | Richfield PD Program | 6601 LYNDALE AVE S | STE 150 | RICHFIELD | MN | 55423-2490 | ||||||||||
Affiliated |
2297 | TOKAY HOME DIALYSIS CENTER | Tokay Home Dialysis-PD | 777 S HAM LN | STE L | LODI | CA | 95242-3593 | ||||||||||
Affiliated |
2302 | SPIVEY PERITONEAL AND HOME DIALYSIS CENTER | Spivey Peritoneal Dialysis and Home Dialysis Center | 1423 STOCKBRIDGE RD | STE B | JONESBORO | GA | 30236-3740 | ||||||||||
Affiliated |
2326 | WARRENSVILLE HEIGHTS PD DIALYSIS | Warrensville Heights PD Dialysis | 4200 WARRENSVILLE CENTER RD | STE 210 | WARRENSVILLE HEIGHTS | OH | 44122-7000 | ||||||||||
Affiliated |
2340 | EASTGATE HOME | Eastgate Home Training | 4435 AICHOLTZ RD | STE 800B | CINCINNATI | OH | 45245-1692 | ||||||||||
Affiliated |
2366 | WESLEY CHAPEL DIALYSIS | Wesley Chapel Dialysis (PD ONLY) | 2255 GREEN HEDGES WAY | WESLEY CHAPEL | FL | 33544-8183 | |||||||||||
Affiliated |
2400 | FRESNO PD | Fresno At Home Center-PD Only | 568 E HERNDON AVE | STE 301 | FRESNO | CA | 93720-2989 | ||||||||||
Affiliated |
2456 | GRAND HOME DIALYSIS PD/HHD | Grand Home Dialysis (PD only) | 14674 W MOUNTAIN VIEW BLVD | STE 204 | SURPRISE | AZ | 85374-2708 | ||||||||||
Affiliated |
2458 | WASHINGTON COUNTY DIALYSIS | Washington County Dialysis PD Only (fka Hagerstown) | 1136 OPAL CT | HAGERSTOWN | MD | 21740-5940 | |||||||||||
Affiliated |
2477 | SAN JOSE PD | San Jose At Home-PD Only (Freestanding) | 4400 STEVENS CREEK BLVD | STE 50 | SAN JOSE | CA | 95129-1104 | ||||||||||
Affiliated |
2483 | FREMONT HOME TRAINING JV | DNVO-Fremont At Home PD/HHD-CA | 39355 CALIFORNIA AVE | FREMONT | CA | 94538 | |||||||||||
Affiliated |
2490 | HOME DIALYSIS OPTIONS OF BALDWIN COUNTY | Home Dialysis Options of Baldwin County-PD Only | 27880 N MAIN ST | STE A | DAPHNE | AL | 36526-7080 | ||||||||||
Affiliated |
3299 | TRI COUNTIES HOME TRAINING | Tri Counties Home Dialysis | 433 S BRIDGE ST | VISALIA | CA | 93277-2801 | |||||||||||
Affiliated |
3640 | WHITE OAK HOME TRAINING DIALYSIS | White Oak Home Training | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | ||||||||||
Affiliated |
3683 | BUTLER COUNTY HOME TRAINING DIALYSIS | Butler County Home Training | 3497 S DIXIE HWY | FRANKLIN | OH | 45005-5717 | |||||||||||
Affiliated |
3727 | HANFORD AT HOME DIALYSIS | Hanford Home Dialysis PD | 900 N DOUTY ST | HANFORD | CA | 93230-3918 | |||||||||||
Affiliated |
3735 | HIOAKS DIALYSIS PD | Hioaks Dialysis PD | 681 HIOAKS RD | STE B | RICHMOND | VA | 23225-4043 | ||||||||||
Affiliated |
3891 | MEMPHIS EAST DIALYSIS PD | Memphis East Dialysis PD | 50 HUMPHREYS CTR | STE 28B | MEMPHIS | TN | 38120-2369 | ||||||||||
Affiliated |
3892 | NASHVILLE HOME TRAINING DIALYSIS PD | Nashville Home Training Dialysis PD | 1919 CHARLOTTE AVE | STE 200 | NASHVILLE | TN | 37203-2245 | ||||||||||
Affiliated |
3989 | DEARBORN HOME DIALYSIS | Dearborn Home Dialysis-PD | 22030 PARK ST | DEARBORN | MI | 48124-2854 | |||||||||||
Affiliated |
4308 | GALLERIA HOME TRAINING DIALYSIS | Galleria Home Training Dialysis PD (aka SW Tennessee) | 9045 HIGHWAY 64 | STE 102 | LAKELAND | TN | 38002-8394 | ||||||||||
Affiliated |
4310 | GREATER TAMPA AT HOME | Greater Tampa At Home PD | 4204 N MACDILL AVE | STE 1B NORTH BLDG | TAMPA | FL | 33607-6364 | ||||||||||
Affiliated |
4315 | LORAIN COUNTY HOME DIALYSIS | DNVO-Lorain County Home Dialysis HHD/PD-OH | 824 E BROAD ST | ELYRIA | OH | 44035-6557 | |||||||||||
Affiliated |
4375 | GARFIELD HOME PROGRAM | Garfield Home Program (PD Only) | 228 N GARFIELD AVE | STE 301 | MONTEREY PARK | CA | 91754-1709 | ||||||||||
Affiliated |
4453 | BINZ HOME TRAINING | Binz Home Training - PD only | 1213 HERMANN DR | STE 180 | HOUSTON | TX | 77004-7018 | ||||||||||
Affiliated |
5021 | FRANKLIN AT HOME PD | Franklin At Home PD | 301 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4117 | |||||||||||
Affiliated |
5028 | CALDWELL DIALYSIS CENTER PD | Caldwell Dialysis Center | 821 S SMEED PKWY | CALDWELL | ID | 83605-5130 | |||||||||||
Affiliated |
5170 | FORT WAYNE HOME DIALYSIS | DNVO-Fort Wayne Home Dialysis (PD-HHD)-IN | 3124 E STATE BLVD | STE 5B | FORT WAYNE | IN | 46805-4763 | ||||||||||
Affiliated |
5556 | VISALIA AT HOME | Visalia At Home PD | 1120 N CHINOWTH ST | VISALIA | CA | 93291-7896 | |||||||||||
Affiliated |
5569 | BLUEMOUND PD | Bluemound PD | 601 N 99TH ST STE 300 | WAUWATOSA | WI | 53226-4362 | |||||||||||
Affiliated |
5581 | WOODLAWN HOME PROGRAM PD | Woodlawn Home Program PD Only | 5841 S MARYLAND AVE | RM L-026 | CHICAGO | IL | 60637-1447 | ||||||||||
Affiliated |
5599 | BEVERLY DIALYSIS PD | Beverly PD | 8109 S WESTERN AVE | CHICAGO | IL | 60620-5939 | |||||||||||
Affiliated |
5600 | WOODLAWN PEDIATRIC HOME PROGRAM | Woodlawn Pediatrics Home Program PD Only | 5841 S MARYLAND AVE L026 | CHICAGO | IL | 60615 | |||||||||||
Affiliated |
5616 | SPRINGHILL HOME TRAINING DIALYSIS | Springhill Home Training (PD Only) | 3401 SPRINGHILL DR | STE 330 | NORTH LITTLE ROCK | AR | 72117-2945 | ||||||||||
Affiliated |
5647 | FIRST COLONIAL DAVITA PD | First Colonial DaVita PD | 1157 FIRST COLONIAL RD | STE 200 | VIRGINIA BEACH | VA | 23454-2432 | ||||||||||
Affiliated |
5898 | AMHERST AT HOME | Amherst At Home | 3200 COOPER FOSTER PRK RD W | LORAIN | OH | 44053-3654 | |||||||||||
Affiliated |
5900 | CATHERDRAL CITY AT HOME | DNVO JV-Cathedral City At Home-CA | 30-885 DATE PALM DR | CATHEDRAL CITY | CA | 92234-2958 | |||||||||||
Affiliated |
5904 | ROBBINSDALE AT HOME | Robbinsdale At Home | 3461 WEST BROADWAY AVE | ROBBINSDALE | MN | 55422-2955 | |||||||||||
Affiliated |
5905 | NORTH PALM BEACH AT HOME | North Palm Beach At Home | 2841 PGA BLVD | PALM BEACH GARDENS | FL | 33410-2910 | |||||||||||
Affiliated |
5907 | SOUTHTOWNS AT HOME | Southtowns At Home (Hamburg) | 4910 CAMP RD | STE 100 | HAMBURG | NY | 14075-2617 | ||||||||||
Affiliated |
5909 | FORT WAYNE HOME AT HOME | DNVO-Fort Wayne Home At Home | 3124 E STATE BLVD | STE 5B | FORT WAYNE | IN | 46805-4763 | ||||||||||
Affiliated |
5910 | FORT WAYNE WEST AT HOME | DNVO JV-Fort Wayne West At Home | 4916 ILLINOIS RD | STE 118 | FORT WAYNE | IN | 46804-5116 | ||||||||||
Affiliated |
5913 | WINCHESTER AT HOME | Winchester At Home | 2301 VALOR DR | WINCHESTER | VA | 22601-6111 | |||||||||||
Affiliated |
5914 | MARSHFIELD AT HOME | Marshfield At Home | 123 NORTHRIDGE ST | MARSHFIELD | WI | 54449-8341 | |||||||||||
Affiliated |
5915 | MOSCOW AT HOME | Moscow At Home | 212 RODEO DR | STE 110 | MOSCOW | ID | 83843-9791 |
Page 112 of 123
Affiliated | 5919 | AVON AT HOME | Avon At Home | 9210 ROCKVILLE RD | STE D | INDIANAPOLIS | IN | 46234-2670 | ||||||||||
Affiliated | 5923 | NORTHSIDE AT HOME | Northside At Home | 320 E NORTH AVE | 4TH FLOOR SOUTH TOWER | PITTSBURGH | PA | 15212-4756 | ||||||||||
Affiliated | 5926 | PANAMA CITY AT HOME | Panama City At Home | 615 HIGHWAY 231 | PANAMA CITY | FL | 32405-4704 | |||||||||||
Affiliated | 5927 | MAGNOLIA OAKS AT HOME | Magnolia Oaks At Home (aka Hinesville, Satilla River) | 2377 HIGHWAY 196 W | BLDG A MAGNOLIA OAKS | HINESVILLE | GA | 31313-8036 | ||||||||||
Affiliated | 5928 | WESTBANK AT HOME | Westbank At Home | 3631 BEHRMAN PL | NEW ORLEANS | LA | 70114-0906 | |||||||||||
Affiliated | 5931 | ROCKSIDE AT HOME | Rockside At Home | 4801 ACORN DR | INDEPENDENCE | OH | 44131-2566 | |||||||||||
Affiliated | 5932 | WADSWORTH AT HOME | Wadsworth At Home | 195 WADSWORTH RD STE 302 | FOUNDERS HALL 3RD FLOOR | WADSWORTH | OH | 44281-9504 | ||||||||||
Affiliated | 5933 | WOODLAWN AT HOME HHD | Woodlawn Home Program At Home | 5841 S MARYLAND AVE | RM L-026 | CHICAGO | IL | 60637-1447 | ||||||||||
Affiliated | 5934 | WESLEY CHAPEL AT HOME | Wesley Chapel At Home | 2255 GREEN HEDGES WAY | WESLEY CHAPEL | FL | 33544-8183 | |||||||||||
Affiliated | 5935 | THOUSAND OAKS AT HOME | Thousand Oaks At Home | 375 ROLLING OAKS DR | STE 100 | THOUSAND OAKS | CA | 91361-1024 | ||||||||||
Affiliated | 5936 | SIMI VALLEY AT HOME | Simi Valley At Home | 2950 SYCAMORE DR | STE 100 | SIMI VALLEY | CA | 93065-1210 | ||||||||||
Affiliated | 5937 | MIDWEST FAIRBORN AT HOME | Midwest Fairborn At Home | 1266 N BROAD ST | FAIRBORN | OH | 45324 | |||||||||||
Affiliated | 5938 | NORTH ST LOUIS COUNTY AT HOME | North St. Louis County At Home | 13119 NEW HALLS FERRY RD | FLORISSANT | MO | 63033-3228 | |||||||||||
Affiliated | 5939 | BLUEMOUND AT HOME | Bluemound At Home | 601 N 99TH ST | STE 110 | WAUWATOSA | WI | 53226 | ||||||||||
Affiliated | 5940 | MESA COUNTY AT HOME | Mesa County At Home (Grand Junction) | 561 25 RD | STE D | GRAND JUNCTION | CO | 81505-1303 | ||||||||||
Affiliated | 5942 | PLANO AT HOME | Plano At Home | 481 SHILOH RD | STE 100 | PLANO | TX | 75074-7231 | ||||||||||
Affiliated | 5943 | WEST BLOOMFIELD AT HOME | West Bloomfield At Home | 6010 W MAPLE RD STE 215 | WEST BLOOMFIELD | MI | 48322-4406 | |||||||||||
Affiliated | 5945 | BINZ HOME TRAINING AT HOME | Binz Home Training At Home | 1213 HERMANN DR STE 180 | HOUSTON | TX | 77004-7070 | |||||||||||
Affiliated | 5947 | HANNIBAL AT HOME | Hannibal At Home | 3140 PALMYRA RD | HANNIBAL | MO | 63401-2204 | |||||||||||
Affiliated | 5949 | BEVERLY AT HOME | Beverly At Home | 8109 SOUTH WESTERN AVE | CHICAGO | IL | 60620-5939 | |||||||||||
Affiliated | 5950 | NORTH JACKSON AT HOME | North Jackson At Home (fka Stonegate) | 217 STERLING FARM DR | JACKSON | TN | 38305-5727 | |||||||||||
Affiliated | 5951 | PORTAGE AT HOME | Portage At Home | 5823 US HIGHWAY 6 | PORTAGE | IN | 46368-4851 | |||||||||||
Affiliated | 5952 | ROGUE VALLEY AT HOME | Rogue Valley At Home | 760 GOLF VIEW DR UNIT 100 | MEDFORD | OR | 97504-9685 | |||||||||||
Affiliated | 5953 | EVERETT AT HOME | Everett At Home | 8130 EVERGREEN WAY STE C | EVERETT | WA | 98203-6419 | |||||||||||
Affiliated | 5954 | OLYMPIA AT HOME | Olympia At Home | 335 COOPER POINT ROAD NW | SUITE 105 | OLYMPIA | WA | 98502-4436 | ||||||||||
Affiliated | 5955 | LORAIN COUNTY HOME AT HOME | DNVO-Lorain County Home At Home | 824 EAST BROAD ST | ELYRIA | OH | 44035-6559 | |||||||||||
Affiliated | 5956 | RENAISSANCE AT HOME | Renaissance At Home | 1840 DARBY DR | FLORENCE | AL | 35630-2623 | |||||||||||
Affiliated | 5957 | POOLER AT HOME | Pooler At Home | 54 TRADERS WAY | LIVE OAK PLAZA | POOLER | GA | 31322-4158 | ||||||||||
Affiliated | 5958 | GULF SHORES AT HOME | Gulf Shores At Home | 3947 GULF SHORES PKWY | UNIT 150 | GULF SHORES | AL | 36542-2735 | ||||||||||
Affiliated | 5959 | FRANKLIN AT HOME | Franklin At Home | 301 CALLOWHILL ST | PHILADELPHIA | PA | 19123-4117 | |||||||||||
Affiliated | 5961 | RENO AT HOME | Reno At Home | 1500 EAST 2ND STREET | STE 101, 106 | RENO | NV | 89502-1189 | ||||||||||
Affiliated | 5963 | JACKSONVILLE SOUTH AT HOME | Jacksonville South At Home | 14965 OLD SAINT AUGUSTINE RD | UNIT 114 | JACKSONVILLE | FL | 32258-9481 | ||||||||||
Affiliated | 5964 | LAKE ST LOUIS AT HOME | Lake St. Louis At Home | 200 BREVCO PLZ | STE 202 | LAKE ST LOUIS | MO | 63367-2950 | ||||||||||
Affiliated | 5965 | UNION CITY AT HOME (GA) | Union City At Home (GA) | 6851 SHANNON PARKWAY | STE 200 | UNION CITY | GA | 30291-2049 | ||||||||||
Affiliated | 5966 | WEBER VALLEY AT HOME | Weber Valley At Home | 1920 W 250TH N | MARRIOTT-SLATERVILLE | UT | 84404-9233 | |||||||||||
Affiliated | 5968 | PARKER DIALYSIS CENTER | Parker At Home | 10371 S PARK GLENN WAY | STE 180 | PARKER | CO | 80138-3871 | ||||||||||
Affiliated | 5971 | KENNESTONE AT HOME | Kennestone At Home | 200 COBB PKWY N | STE 318 | MARIETTA | GA | 30062-3558 | ||||||||||
Affiliated | 5973 | NORTH COLORADO SPRINGS AT HOME | North Colorado Springs At Home | 6071 E WOODMEN RD | STE 100 | COLORADO SPRINGS | CO | 80923-2610 | ||||||||||
Affiliated | 5974 | PGH HOME MODALITY COD/HHD | Pittsburgh Home Modality Center of Excellence At Home | 5171 LIBERTY AVE | STE A | PITTSBURGH | PA | 15224-2254 | ||||||||||
Affiliated | 5977 | FRESNO AT HOME CENTER | Fresno At Home Center-HHD Only | 568 E HERNDON AVE | STE 301 | FRESNO | CA | 93720-2989 | ||||||||||
Affiliated | 5978 | BLUFF CITY AT HOME | Bluff City At Home | 2400 LUCY LEE PKWY | STE E | POPLAR BLUFF | MO | 63901-2427 | ||||||||||
Affiliated | 5979 | NORTH METRO AT HOME | North Metro At Home | 12365 HURON ST | STE 500 | WESTMINSTER | CO | 80234-3498 | ||||||||||
Affiliated | 5980 | FIVE STAR AT HOME | Five Star At Home (fka Las Vegas Multi-Care) | 2400 TECH CENTER CT | LAS VEGAS | NV | 89128-0804 | |||||||||||
Affiliated | 5981 | KIDNEY HOME AT HOME | Kidney HOME (Home Operations & Medical Education) At Home | 2245 ROLLING RUN DR | STE 3 | WINDSOR MILL | MD | 21244-1858 | ||||||||||
Affiliated | 5982 | FARGO AT HOME | Fargo At Home | 4474 23RD AVE S | STE M | FARGO | ND | 58104-8795 | ||||||||||
Affiliated | 5983 | GALLERIA HOME TRAINING AT HOME | Galleria Home Training At Home | 9045 HIGHWAY 64 | STE 102 | LAKELAND | TN | 38002-8394 | ||||||||||
Affiliated | 5986 | BELDEN COMMUNITY AT HOME | Belden Community At Home | 4685 FULTON DR NW | CANTON | OH | 44718-2379 | |||||||||||
Affiliated | 5987 | MAINPLACE AT HOME | Mainplace At Home | 972 W TOWN AND COUNTRY RD | ORANGE | CA | 92868-4714 | |||||||||||
Affiliated | 5988 | PENNSAUKEN AT HOME | Pennsauken At Home | 7024 KAIGHNS AVE | PENNSAUKEN | NJ | 08109-4417 | |||||||||||
Affiliated | 5989 | JEDBURG AT HOME | Jedburg At Home | 2897 W 5TH NORTH ST | SUMMERVILLE | SC | 29483-9674 | |||||||||||
Affiliated | 5993 | CAPE CORAL SOUTH AT HOME | Cape Coral South At Home | 3046 DEL PRADO BLVD S | STE 4A | CAPE CORAL | FL | 33904-7232 | ||||||||||
Affiliated | 5994 | GREATER TAMPA HOME AT HOME | Greater Tampa At Home | 4204 N MACDILL AVE | STE 1B NORTH BLDG | TAMPA | FL | 33607-6364 | ||||||||||
Affiliated | 5995 | ATHENS EAST AT HOME | Athens East At Home | 2026 S MILLEDGE AVE | STE A2 | ATHENS | GA | 30605-6480 | ||||||||||
Affiliated | 5996 | UNIVERSITY UNIT RIVERSIDE AT HOME | University Unit Riverside At Home | 1045 WESTGATE DR | STE 90 | SAINT PAUL | MN | 55114-1079 | ||||||||||
Affiliated | 5997 | WOODRIDGE AT HOME | Woodridge Home At Home | 7425 JANES AVE | STE 103 | WOODRIDGE | IL | 60517-2356 | ||||||||||
Affiliated | 5998 | INDY SOUTH AT HOME | Indy South At Home | 972 EMERSON PKWY | STE E | GREENWOOD | IN | 46143-6202 | ||||||||||
Affiliated | 5999 | LOCKPORT HOME AT HOME | Lockport Home Dialysis At Home | 16626 W 159TH ST | STE 703 | LOCKPORT | IL | 60441-8019 | ||||||||||
Affiliated | 6000 | CAMELBACK AT HOME HEMO | Camelback Dialysis At Home | 7321 E OSBORN DR | SCOTTSDALE | AZ | 85251-6418 | |||||||||||
Affiliated | 6002 | WEST BOUNTIFUL DIALYSIS AT HOME | West Bountiful Dialysis At Home | 724 W 500 S | STE 300 | WEST BOUNTIFUL | UT | 84087-1471 | ||||||||||
Affiliated | 6002 | WEST BOUNTIFUL DIALYSIS AT HOME | West Bountiful Dialysis At Home | 724 W 500 S | STE 300 | WEST BOUNTIFUL | UT | 84087-1471 | ||||||||||
Affiliated | 6004 | CORNERSTONE DIALYSIS AT HOME | Cornerstone Dialysis At Home | 23857 GREENFIELD RD | SOUTHFIELD | MI | 48075-3122 | |||||||||||
Affiliated | 6006 | DIALYSIS CARE OF MOORE COUNTY AT HOME | Dialysis Care of Moore County At Home (aka Pinehurst) | 16 REGIONAL DR | PINEHURST | NC | 28374-8850 | |||||||||||
Affiliated | 6007 | HOME DIALYSIS AT HOME | Home Dialysis At Home (Minneapolis) | 825 S 8TH ST | STE 1224 | MINNEAPOLIS | MN | 55404-1223 | ||||||||||
Affiliated | 6009 | ST PAUL CAPITOL DIALYSIS AT HOME | St Paul Capital Dialysis At Home | 555 PARK ST | STE 210 | SAINT PAUL | MN | 55103-2193 | ||||||||||
Affiliated | 6011 | BALLENGER PT AT HOME | Ballenger Pt. At Home | 2262 S BALLENGER HWY | FLINT | MI | 48503-3447 | |||||||||||
Affiliated | 6012 | LAKEWOOD AT HOME | Lakewood At Home | 1750 PIERCE ST | LAKEWOOD | CO | 80214-1434 | |||||||||||
Affiliated | 6013 | MED-CENTER AT HOME | Med-Center at Home | 7580 FANNIN ST | STE 230 | HOUSTON | TX | 77054-1939 |
Page 113 of 123
Affiliated | 6014 | UTAH VALLEY DIALYSIS AT HOME | Utah Valley Dialysis At Home | 1055 N 500 W | STE 221 | PROVO | UT | 84604-3305 | ||||||||||
Affiliated | 6015 | LOWRY AT HOME | Lowry At Home | 7465 E 1ST AVE | STE A | DENVER | CO | 80230-6877 | ||||||||||
Affiliated | 6016 | MANZANITA AT HOME | Manzanita At Home | 4005 MANZANITA AVE | STE 17 | CARMICHAEL | CA | 95608-1779 | ||||||||||
Affiliated | 6017 | FIRST COLONIAL DAVITA AT HOME | First Colonial DaVita At Home | 1157 FIRST COLONIAL RD | STE 200 | VIRGINIA BEACH | VA | 23454-2432 | ||||||||||
Affiliated | 6019 | LAKEWOOD WASHINGTON AT HOME | Lakewood Washington At Home | 5919 LAKEWOOD TOWNE CENTER BLVD SW | STE A | LAKEWOOD | WA | 98499-6513 | ||||||||||
Affiliated | 6020 | GRAPEVINE AT HOME | Grapevine At Home | 1600 W NORTHWEST HWY | STE 100 | GRAPEVINE | TX | 76051-8131 | ||||||||||
Affiliated | 6021 | GRAND RAPIDS AT HOME (CHERRY STREET) | Grand Rapids At Home (Cherry Street) | 801 CHERRY ST SE | GRAND RAPIDS | MI | 49506-1440 | |||||||||||
Affiliated | 6022 | FEDERAL WAY AT HOME | Federal Way At Home | 1015 S 348TH ST | FEDERAL WAY | WA | 98003-7078 | |||||||||||
Affiliated | 6023 | CENTURY CITY AT HOME | Century City At Home | 10630 SANTA MONICA BLVD | LOS ANGELES | CA | 90025 | |||||||||||
Affiliated | 6024 | REDDING AT HOME | Redding At Home | 1876 PARK MARINA DR | REDDING | CA | 96001-0913 | |||||||||||
Affiliated | 6025 | OLYMPIA FIELDS AT HOME | Olympia Fields At Home | 4557B LINCOLN HWY | STE B | MATTESON | IL | 60443-2318 | ||||||||||
Affiliated | 6026 | MT VERNON AT HOME | Mount Vernon At Home | 1800 JEFFERSON AVE | MOUNT VERNON | IL | 62864-4300 | |||||||||||
Affiliated | 6028 | YAKIMA AT HOME | Yakima At Home | 1221 N 16TH AVE | YAKIMA | WA | 98902-1347 | |||||||||||
Affiliated | 6029 | MID-COLUMBIA AT HOME | Mid Columbia At Home | 6825 BURDEN BLVD | STE A | PASCO | WA | 99301-9584 | ||||||||||
Affiliated | 6030 | GEORGETOWN ON THE POTOMAC AT HOME | Georgetown on the Potomac At Home | 3323 K STREET NW | SUITE 110 | WASHINGTON | DC | 20007 | ||||||||||
Affiliated | 6031 | SIOUX FALLS AT HOME | Sioux Falls At Home | 800 E 21ST ST | SIOUX FALLS | SD | 57105-1016 | |||||||||||
Affiliated | 6032 | HILLSBORO AT HOME | Hillsboro At Home | 2500 NW 229TH AVE | STE 300 BLDG E | HILLSBORO | OR | 97124-7516 | ||||||||||
Affiliated | 6033 | PIKES PEAK AT HOME | Pikes Peak At Home | 2002 LELARAY ST | STE 130 | COLORADO SPRINGS | CO | 80909-2804 | ||||||||||
Affiliated | 6034 | WALNUT CREEK AT HOME | Walnut Creek At Home | 400 N WIGET LN | WALNUT CREEK | CA | 94598-2408 | |||||||||||
Affiliated | 6035 | SAN ANTONIO AT HOME | San Antonio At Home | 5284 MEDICAL DR | STE 100 | SAN ANTONIO | TX | 78229-4849 | ||||||||||
Affiliated | 6036 | SANTA ROSA AT HOME | Santa Rosa At Home | 5819 HIGHWAY 90 | MILTON | FL | 32583-1763 | |||||||||||
Affiliated | 6037 | DUNMORE AT HOME | Dunmore At Home | 1212 ONEILL HWY | DUNMORE | PA | 18512-1717 | |||||||||||
Affiliated | 6038 | PALMERTON AT HOME | Palmerton At Home | 185 DELAWARE AVE | STE C | PALMERTON | PA | 18071-1716 | ||||||||||
Affiliated | 6039 | LONGVIEW AT HOME | Longview At Home | 425 N FREDONIA ST | LONGVIEW | TX | 75601-6464 | |||||||||||
Affiliated | 6040 | JB ZACHARY AT HOME | JB Zachary At Home | 333 CASSELL DR | STE 2300 | BALTIMORE | MD | 21224-6815 | ||||||||||
Affiliated | 6041 | MEMPHIS EAST AT HOME | Memphis East At Home | 50 HUMPHREYS CTR | STE 28B | MEMPHIS | TN | 38120-2369 | ||||||||||
Affiliated | 6042 | PLAINFIELD AT HOME | Plainfield At Home | 1200 RANDOLPH RD | KENYAN HOUSE | PLAINFIELD | NJ | 07060-3361 | ||||||||||
Affiliated | 6045 | CHARLOTTE AT HOME | Charlotte (NC) At Home | 2321 W MOREHEAD ST | STE 102 | CHARLOTTE | NC | 28208-5145 | ||||||||||
Affiliated | 6046 | DALY CITY AT HOME | Daly City At Home | 1498 SOUTHGATE AVE | STE 101 | DALY CITY | CA | 94015-4015 | ||||||||||
Affiliated | 6047 | SALEM AT HOME | Salem At Home (OR) | 3550 LIBERTY RD S | STE 100 | SALEM | OR | 97302-5700 | ||||||||||
Affiliated | 6048 | OMAHA WEST AT HOME | Omaha West At Home | 13014 W DODGE RD | OMAHA | NE | 68154-2148 | |||||||||||
Affiliated | 6049 | TUCSON EAST AT HOME | Tucson East At Home | 6420 E BROADWAY BLVD | STE C300 | TUCSON | AZ | 85710-3512 | ||||||||||
Affiliated | 6050 | WHITE OAK AT HOME | White Oak At Home | 5520 CHEVIOT RD | STE B | CINCINNATI | OH | 45247-7069 | ||||||||||
Affiliated | 6051 | BELPRE AT HOME | Belpre At Home | 2906 WASHINGTON BLVD | BELPRE | OH | 45714-1848 | |||||||||||
Affiliated | 6052 | BIRMINGHAM AT HOME | Birmingham At Home | 2101 7TH AVE S | BIRMINGHAM | AL | 35233-3105 | |||||||||||
Affiliated | 6053 | STAMFORD AT HOME | Stamford At Home | 30 COMMERCE RD | STAMFORD | CT | 06902-4506 | |||||||||||
Affiliated | 6054 | WHITEBRIDGE AT HOME | Whitebridge At Home | 103 WHITE BRIDGE PIKE | STE 6 | NASHVILLE | TN | 37209-4539 | ||||||||||
Affiliated | 6055 | ZANESVILLE AT HOME | Zanesville At Home | 3120 NEWARK RD | ZANESVILLE | OH | 43701-9659 | |||||||||||
Affiliated | 6056 | TYSONS CORNER AT HOME | Tysons Corner At Home | 8391 OLD COURTHOUSE RD | STE 160 | VIENNA | VA | 22182-3819 | ||||||||||
Affiliated | 6057 | BRADFORD AT HOME | Bradford At Home | 665 E MAIN ST | BRADFORD | PA | 16701-1869 | |||||||||||
Affiliated | 6059 | NORTHLAND AT HOME | Northland At Home | 2750 CLAY EDWARDS DR | STE 515 | N KANSAS CITY | MO | 64116-3258 | ||||||||||
Affiliated | 6060 | LAKE WORTH AT HOME | Lake Worth At Home | 2459 S CONGRESS AVE | STE 100 | PALM SPRINGS | FL | 33406-7616 | ||||||||||
Affiliated | 6061 | MEADVILLE AT HOME | Meadville At Home | 19050 PARK AVENUE PLZ | MEADVILLE | PA | 16335-4012 | |||||||||||
Affiliated | 6063 | WILLINGBORO AT HOME | Willingboro At Home | 230 VAN SCIVER PKWY | WILLINGBORO | NJ | 08046-1131 | |||||||||||
Affiliated | 6064 | DERENNE AT HOME | DeRenne At Home | 5303 MONTGOMERY ST | SAVANNAH | GA | 31405-5138 | |||||||||||
Affiliated | 6065 | BRUNSWICK AT HOME | Brunswick At Home | 53 SCRANTON CONNECTOR | BRUNSWICK | GA | 31525-1862 | |||||||||||
Affiliated | 6067 | AIKEN AT HOME | Aiken At Home | 775 MEDICAL PARK DR | AIKEN | SC | 29801-6306 | |||||||||||
Affiliated | 6068 | BRIDGEPORT AT HOME | Bridgeport At Home | 900 MADISON AVE | BRIDGEPORT | CT | 06606-5534 | |||||||||||
Affiliated | 6069 | ST PETERSBURG AT HOME | St Petersburg At Home | 2850 34TH ST S | ST PETERSBURG | FL | 33711-3817 | |||||||||||
Affiliated | 6070 | DENISON AT HOME | Denison At Home | 1220 REBA MACENTIRE LN | DENISON | TX | 75020-9057 | |||||||||||
Affiliated | 6072 | ATLANTIC AT HOME | Atlantic At Home | 6 INDUSTRIAL WAY W | STE B | EATONTOWN | NJ | 07724-2258 | ||||||||||
Affiliated | 6073 | NEWTOWN AT HOME | Newtown At Home (fka St. Mary) | 60 BLACKSMITH RD | NEWTOWN | PA | 18940-1847 | |||||||||||
Affiliated | 6075 | FOX RIVER AT HOME | Fox River At Home | 1910 RIVERSIDE DR | GREEN BAY | WI | 54301-2319 | |||||||||||
Affiliated | 6076 | TOKAY AT HOME | Tokay At Home | 777 S HAM LN | STE L | LODI | CA | 95242-3593 | ||||||||||
Affiliated | 6077 | CAPITAL CITY AT HOME | Capital City At Home | 307 N 46TH ST | LINCOLN | NE | 68503-3714 | |||||||||||
Affiliated | 6081 | GREATER MIAMI AT HOME | Greater Miami At Home | 160 NW 176TH ST | STE 100 | MIAMI | FL | 33169-5023 | ||||||||||
Affiliated | 6083 | EFFINGHAM AT HOME | Effingham At Home | 904 MEDICAL PARK DR | STE 1 | EFFINGHAM | IL | 62401-2193 | ||||||||||
Affiliated | 6084 | SPRINGFIELD CENTRAL AT HOME | Springfield Central At Home | 932 N RUTLEDGE ST | SPRINGFIELD | IL | 62702-3721 | |||||||||||
Affiliated | 6085 | DECATUR EAST WOOD AT HOME | Decatur East Wood At Home | 794 E WOOD ST | DECATUR | IL | 62523-1155 | |||||||||||
Affiliated | 6086 | ILLINI AT HOME | Illini At Home | 507 E UNIVERSITY AVE | CHAMPAIGN | IL | 61820-3828 | |||||||||||
Affiliated | 6087 | JANESVILLE AT HOME | Janesville At Home | 1305 WOODMAN RD | JANESVILLE | WI | 53545-1068 | |||||||||||
Affiliated | 6088 | NEW HAVEN AT HOME | New Haven At Home | 100 CHURCH ST S | STE C | NEW HAVEN | CT | 06519-1703 | ||||||||||
Affiliated | 6089 | NASHUA AT HOME | Nashua At Home | 38 TYLER ST | STE 100 | NASHUA | NH | 03060-2912 | ||||||||||
Affiliated | 6090 | EAST EVANSVILLE AT HOME | East Evansville At Home | 1312 PROFESSIONAL BLVD | EVANSVILLE | IN | 47714-8007 | |||||||||||
Affiliated | 6095 | BROOKRIVER AT HOME | Brookriver At Home | 8101 BROOKRIVER DR | DALLAS | TX | 75247-4003 | |||||||||||
Affiliated | 6098 | METRO EAST AT HOME | Metro East At Home | 5105 W MAIN ST | BELLEVILLE | IL | 62226-4728 | |||||||||||
Affiliated | 6099 | MARION AT HOME | Marion At Home | 324 S 4TH ST | MARION | IL | 62959-1241 |
Page 114 of 123
Affiliated | 6100 | ROXBURY AT HOME | Roxbury At Home | 622 ROXBURY RD | ROCKFORD | IL | 61107-5089 | |||||||||||
Affiliated | 6101 | SYCAMORE AT HOME | Sycamore At Home | 2200 GATEWAY DR | SYCAMORE | IL | 60178-3113 | |||||||||||
Affiliated | 6103 | WESTVIEW AT HOME | Westview At Home | 3749 COMMERCIAL DR | STE B | INDIANAPOLIS | IN | 46222-1676 | ||||||||||
Affiliated | 6105 | OCALA AT HOME | Ocala At Home | 2860 SE 1ST AVE | OCALA | FL | 34471-0406 | |||||||||||
Affiliated | 6106 | COMPLETE CARE AT HOME | Complete Care At Home | 7850 W SAMPLE RD | MARGATE | FL | 33065-4710 | |||||||||||
Affiliated | 6107 | INTERAMERICAN AT HOME | InterAmerican At Home | 7815 CORAL WAY | STE 115 | MIAMI | FL | 33155-6541 | ||||||||||
Affiliated | 6109 | PURCELLVILLE AT HOME | Purcellville At Home | 280 N HATCHER AVE | PURCELLVILLE | VA | 20132-3193 | |||||||||||
Affiliated | 6110 | TABLE ROCK AT HOME | Table Rock At Home | 5610 GAGE ST | STE B | BOISE | ID | 83706 | ||||||||||
Affiliated | 6111 | TWIN FALLS AT HOME | Twin Falls At Home | 1840 CANYON CREST DR | TWIN FALLS | ID | 83301-3007 | |||||||||||
Affiliated | 6113 | FOUR RIVERS AT HOME | Four Rivers At Home | 515 EAST LN | ONTARIO | OR | 97914-3953 | |||||||||||
Affiliated | 6114 | OLYMPIC VIEW AT HOME | Olympic View At Home | 125 16TH AVE E | FL 5 | SEATTLE | WA | 98112-5211 | ||||||||||
Affiliated | 6115 | SPIVEY AT HOME | Spivey At Home | 1423 STOCKBRIDGE RD | STE B | JONESBORO | GA | 30236-3740 | ||||||||||
Affiliated | 6116 | EAST DES MOINES AT HOME | East Des Moines At Home | 1301 PENNSYLVANIA AVE | STE 208 | DES MOINES | IA | 50316-2365 | ||||||||||
Affiliated | 6118 | KETTERING AT HOME | Kettering At Home | 5721 BIGGER RD | KETTERING | OH | 45440-2752 | |||||||||||
Affiliated | 6119 | CITRUS VALLEY AT HOME | Citrus Valley At Home | 894 HARDT ST | SAN BERNARDINO | CA | 92408-2854 | |||||||||||
Affiliated | 6124 | MERIDIAN PARK AT HOME | Meridian Park At Home | 19255 SW 65TH AVE | STE 100 | TUALATIN | OR | 97062-9712 | ||||||||||
Affiliated | 6125 | MARYVILLE AT HOME | Maryville At Home | 2136B VADALABENE DR | MARYVILLE | IL | 62062-5632 | |||||||||||
Affiliated | 6128 | PDI-WORCESTER AT HOME | PDI-Worcester At Home | 19 GLENNIE ST | STE A | WORCESTER | MA | 01605-3918 | ||||||||||
Affiliated | 6129 | PDI-ROCKY HILL AT HOME | PDI-Rocky Hill At Home | 30 WATERCHASE DR | ROCKY HILL | CT | 06067-2110 | |||||||||||
Affiliated | 6133 | WICHITA AT HOME | Wichita At Home | 909 N TOPEKA ST | WICHITA | KS | 67214-3620 | |||||||||||
Affiliated | 6134 | ASHEVILLE KIDNEY AT HOME | Asheville Kidney At Home | 1600 CENTERPARK DR | ASHEVILLE | NC | 28805-6206 | |||||||||||
Affiliated | 6136 | STRONGSVILLE AT HOME | Strongsville At Home | 17792 PEARL RD | STRONGSVILLE | OH | 44136-6909 | |||||||||||
Affiliated | 6137 | BATON ROUGE AT HOME | DSI Divest-Baton Rouge At Home | 3888 NORTH BLVD | STE 101 | BATON ROUGE | LA | 70806-3824 | ||||||||||
Affiliated | 6138 | WEST BROADWAY DIALYSIS AT HOME | West Broadway At Home | 720 W BROADWAY | STE 200 | LOUISVILLE | KY | 40202-3245 | ||||||||||
Affiliated | 6140 | BRONX AT HOME | Bronx At Home | 1615 EASTCHESTER RD | BRONX | NY | 10461-2603 | |||||||||||
Affiliated | 6142 | CLEVE HILL AT HOME | Cleve Hill At Home | 1461 KENSINGTON AVE | BUFFALO | NY | 14215-1436 | |||||||||||
Affiliated | 6144 | WHITE PLAINS AT HOME | White Plains At Home | 200 HAMILTON AVE | STE 13B | WHITE PLAINS | NY | 10601-1859 | ||||||||||
Affiliated | 6146 | LAKE VILLA AT HOME | Lake Villa At Home | 37809 N IL ROUTE 59 | LAKE VILLA | IL | 60046-7332 | |||||||||||
Affiliated | 6148 | TULSA AT HOME | Tulsa At Home | 4436 S HARVARD AVE | TULSA | OK | 74135-2605 | |||||||||||
Affiliated | 6151 | LITHONIA AT HOME | Lithonia At Home | 2485 PARK CENTRAL BLVD | DECATUR | GA | 30035-3902 | |||||||||||
Affiliated | 6152 | LANHAM AT HOME | Lanham At Home | 8855 ANNAPOLIS RD | STE 200 | LANHAM | MD | 20706-2919 | ||||||||||
Affiliated | 6153 | HAMMOND AT HOME | Hammond At Home | 222 DOUGLAS ST | HAMMOND | IN | 46320-1960 | |||||||||||
Affiliated | 6156 | UNION CITY CENTER AT HOME (CA) | Union City Center At Home (CA) | 32930 ALVARADO NILES RD | STE 300 | UNION CITY | CA | 94587-8101 | ||||||||||
Affiliated | 6157 | CHICO AT HOME | Chico At Home | 530 COHASSET RD | CHICO | CA | 95926-2212 | |||||||||||
Affiliated | 6158 | MONTCLAIR AT HOME | Montclair At Home | 5050 PALO VERDE ST | STE 100 | MONTCLAIR | CA | 91763-2333 | ||||||||||
Affiliated | 6161 | PDI - LANCASTER AT HOME | PDI-Lancaster At Home | 1412 E KING ST | LANCASTER | PA | 17602-3240 | |||||||||||
Affiliated | 6162 | PDI JOHNSTOWN AT HOME | PDI-Johnstown At Home | 344 BUDFIELD ST | JOHNSTOWN | PA | 15904-3214 | |||||||||||
Affiliated | 6163 | CAMP HILL AT HOME | Camp Hill At Home | 425 N 21ST ST | PLAZA 21 BLDG 1ST FL | CAMP HILL | PA | 17011-2202 | ||||||||||
Affiliated | 6164 | PDI MONTGOMERY AT HOME | PDI-Montgomery At Home | 1001 FOREST AVE | MONTGOMERY | AL | 36106-1181 | |||||||||||
Affiliated | 6165 | FAIRFAX AT HOME | Fairfax At Home | 8501 ARLINGTON BLVD | STE 100 | FAIRFAX | VA | 22031-4625 | ||||||||||
Affiliated | 6170 | WEST SACRAMENTO AT HOME | West Sacramento At Home | 3450 INDUSTRIAL BLVD | STE 100 | WEST SACRAMENTO | CA | 95691-5003 | ||||||||||
Affiliated | 6171 | EAST MACON AT HOME | East Macon At Home | 165 EMERY HWY | STE 101 | MACON | GA | 31217-3666 | ||||||||||
Affiliated | 6178 | GERMANTOWN AT HOME | Germantown At Home | 20111 CENTURY BLVD | STE C | GERMANTOWN | MD | 20874-9165 | ||||||||||
Affiliated | 6180 | SEDC-WILMINGTON AT HOME | SEDC-Wilmington (NC) At Home | 2215 YAUPON DR | WILMINGTON | NC | 28401-7334 | |||||||||||
Affiliated | 6182 | HERMISTON COMMUNITY AT HOME | Hermiston Community At Home | 1155 W LINDA AVE | HERMISTON | OR | 97838-9601 | |||||||||||
Affiliated | 6183 | SHREVEPORT HHD LA | Shreveport Home Dialysis At Home | 1560 IRVING PL | SHREVEPORT | LA | 71101-4604 | |||||||||||
Affiliated | 6184 | DOWNTOWN SAN ANTONIO AT HOME | Downtown San Antonio At Home | 615 E QUINCY ST | SAN ANTONIO | TX | 78212 | |||||||||||
Affiliated | 6186 | COLUMBIA MO AT HOME | RTC-Columbia (MO) At Home | 1701 E BROADWAY | STE G102 | COLUMBIA | MO | 65201-8029 | ||||||||||
Affiliated | 6188 | REGENCY AT HOME | Regency At Home (fka Jacksonville) | 9535 REGENCY SQUARE BLVD N | JACKSONVILLE | FL | 32225-8128 | |||||||||||
Affiliated | 6193 | WEST GEORGIA AT HOME | West Georgia At Home (fka Columbus (GA)) | 1216 STARK AVE | COLUMBUS | GA | 31906-2500 | |||||||||||
Affiliated | 6194 | BUFORD AT HOME | Buford At Home | 1550 BUFORD HWY | STE 1E | BUFORD | GA | 30518-3666 | ||||||||||
Affiliated | 6195 | KALAMAZOO WEST AT HOME | Kalamazoo West At Home | 1040 N 10TH ST | KALAMAZOO | MI | 49009-6149 | |||||||||||
Affiliated | 6196 | SOUTH VALLEY AT HOME | South Valley At Home | 17815 VENTURA BLVD | STE 100 | ENCINO | CA | 91316-3600 | ||||||||||
Affiliated | 6204 | QUEENS VILLAGE AT HOME | Queens Village At Home | 22202 HEMPSTEAD AVE | STE 170 | QUEENS VILLAGE | NY | 11429-2123 | ||||||||||
Affiliated | 6207 | LANSING AT HOME-MI | Lansing Home Hemodialysis At Home | 1675 WATERTOWER PL | STE 700 | EAST LANSING | MI | 48823-6397 | ||||||||||
Affiliated | 6208 | SOUTH COUNTY AT HOME | South County At Home (Deaconess) | 4145 UNION RD | SAINT LOUIS | MO | 63129-1064 | |||||||||||
Affiliated | 6211 | TACOMA AT HOME | Tacoma At Home | 3401 S 19TH ST | TACOMA | WA | 98405-1909 | |||||||||||
Affiliated | 6213 | CEDAR PARK AT HOME | Cedar Park At Home (fka North Austin) | 1720 E WHITESTONE BLVD | CEDAR PARK | TX | 78613-7640 | |||||||||||
Affiliated | 6214 | SOUTH FORT WORTH DIALYSIS AT HOME | South Fort Worth At Home | 6260 SOUTHWEST BLVD | BENBROOK | TX | 76109-6906 | |||||||||||
Affiliated | 6215 | THE WOODLANDS AT HOME | DNVO-The Woodlands At Home | 9301 PINECROFT DR | SHENANDOAH | TX | 77380-3179 | |||||||||||
Affiliated | 6218 | ARROWHEAD LAKES AT HOME | Arrowhead Lakes At Home | 20325 N 51ST AVE | STE 184 BLDG 11 | GLENDALE | AZ | 85308-4625 | ||||||||||
Affiliated | 6220 | COLUMBUS WEST HOME TRAINING | Columbus West Home Training At Home | 1391 GEORGESVILLE RD | COLUMBUS | OH | 43228-3611 | |||||||||||
Affiliated | 6221 | RICHMOND KIDNEY CENTER AT HOME | Richmond Kidney Center At Home (Staten Island) | 1366 VICTORY BLVD | STATEN ISLAND | NY | 10301-3907 | |||||||||||
Affiliated | 6225 | DIALYSIS CARE OF KANNAPOLIS AT HOME | Dialysis Care of Kannapolis At Home | 1607 N MAIN ST | KANNAPOLIS | NC | 28081-2317 | |||||||||||
Affiliated | 6226 | BUTLER-FARM AT HOME | Butler Farm At Home | 501 BUTLER FARM RD | STE A | HAMPTON | VA | 23666-1777 | ||||||||||
Affiliated | 6228 | NEW PORT RICHEY AT HOME | New Port Richey Kidney At Home | 7421 RIDGE RD | PORT RICHEY | FL | 34668-6933 | |||||||||||
Affiliated | 6229 | GRAND HOME AT HOME | Grand Home At Home | 14674 W MOUNTAIN VIEW BLVD | STE 204 | SURPRISE | AZ | 85374-2708 |
Page 115 of 123
Affiliated | 6230 | WILLIAMSBURG AT HOME | Williamsburg At Home (fka Yorktown) | 500 SENTARA CIR | STE 103 | WILLIAMSBURG | VA | 23188-5727 | ||||||||||
Affiliated | 6231 | BALDWIN COUNTY AT HOME | Home Dialysis Options of Baldwin County At Home | 27880 N MAIN ST | STE A | DAPHNE | AL | 36526-7080 | ||||||||||
Affiliated | 6232 | CLINTON TOWNSHIP AT HOME | Clinton Township at Home | 15918 19 MILE RD | STE 110 | CLINTON TOWNSHIP | MI | 48038-1101 | ||||||||||
Affiliated | 6233 | GROSSE POINTE AT HOME | Grosse Pointe At Home | 18000 E WARREN AVE | STE 100 | DETROIT | MI | 48224-1336 | ||||||||||
Affiliated | 6234 | GREENSBURG AT HOME | Greensburg At Home | 1531 N COMMERCE EAST DR | STE 6 | GREENSBURG | IN | 47240-3259 | ||||||||||
Affiliated | 6236 | GULF BREEZE AT HOME | Gulf Breeze At Home | 1519 MAIN ST | DUNEDIN | FL | 34698-4650 | |||||||||||
Affiliated | 6237 | JACKSONVILLE CENTRAL AT HOME | Jacksonville Central At Home | 400 T P WHITE DR | JACKSONVILLE | AR | 72076-3287 | |||||||||||
Affiliated | 6238 | SAN JOSE AT HOME | San Jose At Home (Freestanding) | 4400 STEVENS CREEK BLVD | STE 50 | SAN JOSE | CA | 95129-1104 | ||||||||||
Affiliated | 6243 | ORLANDO AT HOME | Orlando At Home (0178) | 14050 TOWN LOOP BLVD | STE 104B | ORLANDO | FL | 32837-6190 | ||||||||||
Affiliated | 6244 | KENNEDY HOME DIALYSIS-AT HOME | Kennedy Home Dialysis-At Home | 5509 N CUMBERLAND AVE | STE 515 | CHICAGO | IL | 60656-4702 | ||||||||||
Affiliated | 6245 | YPSILANTI AT HOME | Ypsilanti At Home | 2762 WASHTENAW RD | YPSILANTI | MI | 48197-1506 | |||||||||||
Affiliated | 6246 | JACKSONVILLE AT HOME | SEDC (NC II) Jacksonville At Home | 14 OFFICE PARK DR | JACKSONVILLE | NC | 28546-7325 | |||||||||||
Affiliated | 6247 | LEBANON AT HOME | Lebanon At Home | 918 COLUMBUS AVE | STE 2 UNIT B | LEBANON | OH | 45036-1402 | ||||||||||
Affiliated | 6248 | SLIDELL KIDNEY CARE AT HOME | Slidell Kidney Care At Home | 1150 ROBERT BLVD | STE 240 | SLIDELL | LA | 70458-2005 | ||||||||||
Affiliated | 6249 | WATERBURY AT HOME | Waterbury At Home | 150 MATTATUCK HEIGHTS RD | WATERBURY | CT | 06705-3893 | |||||||||||
Affiliated | 6251 | WHITE LANE AT HOME | White Lane At Home | 7701 WHITE LN | STE D | BAKERSFIELD | CA | 93309-0201 | ||||||||||
Affiliated | 6253 | HANFORD AT HOME | Hanford At Home | 900 N DOUTY ST | HANFORD | CA | 93230-3918 | |||||||||||
Affiliated | 6254 | ANAHEIM AT HOME | Anaheim At Home | 1107 W LA PALMA AVE | ANAHEIM | CA | 92801-2804 | |||||||||||
Affiliated | 6255 | MERCED AT HOME | Merced At Home | 3150 NORTH G ST | STE B | MERCED | CA | 95340-1346 | ||||||||||
Affiliated | 6257 | ST JOSEPH AT HOME | St. Joseph At Home | 5514 CORPORATE DR | STE 100 | SAINT JOSEPH | MO | 64507-7752 | ||||||||||
Affiliated | 6258 | CENTRAL LITTLE ROCK AT HOME | Central Little Rock At Home | 5800 W 10TH ST | STE 510 | LITTLE ROCK | AR | 72204-1760 | ||||||||||
Affiliated | 6260 | DURHAM WEST AT HOME | Durham West At Home | 4307 WESTERN PARK PL | STE 101 | DURHAM | NC | 27705-1204 | ||||||||||
Affiliated | 6262 | TOLEDO AT HOME | Toledo At Home | 1614 S BYRNE RD | TOLEDO | OH | 43614-3464 | |||||||||||
Affiliated | 6263 | HIOAKS AT HOME | Hioaks At Home | 681 HIOAKS RD | STE D | RICHMOND | VA | 23225-4043 | ||||||||||
Affiliated | 6264 | ELIZABETH AT HOME | Elizabeth At Home | 201 MCKEESPORT RD | ELIZABETH | PA | 15037-1623 | |||||||||||
Affiliated | 6265 | ABINGTON AT HOME | Abington At Home | 3940A COMMERCE AVE | WILLOW GROVE | PA | 19090-1705 | |||||||||||
Affiliated | 6267 | NORTH ORANGEBURG AT HOME | North Orangeburg At Home | 124 FIRE TOWER RD | ORANGEBURG | SC | 29118-1401 | |||||||||||
Affiliated | 6268 | DEARBORN HOME DIALYSIS - AT HOME | Dearborn Home Dialysis-At Home | 22030 PARK ST | DEARBORN | MI | 48124-2854 | |||||||||||
Affiliated | 6269 | OCEAN SPRINGS AT HOME | Ocean Springs At Home | 13150 PONCE DEL LEON | OCEAN SPRINGS | MS | 39564-2460 | |||||||||||
Affiliated | 6270 | HAKC - HUNTINGTON AT HOME | HAKC-Huntington At Home | 256 BROADWAY | HUNTINGTON STATION | NY | 11746-1403 | |||||||||||
Affiliated | 6271 | 42ND ST AT HOME | Philadelphia 42nd Street At Home | 4126 WALNUT ST | PHILADELPHIA | PA | 19104-3511 | |||||||||||
Affiliated | 6275 | CHARLOTTESVILLE NORTH AT HOME | Charlottesville North At Home | 1800 TIMBERWOOD BLVD | STE C | CHARLOTTESVILLE | VA | 22911-7544 | ||||||||||
Affiliated | 6276 | HEARTLAND AT HOME | Heartland At Home | 925 NE 8TH ST | OKLAHOMA CITY | OK | 73104-5800 | |||||||||||
Affiliated | 6278 | LAKELAND SOUTH AT HOME | Lakeland South At Home | 5050 S FLORIDA AVE | STE 1 | LAKELAND | FL | 33813-2501 | ||||||||||
Affiliated | 6282 | RAINBOW CITY AT HOME | Rainbow City At Home | 2800 RAINBOW DR | RAINBOW CITY | AL | 35906-5811 | |||||||||||
Affiliated | 6283 | ATHENS AT HOME | Athens At Home | 15953 ATHENS LIMESTONE DR | STE 15 | ATHENS | AL | 35613-2214 | ||||||||||
Affiliated | 6284 | SYLACAUGA AT HOME | Sylacauga At Home | 331 JAMES PAYTON BLVD | SYLACAUGA | AL | 35150 | |||||||||||
Affiliated | 6287 | PITTSBURGH AT HOME | Pittsburgh At Home | 4312 PENN AVE | PITTSBURGH | PA | 15224-1310 | |||||||||||
Affiliated | 6289 | RADNOR AT HOME | Radnor At Home | 250 KING OF PRUSSIA RD | RADNOR | PA | 19087-5220 | |||||||||||
Affiliated | 6291 | RADFORD AT HOME | Radford At Home | 600 E MAIN ST | STE B | RADFORD | VA | 24141-1826 | ||||||||||
Affiliated | 6292 | HARRISONBURG AT HOME | Harrisonburg At Home | 871 CANTRELL AVE | STE 100 | HARRISONBURG | VA | 22801-4323 | ||||||||||
Affiliated | 6293 | KERRVILLE AT HOME | Kerrville At Home | 515 GRANADA PL | KERRVILLE | TX | 78028-5992 | |||||||||||
Affiliated | 6294 | WEST TALLAHASSEE AT HOME | West Tallahassee At Home | 2645 W TENNESSEE ST | STE 8 | TALLAHASSEE | FL | 32304-2521 | ||||||||||
Affiliated | 6295 | ROME AT HOME | Rome At Home | 15 JOHN MADDOX DR NW | ROME | GA | 30165-1413 | |||||||||||
Affiliated | 6297 | ST LOUIS WEST AT HOME | St. Louis West At Home | 450 N LINDBERGH BLVD | STE 100C | CREVE COEUR | MO | 63141-7858 | ||||||||||
Affiliated | 6298 | COOKEVILLE AT HOME | Cookeville At Home | 140 W 7TH ST | COOKEVILLE | TN | 38501-1726 | |||||||||||
Affiliated | 6300 | DOTHAN AT HOME | Dothan At Home | 216 GRACELAND DR | DOTHAN | AL | 36305-7346 | |||||||||||
Affiliated | 6302 | HENRICO COUNTY AT HOME | Henrico County At Home | 5270 CHAMBERLAYNE RD | RICHMOND | VA | 23227-2950 | |||||||||||
Affiliated | 6303 | WEYMOUTH CLINIC AT HOME | Weymouth At Home | 330 LIBBEY INDUSTRIAL PKWY | STE 900 | WEYMOUTH | MA | 02189-3122 | ||||||||||
Affiliated | 6304 | ERIE AT HOME | Erie At Home | 350 E BAYFRONT PKWY | STE A | ERIE | PA | 16507-2410 | ||||||||||
Affiliated | 6305 | WILSON AT HOME | Wilson At Home | 1605 MEDICAL PARK DR W | WILSON | NC | 27893-2799 | |||||||||||
Affiliated | 6306 | NORTH FULTON AT HOME | North Fulton At Home | 1250 NORTHMEADOW PKWY | STE 120 | ROSWELL | GA | 30076-4914 | ||||||||||
Affiliated | 6311 | BRADENTON AT HOME | Bradenton At Home | 3501 CORTEZ RD W | STE 104 | BRADENTON | FL | 34210-3104 | ||||||||||
Affiliated | 6312 | COLUMBIA UNIVERSITY AT HOME | Columbia University At Home | 60 HAVEN AVENUE | NEW YORK | NY | 10032-2604 | |||||||||||
Affiliated | 6313 | NEW BEDFORD AT HOME | New Bedford At Home | 524 UNION ST | NEW BEDFORD | MA | 02740-3546 | |||||||||||
Affiliated | 6314 | MUSKEGON AT HOME | Muskegon At Home | 1277 MERCY DR | MUSKEGON | MI | 49444-4605 | |||||||||||
Affiliated | 6315 | WELLINGTON CIRCLE AT HOME | Wellington Circle At Home | 10 CABOT RD | STE 103B | MEDFORD | MA | 02155-5173 | ||||||||||
Affiliated | 6316 | FREDERICK AT HOME | Frederick At Home | 140 THOMAS JOHNSON DR | STE 100 | FREDERICK | MD | 21702-4475 | ||||||||||
Affiliated | 6317 | SELINSGROVE AT HOME | Selinsgrove At Home | 1030 N SUSQUEHANNA TRL | SELINSGROVE | PA | 17870-7767 | |||||||||||
Affiliated | 6318 | LAKE CHARLES SOUTHWEST AT HOME | Lake Charles Southwest At Home | 300 18th ST | LAKE CHARLES | LA | 70601-7342 | |||||||||||
Affiliated | 6319 | LENEXA AT HOME | Lenexa At Home | 8630 HALSEY ST | LENEXA | KS | 66215-2880 | |||||||||||
Affiliated | 6321 | NASHVILLE HOME TRAINING AT HOME | Nashville Home Training At Home | 1919 CHARLOTTE AVE | STE 200 | NASHVILLE | TN | 37203-2245 | ||||||||||
Affiliated | 6322 | GOLDSBORO AT HOME | Goldsboro At Home | 2609 HOSPITAL RD | GOLDSBORO | NC | 27534-9424 | |||||||||||
Affiliated | 6323 | MIAMI CAMPUS AT HOME | Miami Campus At Home | 1500 NW 12TH AVE | STE 106 | MIAMI | FL | 33136-1028 | ||||||||||
Affiliated | 6324 | DAYTONA BEACH AT HOME | Daytona Beach At Home | 578 HEALTH BLVD | DAYTONA BEACH | FL | 32114-1492 | |||||||||||
Affiliated | 6325 | GRASS VALLEY AT HOME | Grass Valley At Home | 360 CROWN POINT CIR | STE 210 | GRASS VALLEY | CA | 95945-2543 | ||||||||||
Affiliated | 6326 | POMONA AT HOME | Pomona At Home | 2111 NORTH GAREY AVENUE | POMONA | CA | 91767 |
Page 116 of 123
Affiliated | 6327 | MID ATLANTA HOME AT HOME | MidAtlanta Home At Home | 418 DECATUR ST SE | SUITE B | ATLANTA | GA | 30312-1801 | ||||||||||
Affiliated | 6328 | MARTINSVILLE AT HOME | Martinsville Dialysis | 33 BRIDGE ST S | MARTINSVILLE | VA | 24112-6214 | |||||||||||
Affiliated | 6329 | HUBBARD ROAD AT HOME | Hubbard Road At Home | 1963 HUBBARD RD | MADISON | OH | 44057 | |||||||||||
Affiliated | 6350 | PLAINFIELD RENAL CENTER AT HOME | Plainfield Renal At Home (P278) | 8110 NETWORK DR | PLAINFIELD | IN | 46168-9024 | |||||||||||
Affiliated | 6351 | NORTH ANDOVER RENAL CENTER AT HOME | North Andover Renal At Home (P178) | 201 SUTTON ST | NORTH ANDOVER | MA | 1845 | |||||||||||
Affiliated | 6352 | JACKSON NORTH DIALYSIS AT HOME | Jackson North At Home (P181) | 571 BEASLEY RD | STE B | JACKSON | MS | 39206-3042 | ||||||||||
Affiliated | 6353 | SUMMIT RENAL AT HOME | Summit Renal At Home (P186) | 73 MASSILLON RD | AKRON | OH | 44312-1028 | |||||||||||
Affiliated | 6354 | MARLTON DIALYSIS AT HOME | Marlton At Home (P200) | 769 E RTE 70 | MARLTON | NJ | 08053-2341 | |||||||||||
Affiliated | 6355 | CENTRAL FORT WAYNE DIALYSIS AT HOME | Central Fort Wayne At Home (P223) | 1940 BLUFTON RD | FORT WAYNE | IN | 46809-1307 | |||||||||||
Affiliated | 6356 | LAS CRUCES RENAL CENTER AT HOME | Las Cruces Renal At Home (P237) | 3961 E LOHMAN AVE | STE 29 | LAS CRUCES | NM | 88011-8272 | ||||||||||
Affiliated | 6357 | NORTHEAST PORTLAND RENAL CENTER AT HOME | Northeast Portland Renal At Home (P240) | 703 NE HANCOCK ST | PORTLAND | OR | 97212-3955 | |||||||||||
Affiliated | 6358 | KANSAS CITY RENAL CENTER AT HOME | Kansas City Renal At Home (P264) | 4333 MADISON AVE | KANSAS CITY | MO | 64111-3429 | |||||||||||
Affiliated | 6359 | COASTAL DIALYSIS AT HOME | South Texas Renal At Home (P257) | 4300 S PADRE ISLAND DR | CORPUS CHRISTI | TX | 78411-4433 | |||||||||||
Affiliated | 6360 | NORTH SPOKANE RENAL CENTER AT HOME | North Spokane Renal At Home (P262) | 12610 E MARIBEAU PRKWY | STE 100 | SPOKANE | WA | 99216 | ||||||||||
Affiliated | 5659 | TEMPE DIALYSIS PD | Tempe Dialysis Center PD | 2149 EAST WARNER RD | STE 109 | TEMPE | AZ | 85284-3496 | ||||||||||
Affiliated | 5660 | ARROWHEAD LAKES DIALYSIS PD | Arrowhead Lakes Dialysis PD | 20325 N 51ST AVE | BLDG 11, STE 184 | GLENDALE | AZ | 85308-4625 | ||||||||||
Affiliated | 5916 | SHAKER SQUARE AT HOME | Shaker Square At Home | 12800 SHAKER BLVD | STE 1 | CLEVELAND | OH | 44120-2004 | ||||||||||
Affiliated | 6130 | SIERRA ROSE AT HOME | Sierra Rose At Home | 685 SIERRA ROSE DR | RENO | NV | 89511-2060 | |||||||||||
Affiliated | 6217 | TEMPE AT HOME | Tempe At Home | 2149 E WARNER RD | STE 109 | TEMPE | AZ | 85284-3496 | ||||||||||
Affiliated | 6281 | TUSCALOOSA AT HOME | Tuscaloosa At Home | 805 OLD MILL ST | TUSCALOOSA | AL | 35401-7132 | |||||||||||
TEMPORARY CLOSURES | ||||||||||||||||||
(Included above are several centers that have temporarily suspended operations for a variety of reasons, but are scheduled to resume operations within the coming few months) | ||||||||||||||||||
614 | Lynwood | |||||||||||||||||
643 | Vidalia | |||||||||||||||||
3518 | Huntingdon Valley Dialysis | |||||||||||||||||
626 | Tuba City | |||||||||||||||||
903 | Littleton |
Page 117 of 123
Exhibit SR-1
Purchase Data Submission Form
Contract #: «Contract» Dialysis Center: DaVita Inc.
1. | Purchase Data For Measurement Period: [Enter Measurement Period (for example, Q4 2013)] |
ESA 1: | [Product NameX] |
|||
ESA 2: | [Product NameY] |
|||
ESA 3: | [Product NameZ] |
[Example 1 for illustration purposes only]
Dialysis Center Committed Purchasers | ||
ESA |
Total Number of [DELETED] Purchased | |
ESA 1 | 1,000 [DELETED] | |
ESA 2 | XX mcg | |
ESA 3 | 2,000 [DELETED] |
[Example 2 for illustration purposes only]
Dialysis Center Purchasers | ||
ESA |
Total Number of [DELETED] Purchased | |
ESA 1 | 1,000 [DELETED] | |
ESA 2 | XX mcg | |
ESA 3 | 2,000 [DELETED] |
2. | Number of patients who received any and each ESA or combination from Dialysis Center Purchasers during the entire Measurement Period. |
Page 118 of 123
[Example 1 for illustration purposes only]
ESA |
Total Number of Patients | |
ESA 1 |
50 | |
ESA 2 |
10 | |
ESA 3 |
5 |
[Example 2 for illustration purposes only]
ESA |
Total Number of Patients | |
ESA 1 |
60 | |
ESA 2 |
[Example 3 for illustration purposes only]
ESA |
Total Number of Patients | |
ESA 1 |
100 | |
ESA 3 |
[Example 4 for illustration purposes only]
ESA |
Total Number of Patients | |
ESA 2 |
100 | |
ESA 3 |
Completed Purchase Data Submission Forms should be submitted electronically as an Excel file to Amgen by e-mail at [DELETED], or as otherwise specified in writing by Amgen.
Page 119 of 123
Schedule 1
Data
Category |
Data Element |
Facility |
Patient | |||
Facility Reference |
Facility Name |
ü | ||||
Address |
ü | |||||
City, State, Zip |
ü | |||||
Phone |
ü | |||||
Facility ID (unique within account) |
ü | |||||
Regional ID (unique within account) |
ü | |||||
State in which facility is located |
ü | |||||
Patient Demographics |
De-identified Patient ID |
ü | ||||
Date of Service (Treatment Date) |
ü | |||||
Treatment Date/Date of Encounter (evaluated as treatment date) |
ü | |||||
[DELETED] (in [DELETED]) |
ü | |||||
[DELETED] Date |
ü | |||||
Date of [DELETED] (month, day & year) |
ü | |||||
Date of [DELETED] |
ü | |||||
[DELETED] Date |
ü | |||||
[DELETED] Date |
ü | |||||
[DELETED] |
By the end of Q4 2012 | |||||
[DELETED] Type ([DELETED])* |
ü | |||||
[DELETED] Date* |
ü | |||||
Primary Payor (Govnt - Medicare, Medicaid, VA or Commercial - Medicare Advantage, MCO, HMO, PPO) |
By the end of Q1 2012 | |||||
Secondary Payor (Govnt - Medicare, Medicaid, VA or Commercial - Medicare Advantage, MCO, HMO, PPO) |
By the end of Q1 2012 | |||||
Medications |
ESA Name |
ü | ||||
ESA Dose (EPOGEN / Aranesp) |
ü | |||||
EPOGEN Administration Frequency (On DVA offered Protocol) |
By the end of Q1 2012 | |||||
Aranesp Administration Frequency* |
By the end of Q1 2012 | |||||
ESA Route of Administration |
By the end of Q1 2012 | |||||
ESA Start Date |
By the end of Q1 2012 | |||||
ESA Stop Date (Missed dose due to held)* |
By the end of Q1 2012 | |||||
[DELETED] Name |
ü |
Page 120 of 123
[DELETED] |
ü | |||
[DELETED] Administration Frequency (Maintenance / Loading)* |
By the end of Q1 2012 | |||
[DELETED] Order (Not administered, stop)* |
By the end of Q1 2012 | |||
Vitamin D Name |
ü | |||
Vitamin D Dose |
ü | |||
Vitamin D Order (Stop date)* |
By the end of Q1 2012 | |||
Lab Measurements |
Hemoglobin |
ü | ||
[DELETED] |
ü | |||
[DELETED] |
ü | |||
[DELETED] / [DELETED] |
ü | |||
[DELETED] ([DELETED]) |
ü | |||
[DELETED] ([DELETED] or [DELETED]) |
ü | |||
[DELETED] |
ü | |||
Corrected [DELETED] |
ü | |||
Corrected [DELETED] Product |
ü | |||
Albumin |
ü | |||
Other Measurements |
[DELETED] ([DELETED]) |
ü | ||
[DELETED] |
ü | |||
[DELETED] |
ü | |||
Kt/v |
ü | |||
URR (until CMS no longer requires) |
ü | |||
Modality |
ü | |||
PD treatments (# pts per month) |
ü | |||
Home HD treatments (# pts per month)* |
ü | |||
Home HD treatments (# txs per month) |
By the end of Q1 2012 |
* | For designated fields, Dialysis Center will provide Amgen business rules to calculate value of the field based on the submitted Data. |
Timing on providing Data with specific target date in the data column means Data or business rules will be delivered to Amgen by the end of the specified Quarter. For example: by end of Q1 2012 means deadline for delivery is March 31, 2012.
Page 121 of 123
Schedule 2
Compensation Data
Product Data Submission Requirements. Compensation Data shall be sent in either Excel or a tab-delimited text file to the following email address: [DELETED]. The file naming convention shall include the Dialysis Center name, EPOGEN, and data month and year (i.e. DaVita_Epogen_January_2011). Dialysis Center must supply all of the information set forth in the table below.
ID |
Data Field Name |
Data Field Description | ||
1 |
Unique Account Identifier | DaVitas numeric identifier for each account (PFac & OFac) | ||
2 |
Account Name | Account requesting EPOGEN | ||
3 |
Account Street Address | Account requesting EPOGEN | ||
4 |
Account City | Account requesting EPOGEN | ||
5 |
Account State | Account requesting EPOGEN | ||
6 |
Account zip | Account requesting EPOGEN | ||
7 |
Dispensing Pharmacy for EPOGEN | DaVitas numeric identifier for location that has dispensed EPOGEN | ||
8 |
EPOGEN NDC Number | |||
9 |
EPOGEN Description | Name of EPOGEN including strength (Label Name) | ||
10 |
Quantity Shipped | |||
11 |
Unit Of Measure | Tabs, bottles, vials, etc. | ||
12 |
EPOGEN shipped/dispensed date |
Page 122 of 123
Schedule 3
Available EPOGEN SKU Schedule
EPOGEN® (Epoetin alfa):
VII. NDC |
Description | |
55513-126-10 |
2,000 Unit, 1 mL (2,000 Units/mL) single-use vial 10 vials/pack, 10 packs/case | |
55513-267-10 |
3,000 Unit, 1 mL (3,000 Units/mL) single-use vial 10 vials/pack, 10 packs/case | |
55513-148-10 |
4,000 Unit, 1 mL (4,000 Units/mL) single-use vial 10 vials/pack, 10 packs/case | |
55513-144-10 |
10,000 Unit, 1 mL (10,000 Units/mL) single-use vial 10 vials/pack, 10 packs/case | |
55513-283-10 |
20,000 Unit, 2 mL (10,000 Units/mL) multi-use vial 10 vials/pack, 4 packs/case | |
55513-478-10 |
20,000 Unit, 1 mL (20,000 Units/mL) multi-use vial 10 vials/pack, 4 packs/case |
Page 123 of 123
Exhibit 12.1
DAVITA INC.
RATIO OF EARNINGS TO FIXED CHARGES
The ratio of earnings to fixed charges is computed by dividing earnings by fixed charges. Earnings for this purpose are defined as pretax income from continuing operations adjusted by adding back fixed charges expensed during the period less noncontrolling interests. Fixed charges include debt expense (interest expense and the amortization of deferred financing costs), the estimated interest component of rent expense on operating leases, and capitalized interest.
Year ended December 31, | ||||||||||||||||||||
2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||
Earnings adjusted for fixed charges: |
||||||||||||||||||||
Income from continuing operations before income taxes |
$ | 892,674 | $ | 743,990 | $ | 757,579 | $ | 656,720 | $ | 673,967 | ||||||||||
Add: |
||||||||||||||||||||
Debt expense |
241,090 | 181,607 | 185,755 | 224,716 | 257,147 | |||||||||||||||
Interest portion of rent expense |
96,205 | 86,879 | 80,912 | 72,404 | 64,457 | |||||||||||||||
Less: Noncontrolling interests |
(96,049 | ) | (79,406 | ) | (57,803 | ) | (47,331 | ) | (46,702 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
241,246 | 189,080 | 208,864 | 249,789 | 274,902 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,133,920 | $ | 933,070 | $ | 966,443 | $ | 906,509 | $ | 948,869 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Fixed charges: |
||||||||||||||||||||
Debt expense |
$ | 241,090 | $ | 181,607 | $ | 185,755 | $ | 224,716 | $ | 257,147 | ||||||||||
Interest portion of rent expense |
96,205 | 86,879 | 80,912 | 72,404 | 64,457 | |||||||||||||||
Capitalized interest |
4,887 | 2,621 | 3,627 | 4,189 | 3,878 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 342,182 | $ | 271,107 | $ | 270,294 | $ | 301,309 | $ | 325,482 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratio of earnings to fixed charges |
3.31 | 3.44 | 3.58 | 3.01 | 2.92 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
Exhibit 21.1
SUBSIDIARIES OF THE COMPANY
Name |
Structure |
Jurisdiction of |
||||
Aberdeen Dialysis, LLC | Limited Liability Company | DE | ||||
Alamosa Dialysis, LLC | Limited Liability Company | DE | ||||
American Fork Dialysis, LLC | Limited Liability Company | DE | ||||
Amery Dialysis, LLC | Limited Liability Company | DE | ||||
Anderson Kidney Dialysis, LLC | Limited Liability Company | DE | ||||
Animas Dialysis, LLC | Limited Liability Company | DE | ||||
Arcadia Gardens Dialysis, LLC | Limited Liability Company | DE | ||||
Astro, Hobby, West Mt. Renal Care Limited Partnership |
Limited Partnership | DE | ||||
Austin Dialysis Centers, L.P. | Limited Partnership | DE | ||||
Barton Dialysis, LLC | Limited Liability Company | DE | ||||
Beacon Dialysis, LLC | Limited Liability Company | DE | ||||
Bear Creek Dialysis, L.P. | Limited Partnership | DE | ||||
Beverly Dialysis, LLC | Limited Liability Company | DE | ||||
Beverly Hills Dialysis Partnership | Partnership | CA | ||||
Birch Dialysis, LLC | Limited Liability Company | OH | ||||
Bladon Dialysis, LLC | Limited Liability Company | DE | ||||
Blake Dialysis, LLC | Limited Liability Company | DE | ||||
Blanco Dialysis, LLC | Limited Liability Company | DE | ||||
Bluegrass Dialysis, LLC | Limited Liability Company | DE | ||||
Bottle Dialysis, LLC | Limited Liability Company | DE | ||||
Brantley Dialysis, LLC | Limited Liability Company | DE | ||||
Bridges Dialysis, LLC | Limited Liability Company | DE | ||||
Bright Dialysis Center, LLC | Limited Liability Company | DE | ||||
Brighton Dialysis Center, LLC | Limited Liability Company | DE | ||||
Brook Dialysis, LLC | Limited Liability Company | DE | ||||
Brownsville Kidney Center, Ltd | Limited Partnership | TX | ||||
Bruno Dialysis, LLC | Limited Liability Company | DE | ||||
Buford Dialysis, LLC | Limited Liability Company | DE | ||||
Bullards Dialysis, LLC | Limited Liability Company | DE | ||||
Burney Dialysis, LLC | Limited Liability Company | DE | ||||
Caballo Dialysis, LLC | Limited Liability Company | DE | ||||
Caddo Dialysis, LLC | Limited Liability Company | DE | ||||
Canyon Springs Dialysis, LLC | Limited Liability Company | DE | ||||
Capelville Dialysis, LLC | Limited Liability Company | DE | ||||
Capes Dialysis, LLC | Limited Liability Company | DE | ||||
Capital Dialysis Partnership | Partnership | CA | ||||
Carroll County Dialysis Facility Limited Partnership |
Limited Partnership | MD | ||||
Cascades Dialysis, LLC | Limited Liability Company | DE | ||||
Cedar Dialysis, LLC | Limited Liability Company | DE | ||||
Centennial LV, LLC | Limited Liability Company | DE | ||||
Central Carolina Dialysis Centers, LLC | Limited Liability Company | DE | ||||
Central Georgia Dialysis, LLC | Limited Liability Company | DE | ||||
Central Iowa Dialysis Partners, LLC | Limited Liability Company | DE |
Page 1 of 8
Name |
Structure |
Jurisdiction of |
||||
Central Kentucky Dialysis Centers, LLC |
Limited Liability Company | DE | ||||
Cerito Dialysis Partners, LLC |
Limited Liability Company | DE | ||||
Channel Dialysis, LLC |
Limited Liability Company | DE | ||||
Chicago Heights Dialysis, LLC |
Limited Liability Company | DE | ||||
Chipeta Dialysis, LLC |
Limited Liability Company | DE | ||||
Churchill Dialysis, LLC |
Limited Liability Company | DE | ||||
Cinco Rios Dialysis, LLC |
Limited Liability Company | DE | ||||
Clinton Township Dialysis, LLC |
Limited Liability Company | DE | ||||
Coast Dialysis, LLC |
Limited Liability Company | DE | ||||
Columbus-RNA-DaVita, LLC |
Limited Liability Company | DE | ||||
Commerce Township Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Continental Dialysis Center, Inc. |
Corporation | VA | ||||
Continental Dialysis Center of Springfield-Fairfax, Inc. |
Corporation | VA | ||||
Court Dialysis, LLC |
Limited Liability Company | DE | ||||
Creek Dialysis, LLC |
Limited Liability Company | DE | ||||
Crystals Dialysis, LLC |
Limited Liability Company | DE | ||||
Dallas-Fort Worth Nephrology, L.P. |
Limited Partnership | DE | ||||
Dallas-Fort Worth Nephrology II, LLC |
Limited Liability Company | DE | ||||
Damon Dialysis, LLC |
Limited Liability Company | DE | ||||
DaVita Care Pte, Ltd |
Limited Partnership | Singapore | ||||
DaVita Dakota Dialysis Center, LLC |
Limited Liability Company | DE | ||||
DaVita DPC Holding Co., LLC |
Limited Liability Company | DE | ||||
DaVita El Paso East, L.P. |
Limited Partnership | DE | ||||
DaVita of New York, Inc. |
Corporation | NY | ||||
DaVita Renal Pte, Ltd |
Private Company | Singapore | ||||
DaVita-Riverside, LLC |
Limited Liability Company | DE | ||||
DaVita-Riverside II, LLC |
Limited Liability Company | DE | ||||
DaVita Rx, LLC |
Limited Liability Company | DE | ||||
DaVita Tidewater, LLC |
Limited Liability Company | DE | ||||
DaVita Tidewater-Virginia Beach, LLC |
Limited Liability Company | DE | ||||
DaVita VillageHealth Insurance of Alabama, Inc. |
Corporation | AL | ||||
DaVita VillageHealth of Georgia, Inc. |
Corporation | GA | ||||
DaVita VillageHealth of Ohio, Inc. |
Corporation | OH | ||||
DaVita VillageHealth of Virginia, Inc. |
Corporation | VA | ||||
Dialysis of Des Moines, LLC |
Limited Liability Company | DE | ||||
Dialysis of North Atlanta, LLC |
Limited Liability Company | DE | ||||
Dialysis of Northern Illinois, LLC |
Limited Liability Company | DE | ||||
Dialysis Specialists of Dallas, Inc. |
Corporation | TX | ||||
DNP Management Company, LLC |
Limited Liability Company | DE | ||||
Dolores Dialysis, LLC |
Limited Liability Company | DE | ||||
Dome dialysis, LLC |
Limited Liability Company | DE | ||||
Doves Dialysis, LLC |
Limited Liability Company | DE | ||||
Downriver Centers, Inc. |
Corporation | MI | ||||
Downtown Houston Dialysis Center, L.P. |
Limited Partnership | DE | ||||
Durango Dialysis Center, LLC |
Limited Liability Company | DE | ||||
DV Care GmbH |
Gesellschaft mit beschränkter Haftung(GmbH) | Germany |
Page 2 of 8
Name |
Structure |
Jurisdiction of |
||||
DVA Healthcare of Maryland, Inc. |
Corporation | MD | ||||
DVA Healthcare of Massachusetts, Inc. |
Corporation | MA | ||||
DVA Healthcare of New London, LLC |
Limited Liability Company | TN | ||||
DVA Healthcare of Norwich, LLC |
Limited Liability Company | TN | ||||
DVA Healthcare of Pennsylvania, Inc. |
Corporation | PA | ||||
DVA Healthcare of Tuscaloosa, LLC |
Limited Liability Company | TN | ||||
DVA Healthcare Renal Care, Inc. |
Corporation | NV | ||||
DVA Healthcare-Southwest Ohio, LLC |
Limited Liability Company | TN | ||||
DVA Laboratory Services, Inc. |
Corporation | FL | ||||
DVA of New York, Inc. |
Corporation | NY | ||||
DVA Renal Healthcare, Inc. |
Corporation | TN | ||||
DVA/Washington University Healthcare of Greater St. Louis, LLC |
Limited Liability Company | DE | ||||
East End Dialysis Center, Inc. |
Corporation | VA | ||||
East Ft. Lauderdale, LLC |
Limited Liability Company | DE | ||||
East Houston Kidney Center, L.P. |
Limited Partnership | DE | ||||
Elberton Dialysis Facility, Inc. |
Corporation | GA | ||||
Elk Grove Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Empire State DC, Inc. |
Corporation | NY | ||||
Enchanted Dialysis, LLC |
Limited Liability Company | DE | ||||
Fairfield Dialysis, LLC |
Limited Liability Company | DE | ||||
Falcon, LLC |
Limited Liability Company | DE | ||||
Falls Dialysis, LLC |
Limited Liability Company | DE | ||||
Fields Dialysis, LLC |
Limited Liability Company | DE | ||||
Five Star Dialysis, LLC |
Limited Liability Company | DE | ||||
Flamingo Park Kidney Center, Inc. |
Corporation | FL | ||||
Flor Dialysis, LLC |
Limited Liability Company | DE | ||||
Forester Dialysis, LLC |
Limited Liability Company | DE | ||||
Fort Dialysis, LLC |
Limited Liability Company | DE | ||||
Freehold Artificial Kidney Center, LLC |
Limited Liability Company | NJ | ||||
Fullerton Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Gardenside Dialysis, LLC |
Limited Liability Company | DE | ||||
Garner Dialysis, LLC |
Limited Liability Company | DE | ||||
Give Life Dialysis, LLC |
Limited Liability Company | DE | ||||
Golden Sun Bear, LLC |
Limited Liability Company | DE | ||||
Grand Home Dialysis, LLC |
Limited Liability Company | DE | ||||
Great Dialysis, LLC |
Limited Liability Company | DE | ||||
Greater Las Vegas Dialysis LLC |
Limited Liability Company | DE | ||||
Greater Los Angeles Dialysis Centers, LLC |
Limited Liability Company | DE | ||||
Green County Dialysis, LLC |
Limited Liability Company | DE | ||||
Green Desert Dialysis, LLC |
Limited Liability Company | DE | ||||
Greenwood Dialysis, LLC |
Limited Liability Company | DE | ||||
Griffin Dialysis, LLC |
Limited Liability Company | DE | ||||
Grove Dialysis, LLC |
Limited Liability Company | DE | ||||
Hagerstown Dialysis, LLC |
Limited Liability Company | DE | ||||
Hanford Dialysis, LLC |
Limited Liability Company | DE | ||||
Hart Dialysis, LLC |
Limited Liability Company | DE | ||||
Hawaiian Gardens Dialysis, LLC |
Limited Liability Company | DE |
Page 3 of 8
Name |
Structure |
Jurisdiction of |
||||
Hills Dialysis, LLC |
Limited Liability Company | DE | ||||
Historic Dialysis, LLC |
Limited Liability Company | DE | ||||
HomeChoice Partners, Inc |
Corporation | DE | ||||
Honey Dialysis, LLC |
Limited Liability Company | DE | ||||
Honeyman Dialysis, LLC |
Limited Liability Company | DE | ||||
Houston Acute Dialysis, L.P. |
Limited Partnership | DE | ||||
Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership |
Limited Partnership | DE | ||||
Huntington Artificial Kidney Center, Ltd. |
Limited Liability Company | NY | ||||
Huntington Park Dialysis, LLC |
Limited Liability Company | DE | ||||
Hyattsville Dialysis, LLC |
Limited Liability Company | DE | ||||
Indian River Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Ionia Dialysis, LLC |
Limited Liability Company | DE | ||||
ISD Bartlett, LLC |
Limited Liability Company | DE | ||||
ISD Bends Dialysis, LLC |
Limited Liability Company | DE | ||||
ISD Brandon, LLC |
Limited Liability Company | DE | ||||
ISD Buffalo Grove, LLC |
Limited Liability Company | DE | ||||
ISD Canton, LLC |
Limited Liability Company | DE | ||||
ISD Corpus Christi, LLC |
Limited Liability Company | DE | ||||
ISD I Holding Company, Inc. |
Corporation | DE | ||||
ISD II Holding Company, Inc. |
Corporation | DE | ||||
ISD Kansas City, LLC |
Limited Liability Company | DE | ||||
ISD Kendallville, LLC |
Limited Liability Company | DE | ||||
ISD Las Vegas, LLC |
Limited Liability Company | DE | ||||
ISD Lees Summit, LLC |
Limited Liability Company | DE | ||||
ISD Plainfield, LLC |
Limited Liability Company | DE | ||||
ISD Renal, Inc. |
Corporation | DE | ||||
ISD Schaumburg, LLC |
Limited Liability Company | DE | ||||
ISD Spring Valley, LLC |
Limited Liability Company | DE | ||||
ISD Summit Renal Care, LLC |
Limited Liability Company | DE | ||||
ISD Trenton, LLC |
Limited Liability Company | DE | ||||
Jedburg Dialysis, LLC |
Limited Liability Company | DE | ||||
Joliet Dialysis, LLC |
Limited Liability Company | DE | ||||
Kearn Dialysis, LLC |
Limited Liability Company | DE | ||||
Kidney Centers of Michigan, LLC |
Limited Liability Company | DE | ||||
Kidney Home Center, LLC |
Limited Liability Company | DE | ||||
Kimball Dialysis, LLC |
Limited Liability Company | DE | ||||
Knickerbocker Dialysis, Inc. |
Corporation | NY | ||||
Landing Dialysis, LLC |
Limited Liability Company | DE | ||||
Las Vegas Pediatric Dialysis, LLC |
Limited Liability Company | DE | ||||
Lawrenceburg Dialysis, LLC |
Limited Liability Company | DE | ||||
Leasburg Dialysis, LLC |
Limited Liability Company | DE | ||||
Liberty RC, Inc. |
Corporation | NY | ||||
Lighthouse Dialysis, LLC |
Limited Liability Company | DE | ||||
Limon Dialysis, LLC |
Limited Liability Company | DE | ||||
Lincoln Park Dialysis Services, Inc. |
Corporation | IL | ||||
Little Rock Dialysis Centers, LLC |
Limited Liability Company | DE | ||||
Livingston Dialysis, LLC |
Limited Liability Company | DE |
Page 4 of 8
Name |
Structure |
Jurisdiction of |
||||
Llano Dialysis, LLC |
Limited Liability Company | DE | ||||
Lockhart Dialysis, LLC |
Limited Liability Company | DE | ||||
Lockport Dialysis, LLC |
Limited Liability Company | DE | ||||
Lone Dialysis, LLC |
Limited Liability Company | DE | ||||
Long Beach Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Lord Baltimore Dialysis, LLC |
Limited Liability Company | DE | ||||
Lory Dialysis, LLC |
Limited Liability Company | DE | ||||
Los Angeles Dialysis Center |
Partnership | CA | ||||
Los Arcos Dialysis, LLC |
Limited Liability Company | DE | ||||
Loup Dialysis, LLC |
Limited Liability Company | DE | ||||
Lurleen Dialysis, LLC |
Limited Liability Company | DE | ||||
Mammoth Dialysis, LLC |
Limited Liability Company | DE | ||||
Manzano Dialysis, LLC |
Limited Liability Company | DE | ||||
Maple Grove Dialysis, LLC |
Limited Liability Company | DE | ||||
Maples Dialysis, LLC |
Limited Liability Company | DE | ||||
Marlton Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Marysville Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Mason-Dixon Dialysis Facilities, Inc. |
Corporation | MD | ||||
Memorial Dialysis Center, L.P. |
Limited Partnership | DE | ||||
Mena Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Meridian Dialysis, LLC |
Limited Liability Company | DE | ||||
Mesilla Dialysis, LLC |
Limited Liability Company | DE | ||||
Middlesex Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Minam Dialysis, LLC |
Limited Liability Company | DE | ||||
Miramar Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Moncrief Dialysis Center/Total Renal Care Limited Partnership |
Limited Partnership | DE | ||||
Morro Dialysis, LLC |
Limited Liability Company | DE | ||||
Mountain West Dialysis Services, LLC |
Limited Liability Company | DE | ||||
Muskogee Dialysis, LLC |
Limited Liability Company | DE | ||||
National Trail Dialysis, LLC |
Limited Liability Company | DE | ||||
Natomas Dialysis, LLC |
Limited Liability Company | DE | ||||
Nephrolife Care (India) Pte. Ltd. |
Corporation | India | ||||
Nephrology Medical Associates of Georgia, LLC |
Limited Liability Company | DE | ||||
Neptune Artificial Kidney Center, LLC |
Limited Liability Company | NJ | ||||
New Bay Dialysis, LLC |
Limited Liability Company | DE | ||||
New Springs Dialysis, LLC |
Limited Liability Company | DE | ||||
North Austin Dialysis, LLC |
Limited Liability Company | DE | ||||
North Colorado Springs Dialysis, LLC |
Limited Liability Company | DE | ||||
Northwest Tucson Dialysis, LLC |
Limited Liability Company | DE | ||||
Nuevo Dialysis, LLC |
Limited Liability Company | DE | ||||
Oasis Dialysis, LLC |
Limited Liability Company | DE | ||||
Ohio River Dialysis, LLC |
Limited Liability Company | DE | ||||
Open Access Lifeline, LLC |
Limited Liability Company | DE | ||||
Orange Dialysis, LLC |
Limited Liability Company | CA | ||||
Owasso Dialysis, LLC |
Limited Liability Company | DE | ||||
Paladina Health Group of Washington, P.C. |
Limited Liability Company | WA |
Page 5 of 8
Name |
Structure |
Jurisdiction of |
||||
Paladina Health, LLC |
Limited Liability Company | DE | ||||
Palomar Dialysis, LLC |
Limited Liability Company | DE | ||||
Patch Dialysis, LLC |
Limited Liability Company | DE | ||||
Peaks Dialysis, LLC |
Limited Liability Company | DE | ||||
Pfeiffer Dialysis, LLC |
Limited Liability Company | DE | ||||
Physicians Choice Dialysis of Alabama, LLC |
Limited Liability Company | DE | ||||
Physicians Dialysis Acquisitions, Inc. |
Corporation | DE | ||||
Physicians Dialysis of Houston, LLP |
Limited Liability Partnership | TX | ||||
Physicians Dialysis of Lancaster, LLC |
Limited Liability Company | PA | ||||
Physicians Dialysis Ventures, Inc |
Corporation | DE | ||||
Physicians Dialysis, Inc. |
Corporation | DE | ||||
Pike Dialysis, LLC |
Limited Liability Company | DE | ||||
Pittsburg Dialysis Partners, LLC |
Limited Liability Company | DE | ||||
Plaine Dialysis, LLC |
Limited Liability Company | DE | ||||
Platte Dialysis, LLC |
Limited Liability Company | DE | ||||
Pointe Dialysis, LLC |
Limited Liability Company | DE | ||||
Portola Dialysis, LLC |
Limited Liability Company | DE | ||||
Rancho Dialysis, LLC |
Limited Liability Company | DE | ||||
Rayburn Dialysis, LLC |
Limited Liability Company | DE | ||||
Red Willow Dialysis, LLC |
Limited Liability Company | DE | ||||
Refuge Dialysis, LLC |
Limited Liability Company | DE | ||||
Renal Clinic Of Houston, LLC |
Limited Liability Company | DE | ||||
Renal Life Link, Inc. |
Corporation | DE | ||||
Renal Treatment CentersCalifornia, Inc. |
Corporation | DE | ||||
Renal Treatment CentersIllinois, Inc. |
Corporation | DE | ||||
Renal Treatment Centers, Inc. |
Corporation | DE | ||||
Renal Treatment CentersMid-Atlantic, Inc. |
Corporation | DE | ||||
Renal Treatment CentersNortheast, Inc. |
Corporation | DE | ||||
Renal Treatment CentersSoutheast, L.P. |
Limited Partnership | DE | ||||
Renal Treatment CentersWest, Inc. |
Corporation | DE | ||||
Rickwood Dialysis, LLC |
Limited Liability Company | DE | ||||
Riddle Dialysis, LLC |
Limited Liability Company | DE | ||||
Rio Dialysis, LLC |
Limited Liability Company | DE | ||||
Ripley Dialysis, LLC |
Limited Liability Company | DE | ||||
Rita Ranch Dialysis, LLC |
Limited Liability Company | DE | ||||
River Valley Dialysis, LLC |
Limited Liability Company | DE | ||||
RMS Lifeline, Inc. |
Corporation | DE | ||||
RNA-DaVita Dialysis, LLC |
Limited Liability Company | DE | ||||
Robinson Dialysis, LLC |
Limited Liability Company | DE | ||||
Rochester Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Rocky Mountain Dialysis Services, LLC |
Limited Liability Company | DE | ||||
Roose Dialysis, LLC |
Limited Liability Company | DE | ||||
Ross Clark Circle Dialysis, LLC |
Limited Liability Company | DE | ||||
Routt Dialysis, LLC |
Limited Liability Company | DE | ||||
Royale Dialysis, LLC |
Limited Liability Company | DE | ||||
Rusk Dialysis, LLC |
Limited Liability Company | DE | ||||
Russell Dialysis, LLC |
Limited Liability Company | DE |
Page 6 of 8
Name |
Structure |
Jurisdiction of |
||||
Saddleback Dialysis, LLC |
Limited Liability Company | DE | ||||
SafeHarbor Dialysis, LLC |
Limited Liability Company | DE | ||||
SAKDC-DaVita Dialysis Partners, L.P. |
Limited Partnership | DE | ||||
Sandusky Dialysis, LLC |
Limited Liability Company | DE | ||||
San Marcos Dialysis, LLC |
Limited Liability Company | DE | ||||
Santa Fe Springs Dialysis, LLC |
Limited Liability Company | DE | ||||
Seneca Dialysis, LLC |
Limited Liability Company | DE | ||||
Shadow Dialysis, LLC |
Limited Liability Company | DE | ||||
Shayano Dialysis, LLC |
Limited Liability Company | DE | ||||
Sherman Dialysis, LLC |
Limited Liability Company | DE | ||||
Shining Star Dialysis, Inc. |
Corporation | NJ | ||||
Siena Dialysis Center, LLC |
Limited liability Company | DE | ||||
Simeon Dialysis, LLC |
Limited Liability Company | DE | ||||
Soledad Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Somerville Dialysis Center, LLC |
Limited Liability Company | DE | ||||
South Central Florida Dialysis Partners, LLC |
Limited Liability Company | DE | ||||
South Shore Dialysis Center. L.P. |
Limited Partnership | DE | ||||
Southcrest Dialysis, LLC |
Limited Liability Company | DE | ||||
Southeastern Indiana Dialysis, LLC |
Limited Liability Company | DE | ||||
Southern Colorado Joint Ventures, LLC |
Limited Liability Company | DE | ||||
Southern Hills Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Southwest Atlanta Dialysis Centers, LLC |
Limited Liability Company | DE | ||||
Southwest Kidney-DaVita Dialysis Partners, LLC |
Limited Liability Company | DE | ||||
St. Lukes Dialysis, LLC |
Limited Liability Company | DE | ||||
Star Dialysis, LLC |
Limited Liability Company | DE | ||||
Steam Dialysis, LLC |
Limited Liability Company | DE | ||||
Stevenson Dialysis, LLC |
Limited Liability Company | DE | ||||
Stewart Dialysis, LLC |
Limited Liability Company | DE | ||||
Storrie Dialysis, LLC |
Limited Liability Company | DE | ||||
Strongsville Dialysis, LLC |
Limited Liability Company | DE | ||||
Sugarite Dialysis, LLC |
Limited Liability Company | DE | ||||
Sugarloaf Dialysis, LLC |
Limited Liability Company | DE | ||||
Summer Dialysis, LLC |
Limited Liability Company | DE | ||||
Summit Dialysis Center, L.P. |
Limited Partnership | DE | ||||
Sun City Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Sun City West Dialysis Center LLC |
Limited Liability Company | DE | ||||
Sunset Dialysis, LLC |
Limited Liability Company | DE | ||||
Taylor Dialysis, LLC |
Limited Liability Company | DE | ||||
Tel-Huron Dialysis, LLC |
Limited Liability Company | DE | ||||
Tennessee Valley Dialysis Center, LLC |
Limited Liability Company | DE | ||||
The Woodlands Dialysis Center, L.P. |
Limited Partnership | DE | ||||
Tortugas Dialysis, LLC |
Limited Liability Company | DE | ||||
Total Renal Care/Crystal River Dialysis, L.C. |
Limited Liability Company | FL | ||||
Total Renal Care/Eaton Canyon Dialysis Center Partnership |
Partnership | CA | ||||
Total Renal Care, Inc. |
Corporation | CA |
Page 7 of 8
Name |
Structure |
Jurisdiction of |
||||
Total Renal Care North Carolina, LLC |
Limited Liability Company | DE | ||||
Total Renal Care Texas Limited Partnership |
Limited Partnership | DE | ||||
Total Renal Laboratories, Inc. |
Corporation | FL | ||||
Total Renal Research, Inc. |
Corporation | DE | ||||
Transmountain Dialysis, L.P. |
Limited Partnership | DE | ||||
TRC-Dyker Heights, L.P. |
Limited Partnership | NY | ||||
TRC-Four Corners Dialysis Clinics, LLC |
Limited Liability Company | NM | ||||
TRC-Georgetown Regional Dialysis LLC |
Limited Liability Company | DC | ||||
TRC-Indiana LLC |
Limited Liability Company | IN | ||||
TRC-Petersburg, LLC |
Limited Liability Company | DE | ||||
TRC El Paso Limited Partnership |
Limited Partnership | DE | ||||
TRC of New York, Inc. |
Corporation | NY | ||||
TRC West, Inc. |
Corporation | DE | ||||
Tree City Dialysis, LLC |
Limited Liability Company | DE | ||||
Tugman Dialysis, LLC |
Limited Liability Company | DE | ||||
Tulsa Dialysis, LLC |
Limited Liability Company | DE | ||||
Tumalo Dialysis, LLC |
Limited Liability Company | DE | ||||
Turlock Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Tustin Dialysis Center, LLC |
Limited Liability Company | DE | ||||
University Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Upper Valley Dialysis, L.P |
Limited Partnership | DE | ||||
USC-DaVita Dialysis Center, LLC |
Limited Liability Company | CA | ||||
UT Southwestern DVA Healthcare, LLP |
Limited Liability Partnership | TX | ||||
Valley Springs Dialysis, LLC |
Limited Liability Company | DE | ||||
Verde Dialysis, LLC |
Limited Liability Company | DE | ||||
Victory Dialysis, LLC |
Limited Liability Company | DE | ||||
VillageHealth DM, LLC |
Limited Liability Company | DE | ||||
Villanueva Dialysis, LLC |
Limited Liability Company | DE | ||||
Walker Dialysis, LLC |
Limited Liability Company | DE | ||||
Wauseon Dialysis, LLC |
Limited Liability Company | DE | ||||
Wesley Chapel Dialysis, LLC |
Limited Liability Company | DE | ||||
West Elk Grove Dialysis, LLC |
Limited Liability Company | DE | ||||
West Sacramento Dialysis, LLC |
Limited Liability Company | DE | ||||
Weston Dialysis Center, LLC |
Limited Liability Company | DE | ||||
Whitney Dialysis, LLC |
Limited Liability Company | DE | ||||
Wilder Dialysis, LLC |
Limited Liability Company | DE | ||||
Willowbrook Dialysis Center, L.P. |
Limited Partnership | DE | ||||
Winds Dialysis, LLC |
Limited Liability Company | DE | ||||
Wood Dialysis, LLC |
Limited Liability Company | DE | ||||
Wyandotte Central Dialysis, LLC |
Limited Liability Company | DE | ||||
Wyler Dialysis, LLC |
Limited Liability Company | DE | ||||
Ybor City Dialysis, LLC |
Limited Liability Company | DE | ||||
Yucaipa Dialysis, LLC |
Limited Liability Company | DE | ||||
Zephyrhills Dialysis Center, LLC |
Limited Liability Company | DE |
Page 8 of 8
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors and Shareholders
DaVita Inc.:
We consent to the incorporation by reference in the registration statements on Forms S-8 (No. 333-169467, No. 33-84610, No. 33-83018, No. 33-99862, No. 33-99864, No. 333-01620, No. 333-34693, No. 333-34695, No. 333-46887, No. 333-75361, No. 333-56149, No. 333-30734, No. 333-30736, No. 333-63158, No. 333-42653, No. 333-86550, No. 333-86556, No. 333-144097 and No. 333-158220) and Form S-3 (No. 333-169690 and No. 333-69227) of DaVita Inc. of our reports dated February 24, 2012, with respect to the consolidated balance sheets of DaVita Inc. and subsidiaries as of December 31, 2011 and 2010, and the related consolidated statements of income, equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2011, and related financial statement schedule, and the effectiveness of internal control over financial reporting as of December 31, 2011, which reports appear in the December 31, 2011 annual report on Form 10-K of DaVita Inc.
/s/ KPMG LLP |
Seattle, Washington February 24, 2012 |
Exhibit 31.1
SECTION 302 CERTIFICATION
I, Kent J. Thiry, certify that:
1. I have reviewed this annual report on Form 10-K of DaVita Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
/S/ KENT J. THIRY |
Kent J. Thiry Chief Executive Officer |
Date: February 24, 2012
Exhibit 31.2
SECTION 302 CERTIFICATION
I, Luis A. Borgen, certify that:
1. I have reviewed this annual report on Form 10-K of DaVita Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
/S/ LUIS A. BORGEN |
Luis A. Borgen Chief Financial Officer |
Date: February 24, 2012
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of DaVita Inc. (the Company) on Form 10-K for the year ending December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Periodic Report), I, Kent J. Thiry, Chief Executive Officer of the Company, certify, pursuant to 18.U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ KENT J. THIRY |
Kent J. Thiry Chief Executive Officer |
February 24, 2012
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of DaVita Inc. (the Company) on Form 10-K for the year ending December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Periodic Report), I, Luis A. Borgen, Chief Financial Officer of the Company, certify, pursuant to 18.U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/S/ LUIS A. BORGEN |
Luis A. Borgen Chief Financial Officer |
February 24, 2012
Amortizable intangibles (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amortizable Intangible Assets | Amortizable intangible assets were comprised of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amortizable Intangible Liabilities | Amortizable intangible liabilities were comprised of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scheduled Amortization Charges from Intangible Assets and Liabilities | Scheduled amortization charges from intangible assets and liabilities as of December 31, 2011 were as follows:
|
Acquisitions (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisition of Dialysis and Other Businesses | During 2011, 2010, and 2009, the Company acquired total dialysis and other businesses as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Results from Discontinued Operations | The results from discontinued operations related to the dialysis and related lab services segment were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Assets of Discontinued Operations Sold | Net assets of discontinued operations related to the dialysis and related lab services segment as of September 30, 2011, were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pro Forma Summary of Results of Operations |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDSI I Holding Company, Inc
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate Purchase Cost Allocations | The following table summarizes the assets acquired and liabilities assumed in the transaction and recognized at the acquisition date at their estimated fair values, as well as the estimated fair value of the noncontrolling interests in DSI at that date:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other dialysis acquisitions
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate Purchase Cost Allocations | The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of the noncontrolling interests assumed in these transactions:
|
Reconciliation of the Beginning and Ending Liability for Unrecognized Tax Benefits that Do Not Meet the More-Likely-than-not Threshold (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | |
---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
Income Tax Contingency [Line Items] | ||
Balance beginning | $ 8,138 | $ 30,693 |
Additions for tax positions related to current year | 2,052 | 1,515 |
Additions for tax positions related to prior years | 786 | 69 |
Reductions for tax positions related to prior years | (2,033) | (24,139) |
Balance ending | $ 8,943 | $ 8,138 |
Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 12 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
Sep. 30, 2011
|
Jun. 30, 2011
|
Mar. 31, 2011
|
Dec. 31, 2010
|
Sep. 30, 2010
|
Jun. 30, 2010
|
Mar. 31, 2010
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
||||||
Basic: | ||||||||||||||||
Income from continuing operations attributable to DaVita Inc. | $ 481,755 | $ 405,402 | $ 422,291 | |||||||||||||
Decrease (increase) in noncontrolling interest redemption rights in excess of fair value | 335 | (68) | (267) | |||||||||||||
Income from continuing operations for basic earnings per share calculation | 482,090 | 405,334 | 422,024 | |||||||||||||
Discontinued operations attributable to DaVita Inc. | (3,754) | 281 | 393 | |||||||||||||
Net income attributable to DaVita Inc. for basic earnings per share calculation | 478,336 | 405,615 | 422,417 | |||||||||||||
Weighted average shares outstanding during the period | 94,655,000 | 101,497,000 | 103,595,000 | |||||||||||||
Vested stock units | 3,000 | 7,000 | 9,000 | |||||||||||||
Weighted average shares for basic earnings per share calculation | 94,658,027 | 101,504,373 | 103,603,885 | |||||||||||||
Basic income from continuing operations per share attributable to DaVita Inc. | $ 1.60 | $ 1.48 | $ 1.05 | $ 0.98 | $ 0.71 | $ 1.16 | $ 1.06 | $ 1.05 | $ 5.09 | $ 3.99 | $ 4.07 | |||||
Basic net income per share attributable to DaVita Inc. | $ 1.59 | $ 1.45 | $ 1.05 | $ 0.98 | $ 0.71 | $ 1.16 | $ 1.05 | $ 1.05 | $ 5.05 | $ 4.00 | $ 4.08 | |||||
Diluted: | ||||||||||||||||
Income from continuing operations attributable to DaVita Inc. | 481,755 | 405,402 | 422,291 | |||||||||||||
Decrease (increase) in noncontrolling interest redemption rights in excess of fair value | 335 | (68) | (267) | |||||||||||||
Income from continuing operations for diluted earnings per share calculation | 482,090 | 405,334 | 422,024 | |||||||||||||
Discontinued operations attributable to DaVita Inc. | (3,754) | 281 | 393 | |||||||||||||
Net income attributable to DaVita Inc. for diluted earnings per share calculation | $ 478,336 | $ 405,615 | $ 422,417 | |||||||||||||
Weighted average shares outstanding during the period | 94,655,000 | 101,497,000 | 103,595,000 | |||||||||||||
Vested stock units | 3,000 | 7,000 | 9,000 | |||||||||||||
Assumed incremental shares from stock plans | 1,874,000 | 1,555,000 | 564,000 | |||||||||||||
Weighted average shares for diluted earnings per share calculation | 96,532,110 | 103,059,171 | 104,167,685 | |||||||||||||
Diluted income from continuing operations per share attributable to DaVita Inc. | $ 1.58 | $ 1.45 | $ 1.02 | $ 0.96 | $ 0.70 | $ 1.15 | $ 1.04 | $ 1.04 | $ 4.99 | $ 3.93 | $ 4.05 | |||||
Diluted net income per share attributable to DaVita Inc. | $ 1.56 | $ 1.42 | $ 1.03 | $ 0.96 | $ 0.70 | $ 1.15 | $ 1.04 | $ 1.04 | $ 4.96 | $ 3.94 | $ 4.06 | |||||
Anti-dilutive stock-settled awards excluded from calculation | 2,388,000 | [1] | 1,452,000 | [1] | 9,912,000 | [1] | ||||||||||
|
Long-term Debt - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified |
1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 19, 2010
|
Oct. 20, 2010
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
Oct. 20, 2010
Maximum
|
Oct. 20, 2010
Five Year Revolving Credit Facility
|
Oct. 20, 2010
Five Year Term Loan A
|
Oct. 20, 2010
Six Year Term Loan B
|
Oct. 20, 2010
Six Year Term Loan B
Minimum
|
Oct. 20, 2010
Five Year Revolving Credit Facility And Term Loan A
|
Oct. 20, 2010
Five Year Revolving Credit Facility And Term Loan A
Maximum
|
Oct. 20, 2010
Five Year Revolving Credit Facility And Term Loan A
Minimum
|
Aug. 26, 2011
Senior Secured Credit Facility
|
Oct. 20, 2010
Annual Principal Payouts 2011 To 2015
Six Year Term Loan B
|
Oct. 20, 2010
Semi Annual Payment, First Payment
|
Oct. 20, 2010
Semi Annual Payment, Second Payment
|
Aug. 26, 2011
Term Loan A-2
|
Dec. 31, 2011
Term Loan A-2
|
Dec. 31, 2011
Term Loan A-2
Maximum
|
Dec. 31, 2011
Term Loan A-2
Minimum
|
Aug. 26, 2011
Term Loan A-2
Quarterly Payment
|
Oct. 20, 2010
Senior Notes 6.375 Percent Due 2018
|
Dec. 31, 2011
Senior Notes 6.375 Percent Due 2018
|
Dec. 31, 2010
Senior Notes 6.375 Percent Due 2018
|
Oct. 20, 2010
Senior Notes 6.625 Percent Due 2020
|
Dec. 31, 2011
Senior Notes 6.625 Percent Due 2020
|
Dec. 31, 2010
Senior Notes 6.625 Percent Due 2020
|
Dec. 31, 2011
Senior Notes 6.625 Percent Due 2013
|
Nov. 19, 2010
Senior Notes 6.625 Percent Due 2013
|
Jun. 07, 2010
Senior Notes 6.625 Percent Due 2013
|
Dec. 31, 2011
Senior Subordinated Notes 7.25 Percent Due 2015
|
Nov. 19, 2010
Senior Subordinated Notes 7.25 Percent Due 2015
|
Dec. 31, 2011
Senior Notes Debt Agreement October 20 2010
|
Dec. 31, 2011
Term Loan A
|
Dec. 31, 2010
Term Loan A
|
Dec. 31, 2011
Term Loan A
Interest rate swap agreements
Contract
|
Dec. 31, 2011
Term Loan B
|
Dec. 31, 2011
Term Loan B
Interest rate cap
Contract
|
Dec. 31, 2011
Term Loan B
Interest rate cap
Maximum
|
Dec. 31, 2011
Term Loan A and Term Loan B
|
Dec. 31, 2011
Term Loan A and Term Loan B
Maximum
|
Dec. 31, 2011
Term Loan A and Term Loan B
Minimum
|
Dec. 31, 2011
Letter of Credit
|
Dec. 31, 2010
Cash Flow Hedging
|
|
Debt Instrument [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||
Increase for additional borrowings on revolving credit facility | $ 100,000 | ||||||||||||||||||||||||||||||||||||||||||||
Maximum borrowing capacity | 3,000,000 | 250,000 | 1,000,000 | 1,750,000 | 350,000 | 200,000 | |||||||||||||||||||||||||||||||||||||||
Periodic principal payment | 17,500 | 500 | |||||||||||||||||||||||||||||||||||||||||||
Annual principal payment | 2,000 | 500 | 50,000 | 65,625 | 17,500 | ||||||||||||||||||||||||||||||||||||||||
Debt instrument, cash tender offer | 557,644 | 730,827 | |||||||||||||||||||||||||||||||||||||||||||
Senior notes issued | 775,000 | 775,000 | |||||||||||||||||||||||||||||||||||||||||||
Debt instrument, final payment amount | 191,500 | ||||||||||||||||||||||||||||||||||||||||||||
Aggregate debt outstanding principal balances | 700,000 | 850,000 | |||||||||||||||||||||||||||||||||||||||||||
Loan payments description | The new Term Loan A-2 required a principal payment of $500 on December 31, 2011, and thereafter requires annual principal payments of $2,000 with a balance of $191,500 due in 2016, and bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a rating based step-down to 3.25%. | ||||||||||||||||||||||||||||||||||||||||||||
Senior notes, interest rate | 6.375% | 6.625% | 6.625% | 7.25% | |||||||||||||||||||||||||||||||||||||||||
Maturity period | 2016 | 2018 | 2020 | 2013 | 2015 | ||||||||||||||||||||||||||||||||||||||||
Floor rate | 1.00% | ||||||||||||||||||||||||||||||||||||||||||||
Interest rate margin | 3.50% | 3.25% | |||||||||||||||||||||||||||||||||||||||||||
Maximum right to request an increase in the borrowing capacity | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
Interest Rate Description | LIBOR (floor of 1.50%) plus 3.00% subject to a ratings based step-down to 2.75%. | LIBOR plus an interest rate margin of 2.75% until June 30, 2011 | |||||||||||||||||||||||||||||||||||||||||||
Debt Instrument Interest LIBOR Rate | 1.50% | 1.00% | 1.50% | 4.00% | |||||||||||||||||||||||||||||||||||||||||
Debt Instrument Interest Additional Interest Above LIBOR Rate | 3.00% | 2.75% | 2.75% | 2.75% | 2.25% | 3.50% | 3.25% | 2.50% | 3.00% | ||||||||||||||||||||||||||||||||||||
Amount due in 2011 | 87,345 | 50,000 | |||||||||||||||||||||||||||||||||||||||||||
Amount due in 2012 | 125,106 | 50,000 | |||||||||||||||||||||||||||||||||||||||||||
Amount due in 2013 | 176,910 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||
Amount due in 2014 | 676,293 | 150,000 | |||||||||||||||||||||||||||||||||||||||||||
Amount due in 2015 | 1,858,567 | 650,000 | |||||||||||||||||||||||||||||||||||||||||||
Amount due in 2016 | 1,662,500 | ||||||||||||||||||||||||||||||||||||||||||||
Credit Agreement compliance with financial covenants | The borrowings under the Credit Agreement are guaranteed by substantially all of the Company’s direct and indirect wholly-owned domestic subsidiaries and are secured by substantially all of the Company’s and its guarantors’ assets. The Credit Agreement contains customary affirmative and negative covenants such as various restrictions on investments, acquisitions, the payment of dividends, redemptions and acquisitions of capital stock, capital expenditures and other indebtedness, as well as limitations on the amount of tangible net assets in non-guarantor subsidiaries. However, many of these restrictions will not apply as long as the Company’s leverage ratio is below 3.50:1.00. In addition, the Credit Agreement requires compliance with financial covenants including an interest coverage ratio and a leverage ratio that determines the interest rate margins as described above. | ||||||||||||||||||||||||||||||||||||||||||||
Senior notes interest payment period | The New Senior Notes will pay interest on May 1 and November 1 of each year, beginning May 1, 2011 | ||||||||||||||||||||||||||||||||||||||||||||
Leverage ratio | 3.50 | ||||||||||||||||||||||||||||||||||||||||||||
Senior unsecured notes, interest payable date | --05-01 | --11-01 | |||||||||||||||||||||||||||||||||||||||||||
Debt redemption date | Nov. 01, 2013 | Nov. 01, 2014 | |||||||||||||||||||||||||||||||||||||||||||
Proceeds from issuance of debts | 4,300,000 | ||||||||||||||||||||||||||||||||||||||||||||
Proceeds from borrowings on Term Loan A and Term Loan B | 2,750,000 | ||||||||||||||||||||||||||||||||||||||||||||
Proceeds from the issuance of the senior notes | 1,550,000 | ||||||||||||||||||||||||||||||||||||||||||||
Payment of outstanding principal balances of existing senior secured credit facilities and accrued interest | 1,795,363 | ||||||||||||||||||||||||||||||||||||||||||||
Redemption of total amount of debt including principal and interest | 264,742 | 1,297,215 | |||||||||||||||||||||||||||||||||||||||||||
Cash tender premium | 38,933 | ||||||||||||||||||||||||||||||||||||||||||||
Date of Redemption | Nov. 19, 2010 | ||||||||||||||||||||||||||||||||||||||||||||
Premium paid on redemption | 6,677 | ||||||||||||||||||||||||||||||||||||||||||||
Fees, discounts and other expenses | 74,431 | 241,090 | 255,989 | 185,755 | |||||||||||||||||||||||||||||||||||||||||
Excess cash received | 823,000 | ||||||||||||||||||||||||||||||||||||||||||||
Amount paid for existing notes per 1000 principal amount | 1,019.06 | 1,038.75 | |||||||||||||||||||||||||||||||||||||||||||
Aggregate debt outstanding principal amount | 142,356 | 200,000 | 119,173 | ||||||||||||||||||||||||||||||||||||||||||
Redemption price of debt | 101.656% | ||||||||||||||||||||||||||||||||||||||||||||
Debt redemption price per thousand of the remaining outstanding balance | 101.656% | 103.625% | |||||||||||||||||||||||||||||||||||||||||||
Debt redemption charges and write-off of other finance costs | 4,127 | ||||||||||||||||||||||||||||||||||||||||||||
Debt refinancing and redemption charges | 74,382 | 70,255 | |||||||||||||||||||||||||||||||||||||||||||
Term Loan A, Term Loan A-2 and Term Loan B maturity date range | 12 months | 1 month | |||||||||||||||||||||||||||||||||||||||||||
Interest Rate Description | At December 31, 2011, the overall weighted average interest rate for the Term Loan A was determined based upon the LIBOR interest rates in effect for all of the individual tranches plus the interest rate margin. In January 2011, the Company entered into several interest rate swap agreements that had the economic effect of fixing all of the Term Loan A LIBOR variable component of the Company’s interest rate, as described below. At December 31, 2011, the Term Loan A-2 bears interest at LIBOR (floor of 1.00%) plus an interest rate margin of 3.50% subject to a ratings based step-down to 3.25%. At December 31, 2011, the Term Loan B bears interest at LIBOR (floor of 1.50%) plus a margin of 3.00% subject to a ratings based step-down to 2.75%. The Company is subject to these LIBOR-based floors until such time as the LIBOR-based component of the interest rate exceeds 1.00% on the Term Loan A-2 and 1.50% on the Term Loan B. At such time, the Company will then be subject to LIBOR-based interest rate volatility on the LIBOR variable component of its interest rate and the overall weighted average interest rate for the Term Loan A-2 and Term Loan B will then be determined based upon the LIBOR interest rates in effect for all individual tranches plus the interest rate margin. | ||||||||||||||||||||||||||||||||||||||||||||
Number of interest rate agreements | 9 | 5 | |||||||||||||||||||||||||||||||||||||||||||
Interest rate agreements, notional amount | 950,000 | 1,250,000 | |||||||||||||||||||||||||||||||||||||||||||
Fixed interest rate, lower limit | 4.05% | 1.59% | |||||||||||||||||||||||||||||||||||||||||||
Remaining outstanding debt | 483,000 | ||||||||||||||||||||||||||||||||||||||||||||
Fixed Interest Rate, Upper Limit | 4.70% | 1.64% | |||||||||||||||||||||||||||||||||||||||||||
Weighted average effective interest rate | 4.11% | 5.84% | |||||||||||||||||||||||||||||||||||||||||||
Interest rate margin in effect | 1.50% | 2.50% | |||||||||||||||||||||||||||||||||||||||||||
Interest rate agreements, expiration date | Sep. 30, 2014 | Sep. 30, 2014 | |||||||||||||||||||||||||||||||||||||||||||
Unrealized pre-tax losses in other comprehensive income | 10,900 | ||||||||||||||||||||||||||||||||||||||||||||
Undrawn revolving credit facilities | 350,000 | ||||||||||||||||||||||||||||||||||||||||||||
Weighted average effective interest rate | 5.28% | ||||||||||||||||||||||||||||||||||||||||||||
Overall weighted average effective interest rate | 5.27% | ||||||||||||||||||||||||||||||||||||||||||||
Interest expense | 230,953 | 172,265 | 176,100 | ||||||||||||||||||||||||||||||||||||||||||
Amortization of deferred financing costs | 10,137 | 9,342 | 9,655 | ||||||||||||||||||||||||||||||||||||||||||
Outstanding letters of credit | 52,297 | ||||||||||||||||||||||||||||||||||||||||||||
Senior notes | $ 1,550,000 | $ 1,550,000 | $ 775,000 | $ 775,000 | $ 775,000 | $ 775,000 |
Segment Reporting - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Segment Reporting Information [Line Items] | |||
Depreciation and amortization expense | $ 249,060 | $ 218,666 | $ 213,657 |
Dialysis and related lab services
|
|||
Segment Reporting Information [Line Items] | |||
Depreciation and amortization expense | 259,685 | 227,029 | 221,317 |
Total amount of expenditures for property and equipment | 425,228 | 271,559 | |
Other-Ancillary services and strategic initiatives
|
|||
Segment Reporting Information [Line Items] | |||
Depreciation and amortization expense | 6,943 | 6,701 | 7,079 |
Total amount of expenditures for property and equipment | $ 10,692 | $ 7,226 |
DaVita Inc. stock-based compensation and shareholders' equity (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the Status of Awards Under Stock-Based Compensation Plans and Agreements | A combined summary of the status of awards under the Company’s stock-based compensation plans, including base shares for stock-settled stock appreciation rights and shares subject to stock option and stock unit awards, is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Range of Exercise Prices |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the Weighted Average Valuation Inputs | A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of stock options and stock-settled stock appreciation rights granted in the periods indicated is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effects of Changes in DaVita Inc's Ownership Interest on Company's Equity | The effects of changes in DaVita Inc.’s ownership interest on the Company’s equity are as follows:
|
Consolidating financial statements
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidating financial statements |
The following information is presented in accordance with Rule 3-10 of Regulation S-X. The operating and investing activities of the separate legal entities included in the Company’s consolidated financial statements are fully interdependent and integrated. Revenues and operating expenses of the separate legal entities include intercompany charges for management and other services. The senior notes were issued by the Company on October 20, 2010 and are guaranteed by substantially all of its direct and indirect domestic wholly-owned subsidiaries. Each of the guarantor subsidiaries has guaranteed the notes on a joint and several basis. However, the guarantor subsidiaries can be released from their obligations in the event of a sale or other disposition of all or substantially all of the assets of such subsidiary, if such subsidiary guarantor is designated as an unrestricted subsidiary or otherwise ceases to be a restricted subsidiary, and if such subsidiary guarantor no longer guaranties any other indebtedness of the Company. Non-wholly-owned subsidiaries, certain wholly-owned subsidiaries, foreign subsidiaries, joint ventures, partnerships and third parties are not guarantors of these obligations.
Consolidating Statements of Income
Consolidating Balance Sheets
Consolidating Statements of Cash Flows
|
Derivative Instruments (Detail) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
|
---|---|
Interest rate swap agreements | Other long-term liabilities
|
|
Derivative [Line Items] | |
Interest rate swap agreements | $ 23,145 |
Interest rate cap | Other long-term assets
|
|
Derivative [Line Items] | |
Interest rate cap agreements | $ 1,381 |
Allocation of Income Tax Expense (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Income Taxes [Line Items] | |||
Continuing operations | $ 315,744 | $ 260,052 | $ 278,213 |
Discontinued operations | 675 | 187 | 252 |
Loss on discontinued operations | (693) | ||
Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations, Total | $ 315,726 | $ 260,239 | $ 278,465 |
Other Receivables (Detail) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
|
Dec. 31, 2010
|
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Other receivables | $ 269,832 | $ 304,366 |
Supplier rebates and other non-trade receivables
|
||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Other receivables | 195,426 | 238,156 |
Medicare bad debt claims
|
||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Other receivables | 57,232 | 46,250 |
Operating advances under management and administrative services agreements
|
||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Other receivables | $ 17,174 | $ 19,960 |
Long Term Debt (Detail) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
|
Dec. 31, 2010
|
---|---|---|
Debt Instrument [Line Items] | ||
Senior notes | $ 1,550,000 | $ 1,550,000 |
Acquisition obligations and other notes payable | 37,447 | 9,049 |
Capital lease obligations | 43,364 | 8,074 |
Total principal debt outstanding | 4,512,811 | 4,317,123 |
Discount on long-term debt | (7,842) | (8,381) |
Long-term Debt, Total | 4,504,969 | 4,308,742 |
Less current portion | (87,345) | (74,892) |
Long-term debt | 4,417,624 | 4,233,850 |
Term Loan A
|
||
Debt Instrument [Line Items] | ||
Senior Secured Credit Facilities | 950,000 | 1,000,000 |
Term Loan A-2
|
||
Debt Instrument [Line Items] | ||
Senior Secured Credit Facilities | 199,500 | |
Term Loan B
|
||
Debt Instrument [Line Items] | ||
Senior Secured Credit Facilities | $ 1,732,500 | $ 1,750,000 |
Leases - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
Year
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Leases Disclosure [Line Items] | |||
Facilities leased under non-cancellable operating leases term range, minimum | 5 | ||
Facilities leased under non-cancellable operating leases term range, maximum | 15 | ||
Facilities leased under non-cancellable operating leases renewal option range, minimum | 5 | ||
Facilities leased under non-cancellable operating leases renewal option range, maximum | 10 | ||
Rent expense under all operating leases | $ 296,051 | $ 266,849 | $ 248,154 |
Net book value of property and equipment under capital leases | $ 41,514 | $ 7,579 |
Summary of the Weighted Average Valuation Inputs (Detail) (Stock Options And Stock Appreciation Rights)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
Year
|
Dec. 31, 2010
Year
|
Dec. 31, 2009
Year
|
|
Stock Options And Stock Appreciation Rights
|
|||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term | 4.2 | 3.5 | 3.5 |
Expected volatility | 30.00% | 30.00% | 32.00% |
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Risk-free interest rate | 1.60% | 1.70% | 1.80% |
Scheduled Maturities of Long-term Debt (Detail) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
|
---|---|
Debt Instrument [Line Items] | |
2012 | $ 87,345 |
2013 | 125,106 |
2014 | 176,910 |
2015 | 676,293 |
2016 | 1,858,567 |
Thereafter | $ 1,588,590 |
Acquisitions
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions |
During 2011, 2010, and 2009, the Company acquired total dialysis and other businesses as follows:
The assets and liabilities for all acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company’s financial statements and operating results from the effective dates of the acquisitions. Acquisition of DSI Renal Inc. On September 2, 2011, the Company completed its acquisition of all of the outstanding common stock of CDSI I Holding Company, Inc., the parent company of dialysis provider DSI Renal Inc. (DSI), pursuant to an agreement and plan of merger for approximately $723,012 in net cash, plus the assumption of certain liabilities totaling approximately $6,541, subject to certain post-closing adjustments. DSI had 113 outpatient dialysis centers that provide services to approximately 8,000 patients in 23 states. The Company also incurred approximately $21,700 in transaction and integration costs during 2011 associated with this acquisition that are included in general and administrative expenses in the consolidated statements of income. The initial purchase price allocation for the DSI acquisition is recorded at estimated fair values based upon the best information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending issuance of the final tax returns.
The following table summarizes the assets acquired and liabilities assumed in the transaction and recognized at the acquisition date at their estimated fair values, as well as the estimated fair value of the noncontrolling interests in DSI at that date:
Amortizable intangible assets acquired in this acquisition had weighted average estimated useful lives of nine years. Of the goodwill recognized in this acquisition, approximately $262,000 is expected to be deductible for tax purposes over the next 15 years. The noncontrolling interests acquired as part of the acquisition are stated at fair value based upon a third-party appraisal that was informed by implied multiples used in conjunction with the acquisition of the DSI group, as well as the Company’s overall experience and contractual multiples typical for such arrangements. The operating results of DSI are included in the Company’s consolidated financial statements effective September 1, 2011. Other acquisitions During 2011, the Company acquired other dialysis related and other ancillary businesses consisting of 57 dialysis centers in the U.S., eight dialysis centers outside of the U.S. and one vascular access center for a total of $354,430 in net cash and deferred purchase price of $12,469. During 2010 and 2009, the Company acquired other dialysis businesses consisting of 41 centers and 19 centers for a total of $188,951 and $87,955, respectively, in cash and deferred purchase price obligations. The assets and liabilities for all acquisitions were recorded at their estimated fair market values at the dates of the acquisitions and are included in the Company’s financial statements and operating results from the effective dates of the acquisitions. The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of the noncontrolling interests assumed in these transactions:
Amortizable intangible assets acquired during 2011, 2010 and 2009 had weighted-average estimated useful lives of nine, nine and seven years, respectively. In 2011, 2010 and 2009, $352,674, $152,252 and $78,199 of goodwill was associated with the dialysis and related lab services business. In addition, in 2011 $36,170 of goodwill was associated with the other ancillary services and strategic initiatives. The total amount of goodwill deductible for tax purposes associated with these acquisitions for 2011, 2010, and 2009 was approximately $298,000, $154,000 and $72,000, respectively. Discontinued operations Pursuant to a consent order issued by the Federal Trade Commission on September 2, 2011, the Company agreed to divest a total of 30 outpatient dialysis centers and several home-based dialysis programs in order to complete the acquisition of DSI. In conjunction with the consent order, on September 30, 2011, the Company completed the sale of 28 outpatient dialysis centers to Dialysis Newco, Inc. (Dialysis Newco), a portfolio company of Frazier Healthcare VI, L.P. and New Enterprise Associates 13, Limited Partnership pursuant to an asset purchase agreement dated August 26, 2011. Effective October 31, 2011, the Company also completed the sale of two additional outpatient dialysis centers to Dialysis Newco that were previously pending state regulatory approval. The Company anticipates receiving total net cash consideration of approximately $82,000 for all of the outpatient dialysis centers that were divested. As part of this transaction, Dialysis Newco assumed specific liabilities related to the centers it acquired. All other liabilities were retained by the Company. The Company recorded a loss of approximately $4,756, net of tax, during the year ended December 31, 2011 related to the divestiture of its historical DaVita centers. The operating results of the historical DaVita divested centers are reflected as discontinued operations for all periods presented. In addition, the operating results of the DSI divested centers are reflected as discontinued operations in the consolidated financial statements beginning September 1, 2011. The results from discontinued operations related to the dialysis and related lab services segment were as follows:
Net assets of discontinued operations related to the dialysis and related lab services segment as of September 30, 2011, were as follows:
Pro forma financial information The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions and divestitures in 2011 and 2010 had been consummated as of the beginning of 2010, after including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.
|
Segment reporting (Tables)
|
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Segment Revenues, Segment Operating Income Loss and a Reconciliation of Segment Income to Consolidated Income Before Income Taxes | The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Assets by Segment | Summary of assets by segment is as follows:
|
Other liabilities (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Accrued Liabilities | Other accrued liabilities were comprised of the following:
|
Reconciliation between our Effective Tax Rate from Continuing Operations and the U.S. Federal Income Tax Rate (Detail)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Income Taxes [Line Items] | |||
Federal income tax rate | 35.00% | 35.00% | 35.00% |
State taxes, net of federal benefit | 4.10% | 3.90% | 3.70% |
Changes in deferred tax valuation allowances | (0.30%) | (0.10%) | 0.20% |
Other | 0.80% | 0.20% | 0.80% |
Impact of noncontrolling interests primarily attributable to non-tax paying entities | (4.20%) | (4.00%) | (3.00%) |
Effective tax rate | 35.40% | 35.00% | 36.70% |
Pro Forma Summary of Results of Operations (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
12 Months Ended | |
---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
Business Acquisition [Line Items] | ||
Pro forma net revenues | $ 7,309,901 | $ 6,983,641 |
Pro forma net income attributable to DaVita Inc. | 520,625 | 471,635 |
Pro forma income from continuing operations attributable to DaVita Inc. | $ 524,379 | $ 471,354 |
Pro forma basic net income per share attributable to DaVita Inc. | $ 5.50 | $ 4.65 |
Pro forma diluted net income per share attributable to DaVita Inc. | $ 5.39 | $ 4.58 |
Other receivables (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Receivables | Other receivables were comprised of the following:
|
Selected quarterly financial data (unaudited) (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data (Unaudited) |
|
Changes in Book Value of Goodwill (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Jun. 30, 2011
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
Goodwill [Line Items] | |||
Beginning balance | $ 4,091,307 | $ 3,951,196 | |
Acquisitions | 889,506 | 152,252 | |
Divestitures | (9,837) | (12,128) | |
Impairment charge | (24,000) | (24,000) | |
Other adjustments | (13) | ||
Ending balance | $ 4,946,976 | $ 4,091,307 |
VALUATION AND QUALIFYING ACCOUNTS (Detail) (Allowance for Doubtful Accounts, USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Allowance for Doubtful Accounts
|
|||
Valuation and Qualifying Accounts Disclosure [Line Items] | |||
Balance at beginning of year | $ 235,629 | $ 229,317 | $ 211,222 |
DSI Renal Inc. Acquisition | 16,193 | ||
Amounts charged to income | 198,750 | 171,250 | 161,786 |
Amounts written off | 200,229 | 164,938 | 143,691 |
Balance at end of year | $ 250,343 | $ 235,629 | $ 229,317 |
Amortizable Intangible Liabilities (Detail) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
|
Dec. 31, 2010
|
---|---|---|
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Alliance and product supply agreement commitment (See Note 22) | $ 68,200 | $ 68,200 |
Less accumulated amortization | (48,213) | (42,883) |
Alliance and product supply agreement, net | $ 19,987 | $ 25,317 |
Other comprehensive income (Tables)
|
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2011
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Charges and Credits to Other Comprehensive Income | Charges and credits to other comprehensive income have been as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Accumulated Other Comprehensive Income (Loss) | Changes in accumulated other comprehensive income (loss) has been as follows:
|
Accounts receivable
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
|||
Accounts receivable |
Approximately 16% and 15% of the accounts receivable balances as of December 31, 2011 and 2010, respectively, were more than six months old, and there were no significant balances over one year old. Approximately 2% of the Company’s accounts receivable as of December 31, 2011 and 2010, related to amounts due from patients. Accounts receivable are principally from Medicare and Medicaid programs and commercial insurance plans. |
Amortizable Intangibles - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
Finite-Lived Intangible Assets [Line Items] | |||
Net amortization expense | $ 17,568 | $ 15,064 | $ 14,739 |
Lease agreements which are amortized to rent expense | $ 361 | $ 480 | $ 565 |